data_1no8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1no8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.21 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -127.21 107.37 9.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.868 1.267 . . . . 0.0 110.413 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -108.91 105.56 15.16 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.283 1.833 . . . . 0.0 109.229 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.6 tp -89.51 132.86 34.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.775 2.03 . . . . 0.0 110.171 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.44 123.43 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.928 1.691 . . . . 0.0 109.379 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.3 m -127.01 160.38 31.3 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.774 1.629 . . . . 0.0 111.868 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.0 t30 54.37 46.34 25.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.519 1.928 . . . . 0.0 113.792 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 mt -78.48 157.29 28.95 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.151 1.381 . . . . 0.0 109.371 169.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.3 147.13 53.17 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.054 -1.029 . . . . 0.0 112.269 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -57.08 -28.8 62.93 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -81.8 -2.4 90.53 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.229 1.395 . . . . 0.0 115.375 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 80.9 t -66.78 140.19 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.122 1.461 . . . . 0.0 111.067 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.1 m -121.11 158.05 28.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.412 1.485 . . . . 0.0 112.694 -174.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.01 -57.34 10.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.345 1.858 . . . . 0.0 112.996 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.55 89.73 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.557 1.143 . . . . 0.0 113.242 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.11 -50.43 74.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.176 0.99 . . . . 0.0 112.099 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 mm -55.24 -52.18 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.124 0.97 . . . . 0.0 111.467 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -52.27 -51.74 56.75 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.846 0.859 . . . . 0.0 112.201 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -59.05 -53.39 58.94 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.98 1.312 . . . . 0.0 113.156 174.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.99 -43.16 99.55 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.29 0.95 . . . . 0.0 112.446 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -64.92 -41.73 95.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.73 -29.95 69.68 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.34 -57.08 12.65 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.068 0.947 . . . . 0.0 112.562 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -91.71 -16.68 26.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.95 -178.93 16.12 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.474 1.512 . . . . 0.0 114.84 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.57 107.46 12.44 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.448 1.899 . . . . 0.0 110.257 -169.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 pp -132.29 148.83 52.46 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -83.76 -51.49 7.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.725 2.41 . . . . 0.0 110.511 170.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.24 148.55 30.6 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.784 1.633 . . . . 0.0 111.374 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.61 131.83 23.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.902 1.281 . . . . 0.0 110.841 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.58 157.8 44.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.372 1.469 . . . . 0.0 113.063 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t . . . . . 0 N--CA 1.482 1.132 0 C-N-CA 126.486 1.914 . . . . 0.0 110.819 179.905 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.8 m -147.48 144.59 28.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.831 1.652 . . . . 0.0 109.708 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -143.44 163.03 34.24 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.498 1.519 . . . . 0.0 112.478 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -143.02 133.97 25.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.155 1.382 . . . . 0.0 110.848 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.62 118.24 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.192 1.397 . . . . 0.0 110.004 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -81.75 100.75 9.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.661 1.585 . . . . 0.0 108.266 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -80.29 154.88 27.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.171 1.788 . . . . 0.0 112.724 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.19 -30.65 58.1 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.832 1.253 . . . . 0.0 111.733 169.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -141.04 116.26 9.97 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.218 1.807 . . . . 0.0 111.249 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -28.63 68.77 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.84 -48.17 81.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.881 0.872 . . . . 0.0 111.972 171.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.79 -39.51 94.43 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.675 1.19 . . . . 0.0 112.214 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.07 83.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.376 1.071 . . . . 0.0 112.508 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.8 tp -59.36 -44.33 92.73 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.187 1.395 . . . . 0.0 111.746 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -51.33 -55.21 19.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.781 1.232 . . . . 0.0 110.955 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.97 -48.3 76.06 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.383 1.073 . . . . 0.0 112.846 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 25.8 ttt -51.18 -60.54 3.0 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.831 1.653 . . . . 0.0 111.399 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -56.84 -44.98 82.63 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.132 0.973 . . . . 0.0 112.695 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -59.77 -44.51 93.84 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.854 1.262 . . . . 0.0 113.545 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -109.9 -16.69 13.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -59.8 115.37 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.34 1.427 . . . . 0.0 111.196 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.33 -24.78 26.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.992 1.758 . . . . 0.0 114.026 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.05 132.96 90.03 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 124.594 1.158 . . . . 0.0 110.628 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.45 142.27 23.47 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.932 2.421 . . . . 0.0 112.44 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 64.6 tp -128.14 105.32 8.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.647 1.979 . . . . 0.0 107.694 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 49.27 57.74 6.15 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.402 1.481 . . . . 0.0 111.272 -169.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.21 -54.06 4.93 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.311 1.434 . . . . 0.0 113.48 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -59.87 119.25 39.48 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 126.43 1.892 . . . . 0.0 112.103 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.58 120.7 6.87 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.952 2.435 . . . . 0.0 111.29 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.0 mtm -65.07 138.53 58.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.309 1.044 . . . . 0.0 111.059 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -122.47 125.53 46.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.643 1.177 . . . . 0.0 110.062 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.3 mt -124.46 141.19 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.508 1.123 . . . . 0.0 111.671 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -139.69 146.04 39.14 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.701 2.0 . . . . 0.0 110.869 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 66.5 tp . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 125.244 1.418 . . . . 0.0 111.889 -176.415 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -78.03 96.22 5.04 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.1 0.96 . . . . 0.0 110.963 -174.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -88.59 101.17 13.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.353 1.861 . . . . 0.0 107.426 169.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.4 tp -88.21 133.73 33.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.585 1.954 . . . . 0.0 110.028 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.89 136.84 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.41 1.484 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.0 m -140.34 167.92 21.03 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.451 1.9 . . . . 0.0 111.934 -171.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.7 t30 51.44 46.81 25.93 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.346 1.858 . . . . 0.0 113.006 -173.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -87.12 167.1 14.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.845 1.658 . . . . 0.0 109.993 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -75.45 150.58 38.24 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.964 -1.085 . . . . 0.0 110.603 169.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -49.44 -41.77 40.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.504 1.121 . . . . 0.0 113.546 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.71 9.46 73.85 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.712 1.625 . . . . 0.0 115.761 -173.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.45 147.54 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.046 1.423 . . . . 0.0 109.528 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -129.94 155.61 45.78 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -45.75 -58.14 3.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.527 2.331 . . . . 0.0 112.101 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.63 80.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.38 1.472 . . . . 0.0 113.168 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.12 -52.55 65.24 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.51 1.124 . . . . 0.0 112.143 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.5 mm -57.81 -51.52 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.739 1.216 . . . . 0.0 111.229 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -48.46 -54.21 15.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.939 1.295 . . . . 0.0 111.918 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.3 -53.75 53.88 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.663 0.785 . . . . 0.0 112.75 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.15 -45.12 89.87 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.799 0.727 . . . . 0.0 112.567 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -64.71 -43.25 94.03 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.786 0.721 . . . . 0.0 112.382 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.24 -32.77 66.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.62 -41.67 81.8 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.205 1.002 . . . . 0.0 113.16 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -113.25 -10.14 13.37 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.67 162.14 28.65 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.816 1.198 . . . . 0.0 114.382 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.26 108.55 19.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.764 1.626 . . . . 0.0 110.087 -169.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.9 pp -130.91 152.93 49.69 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.2 mmmt -93.56 -49.39 5.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.998 2.919 . . . . 0.0 111.111 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -145.87 143.02 29.34 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.228 1.411 . . . . 0.0 111.28 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -126.94 135.9 51.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.677 1.591 . . . . 0.0 110.556 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.3 166.09 25.65 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.796 2.038 . . . . 0.0 111.7 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 N--CA 1.481 1.111 0 C-N-CA 125.942 1.697 . . . . 0.0 110.8 -173.866 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 65.4 p -139.19 156.37 47.16 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.684 1.193 . . . . 0.0 112.739 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.06 159.37 42.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.325 1.85 . . . . 0.0 111.378 172.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.63 115.03 9.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.734 1.614 . . . . 0.0 109.801 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.2 t -127.7 115.54 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.238 1.015 . . . . 0.0 110.249 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -80.83 104.75 11.55 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.366 1.467 . . . . 0.0 109.457 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -82.08 155.13 25.24 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.68 1.592 . . . . 0.0 112.163 171.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -80.46 -59.54 2.66 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.401 -0.812 . . . . 0.0 112.323 169.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -88.65 126.99 35.56 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.163 1.385 . . . . 0.0 111.441 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -46.13 89.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.127 1.371 . . . . 0.0 111.822 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.45 -46.22 87.0 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.761 1.224 . . . . 0.0 112.306 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -65.75 -36.61 84.04 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.061 0.945 . . . . 0.0 112.928 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.02 -48.17 83.03 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.291 -0.88 . . . . 0.0 111.936 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.96 -42.79 90.7 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.551 1.14 . . . . 0.0 112.377 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -51.74 -57.79 8.26 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.777 1.631 . . . . 0.0 110.427 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.11 60.48 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.725 1.21 . . . . 0.0 112.425 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 21.9 ttt -49.62 -62.45 1.55 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.162 1.385 . . . . 0.0 111.667 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -57.57 -49.16 77.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.622 1.169 . . . . 0.0 112.974 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -63.24 -48.01 80.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.868 0.867 . . . . 0.0 113.258 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.05 -13.74 24.91 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -60.28 108.27 0.77 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.87 1.214 . . . . 0.0 110.739 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 119.06 -30.63 5.78 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.345 1.926 . . . . 0.0 113.933 -173.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.4 134.57 90.96 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.168 1.387 . . . . 0.0 110.635 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.41 146.05 24.32 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.822 2.348 . . . . 0.0 113.334 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 37.3 tp -135.65 108.53 7.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.762 1.625 . . . . 0.0 108.425 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 50.16 63.25 2.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.694 1.597 . . . . 0.0 111.654 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.48 -63.05 4.53 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.174 1.369 . . . . 0.0 113.384 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -63.56 131.94 95.01 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.184 1.393 . . . . 0.0 112.408 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 123.61 9.38 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.749 2.966 . . . . 0.0 111.694 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.17 132.28 49.92 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.289 1.035 . . . . 0.0 111.55 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -110.14 130.38 55.55 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.2 1.4 . . . . 0.0 109.124 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.3 mt -128.59 143.37 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.846 0.859 . . . . 0.0 111.857 -169.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -140.06 146.18 38.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.243 2.217 . . . . 0.0 110.431 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.47 0.527 0 C-N-CA 125.099 1.36 . . . . 0.0 110.581 -179.073 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.04 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -102.94 119.59 39.12 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.14 1.376 . . . . 0.0 110.64 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 87.6 mt -127.34 131.72 50.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.494 1.518 . . . . 0.0 111.618 -171.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.9 tp -77.42 137.99 39.01 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.481 1.513 . . . . 0.0 109.091 169.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.9 122.75 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.324 1.85 . . . . 0.0 108.087 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.9 m -133.75 169.24 17.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.917 1.287 . . . . 0.0 112.937 -169.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.3 t30 54.81 46.18 25.07 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.788 2.035 . . . . 0.0 113.079 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 mt -82.37 165.59 20.16 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.485 1.514 . . . . 0.0 110.057 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.48 145.87 43.22 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.006 -1.058 . . . . 0.0 111.317 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -58.03 -26.37 62.35 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.59 -1.56 90.09 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.117 1.341 . . . . 0.0 115.477 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.4 138.39 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.229 1.514 . . . . 0.0 111.232 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.2 m -113.45 155.9 24.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.172 1.389 . . . . 0.0 113.124 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.05 -57.27 11.69 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.604 1.961 . . . . 0.0 112.991 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.29 93.45 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.214 1.005 . . . . 0.0 112.919 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -56.86 -50.42 72.52 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.294 -0.879 . . . . 0.0 111.853 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.1 mm -55.15 -53.38 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.446 1.098 . . . . 0.0 111.741 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -47.84 -59.47 3.3 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.611 0.765 . . . . 0.0 111.76 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -63.54 -43.28 97.57 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -47.0 81.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.743 1.156 . . . . 0.0 111.93 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -64.71 -40.69 95.78 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.99 -17.11 61.75 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.33 -59.03 3.11 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.915 -1.116 . . . . 0.0 111.786 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -88.16 -21.85 24.38 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.13 -178.31 15.26 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.652 1.596 . . . . 0.0 113.234 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.6 m -125.21 122.31 36.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.238 1.415 . . . . 0.0 109.549 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.66 147.09 52.33 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -91.2 -34.89 14.82 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.454 1.902 . . . . 0.0 110.949 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -137.16 142.35 42.2 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.962 1.305 . . . . 0.0 112.41 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.42 128.96 12.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.478 1.511 . . . . 0.0 109.992 169.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.0 153.25 37.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.666 1.186 . . . . 0.0 112.876 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.6 t . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 126.488 1.915 . . . . 0.0 110.009 173.383 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 N-CA-C 111.996 -0.441 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 55.6 p -133.7 146.21 50.6 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.315 1.446 . . . . 0.0 112.81 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.41 171.99 15.67 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.291 2.236 . . . . 0.0 111.35 -174.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -143.68 135.86 26.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.889 1.676 . . . . 0.0 110.46 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.51 129.23 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.585 1.154 . . . . 0.0 110.064 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -109.1 96.91 6.63 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.357 1.463 . . . . 0.0 108.889 173.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -73.03 140.41 47.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.005 2.122 . . . . 0.0 110.103 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.81 -16.97 63.37 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 28.8 mtm105 -134.82 134.12 40.49 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.224 1.81 . . . . 0.0 110.893 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -55.27 -46.63 76.13 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.208 1.403 . . . . 0.0 112.575 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.96 -51.56 61.06 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.256 1.022 . . . . 0.0 112.028 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.55 -41.39 98.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.626 1.17 . . . . 0.0 113.077 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.67 -56.56 17.88 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.692 1.197 . . . . 0.0 111.637 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.18 -42.28 90.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.254 1.422 . . . . 0.0 112.561 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -52.12 -61.69 2.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.162 1.385 . . . . 0.0 110.89 170.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.01 -47.86 67.99 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.657 1.183 . . . . 0.0 112.601 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 35.8 ttp -51.13 -60.72 2.81 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.411 1.484 . . . . 0.0 111.29 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -59.3 -45.04 92.38 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.87 1.268 . . . . 0.0 112.879 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -58.71 -48.37 81.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.483 1.113 . . . . 0.0 113.362 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -103.48 -17.33 15.26 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -60.85 111.13 1.53 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 120.273 1.397 . . . . 0.0 111.142 170.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.05 -22.46 27.44 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.146 1.831 . . . . 0.0 114.39 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 76.3 t -70.12 133.18 87.85 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 118.573 1.186 . . . . 0.0 110.83 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.14 139.14 21.13 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.898 2.398 . . . . 0.0 112.505 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.0 tp -126.65 106.16 9.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.671 1.988 . . . . 0.0 107.887 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 47.86 57.89 5.58 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.484 1.513 . . . . 0.0 111.321 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.64 -54.4 4.8 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.228 1.394 . . . . 0.0 113.468 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.44 119.07 43.33 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.962 1.705 . . . . 0.0 112.44 -172.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.09 117.83 5.36 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.884 2.389 . . . . 0.0 111.076 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.53 141.43 58.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.596 1.158 . . . . 0.0 111.906 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -122.91 130.86 53.37 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.326 1.45 . . . . 0.0 110.249 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.7 mm -117.48 133.35 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.533 1.133 . . . . 0.0 109.918 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -140.34 151.56 45.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.835 1.254 . . . . 0.0 112.684 -171.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.542 0.651 0 C-N-CA 126.839 2.056 . . . . 0.0 112.052 177.372 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -75.65 126.75 31.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.979 1.312 . . . . 0.0 111.74 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -137.69 111.45 8.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.514 1.926 . . . . 0.0 110.274 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.2 tp -85.52 132.78 34.14 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.769 2.028 . . . . 0.0 110.062 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.2 t -122.47 112.74 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.428 1.491 . . . . 0.0 108.447 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.7 m -117.91 164.13 15.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.311 1.044 . . . . 0.0 111.887 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 54.73 47.67 21.94 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.324 1.85 . . . . 0.0 114.217 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.28 152.41 32.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.907 1.283 . . . . 0.0 108.932 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.71 147.36 53.37 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.869 -1.144 . . . . 0.0 110.789 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -54.93 -28.68 52.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.488 1.115 . . . . 0.0 113.881 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.67 1.02 85.32 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.329 1.442 . . . . 0.0 115.779 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.6 t -66.7 114.75 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.926 1.863 . . . . 0.0 110.484 175.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.5 m -70.73 151.99 44.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.784 1.234 . . . . 0.0 112.598 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -55.18 -48.52 73.67 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.486 1.514 . . . . 0.0 112.751 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.19 76.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.221 1.408 . . . . 0.0 113.665 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -58.5 -53.86 53.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.116 0.966 . . . . 0.0 112.807 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.5 mm -54.59 -55.48 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.342 1.057 . . . . 0.0 110.999 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -49.34 -55.74 11.86 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.255 1.422 . . . . 0.0 111.875 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.43 -49.81 76.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.533 1.133 . . . . 0.0 113.311 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -43.92 95.83 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.215 0.916 . . . . 0.0 111.417 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -66.71 -44.98 80.17 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.862 1.265 . . . . 0.0 112.708 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.0 -14.42 54.0 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.78 -63.46 1.07 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.919 -1.113 . . . . 0.0 111.479 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -83.28 -21.11 33.38 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.4 -168.76 11.68 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.151 1.834 . . . . 0.0 112.921 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 m -140.91 129.23 22.37 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.42 1.088 . . . . 0.0 110.618 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -136.54 152.57 50.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -171.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -83.0 -51.81 7.23 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.74 2.416 . . . . 0.0 111.133 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -146.54 147.92 31.64 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.084 1.353 . . . . 0.0 112.387 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.36 137.55 27.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.954 1.702 . . . . 0.0 110.825 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.42 116.19 6.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.727 1.211 . . . . 0.0 112.557 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.48 1.054 0 C-N-CA 125.486 1.514 . . . . 0.0 109.755 169.791 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.833 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.2 m -150.5 153.06 35.16 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.64 1.576 . . . . 0.0 109.757 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.55 156.69 43.85 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.266 1.426 . . . . 0.0 112.513 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -123.2 131.67 53.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.816 1.646 . . . . 0.0 109.805 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.01 144.3 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.33 1.452 . . . . 0.0 109.722 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -126.29 102.78 7.33 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.99 1.716 . . . . 0.0 108.949 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -78.13 166.38 22.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.869 1.668 . . . . 0.0 112.706 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -61.31 -35.39 77.23 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.085 0.954 . . . . 0.0 112.796 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.74 147.03 34.93 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.44 1.496 . . . . 0.0 112.474 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -55.07 -46.02 75.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.437 1.495 . . . . 0.0 112.587 170.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -50.95 -48.11 60.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.395 1.078 . . . . 0.0 112.8 172.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.21 -39.17 82.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.1 0.96 . . . . 0.0 112.568 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.08 -45.85 86.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.72 0.808 . . . . 0.0 112.035 169.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.63 -44.15 96.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.372 1.469 . . . . 0.0 111.839 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -52.7 -54.54 32.16 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.185 1.394 . . . . 0.0 111.408 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.52 -51.67 58.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.772 1.229 . . . . 0.0 112.378 173.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 30.8 ttp -52.54 -62.4 1.67 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.581 1.552 . . . . 0.0 111.286 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -57.14 -45.15 83.79 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.742 1.217 . . . . 0.0 112.755 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.87 -46.69 89.6 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.351 1.06 . . . . 0.0 113.042 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -107.75 -12.28 15.25 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -169.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -59.23 119.54 7.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.294 1.406 . . . . 0.0 111.583 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.89 -18.22 57.54 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.019 1.771 . . . . 0.0 114.323 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -72.29 128.09 89.35 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 118.839 1.319 . . . . 0.0 111.077 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.12 136.16 71.0 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.943 3.096 . . . . 0.0 113.844 172.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.0 tp -133.77 103.46 5.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.495 1.518 . . . . 0.0 107.567 169.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 51.32 62.28 2.79 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.8 1.64 . . . . 0.0 111.08 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.86 -61.64 4.71 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.467 1.508 . . . . 0.0 113.343 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -65.09 125.2 88.77 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.681 1.592 . . . . 0.0 112.118 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.8 126.23 9.96 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.486 2.791 . . . . 0.0 111.631 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -68.29 120.54 14.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.312 1.045 . . . . 0.0 111.797 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -94.17 103.49 15.53 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.92 1.288 . . . . 0.0 108.921 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -113.5 134.23 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.311 1.045 . . . . 0.0 110.862 -169.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -142.59 123.0 13.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.534 1.534 . . . . 0.0 112.157 -171.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 169.637 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 CA-C-O 121.427 0.46 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -139.59 150.75 45.39 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.372 1.469 . . . . 0.0 112.08 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.5 mt -125.42 144.52 50.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.964 1.706 . . . . 0.0 111.204 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.5 tp -117.02 99.91 7.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.874 1.669 . . . . 0.0 107.579 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.21 129.18 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.594 1.557 . . . . 0.0 108.174 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.6 m -133.28 170.85 14.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.249 1.42 . . . . 0.0 111.947 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.3 t30 56.93 38.48 29.42 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.207 1.803 . . . . 0.0 113.269 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.07 165.31 20.72 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.294 1.437 . . . . 0.0 110.552 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.76 144.34 52.75 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.39 -0.819 . . . . 0.0 109.811 168.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -56.63 -33.68 66.54 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.94 27.76 16.35 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.499 1.523 . . . . 0.0 115.244 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.59 124.74 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 118.912 1.356 . . . . 0.0 109.652 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.8 m -72.0 135.21 46.31 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.548 0.739 . . . . 0.0 112.031 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.38 -47.74 80.87 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.493 1.117 . . . . 0.0 112.935 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.38 -46.91 76.5 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.689 1.196 . . . . 0.0 112.702 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.27 -48.03 81.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.179 0.992 . . . . 0.0 112.117 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 mm -55.37 -53.65 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.454 1.102 . . . . 0.0 112.087 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -50.16 -55.39 15.29 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.697 0.681 . . . . 0.0 111.474 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -56.66 -52.06 66.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.483 1.113 . . . . 0.0 113.228 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.31 -44.92 90.09 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.12 0.873 . . . . 0.0 112.367 -175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -63.48 -43.48 97.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.579 0.627 . . . . 0.0 112.557 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.2 -19.6 64.66 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.27 -63.24 1.12 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.185 0.994 . . . . 0.0 111.724 172.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.08 -19.17 44.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -138.32 -177.33 15.18 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.336 1.446 . . . . 0.0 113.959 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.7 m -124.62 116.11 21.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.512 1.525 . . . . 0.0 110.238 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.92 144.72 50.57 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -169.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -81.6 -42.71 19.67 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.947 2.099 . . . . 0.0 109.991 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -147.31 145.47 29.37 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.687 1.595 . . . . 0.0 111.915 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.16 114.7 7.62 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.894 1.677 . . . . 0.0 108.126 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.63 113.37 10.96 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.613 1.165 . . . . 0.0 112.165 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 125.325 1.45 . . . . 0.0 110.469 171.386 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.86 0 CA-C-O 120.437 -0.091 . . . . 0.0 113.025 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.5 p -136.79 158.73 43.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.199 1.4 . . . . 0.0 112.958 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.73 138.43 23.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.496 1.518 . . . . 0.0 111.849 172.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -106.92 124.9 50.29 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.578 1.951 . . . . 0.0 110.431 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.3 t -129.34 139.31 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.008 1.323 . . . . 0.0 110.115 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -128.96 120.33 25.91 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.919 2.088 . . . . 0.0 109.199 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -103.31 163.59 12.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.581 1.952 . . . . 0.0 113.341 -169.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.35 -36.13 58.36 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 169.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 42.5 mtm-85 -133.77 129.1 36.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.082 1.753 . . . . 0.0 111.278 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -54.68 -45.87 74.0 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.597 1.559 . . . . 0.0 113.083 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.65 -46.72 70.66 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.925 1.29 . . . . 0.0 112.801 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.08 -42.84 93.76 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.466 1.106 . . . . 0.0 112.696 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.22 71.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.707 0.803 . . . . 0.0 111.734 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.65 -47.03 80.66 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.535 1.134 . . . . 0.0 112.58 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -50.81 -58.96 4.66 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.863 1.265 . . . . 0.0 111.165 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.4 -48.12 62.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.355 1.062 . . . . 0.0 112.659 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -55.29 -65.55 0.57 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.071 1.348 . . . . 0.0 111.322 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -61.61 -34.11 75.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -64.05 -42.02 97.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.524 1.13 . . . . 0.0 113.403 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -110.66 -18.43 13.16 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -59.24 115.4 3.18 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.875 1.216 . . . . 0.0 111.19 170.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 103.78 -23.46 32.47 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.857 1.694 . . . . 0.0 114.403 -175.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.8 134.87 90.06 Favored Pre-proline 0 N--CA 1.477 0.924 0 CA-C-N 118.643 1.221 . . . . 0.0 110.216 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.35 141.85 29.29 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.671 2.248 . . . . 0.0 112.93 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -125.33 99.97 6.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.46 2.304 . . . . 0.0 106.855 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 44.02 70.53 0.31 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.992 1.717 . . . . 0.0 111.902 -169.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.6 -57.63 5.05 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.781 1.657 . . . . 0.0 113.531 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -65.76 122.76 82.33 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.996 2.119 . . . . 0.0 112.369 -172.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.79 123.87 10.15 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.867 2.378 . . . . 0.0 111.088 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.1 mtm -61.61 123.6 18.34 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.064 0.945 . . . . 0.0 111.091 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -106.83 104.89 14.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.236 1.414 . . . . 0.0 109.123 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.3 mt -106.76 130.31 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.144 0.978 . . . . 0.0 110.85 -172.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -109.43 147.08 33.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.531 1.933 . . . . 0.0 109.627 173.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 N--CA 1.47 0.533 0 C-N-CA 125.249 1.419 . . . . 0.0 112.386 -179.885 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.9 0 CA-C-O 120.823 0.124 . . . . 0.0 113.153 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -117.58 103.73 10.35 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.08 1.752 . . . . 0.0 109.626 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -88.55 105.37 17.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.575 2.35 . . . . 0.0 108.994 -173.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.1 tp -88.88 122.65 32.48 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.756 2.022 . . . . 0.0 109.983 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.8 t -112.11 136.55 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.101 1.76 . . . . 0.0 109.115 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.2 m -137.52 163.13 31.9 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.188 1.795 . . . . 0.0 112.307 -174.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.1 t30 57.01 33.5 23.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.933 2.093 . . . . 0.0 113.918 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.9 mt -72.0 159.03 34.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.139 0.975 . . . . 0.0 110.28 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.83 139.81 57.78 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.535 -0.728 . . . . 0.0 110.571 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.75 -20.9 62.33 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.82 11.9 62.59 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.717 1.627 . . . . 0.0 115.558 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.06 123.99 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.719 1.76 . . . . 0.0 110.33 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.6 m -81.84 149.13 28.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.445 1.098 . . . . 0.0 113.105 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.34 -54.11 50.56 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.85 1.66 . . . . 0.0 112.69 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -39.33 81.81 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.57 1.148 . . . . 0.0 112.951 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.43 -51.05 71.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.835 0.854 . . . . 0.0 111.979 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.9 mm -55.0 -53.06 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.922 0.889 . . . . 0.0 111.511 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.07 -55.32 15.34 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.796 0.839 . . . . 0.0 111.973 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -59.55 -50.96 71.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.964 1.306 . . . . 0.0 113.212 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -63.36 -43.55 97.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.271 0.941 . . . . 0.0 111.886 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -63.4 -44.99 93.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.062 0.545 . . . . 0.0 112.427 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.03 -31.87 67.42 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.5 -52.53 65.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.265 1.026 . . . . 0.0 112.77 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -95.59 -23.67 16.94 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.29 162.04 23.62 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.373 1.463 . . . . 0.0 114.458 -172.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 37.5 m -102.49 103.34 13.7 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.471 1.508 . . . . 0.0 110.424 -173.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -121.48 165.05 16.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 -35.88 2.85 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.776 2.431 . . . . 0.0 111.557 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -140.58 151.09 44.41 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.61 0.764 . . . . 0.0 111.924 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.25 141.89 35.82 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.738 1.615 . . . . 0.0 110.446 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -146.92 152.33 38.49 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.983 1.713 . . . . 0.0 111.608 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 N--CA 1.48 1.061 0 C-N-CA 126.1 1.76 . . . . 0.0 109.875 177.059 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 N-CA-C 113.344 0.098 . . . . 0.0 113.344 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 78.1 p -137.08 155.69 49.32 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.469 1.108 . . . . 0.0 112.257 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -143.69 158.81 43.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.417 1.487 . . . . 0.0 111.649 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -139.84 120.63 14.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.533 1.533 . . . . 0.0 110.135 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 51.5 t -124.52 118.7 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.143 1.377 . . . . 0.0 109.723 -174.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -93.04 105.55 17.64 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.712 1.205 . . . . 0.0 108.502 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -82.6 152.38 25.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.643 2.777 . . . . 0.0 112.103 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -62.93 -48.36 79.24 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.153 0.581 . . . . 0.0 112.276 170.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -123.92 138.44 54.48 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.854 1.262 . . . . 0.0 112.302 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -59.24 -46.75 87.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.559 1.544 . . . . 0.0 112.966 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.72 62.64 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.764 1.226 . . . . 0.0 113.484 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.51 -43.28 85.71 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.834 0.853 . . . . 0.0 112.32 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.87 -46.51 84.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.101 0.96 . . . . 0.0 112.514 170.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.85 -47.75 79.64 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.941 2.097 . . . . 0.0 111.182 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -51.65 -52.91 44.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.425 1.09 . . . . 0.0 111.841 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.1 -47.03 78.82 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.732 0.813 . . . . 0.0 112.845 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 41.1 ttp -53.1 -60.7 2.96 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.466 1.507 . . . . 0.0 111.454 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -35.64 80.95 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -61.63 -45.93 91.95 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.381 1.072 . . . . 0.0 113.166 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -106.11 -17.38 14.34 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 -169.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -59.65 114.75 2.9 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.204 1.366 . . . . 0.0 111.335 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.71 -23.47 26.02 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.178 1.846 . . . . 0.0 114.138 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 65.7 t -67.82 131.97 92.49 Favored Pre-proline 0 N--CA 1.476 0.866 0 CA-C-N 118.596 1.198 . . . . 0.0 110.886 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.92 121.54 5.46 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.309 2.673 . . . . 0.0 111.972 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 24.2 tp -77.55 79.2 4.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.196 1.399 . . . . 0.0 109.266 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 45.96 35.88 2.66 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.675 1.99 . . . . 0.0 113.633 -170.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 144.04 -79.94 0.24 Allowed Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.916 1.722 . . . . 0.0 112.561 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -64.11 127.06 91.46 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.172 1.389 . . . . 0.0 112.762 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.73 122.5 7.37 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.19 2.593 . . . . 0.0 111.788 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.1 mtm -66.73 136.19 55.13 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.048 0.939 . . . . 0.0 110.959 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -118.02 129.29 55.49 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.723 1.209 . . . . 0.0 109.735 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.5 mt -129.87 141.12 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.944 0.897 . . . . 0.0 112.282 -169.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -137.53 154.3 49.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.835 2.454 . . . . 0.0 110.482 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 64.8 tp . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 125.045 1.338 . . . . 0.0 111.493 -177.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.47 167.09 31.51 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 118.8 1.3 . . . . 0.0 112.628 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 89.5 mt -142.23 162.57 35.14 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.037 2.135 . . . . 0.0 111.678 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.8 tp -123.86 106.64 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.199 1.8 . . . . 0.0 106.917 168.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.94 129.39 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.8 m -129.78 171.9 12.21 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.68 1.192 . . . . 0.0 111.701 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.7 t30 50.77 65.07 1.58 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.876 1.671 . . . . 0.0 112.727 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.48 153.95 21.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.872 2.069 . . . . 0.0 109.685 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.44 143.81 57.46 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.737 -1.227 . . . . 0.0 110.588 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -53.4 -34.3 57.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.197 0.999 . . . . 0.0 113.567 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.23 9.0 78.67 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.343 1.449 . . . . 0.0 115.786 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.93 121.26 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.679 1.739 . . . . 0.0 109.919 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.8 m -72.78 146.31 46.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.459 1.104 . . . . 0.0 113.235 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.3 -58.32 8.78 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.798 1.639 . . . . 0.0 113.165 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.79 -37.19 78.42 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.957 0.903 . . . . 0.0 113.001 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.0 -52.31 66.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.815 0.846 . . . . 0.0 112.072 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.6 mm -54.04 -53.31 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.985 0.914 . . . . 0.0 111.318 169.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -52.32 -52.57 52.36 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.146 0.979 . . . . 0.0 112.092 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.84 -50.78 70.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.899 1.28 . . . . 0.0 113.435 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.6 -45.2 91.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.524 1.056 . . . . 0.0 112.275 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -63.0 -40.15 96.91 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.528 0.604 . . . . 0.0 112.37 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.48 -13.57 52.71 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -73.59 -61.67 1.75 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.906 -1.121 . . . . 0.0 111.252 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -85.68 -12.05 52.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.4 166.48 24.47 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.138 1.827 . . . . 0.0 112.883 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.4 m -111.99 97.72 6.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.573 1.549 . . . . 0.0 109.665 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 152' ' ' PHE . 3.7 pp -118.34 144.03 46.18 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -169.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.41 -48.62 15.09 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.803 2.041 . . . . 0.0 110.702 171.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -152.43 149.05 28.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.743 1.217 . . . . 0.0 112.362 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.58 130.41 24.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.591 1.556 . . . . 0.0 109.708 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.15 109.87 8.63 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.465 1.506 . . . . 0.0 111.544 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 N--CA 1.476 0.864 0 C-N-CA 126.18 1.792 . . . . 0.0 111.442 179.233 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 N-CA-C 113.743 0.257 . . . . 0.0 113.743 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.6 p -140.69 167.51 22.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.229 1.812 . . . . 0.0 111.179 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.45 125.9 12.4 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.28 1.432 . . . . 0.0 111.555 169.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.16 123.97 28.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.446 1.498 . . . . 0.0 109.849 170.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.7 140.38 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 118.907 0.776 . . . . 0.0 111.122 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -126.12 127.8 46.34 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.024 1.729 . . . . 0.0 110.176 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 131' ' ' LEU . 30.8 m-85 -110.6 158.83 18.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.19 2.196 . . . . 0.0 113.964 -169.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -76.26 -29.63 57.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.626 0.77 . . . . 0.0 112.858 170.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -141.27 129.38 22.1 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.466 1.506 . . . . 0.0 112.087 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -40.05 83.08 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.935 1.694 . . . . 0.0 112.914 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.81 -51.61 68.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.117 0.967 . . . . 0.0 112.334 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.49 -46.47 86.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.274 1.03 . . . . 0.0 112.059 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.6 -50.78 67.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.524 1.13 . . . . 0.0 112.374 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.48 -48.0 80.4 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.541 1.536 . . . . 0.0 112.102 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.25 -52.72 60.46 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.324 1.45 . . . . 0.0 112.319 172.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.87 -50.85 67.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.903 1.281 . . . . 0.0 112.011 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.9 ttt -52.19 -59.73 4.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.791 1.636 . . . . 0.0 112.032 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -51.98 -45.56 64.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.538 1.135 . . . . 0.0 112.557 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.31 -52.34 64.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.516 1.127 . . . . 0.0 113.063 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -95.82 -12.56 25.09 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -169.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -58.91 118.57 5.92 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.764 -1.21 . . . . 0.0 111.139 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.6 -16.74 54.55 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.54 1.543 . . . . 0.0 114.598 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 85.0 t -69.27 126.77 92.94 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 119.11 1.455 . . . . 0.0 110.702 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -60.16 136.93 72.08 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.773 2.982 . . . . 0.0 114.195 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 50.9 tp -136.87 101.33 4.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.503 1.521 . . . . 0.0 108.079 169.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 52.08 65.37 1.52 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.228 1.811 . . . . 0.0 111.986 -169.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.42 -65.5 4.11 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.784 1.183 . . . . 0.0 112.916 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -58.91 125.89 79.2 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.243 1.417 . . . . 0.0 112.22 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.74 127.37 12.26 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.241 2.628 . . . . 0.0 111.252 170.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.5 mtm -62.26 111.87 2.16 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.203 1.001 . . . . 0.0 111.401 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -93.2 91.56 7.33 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.362 1.465 . . . . 0.0 109.104 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 15.6 mt -89.91 138.54 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.425 1.09 . . . . 0.0 110.432 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -128.39 137.46 51.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.663 1.985 . . . . 0.0 110.875 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -170.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -85.86 116.23 23.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.897 1.279 . . . . 0.0 109.316 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.39 101.16 7.96 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.51 1.924 . . . . 0.0 109.095 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.3 tp -83.47 133.1 34.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.26 1.824 . . . . 0.0 109.985 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.3 81.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.847 2.059 . . . . 0.0 108.419 -173.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.6 m -79.72 158.14 27.0 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.72 1.208 . . . . 0.0 112.491 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.1 t30 57.89 64.65 1.48 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.381 1.872 . . . . 0.0 113.212 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.3 mt -98.38 -116.01 0.14 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.696 1.998 . . . . 0.0 108.738 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -149.34 148.27 29.31 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.313 1.845 . . . . 0.0 110.436 172.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -74.16 71.59 1.67 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.921 1.688 . . . . 0.0 111.442 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 152.19 7.69 0.11 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.388 1.47 . . . . 0.0 116.168 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.1 t -58.35 128.8 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.485 1.643 . . . . 0.0 110.513 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.2 m -70.06 147.51 49.95 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.322 1.049 . . . . 0.0 112.46 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.86 -57.86 10.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.508 0.723 . . . . 0.0 111.651 174.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.51 -39.32 67.48 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.886 1.275 . . . . 0.0 113.239 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.65 -58.16 9.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.111 0.964 . . . . 0.0 112.039 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.8 mm -56.73 -52.28 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.438 1.095 . . . . 0.0 111.407 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -48.56 -57.54 6.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.862 1.665 . . . . 0.0 111.549 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.17 -49.28 76.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.725 1.21 . . . . 0.0 113.229 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.34 -43.41 97.8 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.671 1.123 . . . . 0.0 112.167 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -63.09 -43.96 97.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.224 0.61 . . . . 0.0 112.312 172.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.44 -19.84 63.9 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.28 -61.54 1.73 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.971 -1.081 . . . . 0.0 111.887 173.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -80.41 -25.58 38.97 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.08 -175.05 13.61 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.334 1.445 . . . . 0.0 113.53 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.6 m -127.13 122.58 34.61 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.052 . . . . 0.0 110.99 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.4 142.02 51.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.648 1.179 . . . . 0.0 113.651 -170.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.52 -44.43 19.12 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.285 2.234 . . . . 0.0 110.953 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -148.47 151.7 35.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.975 0.91 . . . . 0.0 112.695 -175.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.54 150.5 42.22 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.669 1.587 . . . . 0.0 111.637 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.23 154.98 39.9 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.36 1.864 . . . . 0.0 111.766 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 124.427 1.091 . . . . 0.0 112.284 -174.772 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.01 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.4 m -157.67 152.07 24.86 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.928 2.491 . . . . 0.0 109.057 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -126.84 166.17 17.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.213 1.405 . . . . 0.0 111.991 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.45 133.77 23.11 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.453 1.501 . . . . 0.0 110.098 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.5 t -133.34 122.6 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.357 1.463 . . . . 0.0 109.877 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -91.55 110.03 21.34 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.488 -0.758 . . . . 0.0 109.912 169.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -80.84 149.7 29.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.047 2.139 . . . . 0.0 111.783 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.35 -19.96 63.85 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -139.05 128.57 24.45 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.542 1.937 . . . . 0.0 111.389 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -57.08 -49.23 76.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.042 1.737 . . . . 0.0 111.839 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.94 -44.57 70.75 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.489 1.116 . . . . 0.0 112.757 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -64.61 -39.66 94.12 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.66 1.184 . . . . 0.0 112.46 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.84 -45.64 91.76 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.175 0.59 . . . . 0.0 111.689 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.19 -46.67 88.92 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.335 1.454 . . . . 0.0 111.572 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -48.46 -53.87 16.33 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.005 1.722 . . . . 0.0 111.651 171.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.0 -47.95 81.48 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.883 0.873 . . . . 0.0 112.707 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 17.2 ttp -52.13 -60.56 3.05 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.537 1.535 . . . . 0.0 111.833 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.99 -36.25 80.93 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.677 0.791 . . . . 0.0 113.113 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -64.43 -44.54 90.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.351 1.06 . . . . 0.0 113.43 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.18 -15.83 14.57 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -169.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -60.8 113.11 2.32 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.204 1.366 . . . . 0.0 111.952 174.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.91 -21.91 32.91 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.852 1.692 . . . . 0.0 114.343 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.8 132.03 92.51 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 118.626 1.213 . . . . 0.0 110.533 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.56 145.83 18.74 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.954 2.436 . . . . 0.0 113.374 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.7 tp -135.54 115.1 12.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.196 2.198 . . . . 0.0 108.612 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 38.66 62.34 1.05 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.385 1.874 . . . . 0.0 113.57 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.59 2.16 90.6 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.282 1.42 . . . . 0.0 116.218 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -131.08 123.33 19.77 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.798 1.639 . . . . 0.0 112.155 -170.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.45 122.02 7.94 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.978 2.452 . . . . 0.0 111.225 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.5 mtm -64.21 130.49 44.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.261 1.025 . . . . 0.0 110.811 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -116.24 114.73 24.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.161 1.385 . . . . 0.0 109.427 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.8 mm -108.07 138.66 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.552 0.741 . . . . 0.0 111.273 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -135.99 140.81 44.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.918 1.687 . . . . 0.0 110.472 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.2 tt . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 125.166 1.386 . . . . 0.0 110.542 -170.632 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -137.43 131.03 31.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.2 1.0 . . . . 0.0 112.292 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -115.91 155.28 28.25 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.248 1.819 . . . . 0.0 110.465 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.5 tp -130.82 94.14 3.56 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.115 1.766 . . . . 0.0 106.976 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -69.7 127.49 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.8 m -128.91 171.31 12.43 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.128 1.371 . . . . 0.0 111.495 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.5 t30 58.79 30.3 19.87 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.258 1.823 . . . . 0.0 113.615 -169.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.47 162.61 26.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.529 1.131 . . . . 0.0 109.385 169.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -83.04 157.86 22.72 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.264 -0.897 . . . . 0.0 113.098 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -54.25 -37.22 64.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.599 1.159 . . . . 0.0 112.155 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.29 8.87 78.75 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.173 1.368 . . . . 0.0 116.318 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.2 130.72 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.762 1.781 . . . . 0.0 110.454 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.4 m -82.61 138.91 34.05 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.504 1.122 . . . . 0.0 112.302 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -56.78 -55.25 36.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.338 1.455 . . . . 0.0 113.395 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.46 80.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.899 0.88 . . . . 0.0 113.11 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.88 -51.39 70.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.826 0.851 . . . . 0.0 112.009 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.74 -52.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.263 1.025 . . . . 0.0 111.275 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -51.22 -55.28 18.86 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.745 0.818 . . . . 0.0 112.052 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.48 -50.73 72.68 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.678 1.191 . . . . 0.0 113.12 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.48 -45.27 91.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.379 0.991 . . . . 0.0 112.413 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -63.16 -40.89 98.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.836 0.744 . . . . 0.0 112.466 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.9 -13.21 61.46 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -71.81 -62.23 1.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.989 -1.069 . . . . 0.0 111.113 172.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -78.54 -35.46 46.1 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.61 173.18 15.47 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.489 1.518 . . . . 0.0 113.372 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.7 m -119.99 112.87 19.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.066 1.346 . . . . 0.0 109.432 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -135.07 151.6 50.91 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -169.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -73.6 -53.97 9.26 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.512 1.925 . . . . 0.0 110.426 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -154.05 153.17 31.44 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.4 139.46 45.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.529 1.932 . . . . 0.0 109.403 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.13 100.04 3.56 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.588 1.555 . . . . 0.0 111.646 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t . . . . . 0 N--CA 1.477 0.888 0 C-N-CA 125.098 1.359 . . . . 0.0 110.692 170.136 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.863 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 52.6 p -138.24 163.23 32.28 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.824 1.249 . . . . 0.0 113.261 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.4 116.05 9.16 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.086 1.754 . . . . 0.0 111.179 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -73.56 133.74 43.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.139 0.976 . . . . 0.0 108.74 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.4 t -136.07 123.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.942 0.897 . . . . 0.0 109.874 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -109.47 112.94 25.34 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.418 1.487 . . . . 0.0 109.759 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -90.28 158.61 17.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.92 2.488 . . . . 0.0 112.944 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.22 -41.44 85.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.305 0.642 . . . . 0.0 112.357 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -132.2 134.73 45.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.868 1.667 . . . . 0.0 111.196 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -66.64 -28.93 68.87 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.17 -46.75 88.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.999 0.92 . . . . 0.0 111.301 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.48 -40.98 96.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.205 1.002 . . . . 0.0 112.361 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.24 -58.22 7.82 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.343 1.057 . . . . 0.0 111.536 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -53.12 -48.38 67.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.032 1.733 . . . . 0.0 112.077 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -52.24 -55.87 18.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.745 1.218 . . . . 0.0 111.814 173.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.01 -46.03 75.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.5 1.12 . . . . 0.0 112.625 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -52.42 -62.8 1.41 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.169 1.388 . . . . 0.0 110.812 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.27 -36.51 77.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -66.67 -44.27 82.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.249 1.02 . . . . 0.0 113.467 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -105.63 -15.12 15.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -61.85 105.59 0.58 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.662 1.119 . . . . 0.0 110.519 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.21 -21.87 9.9 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.748 2.118 . . . . 0.0 114.298 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.5 t -79.26 131.85 64.6 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 118.653 1.227 . . . . 0.0 111.695 -170.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.52 138.87 66.54 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.465 3.443 . . . . 0.0 115.457 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -138.42 103.31 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.045 2.138 . . . . 0.0 106.371 169.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 52.78 60.42 3.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.512 1.525 . . . . 0.0 111.288 -168.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.76 -64.88 4.14 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.548 1.547 . . . . 0.0 113.178 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -62.03 135.77 94.91 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.818 1.647 . . . . 0.0 112.711 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.82 131.49 12.29 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.339 2.692 . . . . 0.0 112.238 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.3 mtm -62.88 132.56 52.54 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.96 0.904 . . . . 0.0 110.917 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -118.44 115.57 24.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.608 1.163 . . . . 0.0 108.459 171.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.6 mt -105.84 126.62 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.901 0.858 . . . . 0.0 112.215 -169.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -99.13 150.44 22.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.099 2.16 . . . . 0.0 109.483 169.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 124.52 1.128 . . . . 0.0 112.797 -179.361 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -81.76 93.66 6.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.994 0.918 . . . . 0.0 109.588 172.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -89.42 101.14 13.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.966 1.306 . . . . 0.0 108.795 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.7 tp -89.95 127.59 36.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.36 1.864 . . . . 0.0 109.816 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.62 127.83 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.472 1.509 . . . . 0.0 108.859 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.0 m -128.24 168.59 15.25 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.468 1.907 . . . . 0.0 111.066 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.3 t30 59.16 51.79 6.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.996 1.719 . . . . 0.0 112.555 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.4 mt -95.48 172.82 7.84 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.715 1.606 . . . . 0.0 110.287 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -139.84 158.01 44.79 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.204 -0.935 . . . . 0.0 112.779 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -57.48 104.03 0.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.688 1.195 . . . . 0.0 110.874 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.8 -45.25 0.62 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.696 2.093 . . . . 0.0 109.474 -169.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.6 t -64.39 134.79 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.238 1.015 . . . . 0.0 108.832 169.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 61.1 m -121.74 153.76 37.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.513 1.125 . . . . 0.0 112.155 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.28 -56.73 12.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.95 1.7 . . . . 0.0 112.542 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.56 -37.78 82.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.592 1.157 . . . . 0.0 113.319 174.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -63.3 -51.7 64.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.8 0.84 . . . . 0.0 111.551 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.5 mm -54.21 -52.91 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.405 1.082 . . . . 0.0 111.221 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -51.33 -53.94 31.16 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.109 0.963 . . . . 0.0 112.323 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -60.58 -51.46 69.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.689 1.195 . . . . 0.0 113.252 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -63.6 -44.28 94.45 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.164 0.893 . . . . 0.0 112.182 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -62.69 -43.71 98.12 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.61 67.96 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.57 -53.69 52.91 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.097 0.959 . . . . 0.0 112.789 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -95.93 -16.14 21.93 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -140.59 164.36 26.34 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.019 1.295 . . . . 0.0 114.414 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -104.26 111.17 23.68 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.924 1.29 . . . . 0.0 110.943 -172.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -129.3 145.66 51.33 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.49 1.116 . . . . 0.0 113.323 -171.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -87.63 -39.39 15.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.029 1.732 . . . . 0.0 111.1 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -144.26 146.85 32.89 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.469 1.108 . . . . 0.0 112.126 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -146.96 123.41 11.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.135 1.374 . . . . 0.0 110.818 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.22 155.73 42.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.701 1.2 . . . . 0.0 112.989 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 126.804 2.042 . . . . 0.0 110.207 178.074 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 N-CA-C 112.098 -0.401 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.7 m -146.96 148.98 32.3 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.157 1.383 . . . . 0.0 110.82 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.66 154.48 46.42 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.593 1.557 . . . . 0.0 111.647 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -128.48 124.63 36.61 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.656 1.583 . . . . 0.0 109.907 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.09 110.09 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 125.193 1.397 . . . . 0.0 108.683 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -82.47 92.62 7.09 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.998 1.319 . . . . 0.0 108.5 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -70.6 150.13 46.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.794 1.638 . . . . 0.0 111.265 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -74.82 -27.93 60.49 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 34.7 mtm105 -135.99 138.84 42.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.241 1.817 . . . . 0.0 111.16 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -67.08 -44.13 80.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.72 1.608 . . . . 0.0 112.086 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.12 -46.85 68.92 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.677 0.791 . . . . 0.0 112.319 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.56 -44.61 96.72 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.774 1.63 . . . . 0.0 112.26 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.77 87.69 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.183 0.993 . . . . 0.0 112.878 170.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.2 -38.81 84.45 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.557 1.543 . . . . 0.0 112.428 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -49.3 -61.89 1.84 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.531 1.133 . . . . 0.0 110.059 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.38 -47.54 72.56 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.806 1.242 . . . . 0.0 112.598 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -51.51 -61.2 2.39 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.415 1.486 . . . . 0.0 111.437 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -60.16 -44.75 94.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.921 0.888 . . . . 0.0 112.388 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.29 -44.25 92.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.258 1.423 . . . . 0.0 113.387 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -109.14 -14.56 14.49 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -60.27 115.68 3.69 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.48 1.491 . . . . 0.0 111.305 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.77 55.51 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.826 1.679 . . . . 0.0 114.546 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.29 130.68 79.56 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 118.9 1.35 . . . . 0.0 110.852 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.43 135.69 69.47 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.764 2.976 . . . . 0.0 114.9 174.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.1 tp -142.02 113.76 7.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.553 1.941 . . . . 0.0 108.184 169.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 49.4 61.42 3.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.405 1.482 . . . . 0.0 111.398 -169.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.58 -61.54 4.62 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.363 1.459 . . . . 0.0 113.364 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -67.26 140.24 95.31 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 125.319 1.447 . . . . 0.0 113.719 -172.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -73.15 125.92 10.71 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.99 2.46 . . . . 0.0 110.453 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 74.6 mtm -63.5 127.8 32.94 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.366 1.067 . . . . 0.0 111.849 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -105.16 119.32 38.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.566 1.146 . . . . 0.0 109.326 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.4 mt -118.94 139.85 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.939 . . . . 0.0 112.312 -169.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -134.37 147.5 50.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.405 2.282 . . . . 0.0 110.196 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 51.6 tp . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 124.78 1.232 . . . . 0.0 111.235 -176.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.174 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -74.36 130.28 39.37 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.072 0.936 . . . . 0.0 110.827 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.34 124.74 23.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.906 2.082 . . . . 0.0 109.317 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.4 tp -114.56 108.02 16.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.662 1.585 . . . . 0.0 110.488 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.6 t -92.07 129.52 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.328 1.451 . . . . 0.0 108.874 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.5 m -134.81 173.25 11.9 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.006 1.722 . . . . 0.0 111.87 -175.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.7 t30 55.51 35.8 25.85 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.304 1.841 . . . . 0.0 113.192 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.73 168.94 19.14 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.649 1.179 . . . . 0.0 110.428 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -65.96 155.23 37.17 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.23 -0.918 . . . . 0.0 111.679 171.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -50.99 -28.34 9.72 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.764 2.025 . . . . 0.0 114.697 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -145.69 55.57 0.54 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-N 119.151 0.887 . . . . 0.0 115.019 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.99 136.77 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 118.085 0.943 . . . . 0.0 109.766 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 52.1 m -69.83 138.31 52.5 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.582 -0.699 . . . . 0.0 112.134 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -60.31 -53.57 56.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.524 1.129 . . . . 0.0 112.648 -174.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.92 83.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.448 1.099 . . . . 0.0 112.688 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -56.51 -53.39 58.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.856 0.862 . . . . 0.0 112.248 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.2 mm -56.83 -53.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.845 0.858 . . . . 0.0 111.458 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -53.15 -53.76 45.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.015 0.526 . . . . 0.0 112.116 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.01 -50.47 73.96 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.945 1.298 . . . . 0.0 113.054 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.48 -46.35 90.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.653 1.115 . . . . 0.0 111.914 -176.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.85 -43.08 97.21 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.94 -21.09 66.77 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.98 -58.78 5.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.96 -1.087 . . . . 0.0 111.892 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -82.31 -35.58 27.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -110.12 161.77 12.84 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.585 1.564 . . . . 0.0 114.185 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.8 m -106.09 101.81 11.27 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.878 1.671 . . . . 0.0 109.68 -174.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -137.08 153.99 50.43 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -169.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -85.94 -50.96 6.68 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.642 2.377 . . . . 0.0 111.486 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.71 150.63 33.49 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.274 1.03 . . . . 0.0 113.07 -170.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.38 138.16 32.81 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 110.787 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.79 107.16 5.01 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.937 1.295 . . . . 0.0 112.23 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 125.898 1.679 . . . . 0.0 111.009 173.38 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.081 0 CA-C-O 120.016 -0.324 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.6 m -147.38 145.3 29.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.698 1.199 . . . . 0.0 111.438 -173.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -137.41 126.49 24.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.915 1.286 . . . . 0.0 111.735 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -93.45 126.85 38.81 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.052 1.341 . . . . 0.0 109.795 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.9 t -131.24 136.09 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.554 1.542 . . . . 0.0 110.164 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -118.05 98.85 6.53 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.212 1.805 . . . . 0.0 108.779 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -75.86 158.73 31.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.474 1.51 . . . . 0.0 111.938 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -70.41 -27.32 64.19 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.774 -0.579 . . . . 0.0 112.296 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -142.91 135.0 27.18 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.564 1.546 . . . . 0.0 112.674 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -53.87 -40.5 66.62 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.48 2.312 . . . . 0.0 112.518 170.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.33 -47.44 62.68 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.281 1.032 . . . . 0.0 112.656 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -71.26 -38.01 71.92 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.275 -0.89 . . . . 0.0 112.937 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.67 -47.08 74.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.77 0.828 . . . . 0.0 111.834 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.1 -48.12 79.4 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.382 1.473 . . . . 0.0 113.036 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -52.28 -53.33 45.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.264 1.026 . . . . 0.0 111.842 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.03 -50.34 69.32 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.199 0.999 . . . . 0.0 112.445 174.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -53.03 -63.15 1.24 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.137 1.775 . . . . 0.0 111.506 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -59.99 -36.85 78.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.693 0.797 . . . . 0.0 113.026 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -66.89 -52.16 46.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.747 1.219 . . . . 0.0 112.857 176.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -96.17 -16.3 21.56 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 -169.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -59.32 109.74 0.94 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 120.154 1.343 . . . . 0.0 111.178 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 113.25 -24.74 12.1 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 126.254 1.883 . . . . 0.0 114.231 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.35 133.69 89.22 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.873 1.269 . . . . 0.0 110.66 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.68 148.88 33.27 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.946 2.431 . . . . 0.0 113.12 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 42.2 tp -128.87 94.73 3.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.4 1.88 . . . . 0.0 109.194 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 46.56 50.65 12.68 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.442 1.897 . . . . 0.0 112.931 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 114.94 -78.3 0.27 Allowed Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.065 1.793 . . . . 0.0 112.779 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.35 135.7 75.99 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 126.328 1.851 . . . . 0.0 113.351 -176.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.06 126.83 10.85 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.096 2.531 . . . . 0.0 111.207 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.5 mtm -63.66 128.72 37.09 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.613 0.765 . . . . 0.0 110.135 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -116.61 119.91 37.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.341 1.056 . . . . 0.0 109.502 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -117.55 139.93 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.198 0.999 . . . . 0.0 111.749 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -131.27 144.54 51.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.93 2.092 . . . . 0.0 110.539 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 CA--C 1.545 0.754 0 C-N-CA 124.591 1.157 . . . . 0.0 110.426 175.812 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.172 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.01 154.65 44.21 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.625 1.712 . . . . 0.0 114.29 -178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.8 mt -120.97 118.69 30.51 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.86 2.064 . . . . 0.0 110.43 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.7 tp -82.45 109.04 16.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.0 t -92.22 83.26 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.103 1.761 . . . . 0.0 107.707 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.3 m -80.25 155.3 27.39 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.727 0.811 . . . . 0.0 112.101 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.28 79.12 0.23 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.762 2.025 . . . . 0.0 113.0 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -127.91 144.97 51.09 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.281 2.232 . . . . 0.0 109.641 171.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -77.2 151.39 35.24 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.84 -0.538 . . . . 0.0 112.358 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -57.87 -24.28 56.87 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.905 0.882 . . . . 0.0 113.337 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.85 -15.48 78.17 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 125.151 1.358 . . . . 0.0 115.792 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.21 123.21 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.585 1.693 . . . . 0.0 110.925 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 54.4 m -77.95 146.48 35.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.771 1.228 . . . . 0.0 111.982 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.78 -52.46 65.62 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.869 0.867 . . . . 0.0 112.013 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.28 62.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.753 1.221 . . . . 0.0 113.363 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.08 -55.51 34.13 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.978 0.911 . . . . 0.0 112.285 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.6 mm -55.8 -53.31 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.882 1.273 . . . . 0.0 111.082 172.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -48.97 -55.77 10.89 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.134 1.774 . . . . 0.0 111.696 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.61 -49.32 75.69 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.626 1.17 . . . . 0.0 113.379 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.23 -44.62 94.74 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.81 1.186 . . . . 0.0 112.204 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -62.09 -41.91 98.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.724 0.693 . . . . 0.0 112.227 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.29 -15.72 62.81 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.21 -60.1 2.4 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.878 -1.139 . . . . 0.0 111.533 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -81.31 -31.34 33.59 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.88 -177.57 15.23 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.644 1.592 . . . . 0.0 113.104 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.5 m -124.52 122.74 38.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.763 1.225 . . . . 0.0 110.057 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -132.37 146.94 52.33 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -78.49 -49.13 13.95 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.514 2.325 . . . . 0.0 110.986 171.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -148.12 146.11 28.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.49 1.516 . . . . 0.0 112.298 -170.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -132.47 139.67 48.07 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.245 1.818 . . . . 0.0 109.37 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.25 100.06 3.41 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.482 1.513 . . . . 0.0 111.695 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 N--CA 1.48 1.03 0 C-N-CA 125.253 1.421 . . . . 0.0 110.709 171.224 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.49 0 CA-C-O 121.494 0.496 . . . . 0.0 113.053 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.7 m -160.48 158.68 29.75 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.476 2.71 . . . . 0.0 108.473 -171.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.17 166.49 21.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.5 1.12 . . . . 0.0 112.651 174.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -125.52 129.49 49.86 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.541 1.936 . . . . 0.0 109.396 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.98 115.06 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.681 1.192 . . . . 0.0 109.058 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -100.57 112.65 25.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.579 1.551 . . . . 0.0 109.647 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -84.23 163.45 19.68 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.076 2.55 . . . . 0.0 113.29 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.5 -45.04 89.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.795 0.838 . . . . 0.0 111.653 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.4 mmt-85 -137.88 141.76 40.68 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.706 1.602 . . . . 0.0 111.328 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -60.09 -34.3 73.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.764 1.626 . . . . 0.0 113.284 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.88 -51.36 69.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.247 1.019 . . . . 0.0 112.243 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.63 -40.68 95.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.004 0.921 . . . . 0.0 112.083 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.17 -54.59 37.7 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.389 1.075 . . . . 0.0 112.007 170.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 67.4 tp -53.28 -49.93 65.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.173 1.389 . . . . 0.0 112.783 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -53.03 -51.43 61.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.001 1.32 . . . . 0.0 112.173 175.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.08 78.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.012 0.925 . . . . 0.0 112.755 172.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 4.7 ttp -54.01 -58.06 8.7 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.945 1.298 . . . . 0.0 112.017 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -33.67 73.37 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -68.23 -45.01 74.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.293 1.037 . . . . 0.0 113.159 176.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -103.7 -13.35 16.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -169.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -60.13 109.78 1.05 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.225 1.375 . . . . 0.0 112.04 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.32 -17.82 39.77 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.993 1.759 . . . . 0.0 114.586 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.98 132.71 86.43 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 118.854 1.327 . . . . 0.0 110.372 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.04 142.25 19.42 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.822 2.348 . . . . 0.0 112.804 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 61.2 tp -135.35 115.67 13.49 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.063 1.745 . . . . 0.0 108.448 169.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 49.24 57.64 6.26 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.364 1.465 . . . . 0.0 111.222 -169.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.68 -56.49 4.75 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.402 1.477 . . . . 0.0 113.303 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -58.15 117.51 20.36 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 127.349 2.259 . . . . 0.0 113.835 -173.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -60.02 118.21 5.06 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.356 2.704 . . . . 0.0 110.879 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.7 mtm -70.16 116.59 10.69 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.78 0.832 . . . . 0.0 110.862 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.99 94.72 9.41 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.076 0.951 . . . . 0.0 108.806 174.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.6 mm -86.34 129.18 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.323 0.649 . . . . 0.0 109.986 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -125.21 115.53 20.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.96 1.304 . . . . 0.0 111.0 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 CA--C 1.538 0.486 0 C-N-CA 125.64 1.576 . . . . 0.0 110.755 171.224 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.235 0 CA-C-O 121.829 0.683 . . . . 0.0 114.788 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -149.59 133.0 16.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.514 1.926 . . . . 0.0 109.808 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -137.79 105.27 5.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.935 1.694 . . . . 0.0 109.577 -170.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.9 tp -90.2 137.94 31.93 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.753 2.021 . . . . 0.0 110.039 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -130.61 127.48 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.918 1.287 . . . . 0.0 109.578 174.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.9 m -128.1 174.41 9.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.222 1.809 . . . . 0.0 110.872 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.2 t30 58.57 38.31 25.32 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.394 1.478 . . . . 0.0 112.467 -172.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.3 mt -88.73 -155.1 0.32 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.56 1.544 . . . . 0.0 109.497 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -138.96 151.7 47.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.543 1.537 . . . . 0.0 110.883 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -53.46 -24.61 13.32 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.74 -23.54 65.42 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 125.382 1.468 . . . . 0.0 115.234 172.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.35 141.54 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 118.906 1.353 . . . . 0.0 110.523 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 61.6 m -133.1 161.1 35.29 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.68 1.592 . . . . 0.0 111.788 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -53.86 -57.36 11.21 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.881 0.872 . . . . 0.0 113.2 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.61 72.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.828 0.851 . . . . 0.0 113.248 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.01 -55.56 33.41 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.066 0.946 . . . . 0.0 111.855 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.6 mm -55.49 -54.82 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.027 1.331 . . . . 0.0 111.227 172.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -47.9 -56.98 6.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.672 1.989 . . . . 0.0 111.441 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.06 -49.97 73.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.462 1.105 . . . . 0.0 113.259 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -62.41 -44.54 96.18 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.475 1.034 . . . . 0.0 112.07 -175.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -63.88 -43.47 95.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.412 0.685 . . . . 0.0 112.624 173.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.7 -20.93 62.26 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.58 -60.16 2.97 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.076 -1.015 . . . . 0.0 112.019 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -89.63 -21.33 22.86 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -174.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -134.7 -176.9 14.59 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.658 1.599 . . . . 0.0 112.885 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -127.38 129.17 47.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.279 1.032 . . . . 0.0 110.497 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.7 144.77 47.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.627 1.171 . . . . 0.0 113.801 -169.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -73.54 -50.57 20.67 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.938 2.095 . . . . 0.0 110.62 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -150.46 158.62 44.35 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.592 1.157 . . . . 0.0 112.87 -173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.43 155.69 46.88 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.005 1.722 . . . . 0.0 111.089 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.83 154.77 38.95 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.239 2.216 . . . . 0.0 110.672 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.9 t . . . . . 0 N--CA 1.48 1.047 0 C-N-CA 126.225 1.81 . . . . 0.0 110.401 -176.179 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.816 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 m -123.96 145.8 48.92 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.155 1.782 . . . . 0.0 110.969 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.68 150.94 46.73 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.867 2.067 . . . . 0.0 110.339 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -143.28 121.46 12.21 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.42 1.488 . . . . 0.0 110.028 -173.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 52.7 t -122.4 118.39 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.173 1.389 . . . . 0.0 109.514 -173.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -88.53 95.47 10.25 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -69.03 160.49 30.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.543 1.937 . . . . 0.0 112.957 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.78 -51.8 68.18 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.629 -0.669 . . . . 0.0 111.705 169.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.53 148.34 45.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.436 1.494 . . . . 0.0 112.523 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.89 -32.41 71.87 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.58 -49.73 76.37 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.109 0.964 . . . . 0.0 112.459 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.76 -37.91 89.2 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.12 0.968 . . . . 0.0 111.979 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.22 -46.61 85.56 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.874 0.87 . . . . 0.0 112.037 169.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.95 -49.98 72.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.479 1.512 . . . . 0.0 111.493 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -50.08 -54.33 21.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.46 1.504 . . . . 0.0 111.677 174.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.2 75.64 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.29 1.036 . . . . 0.0 112.803 173.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -54.76 -63.26 1.21 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.675 1.19 . . . . 0.0 111.422 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -59.57 -32.77 70.67 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -64.49 -51.09 64.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.693 1.197 . . . . 0.0 113.148 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -106.89 -11.07 15.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -169.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -61.86 117.1 5.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.341 1.428 . . . . 0.0 111.857 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 92.59 -12.44 69.77 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.025 1.298 . . . . 0.0 114.83 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 64.7 t -66.94 135.24 94.08 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 119.205 1.502 . . . . 0.0 109.858 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.3 145.97 31.06 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.793 2.329 . . . . 0.0 112.724 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.5 tp -122.27 92.5 3.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.259 1.824 . . . . 0.0 108.992 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 47.65 50.05 15.62 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.287 1.835 . . . . 0.0 112.715 -169.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 116.07 -75.62 0.27 Allowed Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.114 1.816 . . . . 0.0 112.885 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.61 131.81 85.64 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 126.264 1.826 . . . . 0.0 113.549 -175.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.13 130.09 13.86 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.256 2.638 . . . . 0.0 111.683 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -68.28 114.59 6.88 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.426 1.09 . . . . 0.0 111.401 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -86.16 103.35 14.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.224 1.009 . . . . 0.0 109.349 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.3 mt -99.96 137.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.832 0.853 . . . . 0.0 111.516 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -133.26 152.17 51.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.0 2.52 . . . . 0.0 110.671 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 123.969 0.908 . . . . 0.0 113.274 -169.737 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -134.13 133.62 41.25 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.457 1.129 . . . . 0.0 111.561 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.7 mt -117.04 120.01 37.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.995 1.718 . . . . 0.0 111.302 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.0 tp -84.22 129.29 34.9 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 t -119.4 137.84 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.888 1.275 . . . . 0.0 109.215 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.3 m -136.73 165.99 24.63 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.123 2.169 . . . . 0.0 111.416 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.7 t30 52.95 59.63 4.33 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.493 1.917 . . . . 0.0 113.119 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.9 mt -109.7 147.72 32.65 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.247 1.819 . . . . 0.0 107.92 169.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -78.6 156.43 29.12 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.286 -0.884 . . . . 0.0 112.595 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -52.35 -34.48 47.69 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.702 1.201 . . . . 0.0 112.472 169.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.86 -7.34 87.44 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.217 1.389 . . . . 0.0 116.31 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.93 119.09 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.903 1.852 . . . . 0.0 110.492 177.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.7 m -78.82 147.53 33.2 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.055 1.342 . . . . 0.0 112.844 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.21 -53.62 55.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.471 1.508 . . . . 0.0 112.807 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.17 79.11 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.407 1.083 . . . . 0.0 113.189 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.41 -52.32 66.1 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.934 0.894 . . . . 0.0 112.211 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.8 mm -55.89 -51.81 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.39 1.076 . . . . 0.0 111.342 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -50.48 -54.51 21.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.202 1.001 . . . . 0.0 111.952 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.46 -50.9 72.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.68 1.192 . . . . 0.0 113.32 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.52 -44.75 89.88 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.549 1.068 . . . . 0.0 112.743 -174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -62.62 -39.81 94.98 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.904 0.774 . . . . 0.0 112.209 173.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.25 -2.72 11.32 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 174.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.47 -62.04 1.69 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.819 -1.176 . . . . 0.0 110.779 170.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -76.82 -19.66 57.27 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -139.45 -162.42 9.11 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.442 1.496 . . . . 0.0 111.94 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.08 136.93 42.39 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 118.104 0.952 . . . . 0.0 111.709 175.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.89 147.17 46.3 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.548 1.139 . . . . 0.0 113.472 -170.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.21 -46.54 20.16 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.391 2.276 . . . . 0.0 111.291 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -149.25 145.71 27.23 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.474 1.11 . . . . 0.0 112.611 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.63 143.47 50.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.265 1.826 . . . . 0.0 110.194 169.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.38 99.9 3.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.441 1.496 . . . . 0.0 111.542 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.7 t . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 125.699 1.6 . . . . 0.0 111.59 175.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.392 0 CA-C-O 121.231 0.35 . . . . 0.0 113.823 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 81.8 p -142.09 172.65 12.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.762 2.425 . . . . 0.0 112.003 -173.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.08 164.4 38.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.893 1.277 . . . . 0.0 111.584 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -131.2 126.2 34.95 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.999 1.72 . . . . 0.0 109.503 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.85 114.07 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.175 0.99 . . . . 0.0 110.938 -171.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -89.94 104.24 16.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.919 1.687 . . . . 0.0 109.901 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -77.42 150.63 35.0 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.683 2.793 . . . . 0.0 113.108 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -61.84 -36.91 82.59 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 47.1 mtm-85 -135.79 129.67 32.85 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.724 2.01 . . . . 0.0 110.088 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -66.23 -29.86 70.2 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.93 75.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.965 0.906 . . . . 0.0 111.796 170.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -62.73 -39.16 93.2 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.861 1.264 . . . . 0.0 112.137 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.16 37.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.561 1.145 . . . . 0.0 112.068 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 64.9 tp -52.98 -48.55 67.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.261 1.424 . . . . 0.0 112.116 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -51.89 -59.58 4.16 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.534 1.533 . . . . 0.0 111.47 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.52 -48.78 62.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.909 1.283 . . . . 0.0 112.618 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.7 ttp -53.58 -61.83 2.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.296 1.438 . . . . 0.0 111.492 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -62.04 -35.52 78.84 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.94 -56.23 14.52 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.477 1.111 . . . . 0.0 113.181 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -91.9 -13.85 30.57 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -168.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -61.2 107.3 0.73 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.104 1.32 . . . . 0.0 110.531 169.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 114.51 -24.2 11.48 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.306 1.908 . . . . 0.0 114.311 -174.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.83 133.85 86.16 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.765 1.226 . . . . 0.0 110.694 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.3 142.66 21.52 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.846 2.364 . . . . 0.0 113.245 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 42.1 tp -133.76 110.08 9.56 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.779 2.032 . . . . 0.0 108.13 169.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 47.63 60.17 3.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.491 1.517 . . . . 0.0 111.731 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.93 -55.96 5.05 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.177 1.37 . . . . 0.0 113.302 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -59.33 121.78 58.86 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.067 1.747 . . . . 0.0 112.978 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 117.56 5.1 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.492 2.128 . . . . 0.0 110.177 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -64.17 133.43 52.89 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.44 1.096 . . . . 0.0 111.128 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -109.53 124.48 51.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.154 0.981 . . . . 0.0 109.804 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.8 mt -127.13 137.84 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.974 1.31 . . . . 0.0 110.924 -170.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -138.95 123.02 17.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.802 1.641 . . . . 0.0 111.331 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 42.5 tp . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.972 1.309 . . . . 0.0 111.25 171.671 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -147.89 126.89 12.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.099 1.449 . . . . 0.0 111.774 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.7 121.14 44.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.438 1.495 . . . . 0.0 111.608 174.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.0 tp -81.73 128.79 34.35 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 168.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.07 135.81 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.987 1.315 . . . . 0.0 108.388 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.55 170.37 16.19 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.525 1.53 . . . . 0.0 111.43 -176.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.2 t30 56.0 42.5 28.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.503 1.521 . . . . 0.0 112.611 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.0 mt -81.82 150.91 27.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.842 0.857 . . . . 0.0 110.03 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.07 140.26 35.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.513 0.725 . . . . 0.0 111.689 174.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -67.86 88.92 0.27 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.29 1.043 . . . . 0.0 109.539 170.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 156.93 -25.64 0.49 Allowed Glycine 0 CA--C 1.538 1.483 0 C-N-CA 127.073 2.273 . . . . 0.0 112.56 -169.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.1 t -58.3 118.01 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.87 1.268 . . . . 0.0 109.931 170.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 64.7 m -77.44 145.41 37.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.915 0.886 . . . . 0.0 112.714 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.28 -53.34 58.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.376 1.47 . . . . 0.0 112.633 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.18 87.5 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.44 1.096 . . . . 0.0 113.027 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.16 -47.96 83.75 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.622 0.769 . . . . 0.0 112.1 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mm -54.53 -53.19 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.903 0.881 . . . . 0.0 111.063 169.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -52.03 -54.0 35.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.485 0.584 . . . . 0.0 112.265 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.14 -50.72 72.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.712 1.205 . . . . 0.0 113.307 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.59 -45.46 90.28 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.122 0.874 . . . . 0.0 111.928 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -62.8 -44.36 96.37 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.573 0.624 . . . . 0.0 112.384 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.35 -31.52 65.81 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.82 -48.37 81.54 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.305 1.042 . . . . 0.0 112.666 174.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -101.43 -17.16 16.6 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -173.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -141.16 157.43 26.03 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 119.613 1.097 . . . . 0.0 114.25 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.6 m -96.55 109.46 22.05 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.98 1.312 . . . . 0.0 109.736 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.0 143.3 50.02 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.673 1.189 . . . . 0.0 114.001 -169.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.2 -48.64 19.66 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.686 2.394 . . . . 0.0 110.29 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -148.28 147.78 29.71 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.291 1.437 . . . . 0.0 111.933 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.34 122.14 13.5 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.23 1.412 . . . . 0.0 109.795 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.08 138.5 26.71 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.868 0.867 . . . . 0.0 112.671 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 N--CA 1.477 0.905 0 C-N-CA 126.417 1.887 . . . . 0.0 111.082 -174.757 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.336 0 N-CA-C 113.66 0.224 . . . . 0.0 113.66 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.3 p -136.39 167.74 20.77 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.568 1.947 . . . . 0.0 112.006 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.16 170.35 18.63 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.928 -1.108 . . . . 0.0 111.423 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -136.2 121.64 19.39 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.156 1.782 . . . . 0.0 108.676 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.0 t -120.46 114.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.469 1.108 . . . . 0.0 108.925 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -100.33 111.19 23.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.918 2.087 . . . . 0.0 108.719 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -92.12 167.25 12.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.49 2.716 . . . . 0.0 113.165 -174.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -61.98 -54.13 45.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.741 0.816 . . . . 0.0 111.139 169.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -141.02 147.29 38.45 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.06 1.744 . . . . 0.0 112.038 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -54.43 -30.35 52.31 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.894 1.678 . . . . 0.0 114.211 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.7 -55.1 36.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.418 1.087 . . . . 0.0 112.496 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.44 -36.15 80.63 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.638 -0.664 . . . . 0.0 112.303 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.76 -54.91 38.63 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.246 1.018 . . . . 0.0 111.891 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.7 mt -53.99 -47.68 71.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.125 1.37 . . . . 0.0 112.505 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -50.68 -58.35 6.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.95 1.3 . . . . 0.0 111.534 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.87 -49.1 69.25 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.727 1.211 . . . . 0.0 112.628 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 53.4 ttp -53.22 -59.26 4.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.511 1.524 . . . . 0.0 111.779 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -25.53 68.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -75.0 -48.77 22.45 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.983 0.913 . . . . 0.0 113.195 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -102.37 -11.59 18.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 -169.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -59.06 116.7 4.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.028 1.285 . . . . 0.0 111.403 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 100.89 -13.3 59.15 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.788 1.661 . . . . 0.0 114.732 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.7 t -71.47 128.58 89.82 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 119.258 1.529 . . . . 0.0 110.945 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.52 136.87 77.03 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.882 3.054 . . . . 0.0 114.375 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 35.5 tp -139.49 110.57 6.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.861 1.664 . . . . 0.0 108.344 169.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 49.54 60.5 3.74 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.439 1.496 . . . . 0.0 111.536 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.31 -63.64 4.39 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.136 1.351 . . . . 0.0 113.147 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.33 134.78 94.68 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.902 1.281 . . . . 0.0 112.804 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.51 127.14 12.19 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.31 2.673 . . . . 0.0 111.714 172.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -66.02 117.61 8.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.62 1.168 . . . . 0.0 112.094 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -85.49 115.67 23.35 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.2 mt -120.83 132.0 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.643 1.177 . . . . 0.0 110.668 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -144.63 124.77 13.67 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.435 1.494 . . . . 0.0 112.139 -169.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 12.2 tp . . . . . 0 CA--C 1.541 0.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.81 169.716 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -92.48 83.98 5.04 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.123 0.961 . . . . 0.0 109.907 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -80.46 128.7 33.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.19 2.196 . . . . 0.0 109.114 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.6 tp -121.32 109.75 15.29 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.643 1.577 . . . . 0.0 110.307 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.4 138.71 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.57 1.548 . . . . 0.0 109.11 170.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.6 m -139.06 168.38 19.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.988 2.115 . . . . 0.0 111.494 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.7 t30 55.69 41.39 30.48 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.311 1.845 . . . . 0.0 113.147 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.81 154.73 31.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.286 1.034 . . . . 0.0 110.314 169.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.61 144.98 55.29 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.524 -0.735 . . . . 0.0 111.197 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -73.11 68.99 1.0 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.732 1.213 . . . . 0.0 110.795 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.36 -11.86 0.06 OUTLIER Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.745 1.64 . . . . 0.0 115.587 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.05 119.87 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.72 1.76 . . . . 0.0 110.642 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -72.0 140.62 49.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.255 1.022 . . . . 0.0 112.893 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.85 -47.18 86.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.845 1.258 . . . . 0.0 112.501 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.96 -45.6 74.95 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.461 1.104 . . . . 0.0 112.694 172.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.95 -47.91 84.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.825 0.85 . . . . 0.0 111.991 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mm -53.46 -53.79 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.523 1.129 . . . . 0.0 111.921 170.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -50.7 -57.23 8.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.543 0.737 . . . . 0.0 111.222 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -56.0 -50.46 70.79 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.299 1.04 . . . . 0.0 113.16 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.69 -48.56 71.65 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.995 0.816 . . . . 0.0 112.23 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -63.82 -41.34 97.88 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.78 0.718 . . . . 0.0 112.664 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.58 -10.48 52.29 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -75.42 -60.97 2.07 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.863 -1.148 . . . . 0.0 111.314 172.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -81.26 -30.18 34.16 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.83 -169.76 13.21 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.722 1.63 . . . . 0.0 112.568 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 m -136.94 123.88 21.42 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.587 -0.949 . . . . 0.0 111.703 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 pp -128.63 145.84 51.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.235 1.414 . . . . 0.0 113.439 -170.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -82.48 -47.31 12.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.914 2.086 . . . . 0.0 111.298 173.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -145.89 149.98 35.27 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.391 1.076 . . . . 0.0 112.324 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.58 147.64 37.99 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.054 1.342 . . . . 0.0 111.599 169.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.58 109.58 4.3 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.457 1.503 . . . . 0.0 111.776 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.478 0.935 0 C-N-CA 124.742 1.217 . . . . 0.0 109.716 169.58 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 CA-C-O 120.527 -0.041 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.2 p -140.96 159.27 42.57 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.271 1.428 . . . . 0.0 111.773 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.87 119.59 11.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.714 1.205 . . . . 0.0 111.426 171.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.52 130.95 34.54 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.203 1.001 . . . . 0.0 109.965 172.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.19 117.66 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.681 1.593 . . . . 0.0 109.794 -174.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -87.96 101.23 13.55 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.931 0.892 . . . . 0.0 109.382 171.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -74.29 153.76 39.23 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.984 2.114 . . . . 0.0 112.015 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -62.66 -37.15 85.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 91.1 mmt-85 -141.26 141.21 33.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.51 1.524 . . . . 0.0 111.854 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -58.42 -42.9 88.29 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.572 1.549 . . . . 0.0 113.114 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.23 -51.8 61.0 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.191 0.997 . . . . 0.0 112.697 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.15 -42.28 99.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.195 0.998 . . . . 0.0 112.572 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.5 -47.22 79.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.318 1.047 . . . . 0.0 112.672 170.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.64 -46.99 88.2 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.567 1.547 . . . . 0.0 111.773 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -50.94 -56.44 12.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.818 1.247 . . . . 0.0 111.412 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.49 -50.98 61.66 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.22 1.008 . . . . 0.0 112.599 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 31.2 ttp -52.8 -62.43 1.65 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.754 1.622 . . . . 0.0 111.673 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -62.95 -37.33 86.62 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -65.09 -54.46 29.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.639 1.176 . . . . 0.0 112.557 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -90.59 -14.77 31.81 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -169.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.1 109.32 0.82 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 120.101 1.318 . . . . 0.0 110.923 169.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 116.74 -28.84 7.19 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 126.461 1.982 . . . . 0.0 113.923 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.12 134.2 85.38 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.121 1.368 . . . . 0.0 110.737 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.64 141.74 25.19 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.944 2.429 . . . . 0.0 112.721 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.2 tp -137.08 111.68 8.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.762 1.625 . . . . 0.0 108.734 169.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 50.69 60.16 4.06 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.756 1.622 . . . . 0.0 111.489 -169.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.01 -63.74 4.39 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.1 1.333 . . . . 0.0 113.195 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -63.91 135.03 96.13 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.737 1.215 . . . . 0.0 112.659 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.66 123.63 9.59 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.404 2.736 . . . . 0.0 111.105 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.7 mtm -62.88 129.77 41.88 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.076 0.95 . . . . 0.0 111.214 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -109.12 125.44 52.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.638 1.175 . . . . 0.0 108.291 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.29 138.64 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 118.823 0.738 . . . . 0.0 111.904 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -131.37 153.91 49.16 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.334 2.654 . . . . 0.0 109.978 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.8 tp . . . . . 0 N--CA 1.469 0.5 0 C-N-CA 124.839 1.256 . . . . 0.0 111.041 179.147 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -137.76 136.62 37.46 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.909 0.855 . . . . 0.0 112.671 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.76 141.05 44.43 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.129 0.972 . . . . 0.0 110.9 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.7 tp -110.67 115.51 29.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.917 2.087 . . . . 0.0 106.717 169.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.89 135.26 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.436 1.095 . . . . 0.0 110.017 -169.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 55.0 m -139.23 161.86 36.39 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.061 1.745 . . . . 0.0 112.246 -174.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.4 t30 51.11 43.26 29.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.294 2.238 . . . . 0.0 114.658 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.1 mt -78.69 164.87 24.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.264 1.426 . . . . 0.0 108.862 168.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.08 159.48 33.53 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.717 -1.239 . . . . 0.0 112.633 169.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -64.55 -41.4 96.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.585 1.554 . . . . 0.0 112.629 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.6 53.04 2.7 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.48 1.514 . . . . 0.0 112.791 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.5 t -116.11 113.74 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 126.038 1.735 . . . . 0.0 109.795 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -72.8 142.29 48.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.242 1.017 . . . . 0.0 112.26 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -56.65 -54.94 40.32 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.468 1.507 . . . . 0.0 112.316 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.31 -34.94 74.5 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.371 1.068 . . . . 0.0 113.567 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.48 -52.74 63.24 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.324 0.965 . . . . 0.0 111.465 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.1 mm -55.0 -52.7 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.343 1.057 . . . . 0.0 110.899 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -50.78 -56.29 12.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.976 0.91 . . . . 0.0 112.105 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -60.14 -48.22 82.62 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.106 1.362 . . . . 0.0 112.963 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -46.61 81.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.415 1.007 . . . . 0.0 112.121 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -60.6 -40.83 93.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.884 0.765 . . . . 0.0 112.048 173.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.5 -6.22 18.67 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -77.35 -59.83 2.62 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.755 -1.216 . . . . 0.0 111.231 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -84.46 -25.54 28.86 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -121.81 -179.58 16.02 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.657 1.599 . . . . 0.0 112.274 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.4 m -123.85 118.58 27.44 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.819 1.247 . . . . 0.0 110.223 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.76 165.08 26.76 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -169.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -93.25 -58.19 2.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.743 2.017 . . . . 0.0 111.176 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -157.93 142.67 16.42 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.408 1.083 . . . . 0.0 113.369 -172.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -105.64 155.71 18.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.658 1.183 . . . . 0.0 111.67 169.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -144.08 88.25 1.95 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.201 1.8 . . . . 0.0 110.1 173.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.476 0.857 0 C-N-CA 125.589 1.556 . . . . 0.0 110.743 178.091 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 CA-C-O 120.365 -0.131 . . . . 0.0 113.232 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.3 p -141.64 164.17 30.94 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.095 1.758 . . . . 0.0 110.967 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.1 167.26 30.44 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.231 -0.918 . . . . 0.0 112.693 169.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -130.84 132.73 45.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.417 1.887 . . . . 0.0 108.717 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.8 t -135.38 109.01 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 118.93 0.786 . . . . 0.0 111.148 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -73.84 123.35 24.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.118 1.367 . . . . 0.0 110.31 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.0 161.02 17.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.9 2.48 . . . . 0.0 112.92 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -59.19 -48.28 82.21 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.844 0.858 . . . . 0.0 112.577 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -143.2 152.73 42.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.364 1.866 . . . . 0.0 110.471 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -59.92 -43.94 94.62 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.186 0.994 . . . . 0.0 112.631 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.83 -46.58 71.22 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.357 1.063 . . . . 0.0 112.905 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.58 -48.44 79.42 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.211 1.404 . . . . 0.0 111.648 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.01 -48.33 73.51 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.195 1.398 . . . . 0.0 112.637 172.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.9 tp -53.29 -42.03 66.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.734 1.614 . . . . 0.0 113.101 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -51.2 -59.94 3.65 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.502 1.121 . . . . 0.0 111.437 171.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.9 -48.88 69.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.273 1.429 . . . . 0.0 112.482 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 21.0 ttp -51.6 -61.34 2.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.011 1.724 . . . . 0.0 111.563 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -56.36 -45.86 80.26 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.461 1.504 . . . . 0.0 112.353 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -58.4 -51.18 70.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.49 1.116 . . . . 0.0 113.176 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -97.73 -16.62 19.82 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -172.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -58.33 109.26 0.74 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 120.332 1.424 . . . . 0.0 111.388 171.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.56 -26.5 8.06 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.278 1.894 . . . . 0.0 114.041 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.78 135.0 95.35 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.065 1.346 . . . . 0.0 111.044 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.33 134.19 15.41 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.923 2.416 . . . . 0.0 111.708 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 63.5 tp -125.13 102.13 7.34 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.351 1.86 . . . . 0.0 108.196 175.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 44.32 62.04 2.16 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.005 1.722 . . . . 0.0 111.763 -169.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.83 -60.88 4.42 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.105 1.336 . . . . 0.0 112.995 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -60.46 118.94 38.76 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.858 1.663 . . . . 0.0 111.993 -172.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.07 118.85 5.82 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.902 2.401 . . . . 0.0 111.354 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.9 mtp -59.74 137.95 57.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.652 1.581 . . . . 0.0 112.013 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -121.08 131.51 54.31 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.731 1.212 . . . . 0.0 110.11 170.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.3 mt -131.07 137.35 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.258 1.023 . . . . 0.0 111.065 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -130.29 171.76 12.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 129.34 3.056 . . . . 0.0 109.912 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 171.527 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 CA-C-O 120.08 -0.289 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -83.53 99.33 10.07 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.057 0.928 . . . . 0.0 111.004 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 76.1 mt -75.83 108.83 8.96 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.682 1.193 . . . . 0.0 110.19 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.4 tp -80.66 125.21 29.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.784 1.233 . . . . 0.0 107.8 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.32 131.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.376 1.07 . . . . 0.0 109.135 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.7 m -135.01 168.8 18.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.763 1.625 . . . . 0.0 111.728 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.2 t30 51.65 56.5 7.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.059 1.744 . . . . 0.0 112.438 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.8 mt -101.12 151.7 21.51 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.297 1.839 . . . . 0.0 110.94 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -69.22 142.05 54.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.776 -0.577 . . . . 0.0 110.937 169.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -62.34 -16.84 56.79 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -78.43 -13.44 83.23 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.413 1.482 . . . . 0.0 115.092 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 80.4 t -66.47 136.34 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 119.26 1.53 . . . . 0.0 109.997 172.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 65.4 m -140.9 169.21 18.04 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.551 1.54 . . . . 0.0 112.355 -175.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -46.34 -58.1 4.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.703 2.001 . . . . 0.0 113.693 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.89 -49.45 71.18 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.989 0.916 . . . . 0.0 112.813 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.1 -49.53 76.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.728 1.211 . . . . 0.0 112.31 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mm -54.19 -55.55 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.839 1.255 . . . . 0.0 111.349 171.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -53.19 -53.46 50.27 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.776 0.716 . . . . 0.0 111.685 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -54.51 -51.51 64.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.859 0.864 . . . . 0.0 113.058 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -49.57 72.6 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.857 0.753 . . . . 0.0 112.555 -176.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -67.09 -38.49 85.8 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.72 -20.22 64.69 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.33 -66.45 0.54 Allowed 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.959 -1.088 . . . . 0.0 110.751 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -85.56 -17.93 34.85 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -172.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.57 -159.79 8.49 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.429 1.49 . . . . 0.0 112.862 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.1 m -144.83 133.89 22.69 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.292 1.046 . . . . 0.0 110.996 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.59 146.81 52.19 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.892 1.277 . . . . 0.0 114.365 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -74.39 -52.32 12.46 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.441 1.896 . . . . 0.0 110.194 169.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -149.03 158.84 44.5 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.23 160.67 37.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.072 1.749 . . . . 0.0 110.847 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.89 149.42 23.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.329 1.852 . . . . 0.0 110.699 170.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.48 1.057 0 C-N-CA 123.976 0.91 . . . . 0.0 110.803 176.006 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.131 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.0 p -146.45 150.18 35.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.773 2.029 . . . . 0.0 111.258 -170.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.32 167.87 23.22 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.202 1.801 . . . . 0.0 112.511 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -132.93 131.4 40.8 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.83 2.052 . . . . 0.0 109.668 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.1 t -132.92 109.33 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.529 1.132 . . . . 0.0 109.644 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -90.63 98.98 12.1 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.253 1.421 . . . . 0.0 110.064 -176.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -73.3 155.18 39.72 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.284 1.834 . . . . 0.0 114.249 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -68.72 -45.48 71.44 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.419 1.488 . . . . 0.0 112.088 171.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 -122.38 124.04 42.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.176 1.79 . . . . 0.0 110.325 -169.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -58.6 -47.27 84.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.843 1.257 . . . . 0.0 112.176 175.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.18 -48.31 61.96 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.35 1.06 . . . . 0.0 112.783 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -67.46 -35.43 79.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.679 1.191 . . . . 0.0 112.557 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.31 -45.56 92.95 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.037 0.935 . . . . 0.0 112.353 170.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -53.8 -49.93 67.23 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.709 1.141 . . . . 0.0 111.607 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -51.59 -58.2 7.0 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.409 1.084 . . . . 0.0 111.353 174.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -50.09 -51.93 38.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.106 1.362 . . . . 0.0 112.663 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 60.9 ttp -53.63 -62.69 1.49 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.548 1.539 . . . . 0.0 111.5 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -62.49 -37.58 86.55 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -64.03 -51.04 66.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.234 1.413 . . . . 0.0 112.687 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -99.0 -14.17 19.59 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -169.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -58.83 112.61 1.71 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.154 1.343 . . . . 0.0 111.226 170.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.57 -23.25 26.81 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.054 1.788 . . . . 0.0 114.371 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.7 t -73.15 135.51 79.76 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.887 1.275 . . . . 0.0 110.393 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.53 142.92 26.86 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.952 2.435 . . . . 0.0 113.068 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.5 tp -131.82 106.27 7.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.838 1.655 . . . . 0.0 107.852 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 50.65 61.22 3.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.755 1.622 . . . . 0.0 111.377 -169.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.53 -62.95 4.21 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.135 1.35 . . . . 0.0 113.311 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -65.43 128.49 93.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.844 1.258 . . . . 0.0 112.392 -172.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.91 122.92 9.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.725 2.95 . . . . 0.0 111.897 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.4 mtm -63.18 126.06 26.15 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.065 1.346 . . . . 0.0 111.831 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -103.19 113.5 27.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.986 1.315 . . . . 0.0 109.191 172.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mt -118.37 134.69 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.552 1.141 . . . . 0.0 111.484 -169.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -136.94 153.72 50.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.335 2.254 . . . . 0.0 110.089 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.2 tp . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 124.842 1.257 . . . . 0.0 111.453 -176.381 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.87 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -132.74 152.21 51.8 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.079 0.943 . . . . 0.0 111.957 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -129.05 101.64 6.14 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.137 1.775 . . . . 0.0 108.208 -169.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.6 tp -84.45 133.36 34.49 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.14 1.376 . . . . 0.0 109.394 175.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.5 t -122.05 130.48 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.85 1.26 . . . . 0.0 108.944 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -115.19 159.73 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.968 1.707 . . . . 0.0 110.474 172.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.3 t30 60.74 71.66 0.56 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.307 1.843 . . . . 0.0 112.227 -169.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.5 mt -131.33 154.6 48.39 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.873 2.469 . . . . 0.0 108.964 169.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -88.63 151.27 22.57 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.72 -0.613 . . . . 0.0 112.364 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -58.2 -28.07 64.46 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.187 -0.945 . . . . 0.0 112.294 172.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.97 -17.08 65.0 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.052 1.31 . . . . 0.0 115.467 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.99 116.67 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.419 1.609 . . . . 0.0 110.453 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.5 m -76.31 151.24 36.78 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.698 1.199 . . . . 0.0 111.852 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.51 -50.34 74.11 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.608 -0.683 . . . . 0.0 112.243 172.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 -38.91 59.86 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.06 -56.37 23.17 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.29 1.036 . . . . 0.0 112.231 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 23.6 mm -56.1 -53.89 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.197 1.399 . . . . 0.0 111.157 173.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -47.3 -57.77 4.86 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.829 2.052 . . . . 0.0 111.47 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -59.92 -50.97 71.7 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.506 1.122 . . . . 0.0 113.122 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.6 -45.2 93.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.402 1.001 . . . . 0.0 112.149 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -63.22 -44.24 95.84 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.433 0.693 . . . . 0.0 112.415 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.13 -18.56 63.57 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -69.46 -60.14 2.52 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.818 -1.176 . . . . 0.0 111.834 173.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -85.44 -22.76 28.15 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.06 -167.31 11.2 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.681 1.61 . . . . 0.0 112.735 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.2 m -136.81 129.3 30.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.082 0.953 . . . . 0.0 111.078 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.8 pp -130.06 144.49 51.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.88 1.272 . . . . 0.0 113.376 -169.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -75.17 -50.17 17.13 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.913 2.085 . . . . 0.0 110.497 169.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.94 154.79 38.86 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.78 1.232 . . . . 0.0 112.132 -172.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -138.58 151.72 47.54 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.446 1.499 . . . . 0.0 111.541 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.12 159.21 44.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.678 1.991 . . . . 0.0 110.903 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 124.266 1.026 . . . . 0.0 110.818 -177.494 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 CA-C-O 121.11 0.283 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 37.0 p -142.01 167.71 21.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.67 1.988 . . . . 0.0 113.548 -169.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.7 157.11 43.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.725 2.01 . . . . 0.0 110.618 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -140.14 126.89 20.51 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.982 1.313 . . . . 0.0 110.212 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 52.2 t -122.34 116.03 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.813 1.245 . . . . 0.0 109.033 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -83.32 105.65 14.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.023 1.329 . . . . 0.0 108.19 173.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -82.08 153.33 26.16 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.423 2.289 . . . . 0.0 113.079 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.76 -34.01 77.19 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.987 0.915 . . . . 0.0 113.409 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -138.15 146.34 42.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.486 1.514 . . . . 0.0 113.295 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -64.18 -45.63 87.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.791 1.636 . . . . 0.0 111.782 172.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.03 -49.48 60.42 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.47 1.108 . . . . 0.0 112.265 171.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.35 -40.83 90.08 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.622 1.169 . . . . 0.0 112.792 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.37 -49.4 74.55 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.582 1.153 . . . . 0.0 112.419 170.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 54.6 tp -57.04 -49.76 74.82 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.352 1.461 . . . . 0.0 111.884 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -50.1 -52.85 31.44 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.354 1.461 . . . . 0.0 111.434 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.96 -50.86 69.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.017 0.927 . . . . 0.0 112.519 173.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -54.5 -60.23 3.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.376 1.07 . . . . 0.0 112.17 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -37.19 75.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -69.17 -43.83 73.45 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.161 0.984 . . . . 0.0 112.906 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -108.42 -8.41 15.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -169.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -58.46 116.43 3.64 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 120.054 1.297 . . . . 0.0 111.459 171.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.58 -21.54 44.72 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.869 1.7 . . . . 0.0 114.575 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.28 136.67 88.93 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 118.72 1.26 . . . . 0.0 110.451 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.8 143.57 29.95 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.725 2.284 . . . . 0.0 113.197 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -131.67 106.76 8.36 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.301 2.24 . . . . 0.0 107.015 171.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 48.0 61.67 2.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.336 1.454 . . . . 0.0 111.494 -169.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.39 -53.92 4.71 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.254 1.407 . . . . 0.0 113.483 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -59.47 119.17 37.35 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.522 1.929 . . . . 0.0 112.779 -174.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.54 120.73 7.65 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.619 2.212 . . . . 0.0 110.726 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.5 mtm -67.3 116.96 8.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.982 1.313 . . . . 0.0 112.13 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -89.59 101.43 14.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.264 1.025 . . . . 0.0 108.941 170.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.4 mt -103.89 139.81 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.275 1.03 . . . . 0.0 111.827 -170.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -134.27 126.61 30.13 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.415 1.886 . . . . 0.0 111.191 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 124.769 1.228 . . . . 0.0 109.874 169.647 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 N-CA-C 112.629 -0.188 . . . . 0.0 112.629 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -149.08 130.59 14.84 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.576 -0.955 . . . . 0.0 111.519 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 41.9 mt -119.43 121.24 39.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.018 1.727 . . . . 0.0 111.879 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.9 tp -86.05 116.01 24.0 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 168.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 49.1 t -101.83 131.05 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 108.134 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.2 m -138.78 167.84 21.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.762 1.625 . . . . 0.0 112.318 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.7 t30 52.84 46.88 25.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.005 1.722 . . . . 0.0 112.948 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.9 mt -90.76 164.34 14.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.766 1.227 . . . . 0.0 109.59 169.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.93 150.88 47.93 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.392 -0.817 . . . . 0.0 110.652 169.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -58.07 -20.82 42.48 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -128.78 39.76 1.81 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.879 1.228 . . . . 0.0 115.812 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.58 131.8 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.367 1.583 . . . . 0.0 109.276 169.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.1 m -69.92 138.92 52.81 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.487 0.715 . . . . 0.0 112.344 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.87 -52.16 66.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.068 1.347 . . . . 0.0 112.309 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.87 -40.47 80.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.98 1.312 . . . . 0.0 113.092 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.61 -52.35 65.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.9 0.88 . . . . 0.0 112.127 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.1 mm -55.11 -52.86 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.949 0.9 . . . . 0.0 111.266 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -51.89 -52.45 49.68 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.925 0.89 . . . . 0.0 112.294 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -60.43 -51.97 67.23 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.031 1.332 . . . . 0.0 113.27 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.19 -43.54 97.93 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.337 0.972 . . . . 0.0 112.22 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -62.16 -44.87 95.65 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.533 0.606 . . . . 0.0 112.022 172.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.69 -32.64 67.55 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.62 -47.3 86.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.198 0.999 . . . . 0.0 112.874 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -100.82 -15.86 17.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.92 155.1 25.75 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.641 1.115 . . . . 0.0 114.033 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.7 m -91.53 99.23 12.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.858 1.263 . . . . 0.0 110.006 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 pp -111.47 141.82 44.53 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.296 1.038 . . . . 0.0 113.742 -171.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -82.22 -46.25 13.97 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.153 2.581 . . . . 0.0 110.427 170.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -146.12 144.99 30.34 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.395 1.478 . . . . 0.0 111.481 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.62 121.96 11.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.378 1.471 . . . . 0.0 110.447 171.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.08 139.86 30.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.624 1.17 . . . . 0.0 112.704 -176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.481 1.091 0 C-N-CA 126.363 1.865 . . . . 0.0 111.159 -173.461 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 N-CA-C 112.159 -0.377 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.9 p -144.16 163.53 33.34 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.759 1.623 . . . . 0.0 111.416 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.73 168.49 20.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.635 1.174 . . . . 0.0 111.405 170.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -135.18 118.81 17.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.162 1.785 . . . . 0.0 108.828 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.61 116.65 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.239 1.016 . . . . 0.0 110.093 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -101.83 124.93 48.29 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.643 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -103.23 154.7 19.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.951 2.9 . . . . 0.0 113.042 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -68.78 -29.75 68.19 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.905 1.282 . . . . 0.0 113.63 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -138.38 136.06 35.94 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.248 1.419 . . . . 0.0 113.018 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.41 -53.55 56.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.403 2.281 . . . . 0.0 112.449 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.44 -45.37 84.78 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.191 1.397 . . . . 0.0 112.415 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.83 -38.91 92.56 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.504 -0.748 . . . . 0.0 112.567 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.96 51.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.282 0.633 . . . . 0.0 111.337 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.26 -50.22 59.65 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.5 1.92 . . . . 0.0 112.334 174.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -50.68 -59.99 3.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.805 1.642 . . . . 0.0 111.206 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.65 -46.47 70.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.381 1.073 . . . . 0.0 112.393 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.5 ttp -52.83 -59.48 4.45 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.957 1.303 . . . . 0.0 111.839 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -55.53 -50.45 69.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.217 1.007 . . . . 0.0 112.273 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -59.03 -46.34 88.46 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.851 1.661 . . . . 0.0 113.115 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -100.81 -14.81 17.85 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -60.53 106.26 0.53 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.001 1.273 . . . . 0.0 111.178 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.33 -27.33 7.37 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 126.569 2.033 . . . . 0.0 114.087 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 64.2 t -68.88 132.77 90.43 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.06 1.344 . . . . 0.0 110.876 -174.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.1 145.87 22.32 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.902 2.401 . . . . 0.0 113.39 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.8 tt -130.5 108.18 9.76 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.111 2.165 . . . . 0.0 107.32 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 44.0 57.04 4.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.936 1.694 . . . . 0.0 112.048 -169.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 87.9 -51.12 4.03 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.985 1.278 . . . . 0.0 113.706 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -62.8 119.38 50.77 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.54 1.536 . . . . 0.0 111.448 -174.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.29 118.55 5.74 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.831 2.354 . . . . 0.0 110.924 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.61 127.34 31.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.091 0.956 . . . . 0.0 110.957 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -100.78 131.11 46.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.524 1.13 . . . . 0.0 109.036 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.1 mm -124.1 135.51 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.788 0.835 . . . . 0.0 109.946 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.22 117.76 19.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.344 1.458 . . . . 0.0 110.674 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 39.7 tp . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 124.754 1.222 . . . . 0.0 110.147 169.967 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.173 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.36 112.79 19.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.709 1.203 . . . . 0.0 111.522 179.029 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.5 117.88 23.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.842 2.457 . . . . 0.0 108.53 178.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.3 tp -105.69 125.62 51.2 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.808 2.043 . . . . 0.0 110.484 -176.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.6 t -112.78 125.44 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.148 1.779 . . . . 0.0 109.195 179.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.6 m -120.92 163.08 18.78 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.858 2.063 . . . . 0.0 110.909 177.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.7 t30 51.62 57.0 7.03 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.124 1.369 . . . . 0.0 111.281 -169.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.8 118.73 33.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.522 2.329 . . . . 0.0 107.784 -173.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.07 140.99 58.35 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -54.61 -29.02 50.67 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.777 1.631 . . . . 0.0 114.169 -178.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -75.72 -15.89 81.0 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.974 1.273 . . . . 0.0 115.353 177.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.18 122.42 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 119.155 1.478 . . . . 0.0 110.797 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.5 m -79.48 148.36 31.89 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.117 0.967 . . . . 0.0 113.22 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.75 -54.23 48.69 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.305 1.842 . . . . 0.0 112.631 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.65 87.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.035 0.934 . . . . 0.0 112.907 174.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.06 -47.55 84.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.587 0.755 . . . . 0.0 111.939 176.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mm -55.03 -52.53 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.035 0.934 . . . . 0.0 111.196 169.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -52.46 -52.2 55.39 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.126 0.571 . . . . 0.0 112.33 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.88 -50.51 73.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.94 1.296 . . . . 0.0 113.46 175.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.82 -44.96 91.69 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.394 0.997 . . . . 0.0 112.032 -176.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -61.75 -41.21 97.39 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 173.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.9 -13.58 46.55 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 175.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -74.59 -63.42 1.25 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.861 -1.15 . . . . 0.0 111.481 173.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -84.4 -12.78 53.82 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -175.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.36 -178.13 18.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.479 1.514 . . . . 0.0 112.942 176.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -126.65 127.49 45.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.984 1.314 . . . . 0.0 109.926 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -134.61 149.66 50.6 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.637 1.175 . . . . 0.0 114.145 -169.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -77.68 -49.87 13.62 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.643 1.977 . . . . 0.0 110.407 169.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -149.78 150.83 32.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.687 1.195 . . . . 0.0 113.111 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -127.25 154.53 44.76 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.863 1.665 . . . . 0.0 110.148 168.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.26 153.38 29.04 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.723 1.609 . . . . 0.0 112.068 179.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.481 1.124 0 C-N-CA 126.82 2.048 . . . . 0.0 109.362 174.046 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.898 0 N-CA-C 113.43 0.132 . . . . 0.0 113.43 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.8 p -143.91 154.41 43.31 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.501 1.521 . . . . 0.0 111.617 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.28 159.1 42.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.969 1.307 . . . . 0.0 111.766 173.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -144.2 133.75 23.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.876 1.67 . . . . 0.0 110.746 -172.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.86 114.79 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.446 1.098 . . . . 0.0 110.432 -177.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -79.46 104.15 9.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.328 1.451 . . . . 0.0 108.874 170.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -82.79 163.59 21.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.159 1.783 . . . . 0.0 113.389 -175.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -70.21 -51.48 30.62 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.827 0.851 . . . . 0.0 112.506 169.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -131.26 145.67 51.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.286 1.834 . . . . 0.0 112.354 -172.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -54.88 -56.65 17.21 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.924 2.09 . . . . 0.0 112.814 176.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.24 -47.13 72.58 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.887 1.275 . . . . 0.0 112.422 177.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -61.86 -38.86 89.83 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.459 1.103 . . . . 0.0 112.71 176.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.19 -46.46 80.68 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.458 0.703 . . . . 0.0 112.427 170.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.0 tp -59.12 -42.19 89.98 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.492 1.517 . . . . 0.0 112.147 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -48.0 -60.03 2.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.564 1.546 . . . . 0.0 110.728 169.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.73 -49.04 69.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.989 1.315 . . . . 0.0 112.592 176.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 25.0 ttp -51.81 -60.04 3.63 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.625 1.17 . . . . 0.0 111.643 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.26 -48.4 81.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.76 1.224 . . . . 0.0 112.319 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -58.1 -49.53 76.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.558 1.543 . . . . 0.0 112.993 -178.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -99.92 -12.37 19.87 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -169.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -59.47 110.57 1.14 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.336 1.425 . . . . 0.0 111.194 169.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.36 -23.8 19.61 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.494 1.997 . . . . 0.0 114.172 -175.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -74.28 134.41 76.97 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.825 1.25 . . . . 0.0 110.95 -174.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.37 139.43 20.84 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.008 2.472 . . . . 0.0 112.719 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.8 tp -136.07 113.7 10.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.508 1.523 . . . . 0.0 108.628 169.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 49.11 61.4 3.15 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.609 1.564 . . . . 0.0 111.2 -169.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.4 -62.48 4.56 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.431 1.491 . . . . 0.0 113.373 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -66.06 128.42 93.82 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.866 1.266 . . . . 0.0 112.907 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.73 116.41 4.65 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.451 2.768 . . . . 0.0 110.868 171.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.6 mtm -65.72 124.94 23.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.651 1.18 . . . . 0.0 111.666 -178.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -98.6 118.14 34.62 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mt -119.38 137.57 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.844 0.858 . . . . 0.0 112.305 -169.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -135.02 155.99 49.82 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.413 2.685 . . . . 0.0 110.032 -175.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 N--CA 1.468 0.447 0 C-N-CA 124.448 1.099 . . . . 0.0 110.797 -177.348 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.162 0 N-CA-C 113.547 0.179 . . . . 0.0 113.547 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -72.05 149.72 44.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.448 1.099 . . . . 0.0 112.112 176.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.4 mt -136.33 139.31 42.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 130.107 3.363 . . . . 0.0 108.758 174.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 65.7 tp -122.32 118.82 29.39 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.892 1.677 . . . . 0.0 108.607 174.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.82 112.25 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.123 1.369 . . . . 0.0 108.709 -169.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -127.62 173.97 9.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.789 1.235 . . . . 0.0 112.54 -169.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.0 t30 52.34 43.12 31.12 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.119 1.767 . . . . 0.0 112.891 -169.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.7 mt -77.36 153.99 33.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.149 0.98 . . . . 0.0 108.566 169.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -68.02 141.98 56.05 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.732 -1.23 . . . . 0.0 109.957 169.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -61.55 -19.03 61.68 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.03 0.54 82.11 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.452 1.501 . . . . 0.0 115.472 174.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.07 118.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.733 1.766 . . . . 0.0 110.916 175.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.5 m -71.45 148.03 47.26 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.717 1.207 . . . . 0.0 112.765 178.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -53.63 -54.38 38.55 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.831 1.652 . . . . 0.0 112.846 174.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.89 78.47 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.532 1.133 . . . . 0.0 113.299 177.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.85 -51.02 71.79 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.949 0.9 . . . . 0.0 112.364 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.6 mm -56.52 -52.73 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.344 1.057 . . . . 0.0 111.008 171.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -51.82 -51.85 53.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.896 0.878 . . . . 0.0 112.414 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.72 -50.06 73.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.199 1.4 . . . . 0.0 113.545 174.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.04 -43.74 98.18 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.878 1.217 . . . . 0.0 112.455 -175.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -63.51 -42.5 98.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.557 0.617 . . . . 0.0 112.371 172.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.21 71.25 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 173.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.22 -42.38 86.12 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.448 1.099 . . . . 0.0 113.085 177.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -108.36 -1.63 19.82 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -174.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.02 165.25 34.66 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 120.047 1.294 . . . . 0.0 114.628 177.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.8 m -101.47 122.94 44.7 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.096 0.958 . . . . 0.0 110.758 -177.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.05 161.9 36.83 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -93.74 -46.82 7.06 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.148 1.779 . . . . 0.0 112.131 175.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -141.94 143.31 33.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.295 1.038 . . . . 0.0 112.549 -173.094 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.49 118.11 6.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.808 1.643 . . . . 0.0 109.418 169.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.35 121.6 12.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.966 1.306 . . . . 0.0 112.414 -172.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 125.839 1.656 . . . . 0.0 110.098 170.649 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.725 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.3 m -141.39 143.0 33.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.672 1.589 . . . . 0.0 110.826 -174.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.83 139.29 34.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.325 1.45 . . . . 0.0 112.69 176.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -93.7 129.94 39.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.573 1.549 . . . . 0.0 109.429 169.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.6 t -133.16 143.59 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.596 1.559 . . . . 0.0 108.878 -177.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -145.47 108.24 4.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.755 -1.215 . . . . 0.0 111.006 -173.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -86.19 175.27 8.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.882 2.073 . . . . 0.0 113.628 -171.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -91.54 -65.68 0.99 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.743 1.217 . . . . 0.0 110.861 169.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -83.12 132.37 35.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.187 1.395 . . . . 0.0 111.89 -176.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -50.42 73.1 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.439 1.496 . . . . 0.0 112.105 179.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.36 -45.79 84.01 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.513 1.125 . . . . 0.0 112.246 176.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -63.7 -39.82 95.25 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.022 1.329 . . . . 0.0 112.55 177.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.51 -52.1 67.01 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.163 0.985 . . . . 0.0 111.809 170.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 62.2 tp -54.94 -47.36 74.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.142 0.977 . . . . 0.0 112.057 174.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -50.23 -57.18 8.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.633 1.573 . . . . 0.0 111.356 171.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -50.87 -46.07 60.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.651 1.18 . . . . 0.0 112.865 176.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 24.4 ttp -57.16 -67.26 0.34 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.688 0.676 . . . . 0.0 111.507 172.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -62.67 -36.02 81.54 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -170.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -64.18 -42.58 96.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.93 1.292 . . . . 0.0 112.931 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.25 -13.65 14.86 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -169.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.65 113.96 2.27 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.776 1.171 . . . . 0.0 111.116 169.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.58 -16.75 54.57 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.909 1.718 . . . . 0.0 114.699 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.44 129.49 85.6 Favored Pre-proline 0 N--CA 1.477 0.912 0 CA-C-N 119.085 1.442 . . . . 0.0 110.813 -176.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.98 140.19 93.05 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.809 3.006 . . . . 0.0 115.1 176.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.6 tp -138.28 104.59 5.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.366 2.266 . . . . 0.0 107.539 169.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 48.31 62.01 2.74 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.387 1.475 . . . . 0.0 111.718 -169.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.69 -59.51 4.95 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.19 1.376 . . . . 0.0 113.214 -179.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.5 mtt-85 -60.55 127.67 87.16 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.733 1.613 . . . . 0.0 112.682 -175.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.82 122.61 8.66 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.757 2.305 . . . . 0.0 110.756 170.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.5 mtm -61.69 121.61 13.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.099 0.96 . . . . 0.0 111.589 178.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -93.41 103.06 15.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.866 1.266 . . . . 0.0 108.917 174.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -115.83 131.85 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.33 1.052 . . . . 0.0 111.342 -171.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -122.54 150.18 42.92 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.647 2.379 . . . . 0.0 109.394 175.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.4 tp . . . . . 0 CA--C 1.548 0.89 0 C-N-CA 124.882 1.273 . . . . 0.0 110.075 174.732 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 112.609 -0.196 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -146.52 138.42 24.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.341 1.056 . . . . 0.0 111.139 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.1 mt -134.67 126.27 28.78 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.709 1.604 . . . . 0.0 112.221 -175.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.7 tp -90.8 124.7 35.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.228 1.411 . . . . 0.0 107.603 169.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.71 92.0 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.677 1.591 . . . . 0.0 108.597 -171.007 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.0 m -88.19 167.65 13.42 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.129 1.771 . . . . 0.0 112.581 -177.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.0 t30 55.35 66.77 1.14 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.175 2.19 . . . . 0.0 113.447 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.7 mt -116.16 -168.81 1.49 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.582 2.353 . . . . 0.0 110.42 174.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.85 150.35 47.82 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.129 -0.982 . . . . 0.0 112.322 173.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -51.01 -40.89 59.23 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.465 1.106 . . . . 0.0 112.977 175.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.27 69.51 0.43 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.479 1.514 . . . . 0.0 111.941 173.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.78 134.48 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.954 1.702 . . . . 0.0 111.855 172.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.0 m -85.52 126.25 33.7 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.819 -0.551 . . . . 0.0 110.394 170.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.44 -48.46 79.08 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.381 1.072 . . . . 0.0 111.961 179.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.17 75.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.278 1.431 . . . . 0.0 113.233 175.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.56 -53.16 61.45 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.176 0.991 . . . . 0.0 111.993 178.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 47.7 mm -57.34 -53.58 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.63 1.172 . . . . 0.0 111.169 173.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -49.47 -54.57 17.04 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.315 1.046 . . . . 0.0 111.553 177.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -61.37 -50.1 74.24 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.023 0.829 . . . . 0.0 112.657 178.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -47.53 85.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.939 0.79 . . . . 0.0 112.31 -176.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -64.91 -46.91 79.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.641 0.655 . . . . 0.0 112.303 175.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.99 -35.49 64.41 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -55.54 -45.52 77.2 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.34 1.056 . . . . 0.0 112.98 175.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -102.53 -19.36 14.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -175.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -152.63 157.68 27.43 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-N 120.096 1.316 . . . . 0.0 114.303 177.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.4 m -84.63 95.91 9.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.68 -0.894 . . . . 0.0 111.727 -172.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.21 143.34 29.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.635 0.774 . . . . 0.0 111.809 172.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -85.63 -48.51 8.81 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.575 2.35 . . . . 0.0 110.309 169.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -149.45 149.09 30.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.742 1.217 . . . . 0.0 112.444 -177.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -122.77 153.86 38.95 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.094 1.758 . . . . 0.0 110.96 169.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.57 -176.33 5.26 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.696 2.398 . . . . 0.0 110.938 -176.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.875 0 C-N-CA 127.909 2.483 . . . . 0.0 110.099 176.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.71 0 CA-C-O 119.894 -0.392 . . . . 0.0 113.606 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.0 m -141.86 113.77 7.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.0 1.32 . . . . 0.0 110.077 176.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.79 164.01 12.75 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.159 1.383 . . . . 0.0 111.373 173.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -143.4 126.49 16.43 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.57 1.148 . . . . 0.0 110.37 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.4 t -136.6 136.75 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.14 0.976 . . . . 0.0 110.989 -169.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -115.91 138.75 50.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.307 1.843 . . . . 0.0 109.368 178.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -127.39 158.39 37.43 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.149 2.58 . . . . 0.0 113.708 -169.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -64.47 -32.71 74.46 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.483 1.513 . . . . 0.0 114.439 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -135.93 147.56 48.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.088 1.355 . . . . 0.0 112.803 -169.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -58.92 -52.75 64.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.444 1.498 . . . . 0.0 111.734 169.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.98 -50.44 64.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.088 1.355 . . . . 0.0 112.195 177.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.65 -51.4 63.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.234 1.414 . . . . 0.0 112.023 175.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.76 -50.98 71.9 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.586 0.754 . . . . 0.0 112.429 176.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 80.3 mt -58.34 -47.09 84.86 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.474 1.11 . . . . 0.0 112.764 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -54.22 -55.51 27.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.943 1.297 . . . . 0.0 111.582 172.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.32 -52.74 51.46 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.691 1.196 . . . . 0.0 112.561 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 34.8 ttm -50.03 -62.03 1.81 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.665 1.586 . . . . 0.0 111.617 175.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.75 -46.8 88.02 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.121 1.368 . . . . 0.0 112.64 -177.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -63.03 -45.4 92.51 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.477 1.111 . . . . 0.0 113.206 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.0 -15.72 17.37 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -169.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -60.66 110.35 1.27 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.969 1.259 . . . . 0.0 110.682 169.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.96 -25.72 11.27 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.561 2.029 . . . . 0.0 114.191 -175.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.81 132.0 90.89 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.564 1.146 . . . . 0.0 111.433 -171.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.22 106.89 1.96 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.527 2.818 . . . . 0.0 112.283 -177.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 tp -75.23 89.87 2.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.177 1.391 . . . . 0.0 109.352 169.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 44.46 58.51 3.79 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.363 1.865 . . . . 0.0 111.33 -169.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 100.72 -47.54 1.23 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.627 1.584 . . . . 0.0 113.702 -177.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -68.33 107.91 2.36 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 127.002 2.121 . . . . 0.0 112.463 -169.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.17 107.9 2.22 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.984 1.789 . . . . 0.0 110.863 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.91 134.68 55.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.256 1.022 . . . . 0.0 111.138 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -119.64 112.83 19.8 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.853 0.861 . . . . 0.0 110.459 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.0 mt -108.11 132.67 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.146 0.979 . . . . 0.0 111.223 -169.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -131.03 141.48 50.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.343 2.257 . . . . 0.0 109.978 -173.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 CA--C 1.544 0.734 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 175.054 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.208 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -150.26 101.8 3.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.7 1.2 . . . . 0.0 110.412 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 34.1 mt -95.73 107.17 19.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.339 1.055 . . . . 0.0 111.605 -177.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.5 tp -76.18 129.4 36.68 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 168.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.61 111.85 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.96 1.304 . . . . 0.0 108.737 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.3 m -112.53 169.95 8.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.218 1.407 . . . . 0.0 110.975 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.7 t30 57.13 78.18 0.24 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.924 1.69 . . . . 0.0 112.11 -174.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.8 mt -132.03 157.54 43.86 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.201 2.2 . . . . 0.0 110.336 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.55 145.8 50.82 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.046 -1.034 . . . . 0.0 111.656 170.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -57.22 -29.0 63.39 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -177.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -109.34 28.02 11.61 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.256 1.408 . . . . 0.0 115.261 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.59 119.2 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.174 1.487 . . . . 0.0 110.012 169.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.8 m -74.13 145.51 44.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.434 1.094 . . . . 0.0 112.568 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.68 -51.47 68.63 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.826 0.85 . . . . 0.0 112.094 171.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.45 -53.05 19.31 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.808 1.643 . . . . 0.0 112.331 175.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.88 -50.96 67.43 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.807 1.243 . . . . 0.0 112.365 177.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.0 mm -56.41 -56.82 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.221 1.008 . . . . 0.0 112.15 174.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -58.03 -43.75 86.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.709 1.141 . . . . 0.0 112.243 -178.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -59.14 -52.49 65.5 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.057 0.844 . . . . 0.0 112.775 173.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -65.03 -47.24 78.12 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.998 0.817 . . . . 0.0 112.374 -176.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -62.45 -40.49 96.78 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.774 0.715 . . . . 0.0 112.558 175.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.25 -13.54 60.54 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 175.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.85 -57.71 4.09 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.839 -1.163 . . . . 0.0 111.424 173.147 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -84.89 -33.95 22.66 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.98 -172.79 15.0 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.845 1.688 . . . . 0.0 112.801 178.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -131.02 120.88 24.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.579 1.152 . . . . 0.0 110.41 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -123.86 142.66 50.92 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -72.87 -52.0 16.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.733 2.413 . . . . 0.0 110.428 169.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -152.84 156.74 39.6 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.353 1.461 . . . . 0.0 112.596 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -128.88 162.77 26.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.842 1.657 . . . . 0.0 111.302 169.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.45 145.36 23.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.24 2.216 . . . . 0.0 109.806 172.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 125.517 1.527 . . . . 0.0 110.462 178.779 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.775 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.6 m -126.18 133.63 51.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.138 0.975 . . . . 0.0 112.34 -173.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.77 160.08 37.89 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.419 1.887 . . . . 0.0 111.148 170.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -145.28 126.68 14.94 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.367 1.467 . . . . 0.0 110.222 -177.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.33 111.67 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.142 0.977 . . . . 0.0 110.863 -171.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -75.71 111.19 10.79 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.288 1.435 . . . . 0.0 109.43 172.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.9 150.99 21.95 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.903 2.081 . . . . 0.0 112.555 -178.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.82 -38.37 90.83 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 177.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -136.39 142.85 43.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.607 1.563 . . . . 0.0 112.335 -174.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -54.47 -52.34 62.17 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.929 1.692 . . . . 0.0 112.136 172.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.91 -51.9 66.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.1 1.36 . . . . 0.0 112.475 176.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -59.88 -40.66 89.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.834 0.854 . . . . 0.0 112.536 177.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.89 -51.64 68.28 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.979 0.912 . . . . 0.0 111.983 171.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 62.8 mt -55.38 -48.08 74.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.776 0.83 . . . . 0.0 112.861 173.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -54.04 -54.49 38.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.665 1.186 . . . . 0.0 112.321 175.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.47 -53.16 57.99 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.573 1.149 . . . . 0.0 112.299 174.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 19.8 ttt -52.37 -60.64 2.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.035 1.734 . . . . 0.0 112.046 177.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -59.83 -37.32 78.88 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -68.79 -46.02 69.78 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.236 1.014 . . . . 0.0 113.165 176.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -100.1 -14.16 18.69 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -169.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -58.52 117.03 4.07 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.88 1.218 . . . . 0.0 111.044 170.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.7 -16.22 58.9 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.27 1.414 . . . . 0.0 114.61 -175.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.8 t -71.84 133.07 84.46 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 118.997 1.399 . . . . 0.0 109.497 175.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.94 142.1 24.75 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.725 2.284 . . . . 0.0 112.51 -177.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 45.7 tp -129.95 105.02 7.7 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.35 1.46 . . . . 0.0 108.133 169.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 52.4 65.57 1.47 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.988 1.715 . . . . 0.0 111.135 -169.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.09 -64.04 4.3 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.24 1.4 . . . . 0.0 113.215 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.5 119.92 57.91 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 126.465 1.906 . . . . 0.0 112.774 -173.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -56.07 121.55 10.19 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.753 3.635 . . . . 0.0 113.58 170.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.47 116.64 5.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.245 1.018 . . . . 0.0 111.748 177.104 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -91.61 98.6 11.75 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.585 1.154 . . . . 0.0 109.22 171.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.3 mt -101.22 133.63 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.066 1.346 . . . . 0.0 111.149 -173.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -140.14 123.86 17.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.063 1.745 . . . . 0.0 111.42 -177.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.7 tp . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 123.765 0.826 . . . . 0.0 109.311 169.694 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.872 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -143.46 152.92 42.09 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 177.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.7 mt -108.68 154.36 22.11 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.9 1.68 . . . . 0.0 111.535 174.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.2 tp -120.32 124.18 44.95 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.889 2.076 . . . . 0.0 107.474 170.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.89 85.56 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.52 1.928 . . . . 0.0 108.239 -169.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.16 166.96 19.19 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.146 1.379 . . . . 0.0 112.225 -178.058 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.7 t30 60.36 75.21 0.42 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.927 2.091 . . . . 0.0 113.134 177.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.1 mt -127.38 167.58 16.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.895 2.478 . . . . 0.0 111.489 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.2 149.57 46.17 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.96 0.886 . . . . 0.0 113.137 172.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -58.69 -31.97 68.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.556 1.943 . . . . 0.0 114.492 -178.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.49 31.67 7.19 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.541 1.543 . . . . 0.0 114.81 -175.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.71 147.52 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.09 1.356 . . . . 0.0 110.907 169.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.4 m -119.8 147.59 44.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.503 1.521 . . . . 0.0 112.485 -176.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -48.59 -57.7 5.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.682 1.993 . . . . 0.0 112.145 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.37 -46.24 76.52 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.591 1.556 . . . . 0.0 113.561 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.97 -52.78 64.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.164 0.986 . . . . 0.0 111.936 -178.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 43.0 mm -58.21 -52.8 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.384 1.073 . . . . 0.0 111.205 172.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -49.64 -51.69 36.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.953 1.301 . . . . 0.0 112.305 179.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.78 -52.3 65.67 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.368 1.067 . . . . 0.0 113.123 175.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.65 -43.89 97.67 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.214 0.915 . . . . 0.0 112.715 -177.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -62.71 -40.72 98.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.808 0.731 . . . . 0.0 112.475 173.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.15 -26.33 64.66 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 175.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -63.4 -48.88 75.99 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.144 -0.972 . . . . 0.0 112.608 174.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -104.8 -15.58 15.16 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 -173.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.0 162.53 21.79 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.904 1.716 . . . . 0.0 113.638 -176.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.9 m -112.27 100.62 8.95 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.576 1.95 . . . . 0.0 107.727 -178.049 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.25 157.2 44.99 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -168.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -77.5 -57.42 3.83 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.693 1.997 . . . . 0.0 110.042 169.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -157.24 145.65 19.48 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.234 1.414 . . . . 0.0 112.792 -174.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.18 133.78 55.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.378 1.471 . . . . 0.0 108.564 168.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.9 158.02 44.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.584 1.154 . . . . 0.0 113.115 -169.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.686 0 C-N-CA 126.625 1.97 . . . . 0.0 109.599 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.841 0 CA-C-O 119.699 -0.5 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.0 m -146.41 126.0 13.33 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.429 1.492 . . . . 0.0 111.019 -175.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.93 162.49 12.88 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.373 1.469 . . . . 0.0 112.599 177.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -133.51 127.51 33.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.778 1.631 . . . . 0.0 109.986 -172.079 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.0 t -134.07 116.8 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.518 -0.739 . . . . 0.0 112.479 -169.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -90.18 116.17 27.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.963 2.105 . . . . 0.0 110.606 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -99.54 152.63 19.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.618 1.567 . . . . 0.0 113.885 -173.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -63.93 -48.55 76.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.034 0.934 . . . . 0.0 111.794 171.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -133.54 135.41 44.35 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.116 1.366 . . . . 0.0 110.912 -175.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -58.12 -43.34 87.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.263 1.425 . . . . 0.0 112.778 178.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.58 -50.45 60.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.488 1.115 . . . . 0.0 112.618 171.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.92 -46.61 89.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.945 0.898 . . . . 0.0 112.006 174.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.13 -52.87 48.96 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.513 1.125 . . . . 0.0 112.333 173.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.6 tp -55.42 -51.17 67.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.482 1.513 . . . . 0.0 112.224 174.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -52.06 51.76 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.669 1.587 . . . . 0.0 112.48 174.132 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.18 -52.93 63.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.433 1.093 . . . . 0.0 111.856 173.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -54.51 -58.89 5.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.696 1.598 . . . . 0.0 112.494 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -59.17 -36.48 75.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -177.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -67.81 -49.11 64.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.381 1.073 . . . . 0.0 112.996 174.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -94.09 -13.72 26.53 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -57.92 112.9 1.64 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.702 1.137 . . . . 0.0 110.93 169.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.5 -18.6 41.08 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.546 1.546 . . . . 0.0 114.713 -175.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 81.2 t -69.52 133.78 88.84 Favored Pre-proline 0 N--CA 1.478 0.934 0 CA-C-N 118.968 1.384 . . . . 0.0 110.189 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.38 141.78 23.16 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.872 2.381 . . . . 0.0 113.154 -175.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.3 tt -132.3 108.69 9.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.539 1.935 . . . . 0.0 107.312 169.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 48.33 64.27 1.73 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.819 1.648 . . . . 0.0 111.566 -169.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.92 -55.44 4.77 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.883 1.706 . . . . 0.0 113.649 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -65.81 124.02 86.41 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 127.008 2.123 . . . . 0.0 112.47 -173.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.32 122.97 9.48 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.291 2.661 . . . . 0.0 111.185 174.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.42 116.27 5.39 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.184 0.994 . . . . 0.0 111.347 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -84.78 100.66 11.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.961 0.905 . . . . 0.0 108.975 170.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.3 mt -107.18 130.07 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.793 0.837 . . . . 0.0 110.714 -175.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.21 -179.97 6.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.594 1.558 . . . . 0.0 110.591 171.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 N--CA 1.47 0.563 0 C-N-CA 125.182 1.393 . . . . 0.0 112.474 -176.666 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.877 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -133.92 125.83 29.11 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.062 0.945 . . . . 0.0 110.526 -178.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.9 mt -106.52 131.11 54.07 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.606 1.163 . . . . 0.0 110.821 170.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.6 tp -99.06 100.43 11.58 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.685 1.594 . . . . 0.0 106.821 169.042 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.28 132.94 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 m -134.05 172.32 12.99 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.55 1.54 . . . . 0.0 111.381 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.3 t30 56.63 51.16 11.5 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.005 1.722 . . . . 0.0 112.662 -172.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.58 -158.51 0.67 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.072 1.749 . . . . 0.0 109.214 169.414 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -154.98 169.24 24.53 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.492 1.517 . . . . 0.0 110.728 178.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.32 -32.1 70.91 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.896 -1.128 . . . . 0.0 112.513 169.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.97 -28.76 69.23 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.487 1.518 . . . . 0.0 114.646 174.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.0 t -72.71 108.15 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.578 1.189 . . . . 0.0 109.64 174.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.6 m -69.81 144.0 52.76 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.02 0.928 . . . . 0.0 112.876 -177.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -54.19 -55.09 31.24 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.743 1.617 . . . . 0.0 112.886 176.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.87 75.77 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.483 1.113 . . . . 0.0 113.266 176.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.21 -52.24 63.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.704 0.802 . . . . 0.0 111.61 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.0 mm -53.26 -52.93 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.121 0.969 . . . . 0.0 111.12 169.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -52.53 -52.93 52.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.972 0.909 . . . . 0.0 112.175 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -60.2 -52.16 66.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.553 1.141 . . . . 0.0 113.16 174.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 pp -63.84 -43.93 94.7 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.364 0.984 . . . . 0.0 112.308 -174.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -62.12 -45.15 94.74 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.485 0.584 . . . . 0.0 112.068 172.143 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.7 -32.84 70.88 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 178.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.18 -51.21 70.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.084 0.954 . . . . 0.0 112.483 173.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -93.23 -13.03 28.81 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -174.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.55 154.36 25.89 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 120.015 1.279 . . . . 0.0 114.664 177.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.2 m -86.19 107.41 17.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.369 1.068 . . . . 0.0 110.309 -175.289 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 pp -125.96 146.31 49.92 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -173.019 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -86.72 -39.09 16.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.635 2.374 . . . . 0.0 111.547 169.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -150.22 147.38 27.62 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.591 0.632 . . . . 0.0 112.47 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.26 120.97 11.18 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.668 1.587 . . . . 0.0 109.486 171.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -138.4 117.24 12.35 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.38 1.472 . . . . 0.0 111.863 -172.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.4 t . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 126.065 1.746 . . . . 0.0 111.134 178.052 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.934 0 CA-C-O 120.048 -0.307 . . . . 0.0 113.326 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.9 p -141.53 168.28 20.15 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.301 1.44 . . . . 0.0 112.642 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.07 141.27 24.0 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.674 1.189 . . . . 0.0 111.398 169.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.91 126.02 43.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.478 1.511 . . . . 0.0 109.429 173.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.3 t -130.08 122.8 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.173 0.989 . . . . 0.0 110.509 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -109.1 119.01 38.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.113 2.165 . . . . 0.0 111.14 -176.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -102.75 154.47 19.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.809 2.844 . . . . 0.0 113.645 -169.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -82.38 -16.17 50.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.619 1.567 . . . . 0.0 114.554 175.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.8 mtm-85 -142.34 132.56 24.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.689 1.596 . . . . 0.0 111.042 177.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -56.13 -50.35 71.35 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.107 1.363 . . . . 0.0 112.545 172.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.43 -47.43 69.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.875 1.27 . . . . 0.0 112.162 175.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.18 -42.23 99.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.943 0.897 . . . . 0.0 112.625 175.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.72 -53.34 57.81 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.785 0.834 . . . . 0.0 111.534 171.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 59.3 tp -54.07 -52.1 62.0 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.826 1.25 . . . . 0.0 112.439 174.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -49.86 -54.77 17.4 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.253 1.821 . . . . 0.0 112.154 173.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.63 -50.84 69.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.534 1.133 . . . . 0.0 112.306 174.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 16.7 ttp -52.15 -60.1 3.6 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.03 1.332 . . . . 0.0 111.595 175.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -53.73 -49.51 67.99 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.239 1.416 . . . . 0.0 112.32 179.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -61.83 -47.24 85.98 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.72 1.208 . . . . 0.0 113.045 -179.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -99.82 -14.36 18.84 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -169.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.28 113.72 2.3 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.785 1.175 . . . . 0.0 110.984 169.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.43 -20.15 35.41 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.762 1.649 . . . . 0.0 114.48 -175.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.46 133.02 87.23 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-N 118.757 1.279 . . . . 0.0 110.306 -178.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.16 138.83 23.17 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.923 2.415 . . . . 0.0 112.457 -177.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.1 tp -134.93 112.37 10.58 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.1 1.76 . . . . 0.0 108.373 170.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 49.32 61.68 3.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.303 1.441 . . . . 0.0 111.189 -169.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.99 -59.94 4.47 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.798 1.666 . . . . 0.0 113.493 -179.051 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -61.95 127.82 89.75 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 127.062 2.145 . . . . 0.0 112.83 -174.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.98 124.67 10.79 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.178 2.585 . . . . 0.0 111.147 172.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.49 120.37 11.57 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.117 0.967 . . . . 0.0 111.162 177.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -98.91 102.32 14.0 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.783 1.233 . . . . 0.0 108.865 176.036 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.1 mt -108.69 135.98 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.047 0.939 . . . . 0.0 111.271 -169.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -128.87 123.98 34.09 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.103 1.761 . . . . 0.0 111.082 -177.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 CA--C 1.534 0.346 0 C-N-CA 124.77 1.228 . . . . 0.0 111.076 172.361 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.945 0 N-CA-C 112.338 -0.305 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -117.91 99.63 7.04 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.285 1.434 . . . . 0.0 109.961 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -100.73 101.4 12.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.607 1.563 . . . . 0.0 109.043 -176.099 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.8 tp -84.37 137.28 33.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.136 1.774 . . . . 0.0 110.505 177.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.0 t -129.41 129.32 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.46 1.904 . . . . 0.0 108.948 -176.517 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.0 m -139.64 166.48 24.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.25 1.42 . . . . 0.0 112.116 -176.006 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.1 t30 54.71 46.95 23.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.07 1.748 . . . . 0.0 112.914 -172.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.2 mt -83.89 164.83 19.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.3 1.44 . . . . 0.0 110.754 169.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.95 145.35 56.0 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 110.957 169.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -53.87 -35.0 61.08 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.561 1.544 . . . . 0.0 114.16 -176.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.47 16.28 58.0 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.392 1.473 . . . . 0.0 115.467 -174.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.26 135.25 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.217 1.509 . . . . 0.0 110.578 170.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.4 m -114.6 158.13 22.13 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.146 1.778 . . . . 0.0 111.583 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -52.36 -55.75 19.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.524 1.13 . . . . 0.0 113.641 -176.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.49 -38.99 67.1 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.197 0.999 . . . . 0.0 113.561 -177.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.83 -56.15 25.94 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.968 0.907 . . . . 0.0 111.916 176.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.2 mm -55.76 -53.01 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 0.0 111.02 172.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -48.44 -56.95 6.86 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.181 1.792 . . . . 0.0 111.673 178.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.2 -49.49 75.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.435 1.094 . . . . 0.0 113.323 176.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.3 -45.44 91.34 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.492 1.042 . . . . 0.0 112.201 -174.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -62.91 -40.88 98.94 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 174.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.51 -14.98 56.51 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 175.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.6 -61.91 1.71 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.825 -1.172 . . . . 0.0 111.883 173.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -85.18 -13.05 51.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -175.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -146.41 -167.79 13.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.71 1.624 . . . . 0.0 112.909 176.414 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.05 126.69 27.14 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.159 1.384 . . . . 0.0 110.177 -173.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.06 143.61 50.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.464 1.106 . . . . 0.0 113.737 -169.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -73.08 -49.61 27.62 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.966 2.106 . . . . 0.0 110.335 169.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -150.11 152.15 34.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.416 1.086 . . . . 0.0 113.237 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -119.86 151.91 38.15 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.319 1.848 . . . . 0.0 109.869 169.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.6 146.01 26.26 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.97 1.708 . . . . 0.0 110.402 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.1 t . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 125.364 1.465 . . . . 0.0 109.847 -177.877 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.247 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -137.01 155.04 50.21 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.698 1.599 . . . . 0.0 112.127 179.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.5 166.86 26.93 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.998 1.719 . . . . 0.0 111.463 175.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -147.76 126.73 12.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.635 1.574 . . . . 0.0 109.645 -174.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.02 116.43 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.726 1.21 . . . . 0.0 109.175 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -82.6 102.87 11.72 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -77.28 155.34 32.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.177 1.791 . . . . 0.0 113.238 -175.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.19 -29.48 54.34 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.701 1.2 . . . . 0.0 113.298 172.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 138.26 38.04 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.285 1.434 . . . . 0.0 111.341 176.707 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -64.77 -36.73 85.26 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 113.914 178.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.37 -46.83 86.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.121 0.968 . . . . 0.0 111.672 174.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -58.98 -44.23 91.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.492 1.517 . . . . 0.0 112.016 173.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.05 -52.25 63.77 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.75 1.22 . . . . 0.0 112.612 170.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.47 -48.24 79.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.857 1.263 . . . . 0.0 112.292 176.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -49.55 -56.99 7.96 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.135 1.374 . . . . 0.0 111.229 171.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.68 -47.13 63.99 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.801 0.84 . . . . 0.0 112.362 175.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.5 ttp -56.17 -62.36 1.77 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.979 0.912 . . . . 0.0 112.467 177.034 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -61.43 -35.27 77.09 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.27 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.0 -52.81 62.47 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.365 1.466 . . . . 0.0 112.662 174.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -97.39 -14.97 20.9 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -169.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -59.67 110.33 1.12 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 120.16 1.346 . . . . 0.0 112.094 175.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.3 -17.36 40.58 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.149 1.833 . . . . 0.0 114.67 -177.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.61 130.27 94.09 Favored Pre-proline 0 N--CA 1.479 0.985 0 CA-C-N 118.953 1.376 . . . . 0.0 111.009 -174.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.28 112.25 2.75 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.339 2.693 . . . . 0.0 112.54 -174.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 59.7 tp -76.54 82.5 3.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.47 1.508 . . . . 0.0 109.268 169.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 43.35 55.1 4.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.873 2.069 . . . . 0.0 112.026 -169.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 116.23 -64.82 0.33 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.009 1.766 . . . . 0.0 112.556 -177.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.01 111.03 3.53 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 126.812 2.045 . . . . 0.0 112.266 -171.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.14 113.31 3.39 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.273 1.982 . . . . 0.0 110.654 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -66.93 118.71 10.78 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.005 0.922 . . . . 0.0 111.157 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -84.89 120.74 26.81 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.904 0.882 . . . . 0.0 109.024 171.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.6 mm -118.43 138.17 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.738 0.815 . . . . 0.0 109.997 179.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -137.09 134.84 36.91 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.149 1.38 . . . . 0.0 111.065 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 CA--C 1.538 0.485 0 C-N-CA 126.3 1.84 . . . . 0.0 107.88 174.634 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.355 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -134.98 101.6 4.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.852 1.261 . . . . 0.0 110.68 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -103.61 122.0 44.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.087 2.155 . . . . 0.0 109.231 -171.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.8 tp -115.47 102.94 10.27 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.309 1.844 . . . . 0.0 110.424 -176.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.5 t -78.73 130.64 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.166 1.387 . . . . 0.0 108.373 169.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 m -127.69 172.3 10.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.115 1.366 . . . . 0.0 111.411 175.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.7 t30 57.46 50.4 11.31 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.847 1.659 . . . . 0.0 112.763 -173.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.2 mt -98.78 -168.22 1.6 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.883 1.673 . . . . 0.0 109.306 169.145 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -148.61 161.94 40.69 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.967 -1.083 . . . . 0.0 111.972 174.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -61.14 101.52 0.16 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.208 1.403 . . . . 0.0 109.383 169.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.48 -39.0 0.62 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.211 1.386 . . . . 0.0 111.859 -169.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.73 110.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.122 0.969 . . . . 0.0 109.611 170.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -71.98 144.24 48.94 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.766 0.826 . . . . 0.0 112.737 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.71 -52.79 63.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.841 1.656 . . . . 0.0 112.385 178.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.54 82.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.618 1.167 . . . . 0.0 113.404 174.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.84 -48.69 79.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.086 0.857 . . . . 0.0 111.763 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.4 mm -54.77 -52.87 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.883 0.873 . . . . 0.0 111.065 169.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -51.75 -54.21 31.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.246 0.618 . . . . 0.0 112.067 178.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.58 -50.34 74.17 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.873 1.269 . . . . 0.0 113.31 176.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.11 -44.86 90.99 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.315 0.961 . . . . 0.0 112.041 -176.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -61.27 -42.69 99.07 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 173.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.54 -15.3 57.61 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.29 -63.45 1.18 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.949 -1.095 . . . . 0.0 111.609 173.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -82.17 -18.91 41.08 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -175.465 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -139.22 -176.37 14.68 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.579 1.561 . . . . 0.0 113.346 178.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.9 m -126.91 120.96 30.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.367 1.467 . . . . 0.0 110.373 -176.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 pp -126.07 146.41 49.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.004 1.322 . . . . 0.0 112.995 -169.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -78.52 -49.19 13.8 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.803 2.441 . . . . 0.0 110.303 170.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -149.19 147.89 28.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.632 1.173 . . . . 0.0 111.884 -179.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -137.62 135.34 36.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.454 1.502 . . . . 0.0 110.464 171.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.06 146.77 32.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.865 1.266 . . . . 0.0 112.192 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.479 1.024 0 C-N-CA 125.844 1.658 . . . . 0.0 110.492 -179.402 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.9 p -144.55 159.4 42.85 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.664 1.585 . . . . 0.0 112.266 -176.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.78 140.85 33.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.863 1.265 . . . . 0.0 111.018 169.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -120.33 125.88 49.14 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.067 1.747 . . . . 0.0 110.009 -174.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.8 t -126.68 115.75 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.156 1.382 . . . . 0.0 109.809 -176.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -88.23 111.4 21.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.218 2.207 . . . . 0.0 108.461 175.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -98.82 159.31 15.04 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.426 2.29 . . . . 0.0 113.975 -169.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.73 -50.46 70.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.276 1.03 . . . . 0.0 111.83 169.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -138.06 144.26 40.87 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.733 1.613 . . . . 0.0 112.214 -173.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -62.63 -35.88 81.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.758 1.223 . . . . 0.0 112.901 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.13 -47.01 78.94 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.441 1.096 . . . . 0.0 112.435 172.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -65.88 -41.96 90.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.705 1.202 . . . . 0.0 112.038 176.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.62 82.61 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.859 0.864 . . . . 0.0 112.264 169.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.88 -45.62 93.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.986 1.714 . . . . 0.0 112.046 177.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -49.63 -58.15 5.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.958 1.303 . . . . 0.0 110.31 169.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.43 -49.6 61.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.93 0.892 . . . . 0.0 112.65 176.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 41.6 ttp -54.89 -62.01 1.94 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.362 1.065 . . . . 0.0 111.723 176.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -61.05 -38.59 86.73 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -66.68 -41.87 87.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.685 1.194 . . . . 0.0 112.899 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -109.09 -13.24 14.73 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -169.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -58.63 116.74 3.9 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.172 1.351 . . . . 0.0 111.425 171.348 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.33 -25.07 27.18 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.972 1.749 . . . . 0.0 114.359 -175.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.82 135.3 87.8 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.771 1.229 . . . . 0.0 110.356 -177.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -74.91 139.42 24.5 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.821 2.348 . . . . 0.0 112.816 -178.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.4 tp -139.24 119.12 13.29 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.936 1.694 . . . . 0.0 108.677 169.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.75 56.99 7.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.428 1.491 . . . . 0.0 110.729 -169.094 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.78 -60.74 4.36 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.54 1.543 . . . . 0.0 113.466 -179.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.45 135.91 96.54 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.948 1.699 . . . . 0.0 112.872 -172.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.2 124.28 10.34 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.497 2.798 . . . . 0.0 111.211 174.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.4 mtm -62.76 117.78 6.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.506 1.122 . . . . 0.0 111.729 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -95.65 99.04 10.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.949 1.3 . . . . 0.0 108.393 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.6 mt -103.86 135.43 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.667 0.787 . . . . 0.0 111.363 -169.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -127.91 151.16 49.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.969 2.508 . . . . 0.0 110.302 -177.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 34.8 tp . . . . . 0 N--CA 1.467 0.409 0 C-N-CA 125.737 1.615 . . . . 0.0 109.568 179.856 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.076 0 N-CA-C 112.704 -0.158 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -76.59 137.95 39.84 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.971 0.908 . . . . 0.0 112.458 178.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -138.52 129.58 26.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 129.02 2.928 . . . . 0.0 108.112 -175.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.73 112.15 20.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.551 1.94 . . . . 0.0 110.035 -175.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.4 t -87.04 135.1 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.58 1.552 . . . . 0.0 108.637 171.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.7 m -139.18 165.44 27.16 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.608 1.563 . . . . 0.0 112.575 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.4 t30 57.8 47.65 15.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.147 2.179 . . . . 0.0 113.299 -175.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.51 161.53 15.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.256 1.822 . . . . 0.0 110.3 169.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.93 144.53 54.15 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.166 -0.959 . . . . 0.0 111.008 169.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -59.35 -21.72 60.23 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.83 19.75 32.6 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.727 1.632 . . . . 0.0 115.425 178.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.29 129.37 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.483 1.641 . . . . 0.0 110.365 169.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.8 m -75.69 140.64 42.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.006 0.923 . . . . 0.0 112.55 -178.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.54 -50.67 72.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.018 1.327 . . . . 0.0 112.298 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.77 -46.62 71.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.309 1.444 . . . . 0.0 112.619 174.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -56.98 -53.3 59.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.397 1.079 . . . . 0.0 112.381 179.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.0 mm -57.33 -52.81 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.134 0.973 . . . . 0.0 111.583 173.02 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -50.33 -50.62 50.4 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.546 1.139 . . . . 0.0 112.006 178.104 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.09 -53.84 47.26 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.505 1.122 . . . . 0.0 112.917 175.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.13 -43.0 99.6 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.216 0.916 . . . . 0.0 112.643 -173.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -64.07 -44.79 91.31 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.64 0.654 . . . . 0.0 112.131 172.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.46 -27.5 66.14 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 176.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.66 -59.5 4.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.187 0.995 . . . . 0.0 111.942 173.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -83.8 -15.25 49.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -175.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -148.17 156.22 26.8 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.947 1.248 . . . . 0.0 113.96 175.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.4 m -94.79 111.48 23.26 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.753 1.221 . . . . 0.0 109.934 -173.304 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -137.3 155.8 49.01 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -87.38 -48.17 8.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.785 2.434 . . . . 0.0 111.487 -173.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -151.02 145.66 25.68 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.623 1.169 . . . . 0.0 113.141 -176.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.27 140.85 46.71 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.239 1.816 . . . . 0.0 110.095 169.115 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -146.51 107.59 4.18 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.933 1.693 . . . . 0.0 111.533 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.3 t . . . . . 0 N--CA 1.478 0.956 0 C-N-CA 125.303 1.441 . . . . 0.0 110.625 176.063 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 N-CA-C 113.224 0.05 . . . . 0.0 113.224 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.4 p -143.47 167.68 21.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.699 1.599 . . . . 0.0 111.395 -179.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -144.78 126.38 15.09 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.797 0.839 . . . . 0.0 111.782 169.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -80.15 124.54 28.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.974 1.71 . . . . 0.0 109.735 169.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.45 140.66 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.702 1.201 . . . . 0.0 110.107 -175.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -122.75 105.42 10.03 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.769 1.627 . . . . 0.0 109.204 177.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -78.62 160.54 27.51 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.364 1.866 . . . . 0.0 111.743 176.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -76.43 -27.18 56.13 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 171.077 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.18 136.62 38.36 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.453 1.501 . . . . 0.0 111.914 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -56.45 -44.37 80.45 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.808 1.643 . . . . 0.0 113.316 173.047 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.38 -46.71 76.5 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.091 0.956 . . . . 0.0 112.597 176.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -66.52 -41.4 88.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.928 1.291 . . . . 0.0 112.178 177.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.9 -48.75 75.07 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.906 0.882 . . . . 0.0 111.934 169.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.97 -46.41 89.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.538 1.535 . . . . 0.0 112.463 176.102 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -50.71 -56.39 12.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.169 1.388 . . . . 0.0 111.133 171.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.16 -49.27 69.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.55 1.14 . . . . 0.0 112.393 174.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.7 ttp -51.99 -59.12 4.71 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.81 1.244 . . . . 0.0 111.788 176.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -56.01 -49.03 74.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.95 1.3 . . . . 0.0 112.361 178.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -60.18 -45.15 94.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.549 1.14 . . . . 0.0 113.468 -178.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -102.15 -16.14 16.47 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -169.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -61.61 106.26 0.64 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 119.922 1.237 . . . . 0.0 110.786 169.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.96 -27.77 7.3 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 126.567 2.032 . . . . 0.0 114.142 -174.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.61 134.32 84.22 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 125.102 1.361 . . . . 0.0 111.012 -173.402 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.55 138.71 24.58 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.984 2.456 . . . . 0.0 112.714 -177.236 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -140.13 107.63 5.58 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.736 2.014 . . . . 0.0 108.095 175.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 48.45 66.48 1.06 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.742 1.617 . . . . 0.0 111.82 -169.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.26 -57.56 4.39 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.112 1.815 . . . . 0.0 113.403 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -65.16 131.82 95.2 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 127.036 2.134 . . . . 0.0 112.625 -173.24 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.83 119.53 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.876 2.384 . . . . 0.0 110.251 169.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.5 mtm -60.63 143.99 52.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.604 0.762 . . . . 0.0 111.968 178.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -119.59 130.95 55.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.236 1.414 . . . . 0.0 108.68 171.021 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mm -124.94 141.49 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.52 0.728 . . . . 0.0 110.052 -173.64 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -138.92 148.73 43.96 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.672 1.989 . . . . 0.0 110.273 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.474 0.772 0 C-N-CA 124.044 0.937 . . . . 0.0 112.225 173.094 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 CA-C-O 119.472 -0.627 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -136.53 152.51 50.59 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -173.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 71.9 mt -122.04 131.23 53.88 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.77 2.028 . . . . 0.0 112.266 -169.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.2 tp -86.54 111.28 20.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 168.317 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -98.61 130.51 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.108 1.363 . . . . 0.0 107.75 175.221 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.5 m -136.44 165.31 26.12 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 111.854 -174.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.9 t30 57.56 32.48 21.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.569 1.948 . . . . 0.0 114.395 -171.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.11 148.05 42.17 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 167.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.68 144.25 57.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.515 174.331 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -54.15 -36.58 63.48 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -169.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.42 20.15 51.85 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.115 1.341 . . . . 0.0 115.916 178.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.43 130.74 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.281 1.541 . . . . 0.0 110.774 171.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -76.15 140.53 41.8 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.383 1.073 . . . . 0.0 112.669 -177.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.43 -51.82 67.86 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.138 1.375 . . . . 0.0 112.696 175.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.29 80.16 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.443 1.097 . . . . 0.0 113.283 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.92 -51.4 69.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.884 0.874 . . . . 0.0 112.076 177.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.0 mm -57.05 -52.55 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.591 1.156 . . . . 0.0 111.351 172.043 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -49.38 -56.07 10.84 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.739 1.216 . . . . 0.0 111.844 176.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -57.79 -51.07 71.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.704 1.201 . . . . 0.0 113.07 176.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -63.8 -47.89 79.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.21 0.914 . . . . 0.0 112.35 -175.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -63.34 -38.61 91.83 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.7 0.682 . . . . 0.0 112.68 175.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.98 -13.76 60.42 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 174.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.16 -58.19 3.79 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.867 -1.146 . . . . 0.0 111.408 173.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -86.96 -32.58 20.01 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -176.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.43 172.25 14.88 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.525 1.536 . . . . 0.0 112.523 176.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 90.8 m -118.15 102.23 8.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.802 1.241 . . . . 0.0 109.439 178.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 pp -105.94 139.38 40.58 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -169.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -78.4 -45.37 22.52 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.686 2.794 . . . . 0.0 110.262 169.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -143.79 143.52 31.39 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.078 1.751 . . . . 0.0 111.506 -174.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.64 119.46 12.56 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.769 1.627 . . . . 0.0 108.587 169.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -137.45 104.08 5.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.995 0.918 . . . . 0.0 111.635 -175.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 125.411 1.484 . . . . 0.0 110.216 169.974 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.086 0 CA-C-O 120.964 0.202 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 81.5 p -139.32 165.14 27.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.096 1.359 . . . . 0.0 112.49 -175.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -150.29 161.64 42.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.743 1.617 . . . . 0.0 111.926 171.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -128.87 115.05 17.29 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.448 1.499 . . . . 0.0 110.234 174.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 14.3 t -124.89 125.62 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.694 1.198 . . . . 0.0 110.719 -169.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -115.13 127.56 55.65 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.613 1.965 . . . . 0.0 109.888 -171.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -114.12 156.59 23.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 127.68 2.392 . . . . 0.0 112.184 -171.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -58.7 -28.44 65.8 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.762 1.394 . . . . 0.0 114.762 -176.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -139.68 149.96 44.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.128 2.171 . . . . 0.0 110.618 176.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -57.64 -41.25 81.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.196 1.398 . . . . 0.0 112.142 170.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.04 -48.74 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.478 1.111 . . . . 0.0 112.376 169.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.26 -43.18 99.43 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.177 0.991 . . . . 0.0 112.62 176.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.12 -52.15 64.17 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.084 0.954 . . . . 0.0 111.504 169.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 28.5 mt -56.2 -44.02 79.07 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.69 -1.257 . . . . 0.0 113.715 176.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -52.6 -57.52 9.73 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.969 1.259 . . . . 0.0 111.842 171.169 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.68 -51.66 59.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.571 1.148 . . . . 0.0 112.0 177.037 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 22.6 ttt -53.87 -63.25 1.21 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.466 1.507 . . . . 0.0 112.168 176.086 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -60.75 -37.88 83.32 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -173.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -68.19 -43.49 77.99 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 113.169 177.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -103.42 -13.37 16.66 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -169.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -59.69 114.31 2.69 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.032 1.287 . . . . 0.0 110.867 169.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.34 -22.63 34.0 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.006 1.765 . . . . 0.0 114.424 -174.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.4 t -71.31 136.1 84.24 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.772 1.229 . . . . 0.0 110.423 -177.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.27 139.38 29.1 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.943 2.429 . . . . 0.0 112.626 -178.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -132.81 109.8 9.9 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.889 2.076 . . . . 0.0 106.871 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 51.65 57.39 6.6 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.145 1.378 . . . . 0.0 110.602 -168.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.47 -52.3 4.09 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.934 1.73 . . . . 0.0 113.726 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -68.79 129.13 92.63 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.809 2.044 . . . . 0.0 112.221 -171.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.55 125.24 11.01 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.2 2.6 . . . . 0.0 111.722 179.13 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.2 mtm -65.96 125.85 26.71 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.522 1.129 . . . . 0.0 112.101 177.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -99.06 112.73 24.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.918 1.287 . . . . 0.0 108.788 170.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mt -118.67 132.64 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.48 1.112 . . . . 0.0 111.2 -172.404 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -137.16 126.99 25.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.793 1.637 . . . . 0.0 111.635 -172.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 46.5 tp . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 124.33 1.052 . . . . 0.0 110.617 172.13 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.037 0 N-CA-C 112.305 -0.318 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -152.46 125.44 8.53 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.04 0.936 . . . . 0.0 112.177 178.885 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.4 mt -121.1 125.86 48.31 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.988 1.715 . . . . 0.0 112.38 -172.487 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.3 tp -89.01 116.57 27.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.698 1.999 . . . . 0.0 106.096 168.382 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.5 128.09 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.987 1.315 . . . . 0.0 108.12 -176.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.0 m -133.96 163.23 30.0 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.778 1.631 . . . . 0.0 112.478 -169.644 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.0 t30 54.55 35.09 22.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.078 2.151 . . . . 0.0 113.369 -169.769 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.41 154.17 37.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.553 1.141 . . . . 0.0 110.314 169.518 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.35 150.82 29.75 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -57.97 -25.49 61.09 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.305 1.042 . . . . 0.0 113.437 172.728 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -78.3 -7.47 87.81 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 125.285 1.421 . . . . 0.0 115.953 175.705 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.2 149.86 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 119.437 1.618 . . . . 0.0 111.118 174.529 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.5 m -129.57 158.13 40.14 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.603 1.561 . . . . 0.0 111.792 177.419 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.3 -51.26 70.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.247 1.419 . . . . 0.0 112.556 178.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.06 86.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.973 0.909 . . . . 0.0 112.749 174.45 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -59.15 -51.33 70.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.169 0.988 . . . . 0.0 112.149 176.469 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 15.1 mm -54.68 -53.91 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.533 1.133 . . . . 0.0 111.138 171.074 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -49.96 -57.5 7.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.41 1.084 . . . . 0.0 111.603 178.158 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -56.85 -50.85 71.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.251 1.021 . . . . 0.0 113.085 177.004 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -47.8 81.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.106 0.866 . . . . 0.0 112.235 -175.238 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -65.98 -41.66 90.84 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 176.011 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.59 -24.69 65.66 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 176.478 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.8 -54.14 43.58 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.144 -0.972 . . . . 0.0 112.027 174.033 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -98.33 -15.72 19.64 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -173.653 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.24 -177.57 17.45 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.575 1.56 . . . . 0.0 113.262 178.851 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.3 m -119.36 94.02 4.28 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.152 0.981 . . . . 0.0 111.264 -177.536 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.33 157.8 20.45 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.031 0.932 . . . . 0.0 112.263 179.205 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -115.57 -37.11 4.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.575 2.75 . . . . 0.0 111.717 173.676 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.423 ' HZ1' ' CE1' ' A' ' 151' ' ' HIS . 2.6 ttpm? -140.54 144.77 36.1 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.034 1.334 . . . . 0.0 111.511 178.091 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.51 143.93 46.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.67 1.588 . . . . 0.0 110.53 169.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.34 147.98 26.96 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.766 2.027 . . . . 0.0 109.382 173.396 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.483 1.197 0 C-N-CA 124.645 1.178 . . . . 0.0 111.023 -173.714 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 112.329 -0.309 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.5 m -141.31 145.75 35.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.339 1.455 . . . . 0.0 111.577 -169.709 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.37 162.3 34.74 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.402 1.881 . . . . 0.0 112.398 174.066 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -137.24 106.95 6.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.991 2.116 . . . . 0.0 109.654 -175.299 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 13.2 t -124.23 126.8 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.168 0.987 . . . . 0.0 109.972 -170.035 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.423 ' CE1' ' HZ1' ' A' ' 133' ' ' LYS . 36.9 m170 -115.4 144.52 43.67 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.426 1.49 . . . . 0.0 110.21 -175.479 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -132.85 154.44 50.34 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.371 2.269 . . . . 0.0 112.94 -168.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.56 -29.43 70.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.241 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -131.24 126.24 34.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.065 1.746 . . . . 0.0 111.393 -173.656 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.6 -43.57 98.62 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.217 1.407 . . . . 0.0 112.508 174.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.01 -48.96 61.32 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.585 1.154 . . . . 0.0 112.772 169.872 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.83 -42.06 97.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.626 1.17 . . . . 0.0 112.758 177.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.52 69.03 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.711 0.805 . . . . 0.0 111.829 169.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.5 tp -56.66 -46.81 80.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.074 1.349 . . . . 0.0 112.202 177.408 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -49.45 -57.93 6.09 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.628 1.571 . . . . 0.0 111.318 171.47 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.77 -50.36 66.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.614 1.166 . . . . 0.0 112.846 175.554 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 23.7 ttp -51.51 -59.17 4.55 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.137 1.375 . . . . 0.0 111.476 176.348 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -55.93 -46.94 78.33 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.004 1.321 . . . . 0.0 112.412 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.01 -41.7 97.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.904 1.282 . . . . 0.0 113.538 -178.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -109.19 -15.82 14.22 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -170.248 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.82 113.88 2.5 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.229 1.377 . . . . 0.0 110.995 169.803 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.03 -24.15 19.53 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.337 1.922 . . . . 0.0 114.129 -175.688 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t -69.67 128.66 91.9 Favored Pre-proline 0 N--CA 1.477 0.879 0 CA-C-N 118.643 1.221 . . . . 0.0 111.706 -170.746 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.78 123.58 13.56 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 124.121 3.214 . . . . 0.0 114.355 173.883 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 tp -86.96 77.07 9.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.732 1.613 . . . . 0.0 107.482 169.009 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 47.07 36.09 3.95 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.552 1.941 . . . . 0.0 113.504 -169.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 143.84 -77.06 0.28 Allowed Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.715 1.626 . . . . 0.0 112.876 -178.617 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -65.4 126.88 92.33 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 125.185 1.394 . . . . 0.0 112.302 -176.192 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.3 121.72 7.03 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.725 2.283 . . . . 0.0 111.697 -177.673 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.4 mtm -65.04 142.6 58.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.98 0.912 . . . . 0.0 111.4 174.103 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -124.95 125.27 43.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.542 1.137 . . . . 0.0 110.032 176.126 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.1 mt -128.52 137.26 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.171 0.988 . . . . 0.0 110.987 -170.292 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -137.07 125.84 23.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.988 1.715 . . . . 0.0 111.043 -177.873 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.467 0.387 0 C-N-CA 123.989 0.916 . . . . 0.0 108.643 169.885 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.897 0 N-CA-C 112.66 -0.176 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -140.57 133.49 29.19 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.886 1.275 . . . . 0.0 111.191 -176.912 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.5 mt -119.65 122.51 41.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.802 1.641 . . . . 0.0 111.746 176.112 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.4 tp -81.63 129.15 34.59 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.863 1.665 . . . . 0.0 106.852 168.401 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.01 132.86 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.669 1.188 . . . . 0.0 108.87 -176.226 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.9 m -137.46 163.02 32.1 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.205 1.802 . . . . 0.0 111.657 -172.229 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.4 t30 47.61 52.39 12.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.47 1.908 . . . . 0.0 113.158 -173.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.4 mt -84.22 168.87 15.32 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.834 1.654 . . . . 0.0 111.254 169.838 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.8 156.05 31.91 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.903 0.859 . . . . 0.0 112.039 169.624 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -77.41 -36.13 53.59 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.758 1.223 . . . . 0.0 112.15 -178.673 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.25 53.86 4.91 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.565 1.555 . . . . 0.0 112.539 -178.865 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.5 t -125.03 145.74 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.36 2.264 . . . . 0.0 111.57 -169.913 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.0 m -144.3 169.38 18.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.139 1.776 . . . . 0.0 111.819 -175.858 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -48.71 -57.82 5.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.773 2.029 . . . . 0.0 112.562 -178.089 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.19 87.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.189 1.395 . . . . 0.0 113.489 177.536 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.0 -52.2 66.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.151 0.98 . . . . 0.0 112.265 -179.839 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 36.2 mm -56.64 -52.45 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.882 0.873 . . . . 0.0 110.899 171.248 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -49.33 -56.18 10.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.014 0.926 . . . . 0.0 112.324 178.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -57.02 -52.37 65.55 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.853 0.861 . . . . 0.0 112.951 176.823 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.52 -46.43 90.19 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.893 0.77 . . . . 0.0 112.496 -176.851 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -65.09 -47.65 76.48 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.611 0.642 . . . . 0.0 112.438 174.492 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.52 64.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.244 1.017 . . . . 0.0 113.352 179.554 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.41 -45.29 72.9 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.43 1.092 . . . . 0.0 113.017 174.763 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -98.13 -19.06 18.15 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -177.41 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -159.98 153.51 24.49 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-N 120.356 1.435 . . . . 0.0 115.326 172.18 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 47.4 m -75.03 129.9 38.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.206 1.403 . . . . 0.0 111.42 -174.104 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 pp -135.62 147.04 48.49 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.643 1.177 . . . . 0.0 113.531 -174.032 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -73.91 -52.12 13.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.979 2.511 . . . . 0.0 110.246 170.03 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -150.07 153.37 36.32 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.144 1.778 . . . . 0.0 111.488 -177.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.55 133.82 27.97 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.929 1.691 . . . . 0.0 109.362 169.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.63 158.85 44.42 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.541 1.136 . . . . 0.0 113.754 -170.005 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 127.608 2.363 . . . . 0.0 108.67 169.901 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.912 0 CA-C-O 119.674 -0.514 . . . . 0.0 112.767 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.2 m -140.47 121.15 14.31 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.951 1.3 . . . . 0.0 111.528 -171.613 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.09 169.4 14.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.31 1.844 . . . . 0.0 113.232 -174.734 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -138.59 123.89 19.3 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.266 1.426 . . . . 0.0 110.832 -178.462 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.1 t -128.09 116.59 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.291 1.036 . . . . 0.0 110.904 -174.377 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -92.68 101.75 14.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.35 1.86 . . . . 0.0 108.336 179.062 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -77.38 166.56 22.97 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.653 1.981 . . . . 0.0 113.129 -178.753 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -54.26 -48.25 71.39 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 171.125 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -153.9 136.56 15.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 129.013 2.925 . . . . 0.0 109.516 -171.705 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -60.8 -37.87 83.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.086 0.954 . . . . 0.0 113.552 -176.825 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.4 -48.64 62.54 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.823 1.249 . . . . 0.0 113.093 169.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.12 -44.31 80.22 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.158 0.983 . . . . 0.0 112.021 173.654 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -51.87 -48.52 64.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.132 1.373 . . . . 0.0 112.853 175.12 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.5 tp -52.16 -43.47 64.12 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.49 1.916 . . . . 0.0 113.075 176.69 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -57.18 -55.19 37.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.111 0.965 . . . . 0.0 111.33 174.42 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.54 78.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.8 1.24 . . . . 0.0 112.55 175.263 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 23.6 ttp -50.61 -59.06 4.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.163 1.785 . . . . 0.0 111.272 175.488 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -56.43 -47.5 78.95 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.486 1.114 . . . . 0.0 112.44 177.572 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -58.26 -47.53 83.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.391 1.076 . . . . 0.0 113.279 179.118 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -95.22 -18.87 20.5 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -171.214 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -59.93 109.55 0.97 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 119.797 1.181 . . . . 0.0 110.591 169.684 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.25 -30.45 6.26 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.371 1.939 . . . . 0.0 113.714 -174.016 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.28 133.52 93.31 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 125.15 1.38 . . . . 0.0 110.766 -175.241 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.17 143.63 20.24 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.882 2.388 . . . . 0.0 112.94 -177.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 tp -125.29 107.38 10.65 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.85 2.06 . . . . 0.0 107.92 169.744 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 39.71 58.1 2.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.264 1.826 . . . . 0.0 112.463 -169.89 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.79 -45.4 2.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.122 1.344 . . . . 0.0 114.192 -179.563 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -73.13 116.59 52.3 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.23 1.412 . . . . 0.0 111.377 -171.012 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.8 114.54 3.74 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.68 2.253 . . . . 0.0 110.953 174.892 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.61 138.72 58.56 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.431 1.092 . . . . 0.0 111.754 -178.392 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -118.74 126.93 52.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.442 1.497 . . . . 0.0 109.586 175.236 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.6 mt -130.54 138.57 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.012 0.925 . . . . 0.0 111.173 -169.773 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -143.06 126.62 16.87 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.917 1.687 . . . . 0.0 111.518 -173.083 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.54 0.595 0 O-C-N 121.433 -0.792 . . . . 0.0 111.523 170.139 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.21 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -127.21 107.37 9.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.868 1.267 . . . . 0.0 110.413 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -108.91 105.56 15.16 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.283 1.833 . . . . 0.0 109.229 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.6 tp -89.51 132.86 34.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.775 2.03 . . . . 0.0 110.171 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.44 123.43 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.928 1.691 . . . . 0.0 109.379 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.3 m -127.01 160.38 31.3 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.774 1.629 . . . . 0.0 111.868 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.0 t30 54.37 46.34 25.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.519 1.928 . . . . 0.0 113.792 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 mt -78.48 157.29 28.95 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.151 1.381 . . . . 0.0 109.371 169.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.3 147.13 53.17 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.054 -1.029 . . . . 0.0 112.269 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -57.08 -28.8 62.93 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -81.8 -2.4 90.53 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.229 1.395 . . . . 0.0 115.375 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 80.9 t -66.78 140.19 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.122 1.461 . . . . 0.0 111.067 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.1 m -121.11 158.05 28.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.412 1.485 . . . . 0.0 112.694 -174.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.01 -57.34 10.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.345 1.858 . . . . 0.0 112.996 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.55 89.73 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.557 1.143 . . . . 0.0 113.242 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.11 -50.43 74.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.176 0.99 . . . . 0.0 112.099 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 mm -55.24 -52.18 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.124 0.97 . . . . 0.0 111.467 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -52.27 -51.74 56.75 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.846 0.859 . . . . 0.0 112.201 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -59.05 -53.39 58.94 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.98 1.312 . . . . 0.0 113.156 174.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.99 -43.16 99.55 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.29 0.95 . . . . 0.0 112.446 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -64.92 -41.73 95.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.73 -29.95 69.68 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 175.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.34 -57.08 12.65 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.068 0.947 . . . . 0.0 112.562 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -91.71 -16.68 26.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.95 -178.93 16.12 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.474 1.512 . . . . 0.0 114.84 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.57 107.46 12.44 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.448 1.899 . . . . 0.0 110.257 -169.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 pp -132.29 148.83 52.46 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -83.76 -51.49 7.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.725 2.41 . . . . 0.0 110.511 170.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.24 148.55 30.6 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.784 1.633 . . . . 0.0 111.374 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.61 131.83 23.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.902 1.281 . . . . 0.0 110.841 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.58 157.8 44.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.372 1.469 . . . . 0.0 113.063 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -119.89 152.96 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 126.486 1.914 . . . . 0.0 110.819 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -50.44 -46.54 56.59 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.661 1.984 . . . . 0.0 115.364 -169.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -62.76 124.44 21.04 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.852 0.861 . . . . 0.0 112.195 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -150.76 -71.28 0.17 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.5 1.12 . . . . 0.0 111.45 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -128.43 63.86 1.43 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.595 1.958 . . . . 0.0 108.549 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.3 p -152.41 -71.13 0.15 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.932 1.693 . . . . 0.0 111.548 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.92 56.76 12.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.166 1.365 . . . . 0.0 112.077 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.07 134.5 48.12 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.304 1.842 . . . . 0.0 111.328 -172.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 m -67.72 106.89 2.38 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.478 1.511 . . . . 0.0 111.664 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.5 tp -141.69 -73.89 0.32 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.452 1.501 . . . . 0.0 110.842 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.7 81.76 1.52 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.151 1.357 . . . . 0.0 111.63 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.8 m -147.48 144.59 28.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.831 1.652 . . . . 0.0 109.708 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -143.44 163.03 34.24 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.498 1.519 . . . . 0.0 112.478 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -143.02 133.97 25.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.155 1.382 . . . . 0.0 110.848 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.62 118.24 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.192 1.397 . . . . 0.0 110.004 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -81.75 100.75 9.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.661 1.585 . . . . 0.0 108.266 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -80.29 154.88 27.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.171 1.788 . . . . 0.0 112.724 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.19 -30.65 58.1 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.832 1.253 . . . . 0.0 111.733 169.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -141.04 116.26 9.97 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.218 1.807 . . . . 0.0 111.249 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -28.63 68.77 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.84 -48.17 81.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.881 0.872 . . . . 0.0 111.972 171.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.79 -39.51 94.43 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.675 1.19 . . . . 0.0 112.214 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.07 83.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.376 1.071 . . . . 0.0 112.508 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.8 tp -59.36 -44.33 92.73 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.187 1.395 . . . . 0.0 111.746 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -51.33 -55.21 19.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.781 1.232 . . . . 0.0 110.955 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.97 -48.3 76.06 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.383 1.073 . . . . 0.0 112.846 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 25.8 ttt -51.18 -60.54 3.0 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.831 1.653 . . . . 0.0 111.399 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -56.84 -44.98 82.63 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.132 0.973 . . . . 0.0 112.695 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -59.77 -44.51 93.84 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.854 1.262 . . . . 0.0 113.545 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -109.9 -16.69 13.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -59.8 115.37 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.34 1.427 . . . . 0.0 111.196 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.33 -24.78 26.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.992 1.758 . . . . 0.0 114.026 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.05 132.96 90.03 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 124.594 1.158 . . . . 0.0 110.628 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.45 142.27 23.47 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.932 2.421 . . . . 0.0 112.44 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 64.6 tp -128.14 105.32 8.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.647 1.979 . . . . 0.0 107.694 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 49.27 57.74 6.15 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.402 1.481 . . . . 0.0 111.272 -169.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.21 -54.06 4.93 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.311 1.434 . . . . 0.0 113.48 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -59.87 119.25 39.48 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 126.43 1.892 . . . . 0.0 112.103 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.58 120.7 6.87 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.952 2.435 . . . . 0.0 111.29 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.0 mtm -65.07 138.53 58.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.309 1.044 . . . . 0.0 111.059 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -122.47 125.53 46.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.643 1.177 . . . . 0.0 110.062 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.3 mt -124.46 141.19 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.508 1.123 . . . . 0.0 111.671 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -139.69 146.04 39.14 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.701 2.0 . . . . 0.0 110.869 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 66.5 tp -123.97 137.32 54.63 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.244 1.418 . . . . 0.0 111.889 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.73 148.13 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.307 2.243 . . . . 0.0 109.404 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 9.4 m -142.49 138.98 31.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.053 1.341 . . . . 0.0 109.974 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.413 1.885 . . . . 0.0 114.133 -178.688 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -78.03 96.22 5.04 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.1 0.96 . . . . 0.0 110.963 -174.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -88.59 101.17 13.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.353 1.861 . . . . 0.0 107.426 169.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.4 tp -88.21 133.73 33.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.585 1.954 . . . . 0.0 110.028 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.89 136.84 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.41 1.484 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.0 m -140.34 167.92 21.03 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.451 1.9 . . . . 0.0 111.934 -171.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.7 t30 51.44 46.81 25.93 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.346 1.858 . . . . 0.0 113.006 -173.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -87.12 167.1 14.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.845 1.658 . . . . 0.0 109.993 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -75.45 150.58 38.24 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.964 -1.085 . . . . 0.0 110.603 169.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -49.44 -41.77 40.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.504 1.121 . . . . 0.0 113.546 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.71 9.46 73.85 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.712 1.625 . . . . 0.0 115.761 -173.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.45 147.54 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.046 1.423 . . . . 0.0 109.528 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -129.94 155.61 45.78 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -45.75 -58.14 3.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.527 2.331 . . . . 0.0 112.101 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.63 80.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.38 1.472 . . . . 0.0 113.168 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.12 -52.55 65.24 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.51 1.124 . . . . 0.0 112.143 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.5 mm -57.81 -51.52 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.739 1.216 . . . . 0.0 111.229 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -48.46 -54.21 15.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.939 1.295 . . . . 0.0 111.918 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.3 -53.75 53.88 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.663 0.785 . . . . 0.0 112.75 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.15 -45.12 89.87 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.799 0.727 . . . . 0.0 112.567 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -64.71 -43.25 94.03 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.786 0.721 . . . . 0.0 112.382 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.24 -32.77 66.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.62 -41.67 81.8 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.205 1.002 . . . . 0.0 113.16 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -113.25 -10.14 13.37 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.67 162.14 28.65 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.816 1.198 . . . . 0.0 114.382 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.26 108.55 19.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.764 1.626 . . . . 0.0 110.087 -169.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.9 pp -130.91 152.93 49.69 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.2 mmmt -93.56 -49.39 5.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.998 2.919 . . . . 0.0 111.111 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -145.87 143.02 29.34 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.228 1.411 . . . . 0.0 111.28 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -126.94 135.9 51.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.677 1.591 . . . . 0.0 110.556 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.3 166.09 25.65 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.796 2.038 . . . . 0.0 111.7 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 88.3 t -134.72 159.35 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.942 1.697 . . . . 0.0 110.8 -173.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -38.75 -48.61 1.52 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.772 2.029 . . . . 0.0 115.944 -171.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -65.88 -16.12 63.55 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -80.96 -55.28 4.89 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.569 169.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -68.03 -36.98 80.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.004 1.722 . . . . 0.0 113.754 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.8 m -135.65 -174.88 3.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.226 2.61 . . . . 0.0 110.867 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.59 -66.62 2.08 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 120.978 -1.076 . . . . 0.0 111.891 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.25 139.19 19.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.178 2.191 . . . . 0.0 109.494 173.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.5 m -127.31 173.28 9.9 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.601 1.16 . . . . 0.0 111.261 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.68 -40.18 78.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.486 0.714 . . . . 0.0 112.357 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.91 96.88 0.12 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.428 1.49 . . . . 0.0 111.169 171.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 65.4 p -139.19 156.37 47.16 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.684 1.193 . . . . 0.0 112.739 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.06 159.37 42.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.325 1.85 . . . . 0.0 111.378 172.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.63 115.03 9.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.734 1.614 . . . . 0.0 109.801 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.2 t -127.7 115.54 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.238 1.015 . . . . 0.0 110.249 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -80.83 104.75 11.55 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.366 1.467 . . . . 0.0 109.457 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -82.08 155.13 25.24 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.68 1.592 . . . . 0.0 112.163 171.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -80.46 -59.54 2.66 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.401 -0.812 . . . . 0.0 112.323 169.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -88.65 126.99 35.56 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.163 1.385 . . . . 0.0 111.441 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -46.13 89.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.127 1.371 . . . . 0.0 111.822 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.45 -46.22 87.0 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.761 1.224 . . . . 0.0 112.306 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -65.75 -36.61 84.04 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.061 0.945 . . . . 0.0 112.928 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.02 -48.17 83.03 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.291 -0.88 . . . . 0.0 111.936 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.96 -42.79 90.7 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.551 1.14 . . . . 0.0 112.377 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -51.74 -57.79 8.26 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.777 1.631 . . . . 0.0 110.427 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.11 60.48 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.725 1.21 . . . . 0.0 112.425 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 21.9 ttt -49.62 -62.45 1.55 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.162 1.385 . . . . 0.0 111.667 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -57.57 -49.16 77.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.622 1.169 . . . . 0.0 112.974 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -63.24 -48.01 80.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.868 0.867 . . . . 0.0 113.258 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.05 -13.74 24.91 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -60.28 108.27 0.77 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.87 1.214 . . . . 0.0 110.739 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 119.06 -30.63 5.78 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.345 1.926 . . . . 0.0 113.933 -173.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.4 134.57 90.96 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.168 1.387 . . . . 0.0 110.635 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.41 146.05 24.32 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.822 2.348 . . . . 0.0 113.334 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 37.3 tp -135.65 108.53 7.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.762 1.625 . . . . 0.0 108.425 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 50.16 63.25 2.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.694 1.597 . . . . 0.0 111.654 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.48 -63.05 4.53 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.174 1.369 . . . . 0.0 113.384 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -63.56 131.94 95.01 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.184 1.393 . . . . 0.0 112.408 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 123.61 9.38 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.749 2.966 . . . . 0.0 111.694 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.17 132.28 49.92 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.289 1.035 . . . . 0.0 111.55 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -110.14 130.38 55.55 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.2 1.4 . . . . 0.0 109.124 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.3 mt -128.59 143.37 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.846 0.859 . . . . 0.0 111.857 -169.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -140.06 146.18 38.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.243 2.217 . . . . 0.0 110.431 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -132.79 129.3 38.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.099 1.36 . . . . 0.0 110.581 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.58 142.71 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.958 1.303 . . . . 0.0 111.797 171.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 6.3 m -64.36 148.1 51.13 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.595 1.958 . . . . 0.0 113.071 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 127.075 2.15 . . . . 0.0 113.851 173.839 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.04 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -102.94 119.59 39.12 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.14 1.376 . . . . 0.0 110.64 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 87.6 mt -127.34 131.72 50.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.494 1.518 . . . . 0.0 111.618 -171.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.9 tp -77.42 137.99 39.01 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.481 1.513 . . . . 0.0 109.091 169.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.9 122.75 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.324 1.85 . . . . 0.0 108.087 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.9 m -133.75 169.24 17.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.917 1.287 . . . . 0.0 112.937 -169.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.3 t30 54.81 46.18 25.07 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.788 2.035 . . . . 0.0 113.079 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 mt -82.37 165.59 20.16 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.485 1.514 . . . . 0.0 110.057 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.48 145.87 43.22 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.006 -1.058 . . . . 0.0 111.317 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -58.03 -26.37 62.35 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.59 -1.56 90.09 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.117 1.341 . . . . 0.0 115.477 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.4 138.39 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.229 1.514 . . . . 0.0 111.232 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.2 m -113.45 155.9 24.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.172 1.389 . . . . 0.0 113.124 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.05 -57.27 11.69 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.604 1.961 . . . . 0.0 112.991 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.29 93.45 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.214 1.005 . . . . 0.0 112.919 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -56.86 -50.42 72.52 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.294 -0.879 . . . . 0.0 111.853 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.1 mm -55.15 -53.38 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.446 1.098 . . . . 0.0 111.741 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -47.84 -59.47 3.3 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.611 0.765 . . . . 0.0 111.76 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -63.54 -43.28 97.57 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -47.0 81.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.743 1.156 . . . . 0.0 111.93 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -64.71 -40.69 95.78 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.99 -17.11 61.75 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.33 -59.03 3.11 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.915 -1.116 . . . . 0.0 111.786 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -88.16 -21.85 24.38 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.13 -178.31 15.26 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.652 1.596 . . . . 0.0 113.234 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.6 m -125.21 122.31 36.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.238 1.415 . . . . 0.0 109.549 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.66 147.09 52.33 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -91.2 -34.89 14.82 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.454 1.902 . . . . 0.0 110.949 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -137.16 142.35 42.2 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.962 1.305 . . . . 0.0 112.41 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.42 128.96 12.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.478 1.511 . . . . 0.0 109.992 169.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.0 153.25 37.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.666 1.186 . . . . 0.0 112.876 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.83 149.22 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.488 1.915 . . . . 0.0 110.009 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -51.92 -40.23 60.4 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -68.94 159.17 33.19 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -144.92 -59.15 0.36 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.255 1.422 . . . . 0.0 111.709 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -130.82 -45.55 1.05 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.934 1.693 . . . . 0.0 113.205 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.8 p -55.45 -53.63 53.85 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.355 1.862 . . . . 0.0 114.052 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.57 39.73 78.56 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.011 1.291 . . . . 0.0 113.028 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -60.06 152.39 24.19 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.299 1.839 . . . . 0.0 113.243 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 39.5 m -73.13 82.09 1.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.088 1.355 . . . . 0.0 111.399 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 50.0 tp -146.39 152.05 38.45 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.998 2.119 . . . . 0.0 109.737 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.99 70.4 0.52 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.019 1.295 . . . . 0.0 111.996 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 55.6 p -133.7 146.21 50.6 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.315 1.446 . . . . 0.0 112.81 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.41 171.99 15.67 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.291 2.236 . . . . 0.0 111.35 -174.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -143.68 135.86 26.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.889 1.676 . . . . 0.0 110.46 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.51 129.23 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.585 1.154 . . . . 0.0 110.064 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -109.1 96.91 6.63 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.357 1.463 . . . . 0.0 108.889 173.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -73.03 140.41 47.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.005 2.122 . . . . 0.0 110.103 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.81 -16.97 63.37 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 28.8 mtm105 -134.82 134.12 40.49 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.224 1.81 . . . . 0.0 110.893 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -55.27 -46.63 76.13 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.208 1.403 . . . . 0.0 112.575 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.96 -51.56 61.06 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.256 1.022 . . . . 0.0 112.028 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.55 -41.39 98.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.626 1.17 . . . . 0.0 113.077 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.67 -56.56 17.88 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.692 1.197 . . . . 0.0 111.637 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.18 -42.28 90.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.254 1.422 . . . . 0.0 112.561 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -52.12 -61.69 2.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.162 1.385 . . . . 0.0 110.89 170.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.01 -47.86 67.99 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.657 1.183 . . . . 0.0 112.601 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 35.8 ttp -51.13 -60.72 2.81 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.411 1.484 . . . . 0.0 111.29 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -59.3 -45.04 92.38 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.87 1.268 . . . . 0.0 112.879 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -58.71 -48.37 81.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.483 1.113 . . . . 0.0 113.362 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -103.48 -17.33 15.26 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -60.85 111.13 1.53 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 120.273 1.397 . . . . 0.0 111.142 170.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.05 -22.46 27.44 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.146 1.831 . . . . 0.0 114.39 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 76.3 t -70.12 133.18 87.85 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 118.573 1.186 . . . . 0.0 110.83 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.14 139.14 21.13 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.898 2.398 . . . . 0.0 112.505 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.0 tp -126.65 106.16 9.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.671 1.988 . . . . 0.0 107.887 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 47.86 57.89 5.58 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.484 1.513 . . . . 0.0 111.321 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.64 -54.4 4.8 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.228 1.394 . . . . 0.0 113.468 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.44 119.07 43.33 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.962 1.705 . . . . 0.0 112.44 -172.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.09 117.83 5.36 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.884 2.389 . . . . 0.0 111.076 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.53 141.43 58.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.596 1.158 . . . . 0.0 111.906 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -122.91 130.86 53.37 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.326 1.45 . . . . 0.0 110.249 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.7 mm -117.48 133.35 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.533 1.133 . . . . 0.0 109.918 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -140.34 151.56 45.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.835 1.254 . . . . 0.0 112.684 -171.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -134.72 174.47 10.54 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.839 2.056 . . . . 0.0 112.052 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.66 103.53 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.111 1.364 . . . . 0.0 108.822 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.0 p -65.95 -54.53 25.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.554 1.142 . . . . 0.0 112.188 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.25 1.115 0 C-N-CA 127.176 2.19 . . . . 0.0 112.145 179.909 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -75.65 126.75 31.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.979 1.312 . . . . 0.0 111.74 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -137.69 111.45 8.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.514 1.926 . . . . 0.0 110.274 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.2 tp -85.52 132.78 34.14 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.769 2.028 . . . . 0.0 110.062 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.2 t -122.47 112.74 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.428 1.491 . . . . 0.0 108.447 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.7 m -117.91 164.13 15.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.311 1.044 . . . . 0.0 111.887 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 54.73 47.67 21.94 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.324 1.85 . . . . 0.0 114.217 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.28 152.41 32.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.907 1.283 . . . . 0.0 108.932 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.71 147.36 53.37 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.869 -1.144 . . . . 0.0 110.789 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -54.93 -28.68 52.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.488 1.115 . . . . 0.0 113.881 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.67 1.02 85.32 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.329 1.442 . . . . 0.0 115.779 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.6 t -66.7 114.75 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.926 1.863 . . . . 0.0 110.484 175.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.5 m -70.73 151.99 44.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.784 1.234 . . . . 0.0 112.598 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -55.18 -48.52 73.67 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.486 1.514 . . . . 0.0 112.751 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.19 76.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.221 1.408 . . . . 0.0 113.665 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -58.5 -53.86 53.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.116 0.966 . . . . 0.0 112.807 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.5 mm -54.59 -55.48 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.342 1.057 . . . . 0.0 110.999 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -49.34 -55.74 11.86 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.255 1.422 . . . . 0.0 111.875 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.43 -49.81 76.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.533 1.133 . . . . 0.0 113.311 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -43.92 95.83 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.215 0.916 . . . . 0.0 111.417 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -66.71 -44.98 80.17 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.862 1.265 . . . . 0.0 112.708 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.0 -14.42 54.0 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.78 -63.46 1.07 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.919 -1.113 . . . . 0.0 111.479 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -83.28 -21.11 33.38 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.4 -168.76 11.68 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.151 1.834 . . . . 0.0 112.921 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 m -140.91 129.23 22.37 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.42 1.088 . . . . 0.0 110.618 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -136.54 152.57 50.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -171.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -83.0 -51.81 7.23 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.74 2.416 . . . . 0.0 111.133 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -146.54 147.92 31.64 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.084 1.353 . . . . 0.0 112.387 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.36 137.55 27.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.954 1.702 . . . . 0.0 110.825 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.42 116.19 6.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.727 1.211 . . . . 0.0 112.557 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.08 142.8 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.486 1.514 . . . . 0.0 109.755 169.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -45.57 -46.35 14.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 127.257 2.223 . . . . 0.0 115.034 -169.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -56.78 -18.17 11.77 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -174.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -50.0 -36.32 28.07 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.994 1.717 . . . . 0.0 112.613 169.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -137.5 -45.75 0.55 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.305 1.842 . . . . 0.0 114.101 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.2 m -77.24 95.96 4.44 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.838 1.255 . . . . 0.0 110.932 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.1 58.96 4.32 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.004 0.811 . . . . 0.0 113.312 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -142.1 164.96 28.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.598 1.559 . . . . 0.0 113.679 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.9 m -73.21 113.24 10.05 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.481 1.112 . . . . 0.0 109.084 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 60.5 tp -147.8 -76.52 0.17 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.017 1.327 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.52 77.65 1.36 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.124 1.345 . . . . 0.0 111.41 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.2 m -150.5 153.06 35.16 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.64 1.576 . . . . 0.0 109.757 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.55 156.69 43.85 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.266 1.426 . . . . 0.0 112.513 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -123.2 131.67 53.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.816 1.646 . . . . 0.0 109.805 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.01 144.3 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.33 1.452 . . . . 0.0 109.722 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -126.29 102.78 7.33 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.99 1.716 . . . . 0.0 108.949 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -78.13 166.38 22.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.869 1.668 . . . . 0.0 112.706 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -61.31 -35.39 77.23 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.085 0.954 . . . . 0.0 112.796 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.74 147.03 34.93 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.44 1.496 . . . . 0.0 112.474 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -55.07 -46.02 75.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.437 1.495 . . . . 0.0 112.587 170.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -50.95 -48.11 60.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.395 1.078 . . . . 0.0 112.8 172.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.21 -39.17 82.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.1 0.96 . . . . 0.0 112.568 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.08 -45.85 86.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.72 0.808 . . . . 0.0 112.035 169.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.63 -44.15 96.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.372 1.469 . . . . 0.0 111.839 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -52.7 -54.54 32.16 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.185 1.394 . . . . 0.0 111.408 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.52 -51.67 58.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.772 1.229 . . . . 0.0 112.378 173.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 30.8 ttp -52.54 -62.4 1.67 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.581 1.552 . . . . 0.0 111.286 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -57.14 -45.15 83.79 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.742 1.217 . . . . 0.0 112.755 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.87 -46.69 89.6 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.351 1.06 . . . . 0.0 113.042 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -107.75 -12.28 15.25 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -169.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -59.23 119.54 7.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.294 1.406 . . . . 0.0 111.583 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.89 -18.22 57.54 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.019 1.771 . . . . 0.0 114.323 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -72.29 128.09 89.35 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 118.839 1.319 . . . . 0.0 111.077 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.12 136.16 71.0 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.943 3.096 . . . . 0.0 113.844 172.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.0 tp -133.77 103.46 5.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.495 1.518 . . . . 0.0 107.567 169.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 51.32 62.28 2.79 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.8 1.64 . . . . 0.0 111.08 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.86 -61.64 4.71 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.467 1.508 . . . . 0.0 113.343 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -65.09 125.2 88.77 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.681 1.592 . . . . 0.0 112.118 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.8 126.23 9.96 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.486 2.791 . . . . 0.0 111.631 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -68.29 120.54 14.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.312 1.045 . . . . 0.0 111.797 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -94.17 103.49 15.53 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.92 1.288 . . . . 0.0 108.921 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -113.5 134.23 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.311 1.045 . . . . 0.0 110.862 -169.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -142.59 123.0 13.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.534 1.534 . . . . 0.0 112.157 -171.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.32 122.44 24.43 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 169.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.85 80.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 122.488 1.137 . . . . 0.0 112.051 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 7.6 p -80.25 135.0 36.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.66 1.184 . . . . 0.0 111.445 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 37.1 m . . . . . 0 C--O 1.252 1.215 0 C-N-CA 126.583 1.953 . . . . 0.0 113.945 -178.163 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 CA-C-O 121.427 0.46 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -139.59 150.75 45.39 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.372 1.469 . . . . 0.0 112.08 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.5 mt -125.42 144.52 50.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.964 1.706 . . . . 0.0 111.204 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.5 tp -117.02 99.91 7.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.874 1.669 . . . . 0.0 107.579 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.21 129.18 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.594 1.557 . . . . 0.0 108.174 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.6 m -133.28 170.85 14.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.249 1.42 . . . . 0.0 111.947 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.3 t30 56.93 38.48 29.42 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.207 1.803 . . . . 0.0 113.269 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.07 165.31 20.72 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.294 1.437 . . . . 0.0 110.552 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.76 144.34 52.75 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.39 -0.819 . . . . 0.0 109.811 168.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -56.63 -33.68 66.54 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.94 27.76 16.35 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.499 1.523 . . . . 0.0 115.244 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.59 124.74 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 118.912 1.356 . . . . 0.0 109.652 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.8 m -72.0 135.21 46.31 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.548 0.739 . . . . 0.0 112.031 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.38 -47.74 80.87 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.493 1.117 . . . . 0.0 112.935 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.38 -46.91 76.5 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.689 1.196 . . . . 0.0 112.702 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.27 -48.03 81.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.179 0.992 . . . . 0.0 112.117 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 mm -55.37 -53.65 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.454 1.102 . . . . 0.0 112.087 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -50.16 -55.39 15.29 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.697 0.681 . . . . 0.0 111.474 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -56.66 -52.06 66.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.483 1.113 . . . . 0.0 113.228 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.31 -44.92 90.09 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.12 0.873 . . . . 0.0 112.367 -175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -63.48 -43.48 97.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.579 0.627 . . . . 0.0 112.557 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.2 -19.6 64.66 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.27 -63.24 1.12 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.185 0.994 . . . . 0.0 111.724 172.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.08 -19.17 44.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -138.32 -177.33 15.18 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.336 1.446 . . . . 0.0 113.959 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.7 m -124.62 116.11 21.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.512 1.525 . . . . 0.0 110.238 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.92 144.72 50.57 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -169.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -81.6 -42.71 19.67 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.947 2.099 . . . . 0.0 109.991 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -147.31 145.47 29.37 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.687 1.595 . . . . 0.0 111.915 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.16 114.7 7.62 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.894 1.677 . . . . 0.0 108.126 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.63 113.37 10.96 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.613 1.165 . . . . 0.0 112.165 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.79 153.9 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.325 1.45 . . . . 0.0 110.469 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -42.94 -48.55 5.91 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.715 2.006 . . . . 0.0 115.829 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -73.57 148.59 42.82 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -145.65 -63.68 0.33 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.984 1.714 . . . . 0.0 109.298 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -133.75 77.15 1.7 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.965 2.506 . . . . 0.0 105.394 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 m -135.84 166.31 23.6 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.225 1.41 . . . . 0.0 113.928 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -163.51 65.01 0.24 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.151 1.357 . . . . 0.0 112.158 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -136.41 148.72 47.93 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.16 1.784 . . . . 0.0 112.107 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 55.1 m -74.37 86.12 1.99 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.96 1.304 . . . . 0.0 109.955 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.6 tp -140.73 142.63 34.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.326 2.25 . . . . 0.0 109.161 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.39 70.75 0.41 Allowed Glycine 0 N--CA 1.469 0.86 0 C-N-CA 123.855 0.74 . . . . 0.0 113.025 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.5 p -136.79 158.73 43.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.199 1.4 . . . . 0.0 112.958 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.73 138.43 23.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.496 1.518 . . . . 0.0 111.849 172.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -106.92 124.9 50.29 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.578 1.951 . . . . 0.0 110.431 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.3 t -129.34 139.31 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.008 1.323 . . . . 0.0 110.115 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -128.96 120.33 25.91 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.919 2.088 . . . . 0.0 109.199 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -103.31 163.59 12.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.581 1.952 . . . . 0.0 113.341 -169.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.35 -36.13 58.36 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 169.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 42.5 mtm-85 -133.77 129.1 36.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.082 1.753 . . . . 0.0 111.278 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -54.68 -45.87 74.0 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.597 1.559 . . . . 0.0 113.083 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.65 -46.72 70.66 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.925 1.29 . . . . 0.0 112.801 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.08 -42.84 93.76 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.466 1.106 . . . . 0.0 112.696 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.22 71.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.707 0.803 . . . . 0.0 111.734 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.65 -47.03 80.66 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.535 1.134 . . . . 0.0 112.58 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -50.81 -58.96 4.66 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.863 1.265 . . . . 0.0 111.165 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.4 -48.12 62.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.355 1.062 . . . . 0.0 112.659 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -55.29 -65.55 0.57 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.071 1.348 . . . . 0.0 111.322 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -61.61 -34.11 75.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -64.05 -42.02 97.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.524 1.13 . . . . 0.0 113.403 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -110.66 -18.43 13.16 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -59.24 115.4 3.18 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.875 1.216 . . . . 0.0 111.19 170.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 103.78 -23.46 32.47 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.857 1.694 . . . . 0.0 114.403 -175.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.8 134.87 90.06 Favored Pre-proline 0 N--CA 1.477 0.924 0 CA-C-N 118.643 1.221 . . . . 0.0 110.216 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.35 141.85 29.29 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.671 2.248 . . . . 0.0 112.93 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -125.33 99.97 6.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.46 2.304 . . . . 0.0 106.855 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 44.02 70.53 0.31 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.992 1.717 . . . . 0.0 111.902 -169.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.6 -57.63 5.05 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.781 1.657 . . . . 0.0 113.531 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -65.76 122.76 82.33 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.996 2.119 . . . . 0.0 112.369 -172.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.79 123.87 10.15 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.867 2.378 . . . . 0.0 111.088 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.1 mtm -61.61 123.6 18.34 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.064 0.945 . . . . 0.0 111.091 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -106.83 104.89 14.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.236 1.414 . . . . 0.0 109.123 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.3 mt -106.76 130.31 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.144 0.978 . . . . 0.0 110.85 -172.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -109.43 147.08 33.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.531 1.933 . . . . 0.0 109.627 173.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -132.73 150.0 52.21 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.249 1.419 . . . . 0.0 112.386 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.45 127.56 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.51 0.724 . . . . 0.0 111.343 175.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.6 p -68.21 -58.77 3.91 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.396 1.478 . . . . 0.0 111.959 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.251 1.159 0 C-N-CA 127.134 2.174 . . . . 0.0 113.76 177.01 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.9 0 CA-C-O 120.823 0.124 . . . . 0.0 113.153 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -117.58 103.73 10.35 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.08 1.752 . . . . 0.0 109.626 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -88.55 105.37 17.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.575 2.35 . . . . 0.0 108.994 -173.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.1 tp -88.88 122.65 32.48 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.756 2.022 . . . . 0.0 109.983 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.8 t -112.11 136.55 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.101 1.76 . . . . 0.0 109.115 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.2 m -137.52 163.13 31.9 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.188 1.795 . . . . 0.0 112.307 -174.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.1 t30 57.01 33.5 23.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.933 2.093 . . . . 0.0 113.918 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.9 mt -72.0 159.03 34.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.139 0.975 . . . . 0.0 110.28 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.83 139.81 57.78 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.535 -0.728 . . . . 0.0 110.571 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.75 -20.9 62.33 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.82 11.9 62.59 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.717 1.627 . . . . 0.0 115.558 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.06 123.99 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.719 1.76 . . . . 0.0 110.33 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.6 m -81.84 149.13 28.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.445 1.098 . . . . 0.0 113.105 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.34 -54.11 50.56 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.85 1.66 . . . . 0.0 112.69 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -39.33 81.81 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.57 1.148 . . . . 0.0 112.951 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.43 -51.05 71.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.835 0.854 . . . . 0.0 111.979 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.9 mm -55.0 -53.06 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.922 0.889 . . . . 0.0 111.511 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.07 -55.32 15.34 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.796 0.839 . . . . 0.0 111.973 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -59.55 -50.96 71.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.964 1.306 . . . . 0.0 113.212 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -63.36 -43.55 97.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.271 0.941 . . . . 0.0 111.886 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -63.4 -44.99 93.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.062 0.545 . . . . 0.0 112.427 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.03 -31.87 67.42 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.5 -52.53 65.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.265 1.026 . . . . 0.0 112.77 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -95.59 -23.67 16.94 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.29 162.04 23.62 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.373 1.463 . . . . 0.0 114.458 -172.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 37.5 m -102.49 103.34 13.7 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.471 1.508 . . . . 0.0 110.424 -173.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -121.48 165.05 16.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 -35.88 2.85 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.776 2.431 . . . . 0.0 111.557 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -140.58 151.09 44.41 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.61 0.764 . . . . 0.0 111.924 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.25 141.89 35.82 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.738 1.615 . . . . 0.0 110.446 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -146.92 152.33 38.49 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.983 1.713 . . . . 0.0 111.608 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.0 t -132.14 147.0 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.1 1.76 . . . . 0.0 109.875 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -55.14 -40.92 71.13 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -58.08 155.94 10.26 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -168.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -143.65 -175.6 4.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 128.685 2.794 . . . . 0.0 108.095 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -46.57 -39.35 10.87 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.722 1.609 . . . . 0.0 114.177 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.7 m -60.4 -32.19 71.09 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.315 1.846 . . . . 0.0 114.598 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 60.64 50.58 65.99 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.833 1.682 . . . . 0.0 114.398 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -66.76 144.96 56.02 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.737 1.215 . . . . 0.0 113.83 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 45.7 m -73.61 94.59 2.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.691 1.596 . . . . 0.0 111.186 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.7 tp -143.89 -66.16 0.36 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.741 1.616 . . . . 0.0 110.745 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.3 68.14 1.52 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.873 0.749 . . . . 0.0 113.344 171.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 78.1 p -137.08 155.69 49.32 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.469 1.108 . . . . 0.0 112.257 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -143.69 158.81 43.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.417 1.487 . . . . 0.0 111.649 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -139.84 120.63 14.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.533 1.533 . . . . 0.0 110.135 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 51.5 t -124.52 118.7 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.143 1.377 . . . . 0.0 109.723 -174.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -93.04 105.55 17.64 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.712 1.205 . . . . 0.0 108.502 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -82.6 152.38 25.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.643 2.777 . . . . 0.0 112.103 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -62.93 -48.36 79.24 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.153 0.581 . . . . 0.0 112.276 170.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -123.92 138.44 54.48 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.854 1.262 . . . . 0.0 112.302 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -59.24 -46.75 87.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.559 1.544 . . . . 0.0 112.966 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.72 62.64 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.764 1.226 . . . . 0.0 113.484 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.51 -43.28 85.71 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.834 0.853 . . . . 0.0 112.32 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.87 -46.51 84.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.101 0.96 . . . . 0.0 112.514 170.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.85 -47.75 79.64 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.941 2.097 . . . . 0.0 111.182 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -51.65 -52.91 44.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.425 1.09 . . . . 0.0 111.841 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.1 -47.03 78.82 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.732 0.813 . . . . 0.0 112.845 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 41.1 ttp -53.1 -60.7 2.96 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.466 1.507 . . . . 0.0 111.454 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -35.64 80.95 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -61.63 -45.93 91.95 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.381 1.072 . . . . 0.0 113.166 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -106.11 -17.38 14.34 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 -169.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -59.65 114.75 2.9 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.204 1.366 . . . . 0.0 111.335 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.71 -23.47 26.02 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.178 1.846 . . . . 0.0 114.138 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 65.7 t -67.82 131.97 92.49 Favored Pre-proline 0 N--CA 1.476 0.866 0 CA-C-N 118.596 1.198 . . . . 0.0 110.886 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.92 121.54 5.46 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.309 2.673 . . . . 0.0 111.972 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 24.2 tp -77.55 79.2 4.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.196 1.399 . . . . 0.0 109.266 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 45.96 35.88 2.66 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.675 1.99 . . . . 0.0 113.633 -170.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 144.04 -79.94 0.24 Allowed Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.916 1.722 . . . . 0.0 112.561 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -64.11 127.06 91.46 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.172 1.389 . . . . 0.0 112.762 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.73 122.5 7.37 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.19 2.593 . . . . 0.0 111.788 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.1 mtm -66.73 136.19 55.13 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.048 0.939 . . . . 0.0 110.959 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -118.02 129.29 55.49 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.723 1.209 . . . . 0.0 109.735 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.5 mt -129.87 141.12 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.944 0.897 . . . . 0.0 112.282 -169.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -137.53 154.3 49.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.835 2.454 . . . . 0.0 110.482 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 64.8 tp -134.02 133.5 41.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.045 1.338 . . . . 0.0 111.493 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.1 m -136.64 162.39 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.118 1.767 . . . . 0.0 111.135 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.5 m -69.12 -54.52 14.55 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.376 -0.827 . . . . 0.0 110.199 169.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 128.817 2.847 . . . . 0.0 111.408 172.372 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.47 167.09 31.51 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 118.8 1.3 . . . . 0.0 112.628 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 89.5 mt -142.23 162.57 35.14 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.037 2.135 . . . . 0.0 111.678 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.8 tp -123.86 106.64 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.199 1.8 . . . . 0.0 106.917 168.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.94 129.39 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.8 m -129.78 171.9 12.21 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.68 1.192 . . . . 0.0 111.701 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.7 t30 50.77 65.07 1.58 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.876 1.671 . . . . 0.0 112.727 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.48 153.95 21.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.872 2.069 . . . . 0.0 109.685 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.44 143.81 57.46 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.737 -1.227 . . . . 0.0 110.588 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -53.4 -34.3 57.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.197 0.999 . . . . 0.0 113.567 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.23 9.0 78.67 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.343 1.449 . . . . 0.0 115.786 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.93 121.26 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.679 1.739 . . . . 0.0 109.919 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.8 m -72.78 146.31 46.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.459 1.104 . . . . 0.0 113.235 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.3 -58.32 8.78 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.798 1.639 . . . . 0.0 113.165 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.79 -37.19 78.42 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.957 0.903 . . . . 0.0 113.001 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.0 -52.31 66.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.815 0.846 . . . . 0.0 112.072 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.6 mm -54.04 -53.31 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.985 0.914 . . . . 0.0 111.318 169.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -52.32 -52.57 52.36 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.146 0.979 . . . . 0.0 112.092 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.84 -50.78 70.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.899 1.28 . . . . 0.0 113.435 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.6 -45.2 91.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.524 1.056 . . . . 0.0 112.275 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -63.0 -40.15 96.91 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.528 0.604 . . . . 0.0 112.37 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.48 -13.57 52.71 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -73.59 -61.67 1.75 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.906 -1.121 . . . . 0.0 111.252 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -85.68 -12.05 52.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.4 166.48 24.47 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.138 1.827 . . . . 0.0 112.883 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.4 m -111.99 97.72 6.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.573 1.549 . . . . 0.0 109.665 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 152' ' ' PHE . 3.7 pp -118.34 144.03 46.18 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -169.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.41 -48.62 15.09 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.803 2.041 . . . . 0.0 110.702 171.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -152.43 149.05 28.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.743 1.217 . . . . 0.0 112.362 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.58 130.41 24.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.591 1.556 . . . . 0.0 109.708 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.15 109.87 8.63 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.465 1.506 . . . . 0.0 111.544 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.9 t -76.2 152.28 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.18 1.792 . . . . 0.0 111.442 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -47.0 -45.29 20.96 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.135 2.574 . . . . 0.0 116.919 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -71.78 162.96 28.67 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -173.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -143.03 -138.09 0.1 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.682 1.593 . . . . 0.0 109.469 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -61.3 -45.12 95.77 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.602 -1.311 . . . . 0.0 110.637 169.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 m -63.74 137.06 57.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 112.014 169.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.81 65.95 2.83 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.752 1.168 . . . . 0.0 112.31 173.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -57.37 144.36 36.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.847 2.059 . . . . 0.0 112.46 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.1 m -123.85 84.23 2.25 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.259 1.424 . . . . 0.0 110.024 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 68.1 tp -131.67 -68.66 0.64 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.82 1.648 . . . . 0.0 110.944 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.67 64.99 1.05 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.915 0.769 . . . . 0.0 113.743 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.6 p -140.69 167.51 22.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.229 1.812 . . . . 0.0 111.179 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.45 125.9 12.4 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.28 1.432 . . . . 0.0 111.555 169.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.16 123.97 28.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.446 1.498 . . . . 0.0 109.849 170.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.7 140.38 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 118.907 0.776 . . . . 0.0 111.122 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -126.12 127.8 46.34 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.024 1.729 . . . . 0.0 110.176 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 131' ' ' LEU . 30.8 m-85 -110.6 158.83 18.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.19 2.196 . . . . 0.0 113.964 -169.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -76.26 -29.63 57.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.626 0.77 . . . . 0.0 112.858 170.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -141.27 129.38 22.1 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.466 1.506 . . . . 0.0 112.087 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -40.05 83.08 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.935 1.694 . . . . 0.0 112.914 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.81 -51.61 68.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.117 0.967 . . . . 0.0 112.334 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.49 -46.47 86.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.274 1.03 . . . . 0.0 112.059 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.6 -50.78 67.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.524 1.13 . . . . 0.0 112.374 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.48 -48.0 80.4 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.541 1.536 . . . . 0.0 112.102 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.25 -52.72 60.46 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.324 1.45 . . . . 0.0 112.319 172.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.87 -50.85 67.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.903 1.281 . . . . 0.0 112.011 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.9 ttt -52.19 -59.73 4.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.791 1.636 . . . . 0.0 112.032 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -51.98 -45.56 64.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.538 1.135 . . . . 0.0 112.557 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.31 -52.34 64.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.516 1.127 . . . . 0.0 113.063 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -95.82 -12.56 25.09 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -169.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -58.91 118.57 5.92 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.764 -1.21 . . . . 0.0 111.139 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.6 -16.74 54.55 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.54 1.543 . . . . 0.0 114.598 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 85.0 t -69.27 126.77 92.94 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 119.11 1.455 . . . . 0.0 110.702 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -60.16 136.93 72.08 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.773 2.982 . . . . 0.0 114.195 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 50.9 tp -136.87 101.33 4.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.503 1.521 . . . . 0.0 108.079 169.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 52.08 65.37 1.52 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.228 1.811 . . . . 0.0 111.986 -169.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.42 -65.5 4.11 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.784 1.183 . . . . 0.0 112.916 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -58.91 125.89 79.2 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.243 1.417 . . . . 0.0 112.22 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.74 127.37 12.26 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.241 2.628 . . . . 0.0 111.252 170.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.5 mtm -62.26 111.87 2.16 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.203 1.001 . . . . 0.0 111.401 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -93.2 91.56 7.33 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.362 1.465 . . . . 0.0 109.104 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 15.6 mt -89.91 138.54 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.425 1.09 . . . . 0.0 110.432 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -128.39 137.46 51.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.663 1.985 . . . . 0.0 110.875 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -11.86 61.18 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -170.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 9.3 p -153.83 158.52 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.949 2.099 . . . . 0.0 109.72 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.97 135.82 56.1 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.175 -0.953 . . . . 0.0 111.76 169.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.025 1.73 . . . . 0.0 113.674 -179.394 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -85.86 116.23 23.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.897 1.279 . . . . 0.0 109.316 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.39 101.16 7.96 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.51 1.924 . . . . 0.0 109.095 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.3 tp -83.47 133.1 34.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.26 1.824 . . . . 0.0 109.985 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.3 81.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.847 2.059 . . . . 0.0 108.419 -173.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.6 m -79.72 158.14 27.0 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.72 1.208 . . . . 0.0 112.491 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.1 t30 57.89 64.65 1.48 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.381 1.872 . . . . 0.0 113.212 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.3 mt -98.38 -116.01 0.14 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.696 1.998 . . . . 0.0 108.738 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -149.34 148.27 29.31 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.313 1.845 . . . . 0.0 110.436 172.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -74.16 71.59 1.67 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.921 1.688 . . . . 0.0 111.442 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 152.19 7.69 0.11 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.388 1.47 . . . . 0.0 116.168 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.1 t -58.35 128.8 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.485 1.643 . . . . 0.0 110.513 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.2 m -70.06 147.51 49.95 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.322 1.049 . . . . 0.0 112.46 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.86 -57.86 10.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.508 0.723 . . . . 0.0 111.651 174.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.51 -39.32 67.48 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.886 1.275 . . . . 0.0 113.239 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.65 -58.16 9.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.111 0.964 . . . . 0.0 112.039 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.8 mm -56.73 -52.28 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.438 1.095 . . . . 0.0 111.407 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -48.56 -57.54 6.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.862 1.665 . . . . 0.0 111.549 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.17 -49.28 76.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.725 1.21 . . . . 0.0 113.229 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.34 -43.41 97.8 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.671 1.123 . . . . 0.0 112.167 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -63.09 -43.96 97.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.224 0.61 . . . . 0.0 112.312 172.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.44 -19.84 63.9 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.28 -61.54 1.73 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.971 -1.081 . . . . 0.0 111.887 173.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -80.41 -25.58 38.97 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.08 -175.05 13.61 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.334 1.445 . . . . 0.0 113.53 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.6 m -127.13 122.58 34.61 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.052 . . . . 0.0 110.99 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.4 142.02 51.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.648 1.179 . . . . 0.0 113.651 -170.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.52 -44.43 19.12 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.285 2.234 . . . . 0.0 110.953 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -148.47 151.7 35.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.975 0.91 . . . . 0.0 112.695 -175.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.54 150.5 42.22 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.669 1.587 . . . . 0.0 111.637 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.23 154.98 39.9 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.36 1.864 . . . . 0.0 111.766 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.63 -126.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.427 1.091 . . . . 0.0 112.284 -174.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -64.53 -36.59 84.71 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.413 1.885 . . . . 0.0 115.725 -169.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -63.36 142.38 58.41 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.944 1.298 . . . . 0.0 112.767 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -145.19 143.7 30.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.365 1.466 . . . . 0.0 112.286 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -57.13 -58.2 9.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.246 1.818 . . . . 0.0 112.813 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.1 m -72.07 -45.29 61.31 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.913 1.685 . . . . 0.0 112.469 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 128.68 23.76 1.17 Allowed Glycine 0 CA--C 1.538 1.48 0 C-N-CA 126.56 2.029 . . . . 0.0 114.227 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -65.26 124.81 23.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.435 1.894 . . . . 0.0 111.283 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 45.7 m -65.17 125.05 23.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.17 0.988 . . . . 0.0 110.225 169.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 31.4 tp -143.4 126.23 16.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.975 0.91 . . . . 0.0 112.094 -171.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -116.23 60.91 0.41 Allowed Glycine 0 N--CA 1.471 1.01 0 C-N-CA 126.026 1.774 . . . . 0.0 110.657 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.4 m -157.67 152.07 24.86 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.928 2.491 . . . . 0.0 109.057 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -126.84 166.17 17.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.213 1.405 . . . . 0.0 111.991 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.45 133.77 23.11 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.453 1.501 . . . . 0.0 110.098 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.5 t -133.34 122.6 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.357 1.463 . . . . 0.0 109.877 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -91.55 110.03 21.34 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.488 -0.758 . . . . 0.0 109.912 169.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -80.84 149.7 29.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.047 2.139 . . . . 0.0 111.783 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.35 -19.96 63.85 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -139.05 128.57 24.45 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.542 1.937 . . . . 0.0 111.389 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -57.08 -49.23 76.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.042 1.737 . . . . 0.0 111.839 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.94 -44.57 70.75 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.489 1.116 . . . . 0.0 112.757 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -64.61 -39.66 94.12 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.66 1.184 . . . . 0.0 112.46 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.84 -45.64 91.76 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.175 0.59 . . . . 0.0 111.689 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.19 -46.67 88.92 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.335 1.454 . . . . 0.0 111.572 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -48.46 -53.87 16.33 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.005 1.722 . . . . 0.0 111.651 171.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.0 -47.95 81.48 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.883 0.873 . . . . 0.0 112.707 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 17.2 ttp -52.13 -60.56 3.05 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.537 1.535 . . . . 0.0 111.833 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.99 -36.25 80.93 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.677 0.791 . . . . 0.0 113.113 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -64.43 -44.54 90.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.351 1.06 . . . . 0.0 113.43 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.18 -15.83 14.57 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -169.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -60.8 113.11 2.32 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.204 1.366 . . . . 0.0 111.952 174.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.91 -21.91 32.91 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.852 1.692 . . . . 0.0 114.343 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.8 132.03 92.51 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 118.626 1.213 . . . . 0.0 110.533 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.56 145.83 18.74 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.954 2.436 . . . . 0.0 113.374 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.7 tp -135.54 115.1 12.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.196 2.198 . . . . 0.0 108.612 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 38.66 62.34 1.05 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.385 1.874 . . . . 0.0 113.57 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.59 2.16 90.6 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.282 1.42 . . . . 0.0 116.218 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -131.08 123.33 19.77 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.798 1.639 . . . . 0.0 112.155 -170.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.45 122.02 7.94 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.978 2.452 . . . . 0.0 111.225 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.5 mtm -64.21 130.49 44.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.261 1.025 . . . . 0.0 110.811 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -116.24 114.73 24.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.161 1.385 . . . . 0.0 109.427 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.8 mm -108.07 138.66 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.552 0.741 . . . . 0.0 111.273 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -135.99 140.81 44.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.918 1.687 . . . . 0.0 110.472 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.2 tt -128.82 123.01 31.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.166 1.386 . . . . 0.0 110.542 -170.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.56 173.43 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.908 1.683 . . . . 0.0 111.786 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.8 p -67.2 158.38 31.46 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.624 1.17 . . . . 0.0 113.245 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.252 1.187 0 C-N-CA 127.143 2.177 . . . . 0.0 113.998 178.781 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -137.43 131.03 31.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.2 1.0 . . . . 0.0 112.292 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -115.91 155.28 28.25 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.248 1.819 . . . . 0.0 110.465 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.5 tp -130.82 94.14 3.56 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.115 1.766 . . . . 0.0 106.976 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -69.7 127.49 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.8 m -128.91 171.31 12.43 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.128 1.371 . . . . 0.0 111.495 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.5 t30 58.79 30.3 19.87 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.258 1.823 . . . . 0.0 113.615 -169.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.47 162.61 26.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.529 1.131 . . . . 0.0 109.385 169.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -83.04 157.86 22.72 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.264 -0.897 . . . . 0.0 113.098 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -54.25 -37.22 64.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.599 1.159 . . . . 0.0 112.155 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.29 8.87 78.75 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.173 1.368 . . . . 0.0 116.318 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.2 130.72 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.762 1.781 . . . . 0.0 110.454 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.4 m -82.61 138.91 34.05 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.504 1.122 . . . . 0.0 112.302 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -56.78 -55.25 36.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.338 1.455 . . . . 0.0 113.395 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.46 80.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.899 0.88 . . . . 0.0 113.11 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.88 -51.39 70.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.826 0.851 . . . . 0.0 112.009 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.74 -52.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.263 1.025 . . . . 0.0 111.275 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -51.22 -55.28 18.86 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.745 0.818 . . . . 0.0 112.052 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.48 -50.73 72.68 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.678 1.191 . . . . 0.0 113.12 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.48 -45.27 91.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.379 0.991 . . . . 0.0 112.413 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -63.16 -40.89 98.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.836 0.744 . . . . 0.0 112.466 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.9 -13.21 61.46 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -71.81 -62.23 1.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.989 -1.069 . . . . 0.0 111.113 172.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -78.54 -35.46 46.1 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.61 173.18 15.47 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.489 1.518 . . . . 0.0 113.372 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.7 m -119.99 112.87 19.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.066 1.346 . . . . 0.0 109.432 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -135.07 151.6 50.91 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -169.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -73.6 -53.97 9.26 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.512 1.925 . . . . 0.0 110.426 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -154.05 153.17 31.44 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.4 139.46 45.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.529 1.932 . . . . 0.0 109.403 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.13 100.04 3.56 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.588 1.555 . . . . 0.0 111.646 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.4 156.38 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.098 1.359 . . . . 0.0 110.692 170.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -44.45 -56.2 4.45 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.754 2.421 . . . . 0.0 115.241 -174.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -61.39 149.77 37.35 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.232 0.924 . . . . 0.0 112.261 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.6 t70 69.03 -50.47 0.59 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.176 2.191 . . . . 0.0 113.606 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -54.35 -45.58 72.76 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.605 1.162 . . . . 0.0 110.705 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.7 m -119.28 148.66 42.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.141 2.176 . . . . 0.0 110.341 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.0 -52.95 40.54 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.128 0.87 . . . . 0.0 112.049 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -65.85 138.16 57.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.624 1.57 . . . . 0.0 110.664 169.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.7 m -81.33 129.54 34.66 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.243 1.017 . . . . 0.0 110.636 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.2 -130.13 0.27 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.893 1.677 . . . . 0.0 109.18 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.69 52.52 0.39 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.357 1.456 . . . . 0.0 112.407 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 52.6 p -138.24 163.23 32.28 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.824 1.249 . . . . 0.0 113.261 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.4 116.05 9.16 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.086 1.754 . . . . 0.0 111.179 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -73.56 133.74 43.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.139 0.976 . . . . 0.0 108.74 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.4 t -136.07 123.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.942 0.897 . . . . 0.0 109.874 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -109.47 112.94 25.34 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.418 1.487 . . . . 0.0 109.759 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -90.28 158.61 17.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.92 2.488 . . . . 0.0 112.944 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.22 -41.44 85.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.305 0.642 . . . . 0.0 112.357 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -132.2 134.73 45.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.868 1.667 . . . . 0.0 111.196 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -66.64 -28.93 68.87 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.17 -46.75 88.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.999 0.92 . . . . 0.0 111.301 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.48 -40.98 96.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.205 1.002 . . . . 0.0 112.361 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.24 -58.22 7.82 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.343 1.057 . . . . 0.0 111.536 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -53.12 -48.38 67.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.032 1.733 . . . . 0.0 112.077 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -52.24 -55.87 18.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.745 1.218 . . . . 0.0 111.814 173.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.01 -46.03 75.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.5 1.12 . . . . 0.0 112.625 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -52.42 -62.8 1.41 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.169 1.388 . . . . 0.0 110.812 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.27 -36.51 77.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -66.67 -44.27 82.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.249 1.02 . . . . 0.0 113.467 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -105.63 -15.12 15.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -61.85 105.59 0.58 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.662 1.119 . . . . 0.0 110.519 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.21 -21.87 9.9 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.748 2.118 . . . . 0.0 114.298 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.5 t -79.26 131.85 64.6 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 118.653 1.227 . . . . 0.0 111.695 -170.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.52 138.87 66.54 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.465 3.443 . . . . 0.0 115.457 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -138.42 103.31 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.045 2.138 . . . . 0.0 106.371 169.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 52.78 60.42 3.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.512 1.525 . . . . 0.0 111.288 -168.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.76 -64.88 4.14 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.548 1.547 . . . . 0.0 113.178 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -62.03 135.77 94.91 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.818 1.647 . . . . 0.0 112.711 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.82 131.49 12.29 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.339 2.692 . . . . 0.0 112.238 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.3 mtm -62.88 132.56 52.54 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.96 0.904 . . . . 0.0 110.917 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -118.44 115.57 24.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.608 1.163 . . . . 0.0 108.459 171.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.6 mt -105.84 126.62 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.901 0.858 . . . . 0.0 112.215 -169.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -99.13 150.44 22.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.099 2.16 . . . . 0.0 109.483 169.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.99 159.36 43.07 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.52 1.128 . . . . 0.0 112.797 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.2 m -76.22 93.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 87.2 m -67.11 -41.17 86.68 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.467 -0.771 . . . . 0.0 111.986 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 C--O 1.252 1.212 0 C-N-CA 126.427 1.891 . . . . 0.0 113.69 177.536 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -81.76 93.66 6.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.994 0.918 . . . . 0.0 109.588 172.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -89.42 101.14 13.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.966 1.306 . . . . 0.0 108.795 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.7 tp -89.95 127.59 36.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.36 1.864 . . . . 0.0 109.816 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.62 127.83 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.472 1.509 . . . . 0.0 108.859 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.0 m -128.24 168.59 15.25 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.468 1.907 . . . . 0.0 111.066 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.3 t30 59.16 51.79 6.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.996 1.719 . . . . 0.0 112.555 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.4 mt -95.48 172.82 7.84 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.715 1.606 . . . . 0.0 110.287 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -139.84 158.01 44.79 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.204 -0.935 . . . . 0.0 112.779 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -57.48 104.03 0.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.688 1.195 . . . . 0.0 110.874 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.8 -45.25 0.62 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.696 2.093 . . . . 0.0 109.474 -169.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.6 t -64.39 134.79 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.238 1.015 . . . . 0.0 108.832 169.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 61.1 m -121.74 153.76 37.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.513 1.125 . . . . 0.0 112.155 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.28 -56.73 12.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.95 1.7 . . . . 0.0 112.542 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.56 -37.78 82.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.592 1.157 . . . . 0.0 113.319 174.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -63.3 -51.7 64.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.8 0.84 . . . . 0.0 111.551 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.5 mm -54.21 -52.91 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.405 1.082 . . . . 0.0 111.221 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -51.33 -53.94 31.16 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.109 0.963 . . . . 0.0 112.323 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -60.58 -51.46 69.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.689 1.195 . . . . 0.0 113.252 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -63.6 -44.28 94.45 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.164 0.893 . . . . 0.0 112.182 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -62.69 -43.71 98.12 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.61 67.96 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.57 -53.69 52.91 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.097 0.959 . . . . 0.0 112.789 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -95.93 -16.14 21.93 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -140.59 164.36 26.34 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.019 1.295 . . . . 0.0 114.414 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -104.26 111.17 23.68 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.924 1.29 . . . . 0.0 110.943 -172.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -129.3 145.66 51.33 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.49 1.116 . . . . 0.0 113.323 -171.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -87.63 -39.39 15.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.029 1.732 . . . . 0.0 111.1 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -144.26 146.85 32.89 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.469 1.108 . . . . 0.0 112.126 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -146.96 123.41 11.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.135 1.374 . . . . 0.0 110.818 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.22 155.73 42.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.701 1.2 . . . . 0.0 112.989 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.5 t -110.34 151.73 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.804 2.042 . . . . 0.0 110.207 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -55.63 -45.21 77.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.209 1.804 . . . . 0.0 114.952 -170.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -65.17 154.6 37.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.063 0.945 . . . . 0.0 113.096 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -144.26 -130.58 0.08 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.311 1.444 . . . . 0.0 108.793 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -56.07 -48.12 76.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.033 1.288 . . . . 0.0 110.07 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.6 m -71.38 120.28 16.74 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.397 1.479 . . . . 0.0 110.966 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.87 65.12 4.17 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.687 1.137 . . . . 0.0 111.559 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -59.1 128.73 38.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.163 1.785 . . . . 0.0 112.319 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.0 m -73.81 98.1 2.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.459 1.104 . . . . 0.0 110.084 169.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 60.5 tp -153.47 -68.64 0.15 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.613 1.565 . . . . 0.0 110.626 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.89 75.2 1.2 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.687 1.137 . . . . 0.0 112.098 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.7 m -146.96 148.98 32.3 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.157 1.383 . . . . 0.0 110.82 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.66 154.48 46.42 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.593 1.557 . . . . 0.0 111.647 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -128.48 124.63 36.61 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.656 1.583 . . . . 0.0 109.907 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.09 110.09 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 125.193 1.397 . . . . 0.0 108.683 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -82.47 92.62 7.09 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.998 1.319 . . . . 0.0 108.5 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -70.6 150.13 46.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.794 1.638 . . . . 0.0 111.265 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -74.82 -27.93 60.49 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 34.7 mtm105 -135.99 138.84 42.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.241 1.817 . . . . 0.0 111.16 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -67.08 -44.13 80.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.72 1.608 . . . . 0.0 112.086 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.12 -46.85 68.92 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.677 0.791 . . . . 0.0 112.319 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.56 -44.61 96.72 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.774 1.63 . . . . 0.0 112.26 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.77 87.69 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.183 0.993 . . . . 0.0 112.878 170.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.2 -38.81 84.45 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.557 1.543 . . . . 0.0 112.428 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -49.3 -61.89 1.84 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.531 1.133 . . . . 0.0 110.059 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.38 -47.54 72.56 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.806 1.242 . . . . 0.0 112.598 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -51.51 -61.2 2.39 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.415 1.486 . . . . 0.0 111.437 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -60.16 -44.75 94.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.921 0.888 . . . . 0.0 112.388 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.29 -44.25 92.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.258 1.423 . . . . 0.0 113.387 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -109.14 -14.56 14.49 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -60.27 115.68 3.69 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.48 1.491 . . . . 0.0 111.305 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.77 55.51 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.826 1.679 . . . . 0.0 114.546 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.29 130.68 79.56 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 118.9 1.35 . . . . 0.0 110.852 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.43 135.69 69.47 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.764 2.976 . . . . 0.0 114.9 174.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.1 tp -142.02 113.76 7.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.553 1.941 . . . . 0.0 108.184 169.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 49.4 61.42 3.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.405 1.482 . . . . 0.0 111.398 -169.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.58 -61.54 4.62 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.363 1.459 . . . . 0.0 113.364 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -67.26 140.24 95.31 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 125.319 1.447 . . . . 0.0 113.719 -172.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -73.15 125.92 10.71 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.99 2.46 . . . . 0.0 110.453 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 74.6 mtm -63.5 127.8 32.94 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.366 1.067 . . . . 0.0 111.849 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -105.16 119.32 38.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.566 1.146 . . . . 0.0 109.326 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.4 mt -118.94 139.85 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.939 . . . . 0.0 112.312 -169.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -134.37 147.5 50.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.405 2.282 . . . . 0.0 110.196 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 51.6 tp -136.41 126.64 26.42 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.78 1.232 . . . . 0.0 111.235 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.55 159.63 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.232 1.413 . . . . 0.0 112.189 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 15.2 m -66.94 136.02 54.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.073 1.349 . . . . 0.0 111.6 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 52.1 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.873 1.669 . . . . 0.0 113.637 174.301 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.174 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -74.36 130.28 39.37 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.072 0.936 . . . . 0.0 110.827 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.34 124.74 23.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.906 2.082 . . . . 0.0 109.317 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.4 tp -114.56 108.02 16.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.662 1.585 . . . . 0.0 110.488 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.6 t -92.07 129.52 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.328 1.451 . . . . 0.0 108.874 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.5 m -134.81 173.25 11.9 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.006 1.722 . . . . 0.0 111.87 -175.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.7 t30 55.51 35.8 25.85 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.304 1.841 . . . . 0.0 113.192 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.73 168.94 19.14 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.649 1.179 . . . . 0.0 110.428 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -65.96 155.23 37.17 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.23 -0.918 . . . . 0.0 111.679 171.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -50.99 -28.34 9.72 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.764 2.025 . . . . 0.0 114.697 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -145.69 55.57 0.54 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-N 119.151 0.887 . . . . 0.0 115.019 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.99 136.77 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 118.085 0.943 . . . . 0.0 109.766 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 52.1 m -69.83 138.31 52.5 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.582 -0.699 . . . . 0.0 112.134 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -60.31 -53.57 56.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.524 1.129 . . . . 0.0 112.648 -174.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.92 83.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.448 1.099 . . . . 0.0 112.688 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -56.51 -53.39 58.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.856 0.862 . . . . 0.0 112.248 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.2 mm -56.83 -53.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.845 0.858 . . . . 0.0 111.458 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -53.15 -53.76 45.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.015 0.526 . . . . 0.0 112.116 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.01 -50.47 73.96 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.945 1.298 . . . . 0.0 113.054 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.48 -46.35 90.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.653 1.115 . . . . 0.0 111.914 -176.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.85 -43.08 97.21 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.94 -21.09 66.77 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.98 -58.78 5.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.96 -1.087 . . . . 0.0 111.892 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -82.31 -35.58 27.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -110.12 161.77 12.84 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.585 1.564 . . . . 0.0 114.185 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.8 m -106.09 101.81 11.27 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.878 1.671 . . . . 0.0 109.68 -174.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -137.08 153.99 50.43 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -169.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -85.94 -50.96 6.68 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.642 2.377 . . . . 0.0 111.486 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.71 150.63 33.49 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.274 1.03 . . . . 0.0 113.07 -170.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.38 138.16 32.81 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 110.787 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.79 107.16 5.01 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.937 1.295 . . . . 0.0 112.23 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.6 t -77.33 146.24 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.898 1.679 . . . . 0.0 111.009 173.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -53.22 -50.94 63.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.441 2.297 . . . . 0.0 115.194 -171.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -49.21 -40.52 33.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.972 2.109 . . . . 0.0 115.627 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -73.5 -13.25 61.02 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.812 1.245 . . . . 0.0 114.07 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -122.29 -143.83 0.34 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.167 1.787 . . . . 0.0 111.77 -176.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.9 m -59.57 152.68 21.51 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.823 2.049 . . . . 0.0 114.225 -171.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.05 57.09 3.97 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.952 1.263 . . . . 0.0 113.842 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.2 ptm85 -74.18 -172.07 1.31 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.785 2.034 . . . . 0.0 112.178 169.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.8 m -63.18 120.03 10.71 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.032 0.933 . . . . 0.0 110.337 169.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.9 mp -67.83 141.89 56.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.495 1.118 . . . . 0.0 112.339 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 98.23 53.39 1.26 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.611 1.577 . . . . 0.0 113.036 176.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.6 m -147.38 145.3 29.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.698 1.199 . . . . 0.0 111.438 -173.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -137.41 126.49 24.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.915 1.286 . . . . 0.0 111.735 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -93.45 126.85 38.81 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.052 1.341 . . . . 0.0 109.795 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.9 t -131.24 136.09 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.554 1.542 . . . . 0.0 110.164 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -118.05 98.85 6.53 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.212 1.805 . . . . 0.0 108.779 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -75.86 158.73 31.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.474 1.51 . . . . 0.0 111.938 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -70.41 -27.32 64.19 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.774 -0.579 . . . . 0.0 112.296 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -142.91 135.0 27.18 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.564 1.546 . . . . 0.0 112.674 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -53.87 -40.5 66.62 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.48 2.312 . . . . 0.0 112.518 170.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.33 -47.44 62.68 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.281 1.032 . . . . 0.0 112.656 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -71.26 -38.01 71.92 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.275 -0.89 . . . . 0.0 112.937 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.67 -47.08 74.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.77 0.828 . . . . 0.0 111.834 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.1 -48.12 79.4 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.382 1.473 . . . . 0.0 113.036 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -52.28 -53.33 45.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.264 1.026 . . . . 0.0 111.842 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.03 -50.34 69.32 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.199 0.999 . . . . 0.0 112.445 174.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -53.03 -63.15 1.24 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.137 1.775 . . . . 0.0 111.506 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -59.99 -36.85 78.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.693 0.797 . . . . 0.0 113.026 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -66.89 -52.16 46.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.747 1.219 . . . . 0.0 112.857 176.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -96.17 -16.3 21.56 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 -169.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -59.32 109.74 0.94 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 120.154 1.343 . . . . 0.0 111.178 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 113.25 -24.74 12.1 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 126.254 1.883 . . . . 0.0 114.231 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.35 133.69 89.22 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.873 1.269 . . . . 0.0 110.66 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.68 148.88 33.27 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.946 2.431 . . . . 0.0 113.12 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 42.2 tp -128.87 94.73 3.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.4 1.88 . . . . 0.0 109.194 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 46.56 50.65 12.68 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.442 1.897 . . . . 0.0 112.931 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 114.94 -78.3 0.27 Allowed Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.065 1.793 . . . . 0.0 112.779 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.35 135.7 75.99 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 126.328 1.851 . . . . 0.0 113.351 -176.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.06 126.83 10.85 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.096 2.531 . . . . 0.0 111.207 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.5 mtm -63.66 128.72 37.09 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.613 0.765 . . . . 0.0 110.135 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -116.61 119.91 37.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.341 1.056 . . . . 0.0 109.502 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -117.55 139.93 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.198 0.999 . . . . 0.0 111.749 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -131.27 144.54 51.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.93 2.092 . . . . 0.0 110.539 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.0 tp -88.6 -101.29 0.09 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.591 1.157 . . . . 0.0 110.426 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.4 m -69.61 155.36 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.732 2.013 . . . . 0.0 112.897 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 2.9 p -140.63 147.14 38.87 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.022 2.129 . . . . 0.0 111.106 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 C--O 1.251 1.174 0 C-N-CA 126.133 1.773 . . . . 0.0 113.749 -179.591 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.172 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.01 154.65 44.21 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.625 1.712 . . . . 0.0 114.29 -178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.8 mt -120.97 118.69 30.51 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.86 2.064 . . . . 0.0 110.43 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.7 tp -82.45 109.04 16.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.0 t -92.22 83.26 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.103 1.761 . . . . 0.0 107.707 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.3 m -80.25 155.3 27.39 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.727 0.811 . . . . 0.0 112.101 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.28 79.12 0.23 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.762 2.025 . . . . 0.0 113.0 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -127.91 144.97 51.09 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.281 2.232 . . . . 0.0 109.641 171.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -77.2 151.39 35.24 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.84 -0.538 . . . . 0.0 112.358 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -57.87 -24.28 56.87 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.905 0.882 . . . . 0.0 113.337 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.85 -15.48 78.17 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 125.151 1.358 . . . . 0.0 115.792 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.21 123.21 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.585 1.693 . . . . 0.0 110.925 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 54.4 m -77.95 146.48 35.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.771 1.228 . . . . 0.0 111.982 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.78 -52.46 65.62 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.869 0.867 . . . . 0.0 112.013 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.28 62.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.753 1.221 . . . . 0.0 113.363 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.08 -55.51 34.13 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.978 0.911 . . . . 0.0 112.285 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.6 mm -55.8 -53.31 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.882 1.273 . . . . 0.0 111.082 172.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -48.97 -55.77 10.89 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.134 1.774 . . . . 0.0 111.696 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.61 -49.32 75.69 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.626 1.17 . . . . 0.0 113.379 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.23 -44.62 94.74 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.81 1.186 . . . . 0.0 112.204 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -62.09 -41.91 98.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.724 0.693 . . . . 0.0 112.227 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.29 -15.72 62.81 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.21 -60.1 2.4 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.878 -1.139 . . . . 0.0 111.533 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -81.31 -31.34 33.59 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.88 -177.57 15.23 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.644 1.592 . . . . 0.0 113.104 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.5 m -124.52 122.74 38.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.763 1.225 . . . . 0.0 110.057 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -132.37 146.94 52.33 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -78.49 -49.13 13.95 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.514 2.325 . . . . 0.0 110.986 171.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -148.12 146.11 28.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.49 1.516 . . . . 0.0 112.298 -170.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -132.47 139.67 48.07 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.245 1.818 . . . . 0.0 109.37 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.25 100.06 3.41 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.482 1.513 . . . . 0.0 111.695 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.5 t -75.09 167.14 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.253 1.421 . . . . 0.0 110.709 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -46.87 -37.19 8.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.861 2.064 . . . . 0.0 115.843 -169.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -86.53 -13.2 46.61 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.71 158.6 35.99 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.313 1.045 . . . . 0.0 112.764 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -71.34 83.96 0.78 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.734 1.214 . . . . 0.0 111.375 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 t -153.39 -178.27 6.88 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.6 2.36 . . . . 0.0 110.739 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.2 6.66 28.76 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.997 1.76 . . . . 0.0 115.63 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.87 162.6 15.99 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.82 1.31 . . . . 0.0 113.448 175.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.3 m -61.97 158.89 15.29 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.79 1.236 . . . . 0.0 112.99 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.3 tp -74.5 145.8 43.24 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.775 0.83 . . . . 0.0 111.128 173.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.64 40.75 95.14 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.339 0.971 . . . . 0.0 113.053 -173.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.7 m -160.48 158.68 29.75 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.476 2.71 . . . . 0.0 108.473 -171.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.17 166.49 21.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.5 1.12 . . . . 0.0 112.651 174.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -125.52 129.49 49.86 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.541 1.936 . . . . 0.0 109.396 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.98 115.06 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.681 1.192 . . . . 0.0 109.058 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -100.57 112.65 25.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.579 1.551 . . . . 0.0 109.647 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -84.23 163.45 19.68 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.076 2.55 . . . . 0.0 113.29 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.5 -45.04 89.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.795 0.838 . . . . 0.0 111.653 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.4 mmt-85 -137.88 141.76 40.68 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.706 1.602 . . . . 0.0 111.328 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -60.09 -34.3 73.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.764 1.626 . . . . 0.0 113.284 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.88 -51.36 69.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.247 1.019 . . . . 0.0 112.243 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.63 -40.68 95.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.004 0.921 . . . . 0.0 112.083 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.17 -54.59 37.7 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.389 1.075 . . . . 0.0 112.007 170.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 67.4 tp -53.28 -49.93 65.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.173 1.389 . . . . 0.0 112.783 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -53.03 -51.43 61.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.001 1.32 . . . . 0.0 112.173 175.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.08 78.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.012 0.925 . . . . 0.0 112.755 172.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 4.7 ttp -54.01 -58.06 8.7 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.945 1.298 . . . . 0.0 112.017 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -33.67 73.37 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -68.23 -45.01 74.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.293 1.037 . . . . 0.0 113.159 176.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -103.7 -13.35 16.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -169.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -60.13 109.78 1.05 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.225 1.375 . . . . 0.0 112.04 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.32 -17.82 39.77 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.993 1.759 . . . . 0.0 114.586 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.98 132.71 86.43 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 118.854 1.327 . . . . 0.0 110.372 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.04 142.25 19.42 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.822 2.348 . . . . 0.0 112.804 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 61.2 tp -135.35 115.67 13.49 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.063 1.745 . . . . 0.0 108.448 169.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 49.24 57.64 6.26 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.364 1.465 . . . . 0.0 111.222 -169.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.68 -56.49 4.75 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.402 1.477 . . . . 0.0 113.303 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -58.15 117.51 20.36 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 127.349 2.259 . . . . 0.0 113.835 -173.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -60.02 118.21 5.06 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.356 2.704 . . . . 0.0 110.879 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.7 mtm -70.16 116.59 10.69 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.78 0.832 . . . . 0.0 110.862 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.99 94.72 9.41 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.076 0.951 . . . . 0.0 108.806 174.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.6 mm -86.34 129.18 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.323 0.649 . . . . 0.0 109.986 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -125.21 115.53 20.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.96 1.304 . . . . 0.0 111.0 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.9 tp -79.16 139.55 37.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.64 1.576 . . . . 0.0 110.755 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 5.4 m -64.32 105.2 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-O 121.699 0.761 . . . . 0.0 110.908 169.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 94.2 m -80.87 117.16 21.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.39 1.076 . . . . 0.0 110.409 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.459 1.903 . . . . 0.0 113.712 -179.487 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.235 0 CA-C-O 121.829 0.683 . . . . 0.0 114.788 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -149.59 133.0 16.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.514 1.926 . . . . 0.0 109.808 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -137.79 105.27 5.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.935 1.694 . . . . 0.0 109.577 -170.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.9 tp -90.2 137.94 31.93 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.753 2.021 . . . . 0.0 110.039 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -130.61 127.48 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.918 1.287 . . . . 0.0 109.578 174.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.9 m -128.1 174.41 9.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.222 1.809 . . . . 0.0 110.872 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.2 t30 58.57 38.31 25.32 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.394 1.478 . . . . 0.0 112.467 -172.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.3 mt -88.73 -155.1 0.32 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.56 1.544 . . . . 0.0 109.497 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -138.96 151.7 47.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.543 1.537 . . . . 0.0 110.883 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -53.46 -24.61 13.32 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.74 -23.54 65.42 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 125.382 1.468 . . . . 0.0 115.234 172.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.35 141.54 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 118.906 1.353 . . . . 0.0 110.523 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 61.6 m -133.1 161.1 35.29 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.68 1.592 . . . . 0.0 111.788 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -53.86 -57.36 11.21 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.881 0.872 . . . . 0.0 113.2 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.61 72.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.828 0.851 . . . . 0.0 113.248 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.01 -55.56 33.41 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.066 0.946 . . . . 0.0 111.855 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.6 mm -55.49 -54.82 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.027 1.331 . . . . 0.0 111.227 172.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -47.9 -56.98 6.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.672 1.989 . . . . 0.0 111.441 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.06 -49.97 73.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.462 1.105 . . . . 0.0 113.259 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -62.41 -44.54 96.18 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.475 1.034 . . . . 0.0 112.07 -175.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -63.88 -43.47 95.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.412 0.685 . . . . 0.0 112.624 173.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.7 -20.93 62.26 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.58 -60.16 2.97 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.076 -1.015 . . . . 0.0 112.019 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -89.63 -21.33 22.86 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -174.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -134.7 -176.9 14.59 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.658 1.599 . . . . 0.0 112.885 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -127.38 129.17 47.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.279 1.032 . . . . 0.0 110.497 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.7 144.77 47.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.627 1.171 . . . . 0.0 113.801 -169.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -73.54 -50.57 20.67 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.938 2.095 . . . . 0.0 110.62 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -150.46 158.62 44.35 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.592 1.157 . . . . 0.0 112.87 -173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.43 155.69 46.88 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.005 1.722 . . . . 0.0 111.089 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.83 154.77 38.95 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.239 2.216 . . . . 0.0 110.672 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.9 t -141.1 158.78 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.225 1.81 . . . . 0.0 110.401 -176.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -30.96 -48.52 0.11 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 129.373 3.069 . . . . 0.0 116.525 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -49.81 -39.99 40.3 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.872 1.669 . . . . 0.0 113.658 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -78.61 -61.77 1.9 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.5 1.52 . . . . 0.0 111.258 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -144.24 143.59 31.11 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.412 1.885 . . . . 0.0 111.334 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 m -124.55 148.84 47.54 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.717 1.607 . . . . 0.0 112.822 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -98.98 -43.31 2.64 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.701 2.096 . . . . 0.0 111.045 169.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -128.09 129.85 47.25 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.741 2.016 . . . . 0.0 109.981 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 47.5 m -70.85 69.87 0.47 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.071 1.748 . . . . 0.0 111.822 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 68.1 tp -160.83 -47.93 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.341 2.656 . . . . 0.0 110.214 -173.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.71 103.15 0.17 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.995 1.283 . . . . 0.0 111.109 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 m -123.96 145.8 48.92 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.155 1.782 . . . . 0.0 110.969 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.68 150.94 46.73 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.867 2.067 . . . . 0.0 110.339 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -143.28 121.46 12.21 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.42 1.488 . . . . 0.0 110.028 -173.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 52.7 t -122.4 118.39 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.173 1.389 . . . . 0.0 109.514 -173.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -88.53 95.47 10.25 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -69.03 160.49 30.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.543 1.937 . . . . 0.0 112.957 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.78 -51.8 68.18 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.629 -0.669 . . . . 0.0 111.705 169.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.53 148.34 45.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.436 1.494 . . . . 0.0 112.523 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.89 -32.41 71.87 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.58 -49.73 76.37 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.109 0.964 . . . . 0.0 112.459 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.76 -37.91 89.2 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.12 0.968 . . . . 0.0 111.979 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.22 -46.61 85.56 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.874 0.87 . . . . 0.0 112.037 169.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.95 -49.98 72.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.479 1.512 . . . . 0.0 111.493 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -50.08 -54.33 21.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.46 1.504 . . . . 0.0 111.677 174.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.2 75.64 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.29 1.036 . . . . 0.0 112.803 173.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -54.76 -63.26 1.21 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.675 1.19 . . . . 0.0 111.422 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -59.57 -32.77 70.67 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -64.49 -51.09 64.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.693 1.197 . . . . 0.0 113.148 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -106.89 -11.07 15.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -169.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -61.86 117.1 5.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.341 1.428 . . . . 0.0 111.857 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 92.59 -12.44 69.77 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.025 1.298 . . . . 0.0 114.83 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 64.7 t -66.94 135.24 94.08 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 119.205 1.502 . . . . 0.0 109.858 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.3 145.97 31.06 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.793 2.329 . . . . 0.0 112.724 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.5 tp -122.27 92.5 3.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.259 1.824 . . . . 0.0 108.992 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 47.65 50.05 15.62 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.287 1.835 . . . . 0.0 112.715 -169.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 116.07 -75.62 0.27 Allowed Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.114 1.816 . . . . 0.0 112.885 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.61 131.81 85.64 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 126.264 1.826 . . . . 0.0 113.549 -175.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.13 130.09 13.86 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.256 2.638 . . . . 0.0 111.683 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -68.28 114.59 6.88 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.426 1.09 . . . . 0.0 111.401 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -86.16 103.35 14.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.224 1.009 . . . . 0.0 109.349 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.3 mt -99.96 137.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.832 0.853 . . . . 0.0 111.516 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -133.26 152.17 51.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.0 2.52 . . . . 0.0 110.671 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -148.73 166.57 28.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.969 0.908 . . . . 0.0 113.274 -169.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.38 88.76 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.122 0.969 . . . . 0.0 110.603 169.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.0 p -59.69 -59.09 5.99 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.877 1.671 . . . . 0.0 111.195 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.251 1.161 0 C-N-CA 126.191 1.796 . . . . 0.0 110.995 169.747 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -134.13 133.62 41.25 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.457 1.129 . . . . 0.0 111.561 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.7 mt -117.04 120.01 37.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.995 1.718 . . . . 0.0 111.302 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.0 tp -84.22 129.29 34.9 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 t -119.4 137.84 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.888 1.275 . . . . 0.0 109.215 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.3 m -136.73 165.99 24.63 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.123 2.169 . . . . 0.0 111.416 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.7 t30 52.95 59.63 4.33 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.493 1.917 . . . . 0.0 113.119 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.9 mt -109.7 147.72 32.65 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.247 1.819 . . . . 0.0 107.92 169.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -78.6 156.43 29.12 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.286 -0.884 . . . . 0.0 112.595 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -52.35 -34.48 47.69 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.702 1.201 . . . . 0.0 112.472 169.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.86 -7.34 87.44 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.217 1.389 . . . . 0.0 116.31 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.93 119.09 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.903 1.852 . . . . 0.0 110.492 177.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.7 m -78.82 147.53 33.2 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.055 1.342 . . . . 0.0 112.844 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.21 -53.62 55.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.471 1.508 . . . . 0.0 112.807 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.17 79.11 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.407 1.083 . . . . 0.0 113.189 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.41 -52.32 66.1 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.934 0.894 . . . . 0.0 112.211 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.8 mm -55.89 -51.81 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.39 1.076 . . . . 0.0 111.342 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -50.48 -54.51 21.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.202 1.001 . . . . 0.0 111.952 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.46 -50.9 72.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.68 1.192 . . . . 0.0 113.32 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.52 -44.75 89.88 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.549 1.068 . . . . 0.0 112.743 -174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -62.62 -39.81 94.98 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.904 0.774 . . . . 0.0 112.209 173.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.25 -2.72 11.32 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 174.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.47 -62.04 1.69 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.819 -1.176 . . . . 0.0 110.779 170.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -76.82 -19.66 57.27 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -139.45 -162.42 9.11 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.442 1.496 . . . . 0.0 111.94 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.08 136.93 42.39 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 118.104 0.952 . . . . 0.0 111.709 175.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.89 147.17 46.3 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.548 1.139 . . . . 0.0 113.472 -170.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.21 -46.54 20.16 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.391 2.276 . . . . 0.0 111.291 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -149.25 145.71 27.23 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.474 1.11 . . . . 0.0 112.611 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.63 143.47 50.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.265 1.826 . . . . 0.0 110.194 169.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.38 99.9 3.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.441 1.496 . . . . 0.0 111.542 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.23 147.54 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.699 1.6 . . . . 0.0 111.59 175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.453 ' HB3' ' H ' ' A' ' 147' ' ' THR . 25.6 p80 -25.69 -58.18 0.07 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 130.056 3.342 . . . . 0.0 117.102 -171.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -58.11 -22.43 50.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.276 1.431 . . . . 0.0 114.709 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -66.89 106.87 2.02 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.308 0.958 . . . . 0.0 108.635 168.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -45.53 116.99 1.29 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.574 1.95 . . . . 0.0 115.217 -169.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.3 m -153.35 163.59 39.65 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.47 2.708 . . . . 0.0 110.092 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.92 62.76 3.92 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.086 0.85 . . . . 0.0 113.079 174.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -136.24 160.4 38.81 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.563 1.945 . . . . 0.0 113.8 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.4 m -68.53 142.37 55.26 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.816 1.246 . . . . 0.0 111.104 169.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.63 160.36 32.7 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.421 0.688 . . . . 0.0 111.858 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.57 40.93 26.01 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.752 1.168 . . . . 0.0 113.823 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.453 ' H ' ' HB3' ' A' ' 137' ' ' HIS . 81.8 p -142.09 172.65 12.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.762 2.425 . . . . 0.0 112.003 -173.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.08 164.4 38.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.893 1.277 . . . . 0.0 111.584 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -131.2 126.2 34.95 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.999 1.72 . . . . 0.0 109.503 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.85 114.07 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.175 0.99 . . . . 0.0 110.938 -171.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -89.94 104.24 16.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.919 1.687 . . . . 0.0 109.901 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -77.42 150.63 35.0 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.683 2.793 . . . . 0.0 113.108 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -61.84 -36.91 82.59 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 47.1 mtm-85 -135.79 129.67 32.85 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.724 2.01 . . . . 0.0 110.088 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -66.23 -29.86 70.2 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.93 75.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.965 0.906 . . . . 0.0 111.796 170.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -62.73 -39.16 93.2 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.861 1.264 . . . . 0.0 112.137 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.16 37.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.561 1.145 . . . . 0.0 112.068 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 64.9 tp -52.98 -48.55 67.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.261 1.424 . . . . 0.0 112.116 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -51.89 -59.58 4.16 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.534 1.533 . . . . 0.0 111.47 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.52 -48.78 62.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.909 1.283 . . . . 0.0 112.618 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.7 ttp -53.58 -61.83 2.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.296 1.438 . . . . 0.0 111.492 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -62.04 -35.52 78.84 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.94 -56.23 14.52 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.477 1.111 . . . . 0.0 113.181 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -91.9 -13.85 30.57 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -168.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -61.2 107.3 0.73 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.104 1.32 . . . . 0.0 110.531 169.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 114.51 -24.2 11.48 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.306 1.908 . . . . 0.0 114.311 -174.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.83 133.85 86.16 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.765 1.226 . . . . 0.0 110.694 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.3 142.66 21.52 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.846 2.364 . . . . 0.0 113.245 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 42.1 tp -133.76 110.08 9.56 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.779 2.032 . . . . 0.0 108.13 169.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 47.63 60.17 3.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.491 1.517 . . . . 0.0 111.731 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.93 -55.96 5.05 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.177 1.37 . . . . 0.0 113.302 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -59.33 121.78 58.86 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.067 1.747 . . . . 0.0 112.978 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 117.56 5.1 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.492 2.128 . . . . 0.0 110.177 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -64.17 133.43 52.89 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.44 1.096 . . . . 0.0 111.128 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -109.53 124.48 51.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.154 0.981 . . . . 0.0 109.804 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.8 mt -127.13 137.84 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.974 1.31 . . . . 0.0 110.924 -170.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -138.95 123.02 17.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.802 1.641 . . . . 0.0 111.331 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 42.5 tp -70.77 142.26 51.39 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.972 1.309 . . . . 0.0 111.25 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.7 p -50.46 -48.39 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.419 1.488 . . . . 0.0 113.49 174.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.3 m -71.38 123.26 21.94 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.546 1.139 . . . . 0.0 111.025 173.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.329 1.851 . . . . 0.0 114.022 179.336 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -147.89 126.89 12.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.099 1.449 . . . . 0.0 111.774 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.7 121.14 44.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.438 1.495 . . . . 0.0 111.608 174.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.0 tp -81.73 128.79 34.35 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 168.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.07 135.81 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.987 1.315 . . . . 0.0 108.388 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.55 170.37 16.19 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.525 1.53 . . . . 0.0 111.43 -176.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.2 t30 56.0 42.5 28.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.503 1.521 . . . . 0.0 112.611 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.0 mt -81.82 150.91 27.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.842 0.857 . . . . 0.0 110.03 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.07 140.26 35.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.513 0.725 . . . . 0.0 111.689 174.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -67.86 88.92 0.27 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.29 1.043 . . . . 0.0 109.539 170.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 156.93 -25.64 0.49 Allowed Glycine 0 CA--C 1.538 1.483 0 C-N-CA 127.073 2.273 . . . . 0.0 112.56 -169.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.1 t -58.3 118.01 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.87 1.268 . . . . 0.0 109.931 170.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 64.7 m -77.44 145.41 37.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.915 0.886 . . . . 0.0 112.714 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.28 -53.34 58.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.376 1.47 . . . . 0.0 112.633 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.18 87.5 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.44 1.096 . . . . 0.0 113.027 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.16 -47.96 83.75 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.622 0.769 . . . . 0.0 112.1 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mm -54.53 -53.19 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.903 0.881 . . . . 0.0 111.063 169.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -52.03 -54.0 35.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.485 0.584 . . . . 0.0 112.265 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.14 -50.72 72.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.712 1.205 . . . . 0.0 113.307 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.59 -45.46 90.28 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.122 0.874 . . . . 0.0 111.928 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -62.8 -44.36 96.37 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.573 0.624 . . . . 0.0 112.384 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.35 -31.52 65.81 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.82 -48.37 81.54 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.305 1.042 . . . . 0.0 112.666 174.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -101.43 -17.16 16.6 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -173.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -141.16 157.43 26.03 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 119.613 1.097 . . . . 0.0 114.25 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.6 m -96.55 109.46 22.05 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.98 1.312 . . . . 0.0 109.736 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.0 143.3 50.02 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.673 1.189 . . . . 0.0 114.001 -169.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.2 -48.64 19.66 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.686 2.394 . . . . 0.0 110.29 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -148.28 147.78 29.71 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.291 1.437 . . . . 0.0 111.933 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.34 122.14 13.5 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.23 1.412 . . . . 0.0 109.795 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.08 138.5 26.71 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.868 0.867 . . . . 0.0 112.671 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.24 148.32 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.417 1.887 . . . . 0.0 111.082 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 31.8 p80 -37.44 -47.05 0.85 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 128.541 2.737 . . . . 0.0 116.92 -169.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -47.38 -46.23 25.72 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.97 1.308 . . . . 0.0 111.99 -174.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.87 -57.87 2.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.546 1.538 . . . . 0.0 111.576 170.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -50.37 -50.77 50.47 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.525 1.93 . . . . 0.0 113.434 -171.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 m -105.99 19.77 20.01 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.326 1.851 . . . . 0.0 112.204 -173.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.69 -36.65 1.41 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.902 1.715 . . . . 0.0 115.555 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 166.52 24.41 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.647 2.379 . . . . 0.0 112.591 -172.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.2 m -59.0 113.88 2.3 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.345 1.458 . . . . 0.0 111.891 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.6 tp -136.35 -26.54 1.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.93 1.292 . . . . 0.0 114.411 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.24 37.81 20.24 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.525 1.06 . . . . 0.0 113.66 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.3 p -136.39 167.74 20.77 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.568 1.947 . . . . 0.0 112.006 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.16 170.35 18.63 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.928 -1.108 . . . . 0.0 111.423 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -136.2 121.64 19.39 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.156 1.782 . . . . 0.0 108.676 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.0 t -120.46 114.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.469 1.108 . . . . 0.0 108.925 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -100.33 111.19 23.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.918 2.087 . . . . 0.0 108.719 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -92.12 167.25 12.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.49 2.716 . . . . 0.0 113.165 -174.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -61.98 -54.13 45.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.741 0.816 . . . . 0.0 111.139 169.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -141.02 147.29 38.45 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.06 1.744 . . . . 0.0 112.038 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -54.43 -30.35 52.31 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.894 1.678 . . . . 0.0 114.211 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.7 -55.1 36.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.418 1.087 . . . . 0.0 112.496 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.44 -36.15 80.63 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.638 -0.664 . . . . 0.0 112.303 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.76 -54.91 38.63 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.246 1.018 . . . . 0.0 111.891 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.7 mt -53.99 -47.68 71.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.125 1.37 . . . . 0.0 112.505 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -50.68 -58.35 6.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.95 1.3 . . . . 0.0 111.534 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.87 -49.1 69.25 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.727 1.211 . . . . 0.0 112.628 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 53.4 ttp -53.22 -59.26 4.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.511 1.524 . . . . 0.0 111.779 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -25.53 68.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -75.0 -48.77 22.45 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.983 0.913 . . . . 0.0 113.195 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -102.37 -11.59 18.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 -169.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -59.06 116.7 4.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.028 1.285 . . . . 0.0 111.403 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 100.89 -13.3 59.15 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.788 1.661 . . . . 0.0 114.732 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.7 t -71.47 128.58 89.82 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 119.258 1.529 . . . . 0.0 110.945 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.52 136.87 77.03 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.882 3.054 . . . . 0.0 114.375 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 35.5 tp -139.49 110.57 6.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.861 1.664 . . . . 0.0 108.344 169.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 49.54 60.5 3.74 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.439 1.496 . . . . 0.0 111.536 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.31 -63.64 4.39 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.136 1.351 . . . . 0.0 113.147 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.33 134.78 94.68 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.902 1.281 . . . . 0.0 112.804 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.51 127.14 12.19 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.31 2.673 . . . . 0.0 111.714 172.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -66.02 117.61 8.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.62 1.168 . . . . 0.0 112.094 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -85.49 115.67 23.35 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.2 mt -120.83 132.0 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.643 1.177 . . . . 0.0 110.668 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -144.63 124.77 13.67 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.435 1.494 . . . . 0.0 112.139 -169.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 12.2 tp -68.62 127.04 31.59 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.81 169.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.6 m -104.74 -15.04 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.055 0.942 . . . . 0.0 113.433 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 12.8 m -59.9 136.44 58.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.945 1.298 . . . . 0.0 111.168 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--O 1.251 1.15 0 C-N-CA 125.68 1.592 . . . . 0.0 113.384 176.477 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -92.48 83.98 5.04 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.123 0.961 . . . . 0.0 109.907 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -80.46 128.7 33.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.19 2.196 . . . . 0.0 109.114 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.6 tp -121.32 109.75 15.29 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.643 1.577 . . . . 0.0 110.307 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.4 138.71 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.57 1.548 . . . . 0.0 109.11 170.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.6 m -139.06 168.38 19.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.988 2.115 . . . . 0.0 111.494 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.7 t30 55.69 41.39 30.48 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.311 1.845 . . . . 0.0 113.147 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.81 154.73 31.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.286 1.034 . . . . 0.0 110.314 169.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.61 144.98 55.29 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.524 -0.735 . . . . 0.0 111.197 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -73.11 68.99 1.0 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.732 1.213 . . . . 0.0 110.795 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.36 -11.86 0.06 OUTLIER Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.745 1.64 . . . . 0.0 115.587 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.05 119.87 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.72 1.76 . . . . 0.0 110.642 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -72.0 140.62 49.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.255 1.022 . . . . 0.0 112.893 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.85 -47.18 86.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.845 1.258 . . . . 0.0 112.501 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.96 -45.6 74.95 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.461 1.104 . . . . 0.0 112.694 172.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.95 -47.91 84.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.825 0.85 . . . . 0.0 111.991 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mm -53.46 -53.79 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.523 1.129 . . . . 0.0 111.921 170.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -50.7 -57.23 8.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.543 0.737 . . . . 0.0 111.222 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -56.0 -50.46 70.79 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.299 1.04 . . . . 0.0 113.16 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.69 -48.56 71.65 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.995 0.816 . . . . 0.0 112.23 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -63.82 -41.34 97.88 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.78 0.718 . . . . 0.0 112.664 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.58 -10.48 52.29 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -75.42 -60.97 2.07 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.863 -1.148 . . . . 0.0 111.314 172.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -81.26 -30.18 34.16 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.83 -169.76 13.21 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.722 1.63 . . . . 0.0 112.568 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 m -136.94 123.88 21.42 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.587 -0.949 . . . . 0.0 111.703 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 pp -128.63 145.84 51.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.235 1.414 . . . . 0.0 113.439 -170.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -82.48 -47.31 12.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.914 2.086 . . . . 0.0 111.298 173.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -145.89 149.98 35.27 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.391 1.076 . . . . 0.0 112.324 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.58 147.64 37.99 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.054 1.342 . . . . 0.0 111.599 169.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.58 109.58 4.3 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.457 1.503 . . . . 0.0 111.776 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.86 152.5 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.742 1.217 . . . . 0.0 109.716 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -54.93 -46.86 74.98 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.968 1.707 . . . . 0.0 114.588 -175.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -61.17 151.78 30.43 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.677 0.791 . . . . 0.0 111.866 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 66.95 -46.4 0.46 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.981 2.113 . . . . 0.0 113.476 -169.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -41.91 84.85 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.489 1.916 . . . . 0.0 111.579 169.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.1 m -136.07 156.38 48.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.87 2.468 . . . . 0.0 111.579 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -102.89 66.4 0.36 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.159 1.362 . . . . 0.0 110.591 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -139.46 142.79 37.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.673 1.989 . . . . 0.0 111.315 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.4 m -77.29 75.15 3.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.277 1.031 . . . . 0.0 109.717 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 34.3 tp -107.85 -52.34 2.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.179 1.392 . . . . 0.0 112.917 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.81 59.42 5.16 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.144 0.878 . . . . 0.0 113.164 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.2 p -140.96 159.27 42.57 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.271 1.428 . . . . 0.0 111.773 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.87 119.59 11.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.714 1.205 . . . . 0.0 111.426 171.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.52 130.95 34.54 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.203 1.001 . . . . 0.0 109.965 172.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.19 117.66 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.681 1.593 . . . . 0.0 109.794 -174.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -87.96 101.23 13.55 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.931 0.892 . . . . 0.0 109.382 171.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -74.29 153.76 39.23 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.984 2.114 . . . . 0.0 112.015 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -62.66 -37.15 85.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 91.1 mmt-85 -141.26 141.21 33.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.51 1.524 . . . . 0.0 111.854 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -58.42 -42.9 88.29 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.572 1.549 . . . . 0.0 113.114 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.23 -51.8 61.0 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.191 0.997 . . . . 0.0 112.697 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.15 -42.28 99.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.195 0.998 . . . . 0.0 112.572 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.5 -47.22 79.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.318 1.047 . . . . 0.0 112.672 170.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.64 -46.99 88.2 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.567 1.547 . . . . 0.0 111.773 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -50.94 -56.44 12.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.818 1.247 . . . . 0.0 111.412 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.49 -50.98 61.66 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.22 1.008 . . . . 0.0 112.599 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 31.2 ttp -52.8 -62.43 1.65 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.754 1.622 . . . . 0.0 111.673 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -62.95 -37.33 86.62 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -65.09 -54.46 29.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.639 1.176 . . . . 0.0 112.557 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -90.59 -14.77 31.81 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -169.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.1 109.32 0.82 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 120.101 1.318 . . . . 0.0 110.923 169.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 116.74 -28.84 7.19 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 126.461 1.982 . . . . 0.0 113.923 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.12 134.2 85.38 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.121 1.368 . . . . 0.0 110.737 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.64 141.74 25.19 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.944 2.429 . . . . 0.0 112.721 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.2 tp -137.08 111.68 8.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.762 1.625 . . . . 0.0 108.734 169.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 50.69 60.16 4.06 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.756 1.622 . . . . 0.0 111.489 -169.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.01 -63.74 4.39 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.1 1.333 . . . . 0.0 113.195 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -63.91 135.03 96.13 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.737 1.215 . . . . 0.0 112.659 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.66 123.63 9.59 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.404 2.736 . . . . 0.0 111.105 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.7 mtm -62.88 129.77 41.88 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.076 0.95 . . . . 0.0 111.214 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -109.12 125.44 52.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.638 1.175 . . . . 0.0 108.291 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.29 138.64 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 118.823 0.738 . . . . 0.0 111.904 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -131.37 153.91 49.16 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.334 2.654 . . . . 0.0 109.978 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.8 tp -134.44 127.24 31.12 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.839 1.256 . . . . 0.0 111.041 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.32 -172.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.174 1.789 . . . . 0.0 111.14 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 16.6 m -144.31 139.22 28.42 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.205 1.402 . . . . 0.0 110.317 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.618 1.967 . . . . 0.0 114.059 -178.317 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -137.76 136.62 37.46 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.909 0.855 . . . . 0.0 112.671 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.76 141.05 44.43 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.129 0.972 . . . . 0.0 110.9 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.7 tp -110.67 115.51 29.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.917 2.087 . . . . 0.0 106.717 169.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.89 135.26 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.436 1.095 . . . . 0.0 110.017 -169.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 55.0 m -139.23 161.86 36.39 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.061 1.745 . . . . 0.0 112.246 -174.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.4 t30 51.11 43.26 29.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.294 2.238 . . . . 0.0 114.658 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.1 mt -78.69 164.87 24.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.264 1.426 . . . . 0.0 108.862 168.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.08 159.48 33.53 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.717 -1.239 . . . . 0.0 112.633 169.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -64.55 -41.4 96.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.585 1.554 . . . . 0.0 112.629 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.6 53.04 2.7 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.48 1.514 . . . . 0.0 112.791 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.5 t -116.11 113.74 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 126.038 1.735 . . . . 0.0 109.795 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -72.8 142.29 48.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.242 1.017 . . . . 0.0 112.26 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -56.65 -54.94 40.32 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.468 1.507 . . . . 0.0 112.316 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.31 -34.94 74.5 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.371 1.068 . . . . 0.0 113.567 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.48 -52.74 63.24 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.324 0.965 . . . . 0.0 111.465 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.1 mm -55.0 -52.7 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.343 1.057 . . . . 0.0 110.899 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -50.78 -56.29 12.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.976 0.91 . . . . 0.0 112.105 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -60.14 -48.22 82.62 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.106 1.362 . . . . 0.0 112.963 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -46.61 81.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.415 1.007 . . . . 0.0 112.121 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -60.6 -40.83 93.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.884 0.765 . . . . 0.0 112.048 173.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.5 -6.22 18.67 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -77.35 -59.83 2.62 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.755 -1.216 . . . . 0.0 111.231 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -84.46 -25.54 28.86 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -121.81 -179.58 16.02 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.657 1.599 . . . . 0.0 112.274 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.4 m -123.85 118.58 27.44 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.819 1.247 . . . . 0.0 110.223 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.76 165.08 26.76 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -169.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -93.25 -58.19 2.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.743 2.017 . . . . 0.0 111.176 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -157.93 142.67 16.42 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.408 1.083 . . . . 0.0 113.369 -172.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -105.64 155.71 18.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.658 1.183 . . . . 0.0 111.67 169.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -144.08 88.25 1.95 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.201 1.8 . . . . 0.0 110.1 173.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.0 t -82.16 134.54 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.589 1.556 . . . . 0.0 110.743 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -21.09 -71.1 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 129.436 3.094 . . . . 0.0 116.352 -169.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -48.32 -29.34 3.81 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.394 1.878 . . . . 0.0 115.48 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.28 -32.71 70.27 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.397 1.479 . . . . 0.0 113.409 175.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -134.37 -42.77 0.78 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.124 1.369 . . . . 0.0 114.564 -169.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 54.0 m -60.98 145.73 49.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.113 1.365 . . . . 0.0 112.311 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -58.66 -30.35 65.5 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.92 1.247 . . . . 0.0 114.861 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.29 158.98 43.17 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.783 2.033 . . . . 0.0 111.809 173.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 47.1 m -62.3 133.99 55.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.336 1.055 . . . . 0.0 111.046 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.38 -56.48 0.75 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.517 1.127 . . . . 0.0 113.586 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 113.78 53.66 0.44 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.98 1.276 . . . . 0.0 113.232 -174.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.3 p -141.64 164.17 30.94 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.095 1.758 . . . . 0.0 110.967 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.1 167.26 30.44 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.231 -0.918 . . . . 0.0 112.693 169.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -130.84 132.73 45.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.417 1.887 . . . . 0.0 108.717 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.8 t -135.38 109.01 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 118.93 0.786 . . . . 0.0 111.148 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -73.84 123.35 24.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.118 1.367 . . . . 0.0 110.31 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.0 161.02 17.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.9 2.48 . . . . 0.0 112.92 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -59.19 -48.28 82.21 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.844 0.858 . . . . 0.0 112.577 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -143.2 152.73 42.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.364 1.866 . . . . 0.0 110.471 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -59.92 -43.94 94.62 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.186 0.994 . . . . 0.0 112.631 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.83 -46.58 71.22 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.357 1.063 . . . . 0.0 112.905 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.58 -48.44 79.42 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.211 1.404 . . . . 0.0 111.648 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.01 -48.33 73.51 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.195 1.398 . . . . 0.0 112.637 172.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.9 tp -53.29 -42.03 66.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.734 1.614 . . . . 0.0 113.101 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -51.2 -59.94 3.65 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.502 1.121 . . . . 0.0 111.437 171.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.9 -48.88 69.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.273 1.429 . . . . 0.0 112.482 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 21.0 ttp -51.6 -61.34 2.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.011 1.724 . . . . 0.0 111.563 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -56.36 -45.86 80.26 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.461 1.504 . . . . 0.0 112.353 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -58.4 -51.18 70.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.49 1.116 . . . . 0.0 113.176 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -97.73 -16.62 19.82 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -172.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -58.33 109.26 0.74 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 120.332 1.424 . . . . 0.0 111.388 171.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.56 -26.5 8.06 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.278 1.894 . . . . 0.0 114.041 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.78 135.0 95.35 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.065 1.346 . . . . 0.0 111.044 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.33 134.19 15.41 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.923 2.416 . . . . 0.0 111.708 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 63.5 tp -125.13 102.13 7.34 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.351 1.86 . . . . 0.0 108.196 175.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 44.32 62.04 2.16 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.005 1.722 . . . . 0.0 111.763 -169.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.83 -60.88 4.42 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.105 1.336 . . . . 0.0 112.995 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -60.46 118.94 38.76 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.858 1.663 . . . . 0.0 111.993 -172.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.07 118.85 5.82 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.902 2.401 . . . . 0.0 111.354 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.9 mtp -59.74 137.95 57.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.652 1.581 . . . . 0.0 112.013 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -121.08 131.51 54.31 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.731 1.212 . . . . 0.0 110.11 170.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.3 mt -131.07 137.35 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.258 1.023 . . . . 0.0 111.065 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -130.29 171.76 12.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 129.34 3.056 . . . . 0.0 109.912 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.06 155.43 46.16 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 171.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.6 152.8 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.389 1.476 . . . . 0.0 111.264 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 4.3 m -67.39 132.62 48.02 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.412 1.085 . . . . 0.0 110.931 173.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.614 1.566 . . . . 0.0 113.699 178.077 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 CA-C-O 120.08 -0.289 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -83.53 99.33 10.07 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.057 0.928 . . . . 0.0 111.004 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 76.1 mt -75.83 108.83 8.96 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.682 1.193 . . . . 0.0 110.19 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.4 tp -80.66 125.21 29.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.784 1.233 . . . . 0.0 107.8 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.32 131.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.376 1.07 . . . . 0.0 109.135 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.7 m -135.01 168.8 18.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.763 1.625 . . . . 0.0 111.728 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.2 t30 51.65 56.5 7.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.059 1.744 . . . . 0.0 112.438 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.8 mt -101.12 151.7 21.51 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.297 1.839 . . . . 0.0 110.94 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -69.22 142.05 54.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.776 -0.577 . . . . 0.0 110.937 169.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -62.34 -16.84 56.79 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -78.43 -13.44 83.23 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.413 1.482 . . . . 0.0 115.092 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 80.4 t -66.47 136.34 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 119.26 1.53 . . . . 0.0 109.997 172.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 65.4 m -140.9 169.21 18.04 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.551 1.54 . . . . 0.0 112.355 -175.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -46.34 -58.1 4.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.703 2.001 . . . . 0.0 113.693 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.89 -49.45 71.18 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.989 0.916 . . . . 0.0 112.813 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.1 -49.53 76.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.728 1.211 . . . . 0.0 112.31 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mm -54.19 -55.55 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.839 1.255 . . . . 0.0 111.349 171.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -53.19 -53.46 50.27 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.776 0.716 . . . . 0.0 111.685 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -54.51 -51.51 64.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.859 0.864 . . . . 0.0 113.058 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -49.57 72.6 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.857 0.753 . . . . 0.0 112.555 -176.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -67.09 -38.49 85.8 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.72 -20.22 64.69 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.33 -66.45 0.54 Allowed 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.959 -1.088 . . . . 0.0 110.751 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -85.56 -17.93 34.85 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -172.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.57 -159.79 8.49 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.429 1.49 . . . . 0.0 112.862 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.1 m -144.83 133.89 22.69 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.292 1.046 . . . . 0.0 110.996 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.59 146.81 52.19 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.892 1.277 . . . . 0.0 114.365 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -74.39 -52.32 12.46 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.441 1.896 . . . . 0.0 110.194 169.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -149.03 158.84 44.5 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.23 160.67 37.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.072 1.749 . . . . 0.0 110.847 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.89 149.42 23.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.329 1.852 . . . . 0.0 110.699 170.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.95 -96.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.976 0.91 . . . . 0.0 110.803 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.576 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -136.44 -98.22 0.22 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.905 1.682 . . . . 0.0 110.926 -169.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.576 ' H ' ' CG ' ' A' ' 137' ' ' HIS . 9.3 p90 43.45 32.05 0.47 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 130.255 3.422 . . . . 0.0 115.795 169.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -162.45 171.4 17.16 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 129.385 3.074 . . . . 0.0 108.913 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -75.85 74.47 2.79 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.738 -1.226 . . . . 0.0 110.441 170.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.6 m -62.75 -39.68 94.89 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.895 1.678 . . . . 0.0 114.038 -173.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 64.47 52.39 43.78 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.336 0.97 . . . . 0.0 111.675 -170.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -146.13 154.85 42.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.112 2.165 . . . . 0.0 111.051 -169.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.4 m -59.9 108.57 0.78 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.242 1.017 . . . . 0.0 109.9 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.3 tp -76.87 166.3 23.52 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.005 0.922 . . . . 0.0 112.994 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.89 46.76 9.16 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.219 0.914 . . . . 0.0 111.208 -169.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.0 p -146.45 150.18 35.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.773 2.029 . . . . 0.0 111.258 -170.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.32 167.87 23.22 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.202 1.801 . . . . 0.0 112.511 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -132.93 131.4 40.8 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.83 2.052 . . . . 0.0 109.668 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.1 t -132.92 109.33 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.529 1.132 . . . . 0.0 109.644 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -90.63 98.98 12.1 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.253 1.421 . . . . 0.0 110.064 -176.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -73.3 155.18 39.72 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.284 1.834 . . . . 0.0 114.249 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -68.72 -45.48 71.44 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.419 1.488 . . . . 0.0 112.088 171.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 -122.38 124.04 42.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.176 1.79 . . . . 0.0 110.325 -169.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -58.6 -47.27 84.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.843 1.257 . . . . 0.0 112.176 175.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.18 -48.31 61.96 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.35 1.06 . . . . 0.0 112.783 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -67.46 -35.43 79.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.679 1.191 . . . . 0.0 112.557 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.31 -45.56 92.95 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.037 0.935 . . . . 0.0 112.353 170.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -53.8 -49.93 67.23 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.709 1.141 . . . . 0.0 111.607 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -51.59 -58.2 7.0 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.409 1.084 . . . . 0.0 111.353 174.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -50.09 -51.93 38.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.106 1.362 . . . . 0.0 112.663 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 60.9 ttp -53.63 -62.69 1.49 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.548 1.539 . . . . 0.0 111.5 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -62.49 -37.58 86.55 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -64.03 -51.04 66.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.234 1.413 . . . . 0.0 112.687 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -99.0 -14.17 19.59 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -169.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -58.83 112.61 1.71 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.154 1.343 . . . . 0.0 111.226 170.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.57 -23.25 26.81 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.054 1.788 . . . . 0.0 114.371 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.7 t -73.15 135.51 79.76 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.887 1.275 . . . . 0.0 110.393 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.53 142.92 26.86 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.952 2.435 . . . . 0.0 113.068 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.5 tp -131.82 106.27 7.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.838 1.655 . . . . 0.0 107.852 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 50.65 61.22 3.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.755 1.622 . . . . 0.0 111.377 -169.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.53 -62.95 4.21 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.135 1.35 . . . . 0.0 113.311 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -65.43 128.49 93.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.844 1.258 . . . . 0.0 112.392 -172.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.91 122.92 9.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.725 2.95 . . . . 0.0 111.897 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.4 mtm -63.18 126.06 26.15 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.065 1.346 . . . . 0.0 111.831 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -103.19 113.5 27.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.986 1.315 . . . . 0.0 109.191 172.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mt -118.37 134.69 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.552 1.141 . . . . 0.0 111.484 -169.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -136.94 153.72 50.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.335 2.254 . . . . 0.0 110.089 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.2 tp -135.2 132.74 38.29 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.842 1.257 . . . . 0.0 111.453 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.57 134.08 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.127 0.971 . . . . 0.0 112.023 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.3 m -66.02 -56.07 13.45 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.482 1.113 . . . . 0.0 112.258 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.641 1.976 . . . . 0.0 113.341 -176.769 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.87 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -132.74 152.21 51.8 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.079 0.943 . . . . 0.0 111.957 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -129.05 101.64 6.14 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.137 1.775 . . . . 0.0 108.208 -169.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.6 tp -84.45 133.36 34.49 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.14 1.376 . . . . 0.0 109.394 175.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.5 t -122.05 130.48 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.85 1.26 . . . . 0.0 108.944 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -115.19 159.73 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.968 1.707 . . . . 0.0 110.474 172.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.3 t30 60.74 71.66 0.56 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.307 1.843 . . . . 0.0 112.227 -169.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.5 mt -131.33 154.6 48.39 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.873 2.469 . . . . 0.0 108.964 169.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -88.63 151.27 22.57 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.72 -0.613 . . . . 0.0 112.364 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -58.2 -28.07 64.46 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.187 -0.945 . . . . 0.0 112.294 172.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.97 -17.08 65.0 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.052 1.31 . . . . 0.0 115.467 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.99 116.67 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.419 1.609 . . . . 0.0 110.453 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.5 m -76.31 151.24 36.78 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.698 1.199 . . . . 0.0 111.852 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.51 -50.34 74.11 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.608 -0.683 . . . . 0.0 112.243 172.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 -38.91 59.86 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.06 -56.37 23.17 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.29 1.036 . . . . 0.0 112.231 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 23.6 mm -56.1 -53.89 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.197 1.399 . . . . 0.0 111.157 173.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -47.3 -57.77 4.86 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.829 2.052 . . . . 0.0 111.47 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -59.92 -50.97 71.7 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.506 1.122 . . . . 0.0 113.122 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.6 -45.2 93.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.402 1.001 . . . . 0.0 112.149 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -63.22 -44.24 95.84 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.433 0.693 . . . . 0.0 112.415 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.13 -18.56 63.57 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -69.46 -60.14 2.52 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.818 -1.176 . . . . 0.0 111.834 173.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -85.44 -22.76 28.15 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.06 -167.31 11.2 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.681 1.61 . . . . 0.0 112.735 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.2 m -136.81 129.3 30.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.082 0.953 . . . . 0.0 111.078 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.8 pp -130.06 144.49 51.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.88 1.272 . . . . 0.0 113.376 -169.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -75.17 -50.17 17.13 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.913 2.085 . . . . 0.0 110.497 169.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.94 154.79 38.86 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.78 1.232 . . . . 0.0 112.132 -172.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -138.58 151.72 47.54 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.446 1.499 . . . . 0.0 111.541 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.12 159.21 44.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.678 1.991 . . . . 0.0 110.903 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.1 -124.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.266 1.026 . . . . 0.0 110.818 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -71.08 -35.55 71.91 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -169.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -69.53 154.35 42.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.038 1.735 . . . . 0.0 114.142 -169.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -150.06 154.92 38.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.934 2.094 . . . . 0.0 110.41 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -49.25 -33.6 13.16 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.96 1.704 . . . . 0.0 113.869 175.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.7 m -59.77 -23.97 63.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.121 1.769 . . . . 0.0 114.26 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.56 49.7 7.08 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.12 1.343 . . . . 0.0 111.855 -170.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -140.94 113.46 8.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.544 1.938 . . . . 0.0 110.58 -174.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.9 m -70.74 138.54 50.59 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.455 1.102 . . . . 0.0 111.68 173.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 35.2 tp -130.71 150.15 52.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.383 1.873 . . . . 0.0 110.229 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.43 51.11 4.45 Favored Glycine 0 N--CA 1.47 0.954 0 O-C-N 120.959 -1.088 . . . . 0.0 112.469 -171.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 37.0 p -142.01 167.71 21.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.67 1.988 . . . . 0.0 113.548 -169.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.7 157.11 43.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.725 2.01 . . . . 0.0 110.618 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -140.14 126.89 20.51 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.982 1.313 . . . . 0.0 110.212 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 52.2 t -122.34 116.03 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.813 1.245 . . . . 0.0 109.033 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -83.32 105.65 14.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.023 1.329 . . . . 0.0 108.19 173.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -82.08 153.33 26.16 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.423 2.289 . . . . 0.0 113.079 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.76 -34.01 77.19 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.987 0.915 . . . . 0.0 113.409 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -138.15 146.34 42.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.486 1.514 . . . . 0.0 113.295 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -64.18 -45.63 87.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.791 1.636 . . . . 0.0 111.782 172.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.03 -49.48 60.42 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.47 1.108 . . . . 0.0 112.265 171.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.35 -40.83 90.08 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.622 1.169 . . . . 0.0 112.792 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.37 -49.4 74.55 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.582 1.153 . . . . 0.0 112.419 170.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 54.6 tp -57.04 -49.76 74.82 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.352 1.461 . . . . 0.0 111.884 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -50.1 -52.85 31.44 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.354 1.461 . . . . 0.0 111.434 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.96 -50.86 69.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.017 0.927 . . . . 0.0 112.519 173.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -54.5 -60.23 3.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.376 1.07 . . . . 0.0 112.17 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -37.19 75.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -69.17 -43.83 73.45 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.161 0.984 . . . . 0.0 112.906 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -108.42 -8.41 15.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -169.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -58.46 116.43 3.64 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 120.054 1.297 . . . . 0.0 111.459 171.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.58 -21.54 44.72 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.869 1.7 . . . . 0.0 114.575 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.28 136.67 88.93 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 118.72 1.26 . . . . 0.0 110.451 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.8 143.57 29.95 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.725 2.284 . . . . 0.0 113.197 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -131.67 106.76 8.36 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.301 2.24 . . . . 0.0 107.015 171.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 48.0 61.67 2.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.336 1.454 . . . . 0.0 111.494 -169.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.39 -53.92 4.71 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.254 1.407 . . . . 0.0 113.483 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -59.47 119.17 37.35 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.522 1.929 . . . . 0.0 112.779 -174.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.54 120.73 7.65 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.619 2.212 . . . . 0.0 110.726 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.5 mtm -67.3 116.96 8.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.982 1.313 . . . . 0.0 112.13 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -89.59 101.43 14.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.264 1.025 . . . . 0.0 108.941 170.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.4 mt -103.89 139.81 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.275 1.03 . . . . 0.0 111.827 -170.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -134.27 126.61 30.13 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.415 1.886 . . . . 0.0 111.191 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 60.9 tp -75.79 131.7 39.95 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.769 1.228 . . . . 0.0 109.874 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.35 171.65 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.38 1.472 . . . . 0.0 112.159 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.7 p -132.77 -69.16 0.58 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.926 1.69 . . . . 0.0 110.806 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 C--O 1.251 1.135 0 C-N-CA 125.95 1.7 . . . . 0.0 112.116 171.165 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 N-CA-C 112.629 -0.188 . . . . 0.0 112.629 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -149.08 130.59 14.84 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.576 -0.955 . . . . 0.0 111.519 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 41.9 mt -119.43 121.24 39.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.018 1.727 . . . . 0.0 111.879 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.9 tp -86.05 116.01 24.0 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 168.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 49.1 t -101.83 131.05 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 108.134 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.2 m -138.78 167.84 21.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.762 1.625 . . . . 0.0 112.318 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.7 t30 52.84 46.88 25.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.005 1.722 . . . . 0.0 112.948 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.9 mt -90.76 164.34 14.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.766 1.227 . . . . 0.0 109.59 169.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.93 150.88 47.93 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.392 -0.817 . . . . 0.0 110.652 169.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -58.07 -20.82 42.48 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -128.78 39.76 1.81 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.879 1.228 . . . . 0.0 115.812 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.58 131.8 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.367 1.583 . . . . 0.0 109.276 169.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.1 m -69.92 138.92 52.81 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.487 0.715 . . . . 0.0 112.344 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.87 -52.16 66.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.068 1.347 . . . . 0.0 112.309 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.87 -40.47 80.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.98 1.312 . . . . 0.0 113.092 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.61 -52.35 65.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.9 0.88 . . . . 0.0 112.127 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.1 mm -55.11 -52.86 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.949 0.9 . . . . 0.0 111.266 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -51.89 -52.45 49.68 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.925 0.89 . . . . 0.0 112.294 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -60.43 -51.97 67.23 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.031 1.332 . . . . 0.0 113.27 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.19 -43.54 97.93 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.337 0.972 . . . . 0.0 112.22 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -62.16 -44.87 95.65 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.533 0.606 . . . . 0.0 112.022 172.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.69 -32.64 67.55 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.62 -47.3 86.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.198 0.999 . . . . 0.0 112.874 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -100.82 -15.86 17.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.92 155.1 25.75 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.641 1.115 . . . . 0.0 114.033 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.7 m -91.53 99.23 12.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.858 1.263 . . . . 0.0 110.006 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 pp -111.47 141.82 44.53 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.296 1.038 . . . . 0.0 113.742 -171.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -82.22 -46.25 13.97 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.153 2.581 . . . . 0.0 110.427 170.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -146.12 144.99 30.34 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.395 1.478 . . . . 0.0 111.481 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.62 121.96 11.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.378 1.471 . . . . 0.0 110.447 171.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.08 139.86 30.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.624 1.17 . . . . 0.0 112.704 -176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.9 t -107.28 144.24 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.363 1.865 . . . . 0.0 111.159 -173.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -41.44 -50.11 3.88 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.468 2.307 . . . . 0.0 114.918 -169.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -58.89 -33.85 70.98 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.75 1.22 . . . . 0.0 113.147 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.57 -52.62 4.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.725 1.61 . . . . 0.0 111.749 173.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 -56.24 -58.19 9.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.616 2.366 . . . . 0.0 113.496 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.5 m -104.61 -35.91 7.67 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.976 2.111 . . . . 0.0 113.002 -169.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.03 -62.11 0.46 Allowed Glycine 0 CA--C 1.531 1.066 0 C-N-CA 126.108 1.813 . . . . 0.0 112.329 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -59.7 126.39 27.42 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.783 1.633 . . . . 0.0 112.11 -178.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.3 m -58.28 121.62 11.22 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.584 1.554 . . . . 0.0 111.875 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 43.8 tp -147.73 -48.72 0.17 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.444 1.098 . . . . 0.0 113.378 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.05 57.96 1.27 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.498 1.047 . . . . 0.0 112.159 -176.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.9 p -144.16 163.53 33.34 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.759 1.623 . . . . 0.0 111.416 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.73 168.49 20.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.635 1.174 . . . . 0.0 111.405 170.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -135.18 118.81 17.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.162 1.785 . . . . 0.0 108.828 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.61 116.65 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.239 1.016 . . . . 0.0 110.093 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -101.83 124.93 48.29 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.643 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -103.23 154.7 19.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.951 2.9 . . . . 0.0 113.042 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -68.78 -29.75 68.19 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.905 1.282 . . . . 0.0 113.63 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -138.38 136.06 35.94 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.248 1.419 . . . . 0.0 113.018 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.41 -53.55 56.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.403 2.281 . . . . 0.0 112.449 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.44 -45.37 84.78 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.191 1.397 . . . . 0.0 112.415 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.83 -38.91 92.56 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.504 -0.748 . . . . 0.0 112.567 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.96 51.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.282 0.633 . . . . 0.0 111.337 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.26 -50.22 59.65 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.5 1.92 . . . . 0.0 112.334 174.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -50.68 -59.99 3.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.805 1.642 . . . . 0.0 111.206 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.65 -46.47 70.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.381 1.073 . . . . 0.0 112.393 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.5 ttp -52.83 -59.48 4.45 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.957 1.303 . . . . 0.0 111.839 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -55.53 -50.45 69.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.217 1.007 . . . . 0.0 112.273 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -59.03 -46.34 88.46 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.851 1.661 . . . . 0.0 113.115 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -100.81 -14.81 17.85 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -60.53 106.26 0.53 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.001 1.273 . . . . 0.0 111.178 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.33 -27.33 7.37 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 126.569 2.033 . . . . 0.0 114.087 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 64.2 t -68.88 132.77 90.43 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.06 1.344 . . . . 0.0 110.876 -174.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.1 145.87 22.32 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.902 2.401 . . . . 0.0 113.39 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.8 tt -130.5 108.18 9.76 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.111 2.165 . . . . 0.0 107.32 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 44.0 57.04 4.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.936 1.694 . . . . 0.0 112.048 -169.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 87.9 -51.12 4.03 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.985 1.278 . . . . 0.0 113.706 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -62.8 119.38 50.77 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.54 1.536 . . . . 0.0 111.448 -174.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.29 118.55 5.74 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.831 2.354 . . . . 0.0 110.924 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.61 127.34 31.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.091 0.956 . . . . 0.0 110.957 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -100.78 131.11 46.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.524 1.13 . . . . 0.0 109.036 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.1 mm -124.1 135.51 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.788 0.835 . . . . 0.0 109.946 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.22 117.76 19.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.344 1.458 . . . . 0.0 110.674 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 39.7 tp -72.38 135.53 45.87 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.754 1.222 . . . . 0.0 110.147 169.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.5 m -123.18 151.26 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.16 0.984 . . . . 0.0 111.548 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.9 m -147.51 135.21 21.02 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.448 1.899 . . . . 0.0 109.86 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.7 m . . . . . 0 C--O 1.252 1.225 0 C-N-CA 125.093 1.357 . . . . 0.0 113.456 177.238 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.173 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.36 112.79 19.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.709 1.203 . . . . 0.0 111.522 179.029 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.5 117.88 23.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.842 2.457 . . . . 0.0 108.53 178.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.3 tp -105.69 125.62 51.2 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.808 2.043 . . . . 0.0 110.484 -176.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.6 t -112.78 125.44 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.148 1.779 . . . . 0.0 109.195 179.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.6 m -120.92 163.08 18.78 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.858 2.063 . . . . 0.0 110.909 177.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.7 t30 51.62 57.0 7.03 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.124 1.369 . . . . 0.0 111.281 -169.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.8 118.73 33.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.522 2.329 . . . . 0.0 107.784 -173.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.07 140.99 58.35 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -54.61 -29.02 50.67 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.777 1.631 . . . . 0.0 114.169 -178.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -75.72 -15.89 81.0 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.974 1.273 . . . . 0.0 115.353 177.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.18 122.42 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 119.155 1.478 . . . . 0.0 110.797 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.5 m -79.48 148.36 31.89 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.117 0.967 . . . . 0.0 113.22 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.75 -54.23 48.69 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.305 1.842 . . . . 0.0 112.631 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.65 87.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.035 0.934 . . . . 0.0 112.907 174.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.06 -47.55 84.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.587 0.755 . . . . 0.0 111.939 176.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mm -55.03 -52.53 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.035 0.934 . . . . 0.0 111.196 169.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -52.46 -52.2 55.39 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.126 0.571 . . . . 0.0 112.33 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.88 -50.51 73.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.94 1.296 . . . . 0.0 113.46 175.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.82 -44.96 91.69 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.394 0.997 . . . . 0.0 112.032 -176.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -61.75 -41.21 97.39 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 173.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.9 -13.58 46.55 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 175.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -74.59 -63.42 1.25 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.861 -1.15 . . . . 0.0 111.481 173.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -84.4 -12.78 53.82 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -175.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.36 -178.13 18.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.479 1.514 . . . . 0.0 112.942 176.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -126.65 127.49 45.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.984 1.314 . . . . 0.0 109.926 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -134.61 149.66 50.6 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.637 1.175 . . . . 0.0 114.145 -169.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -77.68 -49.87 13.62 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.643 1.977 . . . . 0.0 110.407 169.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -149.78 150.83 32.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.687 1.195 . . . . 0.0 113.111 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -127.25 154.53 44.76 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.863 1.665 . . . . 0.0 110.148 168.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.26 153.38 29.04 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.723 1.609 . . . . 0.0 112.068 179.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.9 t -125.65 158.76 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 126.82 2.048 . . . . 0.0 109.362 174.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -58.52 -47.75 83.14 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.409 -1.432 . . . . 0.0 114.226 -174.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -62.12 161.32 11.19 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.873 1.269 . . . . 0.0 113.335 -171.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 t70 66.56 -55.48 0.41 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 127.775 2.43 . . . . 0.0 113.578 -173.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -55.41 -47.08 76.47 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.676 1.59 . . . . 0.0 111.287 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -123.91 115.35 21.14 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.101 1.76 . . . . 0.0 109.792 170.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.85 55.4 4.9 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.446 1.022 . . . . 0.0 113.075 -178.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -146.72 138.35 24.46 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.29 2.236 . . . . 0.0 110.983 -173.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.8 m -60.93 114.32 3.01 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.516 1.126 . . . . 0.0 111.012 173.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.3 tp -139.3 -59.64 0.58 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.265 1.426 . . . . 0.0 111.177 -177.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.27 63.63 1.71 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.103 0.859 . . . . 0.0 113.43 172.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.8 p -143.91 154.41 43.31 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.501 1.521 . . . . 0.0 111.617 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.28 159.1 42.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.969 1.307 . . . . 0.0 111.766 173.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -144.2 133.75 23.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.876 1.67 . . . . 0.0 110.746 -172.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.86 114.79 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.446 1.098 . . . . 0.0 110.432 -177.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -79.46 104.15 9.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.328 1.451 . . . . 0.0 108.874 170.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -82.79 163.59 21.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.159 1.783 . . . . 0.0 113.389 -175.006 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -70.21 -51.48 30.62 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.827 0.851 . . . . 0.0 112.506 169.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -131.26 145.67 51.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.286 1.834 . . . . 0.0 112.354 -172.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -54.88 -56.65 17.21 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.924 2.09 . . . . 0.0 112.814 176.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.24 -47.13 72.58 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.887 1.275 . . . . 0.0 112.422 177.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -61.86 -38.86 89.83 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.459 1.103 . . . . 0.0 112.71 176.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.19 -46.46 80.68 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.458 0.703 . . . . 0.0 112.427 170.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.0 tp -59.12 -42.19 89.98 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.492 1.517 . . . . 0.0 112.147 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -48.0 -60.03 2.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.564 1.546 . . . . 0.0 110.728 169.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.73 -49.04 69.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.989 1.315 . . . . 0.0 112.592 176.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 25.0 ttp -51.81 -60.04 3.63 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.625 1.17 . . . . 0.0 111.643 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.26 -48.4 81.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.76 1.224 . . . . 0.0 112.319 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -58.1 -49.53 76.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.558 1.543 . . . . 0.0 112.993 -178.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -99.92 -12.37 19.87 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -169.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -59.47 110.57 1.14 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.336 1.425 . . . . 0.0 111.194 169.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.36 -23.8 19.61 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.494 1.997 . . . . 0.0 114.172 -175.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -74.28 134.41 76.97 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.825 1.25 . . . . 0.0 110.95 -174.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.37 139.43 20.84 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.008 2.472 . . . . 0.0 112.719 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.8 tp -136.07 113.7 10.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.508 1.523 . . . . 0.0 108.628 169.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 49.11 61.4 3.15 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.609 1.564 . . . . 0.0 111.2 -169.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.4 -62.48 4.56 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.431 1.491 . . . . 0.0 113.373 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -66.06 128.42 93.82 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.866 1.266 . . . . 0.0 112.907 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.73 116.41 4.65 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.451 2.768 . . . . 0.0 110.868 171.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.6 mtm -65.72 124.94 23.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.651 1.18 . . . . 0.0 111.666 -178.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -98.6 118.14 34.62 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mt -119.38 137.57 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.844 0.858 . . . . 0.0 112.305 -169.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -135.02 155.99 49.82 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.413 2.685 . . . . 0.0 110.032 -175.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 47.8 tp -135.86 113.49 10.92 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.448 1.099 . . . . 0.0 110.797 -177.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.01 118.29 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.942 0.897 . . . . 0.0 110.497 -175.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.4 m -144.99 137.49 26.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.987 1.715 . . . . 0.0 110.504 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.0 m . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.502 1.921 . . . . 0.0 114.025 -179.097 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.162 0 N-CA-C 113.547 0.179 . . . . 0.0 113.547 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -72.05 149.72 44.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.448 1.099 . . . . 0.0 112.112 176.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.4 mt -136.33 139.31 42.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 130.107 3.363 . . . . 0.0 108.758 174.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 65.7 tp -122.32 118.82 29.39 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.892 1.677 . . . . 0.0 108.607 174.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.82 112.25 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.123 1.369 . . . . 0.0 108.709 -169.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -127.62 173.97 9.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.789 1.235 . . . . 0.0 112.54 -169.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.0 t30 52.34 43.12 31.12 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.119 1.767 . . . . 0.0 112.891 -169.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.7 mt -77.36 153.99 33.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.149 0.98 . . . . 0.0 108.566 169.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -68.02 141.98 56.05 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.732 -1.23 . . . . 0.0 109.957 169.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -61.55 -19.03 61.68 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.03 0.54 82.11 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.452 1.501 . . . . 0.0 115.472 174.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.07 118.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.733 1.766 . . . . 0.0 110.916 175.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.5 m -71.45 148.03 47.26 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.717 1.207 . . . . 0.0 112.765 178.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -53.63 -54.38 38.55 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.831 1.652 . . . . 0.0 112.846 174.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.89 78.47 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.532 1.133 . . . . 0.0 113.299 177.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.85 -51.02 71.79 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.949 0.9 . . . . 0.0 112.364 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.6 mm -56.52 -52.73 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.344 1.057 . . . . 0.0 111.008 171.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -51.82 -51.85 53.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.896 0.878 . . . . 0.0 112.414 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.72 -50.06 73.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.199 1.4 . . . . 0.0 113.545 174.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.04 -43.74 98.18 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.878 1.217 . . . . 0.0 112.455 -175.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -63.51 -42.5 98.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.557 0.617 . . . . 0.0 112.371 172.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.21 71.25 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 173.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.22 -42.38 86.12 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.448 1.099 . . . . 0.0 113.085 177.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -108.36 -1.63 19.82 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -174.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.02 165.25 34.66 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 120.047 1.294 . . . . 0.0 114.628 177.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.8 m -101.47 122.94 44.7 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.096 0.958 . . . . 0.0 110.758 -177.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.05 161.9 36.83 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -93.74 -46.82 7.06 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.148 1.779 . . . . 0.0 112.131 175.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -141.94 143.31 33.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.295 1.038 . . . . 0.0 112.549 -173.094 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.49 118.11 6.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.808 1.643 . . . . 0.0 109.418 169.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.35 121.6 12.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.966 1.306 . . . . 0.0 112.414 -172.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.72 152.84 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.839 1.656 . . . . 0.0 110.098 170.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -48.94 -48.18 43.12 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.293 1.837 . . . . 0.0 115.042 -172.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -66.01 133.39 50.71 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.872 0.869 . . . . 0.0 112.736 -172.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -156.84 -84.16 0.05 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.232 1.413 . . . . 0.0 110.51 174.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -70.08 -62.13 1.5 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.173 0.989 . . . . 0.0 109.459 170.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.9 m -82.27 159.71 23.11 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.819 1.647 . . . . 0.0 111.222 169.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -139.85 67.82 0.5 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.359 1.457 . . . . 0.0 111.732 176.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.3 mtp85 -67.4 154.24 41.82 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.369 1.468 . . . . 0.0 112.364 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 57.4 m -71.77 81.53 0.88 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.114 1.366 . . . . 0.0 110.021 169.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 60.6 tp -151.28 161.33 42.91 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.525 2.33 . . . . 0.0 109.509 -170.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.13 77.19 0.28 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.809 1.195 . . . . 0.0 111.703 -178.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.3 m -141.39 143.0 33.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.672 1.589 . . . . 0.0 110.826 -174.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.83 139.29 34.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.325 1.45 . . . . 0.0 112.69 176.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -93.7 129.94 39.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.573 1.549 . . . . 0.0 109.429 169.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.6 t -133.16 143.59 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.596 1.559 . . . . 0.0 108.878 -177.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -145.47 108.24 4.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.755 -1.215 . . . . 0.0 111.006 -173.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -86.19 175.27 8.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.882 2.073 . . . . 0.0 113.628 -171.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -91.54 -65.68 0.99 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.743 1.217 . . . . 0.0 110.861 169.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -83.12 132.37 35.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.187 1.395 . . . . 0.0 111.89 -176.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -50.42 73.1 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.439 1.496 . . . . 0.0 112.105 179.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.36 -45.79 84.01 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.513 1.125 . . . . 0.0 112.246 176.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -63.7 -39.82 95.25 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.022 1.329 . . . . 0.0 112.55 177.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.51 -52.1 67.01 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.163 0.985 . . . . 0.0 111.809 170.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 62.2 tp -54.94 -47.36 74.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.142 0.977 . . . . 0.0 112.057 174.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -50.23 -57.18 8.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.633 1.573 . . . . 0.0 111.356 171.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -50.87 -46.07 60.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.651 1.18 . . . . 0.0 112.865 176.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 24.4 ttp -57.16 -67.26 0.34 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.688 0.676 . . . . 0.0 111.507 172.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -62.67 -36.02 81.54 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -170.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -64.18 -42.58 96.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.93 1.292 . . . . 0.0 112.931 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.25 -13.65 14.86 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -169.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.65 113.96 2.27 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.776 1.171 . . . . 0.0 111.116 169.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.58 -16.75 54.57 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.909 1.718 . . . . 0.0 114.699 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.44 129.49 85.6 Favored Pre-proline 0 N--CA 1.477 0.912 0 CA-C-N 119.085 1.442 . . . . 0.0 110.813 -176.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.98 140.19 93.05 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.809 3.006 . . . . 0.0 115.1 176.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.6 tp -138.28 104.59 5.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.366 2.266 . . . . 0.0 107.539 169.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 48.31 62.01 2.74 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.387 1.475 . . . . 0.0 111.718 -169.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.69 -59.51 4.95 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.19 1.376 . . . . 0.0 113.214 -179.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.5 mtt-85 -60.55 127.67 87.16 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.733 1.613 . . . . 0.0 112.682 -175.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.82 122.61 8.66 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.757 2.305 . . . . 0.0 110.756 170.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.5 mtm -61.69 121.61 13.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.099 0.96 . . . . 0.0 111.589 178.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -93.41 103.06 15.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.866 1.266 . . . . 0.0 108.917 174.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -115.83 131.85 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.33 1.052 . . . . 0.0 111.342 -171.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -122.54 150.18 42.92 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.647 2.379 . . . . 0.0 109.394 175.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.4 tp -80.31 -123.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.882 1.273 . . . . 0.0 110.075 174.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 20.4 m -62.38 135.91 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.12 -0.987 . . . . 0.0 110.632 171.101 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 18.7 p -72.33 -62.39 1.45 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.923 1.289 . . . . 0.0 112.969 -170.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.252 1.194 0 C-N-CA 126.77 2.028 . . . . 0.0 112.375 -175.814 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 112.609 -0.196 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -146.52 138.42 24.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.341 1.056 . . . . 0.0 111.139 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.1 mt -134.67 126.27 28.78 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.709 1.604 . . . . 0.0 112.221 -175.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.7 tp -90.8 124.7 35.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.228 1.411 . . . . 0.0 107.603 169.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.71 92.0 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.677 1.591 . . . . 0.0 108.597 -171.007 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.0 m -88.19 167.65 13.42 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.129 1.771 . . . . 0.0 112.581 -177.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.0 t30 55.35 66.77 1.14 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.175 2.19 . . . . 0.0 113.447 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.7 mt -116.16 -168.81 1.49 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.582 2.353 . . . . 0.0 110.42 174.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.85 150.35 47.82 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.129 -0.982 . . . . 0.0 112.322 173.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -51.01 -40.89 59.23 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.465 1.106 . . . . 0.0 112.977 175.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.27 69.51 0.43 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.479 1.514 . . . . 0.0 111.941 173.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.78 134.48 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.954 1.702 . . . . 0.0 111.855 172.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.0 m -85.52 126.25 33.7 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.819 -0.551 . . . . 0.0 110.394 170.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.44 -48.46 79.08 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.381 1.072 . . . . 0.0 111.961 179.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.17 75.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.278 1.431 . . . . 0.0 113.233 175.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.56 -53.16 61.45 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.176 0.991 . . . . 0.0 111.993 178.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 47.7 mm -57.34 -53.58 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.63 1.172 . . . . 0.0 111.169 173.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -49.47 -54.57 17.04 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.315 1.046 . . . . 0.0 111.553 177.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -61.37 -50.1 74.24 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.023 0.829 . . . . 0.0 112.657 178.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -47.53 85.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.939 0.79 . . . . 0.0 112.31 -176.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -64.91 -46.91 79.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.641 0.655 . . . . 0.0 112.303 175.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.99 -35.49 64.41 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -55.54 -45.52 77.2 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.34 1.056 . . . . 0.0 112.98 175.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -102.53 -19.36 14.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -175.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -152.63 157.68 27.43 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-N 120.096 1.316 . . . . 0.0 114.303 177.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.4 m -84.63 95.91 9.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.68 -0.894 . . . . 0.0 111.727 -172.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.21 143.34 29.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.635 0.774 . . . . 0.0 111.809 172.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -85.63 -48.51 8.81 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.575 2.35 . . . . 0.0 110.309 169.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -149.45 149.09 30.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.742 1.217 . . . . 0.0 112.444 -177.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -122.77 153.86 38.95 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.094 1.758 . . . . 0.0 110.96 169.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.57 -176.33 5.26 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.696 2.398 . . . . 0.0 110.938 -176.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.45 151.69 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 127.909 2.483 . . . . 0.0 110.099 176.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -42.72 99.75 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -172.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -71.15 137.29 48.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.999 1.32 . . . . 0.0 112.187 172.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -145.21 -95.88 0.1 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.357 1.063 . . . . 0.0 110.845 177.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -57.96 -40.61 81.0 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.373 1.469 . . . . 0.0 111.825 171.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.1 p -55.46 -53.16 59.77 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.406 2.283 . . . . 0.0 113.524 173.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.53 30.14 76.8 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.378 1.466 . . . . 0.0 113.588 -173.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -77.94 93.33 4.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.495 1.518 . . . . 0.0 110.945 -178.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.1 m -54.92 122.77 11.57 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.995 1.318 . . . . 0.0 111.296 174.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 56.6 tp -153.85 -69.12 0.14 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.743 1.217 . . . . 0.0 111.181 -173.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.39 66.86 0.13 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.461 1.505 . . . . 0.0 113.606 175.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.0 m -141.86 113.77 7.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.0 1.32 . . . . 0.0 110.077 176.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -96.79 164.01 12.75 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.159 1.383 . . . . 0.0 111.373 173.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -143.4 126.49 16.43 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.57 1.148 . . . . 0.0 110.37 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.4 t -136.6 136.75 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.14 0.976 . . . . 0.0 110.989 -169.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -115.91 138.75 50.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.307 1.843 . . . . 0.0 109.368 178.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -127.39 158.39 37.43 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.149 2.58 . . . . 0.0 113.708 -169.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -64.47 -32.71 74.46 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.483 1.513 . . . . 0.0 114.439 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -135.93 147.56 48.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.088 1.355 . . . . 0.0 112.803 -169.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -58.92 -52.75 64.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.444 1.498 . . . . 0.0 111.734 169.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.98 -50.44 64.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.088 1.355 . . . . 0.0 112.195 177.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.65 -51.4 63.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.234 1.414 . . . . 0.0 112.023 175.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.76 -50.98 71.9 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.586 0.754 . . . . 0.0 112.429 176.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 80.3 mt -58.34 -47.09 84.86 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.474 1.11 . . . . 0.0 112.764 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -54.22 -55.51 27.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.943 1.297 . . . . 0.0 111.582 172.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.32 -52.74 51.46 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.691 1.196 . . . . 0.0 112.561 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 34.8 ttm -50.03 -62.03 1.81 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.665 1.586 . . . . 0.0 111.617 175.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.75 -46.8 88.02 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.121 1.368 . . . . 0.0 112.64 -177.171 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -63.03 -45.4 92.51 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.477 1.111 . . . . 0.0 113.206 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.0 -15.72 17.37 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -169.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -60.66 110.35 1.27 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.969 1.259 . . . . 0.0 110.682 169.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.96 -25.72 11.27 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.561 2.029 . . . . 0.0 114.191 -175.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.81 132.0 90.89 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.564 1.146 . . . . 0.0 111.433 -171.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.22 106.89 1.96 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.527 2.818 . . . . 0.0 112.283 -177.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 tp -75.23 89.87 2.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.177 1.391 . . . . 0.0 109.352 169.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 44.46 58.51 3.79 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.363 1.865 . . . . 0.0 111.33 -169.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 100.72 -47.54 1.23 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.627 1.584 . . . . 0.0 113.702 -177.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -68.33 107.91 2.36 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 127.002 2.121 . . . . 0.0 112.463 -169.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.17 107.9 2.22 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.984 1.789 . . . . 0.0 110.863 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.91 134.68 55.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.256 1.022 . . . . 0.0 111.138 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -119.64 112.83 19.8 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.853 0.861 . . . . 0.0 110.459 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.0 mt -108.11 132.67 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.146 0.979 . . . . 0.0 111.223 -169.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -131.03 141.48 50.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.343 2.257 . . . . 0.0 109.978 -173.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.32 144.65 53.56 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 175.054 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.4 t 51.63 -101.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 127.886 2.474 . . . . 0.0 113.22 172.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 3.0 m -154.44 147.39 24.53 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.87 2.068 . . . . 0.0 109.189 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.817 1.247 . . . . 0.0 113.333 173.909 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.208 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -150.26 101.8 3.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.7 1.2 . . . . 0.0 110.412 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 34.1 mt -95.73 107.17 19.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.339 1.055 . . . . 0.0 111.605 -177.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.5 tp -76.18 129.4 36.68 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 168.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.61 111.85 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.96 1.304 . . . . 0.0 108.737 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.3 m -112.53 169.95 8.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.218 1.407 . . . . 0.0 110.975 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.7 t30 57.13 78.18 0.24 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.924 1.69 . . . . 0.0 112.11 -174.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.8 mt -132.03 157.54 43.86 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.201 2.2 . . . . 0.0 110.336 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.55 145.8 50.82 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.046 -1.034 . . . . 0.0 111.656 170.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -57.22 -29.0 63.39 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -177.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -109.34 28.02 11.61 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.256 1.408 . . . . 0.0 115.261 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.59 119.2 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.174 1.487 . . . . 0.0 110.012 169.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.8 m -74.13 145.51 44.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.434 1.094 . . . . 0.0 112.568 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.68 -51.47 68.63 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.826 0.85 . . . . 0.0 112.094 171.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.45 -53.05 19.31 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.808 1.643 . . . . 0.0 112.331 175.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.88 -50.96 67.43 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.807 1.243 . . . . 0.0 112.365 177.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.0 mm -56.41 -56.82 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.221 1.008 . . . . 0.0 112.15 174.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -58.03 -43.75 86.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.709 1.141 . . . . 0.0 112.243 -178.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -59.14 -52.49 65.5 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.057 0.844 . . . . 0.0 112.775 173.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -65.03 -47.24 78.12 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.998 0.817 . . . . 0.0 112.374 -176.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -62.45 -40.49 96.78 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.774 0.715 . . . . 0.0 112.558 175.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.25 -13.54 60.54 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 175.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.85 -57.71 4.09 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.839 -1.163 . . . . 0.0 111.424 173.147 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -84.89 -33.95 22.66 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.98 -172.79 15.0 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.845 1.688 . . . . 0.0 112.801 178.021 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -131.02 120.88 24.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.579 1.152 . . . . 0.0 110.41 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -123.86 142.66 50.92 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -72.87 -52.0 16.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.733 2.413 . . . . 0.0 110.428 169.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -152.84 156.74 39.6 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.353 1.461 . . . . 0.0 112.596 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -128.88 162.77 26.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.842 1.657 . . . . 0.0 111.302 169.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.45 145.36 23.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.24 2.216 . . . . 0.0 109.806 172.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.2 t -140.99 147.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.517 1.527 . . . . 0.0 110.462 178.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -68.02 -48.59 65.29 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.045 1.738 . . . . 0.0 114.466 -178.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . 0.326 20.1 p90 31.2 69.97 0.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 130.567 3.547 . . . . 0.0 114.61 -168.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -145.84 149.26 33.97 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.392 2.277 . . . . 0.0 110.415 173.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -82.91 91.46 7.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.196 0.998 . . . . 0.0 110.334 173.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.9 m -62.93 160.95 13.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.075 1.35 . . . . 0.0 112.665 176.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -56.2 -35.87 66.57 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.124 1.345 . . . . 0.0 114.708 -178.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -134.92 175.69 9.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.376 2.27 . . . . 0.0 110.934 171.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 69.9 m -52.53 113.27 1.01 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.738 1.215 . . . . 0.0 112.022 177.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.4 tp -141.41 -107.6 0.14 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.686 1.594 . . . . 0.0 109.147 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.27 104.66 0.23 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-N 120.073 1.306 . . . . 0.0 111.072 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.6 m -126.18 133.63 51.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.138 0.975 . . . . 0.0 112.34 -173.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.77 160.08 37.89 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.419 1.887 . . . . 0.0 111.148 170.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -145.28 126.68 14.94 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.367 1.467 . . . . 0.0 110.222 -177.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.33 111.67 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.142 0.977 . . . . 0.0 110.863 -171.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -75.71 111.19 10.79 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.288 1.435 . . . . 0.0 109.43 172.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.9 150.99 21.95 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.903 2.081 . . . . 0.0 112.555 -178.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.82 -38.37 90.83 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 177.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -136.39 142.85 43.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.607 1.563 . . . . 0.0 112.335 -174.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -54.47 -52.34 62.17 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.929 1.692 . . . . 0.0 112.136 172.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.91 -51.9 66.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.1 1.36 . . . . 0.0 112.475 176.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -59.88 -40.66 89.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.834 0.854 . . . . 0.0 112.536 177.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.89 -51.64 68.28 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.979 0.912 . . . . 0.0 111.983 171.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 62.8 mt -55.38 -48.08 74.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.776 0.83 . . . . 0.0 112.861 173.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -54.04 -54.49 38.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.665 1.186 . . . . 0.0 112.321 175.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.47 -53.16 57.99 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.573 1.149 . . . . 0.0 112.299 174.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 19.8 ttt -52.37 -60.64 2.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.035 1.734 . . . . 0.0 112.046 177.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -59.83 -37.32 78.88 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -68.79 -46.02 69.78 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.236 1.014 . . . . 0.0 113.165 176.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -100.1 -14.16 18.69 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -169.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -58.52 117.03 4.07 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.88 1.218 . . . . 0.0 111.044 170.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.7 -16.22 58.9 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.27 1.414 . . . . 0.0 114.61 -175.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.8 t -71.84 133.07 84.46 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 118.997 1.399 . . . . 0.0 109.497 175.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.94 142.1 24.75 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.725 2.284 . . . . 0.0 112.51 -177.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 45.7 tp -129.95 105.02 7.7 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.35 1.46 . . . . 0.0 108.133 169.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 52.4 65.57 1.47 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.988 1.715 . . . . 0.0 111.135 -169.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.09 -64.04 4.3 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.24 1.4 . . . . 0.0 113.215 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.5 119.92 57.91 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 126.465 1.906 . . . . 0.0 112.774 -173.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -56.07 121.55 10.19 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.753 3.635 . . . . 0.0 113.58 170.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.47 116.64 5.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.245 1.018 . . . . 0.0 111.748 177.104 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -91.61 98.6 11.75 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.585 1.154 . . . . 0.0 109.22 171.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.3 mt -101.22 133.63 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.066 1.346 . . . . 0.0 111.149 -173.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -140.14 123.86 17.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.063 1.745 . . . . 0.0 111.42 -177.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.7 tp -76.69 114.5 15.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.765 0.826 . . . . 0.0 109.311 169.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.59 74.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.331 1.452 . . . . 0.0 110.249 -178.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 8.3 m -63.45 121.16 13.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.502 1.521 . . . . 0.0 110.576 174.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.729 1.612 . . . . 0.0 113.67 -176.799 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.872 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -143.46 152.92 42.09 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 177.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.7 mt -108.68 154.36 22.11 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.9 1.68 . . . . 0.0 111.535 174.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.2 tp -120.32 124.18 44.95 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.889 2.076 . . . . 0.0 107.474 170.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.89 85.56 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.52 1.928 . . . . 0.0 108.239 -169.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.16 166.96 19.19 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.146 1.379 . . . . 0.0 112.225 -178.058 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.7 t30 60.36 75.21 0.42 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.927 2.091 . . . . 0.0 113.134 177.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.1 mt -127.38 167.58 16.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.895 2.478 . . . . 0.0 111.489 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.2 149.57 46.17 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.96 0.886 . . . . 0.0 113.137 172.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -58.69 -31.97 68.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.556 1.943 . . . . 0.0 114.492 -178.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.49 31.67 7.19 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.541 1.543 . . . . 0.0 114.81 -175.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.71 147.52 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.09 1.356 . . . . 0.0 110.907 169.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.4 m -119.8 147.59 44.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.503 1.521 . . . . 0.0 112.485 -176.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -48.59 -57.7 5.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.682 1.993 . . . . 0.0 112.145 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.37 -46.24 76.52 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.591 1.556 . . . . 0.0 113.561 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.97 -52.78 64.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.164 0.986 . . . . 0.0 111.936 -178.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 43.0 mm -58.21 -52.8 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.384 1.073 . . . . 0.0 111.205 172.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -49.64 -51.69 36.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.953 1.301 . . . . 0.0 112.305 179.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.78 -52.3 65.67 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.368 1.067 . . . . 0.0 113.123 175.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.65 -43.89 97.67 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.214 0.915 . . . . 0.0 112.715 -177.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -62.71 -40.72 98.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.808 0.731 . . . . 0.0 112.475 173.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.15 -26.33 64.66 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 175.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -63.4 -48.88 75.99 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.144 -0.972 . . . . 0.0 112.608 174.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -104.8 -15.58 15.16 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 -173.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.0 162.53 21.79 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.904 1.716 . . . . 0.0 113.638 -176.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.9 m -112.27 100.62 8.95 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.576 1.95 . . . . 0.0 107.727 -178.049 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.25 157.2 44.99 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -168.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -77.5 -57.42 3.83 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.693 1.997 . . . . 0.0 110.042 169.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -157.24 145.65 19.48 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.234 1.414 . . . . 0.0 112.792 -174.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.18 133.78 55.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.378 1.471 . . . . 0.0 108.564 168.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.9 158.02 44.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.584 1.154 . . . . 0.0 113.115 -169.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.97 110.64 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.625 1.97 . . . . 0.0 109.599 178.209 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -69.92 -44.56 69.38 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.729 1.612 . . . . 0.0 112.377 177.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -70.2 167.43 17.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.084 1.754 . . . . 0.0 114.018 -175.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -147.57 -169.96 3.45 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.896 2.078 . . . . 0.0 109.485 169.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.83 119.05 2.59 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.822 -1.174 . . . . 0.0 110.474 169.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.8 m -135.48 152.89 51.79 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.754 1.622 . . . . 0.0 112.221 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.6 -60.46 6.98 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.519 1.057 . . . . 0.0 111.912 174.074 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.89 144.49 55.24 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.547 1.139 . . . . 0.0 111.045 169.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.1 m -63.18 119.24 9.19 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.133 0.973 . . . . 0.0 111.421 178.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 56.9 tp -152.3 131.49 12.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.091 1.356 . . . . 0.0 110.555 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -170.72 84.83 0.08 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.876 0.751 . . . . 0.0 112.723 178.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.0 m -146.41 126.0 13.33 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.429 1.492 . . . . 0.0 111.019 -175.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.93 162.49 12.88 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.373 1.469 . . . . 0.0 112.599 177.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -133.51 127.51 33.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.778 1.631 . . . . 0.0 109.986 -172.079 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.0 t -134.07 116.8 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.518 -0.739 . . . . 0.0 112.479 -169.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -90.18 116.17 27.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.963 2.105 . . . . 0.0 110.606 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -99.54 152.63 19.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.618 1.567 . . . . 0.0 113.885 -173.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -63.93 -48.55 76.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.034 0.934 . . . . 0.0 111.794 171.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -133.54 135.41 44.35 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.116 1.366 . . . . 0.0 110.912 -175.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -58.12 -43.34 87.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.263 1.425 . . . . 0.0 112.778 178.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.58 -50.45 60.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.488 1.115 . . . . 0.0 112.618 171.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.92 -46.61 89.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.945 0.898 . . . . 0.0 112.006 174.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.13 -52.87 48.96 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.513 1.125 . . . . 0.0 112.333 173.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.6 tp -55.42 -51.17 67.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.482 1.513 . . . . 0.0 112.224 174.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -52.06 51.76 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.669 1.587 . . . . 0.0 112.48 174.132 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.18 -52.93 63.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.433 1.093 . . . . 0.0 111.856 173.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -54.51 -58.89 5.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.696 1.598 . . . . 0.0 112.494 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -59.17 -36.48 75.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -177.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -67.81 -49.11 64.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.381 1.073 . . . . 0.0 112.996 174.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -94.09 -13.72 26.53 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -57.92 112.9 1.64 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.702 1.137 . . . . 0.0 110.93 169.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.5 -18.6 41.08 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.546 1.546 . . . . 0.0 114.713 -175.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 81.2 t -69.52 133.78 88.84 Favored Pre-proline 0 N--CA 1.478 0.934 0 CA-C-N 118.968 1.384 . . . . 0.0 110.189 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.38 141.78 23.16 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.872 2.381 . . . . 0.0 113.154 -175.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.3 tt -132.3 108.69 9.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.539 1.935 . . . . 0.0 107.312 169.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 48.33 64.27 1.73 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.819 1.648 . . . . 0.0 111.566 -169.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.92 -55.44 4.77 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.883 1.706 . . . . 0.0 113.649 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -65.81 124.02 86.41 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 127.008 2.123 . . . . 0.0 112.47 -173.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.32 122.97 9.48 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.291 2.661 . . . . 0.0 111.185 174.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.42 116.27 5.39 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.184 0.994 . . . . 0.0 111.347 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -84.78 100.66 11.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.961 0.905 . . . . 0.0 108.975 170.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.3 mt -107.18 130.07 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.793 0.837 . . . . 0.0 110.714 -175.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.21 -179.97 6.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.594 1.558 . . . . 0.0 110.591 171.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -119.5 154.36 33.92 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.182 1.393 . . . . 0.0 112.474 -176.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.58 136.1 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.29 1.436 . . . . 0.0 110.046 -175.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.6 p -140.01 146.04 38.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.973 1.709 . . . . 0.0 111.238 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.034 1.733 . . . . 0.0 113.765 -178.909 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.877 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -133.92 125.83 29.11 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.062 0.945 . . . . 0.0 110.526 -178.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.9 mt -106.52 131.11 54.07 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.606 1.163 . . . . 0.0 110.821 170.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.6 tp -99.06 100.43 11.58 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.685 1.594 . . . . 0.0 106.821 169.042 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.28 132.94 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 m -134.05 172.32 12.99 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.55 1.54 . . . . 0.0 111.381 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.3 t30 56.63 51.16 11.5 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.005 1.722 . . . . 0.0 112.662 -172.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.58 -158.51 0.67 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.072 1.749 . . . . 0.0 109.214 169.414 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -154.98 169.24 24.53 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.492 1.517 . . . . 0.0 110.728 178.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.32 -32.1 70.91 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.896 -1.128 . . . . 0.0 112.513 169.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.97 -28.76 69.23 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.487 1.518 . . . . 0.0 114.646 174.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.0 t -72.71 108.15 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.578 1.189 . . . . 0.0 109.64 174.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.6 m -69.81 144.0 52.76 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.02 0.928 . . . . 0.0 112.876 -177.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -54.19 -55.09 31.24 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.743 1.617 . . . . 0.0 112.886 176.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.87 75.77 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.483 1.113 . . . . 0.0 113.266 176.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.21 -52.24 63.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.704 0.802 . . . . 0.0 111.61 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.0 mm -53.26 -52.93 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.121 0.969 . . . . 0.0 111.12 169.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -52.53 -52.93 52.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.972 0.909 . . . . 0.0 112.175 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -60.2 -52.16 66.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.553 1.141 . . . . 0.0 113.16 174.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 pp -63.84 -43.93 94.7 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.364 0.984 . . . . 0.0 112.308 -174.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -62.12 -45.15 94.74 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.485 0.584 . . . . 0.0 112.068 172.143 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.7 -32.84 70.88 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 178.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.18 -51.21 70.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.084 0.954 . . . . 0.0 112.483 173.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -93.23 -13.03 28.81 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -174.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.55 154.36 25.89 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 120.015 1.279 . . . . 0.0 114.664 177.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.2 m -86.19 107.41 17.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.369 1.068 . . . . 0.0 110.309 -175.289 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 pp -125.96 146.31 49.92 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -173.019 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -86.72 -39.09 16.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.635 2.374 . . . . 0.0 111.547 169.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -150.22 147.38 27.62 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.591 0.632 . . . . 0.0 112.47 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.26 120.97 11.18 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.668 1.587 . . . . 0.0 109.486 171.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -138.4 117.24 12.35 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.38 1.472 . . . . 0.0 111.863 -172.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.4 t -80.65 150.1 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.065 1.746 . . . . 0.0 111.134 178.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -44.52 -51.94 8.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.928 2.491 . . . . 0.0 116.586 -172.07 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -61.04 127.81 33.35 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -169.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -147.75 -74.23 0.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.161 1.385 . . . . 0.0 111.214 176.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -129.25 37.62 4.01 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.678 2.391 . . . . 0.0 110.035 176.011 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.5 m -75.1 155.04 37.53 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.911 2.484 . . . . 0.0 113.578 -169.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.01 40.45 0.58 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.502 1.049 . . . . 0.0 113.984 175.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -150.51 157.32 42.87 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.362 2.265 . . . . 0.0 110.242 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.5 m -59.13 116.18 3.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.045 0.938 . . . . 0.0 110.335 169.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.5 tp -152.72 152.34 31.58 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.936 1.294 . . . . 0.0 111.247 -169.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.44 76.67 0.09 OUTLIER Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.791 0.71 . . . . 0.0 113.326 -175.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.9 p -141.53 168.28 20.15 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.301 1.44 . . . . 0.0 112.642 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.07 141.27 24.0 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.674 1.189 . . . . 0.0 111.398 169.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.91 126.02 43.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.478 1.511 . . . . 0.0 109.429 173.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.3 t -130.08 122.8 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.173 0.989 . . . . 0.0 110.509 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -109.1 119.01 38.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.113 2.165 . . . . 0.0 111.14 -176.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -102.75 154.47 19.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.809 2.844 . . . . 0.0 113.645 -169.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -82.38 -16.17 50.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.619 1.567 . . . . 0.0 114.554 175.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.8 mtm-85 -142.34 132.56 24.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.689 1.596 . . . . 0.0 111.042 177.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -56.13 -50.35 71.35 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.107 1.363 . . . . 0.0 112.545 172.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.43 -47.43 69.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.875 1.27 . . . . 0.0 112.162 175.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.18 -42.23 99.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.943 0.897 . . . . 0.0 112.625 175.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.72 -53.34 57.81 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.785 0.834 . . . . 0.0 111.534 171.722 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 59.3 tp -54.07 -52.1 62.0 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.826 1.25 . . . . 0.0 112.439 174.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -49.86 -54.77 17.4 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.253 1.821 . . . . 0.0 112.154 173.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.63 -50.84 69.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.534 1.133 . . . . 0.0 112.306 174.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 16.7 ttp -52.15 -60.1 3.6 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.03 1.332 . . . . 0.0 111.595 175.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -53.73 -49.51 67.99 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.239 1.416 . . . . 0.0 112.32 179.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -61.83 -47.24 85.98 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.72 1.208 . . . . 0.0 113.045 -179.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -99.82 -14.36 18.84 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -169.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.28 113.72 2.3 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.785 1.175 . . . . 0.0 110.984 169.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.43 -20.15 35.41 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.762 1.649 . . . . 0.0 114.48 -175.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.46 133.02 87.23 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-N 118.757 1.279 . . . . 0.0 110.306 -178.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.16 138.83 23.17 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.923 2.415 . . . . 0.0 112.457 -177.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.1 tp -134.93 112.37 10.58 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.1 1.76 . . . . 0.0 108.373 170.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 49.32 61.68 3.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.303 1.441 . . . . 0.0 111.189 -169.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.99 -59.94 4.47 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.798 1.666 . . . . 0.0 113.493 -179.051 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -61.95 127.82 89.75 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 127.062 2.145 . . . . 0.0 112.83 -174.079 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.98 124.67 10.79 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.178 2.585 . . . . 0.0 111.147 172.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.49 120.37 11.57 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.117 0.967 . . . . 0.0 111.162 177.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -98.91 102.32 14.0 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.783 1.233 . . . . 0.0 108.865 176.036 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.1 mt -108.69 135.98 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.047 0.939 . . . . 0.0 111.271 -169.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -128.87 123.98 34.09 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.103 1.761 . . . . 0.0 111.082 -177.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.8 tp -82.39 122.95 28.65 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.77 1.228 . . . . 0.0 111.076 172.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.9 t -83.39 96.31 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 169.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.0 p -66.98 -61.1 2.11 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.085 1.354 . . . . 0.0 112.738 -170.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.4 m . . . . . 0 C--O 1.252 1.189 0 C-N-CA 127.767 2.427 . . . . 0.0 114.182 -175.446 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.945 0 N-CA-C 112.338 -0.305 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -117.91 99.63 7.04 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.285 1.434 . . . . 0.0 109.961 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -100.73 101.4 12.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.607 1.563 . . . . 0.0 109.043 -176.099 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.8 tp -84.37 137.28 33.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.136 1.774 . . . . 0.0 110.505 177.139 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.0 t -129.41 129.32 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.46 1.904 . . . . 0.0 108.948 -176.517 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.0 m -139.64 166.48 24.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.25 1.42 . . . . 0.0 112.116 -176.006 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.1 t30 54.71 46.95 23.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.07 1.748 . . . . 0.0 112.914 -172.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.2 mt -83.89 164.83 19.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.3 1.44 . . . . 0.0 110.754 169.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.95 145.35 56.0 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 110.957 169.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -53.87 -35.0 61.08 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.561 1.544 . . . . 0.0 114.16 -176.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.47 16.28 58.0 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.392 1.473 . . . . 0.0 115.467 -174.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.26 135.25 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.217 1.509 . . . . 0.0 110.578 170.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.4 m -114.6 158.13 22.13 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.146 1.778 . . . . 0.0 111.583 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -52.36 -55.75 19.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.524 1.13 . . . . 0.0 113.641 -176.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.49 -38.99 67.1 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.197 0.999 . . . . 0.0 113.561 -177.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.83 -56.15 25.94 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.968 0.907 . . . . 0.0 111.916 176.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.2 mm -55.76 -53.01 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 0.0 111.02 172.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -48.44 -56.95 6.86 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.181 1.792 . . . . 0.0 111.673 178.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.2 -49.49 75.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.435 1.094 . . . . 0.0 113.323 176.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.3 -45.44 91.34 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.492 1.042 . . . . 0.0 112.201 -174.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -62.91 -40.88 98.94 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 174.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.51 -14.98 56.51 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 175.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.6 -61.91 1.71 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.825 -1.172 . . . . 0.0 111.883 173.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -85.18 -13.05 51.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -175.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -146.41 -167.79 13.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.71 1.624 . . . . 0.0 112.909 176.414 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.05 126.69 27.14 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.159 1.384 . . . . 0.0 110.177 -173.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.06 143.61 50.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.464 1.106 . . . . 0.0 113.737 -169.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -73.08 -49.61 27.62 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.966 2.106 . . . . 0.0 110.335 169.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -150.11 152.15 34.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.416 1.086 . . . . 0.0 113.237 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -119.86 151.91 38.15 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.319 1.848 . . . . 0.0 109.869 169.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.6 146.01 26.26 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.97 1.708 . . . . 0.0 110.402 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.1 t -133.68 142.22 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.364 1.465 . . . . 0.0 109.847 -177.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -21.04 -69.95 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 129.177 2.991 . . . . 0.0 116.667 -169.769 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -52.69 -41.17 63.63 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.106 2.162 . . . . 0.0 114.557 -179.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.4 -47.12 14.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.496 1.519 . . . . 0.0 111.73 176.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -59.96 -54.76 42.33 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.256 1.822 . . . . 0.0 113.675 -174.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.0 m -119.08 166.97 12.24 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.54 1.536 . . . . 0.0 112.663 -169.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -50.97 -60.94 6.55 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.153 1.359 . . . . 0.0 112.86 178.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.13 104.03 2.77 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.199 1.4 . . . . 0.0 110.237 169.512 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.4 m -129.81 170.51 13.78 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.687 1.995 . . . . 0.0 109.502 173.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 48.3 tp -149.27 132.76 16.66 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.236 0.925 . . . . 0.0 112.036 -177.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.75 35.13 79.41 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.394 0.997 . . . . 0.0 114.425 174.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -137.01 155.04 50.21 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.698 1.599 . . . . 0.0 112.127 179.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.5 166.86 26.93 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.998 1.719 . . . . 0.0 111.463 175.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -147.76 126.73 12.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.635 1.574 . . . . 0.0 109.645 -174.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.02 116.43 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.726 1.21 . . . . 0.0 109.175 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -82.6 102.87 11.72 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -77.28 155.34 32.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.177 1.791 . . . . 0.0 113.238 -175.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.19 -29.48 54.34 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.701 1.2 . . . . 0.0 113.298 172.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 138.26 38.04 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.285 1.434 . . . . 0.0 111.341 176.707 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -64.77 -36.73 85.26 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 113.914 178.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.37 -46.83 86.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.121 0.968 . . . . 0.0 111.672 174.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -58.98 -44.23 91.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.492 1.517 . . . . 0.0 112.016 173.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.05 -52.25 63.77 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.75 1.22 . . . . 0.0 112.612 170.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.47 -48.24 79.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.857 1.263 . . . . 0.0 112.292 176.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -49.55 -56.99 7.96 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.135 1.374 . . . . 0.0 111.229 171.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.68 -47.13 63.99 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.801 0.84 . . . . 0.0 112.362 175.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.5 ttp -56.17 -62.36 1.77 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.979 0.912 . . . . 0.0 112.467 177.034 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -61.43 -35.27 77.09 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.27 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.0 -52.81 62.47 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.365 1.466 . . . . 0.0 112.662 174.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -97.39 -14.97 20.9 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -169.703 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -59.67 110.33 1.12 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 120.16 1.346 . . . . 0.0 112.094 175.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.3 -17.36 40.58 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.149 1.833 . . . . 0.0 114.67 -177.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.61 130.27 94.09 Favored Pre-proline 0 N--CA 1.479 0.985 0 CA-C-N 118.953 1.376 . . . . 0.0 111.009 -174.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.28 112.25 2.75 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.339 2.693 . . . . 0.0 112.54 -174.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 59.7 tp -76.54 82.5 3.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.47 1.508 . . . . 0.0 109.268 169.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 43.35 55.1 4.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.873 2.069 . . . . 0.0 112.026 -169.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 116.23 -64.82 0.33 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.009 1.766 . . . . 0.0 112.556 -177.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.01 111.03 3.53 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 126.812 2.045 . . . . 0.0 112.266 -171.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.14 113.31 3.39 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.273 1.982 . . . . 0.0 110.654 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -66.93 118.71 10.78 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.005 0.922 . . . . 0.0 111.157 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -84.89 120.74 26.81 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.904 0.882 . . . . 0.0 109.024 171.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.6 mm -118.43 138.17 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.738 0.815 . . . . 0.0 109.997 179.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -137.09 134.84 36.91 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.149 1.38 . . . . 0.0 111.065 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.43 127.73 50.02 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.3 1.84 . . . . 0.0 107.88 174.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.9 m -39.38 -53.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.933 2.093 . . . . 0.0 116.131 -169.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.7 p -143.2 124.35 14.51 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.397 1.479 . . . . 0.0 110.919 178.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.879 1.671 . . . . 0.0 113.067 177.738 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.355 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -134.98 101.6 4.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.852 1.261 . . . . 0.0 110.68 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -103.61 122.0 44.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.087 2.155 . . . . 0.0 109.231 -171.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.8 tp -115.47 102.94 10.27 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.309 1.844 . . . . 0.0 110.424 -176.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.5 t -78.73 130.64 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.166 1.387 . . . . 0.0 108.373 169.809 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 m -127.69 172.3 10.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.115 1.366 . . . . 0.0 111.411 175.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.7 t30 57.46 50.4 11.31 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.847 1.659 . . . . 0.0 112.763 -173.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.2 mt -98.78 -168.22 1.6 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.883 1.673 . . . . 0.0 109.306 169.145 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -148.61 161.94 40.69 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.967 -1.083 . . . . 0.0 111.972 174.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -61.14 101.52 0.16 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.208 1.403 . . . . 0.0 109.383 169.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.48 -39.0 0.62 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.211 1.386 . . . . 0.0 111.859 -169.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.73 110.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.122 0.969 . . . . 0.0 109.611 170.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -71.98 144.24 48.94 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.766 0.826 . . . . 0.0 112.737 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.71 -52.79 63.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.841 1.656 . . . . 0.0 112.385 178.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.54 82.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.618 1.167 . . . . 0.0 113.404 174.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.84 -48.69 79.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.086 0.857 . . . . 0.0 111.763 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.4 mm -54.77 -52.87 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.883 0.873 . . . . 0.0 111.065 169.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -51.75 -54.21 31.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.246 0.618 . . . . 0.0 112.067 178.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.58 -50.34 74.17 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.873 1.269 . . . . 0.0 113.31 176.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.11 -44.86 90.99 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.315 0.961 . . . . 0.0 112.041 -176.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -61.27 -42.69 99.07 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 173.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.54 -15.3 57.61 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.29 -63.45 1.18 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.949 -1.095 . . . . 0.0 111.609 173.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -82.17 -18.91 41.08 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -175.465 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -139.22 -176.37 14.68 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.579 1.561 . . . . 0.0 113.346 178.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.9 m -126.91 120.96 30.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.367 1.467 . . . . 0.0 110.373 -176.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 pp -126.07 146.41 49.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.004 1.322 . . . . 0.0 112.995 -169.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -78.52 -49.19 13.8 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.803 2.441 . . . . 0.0 110.303 170.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -149.19 147.89 28.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.632 1.173 . . . . 0.0 111.884 -179.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -137.62 135.34 36.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.454 1.502 . . . . 0.0 110.464 171.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.06 146.77 32.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.865 1.266 . . . . 0.0 112.192 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.17 141.7 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.844 1.658 . . . . 0.0 110.492 -179.402 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -42.38 -50.36 5.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.062 2.145 . . . . 0.0 115.387 -169.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -56.56 -24.93 50.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -172.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.24 -48.49 78.7 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.839 1.255 . . . . 0.0 112.646 174.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -140.74 78.7 1.66 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.804 2.042 . . . . 0.0 109.752 173.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 p -75.13 -66.99 0.69 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.857 1.263 . . . . 0.0 113.22 -171.544 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.46 -54.82 4.05 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.993 1.283 . . . . 0.0 112.069 -170.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -131.68 135.3 46.78 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.937 2.495 . . . . 0.0 110.516 177.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.8 m -63.64 123.42 18.79 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.642 1.177 . . . . 0.0 111.505 175.7 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 55.0 tp -146.27 -73.63 0.22 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.249 1.02 . . . . 0.0 112.262 -176.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.27 81.39 1.28 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.193 1.377 . . . . 0.0 111.849 -175.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.9 p -144.55 159.4 42.85 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.664 1.585 . . . . 0.0 112.266 -176.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.78 140.85 33.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.863 1.265 . . . . 0.0 111.018 169.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -120.33 125.88 49.14 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.067 1.747 . . . . 0.0 110.009 -174.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.8 t -126.68 115.75 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.156 1.382 . . . . 0.0 109.809 -176.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -88.23 111.4 21.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.218 2.207 . . . . 0.0 108.461 175.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -98.82 159.31 15.04 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.426 2.29 . . . . 0.0 113.975 -169.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.73 -50.46 70.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.276 1.03 . . . . 0.0 111.83 169.453 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -138.06 144.26 40.87 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.733 1.613 . . . . 0.0 112.214 -173.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -62.63 -35.88 81.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.758 1.223 . . . . 0.0 112.901 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.13 -47.01 78.94 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.441 1.096 . . . . 0.0 112.435 172.055 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -65.88 -41.96 90.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.705 1.202 . . . . 0.0 112.038 176.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.62 82.61 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.859 0.864 . . . . 0.0 112.264 169.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.88 -45.62 93.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.986 1.714 . . . . 0.0 112.046 177.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -49.63 -58.15 5.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.958 1.303 . . . . 0.0 110.31 169.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.43 -49.6 61.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.93 0.892 . . . . 0.0 112.65 176.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 41.6 ttp -54.89 -62.01 1.94 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.362 1.065 . . . . 0.0 111.723 176.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -61.05 -38.59 86.73 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -66.68 -41.87 87.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.685 1.194 . . . . 0.0 112.899 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -109.09 -13.24 14.73 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -169.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -58.63 116.74 3.9 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.172 1.351 . . . . 0.0 111.425 171.348 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.33 -25.07 27.18 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.972 1.749 . . . . 0.0 114.359 -175.367 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.82 135.3 87.8 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.771 1.229 . . . . 0.0 110.356 -177.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -74.91 139.42 24.5 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.821 2.348 . . . . 0.0 112.816 -178.223 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.4 tp -139.24 119.12 13.29 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.936 1.694 . . . . 0.0 108.677 169.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.75 56.99 7.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.428 1.491 . . . . 0.0 110.729 -169.094 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.78 -60.74 4.36 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.54 1.543 . . . . 0.0 113.466 -179.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.45 135.91 96.54 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.948 1.699 . . . . 0.0 112.872 -172.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.2 124.28 10.34 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.497 2.798 . . . . 0.0 111.211 174.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.4 mtm -62.76 117.78 6.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.506 1.122 . . . . 0.0 111.729 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -95.65 99.04 10.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.949 1.3 . . . . 0.0 108.393 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.6 mt -103.86 135.43 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.667 0.787 . . . . 0.0 111.363 -169.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -127.91 151.16 49.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.969 2.508 . . . . 0.0 110.302 -177.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 34.8 tp -135.59 130.1 33.94 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.737 1.615 . . . . 0.0 109.568 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 57.8 t -59.58 115.75 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.786 0.834 . . . . 0.0 110.007 175.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 11.9 m -58.38 -56.18 25.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.771 1.628 . . . . 0.0 113.221 -169.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.562 1.945 . . . . 0.0 112.063 -174.627 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.076 0 N-CA-C 112.704 -0.158 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -76.59 137.95 39.84 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.971 0.908 . . . . 0.0 112.458 178.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -138.52 129.58 26.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 129.02 2.928 . . . . 0.0 108.112 -175.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.73 112.15 20.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.551 1.94 . . . . 0.0 110.035 -175.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.4 t -87.04 135.1 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.58 1.552 . . . . 0.0 108.637 171.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.7 m -139.18 165.44 27.16 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.608 1.563 . . . . 0.0 112.575 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.4 t30 57.8 47.65 15.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.147 2.179 . . . . 0.0 113.299 -175.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.51 161.53 15.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.256 1.822 . . . . 0.0 110.3 169.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.93 144.53 54.15 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.166 -0.959 . . . . 0.0 111.008 169.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -59.35 -21.72 60.23 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.83 19.75 32.6 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.727 1.632 . . . . 0.0 115.425 178.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.29 129.37 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.483 1.641 . . . . 0.0 110.365 169.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.8 m -75.69 140.64 42.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.006 0.923 . . . . 0.0 112.55 -178.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.54 -50.67 72.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.018 1.327 . . . . 0.0 112.298 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.77 -46.62 71.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.309 1.444 . . . . 0.0 112.619 174.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -56.98 -53.3 59.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.397 1.079 . . . . 0.0 112.381 179.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.0 mm -57.33 -52.81 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.134 0.973 . . . . 0.0 111.583 173.02 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -50.33 -50.62 50.4 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.546 1.139 . . . . 0.0 112.006 178.104 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.09 -53.84 47.26 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.505 1.122 . . . . 0.0 112.917 175.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.13 -43.0 99.6 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.216 0.916 . . . . 0.0 112.643 -173.111 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -64.07 -44.79 91.31 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.64 0.654 . . . . 0.0 112.131 172.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.46 -27.5 66.14 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 176.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.66 -59.5 4.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.187 0.995 . . . . 0.0 111.942 173.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -83.8 -15.25 49.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -175.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -148.17 156.22 26.8 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.947 1.248 . . . . 0.0 113.96 175.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.4 m -94.79 111.48 23.26 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.753 1.221 . . . . 0.0 109.934 -173.304 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -137.3 155.8 49.01 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -87.38 -48.17 8.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.785 2.434 . . . . 0.0 111.487 -173.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -151.02 145.66 25.68 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.623 1.169 . . . . 0.0 113.141 -176.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.27 140.85 46.71 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.239 1.816 . . . . 0.0 110.095 169.115 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -146.51 107.59 4.18 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.933 1.693 . . . . 0.0 111.533 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.15 147.82 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.303 1.441 . . . . 0.0 110.625 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -44.85 -53.3 7.67 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.566 1.946 . . . . 0.0 114.318 -171.425 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -57.06 -35.61 69.55 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.023 1.329 . . . . 0.0 113.751 -171.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.24 -49.3 74.66 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.312 1.445 . . . . 0.0 111.912 173.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -65.98 -51.76 55.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.834 1.654 . . . . 0.0 112.448 178.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.8 m -142.66 130.64 21.8 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.955 2.102 . . . . 0.0 111.271 -174.523 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -62.35 -28.1 70.44 Favored Glycine 0 CA--C 1.539 1.543 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 -173.256 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -59.92 138.36 57.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.546 1.538 . . . . 0.0 112.593 -178.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.6 m -60.31 115.35 3.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.939 1.296 . . . . 0.0 111.069 172.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.6 tp -137.43 -53.68 0.67 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.683 1.193 . . . . 0.0 112.571 -172.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.49 58.27 2.59 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.17 0.89 . . . . 0.0 113.224 174.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.4 p -143.47 167.68 21.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.699 1.599 . . . . 0.0 111.395 -179.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -144.78 126.38 15.09 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.797 0.839 . . . . 0.0 111.782 169.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -80.15 124.54 28.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.974 1.71 . . . . 0.0 109.735 169.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.45 140.66 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.702 1.201 . . . . 0.0 110.107 -175.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -122.75 105.42 10.03 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.769 1.627 . . . . 0.0 109.204 177.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -78.62 160.54 27.51 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.364 1.866 . . . . 0.0 111.743 176.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -76.43 -27.18 56.13 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 171.077 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.18 136.62 38.36 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.453 1.501 . . . . 0.0 111.914 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -56.45 -44.37 80.45 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.808 1.643 . . . . 0.0 113.316 173.047 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.38 -46.71 76.5 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.091 0.956 . . . . 0.0 112.597 176.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -66.52 -41.4 88.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.928 1.291 . . . . 0.0 112.178 177.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.9 -48.75 75.07 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.906 0.882 . . . . 0.0 111.934 169.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.97 -46.41 89.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.538 1.535 . . . . 0.0 112.463 176.102 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -50.71 -56.39 12.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.169 1.388 . . . . 0.0 111.133 171.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.16 -49.27 69.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.55 1.14 . . . . 0.0 112.393 174.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.7 ttp -51.99 -59.12 4.71 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.81 1.244 . . . . 0.0 111.788 176.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -56.01 -49.03 74.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.95 1.3 . . . . 0.0 112.361 178.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -60.18 -45.15 94.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.549 1.14 . . . . 0.0 113.468 -178.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -102.15 -16.14 16.47 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -169.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -61.61 106.26 0.64 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 119.922 1.237 . . . . 0.0 110.786 169.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.96 -27.77 7.3 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 126.567 2.032 . . . . 0.0 114.142 -174.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.61 134.32 84.22 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 125.102 1.361 . . . . 0.0 111.012 -173.402 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.55 138.71 24.58 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.984 2.456 . . . . 0.0 112.714 -177.236 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -140.13 107.63 5.58 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.736 2.014 . . . . 0.0 108.095 175.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 48.45 66.48 1.06 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.742 1.617 . . . . 0.0 111.82 -169.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.26 -57.56 4.39 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.112 1.815 . . . . 0.0 113.403 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -65.16 131.82 95.2 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 127.036 2.134 . . . . 0.0 112.625 -173.24 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.83 119.53 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.876 2.384 . . . . 0.0 110.251 169.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.5 mtm -60.63 143.99 52.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.604 0.762 . . . . 0.0 111.968 178.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -119.59 130.95 55.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.236 1.414 . . . . 0.0 108.68 171.021 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mm -124.94 141.49 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.52 0.728 . . . . 0.0 110.052 -173.64 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -138.92 148.73 43.96 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.672 1.989 . . . . 0.0 110.273 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.19 -176.18 4.11 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.044 0.937 . . . . 0.0 112.225 173.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.0 m -64.07 -158.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.453 1.901 . . . . 0.0 112.573 169.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.6 p -57.6 160.84 4.0 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.122 -1.611 . . . . 0.0 113.313 173.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 C--O 1.251 1.147 0 C-N-CA 125.406 1.482 . . . . 0.0 113.146 172.133 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 CA-C-O 119.472 -0.627 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -136.53 152.51 50.59 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -173.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 71.9 mt -122.04 131.23 53.88 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.77 2.028 . . . . 0.0 112.266 -169.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.2 tp -86.54 111.28 20.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 168.317 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -98.61 130.51 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.108 1.363 . . . . 0.0 107.75 175.221 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.5 m -136.44 165.31 26.12 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 111.854 -174.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.9 t30 57.56 32.48 21.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.569 1.948 . . . . 0.0 114.395 -171.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.11 148.05 42.17 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 167.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.68 144.25 57.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.515 174.331 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -54.15 -36.58 63.48 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -169.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.42 20.15 51.85 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.115 1.341 . . . . 0.0 115.916 178.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.43 130.74 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.281 1.541 . . . . 0.0 110.774 171.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -76.15 140.53 41.8 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.383 1.073 . . . . 0.0 112.669 -177.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.43 -51.82 67.86 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.138 1.375 . . . . 0.0 112.696 175.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.29 80.16 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.443 1.097 . . . . 0.0 113.283 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.92 -51.4 69.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.884 0.874 . . . . 0.0 112.076 177.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.0 mm -57.05 -52.55 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.591 1.156 . . . . 0.0 111.351 172.043 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -49.38 -56.07 10.84 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.739 1.216 . . . . 0.0 111.844 176.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -57.79 -51.07 71.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.704 1.201 . . . . 0.0 113.07 176.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -63.8 -47.89 79.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.21 0.914 . . . . 0.0 112.35 -175.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -63.34 -38.61 91.83 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.7 0.682 . . . . 0.0 112.68 175.729 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.98 -13.76 60.42 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 174.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.16 -58.19 3.79 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.867 -1.146 . . . . 0.0 111.408 173.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -86.96 -32.58 20.01 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -176.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.43 172.25 14.88 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.525 1.536 . . . . 0.0 112.523 176.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 90.8 m -118.15 102.23 8.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.802 1.241 . . . . 0.0 109.439 178.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 pp -105.94 139.38 40.58 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -169.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -78.4 -45.37 22.52 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.686 2.794 . . . . 0.0 110.262 169.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -143.79 143.52 31.39 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.078 1.751 . . . . 0.0 111.506 -174.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.64 119.46 12.56 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.769 1.627 . . . . 0.0 108.587 169.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -137.45 104.08 5.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.995 0.918 . . . . 0.0 111.635 -175.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.5 151.68 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.411 1.484 . . . . 0.0 110.216 169.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -46.07 -47.5 17.12 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.903 2.081 . . . . 0.0 116.038 -170.24 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -69.65 142.52 53.42 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.162 0.982 . . . . 0.0 113.603 -171.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -150.89 -108.66 0.06 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.925 2.09 . . . . 0.0 107.52 171.716 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -52.63 20.29 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.846 1.203 . . . . 0.0 108.174 168.15 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.5 m -70.04 151.32 45.66 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.298 1.439 . . . . 0.0 111.423 169.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -164.28 52.55 0.29 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.781 0.705 . . . . 0.0 113.884 176.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -72.17 171.37 12.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.266 1.026 . . . . 0.0 111.167 169.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 39.7 m -73.11 69.79 1.05 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.52 1.528 . . . . 0.0 112.601 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.41 -64.1 1.2 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.868 1.667 . . . . 0.0 110.459 176.336 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.74 52.86 6.18 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.044 0.831 . . . . 0.0 112.893 178.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 81.5 p -139.32 165.14 27.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.096 1.359 . . . . 0.0 112.49 -175.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -150.29 161.64 42.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.743 1.617 . . . . 0.0 111.926 171.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -128.87 115.05 17.29 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.448 1.499 . . . . 0.0 110.234 174.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 14.3 t -124.89 125.62 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.694 1.198 . . . . 0.0 110.719 -169.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -115.13 127.56 55.65 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.613 1.965 . . . . 0.0 109.888 -171.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -114.12 156.59 23.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 127.68 2.392 . . . . 0.0 112.184 -171.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -58.7 -28.44 65.8 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.762 1.394 . . . . 0.0 114.762 -176.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -139.68 149.96 44.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.128 2.171 . . . . 0.0 110.618 176.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -57.64 -41.25 81.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.196 1.398 . . . . 0.0 112.142 170.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.04 -48.74 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.478 1.111 . . . . 0.0 112.376 169.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.26 -43.18 99.43 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.177 0.991 . . . . 0.0 112.62 176.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.12 -52.15 64.17 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.084 0.954 . . . . 0.0 111.504 169.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 28.5 mt -56.2 -44.02 79.07 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.69 -1.257 . . . . 0.0 113.715 176.703 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -52.6 -57.52 9.73 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.969 1.259 . . . . 0.0 111.842 171.169 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.68 -51.66 59.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.571 1.148 . . . . 0.0 112.0 177.037 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 22.6 ttt -53.87 -63.25 1.21 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.466 1.507 . . . . 0.0 112.168 176.086 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -60.75 -37.88 83.32 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -173.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -68.19 -43.49 77.99 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 113.169 177.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -103.42 -13.37 16.66 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -169.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -59.69 114.31 2.69 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.032 1.287 . . . . 0.0 110.867 169.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.34 -22.63 34.0 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.006 1.765 . . . . 0.0 114.424 -174.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.4 t -71.31 136.1 84.24 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.772 1.229 . . . . 0.0 110.423 -177.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.27 139.38 29.1 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.943 2.429 . . . . 0.0 112.626 -178.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -132.81 109.8 9.9 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.889 2.076 . . . . 0.0 106.871 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 51.65 57.39 6.6 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.145 1.378 . . . . 0.0 110.602 -168.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.47 -52.3 4.09 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.934 1.73 . . . . 0.0 113.726 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -68.79 129.13 92.63 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.809 2.044 . . . . 0.0 112.221 -171.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.55 125.24 11.01 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.2 2.6 . . . . 0.0 111.722 179.13 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.2 mtm -65.96 125.85 26.71 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.522 1.129 . . . . 0.0 112.101 177.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -99.06 112.73 24.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.918 1.287 . . . . 0.0 108.788 170.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mt -118.67 132.64 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.48 1.112 . . . . 0.0 111.2 -172.404 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -137.16 126.99 25.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.793 1.637 . . . . 0.0 111.635 -172.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 46.5 tp -67.49 119.01 11.59 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.33 1.052 . . . . 0.0 110.617 172.13 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.96 -51.24 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.888 1.275 . . . . 0.0 110.028 176.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 18.4 p -80.94 82.17 6.99 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.096 1.758 . . . . 0.0 111.471 179.02 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.25 1.127 0 C-N-CA 126.498 1.919 . . . . 0.0 114.374 -179.619 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.037 0 N-CA-C 112.305 -0.318 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -152.46 125.44 8.53 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.04 0.936 . . . . 0.0 112.177 178.885 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.4 mt -121.1 125.86 48.31 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.988 1.715 . . . . 0.0 112.38 -172.487 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.3 tp -89.01 116.57 27.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.698 1.999 . . . . 0.0 106.096 168.382 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.5 128.09 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.987 1.315 . . . . 0.0 108.12 -176.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.0 m -133.96 163.23 30.0 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.778 1.631 . . . . 0.0 112.478 -169.644 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.0 t30 54.55 35.09 22.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.078 2.151 . . . . 0.0 113.369 -169.769 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.41 154.17 37.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.553 1.141 . . . . 0.0 110.314 169.518 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.35 150.82 29.75 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -57.97 -25.49 61.09 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.305 1.042 . . . . 0.0 113.437 172.728 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -78.3 -7.47 87.81 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 125.285 1.421 . . . . 0.0 115.953 175.705 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.2 149.86 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 119.437 1.618 . . . . 0.0 111.118 174.529 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.5 m -129.57 158.13 40.14 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.603 1.561 . . . . 0.0 111.792 177.419 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.3 -51.26 70.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.247 1.419 . . . . 0.0 112.556 178.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.06 86.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.973 0.909 . . . . 0.0 112.749 174.45 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -59.15 -51.33 70.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.169 0.988 . . . . 0.0 112.149 176.469 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 15.1 mm -54.68 -53.91 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.533 1.133 . . . . 0.0 111.138 171.074 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -49.96 -57.5 7.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.41 1.084 . . . . 0.0 111.603 178.158 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -56.85 -50.85 71.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.251 1.021 . . . . 0.0 113.085 177.004 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -47.8 81.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.106 0.866 . . . . 0.0 112.235 -175.238 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -65.98 -41.66 90.84 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 176.011 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.59 -24.69 65.66 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 176.478 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.8 -54.14 43.58 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.144 -0.972 . . . . 0.0 112.027 174.033 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -98.33 -15.72 19.64 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -173.653 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.24 -177.57 17.45 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.575 1.56 . . . . 0.0 113.262 178.851 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.3 m -119.36 94.02 4.28 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.152 0.981 . . . . 0.0 111.264 -177.536 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.33 157.8 20.45 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.031 0.932 . . . . 0.0 112.263 179.205 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -115.57 -37.11 4.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.575 2.75 . . . . 0.0 111.717 173.676 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.423 ' HZ1' ' CE1' ' A' ' 151' ' ' HIS . 2.6 ttpm? -140.54 144.77 36.1 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.034 1.334 . . . . 0.0 111.511 178.091 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.51 143.93 46.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.67 1.588 . . . . 0.0 110.53 169.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.34 147.98 26.96 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.766 2.027 . . . . 0.0 109.382 173.396 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t -125.38 -153.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.645 1.178 . . . . 0.0 111.023 -173.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.27 -61.59 1.93 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.763 2.425 . . . . 0.0 112.161 -177.852 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.27 162.03 23.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.231 2.212 . . . . 0.0 113.603 172.893 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -144.3 -55.85 0.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.354 1.461 . . . . 0.0 110.219 175.377 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -124.36 -65.96 1.01 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.679 1.992 . . . . 0.0 107.512 168.823 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.6 m -69.44 151.52 45.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.006 1.323 . . . . 0.0 110.891 169.141 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.84 65.23 3.54 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.319 0.962 . . . . 0.0 112.396 173.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -52.41 124.73 14.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.472 1.909 . . . . 0.0 112.305 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.5 m -70.52 86.19 0.63 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.694 1.598 . . . . 0.0 111.558 177.64 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 52.0 tp -150.4 156.22 41.06 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.174 2.189 . . . . 0.0 109.507 -176.562 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -127.85 53.29 0.8 Allowed Glycine 0 N--CA 1.472 1.098 0 C-N-CA 124.878 1.228 . . . . 0.0 112.329 179.335 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.5 m -141.31 145.75 35.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.339 1.455 . . . . 0.0 111.577 -169.709 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.37 162.3 34.74 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.402 1.881 . . . . 0.0 112.398 174.066 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -137.24 106.95 6.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.991 2.116 . . . . 0.0 109.654 -175.299 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 13.2 t -124.23 126.8 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.168 0.987 . . . . 0.0 109.972 -170.035 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.423 ' CE1' ' HZ1' ' A' ' 133' ' ' LYS . 36.9 m170 -115.4 144.52 43.67 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.426 1.49 . . . . 0.0 110.21 -175.479 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -132.85 154.44 50.34 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.371 2.269 . . . . 0.0 112.94 -168.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.56 -29.43 70.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.241 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -131.24 126.24 34.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.065 1.746 . . . . 0.0 111.393 -173.656 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.6 -43.57 98.62 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.217 1.407 . . . . 0.0 112.508 174.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.01 -48.96 61.32 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.585 1.154 . . . . 0.0 112.772 169.872 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.83 -42.06 97.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.626 1.17 . . . . 0.0 112.758 177.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.52 69.03 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.711 0.805 . . . . 0.0 111.829 169.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.5 tp -56.66 -46.81 80.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.074 1.349 . . . . 0.0 112.202 177.408 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -49.45 -57.93 6.09 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.628 1.571 . . . . 0.0 111.318 171.47 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.77 -50.36 66.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.614 1.166 . . . . 0.0 112.846 175.554 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 23.7 ttp -51.51 -59.17 4.55 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.137 1.375 . . . . 0.0 111.476 176.348 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -55.93 -46.94 78.33 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.004 1.321 . . . . 0.0 112.412 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.01 -41.7 97.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.904 1.282 . . . . 0.0 113.538 -178.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -109.19 -15.82 14.22 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -170.248 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.82 113.88 2.5 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.229 1.377 . . . . 0.0 110.995 169.803 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.03 -24.15 19.53 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.337 1.922 . . . . 0.0 114.129 -175.688 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t -69.67 128.66 91.9 Favored Pre-proline 0 N--CA 1.477 0.879 0 CA-C-N 118.643 1.221 . . . . 0.0 111.706 -170.746 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.78 123.58 13.56 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 124.121 3.214 . . . . 0.0 114.355 173.883 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 tp -86.96 77.07 9.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.732 1.613 . . . . 0.0 107.482 169.009 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 47.07 36.09 3.95 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.552 1.941 . . . . 0.0 113.504 -169.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 143.84 -77.06 0.28 Allowed Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.715 1.626 . . . . 0.0 112.876 -178.617 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -65.4 126.88 92.33 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 125.185 1.394 . . . . 0.0 112.302 -176.192 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.3 121.72 7.03 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.725 2.283 . . . . 0.0 111.697 -177.673 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.4 mtm -65.04 142.6 58.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.98 0.912 . . . . 0.0 111.4 174.103 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -124.95 125.27 43.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.542 1.137 . . . . 0.0 110.032 176.126 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.1 mt -128.52 137.26 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.171 0.988 . . . . 0.0 110.987 -170.292 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -137.07 125.84 23.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.988 1.715 . . . . 0.0 111.043 -177.873 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.4 tt -80.43 116.27 20.4 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.989 0.916 . . . . 0.0 108.643 169.885 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 20.6 m -96.6 136.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.002 0.921 . . . . 0.0 112.118 -170.608 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.5 p -82.1 153.23 26.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.841 1.256 . . . . 0.0 112.254 176.48 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.253 1.25 0 C-N-CA 125.77 1.628 . . . . 0.0 112.901 173.83 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.897 0 N-CA-C 112.66 -0.176 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -140.57 133.49 29.19 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.886 1.275 . . . . 0.0 111.191 -176.912 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.5 mt -119.65 122.51 41.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.802 1.641 . . . . 0.0 111.746 176.112 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.4 tp -81.63 129.15 34.59 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.863 1.665 . . . . 0.0 106.852 168.401 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.01 132.86 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.669 1.188 . . . . 0.0 108.87 -176.226 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.9 m -137.46 163.02 32.1 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.205 1.802 . . . . 0.0 111.657 -172.229 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.4 t30 47.61 52.39 12.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.47 1.908 . . . . 0.0 113.158 -173.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.4 mt -84.22 168.87 15.32 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.834 1.654 . . . . 0.0 111.254 169.838 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.8 156.05 31.91 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.903 0.859 . . . . 0.0 112.039 169.624 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -77.41 -36.13 53.59 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.758 1.223 . . . . 0.0 112.15 -178.673 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.25 53.86 4.91 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.565 1.555 . . . . 0.0 112.539 -178.865 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.5 t -125.03 145.74 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.36 2.264 . . . . 0.0 111.57 -169.913 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.0 m -144.3 169.38 18.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.139 1.776 . . . . 0.0 111.819 -175.858 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -48.71 -57.82 5.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.773 2.029 . . . . 0.0 112.562 -178.089 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.19 87.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.189 1.395 . . . . 0.0 113.489 177.536 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.0 -52.2 66.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.151 0.98 . . . . 0.0 112.265 -179.839 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 36.2 mm -56.64 -52.45 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.882 0.873 . . . . 0.0 110.899 171.248 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -49.33 -56.18 10.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.014 0.926 . . . . 0.0 112.324 178.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -57.02 -52.37 65.55 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.853 0.861 . . . . 0.0 112.951 176.823 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.52 -46.43 90.19 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.893 0.77 . . . . 0.0 112.496 -176.851 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -65.09 -47.65 76.48 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.611 0.642 . . . . 0.0 112.438 174.492 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.52 64.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.244 1.017 . . . . 0.0 113.352 179.554 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.41 -45.29 72.9 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.43 1.092 . . . . 0.0 113.017 174.763 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -98.13 -19.06 18.15 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -177.41 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -159.98 153.51 24.49 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-N 120.356 1.435 . . . . 0.0 115.326 172.18 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 47.4 m -75.03 129.9 38.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.206 1.403 . . . . 0.0 111.42 -174.104 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 pp -135.62 147.04 48.49 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.643 1.177 . . . . 0.0 113.531 -174.032 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -73.91 -52.12 13.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.979 2.511 . . . . 0.0 110.246 170.03 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -150.07 153.37 36.32 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.144 1.778 . . . . 0.0 111.488 -177.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.55 133.82 27.97 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.929 1.691 . . . . 0.0 109.362 169.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.63 158.85 44.42 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.541 1.136 . . . . 0.0 113.754 -170.005 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.68 129.62 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 127.608 2.363 . . . . 0.0 108.67 169.901 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -68.48 -44.77 74.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.841 0.856 . . . . 0.0 111.822 178.771 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -69.88 154.0 42.54 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.267 1.427 . . . . 0.0 113.054 177.434 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -141.67 -158.3 0.85 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.785 2.034 . . . . 0.0 108.511 173.736 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -76.61 51.13 0.72 Allowed 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.285 -1.51 . . . . 0.0 111.667 175.188 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.1 m -71.75 -38.71 70.36 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.076 2.151 . . . . 0.0 113.712 -171.051 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.99 -55.25 0.24 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.291 1.9 . . . . 0.0 110.861 -173.506 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.89 98.92 5.11 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.81 2.044 . . . . 0.0 108.231 169.695 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 59.5 m -63.63 128.94 38.06 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.453 0.701 . . . . 0.0 110.388 175.158 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 tp -82.4 -152.31 0.1 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.608 1.163 . . . . 0.0 111.229 -179.398 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.58 50.21 0.48 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.387 0.994 . . . . 0.0 112.767 179.06 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.2 m -140.47 121.15 14.31 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.951 1.3 . . . . 0.0 111.528 -171.613 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.09 169.4 14.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.31 1.844 . . . . 0.0 113.232 -174.734 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -138.59 123.89 19.3 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.266 1.426 . . . . 0.0 110.832 -178.462 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.1 t -128.09 116.59 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.291 1.036 . . . . 0.0 110.904 -174.377 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -92.68 101.75 14.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.35 1.86 . . . . 0.0 108.336 179.062 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -77.38 166.56 22.97 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.653 1.981 . . . . 0.0 113.129 -178.753 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -54.26 -48.25 71.39 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 171.125 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -153.9 136.56 15.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 129.013 2.925 . . . . 0.0 109.516 -171.705 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -60.8 -37.87 83.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.086 0.954 . . . . 0.0 113.552 -176.825 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.4 -48.64 62.54 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.823 1.249 . . . . 0.0 113.093 169.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.12 -44.31 80.22 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.158 0.983 . . . . 0.0 112.021 173.654 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -51.87 -48.52 64.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.132 1.373 . . . . 0.0 112.853 175.12 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.5 tp -52.16 -43.47 64.12 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.49 1.916 . . . . 0.0 113.075 176.69 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -57.18 -55.19 37.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.111 0.965 . . . . 0.0 111.33 174.42 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.54 78.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.8 1.24 . . . . 0.0 112.55 175.263 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 23.6 ttp -50.61 -59.06 4.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.163 1.785 . . . . 0.0 111.272 175.488 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -56.43 -47.5 78.95 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.486 1.114 . . . . 0.0 112.44 177.572 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -58.26 -47.53 83.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.391 1.076 . . . . 0.0 113.279 179.118 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -95.22 -18.87 20.5 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -171.214 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -59.93 109.55 0.97 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 119.797 1.181 . . . . 0.0 110.591 169.684 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.25 -30.45 6.26 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.371 1.939 . . . . 0.0 113.714 -174.016 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.28 133.52 93.31 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 125.15 1.38 . . . . 0.0 110.766 -175.241 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.17 143.63 20.24 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.882 2.388 . . . . 0.0 112.94 -177.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 tp -125.29 107.38 10.65 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.85 2.06 . . . . 0.0 107.92 169.744 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 39.71 58.1 2.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.264 1.826 . . . . 0.0 112.463 -169.89 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.79 -45.4 2.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.122 1.344 . . . . 0.0 114.192 -179.563 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -73.13 116.59 52.3 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.23 1.412 . . . . 0.0 111.377 -171.012 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.8 114.54 3.74 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.68 2.253 . . . . 0.0 110.953 174.892 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.61 138.72 58.56 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.431 1.092 . . . . 0.0 111.754 -178.392 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -118.74 126.93 52.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.442 1.497 . . . . 0.0 109.586 175.236 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.6 mt -130.54 138.57 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.012 0.925 . . . . 0.0 111.173 -169.773 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -143.06 126.62 16.87 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.917 1.687 . . . . 0.0 111.518 -173.083 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -73.73 142.14 46.32 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.433 -0.792 . . . . 0.0 111.523 170.139 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.96 172.07 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -172.495 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.1 p -60.9 138.99 58.12 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.208 1.803 . . . . 0.0 112.825 -179.209 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.25 1.108 0 C-N-CA 125.663 1.585 . . . . 0.0 112.111 177.538 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.21 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -127.21 107.37 9.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.868 1.267 . . . . 0.0 110.413 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -108.91 105.56 15.16 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.283 1.833 . . . . 0.0 109.229 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.6 tp -89.51 132.86 34.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.775 2.03 . . . . 0.0 110.171 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.44 123.43 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.928 1.691 . . . . 0.0 109.379 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.3 m -127.01 160.38 31.3 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.774 1.629 . . . . 0.0 111.868 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.0 t30 54.37 46.34 25.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.519 1.928 . . . . 0.0 113.792 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 mt -78.48 157.29 28.95 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.151 1.381 . . . . 0.0 109.371 169.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.3 147.13 53.17 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.054 -1.029 . . . . 0.0 112.269 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -57.08 -28.8 62.93 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -81.8 -2.4 90.53 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.229 1.395 . . . . 0.0 115.375 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 80.9 t -66.78 140.19 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.122 1.461 . . . . 0.0 111.067 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.1 m -121.11 158.05 28.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.412 1.485 . . . . 0.0 112.694 -174.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.01 -57.34 10.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.345 1.858 . . . . 0.0 112.996 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.55 89.73 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.557 1.143 . . . . 0.0 113.242 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.11 -50.43 74.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.176 0.99 . . . . 0.0 112.099 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 mm -55.24 -52.18 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.124 0.97 . . . . 0.0 111.467 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -52.27 -51.74 56.75 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.846 0.859 . . . . 0.0 112.201 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -59.05 -53.39 58.94 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.98 1.312 . . . . 0.0 113.156 174.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.99 -43.16 99.55 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.29 0.95 . . . . 0.0 112.446 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -64.92 -41.73 95.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.73 -29.95 69.68 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.34 -57.08 12.65 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.068 0.947 . . . . 0.0 112.562 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -91.71 -16.68 26.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.95 -178.93 16.12 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.474 1.512 . . . . 0.0 114.84 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.57 107.46 12.44 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.448 1.899 . . . . 0.0 110.257 -169.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 pp -132.29 148.83 52.46 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -83.76 -51.49 7.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.725 2.41 . . . . 0.0 110.511 170.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.24 148.55 30.6 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.784 1.633 . . . . 0.0 111.374 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.61 131.83 23.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.902 1.281 . . . . 0.0 110.841 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.58 157.8 44.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.372 1.469 . . . . 0.0 113.063 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t . . . . . 0 N--CA 1.482 1.132 0 C-N-CA 126.486 1.914 . . . . 0.0 110.819 179.905 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.8 m -147.48 144.59 28.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.831 1.652 . . . . 0.0 109.708 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -143.44 163.03 34.24 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.498 1.519 . . . . 0.0 112.478 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -143.02 133.97 25.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.155 1.382 . . . . 0.0 110.848 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.62 118.24 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.192 1.397 . . . . 0.0 110.004 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -81.75 100.75 9.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.661 1.585 . . . . 0.0 108.266 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -80.29 154.88 27.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.171 1.788 . . . . 0.0 112.724 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.19 -30.65 58.1 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.832 1.253 . . . . 0.0 111.733 169.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -141.04 116.26 9.97 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.218 1.807 . . . . 0.0 111.249 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -28.63 68.77 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.84 -48.17 81.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.881 0.872 . . . . 0.0 111.972 171.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.79 -39.51 94.43 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.675 1.19 . . . . 0.0 112.214 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.07 83.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.376 1.071 . . . . 0.0 112.508 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.8 tp -59.36 -44.33 92.73 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.187 1.395 . . . . 0.0 111.746 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -51.33 -55.21 19.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.781 1.232 . . . . 0.0 110.955 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.97 -48.3 76.06 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.383 1.073 . . . . 0.0 112.846 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 25.8 ttt -51.18 -60.54 3.0 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.831 1.653 . . . . 0.0 111.399 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -56.84 -44.98 82.63 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.132 0.973 . . . . 0.0 112.695 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -59.77 -44.51 93.84 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.854 1.262 . . . . 0.0 113.545 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -109.9 -16.69 13.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -59.8 115.37 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.34 1.427 . . . . 0.0 111.196 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.33 -24.78 26.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.992 1.758 . . . . 0.0 114.026 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.05 132.96 90.03 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 124.594 1.158 . . . . 0.0 110.628 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.45 142.27 23.47 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.932 2.421 . . . . 0.0 112.44 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 64.6 tp -128.14 105.32 8.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.647 1.979 . . . . 0.0 107.694 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 49.27 57.74 6.15 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.402 1.481 . . . . 0.0 111.272 -169.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.21 -54.06 4.93 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.311 1.434 . . . . 0.0 113.48 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -59.87 119.25 39.48 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 126.43 1.892 . . . . 0.0 112.103 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.58 120.7 6.87 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.952 2.435 . . . . 0.0 111.29 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.0 mtm -65.07 138.53 58.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.309 1.044 . . . . 0.0 111.059 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -122.47 125.53 46.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.643 1.177 . . . . 0.0 110.062 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.3 mt -124.46 141.19 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.508 1.123 . . . . 0.0 111.671 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -139.69 146.04 39.14 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.701 2.0 . . . . 0.0 110.869 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 66.5 tp . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 125.244 1.418 . . . . 0.0 111.889 -176.415 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.411 ' HA3' ' HE2' ' A' ' 155' ' ' LYS . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -78.03 96.22 5.04 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.1 0.96 . . . . 0.0 110.963 -174.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -88.59 101.17 13.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.353 1.861 . . . . 0.0 107.426 169.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.4 tp -88.21 133.73 33.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.585 1.954 . . . . 0.0 110.028 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.89 136.84 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.41 1.484 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.0 m -140.34 167.92 21.03 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.451 1.9 . . . . 0.0 111.934 -171.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.7 t30 51.44 46.81 25.93 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.346 1.858 . . . . 0.0 113.006 -173.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -87.12 167.1 14.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.845 1.658 . . . . 0.0 109.993 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -75.45 150.58 38.24 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.964 -1.085 . . . . 0.0 110.603 169.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -49.44 -41.77 40.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.504 1.121 . . . . 0.0 113.546 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.71 9.46 73.85 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.712 1.625 . . . . 0.0 115.761 -173.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.45 147.54 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.046 1.423 . . . . 0.0 109.528 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -129.94 155.61 45.78 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -45.75 -58.14 3.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.527 2.331 . . . . 0.0 112.101 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.63 80.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.38 1.472 . . . . 0.0 113.168 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.12 -52.55 65.24 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.51 1.124 . . . . 0.0 112.143 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.5 mm -57.81 -51.52 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.739 1.216 . . . . 0.0 111.229 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -48.46 -54.21 15.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.939 1.295 . . . . 0.0 111.918 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.3 -53.75 53.88 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.663 0.785 . . . . 0.0 112.75 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.15 -45.12 89.87 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.799 0.727 . . . . 0.0 112.567 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -64.71 -43.25 94.03 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.786 0.721 . . . . 0.0 112.382 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.24 -32.77 66.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.62 -41.67 81.8 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.205 1.002 . . . . 0.0 113.16 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -113.25 -10.14 13.37 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.67 162.14 28.65 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.816 1.198 . . . . 0.0 114.382 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.26 108.55 19.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.764 1.626 . . . . 0.0 110.087 -169.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.9 pp -130.91 152.93 49.69 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.2 mmmt -93.56 -49.39 5.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.998 2.919 . . . . 0.0 111.111 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -145.87 143.02 29.34 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.228 1.411 . . . . 0.0 111.28 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -126.94 135.9 51.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.677 1.591 . . . . 0.0 110.556 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.3 166.09 25.65 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.796 2.038 . . . . 0.0 111.7 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 N--CA 1.481 1.111 0 C-N-CA 125.942 1.697 . . . . 0.0 110.8 -173.866 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 65.4 p -139.19 156.37 47.16 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.684 1.193 . . . . 0.0 112.739 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.06 159.37 42.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.325 1.85 . . . . 0.0 111.378 172.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.63 115.03 9.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.734 1.614 . . . . 0.0 109.801 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.2 t -127.7 115.54 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.238 1.015 . . . . 0.0 110.249 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -80.83 104.75 11.55 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.366 1.467 . . . . 0.0 109.457 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -82.08 155.13 25.24 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.68 1.592 . . . . 0.0 112.163 171.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -80.46 -59.54 2.66 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.401 -0.812 . . . . 0.0 112.323 169.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -88.65 126.99 35.56 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.163 1.385 . . . . 0.0 111.441 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.411 ' HE2' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -62.72 -46.13 89.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.127 1.371 . . . . 0.0 111.822 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.45 -46.22 87.0 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.761 1.224 . . . . 0.0 112.306 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -65.75 -36.61 84.04 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.061 0.945 . . . . 0.0 112.928 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.02 -48.17 83.03 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.291 -0.88 . . . . 0.0 111.936 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.96 -42.79 90.7 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.551 1.14 . . . . 0.0 112.377 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -51.74 -57.79 8.26 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.777 1.631 . . . . 0.0 110.427 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.11 60.48 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.725 1.21 . . . . 0.0 112.425 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 21.9 ttt -49.62 -62.45 1.55 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.162 1.385 . . . . 0.0 111.667 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -57.57 -49.16 77.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.622 1.169 . . . . 0.0 112.974 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -63.24 -48.01 80.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.868 0.867 . . . . 0.0 113.258 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.05 -13.74 24.91 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -60.28 108.27 0.77 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.87 1.214 . . . . 0.0 110.739 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 119.06 -30.63 5.78 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.345 1.926 . . . . 0.0 113.933 -173.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.4 134.57 90.96 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.168 1.387 . . . . 0.0 110.635 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.41 146.05 24.32 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.822 2.348 . . . . 0.0 113.334 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 37.3 tp -135.65 108.53 7.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.762 1.625 . . . . 0.0 108.425 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 50.16 63.25 2.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.694 1.597 . . . . 0.0 111.654 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.48 -63.05 4.53 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.174 1.369 . . . . 0.0 113.384 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -63.56 131.94 95.01 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.184 1.393 . . . . 0.0 112.408 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 123.61 9.38 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.749 2.966 . . . . 0.0 111.694 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.17 132.28 49.92 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.289 1.035 . . . . 0.0 111.55 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -110.14 130.38 55.55 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.2 1.4 . . . . 0.0 109.124 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.3 mt -128.59 143.37 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.846 0.859 . . . . 0.0 111.857 -169.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -140.06 146.18 38.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.243 2.217 . . . . 0.0 110.431 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.47 0.527 0 C-N-CA 125.099 1.36 . . . . 0.0 110.581 -179.073 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.04 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -102.94 119.59 39.12 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.14 1.376 . . . . 0.0 110.64 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 87.6 mt -127.34 131.72 50.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.494 1.518 . . . . 0.0 111.618 -171.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.9 tp -77.42 137.99 39.01 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.481 1.513 . . . . 0.0 109.091 169.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.9 122.75 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.324 1.85 . . . . 0.0 108.087 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.9 m -133.75 169.24 17.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.917 1.287 . . . . 0.0 112.937 -169.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.3 t30 54.81 46.18 25.07 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.788 2.035 . . . . 0.0 113.079 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 mt -82.37 165.59 20.16 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.485 1.514 . . . . 0.0 110.057 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.48 145.87 43.22 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.006 -1.058 . . . . 0.0 111.317 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -58.03 -26.37 62.35 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.59 -1.56 90.09 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.117 1.341 . . . . 0.0 115.477 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.4 138.39 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.229 1.514 . . . . 0.0 111.232 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.2 m -113.45 155.9 24.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.172 1.389 . . . . 0.0 113.124 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.05 -57.27 11.69 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.604 1.961 . . . . 0.0 112.991 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.29 93.45 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.214 1.005 . . . . 0.0 112.919 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -56.86 -50.42 72.52 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.294 -0.879 . . . . 0.0 111.853 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.1 mm -55.15 -53.38 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.446 1.098 . . . . 0.0 111.741 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -47.84 -59.47 3.3 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.611 0.765 . . . . 0.0 111.76 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -63.54 -43.28 97.57 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -47.0 81.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.743 1.156 . . . . 0.0 111.93 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -64.71 -40.69 95.78 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.99 -17.11 61.75 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.33 -59.03 3.11 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.915 -1.116 . . . . 0.0 111.786 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -88.16 -21.85 24.38 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.13 -178.31 15.26 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.652 1.596 . . . . 0.0 113.234 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.6 m -125.21 122.31 36.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.238 1.415 . . . . 0.0 109.549 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.66 147.09 52.33 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -91.2 -34.89 14.82 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.454 1.902 . . . . 0.0 110.949 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -137.16 142.35 42.2 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.962 1.305 . . . . 0.0 112.41 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.42 128.96 12.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.478 1.511 . . . . 0.0 109.992 169.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.0 153.25 37.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.666 1.186 . . . . 0.0 112.876 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.6 t . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 126.488 1.915 . . . . 0.0 110.009 173.383 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 N-CA-C 111.996 -0.441 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 55.6 p -133.7 146.21 50.6 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.315 1.446 . . . . 0.0 112.81 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.41 171.99 15.67 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.291 2.236 . . . . 0.0 111.35 -174.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -143.68 135.86 26.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.889 1.676 . . . . 0.0 110.46 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.51 129.23 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.585 1.154 . . . . 0.0 110.064 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -109.1 96.91 6.63 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.357 1.463 . . . . 0.0 108.889 173.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -73.03 140.41 47.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.005 2.122 . . . . 0.0 110.103 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.81 -16.97 63.37 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 28.8 mtm105 -134.82 134.12 40.49 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.224 1.81 . . . . 0.0 110.893 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -55.27 -46.63 76.13 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.208 1.403 . . . . 0.0 112.575 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.96 -51.56 61.06 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.256 1.022 . . . . 0.0 112.028 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.55 -41.39 98.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.626 1.17 . . . . 0.0 113.077 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.67 -56.56 17.88 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.692 1.197 . . . . 0.0 111.637 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.18 -42.28 90.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.254 1.422 . . . . 0.0 112.561 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -52.12 -61.69 2.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.162 1.385 . . . . 0.0 110.89 170.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.01 -47.86 67.99 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.657 1.183 . . . . 0.0 112.601 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 35.8 ttp -51.13 -60.72 2.81 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.411 1.484 . . . . 0.0 111.29 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -59.3 -45.04 92.38 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.87 1.268 . . . . 0.0 112.879 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -58.71 -48.37 81.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.483 1.113 . . . . 0.0 113.362 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -103.48 -17.33 15.26 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -60.85 111.13 1.53 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 120.273 1.397 . . . . 0.0 111.142 170.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.05 -22.46 27.44 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.146 1.831 . . . . 0.0 114.39 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 76.3 t -70.12 133.18 87.85 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 118.573 1.186 . . . . 0.0 110.83 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.14 139.14 21.13 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.898 2.398 . . . . 0.0 112.505 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.0 tp -126.65 106.16 9.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.671 1.988 . . . . 0.0 107.887 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 47.86 57.89 5.58 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.484 1.513 . . . . 0.0 111.321 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.64 -54.4 4.8 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.228 1.394 . . . . 0.0 113.468 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.44 119.07 43.33 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.962 1.705 . . . . 0.0 112.44 -172.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.09 117.83 5.36 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.884 2.389 . . . . 0.0 111.076 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.53 141.43 58.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.596 1.158 . . . . 0.0 111.906 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -122.91 130.86 53.37 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.326 1.45 . . . . 0.0 110.249 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.7 mm -117.48 133.35 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.533 1.133 . . . . 0.0 109.918 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -140.34 151.56 45.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.835 1.254 . . . . 0.0 112.684 -171.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.542 0.651 0 C-N-CA 126.839 2.056 . . . . 0.0 112.052 177.372 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -75.65 126.75 31.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.979 1.312 . . . . 0.0 111.74 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -137.69 111.45 8.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.514 1.926 . . . . 0.0 110.274 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.2 tp -85.52 132.78 34.14 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.769 2.028 . . . . 0.0 110.062 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.2 t -122.47 112.74 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.428 1.491 . . . . 0.0 108.447 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.7 m -117.91 164.13 15.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.311 1.044 . . . . 0.0 111.887 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 54.73 47.67 21.94 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.324 1.85 . . . . 0.0 114.217 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.28 152.41 32.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.907 1.283 . . . . 0.0 108.932 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.71 147.36 53.37 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.869 -1.144 . . . . 0.0 110.789 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -54.93 -28.68 52.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.488 1.115 . . . . 0.0 113.881 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.67 1.02 85.32 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.329 1.442 . . . . 0.0 115.779 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.6 t -66.7 114.75 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.926 1.863 . . . . 0.0 110.484 175.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.5 m -70.73 151.99 44.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.784 1.234 . . . . 0.0 112.598 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -55.18 -48.52 73.67 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.486 1.514 . . . . 0.0 112.751 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.19 76.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.221 1.408 . . . . 0.0 113.665 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -58.5 -53.86 53.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.116 0.966 . . . . 0.0 112.807 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.5 mm -54.59 -55.48 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.342 1.057 . . . . 0.0 110.999 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -49.34 -55.74 11.86 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.255 1.422 . . . . 0.0 111.875 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.43 -49.81 76.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.533 1.133 . . . . 0.0 113.311 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -43.92 95.83 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.215 0.916 . . . . 0.0 111.417 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -66.71 -44.98 80.17 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.862 1.265 . . . . 0.0 112.708 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.0 -14.42 54.0 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.78 -63.46 1.07 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.919 -1.113 . . . . 0.0 111.479 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -83.28 -21.11 33.38 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.4 -168.76 11.68 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.151 1.834 . . . . 0.0 112.921 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 m -140.91 129.23 22.37 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.42 1.088 . . . . 0.0 110.618 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -136.54 152.57 50.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -171.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -83.0 -51.81 7.23 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.74 2.416 . . . . 0.0 111.133 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -146.54 147.92 31.64 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.084 1.353 . . . . 0.0 112.387 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.36 137.55 27.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.954 1.702 . . . . 0.0 110.825 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.42 116.19 6.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.727 1.211 . . . . 0.0 112.557 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.48 1.054 0 C-N-CA 125.486 1.514 . . . . 0.0 109.755 169.791 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.833 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.2 m -150.5 153.06 35.16 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.64 1.576 . . . . 0.0 109.757 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.55 156.69 43.85 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.266 1.426 . . . . 0.0 112.513 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -123.2 131.67 53.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.816 1.646 . . . . 0.0 109.805 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.01 144.3 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.33 1.452 . . . . 0.0 109.722 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -126.29 102.78 7.33 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.99 1.716 . . . . 0.0 108.949 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -78.13 166.38 22.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.869 1.668 . . . . 0.0 112.706 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -61.31 -35.39 77.23 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.085 0.954 . . . . 0.0 112.796 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.74 147.03 34.93 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.44 1.496 . . . . 0.0 112.474 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -55.07 -46.02 75.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.437 1.495 . . . . 0.0 112.587 170.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -50.95 -48.11 60.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.395 1.078 . . . . 0.0 112.8 172.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.21 -39.17 82.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.1 0.96 . . . . 0.0 112.568 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.08 -45.85 86.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.72 0.808 . . . . 0.0 112.035 169.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.63 -44.15 96.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.372 1.469 . . . . 0.0 111.839 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -52.7 -54.54 32.16 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.185 1.394 . . . . 0.0 111.408 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.52 -51.67 58.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.772 1.229 . . . . 0.0 112.378 173.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 30.8 ttp -52.54 -62.4 1.67 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.581 1.552 . . . . 0.0 111.286 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -57.14 -45.15 83.79 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.742 1.217 . . . . 0.0 112.755 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.87 -46.69 89.6 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.351 1.06 . . . . 0.0 113.042 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -107.75 -12.28 15.25 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -169.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -59.23 119.54 7.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.294 1.406 . . . . 0.0 111.583 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.89 -18.22 57.54 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.019 1.771 . . . . 0.0 114.323 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -72.29 128.09 89.35 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 118.839 1.319 . . . . 0.0 111.077 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.12 136.16 71.0 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.943 3.096 . . . . 0.0 113.844 172.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.0 tp -133.77 103.46 5.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.495 1.518 . . . . 0.0 107.567 169.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 51.32 62.28 2.79 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.8 1.64 . . . . 0.0 111.08 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.86 -61.64 4.71 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.467 1.508 . . . . 0.0 113.343 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -65.09 125.2 88.77 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.681 1.592 . . . . 0.0 112.118 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.8 126.23 9.96 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.486 2.791 . . . . 0.0 111.631 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -68.29 120.54 14.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.312 1.045 . . . . 0.0 111.797 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -94.17 103.49 15.53 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.92 1.288 . . . . 0.0 108.921 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -113.5 134.23 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.311 1.045 . . . . 0.0 110.862 -169.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -142.59 123.0 13.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.534 1.534 . . . . 0.0 112.157 -171.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 169.637 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 CA-C-O 121.427 0.46 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -139.59 150.75 45.39 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.372 1.469 . . . . 0.0 112.08 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.5 mt -125.42 144.52 50.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.964 1.706 . . . . 0.0 111.204 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.5 tp -117.02 99.91 7.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.874 1.669 . . . . 0.0 107.579 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.21 129.18 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.594 1.557 . . . . 0.0 108.174 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.6 m -133.28 170.85 14.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.249 1.42 . . . . 0.0 111.947 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.3 t30 56.93 38.48 29.42 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.207 1.803 . . . . 0.0 113.269 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.07 165.31 20.72 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.294 1.437 . . . . 0.0 110.552 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.76 144.34 52.75 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.39 -0.819 . . . . 0.0 109.811 168.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -56.63 -33.68 66.54 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.94 27.76 16.35 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.499 1.523 . . . . 0.0 115.244 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.59 124.74 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 118.912 1.356 . . . . 0.0 109.652 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.8 m -72.0 135.21 46.31 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.548 0.739 . . . . 0.0 112.031 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.38 -47.74 80.87 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.493 1.117 . . . . 0.0 112.935 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.38 -46.91 76.5 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.689 1.196 . . . . 0.0 112.702 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.27 -48.03 81.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.179 0.992 . . . . 0.0 112.117 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 mm -55.37 -53.65 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.454 1.102 . . . . 0.0 112.087 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -50.16 -55.39 15.29 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.697 0.681 . . . . 0.0 111.474 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -56.66 -52.06 66.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.483 1.113 . . . . 0.0 113.228 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.31 -44.92 90.09 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.12 0.873 . . . . 0.0 112.367 -175.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -63.48 -43.48 97.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.579 0.627 . . . . 0.0 112.557 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.2 -19.6 64.66 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.27 -63.24 1.12 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.185 0.994 . . . . 0.0 111.724 172.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.08 -19.17 44.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -138.32 -177.33 15.18 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.336 1.446 . . . . 0.0 113.959 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.7 m -124.62 116.11 21.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.512 1.525 . . . . 0.0 110.238 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.92 144.72 50.57 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -169.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -81.6 -42.71 19.67 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.947 2.099 . . . . 0.0 109.991 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -147.31 145.47 29.37 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.687 1.595 . . . . 0.0 111.915 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.16 114.7 7.62 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.894 1.677 . . . . 0.0 108.126 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.63 113.37 10.96 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.613 1.165 . . . . 0.0 112.165 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 125.325 1.45 . . . . 0.0 110.469 171.386 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.86 0 CA-C-O 120.437 -0.091 . . . . 0.0 113.025 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.5 p -136.79 158.73 43.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.199 1.4 . . . . 0.0 112.958 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.73 138.43 23.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.496 1.518 . . . . 0.0 111.849 172.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -106.92 124.9 50.29 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.578 1.951 . . . . 0.0 110.431 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.3 t -129.34 139.31 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.008 1.323 . . . . 0.0 110.115 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -128.96 120.33 25.91 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.919 2.088 . . . . 0.0 109.199 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -103.31 163.59 12.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.581 1.952 . . . . 0.0 113.341 -169.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.35 -36.13 58.36 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 169.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 42.5 mtm-85 -133.77 129.1 36.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.082 1.753 . . . . 0.0 111.278 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -54.68 -45.87 74.0 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.597 1.559 . . . . 0.0 113.083 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.65 -46.72 70.66 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.925 1.29 . . . . 0.0 112.801 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.08 -42.84 93.76 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.466 1.106 . . . . 0.0 112.696 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.22 71.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.707 0.803 . . . . 0.0 111.734 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.65 -47.03 80.66 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.535 1.134 . . . . 0.0 112.58 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -50.81 -58.96 4.66 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.863 1.265 . . . . 0.0 111.165 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.4 -48.12 62.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.355 1.062 . . . . 0.0 112.659 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -55.29 -65.55 0.57 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.071 1.348 . . . . 0.0 111.322 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -61.61 -34.11 75.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -64.05 -42.02 97.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.524 1.13 . . . . 0.0 113.403 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -110.66 -18.43 13.16 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -59.24 115.4 3.18 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.875 1.216 . . . . 0.0 111.19 170.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 103.78 -23.46 32.47 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.857 1.694 . . . . 0.0 114.403 -175.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.8 134.87 90.06 Favored Pre-proline 0 N--CA 1.477 0.924 0 CA-C-N 118.643 1.221 . . . . 0.0 110.216 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.35 141.85 29.29 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.671 2.248 . . . . 0.0 112.93 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -125.33 99.97 6.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.46 2.304 . . . . 0.0 106.855 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 44.02 70.53 0.31 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.992 1.717 . . . . 0.0 111.902 -169.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.6 -57.63 5.05 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.781 1.657 . . . . 0.0 113.531 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -65.76 122.76 82.33 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.996 2.119 . . . . 0.0 112.369 -172.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.79 123.87 10.15 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.867 2.378 . . . . 0.0 111.088 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.1 mtm -61.61 123.6 18.34 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.064 0.945 . . . . 0.0 111.091 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -106.83 104.89 14.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.236 1.414 . . . . 0.0 109.123 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.3 mt -106.76 130.31 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.144 0.978 . . . . 0.0 110.85 -172.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -109.43 147.08 33.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.531 1.933 . . . . 0.0 109.627 173.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 N--CA 1.47 0.533 0 C-N-CA 125.249 1.419 . . . . 0.0 112.386 -179.885 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.9 0 CA-C-O 120.823 0.124 . . . . 0.0 113.153 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -117.58 103.73 10.35 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.08 1.752 . . . . 0.0 109.626 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -88.55 105.37 17.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.575 2.35 . . . . 0.0 108.994 -173.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.1 tp -88.88 122.65 32.48 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.756 2.022 . . . . 0.0 109.983 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.8 t -112.11 136.55 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.101 1.76 . . . . 0.0 109.115 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.2 m -137.52 163.13 31.9 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.188 1.795 . . . . 0.0 112.307 -174.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.1 t30 57.01 33.5 23.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.933 2.093 . . . . 0.0 113.918 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.9 mt -72.0 159.03 34.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.139 0.975 . . . . 0.0 110.28 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.83 139.81 57.78 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.535 -0.728 . . . . 0.0 110.571 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.75 -20.9 62.33 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.82 11.9 62.59 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.717 1.627 . . . . 0.0 115.558 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.06 123.99 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.719 1.76 . . . . 0.0 110.33 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.6 m -81.84 149.13 28.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.445 1.098 . . . . 0.0 113.105 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.34 -54.11 50.56 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.85 1.66 . . . . 0.0 112.69 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -39.33 81.81 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.57 1.148 . . . . 0.0 112.951 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.43 -51.05 71.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.835 0.854 . . . . 0.0 111.979 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.9 mm -55.0 -53.06 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.922 0.889 . . . . 0.0 111.511 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.07 -55.32 15.34 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.796 0.839 . . . . 0.0 111.973 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -59.55 -50.96 71.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.964 1.306 . . . . 0.0 113.212 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -63.36 -43.55 97.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.271 0.941 . . . . 0.0 111.886 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -63.4 -44.99 93.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.062 0.545 . . . . 0.0 112.427 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.03 -31.87 67.42 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.5 -52.53 65.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.265 1.026 . . . . 0.0 112.77 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -95.59 -23.67 16.94 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.29 162.04 23.62 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.373 1.463 . . . . 0.0 114.458 -172.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 37.5 m -102.49 103.34 13.7 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.471 1.508 . . . . 0.0 110.424 -173.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -121.48 165.05 16.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 -35.88 2.85 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.776 2.431 . . . . 0.0 111.557 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -140.58 151.09 44.41 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.61 0.764 . . . . 0.0 111.924 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.25 141.89 35.82 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.738 1.615 . . . . 0.0 110.446 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -146.92 152.33 38.49 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.983 1.713 . . . . 0.0 111.608 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 N--CA 1.48 1.061 0 C-N-CA 126.1 1.76 . . . . 0.0 109.875 177.059 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 N-CA-C 113.344 0.098 . . . . 0.0 113.344 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 78.1 p -137.08 155.69 49.32 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.469 1.108 . . . . 0.0 112.257 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -143.69 158.81 43.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.417 1.487 . . . . 0.0 111.649 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -139.84 120.63 14.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.533 1.533 . . . . 0.0 110.135 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 51.5 t -124.52 118.7 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.143 1.377 . . . . 0.0 109.723 -174.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -93.04 105.55 17.64 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.712 1.205 . . . . 0.0 108.502 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -82.6 152.38 25.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.643 2.777 . . . . 0.0 112.103 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -62.93 -48.36 79.24 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.153 0.581 . . . . 0.0 112.276 170.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -123.92 138.44 54.48 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.854 1.262 . . . . 0.0 112.302 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -59.24 -46.75 87.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.559 1.544 . . . . 0.0 112.966 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.72 62.64 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.764 1.226 . . . . 0.0 113.484 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.51 -43.28 85.71 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.834 0.853 . . . . 0.0 112.32 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.87 -46.51 84.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.101 0.96 . . . . 0.0 112.514 170.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.85 -47.75 79.64 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.941 2.097 . . . . 0.0 111.182 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -51.65 -52.91 44.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.425 1.09 . . . . 0.0 111.841 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.1 -47.03 78.82 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.732 0.813 . . . . 0.0 112.845 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 41.1 ttp -53.1 -60.7 2.96 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.466 1.507 . . . . 0.0 111.454 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -35.64 80.95 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -61.63 -45.93 91.95 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.381 1.072 . . . . 0.0 113.166 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -106.11 -17.38 14.34 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 -169.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -59.65 114.75 2.9 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.204 1.366 . . . . 0.0 111.335 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.71 -23.47 26.02 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.178 1.846 . . . . 0.0 114.138 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 65.7 t -67.82 131.97 92.49 Favored Pre-proline 0 N--CA 1.476 0.866 0 CA-C-N 118.596 1.198 . . . . 0.0 110.886 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.92 121.54 5.46 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.309 2.673 . . . . 0.0 111.972 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 24.2 tp -77.55 79.2 4.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.196 1.399 . . . . 0.0 109.266 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 45.96 35.88 2.66 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.675 1.99 . . . . 0.0 113.633 -170.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 144.04 -79.94 0.24 Allowed Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.916 1.722 . . . . 0.0 112.561 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -64.11 127.06 91.46 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.172 1.389 . . . . 0.0 112.762 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.73 122.5 7.37 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.19 2.593 . . . . 0.0 111.788 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.1 mtm -66.73 136.19 55.13 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.048 0.939 . . . . 0.0 110.959 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -118.02 129.29 55.49 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.723 1.209 . . . . 0.0 109.735 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.5 mt -129.87 141.12 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.944 0.897 . . . . 0.0 112.282 -169.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -137.53 154.3 49.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.835 2.454 . . . . 0.0 110.482 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 64.8 tp . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 125.045 1.338 . . . . 0.0 111.493 -177.951 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.47 167.09 31.51 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 118.8 1.3 . . . . 0.0 112.628 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 89.5 mt -142.23 162.57 35.14 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.037 2.135 . . . . 0.0 111.678 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.8 tp -123.86 106.64 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.199 1.8 . . . . 0.0 106.917 168.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.94 129.39 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.8 m -129.78 171.9 12.21 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.68 1.192 . . . . 0.0 111.701 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.7 t30 50.77 65.07 1.58 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.876 1.671 . . . . 0.0 112.727 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.48 153.95 21.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.872 2.069 . . . . 0.0 109.685 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.44 143.81 57.46 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.737 -1.227 . . . . 0.0 110.588 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -53.4 -34.3 57.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.197 0.999 . . . . 0.0 113.567 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.23 9.0 78.67 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.343 1.449 . . . . 0.0 115.786 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.93 121.26 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.679 1.739 . . . . 0.0 109.919 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.8 m -72.78 146.31 46.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.459 1.104 . . . . 0.0 113.235 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.3 -58.32 8.78 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.798 1.639 . . . . 0.0 113.165 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.79 -37.19 78.42 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.957 0.903 . . . . 0.0 113.001 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.0 -52.31 66.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.815 0.846 . . . . 0.0 112.072 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.6 mm -54.04 -53.31 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.985 0.914 . . . . 0.0 111.318 169.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -52.32 -52.57 52.36 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.146 0.979 . . . . 0.0 112.092 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.84 -50.78 70.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.899 1.28 . . . . 0.0 113.435 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.6 -45.2 91.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.524 1.056 . . . . 0.0 112.275 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -63.0 -40.15 96.91 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.528 0.604 . . . . 0.0 112.37 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.48 -13.57 52.71 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -73.59 -61.67 1.75 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.906 -1.121 . . . . 0.0 111.252 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -85.68 -12.05 52.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.4 166.48 24.47 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.138 1.827 . . . . 0.0 112.883 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.4 m -111.99 97.72 6.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.573 1.549 . . . . 0.0 109.665 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 152' ' ' PHE . 3.7 pp -118.34 144.03 46.18 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -169.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.41 -48.62 15.09 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.803 2.041 . . . . 0.0 110.702 171.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -152.43 149.05 28.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.743 1.217 . . . . 0.0 112.362 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.58 130.41 24.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.591 1.556 . . . . 0.0 109.708 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.15 109.87 8.63 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.465 1.506 . . . . 0.0 111.544 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 N--CA 1.476 0.864 0 C-N-CA 126.18 1.792 . . . . 0.0 111.442 179.233 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 N-CA-C 113.743 0.257 . . . . 0.0 113.743 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.6 p -140.69 167.51 22.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.229 1.812 . . . . 0.0 111.179 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.45 125.9 12.4 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.28 1.432 . . . . 0.0 111.555 169.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.16 123.97 28.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.446 1.498 . . . . 0.0 109.849 170.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.7 140.38 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 118.907 0.776 . . . . 0.0 111.122 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -126.12 127.8 46.34 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.024 1.729 . . . . 0.0 110.176 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 131' ' ' LEU . 30.8 m-85 -110.6 158.83 18.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.19 2.196 . . . . 0.0 113.964 -169.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -76.26 -29.63 57.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.626 0.77 . . . . 0.0 112.858 170.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -141.27 129.38 22.1 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.466 1.506 . . . . 0.0 112.087 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -40.05 83.08 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.935 1.694 . . . . 0.0 112.914 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.81 -51.61 68.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.117 0.967 . . . . 0.0 112.334 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.49 -46.47 86.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.274 1.03 . . . . 0.0 112.059 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.6 -50.78 67.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.524 1.13 . . . . 0.0 112.374 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.48 -48.0 80.4 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.541 1.536 . . . . 0.0 112.102 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.25 -52.72 60.46 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.324 1.45 . . . . 0.0 112.319 172.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.87 -50.85 67.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.903 1.281 . . . . 0.0 112.011 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.9 ttt -52.19 -59.73 4.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.791 1.636 . . . . 0.0 112.032 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -51.98 -45.56 64.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.538 1.135 . . . . 0.0 112.557 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.31 -52.34 64.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.516 1.127 . . . . 0.0 113.063 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -95.82 -12.56 25.09 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -169.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -58.91 118.57 5.92 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.764 -1.21 . . . . 0.0 111.139 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.6 -16.74 54.55 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.54 1.543 . . . . 0.0 114.598 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 85.0 t -69.27 126.77 92.94 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 119.11 1.455 . . . . 0.0 110.702 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -60.16 136.93 72.08 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.773 2.982 . . . . 0.0 114.195 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 50.9 tp -136.87 101.33 4.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.503 1.521 . . . . 0.0 108.079 169.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 52.08 65.37 1.52 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.228 1.811 . . . . 0.0 111.986 -169.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.42 -65.5 4.11 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.784 1.183 . . . . 0.0 112.916 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -58.91 125.89 79.2 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.243 1.417 . . . . 0.0 112.22 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.74 127.37 12.26 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.241 2.628 . . . . 0.0 111.252 170.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.5 mtm -62.26 111.87 2.16 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.203 1.001 . . . . 0.0 111.401 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -93.2 91.56 7.33 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.362 1.465 . . . . 0.0 109.104 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 15.6 mt -89.91 138.54 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.425 1.09 . . . . 0.0 110.432 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -128.39 137.46 51.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.663 1.985 . . . . 0.0 110.875 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -170.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -85.86 116.23 23.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.897 1.279 . . . . 0.0 109.316 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.39 101.16 7.96 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.51 1.924 . . . . 0.0 109.095 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.3 tp -83.47 133.1 34.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.26 1.824 . . . . 0.0 109.985 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.3 81.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.847 2.059 . . . . 0.0 108.419 -173.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.6 m -79.72 158.14 27.0 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.72 1.208 . . . . 0.0 112.491 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.1 t30 57.89 64.65 1.48 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.381 1.872 . . . . 0.0 113.212 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.3 mt -98.38 -116.01 0.14 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.696 1.998 . . . . 0.0 108.738 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -149.34 148.27 29.31 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.313 1.845 . . . . 0.0 110.436 172.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -74.16 71.59 1.67 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.921 1.688 . . . . 0.0 111.442 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 152.19 7.69 0.11 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.388 1.47 . . . . 0.0 116.168 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.1 t -58.35 128.8 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.485 1.643 . . . . 0.0 110.513 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.2 m -70.06 147.51 49.95 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.322 1.049 . . . . 0.0 112.46 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.86 -57.86 10.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.508 0.723 . . . . 0.0 111.651 174.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.51 -39.32 67.48 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.886 1.275 . . . . 0.0 113.239 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.65 -58.16 9.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.111 0.964 . . . . 0.0 112.039 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.8 mm -56.73 -52.28 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.438 1.095 . . . . 0.0 111.407 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -48.56 -57.54 6.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.862 1.665 . . . . 0.0 111.549 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.17 -49.28 76.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.725 1.21 . . . . 0.0 113.229 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.34 -43.41 97.8 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.671 1.123 . . . . 0.0 112.167 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -63.09 -43.96 97.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.224 0.61 . . . . 0.0 112.312 172.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.44 -19.84 63.9 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.28 -61.54 1.73 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.971 -1.081 . . . . 0.0 111.887 173.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -80.41 -25.58 38.97 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.08 -175.05 13.61 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.334 1.445 . . . . 0.0 113.53 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.6 m -127.13 122.58 34.61 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.052 . . . . 0.0 110.99 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.4 142.02 51.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.648 1.179 . . . . 0.0 113.651 -170.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.52 -44.43 19.12 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.285 2.234 . . . . 0.0 110.953 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -148.47 151.7 35.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.975 0.91 . . . . 0.0 112.695 -175.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.54 150.5 42.22 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.669 1.587 . . . . 0.0 111.637 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.23 154.98 39.9 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.36 1.864 . . . . 0.0 111.766 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 124.427 1.091 . . . . 0.0 112.284 -174.772 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.01 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.4 m -157.67 152.07 24.86 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.928 2.491 . . . . 0.0 109.057 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -126.84 166.17 17.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.213 1.405 . . . . 0.0 111.991 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.45 133.77 23.11 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.453 1.501 . . . . 0.0 110.098 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.5 t -133.34 122.6 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.357 1.463 . . . . 0.0 109.877 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -91.55 110.03 21.34 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.488 -0.758 . . . . 0.0 109.912 169.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -80.84 149.7 29.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.047 2.139 . . . . 0.0 111.783 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.35 -19.96 63.85 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -139.05 128.57 24.45 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.542 1.937 . . . . 0.0 111.389 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -57.08 -49.23 76.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.042 1.737 . . . . 0.0 111.839 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.94 -44.57 70.75 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.489 1.116 . . . . 0.0 112.757 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -64.61 -39.66 94.12 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.66 1.184 . . . . 0.0 112.46 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.84 -45.64 91.76 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.175 0.59 . . . . 0.0 111.689 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.19 -46.67 88.92 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.335 1.454 . . . . 0.0 111.572 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -48.46 -53.87 16.33 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.005 1.722 . . . . 0.0 111.651 171.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.0 -47.95 81.48 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.883 0.873 . . . . 0.0 112.707 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 17.2 ttp -52.13 -60.56 3.05 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.537 1.535 . . . . 0.0 111.833 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.99 -36.25 80.93 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.677 0.791 . . . . 0.0 113.113 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -64.43 -44.54 90.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.351 1.06 . . . . 0.0 113.43 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.18 -15.83 14.57 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -169.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -60.8 113.11 2.32 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.204 1.366 . . . . 0.0 111.952 174.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.91 -21.91 32.91 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.852 1.692 . . . . 0.0 114.343 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.8 132.03 92.51 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 118.626 1.213 . . . . 0.0 110.533 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.56 145.83 18.74 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.954 2.436 . . . . 0.0 113.374 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.7 tp -135.54 115.1 12.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.196 2.198 . . . . 0.0 108.612 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 38.66 62.34 1.05 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.385 1.874 . . . . 0.0 113.57 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.59 2.16 90.6 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.282 1.42 . . . . 0.0 116.218 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -131.08 123.33 19.77 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.798 1.639 . . . . 0.0 112.155 -170.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.45 122.02 7.94 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.978 2.452 . . . . 0.0 111.225 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.5 mtm -64.21 130.49 44.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.261 1.025 . . . . 0.0 110.811 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -116.24 114.73 24.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.161 1.385 . . . . 0.0 109.427 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.8 mm -108.07 138.66 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.552 0.741 . . . . 0.0 111.273 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -135.99 140.81 44.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.918 1.687 . . . . 0.0 110.472 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.2 tt . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 125.166 1.386 . . . . 0.0 110.542 -170.632 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -137.43 131.03 31.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.2 1.0 . . . . 0.0 112.292 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -115.91 155.28 28.25 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.248 1.819 . . . . 0.0 110.465 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.5 tp -130.82 94.14 3.56 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.115 1.766 . . . . 0.0 106.976 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -69.7 127.49 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.8 m -128.91 171.31 12.43 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.128 1.371 . . . . 0.0 111.495 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.5 t30 58.79 30.3 19.87 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.258 1.823 . . . . 0.0 113.615 -169.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.47 162.61 26.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.529 1.131 . . . . 0.0 109.385 169.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -83.04 157.86 22.72 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.264 -0.897 . . . . 0.0 113.098 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -54.25 -37.22 64.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.599 1.159 . . . . 0.0 112.155 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.29 8.87 78.75 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.173 1.368 . . . . 0.0 116.318 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.2 130.72 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.762 1.781 . . . . 0.0 110.454 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.4 m -82.61 138.91 34.05 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.504 1.122 . . . . 0.0 112.302 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -56.78 -55.25 36.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.338 1.455 . . . . 0.0 113.395 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.46 80.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.899 0.88 . . . . 0.0 113.11 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.88 -51.39 70.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.826 0.851 . . . . 0.0 112.009 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.74 -52.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.263 1.025 . . . . 0.0 111.275 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -51.22 -55.28 18.86 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.745 0.818 . . . . 0.0 112.052 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.48 -50.73 72.68 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.678 1.191 . . . . 0.0 113.12 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.48 -45.27 91.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.379 0.991 . . . . 0.0 112.413 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -63.16 -40.89 98.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.836 0.744 . . . . 0.0 112.466 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.9 -13.21 61.46 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -71.81 -62.23 1.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.989 -1.069 . . . . 0.0 111.113 172.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -78.54 -35.46 46.1 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.61 173.18 15.47 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.489 1.518 . . . . 0.0 113.372 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.7 m -119.99 112.87 19.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.066 1.346 . . . . 0.0 109.432 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -135.07 151.6 50.91 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -169.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -73.6 -53.97 9.26 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.512 1.925 . . . . 0.0 110.426 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -154.05 153.17 31.44 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.4 139.46 45.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.529 1.932 . . . . 0.0 109.403 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.13 100.04 3.56 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.588 1.555 . . . . 0.0 111.646 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t . . . . . 0 N--CA 1.477 0.888 0 C-N-CA 125.098 1.359 . . . . 0.0 110.692 170.136 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.863 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 52.6 p -138.24 163.23 32.28 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.824 1.249 . . . . 0.0 113.261 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.4 116.05 9.16 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.086 1.754 . . . . 0.0 111.179 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -73.56 133.74 43.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.139 0.976 . . . . 0.0 108.74 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.4 t -136.07 123.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.942 0.897 . . . . 0.0 109.874 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -109.47 112.94 25.34 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.418 1.487 . . . . 0.0 109.759 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -90.28 158.61 17.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.92 2.488 . . . . 0.0 112.944 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.22 -41.44 85.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.305 0.642 . . . . 0.0 112.357 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -132.2 134.73 45.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.868 1.667 . . . . 0.0 111.196 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -66.64 -28.93 68.87 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.17 -46.75 88.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.999 0.92 . . . . 0.0 111.301 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.48 -40.98 96.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.205 1.002 . . . . 0.0 112.361 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.24 -58.22 7.82 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.343 1.057 . . . . 0.0 111.536 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -53.12 -48.38 67.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.032 1.733 . . . . 0.0 112.077 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -52.24 -55.87 18.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.745 1.218 . . . . 0.0 111.814 173.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.01 -46.03 75.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.5 1.12 . . . . 0.0 112.625 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -52.42 -62.8 1.41 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.169 1.388 . . . . 0.0 110.812 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.27 -36.51 77.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -66.67 -44.27 82.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.249 1.02 . . . . 0.0 113.467 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -105.63 -15.12 15.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -61.85 105.59 0.58 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.662 1.119 . . . . 0.0 110.519 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.21 -21.87 9.9 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.748 2.118 . . . . 0.0 114.298 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.5 t -79.26 131.85 64.6 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 118.653 1.227 . . . . 0.0 111.695 -170.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.52 138.87 66.54 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.465 3.443 . . . . 0.0 115.457 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -138.42 103.31 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.045 2.138 . . . . 0.0 106.371 169.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 52.78 60.42 3.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.512 1.525 . . . . 0.0 111.288 -168.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.76 -64.88 4.14 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.548 1.547 . . . . 0.0 113.178 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -62.03 135.77 94.91 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.818 1.647 . . . . 0.0 112.711 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.82 131.49 12.29 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.339 2.692 . . . . 0.0 112.238 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.3 mtm -62.88 132.56 52.54 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.96 0.904 . . . . 0.0 110.917 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -118.44 115.57 24.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.608 1.163 . . . . 0.0 108.459 171.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.6 mt -105.84 126.62 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.901 0.858 . . . . 0.0 112.215 -169.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -99.13 150.44 22.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.099 2.16 . . . . 0.0 109.483 169.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 124.52 1.128 . . . . 0.0 112.797 -179.361 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -81.76 93.66 6.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.994 0.918 . . . . 0.0 109.588 172.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -89.42 101.14 13.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.966 1.306 . . . . 0.0 108.795 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.7 tp -89.95 127.59 36.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.36 1.864 . . . . 0.0 109.816 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.62 127.83 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.472 1.509 . . . . 0.0 108.859 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.0 m -128.24 168.59 15.25 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.468 1.907 . . . . 0.0 111.066 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.3 t30 59.16 51.79 6.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.996 1.719 . . . . 0.0 112.555 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.4 mt -95.48 172.82 7.84 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.715 1.606 . . . . 0.0 110.287 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -139.84 158.01 44.79 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.204 -0.935 . . . . 0.0 112.779 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -57.48 104.03 0.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.688 1.195 . . . . 0.0 110.874 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.8 -45.25 0.62 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.696 2.093 . . . . 0.0 109.474 -169.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.6 t -64.39 134.79 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.238 1.015 . . . . 0.0 108.832 169.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 61.1 m -121.74 153.76 37.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.513 1.125 . . . . 0.0 112.155 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.28 -56.73 12.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.95 1.7 . . . . 0.0 112.542 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.56 -37.78 82.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.592 1.157 . . . . 0.0 113.319 174.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -63.3 -51.7 64.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.8 0.84 . . . . 0.0 111.551 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.5 mm -54.21 -52.91 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.405 1.082 . . . . 0.0 111.221 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -51.33 -53.94 31.16 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.109 0.963 . . . . 0.0 112.323 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -60.58 -51.46 69.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.689 1.195 . . . . 0.0 113.252 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -63.6 -44.28 94.45 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.164 0.893 . . . . 0.0 112.182 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -62.69 -43.71 98.12 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.61 67.96 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.57 -53.69 52.91 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.097 0.959 . . . . 0.0 112.789 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -95.93 -16.14 21.93 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -140.59 164.36 26.34 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.019 1.295 . . . . 0.0 114.414 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -104.26 111.17 23.68 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.924 1.29 . . . . 0.0 110.943 -172.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -129.3 145.66 51.33 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.49 1.116 . . . . 0.0 113.323 -171.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -87.63 -39.39 15.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.029 1.732 . . . . 0.0 111.1 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -144.26 146.85 32.89 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.469 1.108 . . . . 0.0 112.126 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -146.96 123.41 11.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.135 1.374 . . . . 0.0 110.818 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.22 155.73 42.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.701 1.2 . . . . 0.0 112.989 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 126.804 2.042 . . . . 0.0 110.207 178.074 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 N-CA-C 112.098 -0.401 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.7 m -146.96 148.98 32.3 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.157 1.383 . . . . 0.0 110.82 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.66 154.48 46.42 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.593 1.557 . . . . 0.0 111.647 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -128.48 124.63 36.61 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.656 1.583 . . . . 0.0 109.907 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.09 110.09 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 125.193 1.397 . . . . 0.0 108.683 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -82.47 92.62 7.09 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.998 1.319 . . . . 0.0 108.5 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -70.6 150.13 46.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.794 1.638 . . . . 0.0 111.265 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -74.82 -27.93 60.49 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 34.7 mtm105 -135.99 138.84 42.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.241 1.817 . . . . 0.0 111.16 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -67.08 -44.13 80.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.72 1.608 . . . . 0.0 112.086 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.12 -46.85 68.92 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.677 0.791 . . . . 0.0 112.319 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.56 -44.61 96.72 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.774 1.63 . . . . 0.0 112.26 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.77 87.69 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.183 0.993 . . . . 0.0 112.878 170.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.2 -38.81 84.45 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.557 1.543 . . . . 0.0 112.428 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -49.3 -61.89 1.84 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.531 1.133 . . . . 0.0 110.059 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.38 -47.54 72.56 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.806 1.242 . . . . 0.0 112.598 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -51.51 -61.2 2.39 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.415 1.486 . . . . 0.0 111.437 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -60.16 -44.75 94.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.921 0.888 . . . . 0.0 112.388 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.29 -44.25 92.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.258 1.423 . . . . 0.0 113.387 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -109.14 -14.56 14.49 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -60.27 115.68 3.69 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.48 1.491 . . . . 0.0 111.305 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.77 55.51 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.826 1.679 . . . . 0.0 114.546 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.29 130.68 79.56 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 118.9 1.35 . . . . 0.0 110.852 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.43 135.69 69.47 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.764 2.976 . . . . 0.0 114.9 174.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.1 tp -142.02 113.76 7.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.553 1.941 . . . . 0.0 108.184 169.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 49.4 61.42 3.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.405 1.482 . . . . 0.0 111.398 -169.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.58 -61.54 4.62 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.363 1.459 . . . . 0.0 113.364 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -67.26 140.24 95.31 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 125.319 1.447 . . . . 0.0 113.719 -172.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -73.15 125.92 10.71 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.99 2.46 . . . . 0.0 110.453 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 74.6 mtm -63.5 127.8 32.94 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.366 1.067 . . . . 0.0 111.849 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -105.16 119.32 38.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.566 1.146 . . . . 0.0 109.326 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.4 mt -118.94 139.85 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.939 . . . . 0.0 112.312 -169.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -134.37 147.5 50.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.405 2.282 . . . . 0.0 110.196 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 51.6 tp . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 124.78 1.232 . . . . 0.0 111.235 -176.979 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.174 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -74.36 130.28 39.37 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.072 0.936 . . . . 0.0 110.827 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.34 124.74 23.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.906 2.082 . . . . 0.0 109.317 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.4 tp -114.56 108.02 16.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.662 1.585 . . . . 0.0 110.488 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.6 t -92.07 129.52 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.328 1.451 . . . . 0.0 108.874 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.5 m -134.81 173.25 11.9 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.006 1.722 . . . . 0.0 111.87 -175.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.7 t30 55.51 35.8 25.85 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.304 1.841 . . . . 0.0 113.192 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.73 168.94 19.14 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.649 1.179 . . . . 0.0 110.428 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -65.96 155.23 37.17 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.23 -0.918 . . . . 0.0 111.679 171.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -50.99 -28.34 9.72 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.764 2.025 . . . . 0.0 114.697 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -145.69 55.57 0.54 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-N 119.151 0.887 . . . . 0.0 115.019 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.99 136.77 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 118.085 0.943 . . . . 0.0 109.766 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 52.1 m -69.83 138.31 52.5 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.582 -0.699 . . . . 0.0 112.134 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -60.31 -53.57 56.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.524 1.129 . . . . 0.0 112.648 -174.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.92 83.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.448 1.099 . . . . 0.0 112.688 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -56.51 -53.39 58.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.856 0.862 . . . . 0.0 112.248 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.2 mm -56.83 -53.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.845 0.858 . . . . 0.0 111.458 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -53.15 -53.76 45.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.015 0.526 . . . . 0.0 112.116 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.01 -50.47 73.96 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.945 1.298 . . . . 0.0 113.054 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.48 -46.35 90.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.653 1.115 . . . . 0.0 111.914 -176.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.85 -43.08 97.21 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.94 -21.09 66.77 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.98 -58.78 5.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.96 -1.087 . . . . 0.0 111.892 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -82.31 -35.58 27.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -110.12 161.77 12.84 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.585 1.564 . . . . 0.0 114.185 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.8 m -106.09 101.81 11.27 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.878 1.671 . . . . 0.0 109.68 -174.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -137.08 153.99 50.43 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -169.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -85.94 -50.96 6.68 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.642 2.377 . . . . 0.0 111.486 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.71 150.63 33.49 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.274 1.03 . . . . 0.0 113.07 -170.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.38 138.16 32.81 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 110.787 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.79 107.16 5.01 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.937 1.295 . . . . 0.0 112.23 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 125.898 1.679 . . . . 0.0 111.009 173.38 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.081 0 CA-C-O 120.016 -0.324 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.6 m -147.38 145.3 29.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.698 1.199 . . . . 0.0 111.438 -173.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -137.41 126.49 24.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.915 1.286 . . . . 0.0 111.735 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -93.45 126.85 38.81 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.052 1.341 . . . . 0.0 109.795 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.9 t -131.24 136.09 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.554 1.542 . . . . 0.0 110.164 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -118.05 98.85 6.53 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.212 1.805 . . . . 0.0 108.779 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -75.86 158.73 31.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.474 1.51 . . . . 0.0 111.938 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -70.41 -27.32 64.19 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.774 -0.579 . . . . 0.0 112.296 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -142.91 135.0 27.18 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.564 1.546 . . . . 0.0 112.674 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -53.87 -40.5 66.62 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.48 2.312 . . . . 0.0 112.518 170.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.33 -47.44 62.68 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.281 1.032 . . . . 0.0 112.656 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -71.26 -38.01 71.92 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.275 -0.89 . . . . 0.0 112.937 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.67 -47.08 74.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.77 0.828 . . . . 0.0 111.834 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.1 -48.12 79.4 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.382 1.473 . . . . 0.0 113.036 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -52.28 -53.33 45.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.264 1.026 . . . . 0.0 111.842 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.03 -50.34 69.32 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.199 0.999 . . . . 0.0 112.445 174.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -53.03 -63.15 1.24 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.137 1.775 . . . . 0.0 111.506 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -59.99 -36.85 78.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.693 0.797 . . . . 0.0 113.026 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -66.89 -52.16 46.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.747 1.219 . . . . 0.0 112.857 176.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -96.17 -16.3 21.56 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 -169.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -59.32 109.74 0.94 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 120.154 1.343 . . . . 0.0 111.178 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 113.25 -24.74 12.1 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 126.254 1.883 . . . . 0.0 114.231 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.35 133.69 89.22 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.873 1.269 . . . . 0.0 110.66 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.68 148.88 33.27 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.946 2.431 . . . . 0.0 113.12 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 42.2 tp -128.87 94.73 3.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.4 1.88 . . . . 0.0 109.194 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 46.56 50.65 12.68 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.442 1.897 . . . . 0.0 112.931 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 114.94 -78.3 0.27 Allowed Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.065 1.793 . . . . 0.0 112.779 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.35 135.7 75.99 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 126.328 1.851 . . . . 0.0 113.351 -176.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.06 126.83 10.85 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.096 2.531 . . . . 0.0 111.207 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.5 mtm -63.66 128.72 37.09 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.613 0.765 . . . . 0.0 110.135 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -116.61 119.91 37.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.341 1.056 . . . . 0.0 109.502 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -117.55 139.93 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.198 0.999 . . . . 0.0 111.749 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -131.27 144.54 51.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.93 2.092 . . . . 0.0 110.539 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 CA--C 1.545 0.754 0 C-N-CA 124.591 1.157 . . . . 0.0 110.426 175.812 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.172 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.01 154.65 44.21 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.625 1.712 . . . . 0.0 114.29 -178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.8 mt -120.97 118.69 30.51 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.86 2.064 . . . . 0.0 110.43 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.7 tp -82.45 109.04 16.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.0 t -92.22 83.26 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.103 1.761 . . . . 0.0 107.707 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.3 m -80.25 155.3 27.39 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.727 0.811 . . . . 0.0 112.101 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.28 79.12 0.23 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.762 2.025 . . . . 0.0 113.0 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -127.91 144.97 51.09 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.281 2.232 . . . . 0.0 109.641 171.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -77.2 151.39 35.24 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.84 -0.538 . . . . 0.0 112.358 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -57.87 -24.28 56.87 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.905 0.882 . . . . 0.0 113.337 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.85 -15.48 78.17 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 125.151 1.358 . . . . 0.0 115.792 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.21 123.21 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.585 1.693 . . . . 0.0 110.925 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 54.4 m -77.95 146.48 35.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.771 1.228 . . . . 0.0 111.982 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.78 -52.46 65.62 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.869 0.867 . . . . 0.0 112.013 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.28 62.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.753 1.221 . . . . 0.0 113.363 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.08 -55.51 34.13 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.978 0.911 . . . . 0.0 112.285 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.6 mm -55.8 -53.31 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.882 1.273 . . . . 0.0 111.082 172.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -48.97 -55.77 10.89 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.134 1.774 . . . . 0.0 111.696 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.61 -49.32 75.69 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.626 1.17 . . . . 0.0 113.379 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.23 -44.62 94.74 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.81 1.186 . . . . 0.0 112.204 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -62.09 -41.91 98.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.724 0.693 . . . . 0.0 112.227 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.29 -15.72 62.81 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.21 -60.1 2.4 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.878 -1.139 . . . . 0.0 111.533 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -81.31 -31.34 33.59 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.88 -177.57 15.23 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.644 1.592 . . . . 0.0 113.104 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.5 m -124.52 122.74 38.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.763 1.225 . . . . 0.0 110.057 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -132.37 146.94 52.33 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -78.49 -49.13 13.95 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.514 2.325 . . . . 0.0 110.986 171.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -148.12 146.11 28.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.49 1.516 . . . . 0.0 112.298 -170.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -132.47 139.67 48.07 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.245 1.818 . . . . 0.0 109.37 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.25 100.06 3.41 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.482 1.513 . . . . 0.0 111.695 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 N--CA 1.48 1.03 0 C-N-CA 125.253 1.421 . . . . 0.0 110.709 171.224 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.49 0 CA-C-O 121.494 0.496 . . . . 0.0 113.053 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.7 m -160.48 158.68 29.75 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.476 2.71 . . . . 0.0 108.473 -171.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.17 166.49 21.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.5 1.12 . . . . 0.0 112.651 174.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -125.52 129.49 49.86 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.541 1.936 . . . . 0.0 109.396 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.98 115.06 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.681 1.192 . . . . 0.0 109.058 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -100.57 112.65 25.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.579 1.551 . . . . 0.0 109.647 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -84.23 163.45 19.68 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.076 2.55 . . . . 0.0 113.29 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.5 -45.04 89.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.795 0.838 . . . . 0.0 111.653 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.4 mmt-85 -137.88 141.76 40.68 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.706 1.602 . . . . 0.0 111.328 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -60.09 -34.3 73.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.764 1.626 . . . . 0.0 113.284 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.88 -51.36 69.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.247 1.019 . . . . 0.0 112.243 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.63 -40.68 95.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.004 0.921 . . . . 0.0 112.083 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.17 -54.59 37.7 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.389 1.075 . . . . 0.0 112.007 170.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 67.4 tp -53.28 -49.93 65.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.173 1.389 . . . . 0.0 112.783 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -53.03 -51.43 61.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.001 1.32 . . . . 0.0 112.173 175.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.08 78.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.012 0.925 . . . . 0.0 112.755 172.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 4.7 ttp -54.01 -58.06 8.7 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.945 1.298 . . . . 0.0 112.017 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -33.67 73.37 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -68.23 -45.01 74.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.293 1.037 . . . . 0.0 113.159 176.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -103.7 -13.35 16.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -169.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -60.13 109.78 1.05 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.225 1.375 . . . . 0.0 112.04 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.32 -17.82 39.77 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.993 1.759 . . . . 0.0 114.586 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.98 132.71 86.43 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 118.854 1.327 . . . . 0.0 110.372 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.04 142.25 19.42 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.822 2.348 . . . . 0.0 112.804 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 61.2 tp -135.35 115.67 13.49 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.063 1.745 . . . . 0.0 108.448 169.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 49.24 57.64 6.26 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.364 1.465 . . . . 0.0 111.222 -169.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.68 -56.49 4.75 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.402 1.477 . . . . 0.0 113.303 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -58.15 117.51 20.36 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 127.349 2.259 . . . . 0.0 113.835 -173.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -60.02 118.21 5.06 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.356 2.704 . . . . 0.0 110.879 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.7 mtm -70.16 116.59 10.69 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.78 0.832 . . . . 0.0 110.862 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.99 94.72 9.41 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.076 0.951 . . . . 0.0 108.806 174.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.6 mm -86.34 129.18 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.323 0.649 . . . . 0.0 109.986 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -125.21 115.53 20.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.96 1.304 . . . . 0.0 111.0 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 CA--C 1.538 0.486 0 C-N-CA 125.64 1.576 . . . . 0.0 110.755 171.224 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.235 0 CA-C-O 121.829 0.683 . . . . 0.0 114.788 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -149.59 133.0 16.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.514 1.926 . . . . 0.0 109.808 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -137.79 105.27 5.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.935 1.694 . . . . 0.0 109.577 -170.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.9 tp -90.2 137.94 31.93 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.753 2.021 . . . . 0.0 110.039 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -130.61 127.48 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.918 1.287 . . . . 0.0 109.578 174.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.9 m -128.1 174.41 9.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.222 1.809 . . . . 0.0 110.872 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.2 t30 58.57 38.31 25.32 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.394 1.478 . . . . 0.0 112.467 -172.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.3 mt -88.73 -155.1 0.32 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.56 1.544 . . . . 0.0 109.497 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -138.96 151.7 47.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.543 1.537 . . . . 0.0 110.883 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -53.46 -24.61 13.32 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.74 -23.54 65.42 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 125.382 1.468 . . . . 0.0 115.234 172.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.35 141.54 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 118.906 1.353 . . . . 0.0 110.523 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 61.6 m -133.1 161.1 35.29 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.68 1.592 . . . . 0.0 111.788 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -53.86 -57.36 11.21 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.881 0.872 . . . . 0.0 113.2 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.61 72.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.828 0.851 . . . . 0.0 113.248 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.01 -55.56 33.41 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.066 0.946 . . . . 0.0 111.855 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.6 mm -55.49 -54.82 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.027 1.331 . . . . 0.0 111.227 172.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -47.9 -56.98 6.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.672 1.989 . . . . 0.0 111.441 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.06 -49.97 73.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.462 1.105 . . . . 0.0 113.259 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -62.41 -44.54 96.18 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.475 1.034 . . . . 0.0 112.07 -175.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -63.88 -43.47 95.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.412 0.685 . . . . 0.0 112.624 173.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.7 -20.93 62.26 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.58 -60.16 2.97 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.076 -1.015 . . . . 0.0 112.019 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -89.63 -21.33 22.86 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -174.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -134.7 -176.9 14.59 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.658 1.599 . . . . 0.0 112.885 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -127.38 129.17 47.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.279 1.032 . . . . 0.0 110.497 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.7 144.77 47.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.627 1.171 . . . . 0.0 113.801 -169.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -73.54 -50.57 20.67 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.938 2.095 . . . . 0.0 110.62 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -150.46 158.62 44.35 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.592 1.157 . . . . 0.0 112.87 -173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.43 155.69 46.88 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.005 1.722 . . . . 0.0 111.089 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.83 154.77 38.95 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.239 2.216 . . . . 0.0 110.672 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.9 t . . . . . 0 N--CA 1.48 1.047 0 C-N-CA 126.225 1.81 . . . . 0.0 110.401 -176.179 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.816 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 m -123.96 145.8 48.92 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.155 1.782 . . . . 0.0 110.969 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.68 150.94 46.73 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.867 2.067 . . . . 0.0 110.339 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -143.28 121.46 12.21 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.42 1.488 . . . . 0.0 110.028 -173.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 52.7 t -122.4 118.39 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.173 1.389 . . . . 0.0 109.514 -173.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -88.53 95.47 10.25 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -69.03 160.49 30.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.543 1.937 . . . . 0.0 112.957 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.78 -51.8 68.18 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.629 -0.669 . . . . 0.0 111.705 169.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.53 148.34 45.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.436 1.494 . . . . 0.0 112.523 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.89 -32.41 71.87 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.58 -49.73 76.37 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.109 0.964 . . . . 0.0 112.459 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.76 -37.91 89.2 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.12 0.968 . . . . 0.0 111.979 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.22 -46.61 85.56 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.874 0.87 . . . . 0.0 112.037 169.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.95 -49.98 72.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.479 1.512 . . . . 0.0 111.493 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -50.08 -54.33 21.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.46 1.504 . . . . 0.0 111.677 174.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.2 75.64 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.29 1.036 . . . . 0.0 112.803 173.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -54.76 -63.26 1.21 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.675 1.19 . . . . 0.0 111.422 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -59.57 -32.77 70.67 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -64.49 -51.09 64.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.693 1.197 . . . . 0.0 113.148 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -106.89 -11.07 15.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -169.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -61.86 117.1 5.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.341 1.428 . . . . 0.0 111.857 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 92.59 -12.44 69.77 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.025 1.298 . . . . 0.0 114.83 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 64.7 t -66.94 135.24 94.08 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 119.205 1.502 . . . . 0.0 109.858 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.3 145.97 31.06 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.793 2.329 . . . . 0.0 112.724 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.5 tp -122.27 92.5 3.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.259 1.824 . . . . 0.0 108.992 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 47.65 50.05 15.62 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.287 1.835 . . . . 0.0 112.715 -169.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 116.07 -75.62 0.27 Allowed Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.114 1.816 . . . . 0.0 112.885 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.61 131.81 85.64 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 126.264 1.826 . . . . 0.0 113.549 -175.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.13 130.09 13.86 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.256 2.638 . . . . 0.0 111.683 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -68.28 114.59 6.88 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.426 1.09 . . . . 0.0 111.401 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -86.16 103.35 14.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.224 1.009 . . . . 0.0 109.349 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.3 mt -99.96 137.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.832 0.853 . . . . 0.0 111.516 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -133.26 152.17 51.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.0 2.52 . . . . 0.0 110.671 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 123.969 0.908 . . . . 0.0 113.274 -169.737 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -134.13 133.62 41.25 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.457 1.129 . . . . 0.0 111.561 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.7 mt -117.04 120.01 37.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.995 1.718 . . . . 0.0 111.302 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.0 tp -84.22 129.29 34.9 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 t -119.4 137.84 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.888 1.275 . . . . 0.0 109.215 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.3 m -136.73 165.99 24.63 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.123 2.169 . . . . 0.0 111.416 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.7 t30 52.95 59.63 4.33 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.493 1.917 . . . . 0.0 113.119 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.9 mt -109.7 147.72 32.65 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.247 1.819 . . . . 0.0 107.92 169.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -78.6 156.43 29.12 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.286 -0.884 . . . . 0.0 112.595 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -52.35 -34.48 47.69 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.702 1.201 . . . . 0.0 112.472 169.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.86 -7.34 87.44 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.217 1.389 . . . . 0.0 116.31 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.93 119.09 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.903 1.852 . . . . 0.0 110.492 177.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.7 m -78.82 147.53 33.2 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.055 1.342 . . . . 0.0 112.844 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.21 -53.62 55.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.471 1.508 . . . . 0.0 112.807 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.17 79.11 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.407 1.083 . . . . 0.0 113.189 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.41 -52.32 66.1 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.934 0.894 . . . . 0.0 112.211 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.8 mm -55.89 -51.81 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.39 1.076 . . . . 0.0 111.342 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -50.48 -54.51 21.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.202 1.001 . . . . 0.0 111.952 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.46 -50.9 72.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.68 1.192 . . . . 0.0 113.32 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.52 -44.75 89.88 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.549 1.068 . . . . 0.0 112.743 -174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -62.62 -39.81 94.98 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.904 0.774 . . . . 0.0 112.209 173.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.25 -2.72 11.32 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 174.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.47 -62.04 1.69 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.819 -1.176 . . . . 0.0 110.779 170.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -76.82 -19.66 57.27 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -139.45 -162.42 9.11 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.442 1.496 . . . . 0.0 111.94 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.08 136.93 42.39 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 118.104 0.952 . . . . 0.0 111.709 175.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.89 147.17 46.3 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.548 1.139 . . . . 0.0 113.472 -170.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.21 -46.54 20.16 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.391 2.276 . . . . 0.0 111.291 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -149.25 145.71 27.23 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.474 1.11 . . . . 0.0 112.611 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.63 143.47 50.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.265 1.826 . . . . 0.0 110.194 169.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.38 99.9 3.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.441 1.496 . . . . 0.0 111.542 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.7 t . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 125.699 1.6 . . . . 0.0 111.59 175.987 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.392 0 CA-C-O 121.231 0.35 . . . . 0.0 113.823 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 81.8 p -142.09 172.65 12.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.762 2.425 . . . . 0.0 112.003 -173.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.08 164.4 38.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.893 1.277 . . . . 0.0 111.584 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -131.2 126.2 34.95 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.999 1.72 . . . . 0.0 109.503 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.85 114.07 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.175 0.99 . . . . 0.0 110.938 -171.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -89.94 104.24 16.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.919 1.687 . . . . 0.0 109.901 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -77.42 150.63 35.0 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.683 2.793 . . . . 0.0 113.108 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -61.84 -36.91 82.59 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 47.1 mtm-85 -135.79 129.67 32.85 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.724 2.01 . . . . 0.0 110.088 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -66.23 -29.86 70.2 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.93 75.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.965 0.906 . . . . 0.0 111.796 170.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -62.73 -39.16 93.2 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.861 1.264 . . . . 0.0 112.137 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.16 37.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.561 1.145 . . . . 0.0 112.068 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 64.9 tp -52.98 -48.55 67.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.261 1.424 . . . . 0.0 112.116 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -51.89 -59.58 4.16 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.534 1.533 . . . . 0.0 111.47 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.52 -48.78 62.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.909 1.283 . . . . 0.0 112.618 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.7 ttp -53.58 -61.83 2.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.296 1.438 . . . . 0.0 111.492 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -62.04 -35.52 78.84 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.94 -56.23 14.52 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.477 1.111 . . . . 0.0 113.181 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -91.9 -13.85 30.57 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -168.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -61.2 107.3 0.73 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.104 1.32 . . . . 0.0 110.531 169.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 114.51 -24.2 11.48 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.306 1.908 . . . . 0.0 114.311 -174.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.83 133.85 86.16 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.765 1.226 . . . . 0.0 110.694 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.3 142.66 21.52 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.846 2.364 . . . . 0.0 113.245 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 42.1 tp -133.76 110.08 9.56 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.779 2.032 . . . . 0.0 108.13 169.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 47.63 60.17 3.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.491 1.517 . . . . 0.0 111.731 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.93 -55.96 5.05 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.177 1.37 . . . . 0.0 113.302 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -59.33 121.78 58.86 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.067 1.747 . . . . 0.0 112.978 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 117.56 5.1 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.492 2.128 . . . . 0.0 110.177 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -64.17 133.43 52.89 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.44 1.096 . . . . 0.0 111.128 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -109.53 124.48 51.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.154 0.981 . . . . 0.0 109.804 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.8 mt -127.13 137.84 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.974 1.31 . . . . 0.0 110.924 -170.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -138.95 123.02 17.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.802 1.641 . . . . 0.0 111.331 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 42.5 tp . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.972 1.309 . . . . 0.0 111.25 171.671 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -147.89 126.89 12.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.099 1.449 . . . . 0.0 111.774 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.7 121.14 44.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.438 1.495 . . . . 0.0 111.608 174.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.0 tp -81.73 128.79 34.35 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 168.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.07 135.81 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.987 1.315 . . . . 0.0 108.388 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.55 170.37 16.19 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.525 1.53 . . . . 0.0 111.43 -176.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.2 t30 56.0 42.5 28.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.503 1.521 . . . . 0.0 112.611 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.0 mt -81.82 150.91 27.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.842 0.857 . . . . 0.0 110.03 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.07 140.26 35.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.513 0.725 . . . . 0.0 111.689 174.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -67.86 88.92 0.27 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.29 1.043 . . . . 0.0 109.539 170.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 156.93 -25.64 0.49 Allowed Glycine 0 CA--C 1.538 1.483 0 C-N-CA 127.073 2.273 . . . . 0.0 112.56 -169.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.1 t -58.3 118.01 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.87 1.268 . . . . 0.0 109.931 170.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 64.7 m -77.44 145.41 37.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.915 0.886 . . . . 0.0 112.714 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.28 -53.34 58.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.376 1.47 . . . . 0.0 112.633 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.18 87.5 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.44 1.096 . . . . 0.0 113.027 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.16 -47.96 83.75 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.622 0.769 . . . . 0.0 112.1 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mm -54.53 -53.19 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.903 0.881 . . . . 0.0 111.063 169.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -52.03 -54.0 35.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.485 0.584 . . . . 0.0 112.265 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.14 -50.72 72.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.712 1.205 . . . . 0.0 113.307 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.59 -45.46 90.28 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.122 0.874 . . . . 0.0 111.928 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -62.8 -44.36 96.37 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.573 0.624 . . . . 0.0 112.384 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.35 -31.52 65.81 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.82 -48.37 81.54 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.305 1.042 . . . . 0.0 112.666 174.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -101.43 -17.16 16.6 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -173.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -141.16 157.43 26.03 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 119.613 1.097 . . . . 0.0 114.25 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.6 m -96.55 109.46 22.05 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.98 1.312 . . . . 0.0 109.736 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.0 143.3 50.02 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.673 1.189 . . . . 0.0 114.001 -169.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.2 -48.64 19.66 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.686 2.394 . . . . 0.0 110.29 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -148.28 147.78 29.71 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.291 1.437 . . . . 0.0 111.933 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.34 122.14 13.5 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.23 1.412 . . . . 0.0 109.795 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.08 138.5 26.71 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.868 0.867 . . . . 0.0 112.671 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 N--CA 1.477 0.905 0 C-N-CA 126.417 1.887 . . . . 0.0 111.082 -174.757 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.336 0 N-CA-C 113.66 0.224 . . . . 0.0 113.66 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.3 p -136.39 167.74 20.77 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.568 1.947 . . . . 0.0 112.006 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.16 170.35 18.63 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.928 -1.108 . . . . 0.0 111.423 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -136.2 121.64 19.39 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.156 1.782 . . . . 0.0 108.676 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.0 t -120.46 114.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.469 1.108 . . . . 0.0 108.925 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -100.33 111.19 23.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.918 2.087 . . . . 0.0 108.719 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -92.12 167.25 12.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.49 2.716 . . . . 0.0 113.165 -174.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -61.98 -54.13 45.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.741 0.816 . . . . 0.0 111.139 169.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -141.02 147.29 38.45 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.06 1.744 . . . . 0.0 112.038 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -54.43 -30.35 52.31 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.894 1.678 . . . . 0.0 114.211 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.7 -55.1 36.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.418 1.087 . . . . 0.0 112.496 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.44 -36.15 80.63 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.638 -0.664 . . . . 0.0 112.303 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.76 -54.91 38.63 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.246 1.018 . . . . 0.0 111.891 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.7 mt -53.99 -47.68 71.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.125 1.37 . . . . 0.0 112.505 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -50.68 -58.35 6.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.95 1.3 . . . . 0.0 111.534 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.87 -49.1 69.25 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.727 1.211 . . . . 0.0 112.628 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 53.4 ttp -53.22 -59.26 4.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.511 1.524 . . . . 0.0 111.779 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -25.53 68.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -75.0 -48.77 22.45 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.983 0.913 . . . . 0.0 113.195 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -102.37 -11.59 18.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 -169.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -59.06 116.7 4.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.028 1.285 . . . . 0.0 111.403 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 100.89 -13.3 59.15 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.788 1.661 . . . . 0.0 114.732 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.7 t -71.47 128.58 89.82 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 119.258 1.529 . . . . 0.0 110.945 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.52 136.87 77.03 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.882 3.054 . . . . 0.0 114.375 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 35.5 tp -139.49 110.57 6.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.861 1.664 . . . . 0.0 108.344 169.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 49.54 60.5 3.74 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.439 1.496 . . . . 0.0 111.536 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.31 -63.64 4.39 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.136 1.351 . . . . 0.0 113.147 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.33 134.78 94.68 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.902 1.281 . . . . 0.0 112.804 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.51 127.14 12.19 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.31 2.673 . . . . 0.0 111.714 172.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -66.02 117.61 8.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.62 1.168 . . . . 0.0 112.094 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -85.49 115.67 23.35 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.2 mt -120.83 132.0 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.643 1.177 . . . . 0.0 110.668 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -144.63 124.77 13.67 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.435 1.494 . . . . 0.0 112.139 -169.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 12.2 tp . . . . . 0 CA--C 1.541 0.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.81 169.716 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -92.48 83.98 5.04 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.123 0.961 . . . . 0.0 109.907 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -80.46 128.7 33.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.19 2.196 . . . . 0.0 109.114 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.6 tp -121.32 109.75 15.29 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.643 1.577 . . . . 0.0 110.307 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.4 138.71 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.57 1.548 . . . . 0.0 109.11 170.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.6 m -139.06 168.38 19.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.988 2.115 . . . . 0.0 111.494 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.7 t30 55.69 41.39 30.48 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.311 1.845 . . . . 0.0 113.147 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.81 154.73 31.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.286 1.034 . . . . 0.0 110.314 169.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.61 144.98 55.29 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.524 -0.735 . . . . 0.0 111.197 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -73.11 68.99 1.0 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.732 1.213 . . . . 0.0 110.795 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.36 -11.86 0.06 OUTLIER Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.745 1.64 . . . . 0.0 115.587 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.05 119.87 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.72 1.76 . . . . 0.0 110.642 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -72.0 140.62 49.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.255 1.022 . . . . 0.0 112.893 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.85 -47.18 86.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.845 1.258 . . . . 0.0 112.501 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.96 -45.6 74.95 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.461 1.104 . . . . 0.0 112.694 172.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.95 -47.91 84.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.825 0.85 . . . . 0.0 111.991 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mm -53.46 -53.79 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.523 1.129 . . . . 0.0 111.921 170.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -50.7 -57.23 8.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.543 0.737 . . . . 0.0 111.222 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -56.0 -50.46 70.79 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.299 1.04 . . . . 0.0 113.16 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.69 -48.56 71.65 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.995 0.816 . . . . 0.0 112.23 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -63.82 -41.34 97.88 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.78 0.718 . . . . 0.0 112.664 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.58 -10.48 52.29 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -75.42 -60.97 2.07 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.863 -1.148 . . . . 0.0 111.314 172.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -81.26 -30.18 34.16 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.83 -169.76 13.21 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.722 1.63 . . . . 0.0 112.568 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 m -136.94 123.88 21.42 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.587 -0.949 . . . . 0.0 111.703 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 pp -128.63 145.84 51.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.235 1.414 . . . . 0.0 113.439 -170.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -82.48 -47.31 12.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.914 2.086 . . . . 0.0 111.298 173.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -145.89 149.98 35.27 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.391 1.076 . . . . 0.0 112.324 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.58 147.64 37.99 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.054 1.342 . . . . 0.0 111.599 169.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.58 109.58 4.3 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.457 1.503 . . . . 0.0 111.776 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.478 0.935 0 C-N-CA 124.742 1.217 . . . . 0.0 109.716 169.58 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 CA-C-O 120.527 -0.041 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.2 p -140.96 159.27 42.57 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.271 1.428 . . . . 0.0 111.773 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.87 119.59 11.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.714 1.205 . . . . 0.0 111.426 171.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.52 130.95 34.54 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.203 1.001 . . . . 0.0 109.965 172.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.19 117.66 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.681 1.593 . . . . 0.0 109.794 -174.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -87.96 101.23 13.55 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.931 0.892 . . . . 0.0 109.382 171.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -74.29 153.76 39.23 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.984 2.114 . . . . 0.0 112.015 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -62.66 -37.15 85.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 91.1 mmt-85 -141.26 141.21 33.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.51 1.524 . . . . 0.0 111.854 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -58.42 -42.9 88.29 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.572 1.549 . . . . 0.0 113.114 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.23 -51.8 61.0 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.191 0.997 . . . . 0.0 112.697 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.15 -42.28 99.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.195 0.998 . . . . 0.0 112.572 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.5 -47.22 79.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.318 1.047 . . . . 0.0 112.672 170.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.64 -46.99 88.2 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.567 1.547 . . . . 0.0 111.773 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -50.94 -56.44 12.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.818 1.247 . . . . 0.0 111.412 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.49 -50.98 61.66 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.22 1.008 . . . . 0.0 112.599 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 31.2 ttp -52.8 -62.43 1.65 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.754 1.622 . . . . 0.0 111.673 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -62.95 -37.33 86.62 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -65.09 -54.46 29.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.639 1.176 . . . . 0.0 112.557 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -90.59 -14.77 31.81 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -169.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.1 109.32 0.82 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 120.101 1.318 . . . . 0.0 110.923 169.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 116.74 -28.84 7.19 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 126.461 1.982 . . . . 0.0 113.923 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.12 134.2 85.38 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.121 1.368 . . . . 0.0 110.737 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.64 141.74 25.19 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.944 2.429 . . . . 0.0 112.721 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.2 tp -137.08 111.68 8.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.762 1.625 . . . . 0.0 108.734 169.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 50.69 60.16 4.06 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.756 1.622 . . . . 0.0 111.489 -169.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.01 -63.74 4.39 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.1 1.333 . . . . 0.0 113.195 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -63.91 135.03 96.13 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.737 1.215 . . . . 0.0 112.659 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.66 123.63 9.59 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.404 2.736 . . . . 0.0 111.105 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.7 mtm -62.88 129.77 41.88 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.076 0.95 . . . . 0.0 111.214 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -109.12 125.44 52.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.638 1.175 . . . . 0.0 108.291 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.29 138.64 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 118.823 0.738 . . . . 0.0 111.904 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -131.37 153.91 49.16 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.334 2.654 . . . . 0.0 109.978 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.8 tp . . . . . 0 N--CA 1.469 0.5 0 C-N-CA 124.839 1.256 . . . . 0.0 111.041 179.147 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -137.76 136.62 37.46 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.909 0.855 . . . . 0.0 112.671 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.76 141.05 44.43 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.129 0.972 . . . . 0.0 110.9 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.7 tp -110.67 115.51 29.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.917 2.087 . . . . 0.0 106.717 169.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.89 135.26 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.436 1.095 . . . . 0.0 110.017 -169.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 55.0 m -139.23 161.86 36.39 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.061 1.745 . . . . 0.0 112.246 -174.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.4 t30 51.11 43.26 29.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.294 2.238 . . . . 0.0 114.658 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.1 mt -78.69 164.87 24.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.264 1.426 . . . . 0.0 108.862 168.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.08 159.48 33.53 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.717 -1.239 . . . . 0.0 112.633 169.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -64.55 -41.4 96.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.585 1.554 . . . . 0.0 112.629 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.6 53.04 2.7 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.48 1.514 . . . . 0.0 112.791 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.5 t -116.11 113.74 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 126.038 1.735 . . . . 0.0 109.795 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -72.8 142.29 48.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.242 1.017 . . . . 0.0 112.26 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -56.65 -54.94 40.32 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.468 1.507 . . . . 0.0 112.316 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.31 -34.94 74.5 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.371 1.068 . . . . 0.0 113.567 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.48 -52.74 63.24 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.324 0.965 . . . . 0.0 111.465 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.1 mm -55.0 -52.7 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.343 1.057 . . . . 0.0 110.899 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -50.78 -56.29 12.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.976 0.91 . . . . 0.0 112.105 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -60.14 -48.22 82.62 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.106 1.362 . . . . 0.0 112.963 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -46.61 81.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.415 1.007 . . . . 0.0 112.121 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -60.6 -40.83 93.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.884 0.765 . . . . 0.0 112.048 173.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.5 -6.22 18.67 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -77.35 -59.83 2.62 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.755 -1.216 . . . . 0.0 111.231 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -84.46 -25.54 28.86 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -121.81 -179.58 16.02 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.657 1.599 . . . . 0.0 112.274 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.4 m -123.85 118.58 27.44 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.819 1.247 . . . . 0.0 110.223 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.76 165.08 26.76 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -169.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -93.25 -58.19 2.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.743 2.017 . . . . 0.0 111.176 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -157.93 142.67 16.42 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.408 1.083 . . . . 0.0 113.369 -172.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -105.64 155.71 18.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.658 1.183 . . . . 0.0 111.67 169.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -144.08 88.25 1.95 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.201 1.8 . . . . 0.0 110.1 173.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.476 0.857 0 C-N-CA 125.589 1.556 . . . . 0.0 110.743 178.091 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 CA-C-O 120.365 -0.131 . . . . 0.0 113.232 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.3 p -141.64 164.17 30.94 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.095 1.758 . . . . 0.0 110.967 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.1 167.26 30.44 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.231 -0.918 . . . . 0.0 112.693 169.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -130.84 132.73 45.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.417 1.887 . . . . 0.0 108.717 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.8 t -135.38 109.01 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 118.93 0.786 . . . . 0.0 111.148 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -73.84 123.35 24.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.118 1.367 . . . . 0.0 110.31 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.0 161.02 17.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.9 2.48 . . . . 0.0 112.92 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -59.19 -48.28 82.21 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.844 0.858 . . . . 0.0 112.577 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -143.2 152.73 42.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.364 1.866 . . . . 0.0 110.471 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -59.92 -43.94 94.62 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.186 0.994 . . . . 0.0 112.631 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.83 -46.58 71.22 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.357 1.063 . . . . 0.0 112.905 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.58 -48.44 79.42 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.211 1.404 . . . . 0.0 111.648 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.01 -48.33 73.51 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.195 1.398 . . . . 0.0 112.637 172.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.9 tp -53.29 -42.03 66.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.734 1.614 . . . . 0.0 113.101 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -51.2 -59.94 3.65 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.502 1.121 . . . . 0.0 111.437 171.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.9 -48.88 69.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.273 1.429 . . . . 0.0 112.482 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 21.0 ttp -51.6 -61.34 2.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.011 1.724 . . . . 0.0 111.563 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -56.36 -45.86 80.26 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.461 1.504 . . . . 0.0 112.353 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -58.4 -51.18 70.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.49 1.116 . . . . 0.0 113.176 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -97.73 -16.62 19.82 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -172.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -58.33 109.26 0.74 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 120.332 1.424 . . . . 0.0 111.388 171.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.56 -26.5 8.06 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.278 1.894 . . . . 0.0 114.041 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.78 135.0 95.35 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.065 1.346 . . . . 0.0 111.044 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.33 134.19 15.41 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.923 2.416 . . . . 0.0 111.708 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 63.5 tp -125.13 102.13 7.34 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.351 1.86 . . . . 0.0 108.196 175.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 44.32 62.04 2.16 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.005 1.722 . . . . 0.0 111.763 -169.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.83 -60.88 4.42 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.105 1.336 . . . . 0.0 112.995 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -60.46 118.94 38.76 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.858 1.663 . . . . 0.0 111.993 -172.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.07 118.85 5.82 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.902 2.401 . . . . 0.0 111.354 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.9 mtp -59.74 137.95 57.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.652 1.581 . . . . 0.0 112.013 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -121.08 131.51 54.31 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.731 1.212 . . . . 0.0 110.11 170.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.3 mt -131.07 137.35 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.258 1.023 . . . . 0.0 111.065 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -130.29 171.76 12.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 129.34 3.056 . . . . 0.0 109.912 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 171.527 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 CA-C-O 120.08 -0.289 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -83.53 99.33 10.07 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.057 0.928 . . . . 0.0 111.004 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 76.1 mt -75.83 108.83 8.96 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.682 1.193 . . . . 0.0 110.19 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.4 tp -80.66 125.21 29.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.784 1.233 . . . . 0.0 107.8 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.32 131.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.376 1.07 . . . . 0.0 109.135 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.7 m -135.01 168.8 18.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.763 1.625 . . . . 0.0 111.728 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.2 t30 51.65 56.5 7.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.059 1.744 . . . . 0.0 112.438 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.8 mt -101.12 151.7 21.51 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.297 1.839 . . . . 0.0 110.94 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -69.22 142.05 54.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.776 -0.577 . . . . 0.0 110.937 169.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -62.34 -16.84 56.79 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -78.43 -13.44 83.23 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.413 1.482 . . . . 0.0 115.092 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 80.4 t -66.47 136.34 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 119.26 1.53 . . . . 0.0 109.997 172.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 65.4 m -140.9 169.21 18.04 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.551 1.54 . . . . 0.0 112.355 -175.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -46.34 -58.1 4.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.703 2.001 . . . . 0.0 113.693 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.89 -49.45 71.18 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.989 0.916 . . . . 0.0 112.813 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.1 -49.53 76.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.728 1.211 . . . . 0.0 112.31 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mm -54.19 -55.55 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.839 1.255 . . . . 0.0 111.349 171.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -53.19 -53.46 50.27 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.776 0.716 . . . . 0.0 111.685 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -54.51 -51.51 64.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.859 0.864 . . . . 0.0 113.058 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -49.57 72.6 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.857 0.753 . . . . 0.0 112.555 -176.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -67.09 -38.49 85.8 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.72 -20.22 64.69 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.33 -66.45 0.54 Allowed 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.959 -1.088 . . . . 0.0 110.751 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -85.56 -17.93 34.85 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -172.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.57 -159.79 8.49 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.429 1.49 . . . . 0.0 112.862 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.1 m -144.83 133.89 22.69 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.292 1.046 . . . . 0.0 110.996 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.59 146.81 52.19 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.892 1.277 . . . . 0.0 114.365 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -74.39 -52.32 12.46 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.441 1.896 . . . . 0.0 110.194 169.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -149.03 158.84 44.5 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.23 160.67 37.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.072 1.749 . . . . 0.0 110.847 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.89 149.42 23.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.329 1.852 . . . . 0.0 110.699 170.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.48 1.057 0 C-N-CA 123.976 0.91 . . . . 0.0 110.803 176.006 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.131 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.0 p -146.45 150.18 35.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.773 2.029 . . . . 0.0 111.258 -170.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.32 167.87 23.22 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.202 1.801 . . . . 0.0 112.511 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -132.93 131.4 40.8 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.83 2.052 . . . . 0.0 109.668 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.1 t -132.92 109.33 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.529 1.132 . . . . 0.0 109.644 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -90.63 98.98 12.1 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.253 1.421 . . . . 0.0 110.064 -176.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -73.3 155.18 39.72 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.284 1.834 . . . . 0.0 114.249 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -68.72 -45.48 71.44 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.419 1.488 . . . . 0.0 112.088 171.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 -122.38 124.04 42.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.176 1.79 . . . . 0.0 110.325 -169.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -58.6 -47.27 84.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.843 1.257 . . . . 0.0 112.176 175.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.18 -48.31 61.96 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.35 1.06 . . . . 0.0 112.783 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -67.46 -35.43 79.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.679 1.191 . . . . 0.0 112.557 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.31 -45.56 92.95 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.037 0.935 . . . . 0.0 112.353 170.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -53.8 -49.93 67.23 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.709 1.141 . . . . 0.0 111.607 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -51.59 -58.2 7.0 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.409 1.084 . . . . 0.0 111.353 174.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -50.09 -51.93 38.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.106 1.362 . . . . 0.0 112.663 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 60.9 ttp -53.63 -62.69 1.49 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.548 1.539 . . . . 0.0 111.5 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -62.49 -37.58 86.55 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -64.03 -51.04 66.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.234 1.413 . . . . 0.0 112.687 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -99.0 -14.17 19.59 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -169.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -58.83 112.61 1.71 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.154 1.343 . . . . 0.0 111.226 170.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.57 -23.25 26.81 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.054 1.788 . . . . 0.0 114.371 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.7 t -73.15 135.51 79.76 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.887 1.275 . . . . 0.0 110.393 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.53 142.92 26.86 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.952 2.435 . . . . 0.0 113.068 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.5 tp -131.82 106.27 7.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.838 1.655 . . . . 0.0 107.852 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 50.65 61.22 3.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.755 1.622 . . . . 0.0 111.377 -169.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.53 -62.95 4.21 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.135 1.35 . . . . 0.0 113.311 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -65.43 128.49 93.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.844 1.258 . . . . 0.0 112.392 -172.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.91 122.92 9.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.725 2.95 . . . . 0.0 111.897 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.4 mtm -63.18 126.06 26.15 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.065 1.346 . . . . 0.0 111.831 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -103.19 113.5 27.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.986 1.315 . . . . 0.0 109.191 172.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mt -118.37 134.69 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.552 1.141 . . . . 0.0 111.484 -169.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -136.94 153.72 50.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.335 2.254 . . . . 0.0 110.089 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.2 tp . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 124.842 1.257 . . . . 0.0 111.453 -176.381 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.87 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -132.74 152.21 51.8 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.079 0.943 . . . . 0.0 111.957 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -129.05 101.64 6.14 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.137 1.775 . . . . 0.0 108.208 -169.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.6 tp -84.45 133.36 34.49 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.14 1.376 . . . . 0.0 109.394 175.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.5 t -122.05 130.48 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.85 1.26 . . . . 0.0 108.944 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -115.19 159.73 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.968 1.707 . . . . 0.0 110.474 172.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.3 t30 60.74 71.66 0.56 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.307 1.843 . . . . 0.0 112.227 -169.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.5 mt -131.33 154.6 48.39 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.873 2.469 . . . . 0.0 108.964 169.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -88.63 151.27 22.57 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.72 -0.613 . . . . 0.0 112.364 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -58.2 -28.07 64.46 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.187 -0.945 . . . . 0.0 112.294 172.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.97 -17.08 65.0 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.052 1.31 . . . . 0.0 115.467 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.99 116.67 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.419 1.609 . . . . 0.0 110.453 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.5 m -76.31 151.24 36.78 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.698 1.199 . . . . 0.0 111.852 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.51 -50.34 74.11 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.608 -0.683 . . . . 0.0 112.243 172.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 -38.91 59.86 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.06 -56.37 23.17 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.29 1.036 . . . . 0.0 112.231 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 23.6 mm -56.1 -53.89 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.197 1.399 . . . . 0.0 111.157 173.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -47.3 -57.77 4.86 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.829 2.052 . . . . 0.0 111.47 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -59.92 -50.97 71.7 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.506 1.122 . . . . 0.0 113.122 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.6 -45.2 93.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.402 1.001 . . . . 0.0 112.149 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -63.22 -44.24 95.84 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.433 0.693 . . . . 0.0 112.415 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.13 -18.56 63.57 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -69.46 -60.14 2.52 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.818 -1.176 . . . . 0.0 111.834 173.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -85.44 -22.76 28.15 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.06 -167.31 11.2 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.681 1.61 . . . . 0.0 112.735 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.2 m -136.81 129.3 30.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.082 0.953 . . . . 0.0 111.078 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.8 pp -130.06 144.49 51.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.88 1.272 . . . . 0.0 113.376 -169.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -75.17 -50.17 17.13 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.913 2.085 . . . . 0.0 110.497 169.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.94 154.79 38.86 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.78 1.232 . . . . 0.0 112.132 -172.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -138.58 151.72 47.54 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.446 1.499 . . . . 0.0 111.541 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.12 159.21 44.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.678 1.991 . . . . 0.0 110.903 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 124.266 1.026 . . . . 0.0 110.818 -177.494 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 CA-C-O 121.11 0.283 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 37.0 p -142.01 167.71 21.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.67 1.988 . . . . 0.0 113.548 -169.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.7 157.11 43.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.725 2.01 . . . . 0.0 110.618 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -140.14 126.89 20.51 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.982 1.313 . . . . 0.0 110.212 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 52.2 t -122.34 116.03 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.813 1.245 . . . . 0.0 109.033 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -83.32 105.65 14.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.023 1.329 . . . . 0.0 108.19 173.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -82.08 153.33 26.16 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.423 2.289 . . . . 0.0 113.079 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.76 -34.01 77.19 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.987 0.915 . . . . 0.0 113.409 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -138.15 146.34 42.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.486 1.514 . . . . 0.0 113.295 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -64.18 -45.63 87.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.791 1.636 . . . . 0.0 111.782 172.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.03 -49.48 60.42 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.47 1.108 . . . . 0.0 112.265 171.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.35 -40.83 90.08 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.622 1.169 . . . . 0.0 112.792 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.37 -49.4 74.55 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.582 1.153 . . . . 0.0 112.419 170.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 54.6 tp -57.04 -49.76 74.82 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.352 1.461 . . . . 0.0 111.884 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -50.1 -52.85 31.44 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.354 1.461 . . . . 0.0 111.434 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.96 -50.86 69.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.017 0.927 . . . . 0.0 112.519 173.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -54.5 -60.23 3.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.376 1.07 . . . . 0.0 112.17 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -37.19 75.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -69.17 -43.83 73.45 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.161 0.984 . . . . 0.0 112.906 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -108.42 -8.41 15.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -169.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -58.46 116.43 3.64 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 120.054 1.297 . . . . 0.0 111.459 171.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.58 -21.54 44.72 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.869 1.7 . . . . 0.0 114.575 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.28 136.67 88.93 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 118.72 1.26 . . . . 0.0 110.451 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.8 143.57 29.95 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.725 2.284 . . . . 0.0 113.197 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -131.67 106.76 8.36 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.301 2.24 . . . . 0.0 107.015 171.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 48.0 61.67 2.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.336 1.454 . . . . 0.0 111.494 -169.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.39 -53.92 4.71 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.254 1.407 . . . . 0.0 113.483 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -59.47 119.17 37.35 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.522 1.929 . . . . 0.0 112.779 -174.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.54 120.73 7.65 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.619 2.212 . . . . 0.0 110.726 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.5 mtm -67.3 116.96 8.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.982 1.313 . . . . 0.0 112.13 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -89.59 101.43 14.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.264 1.025 . . . . 0.0 108.941 170.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.4 mt -103.89 139.81 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.275 1.03 . . . . 0.0 111.827 -170.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -134.27 126.61 30.13 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.415 1.886 . . . . 0.0 111.191 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 124.769 1.228 . . . . 0.0 109.874 169.647 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 N-CA-C 112.629 -0.188 . . . . 0.0 112.629 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -149.08 130.59 14.84 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.576 -0.955 . . . . 0.0 111.519 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 41.9 mt -119.43 121.24 39.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.018 1.727 . . . . 0.0 111.879 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.9 tp -86.05 116.01 24.0 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 168.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 49.1 t -101.83 131.05 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 108.134 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.2 m -138.78 167.84 21.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.762 1.625 . . . . 0.0 112.318 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.7 t30 52.84 46.88 25.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.005 1.722 . . . . 0.0 112.948 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.9 mt -90.76 164.34 14.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.766 1.227 . . . . 0.0 109.59 169.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.93 150.88 47.93 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.392 -0.817 . . . . 0.0 110.652 169.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -58.07 -20.82 42.48 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -128.78 39.76 1.81 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.879 1.228 . . . . 0.0 115.812 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.58 131.8 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.367 1.583 . . . . 0.0 109.276 169.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.1 m -69.92 138.92 52.81 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.487 0.715 . . . . 0.0 112.344 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.87 -52.16 66.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.068 1.347 . . . . 0.0 112.309 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.87 -40.47 80.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.98 1.312 . . . . 0.0 113.092 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.61 -52.35 65.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.9 0.88 . . . . 0.0 112.127 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.1 mm -55.11 -52.86 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.949 0.9 . . . . 0.0 111.266 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -51.89 -52.45 49.68 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.925 0.89 . . . . 0.0 112.294 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -60.43 -51.97 67.23 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.031 1.332 . . . . 0.0 113.27 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.19 -43.54 97.93 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.337 0.972 . . . . 0.0 112.22 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -62.16 -44.87 95.65 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.533 0.606 . . . . 0.0 112.022 172.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.69 -32.64 67.55 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.62 -47.3 86.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.198 0.999 . . . . 0.0 112.874 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -100.82 -15.86 17.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.92 155.1 25.75 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.641 1.115 . . . . 0.0 114.033 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.7 m -91.53 99.23 12.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.858 1.263 . . . . 0.0 110.006 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 pp -111.47 141.82 44.53 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.296 1.038 . . . . 0.0 113.742 -171.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -82.22 -46.25 13.97 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.153 2.581 . . . . 0.0 110.427 170.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -146.12 144.99 30.34 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.395 1.478 . . . . 0.0 111.481 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.62 121.96 11.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.378 1.471 . . . . 0.0 110.447 171.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.08 139.86 30.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.624 1.17 . . . . 0.0 112.704 -176.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.481 1.091 0 C-N-CA 126.363 1.865 . . . . 0.0 111.159 -173.461 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 N-CA-C 112.159 -0.377 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.9 p -144.16 163.53 33.34 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.759 1.623 . . . . 0.0 111.416 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.73 168.49 20.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.635 1.174 . . . . 0.0 111.405 170.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -135.18 118.81 17.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.162 1.785 . . . . 0.0 108.828 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.61 116.65 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.239 1.016 . . . . 0.0 110.093 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -101.83 124.93 48.29 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.643 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -103.23 154.7 19.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.951 2.9 . . . . 0.0 113.042 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -68.78 -29.75 68.19 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.905 1.282 . . . . 0.0 113.63 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -138.38 136.06 35.94 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.248 1.419 . . . . 0.0 113.018 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.41 -53.55 56.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.403 2.281 . . . . 0.0 112.449 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.44 -45.37 84.78 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.191 1.397 . . . . 0.0 112.415 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.83 -38.91 92.56 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.504 -0.748 . . . . 0.0 112.567 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.96 51.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.282 0.633 . . . . 0.0 111.337 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.26 -50.22 59.65 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.5 1.92 . . . . 0.0 112.334 174.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -50.68 -59.99 3.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.805 1.642 . . . . 0.0 111.206 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.65 -46.47 70.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.381 1.073 . . . . 0.0 112.393 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.5 ttp -52.83 -59.48 4.45 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.957 1.303 . . . . 0.0 111.839 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -55.53 -50.45 69.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.217 1.007 . . . . 0.0 112.273 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -59.03 -46.34 88.46 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.851 1.661 . . . . 0.0 113.115 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -100.81 -14.81 17.85 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -60.53 106.26 0.53 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.001 1.273 . . . . 0.0 111.178 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.33 -27.33 7.37 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 126.569 2.033 . . . . 0.0 114.087 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 64.2 t -68.88 132.77 90.43 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.06 1.344 . . . . 0.0 110.876 -174.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.1 145.87 22.32 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.902 2.401 . . . . 0.0 113.39 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.8 tt -130.5 108.18 9.76 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.111 2.165 . . . . 0.0 107.32 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 44.0 57.04 4.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.936 1.694 . . . . 0.0 112.048 -169.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 87.9 -51.12 4.03 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.985 1.278 . . . . 0.0 113.706 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -62.8 119.38 50.77 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.54 1.536 . . . . 0.0 111.448 -174.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.29 118.55 5.74 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.831 2.354 . . . . 0.0 110.924 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.61 127.34 31.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.091 0.956 . . . . 0.0 110.957 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -100.78 131.11 46.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.524 1.13 . . . . 0.0 109.036 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.1 mm -124.1 135.51 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.788 0.835 . . . . 0.0 109.946 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.22 117.76 19.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.344 1.458 . . . . 0.0 110.674 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 39.7 tp . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 124.754 1.222 . . . . 0.0 110.147 169.967 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.173 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.36 112.79 19.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.709 1.203 . . . . 0.0 111.522 179.029 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.5 117.88 23.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.842 2.457 . . . . 0.0 108.53 178.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.3 tp -105.69 125.62 51.2 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.808 2.043 . . . . 0.0 110.484 -176.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.6 t -112.78 125.44 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.148 1.779 . . . . 0.0 109.195 179.214 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.6 m -120.92 163.08 18.78 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.858 2.063 . . . . 0.0 110.909 177.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.7 t30 51.62 57.0 7.03 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.124 1.369 . . . . 0.0 111.281 -169.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.8 118.73 33.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.522 2.329 . . . . 0.0 107.784 -173.068 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.07 140.99 58.35 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -54.61 -29.02 50.67 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.777 1.631 . . . . 0.0 114.169 -178.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -75.72 -15.89 81.0 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.974 1.273 . . . . 0.0 115.353 177.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.18 122.42 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 119.155 1.478 . . . . 0.0 110.797 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.5 m -79.48 148.36 31.89 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.117 0.967 . . . . 0.0 113.22 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.75 -54.23 48.69 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.305 1.842 . . . . 0.0 112.631 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.65 87.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.035 0.934 . . . . 0.0 112.907 174.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.06 -47.55 84.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.587 0.755 . . . . 0.0 111.939 176.362 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mm -55.03 -52.53 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.035 0.934 . . . . 0.0 111.196 169.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -52.46 -52.2 55.39 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.126 0.571 . . . . 0.0 112.33 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.88 -50.51 73.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.94 1.296 . . . . 0.0 113.46 175.491 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.82 -44.96 91.69 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.394 0.997 . . . . 0.0 112.032 -176.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -61.75 -41.21 97.39 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 173.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.9 -13.58 46.55 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 175.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -74.59 -63.42 1.25 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.861 -1.15 . . . . 0.0 111.481 173.093 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -84.4 -12.78 53.82 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -175.406 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.36 -178.13 18.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.479 1.514 . . . . 0.0 112.942 176.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -126.65 127.49 45.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.984 1.314 . . . . 0.0 109.926 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -134.61 149.66 50.6 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.637 1.175 . . . . 0.0 114.145 -169.281 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -77.68 -49.87 13.62 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.643 1.977 . . . . 0.0 110.407 169.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -149.78 150.83 32.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.687 1.195 . . . . 0.0 113.111 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -127.25 154.53 44.76 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.863 1.665 . . . . 0.0 110.148 168.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.26 153.38 29.04 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.723 1.609 . . . . 0.0 112.068 179.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.481 1.124 0 C-N-CA 126.82 2.048 . . . . 0.0 109.362 174.046 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.898 0 N-CA-C 113.43 0.132 . . . . 0.0 113.43 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.8 p -143.91 154.41 43.31 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.501 1.521 . . . . 0.0 111.617 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.28 159.1 42.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.969 1.307 . . . . 0.0 111.766 173.019 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -144.2 133.75 23.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.876 1.67 . . . . 0.0 110.746 -172.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.86 114.79 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.446 1.098 . . . . 0.0 110.432 -177.364 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -79.46 104.15 9.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.328 1.451 . . . . 0.0 108.874 170.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -82.79 163.59 21.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.159 1.783 . . . . 0.0 113.389 -175.006 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -70.21 -51.48 30.62 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.827 0.851 . . . . 0.0 112.506 169.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -131.26 145.67 51.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.286 1.834 . . . . 0.0 112.354 -172.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -54.88 -56.65 17.21 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.924 2.09 . . . . 0.0 112.814 176.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.24 -47.13 72.58 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.887 1.275 . . . . 0.0 112.422 177.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -61.86 -38.86 89.83 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.459 1.103 . . . . 0.0 112.71 176.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.19 -46.46 80.68 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.458 0.703 . . . . 0.0 112.427 170.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.0 tp -59.12 -42.19 89.98 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.492 1.517 . . . . 0.0 112.147 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -48.0 -60.03 2.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.564 1.546 . . . . 0.0 110.728 169.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.73 -49.04 69.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.989 1.315 . . . . 0.0 112.592 176.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 25.0 ttp -51.81 -60.04 3.63 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.625 1.17 . . . . 0.0 111.643 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.26 -48.4 81.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.76 1.224 . . . . 0.0 112.319 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -58.1 -49.53 76.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.558 1.543 . . . . 0.0 112.993 -178.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -99.92 -12.37 19.87 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -169.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -59.47 110.57 1.14 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.336 1.425 . . . . 0.0 111.194 169.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.36 -23.8 19.61 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.494 1.997 . . . . 0.0 114.172 -175.44 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -74.28 134.41 76.97 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.825 1.25 . . . . 0.0 110.95 -174.16 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.37 139.43 20.84 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.008 2.472 . . . . 0.0 112.719 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.8 tp -136.07 113.7 10.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.508 1.523 . . . . 0.0 108.628 169.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 49.11 61.4 3.15 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.609 1.564 . . . . 0.0 111.2 -169.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.4 -62.48 4.56 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.431 1.491 . . . . 0.0 113.373 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -66.06 128.42 93.82 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.866 1.266 . . . . 0.0 112.907 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.73 116.41 4.65 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.451 2.768 . . . . 0.0 110.868 171.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.6 mtm -65.72 124.94 23.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.651 1.18 . . . . 0.0 111.666 -178.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -98.6 118.14 34.62 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mt -119.38 137.57 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.844 0.858 . . . . 0.0 112.305 -169.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -135.02 155.99 49.82 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.413 2.685 . . . . 0.0 110.032 -175.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 N--CA 1.468 0.447 0 C-N-CA 124.448 1.099 . . . . 0.0 110.797 -177.348 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.162 0 N-CA-C 113.547 0.179 . . . . 0.0 113.547 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -72.05 149.72 44.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.448 1.099 . . . . 0.0 112.112 176.389 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.4 mt -136.33 139.31 42.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 130.107 3.363 . . . . 0.0 108.758 174.163 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 65.7 tp -122.32 118.82 29.39 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.892 1.677 . . . . 0.0 108.607 174.4 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.82 112.25 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.123 1.369 . . . . 0.0 108.709 -169.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -127.62 173.97 9.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.789 1.235 . . . . 0.0 112.54 -169.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.0 t30 52.34 43.12 31.12 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.119 1.767 . . . . 0.0 112.891 -169.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.7 mt -77.36 153.99 33.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.149 0.98 . . . . 0.0 108.566 169.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -68.02 141.98 56.05 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.732 -1.23 . . . . 0.0 109.957 169.319 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -61.55 -19.03 61.68 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.147 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.03 0.54 82.11 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.452 1.501 . . . . 0.0 115.472 174.237 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.07 118.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.733 1.766 . . . . 0.0 110.916 175.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.5 m -71.45 148.03 47.26 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.717 1.207 . . . . 0.0 112.765 178.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -53.63 -54.38 38.55 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.831 1.652 . . . . 0.0 112.846 174.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.89 78.47 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.532 1.133 . . . . 0.0 113.299 177.161 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.85 -51.02 71.79 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.949 0.9 . . . . 0.0 112.364 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.6 mm -56.52 -52.73 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.344 1.057 . . . . 0.0 111.008 171.232 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -51.82 -51.85 53.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.896 0.878 . . . . 0.0 112.414 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.72 -50.06 73.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.199 1.4 . . . . 0.0 113.545 174.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.04 -43.74 98.18 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.878 1.217 . . . . 0.0 112.455 -175.732 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -63.51 -42.5 98.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.557 0.617 . . . . 0.0 112.371 172.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.21 71.25 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 173.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.22 -42.38 86.12 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.448 1.099 . . . . 0.0 113.085 177.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -108.36 -1.63 19.82 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -174.078 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.02 165.25 34.66 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 120.047 1.294 . . . . 0.0 114.628 177.745 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.8 m -101.47 122.94 44.7 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.096 0.958 . . . . 0.0 110.758 -177.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.05 161.9 36.83 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -93.74 -46.82 7.06 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.148 1.779 . . . . 0.0 112.131 175.659 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -141.94 143.31 33.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.295 1.038 . . . . 0.0 112.549 -173.094 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.49 118.11 6.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.808 1.643 . . . . 0.0 109.418 169.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.35 121.6 12.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.966 1.306 . . . . 0.0 112.414 -172.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 125.839 1.656 . . . . 0.0 110.098 170.649 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.725 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.3 m -141.39 143.0 33.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.672 1.589 . . . . 0.0 110.826 -174.409 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.83 139.29 34.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.325 1.45 . . . . 0.0 112.69 176.505 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -93.7 129.94 39.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.573 1.549 . . . . 0.0 109.429 169.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.6 t -133.16 143.59 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.596 1.559 . . . . 0.0 108.878 -177.365 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -145.47 108.24 4.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.755 -1.215 . . . . 0.0 111.006 -173.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -86.19 175.27 8.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.882 2.073 . . . . 0.0 113.628 -171.387 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -91.54 -65.68 0.99 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.743 1.217 . . . . 0.0 110.861 169.529 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -83.12 132.37 35.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.187 1.395 . . . . 0.0 111.89 -176.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -50.42 73.1 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.439 1.496 . . . . 0.0 112.105 179.694 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.36 -45.79 84.01 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.513 1.125 . . . . 0.0 112.246 176.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -63.7 -39.82 95.25 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.022 1.329 . . . . 0.0 112.55 177.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.51 -52.1 67.01 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.163 0.985 . . . . 0.0 111.809 170.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 62.2 tp -54.94 -47.36 74.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.142 0.977 . . . . 0.0 112.057 174.343 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -50.23 -57.18 8.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.633 1.573 . . . . 0.0 111.356 171.675 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -50.87 -46.07 60.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.651 1.18 . . . . 0.0 112.865 176.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 24.4 ttp -57.16 -67.26 0.34 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.688 0.676 . . . . 0.0 111.507 172.16 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -62.67 -36.02 81.54 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -170.272 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -64.18 -42.58 96.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.93 1.292 . . . . 0.0 112.931 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.25 -13.65 14.86 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -169.611 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.65 113.96 2.27 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.776 1.171 . . . . 0.0 111.116 169.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.58 -16.75 54.57 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.909 1.718 . . . . 0.0 114.699 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.44 129.49 85.6 Favored Pre-proline 0 N--CA 1.477 0.912 0 CA-C-N 119.085 1.442 . . . . 0.0 110.813 -176.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.98 140.19 93.05 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.809 3.006 . . . . 0.0 115.1 176.185 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.6 tp -138.28 104.59 5.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.366 2.266 . . . . 0.0 107.539 169.341 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 48.31 62.01 2.74 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.387 1.475 . . . . 0.0 111.718 -169.516 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.69 -59.51 4.95 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.19 1.376 . . . . 0.0 113.214 -179.35 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.5 mtt-85 -60.55 127.67 87.16 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.733 1.613 . . . . 0.0 112.682 -175.591 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.82 122.61 8.66 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.757 2.305 . . . . 0.0 110.756 170.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.5 mtm -61.69 121.61 13.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.099 0.96 . . . . 0.0 111.589 178.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -93.41 103.06 15.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.866 1.266 . . . . 0.0 108.917 174.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -115.83 131.85 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.33 1.052 . . . . 0.0 111.342 -171.078 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -122.54 150.18 42.92 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.647 2.379 . . . . 0.0 109.394 175.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.4 tp . . . . . 0 CA--C 1.548 0.89 0 C-N-CA 124.882 1.273 . . . . 0.0 110.075 174.732 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 112.609 -0.196 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -146.52 138.42 24.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.341 1.056 . . . . 0.0 111.139 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.1 mt -134.67 126.27 28.78 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.709 1.604 . . . . 0.0 112.221 -175.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.7 tp -90.8 124.7 35.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.228 1.411 . . . . 0.0 107.603 169.028 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.71 92.0 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.677 1.591 . . . . 0.0 108.597 -171.007 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.0 m -88.19 167.65 13.42 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.129 1.771 . . . . 0.0 112.581 -177.118 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.0 t30 55.35 66.77 1.14 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.175 2.19 . . . . 0.0 113.447 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.7 mt -116.16 -168.81 1.49 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.582 2.353 . . . . 0.0 110.42 174.685 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.85 150.35 47.82 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.129 -0.982 . . . . 0.0 112.322 173.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -51.01 -40.89 59.23 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.465 1.106 . . . . 0.0 112.977 175.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.27 69.51 0.43 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.479 1.514 . . . . 0.0 111.941 173.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.78 134.48 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.954 1.702 . . . . 0.0 111.855 172.216 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.0 m -85.52 126.25 33.7 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.819 -0.551 . . . . 0.0 110.394 170.408 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.44 -48.46 79.08 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.381 1.072 . . . . 0.0 111.961 179.245 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.17 75.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.278 1.431 . . . . 0.0 113.233 175.102 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.56 -53.16 61.45 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.176 0.991 . . . . 0.0 111.993 178.416 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 47.7 mm -57.34 -53.58 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.63 1.172 . . . . 0.0 111.169 173.087 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -49.47 -54.57 17.04 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.315 1.046 . . . . 0.0 111.553 177.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -61.37 -50.1 74.24 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.023 0.829 . . . . 0.0 112.657 178.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -47.53 85.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.939 0.79 . . . . 0.0 112.31 -176.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -64.91 -46.91 79.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.641 0.655 . . . . 0.0 112.303 175.123 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.99 -35.49 64.41 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -55.54 -45.52 77.2 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.34 1.056 . . . . 0.0 112.98 175.396 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -102.53 -19.36 14.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -175.112 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -152.63 157.68 27.43 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-N 120.096 1.316 . . . . 0.0 114.303 177.143 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.4 m -84.63 95.91 9.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.68 -0.894 . . . . 0.0 111.727 -172.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.21 143.34 29.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.635 0.774 . . . . 0.0 111.809 172.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -85.63 -48.51 8.81 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.575 2.35 . . . . 0.0 110.309 169.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -149.45 149.09 30.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.742 1.217 . . . . 0.0 112.444 -177.687 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -122.77 153.86 38.95 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.094 1.758 . . . . 0.0 110.96 169.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.57 -176.33 5.26 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.696 2.398 . . . . 0.0 110.938 -176.111 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 148' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.875 0 C-N-CA 127.909 2.483 . . . . 0.0 110.099 176.458 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.71 0 CA-C-O 119.894 -0.392 . . . . 0.0 113.606 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.0 m -141.86 113.77 7.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.0 1.32 . . . . 0.0 110.077 176.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . . . -96.79 164.01 12.75 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.159 1.383 . . . . 0.0 111.373 173.445 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -143.4 126.49 16.43 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.57 1.148 . . . . 0.0 110.37 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.4 t -136.6 136.75 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.14 0.976 . . . . 0.0 110.989 -169.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -115.91 138.75 50.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.307 1.843 . . . . 0.0 109.368 178.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -127.39 158.39 37.43 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.149 2.58 . . . . 0.0 113.708 -169.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -64.47 -32.71 74.46 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.483 1.513 . . . . 0.0 114.439 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -135.93 147.56 48.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.088 1.355 . . . . 0.0 112.803 -169.441 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -58.92 -52.75 64.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.444 1.498 . . . . 0.0 111.734 169.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.98 -50.44 64.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.088 1.355 . . . . 0.0 112.195 177.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.65 -51.4 63.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.234 1.414 . . . . 0.0 112.023 175.306 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.76 -50.98 71.9 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.586 0.754 . . . . 0.0 112.429 176.116 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 80.3 mt -58.34 -47.09 84.86 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.474 1.11 . . . . 0.0 112.764 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -54.22 -55.51 27.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.943 1.297 . . . . 0.0 111.582 172.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.32 -52.74 51.46 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.691 1.196 . . . . 0.0 112.561 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 34.8 ttm -50.03 -62.03 1.81 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.665 1.586 . . . . 0.0 111.617 175.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.75 -46.8 88.02 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.121 1.368 . . . . 0.0 112.64 -177.171 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -63.03 -45.4 92.51 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.477 1.111 . . . . 0.0 113.206 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.0 -15.72 17.37 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -169.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -60.66 110.35 1.27 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.969 1.259 . . . . 0.0 110.682 169.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.96 -25.72 11.27 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.561 2.029 . . . . 0.0 114.191 -175.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.81 132.0 90.89 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.564 1.146 . . . . 0.0 111.433 -171.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.22 106.89 1.96 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.527 2.818 . . . . 0.0 112.283 -177.333 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 tp -75.23 89.87 2.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.177 1.391 . . . . 0.0 109.352 169.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 44.46 58.51 3.79 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.363 1.865 . . . . 0.0 111.33 -169.334 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 100.72 -47.54 1.23 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.627 1.584 . . . . 0.0 113.702 -177.23 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -68.33 107.91 2.36 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 127.002 2.121 . . . . 0.0 112.463 -169.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.17 107.9 2.22 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.984 1.789 . . . . 0.0 110.863 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.91 134.68 55.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.256 1.022 . . . . 0.0 111.138 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -119.64 112.83 19.8 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.853 0.861 . . . . 0.0 110.459 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.0 mt -108.11 132.67 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.146 0.979 . . . . 0.0 111.223 -169.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -131.03 141.48 50.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.343 2.257 . . . . 0.0 109.978 -173.699 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 CA--C 1.544 0.734 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 175.054 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.208 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -150.26 101.8 3.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.7 1.2 . . . . 0.0 110.412 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 34.1 mt -95.73 107.17 19.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.339 1.055 . . . . 0.0 111.605 -177.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.5 tp -76.18 129.4 36.68 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 168.614 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.61 111.85 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.96 1.304 . . . . 0.0 108.737 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.3 m -112.53 169.95 8.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.218 1.407 . . . . 0.0 110.975 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.7 t30 57.13 78.18 0.24 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.924 1.69 . . . . 0.0 112.11 -174.615 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.8 mt -132.03 157.54 43.86 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.201 2.2 . . . . 0.0 110.336 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.55 145.8 50.82 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.046 -1.034 . . . . 0.0 111.656 170.023 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -57.22 -29.0 63.39 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -177.489 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -109.34 28.02 11.61 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.256 1.408 . . . . 0.0 115.261 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.59 119.2 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.174 1.487 . . . . 0.0 110.012 169.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.8 m -74.13 145.51 44.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.434 1.094 . . . . 0.0 112.568 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.68 -51.47 68.63 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.826 0.85 . . . . 0.0 112.094 171.361 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.45 -53.05 19.31 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.808 1.643 . . . . 0.0 112.331 175.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.88 -50.96 67.43 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.807 1.243 . . . . 0.0 112.365 177.131 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.0 mm -56.41 -56.82 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.221 1.008 . . . . 0.0 112.15 174.075 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -58.03 -43.75 86.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.709 1.141 . . . . 0.0 112.243 -178.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -59.14 -52.49 65.5 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.057 0.844 . . . . 0.0 112.775 173.599 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -65.03 -47.24 78.12 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.998 0.817 . . . . 0.0 112.374 -176.128 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -62.45 -40.49 96.78 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.774 0.715 . . . . 0.0 112.558 175.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.25 -13.54 60.54 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 175.457 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.85 -57.71 4.09 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.839 -1.163 . . . . 0.0 111.424 173.147 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -84.89 -33.95 22.66 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.98 -172.79 15.0 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.845 1.688 . . . . 0.0 112.801 178.021 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -131.02 120.88 24.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.579 1.152 . . . . 0.0 110.41 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -123.86 142.66 50.92 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -72.87 -52.0 16.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.733 2.413 . . . . 0.0 110.428 169.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -152.84 156.74 39.6 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.353 1.461 . . . . 0.0 112.596 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -128.88 162.77 26.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.842 1.657 . . . . 0.0 111.302 169.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.45 145.36 23.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.24 2.216 . . . . 0.0 109.806 172.077 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 125.517 1.527 . . . . 0.0 110.462 178.779 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.775 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.6 m -126.18 133.63 51.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.138 0.975 . . . . 0.0 112.34 -173.018 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.77 160.08 37.89 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.419 1.887 . . . . 0.0 111.148 170.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -145.28 126.68 14.94 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.367 1.467 . . . . 0.0 110.222 -177.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.33 111.67 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.142 0.977 . . . . 0.0 110.863 -171.082 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -75.71 111.19 10.79 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.288 1.435 . . . . 0.0 109.43 172.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.9 150.99 21.95 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.903 2.081 . . . . 0.0 112.555 -178.333 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.82 -38.37 90.83 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 177.081 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -136.39 142.85 43.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.607 1.563 . . . . 0.0 112.335 -174.004 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -54.47 -52.34 62.17 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.929 1.692 . . . . 0.0 112.136 172.259 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.91 -51.9 66.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.1 1.36 . . . . 0.0 112.475 176.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -59.88 -40.66 89.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.834 0.854 . . . . 0.0 112.536 177.49 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.89 -51.64 68.28 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.979 0.912 . . . . 0.0 111.983 171.49 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 62.8 mt -55.38 -48.08 74.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.776 0.83 . . . . 0.0 112.861 173.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -54.04 -54.49 38.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.665 1.186 . . . . 0.0 112.321 175.193 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.47 -53.16 57.99 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.573 1.149 . . . . 0.0 112.299 174.128 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 19.8 ttt -52.37 -60.64 2.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.035 1.734 . . . . 0.0 112.046 177.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -59.83 -37.32 78.88 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.234 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -68.79 -46.02 69.78 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.236 1.014 . . . . 0.0 113.165 176.801 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -100.1 -14.16 18.69 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -169.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -58.52 117.03 4.07 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.88 1.218 . . . . 0.0 111.044 170.031 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.7 -16.22 58.9 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.27 1.414 . . . . 0.0 114.61 -175.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.8 t -71.84 133.07 84.46 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 118.997 1.399 . . . . 0.0 109.497 175.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.94 142.1 24.75 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.725 2.284 . . . . 0.0 112.51 -177.386 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 45.7 tp -129.95 105.02 7.7 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.35 1.46 . . . . 0.0 108.133 169.742 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 52.4 65.57 1.47 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.988 1.715 . . . . 0.0 111.135 -169.017 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.09 -64.04 4.3 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.24 1.4 . . . . 0.0 113.215 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.5 119.92 57.91 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 126.465 1.906 . . . . 0.0 112.774 -173.201 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -56.07 121.55 10.19 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.753 3.635 . . . . 0.0 113.58 170.273 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.47 116.64 5.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.245 1.018 . . . . 0.0 111.748 177.104 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -91.61 98.6 11.75 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.585 1.154 . . . . 0.0 109.22 171.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.3 mt -101.22 133.63 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.066 1.346 . . . . 0.0 111.149 -173.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -140.14 123.86 17.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.063 1.745 . . . . 0.0 111.42 -177.566 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.7 tp . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 123.765 0.826 . . . . 0.0 109.311 169.694 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.872 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -143.46 152.92 42.09 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 177.121 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.7 mt -108.68 154.36 22.11 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.9 1.68 . . . . 0.0 111.535 174.211 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.2 tp -120.32 124.18 44.95 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.889 2.076 . . . . 0.0 107.474 170.432 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.89 85.56 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.52 1.928 . . . . 0.0 108.239 -169.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.16 166.96 19.19 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.146 1.379 . . . . 0.0 112.225 -178.058 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.7 t30 60.36 75.21 0.42 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.927 2.091 . . . . 0.0 113.134 177.58 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.1 mt -127.38 167.58 16.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.895 2.478 . . . . 0.0 111.489 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.2 149.57 46.17 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.96 0.886 . . . . 0.0 113.137 172.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -58.69 -31.97 68.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.556 1.943 . . . . 0.0 114.492 -178.231 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.49 31.67 7.19 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.541 1.543 . . . . 0.0 114.81 -175.345 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.71 147.52 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.09 1.356 . . . . 0.0 110.907 169.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.4 m -119.8 147.59 44.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.503 1.521 . . . . 0.0 112.485 -176.201 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -48.59 -57.7 5.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.682 1.993 . . . . 0.0 112.145 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.37 -46.24 76.52 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.591 1.556 . . . . 0.0 113.561 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.97 -52.78 64.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.164 0.986 . . . . 0.0 111.936 -178.608 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 43.0 mm -58.21 -52.8 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.384 1.073 . . . . 0.0 111.205 172.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -49.64 -51.69 36.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.953 1.301 . . . . 0.0 112.305 179.258 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.78 -52.3 65.67 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.368 1.067 . . . . 0.0 113.123 175.606 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.65 -43.89 97.67 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.214 0.915 . . . . 0.0 112.715 -177.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -62.71 -40.72 98.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.808 0.731 . . . . 0.0 112.475 173.03 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.15 -26.33 64.66 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 175.808 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -63.4 -48.88 75.99 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.144 -0.972 . . . . 0.0 112.608 174.469 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -104.8 -15.58 15.16 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 -173.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.0 162.53 21.79 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.904 1.716 . . . . 0.0 113.638 -176.459 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.9 m -112.27 100.62 8.95 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.576 1.95 . . . . 0.0 107.727 -178.049 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.25 157.2 44.99 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -168.642 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -77.5 -57.42 3.83 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.693 1.997 . . . . 0.0 110.042 169.856 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -157.24 145.65 19.48 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.234 1.414 . . . . 0.0 112.792 -174.251 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.18 133.78 55.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.378 1.471 . . . . 0.0 108.564 168.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.9 158.02 44.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.584 1.154 . . . . 0.0 113.115 -169.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.686 0 C-N-CA 126.625 1.97 . . . . 0.0 109.599 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.841 0 CA-C-O 119.699 -0.5 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.0 m -146.41 126.0 13.33 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.429 1.492 . . . . 0.0 111.019 -175.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.93 162.49 12.88 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.373 1.469 . . . . 0.0 112.599 177.182 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -133.51 127.51 33.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.778 1.631 . . . . 0.0 109.986 -172.079 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.0 t -134.07 116.8 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.518 -0.739 . . . . 0.0 112.479 -169.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -90.18 116.17 27.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.963 2.105 . . . . 0.0 110.606 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -99.54 152.63 19.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.618 1.567 . . . . 0.0 113.885 -173.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -63.93 -48.55 76.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.034 0.934 . . . . 0.0 111.794 171.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -133.54 135.41 44.35 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.116 1.366 . . . . 0.0 110.912 -175.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -58.12 -43.34 87.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.263 1.425 . . . . 0.0 112.778 178.671 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.58 -50.45 60.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.488 1.115 . . . . 0.0 112.618 171.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.92 -46.61 89.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.945 0.898 . . . . 0.0 112.006 174.344 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.13 -52.87 48.96 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.513 1.125 . . . . 0.0 112.333 173.825 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.6 tp -55.42 -51.17 67.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.482 1.513 . . . . 0.0 112.224 174.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -52.06 51.76 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.669 1.587 . . . . 0.0 112.48 174.132 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.18 -52.93 63.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.433 1.093 . . . . 0.0 111.856 173.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -54.51 -58.89 5.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.696 1.598 . . . . 0.0 112.494 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -59.17 -36.48 75.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -177.138 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -67.81 -49.11 64.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.381 1.073 . . . . 0.0 112.996 174.549 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -94.09 -13.72 26.53 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -57.92 112.9 1.64 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.702 1.137 . . . . 0.0 110.93 169.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.5 -18.6 41.08 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.546 1.546 . . . . 0.0 114.713 -175.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 81.2 t -69.52 133.78 88.84 Favored Pre-proline 0 N--CA 1.478 0.934 0 CA-C-N 118.968 1.384 . . . . 0.0 110.189 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.38 141.78 23.16 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.872 2.381 . . . . 0.0 113.154 -175.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.3 tt -132.3 108.69 9.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.539 1.935 . . . . 0.0 107.312 169.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 48.33 64.27 1.73 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.819 1.648 . . . . 0.0 111.566 -169.208 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.92 -55.44 4.77 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.883 1.706 . . . . 0.0 113.649 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -65.81 124.02 86.41 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 127.008 2.123 . . . . 0.0 112.47 -173.3 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.32 122.97 9.48 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.291 2.661 . . . . 0.0 111.185 174.651 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.42 116.27 5.39 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.184 0.994 . . . . 0.0 111.347 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -84.78 100.66 11.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.961 0.905 . . . . 0.0 108.975 170.269 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.3 mt -107.18 130.07 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.793 0.837 . . . . 0.0 110.714 -175.442 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.21 -179.97 6.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.594 1.558 . . . . 0.0 110.591 171.749 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 N--CA 1.47 0.563 0 C-N-CA 125.182 1.393 . . . . 0.0 112.474 -176.666 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.877 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -133.92 125.83 29.11 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.062 0.945 . . . . 0.0 110.526 -178.606 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.9 mt -106.52 131.11 54.07 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.606 1.163 . . . . 0.0 110.821 170.764 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.6 tp -99.06 100.43 11.58 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.685 1.594 . . . . 0.0 106.821 169.042 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.28 132.94 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.908 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 m -134.05 172.32 12.99 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.55 1.54 . . . . 0.0 111.381 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.3 t30 56.63 51.16 11.5 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.005 1.722 . . . . 0.0 112.662 -172.531 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.58 -158.51 0.67 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.072 1.749 . . . . 0.0 109.214 169.414 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -154.98 169.24 24.53 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.492 1.517 . . . . 0.0 110.728 178.523 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.32 -32.1 70.91 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.896 -1.128 . . . . 0.0 112.513 169.428 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.97 -28.76 69.23 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.487 1.518 . . . . 0.0 114.646 174.07 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.0 t -72.71 108.15 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.578 1.189 . . . . 0.0 109.64 174.719 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.6 m -69.81 144.0 52.76 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.02 0.928 . . . . 0.0 112.876 -177.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -54.19 -55.09 31.24 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.743 1.617 . . . . 0.0 112.886 176.354 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.87 75.77 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.483 1.113 . . . . 0.0 113.266 176.524 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.21 -52.24 63.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.704 0.802 . . . . 0.0 111.61 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.0 mm -53.26 -52.93 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.121 0.969 . . . . 0.0 111.12 169.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -52.53 -52.93 52.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.972 0.909 . . . . 0.0 112.175 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -60.2 -52.16 66.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.553 1.141 . . . . 0.0 113.16 174.543 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 pp -63.84 -43.93 94.7 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.364 0.984 . . . . 0.0 112.308 -174.182 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -62.12 -45.15 94.74 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.485 0.584 . . . . 0.0 112.068 172.143 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.7 -32.84 70.88 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 178.273 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.18 -51.21 70.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.084 0.954 . . . . 0.0 112.483 173.85 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -93.23 -13.03 28.81 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -174.987 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.55 154.36 25.89 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 120.015 1.279 . . . . 0.0 114.664 177.734 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.2 m -86.19 107.41 17.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.369 1.068 . . . . 0.0 110.309 -175.289 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 pp -125.96 146.31 49.92 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -173.019 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -86.72 -39.09 16.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.635 2.374 . . . . 0.0 111.547 169.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -150.22 147.38 27.62 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.591 0.632 . . . . 0.0 112.47 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.26 120.97 11.18 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.668 1.587 . . . . 0.0 109.486 171.31 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -138.4 117.24 12.35 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.38 1.472 . . . . 0.0 111.863 -172.653 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.4 t . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 126.065 1.746 . . . . 0.0 111.134 178.052 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.934 0 CA-C-O 120.048 -0.307 . . . . 0.0 113.326 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.9 p -141.53 168.28 20.15 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.301 1.44 . . . . 0.0 112.642 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.07 141.27 24.0 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.674 1.189 . . . . 0.0 111.398 169.714 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.91 126.02 43.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.478 1.511 . . . . 0.0 109.429 173.047 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.3 t -130.08 122.8 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.173 0.989 . . . . 0.0 110.509 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -109.1 119.01 38.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.113 2.165 . . . . 0.0 111.14 -176.608 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -102.75 154.47 19.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.809 2.844 . . . . 0.0 113.645 -169.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -82.38 -16.17 50.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.619 1.567 . . . . 0.0 114.554 175.246 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.8 mtm-85 -142.34 132.56 24.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.689 1.596 . . . . 0.0 111.042 177.531 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -56.13 -50.35 71.35 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.107 1.363 . . . . 0.0 112.545 172.771 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.43 -47.43 69.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.875 1.27 . . . . 0.0 112.162 175.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.18 -42.23 99.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.943 0.897 . . . . 0.0 112.625 175.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.72 -53.34 57.81 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.785 0.834 . . . . 0.0 111.534 171.722 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 59.3 tp -54.07 -52.1 62.0 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.826 1.25 . . . . 0.0 112.439 174.636 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -49.86 -54.77 17.4 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.253 1.821 . . . . 0.0 112.154 173.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.63 -50.84 69.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.534 1.133 . . . . 0.0 112.306 174.846 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 16.7 ttp -52.15 -60.1 3.6 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.03 1.332 . . . . 0.0 111.595 175.636 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -53.73 -49.51 67.99 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.239 1.416 . . . . 0.0 112.32 179.438 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -61.83 -47.24 85.98 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.72 1.208 . . . . 0.0 113.045 -179.203 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -99.82 -14.36 18.84 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -169.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.28 113.72 2.3 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.785 1.175 . . . . 0.0 110.984 169.825 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.43 -20.15 35.41 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.762 1.649 . . . . 0.0 114.48 -175.796 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.46 133.02 87.23 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-N 118.757 1.279 . . . . 0.0 110.306 -178.566 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.16 138.83 23.17 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.923 2.415 . . . . 0.0 112.457 -177.279 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.1 tp -134.93 112.37 10.58 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.1 1.76 . . . . 0.0 108.373 170.055 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 49.32 61.68 3.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.303 1.441 . . . . 0.0 111.189 -169.216 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.99 -59.94 4.47 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.798 1.666 . . . . 0.0 113.493 -179.051 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -61.95 127.82 89.75 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 127.062 2.145 . . . . 0.0 112.83 -174.079 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.98 124.67 10.79 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.178 2.585 . . . . 0.0 111.147 172.838 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.49 120.37 11.57 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.117 0.967 . . . . 0.0 111.162 177.717 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -98.91 102.32 14.0 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.783 1.233 . . . . 0.0 108.865 176.036 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.1 mt -108.69 135.98 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.047 0.939 . . . . 0.0 111.271 -169.768 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -128.87 123.98 34.09 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.103 1.761 . . . . 0.0 111.082 -177.141 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 CA--C 1.534 0.346 0 C-N-CA 124.77 1.228 . . . . 0.0 111.076 172.361 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.945 0 N-CA-C 112.338 -0.305 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -117.91 99.63 7.04 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.285 1.434 . . . . 0.0 109.961 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -100.73 101.4 12.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.607 1.563 . . . . 0.0 109.043 -176.099 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.8 tp -84.37 137.28 33.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.136 1.774 . . . . 0.0 110.505 177.139 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.0 t -129.41 129.32 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.46 1.904 . . . . 0.0 108.948 -176.517 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.0 m -139.64 166.48 24.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.25 1.42 . . . . 0.0 112.116 -176.006 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.1 t30 54.71 46.95 23.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.07 1.748 . . . . 0.0 112.914 -172.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.2 mt -83.89 164.83 19.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.3 1.44 . . . . 0.0 110.754 169.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.95 145.35 56.0 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 110.957 169.458 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -53.87 -35.0 61.08 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.561 1.544 . . . . 0.0 114.16 -176.231 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.47 16.28 58.0 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.392 1.473 . . . . 0.0 115.467 -174.65 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.26 135.25 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.217 1.509 . . . . 0.0 110.578 170.588 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.4 m -114.6 158.13 22.13 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.146 1.778 . . . . 0.0 111.583 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -52.36 -55.75 19.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.524 1.13 . . . . 0.0 113.641 -176.296 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.49 -38.99 67.1 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.197 0.999 . . . . 0.0 113.561 -177.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.83 -56.15 25.94 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.968 0.907 . . . . 0.0 111.916 176.249 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.2 mm -55.76 -53.01 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 0.0 111.02 172.919 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -48.44 -56.95 6.86 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.181 1.792 . . . . 0.0 111.673 178.963 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.2 -49.49 75.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.435 1.094 . . . . 0.0 113.323 176.793 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.3 -45.44 91.34 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.492 1.042 . . . . 0.0 112.201 -174.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -62.91 -40.88 98.94 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 174.098 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.51 -14.98 56.51 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 175.686 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.6 -61.91 1.71 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.825 -1.172 . . . . 0.0 111.883 173.197 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -85.18 -13.05 51.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -175.274 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -146.41 -167.79 13.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.71 1.624 . . . . 0.0 112.909 176.414 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.05 126.69 27.14 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.159 1.384 . . . . 0.0 110.177 -173.75 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.06 143.61 50.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.464 1.106 . . . . 0.0 113.737 -169.705 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -73.08 -49.61 27.62 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.966 2.106 . . . . 0.0 110.335 169.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -150.11 152.15 34.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.416 1.086 . . . . 0.0 113.237 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -119.86 151.91 38.15 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.319 1.848 . . . . 0.0 109.869 169.079 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.6 146.01 26.26 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.97 1.708 . . . . 0.0 110.402 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.1 t . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 125.364 1.465 . . . . 0.0 109.847 -177.877 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.247 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -137.01 155.04 50.21 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.698 1.599 . . . . 0.0 112.127 179.313 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.5 166.86 26.93 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.998 1.719 . . . . 0.0 111.463 175.108 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -147.76 126.73 12.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.635 1.574 . . . . 0.0 109.645 -174.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.02 116.43 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.726 1.21 . . . . 0.0 109.175 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -82.6 102.87 11.72 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.781 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -77.28 155.34 32.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.177 1.791 . . . . 0.0 113.238 -175.693 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.19 -29.48 54.34 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.701 1.2 . . . . 0.0 113.298 172.663 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 138.26 38.04 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.285 1.434 . . . . 0.0 111.341 176.707 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -64.77 -36.73 85.26 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 113.914 178.466 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.37 -46.83 86.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.121 0.968 . . . . 0.0 111.672 174.688 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -58.98 -44.23 91.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.492 1.517 . . . . 0.0 112.016 173.007 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.05 -52.25 63.77 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.75 1.22 . . . . 0.0 112.612 170.881 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.47 -48.24 79.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.857 1.263 . . . . 0.0 112.292 176.275 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -49.55 -56.99 7.96 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.135 1.374 . . . . 0.0 111.229 171.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.68 -47.13 63.99 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.801 0.84 . . . . 0.0 112.362 175.509 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.5 ttp -56.17 -62.36 1.77 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.979 0.912 . . . . 0.0 112.467 177.034 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -61.43 -35.27 77.09 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.27 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.0 -52.81 62.47 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.365 1.466 . . . . 0.0 112.662 174.816 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -97.39 -14.97 20.9 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -169.703 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -59.67 110.33 1.12 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 120.16 1.346 . . . . 0.0 112.094 175.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.3 -17.36 40.58 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.149 1.833 . . . . 0.0 114.67 -177.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.61 130.27 94.09 Favored Pre-proline 0 N--CA 1.479 0.985 0 CA-C-N 118.953 1.376 . . . . 0.0 111.009 -174.895 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.28 112.25 2.75 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.339 2.693 . . . . 0.0 112.54 -174.515 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 59.7 tp -76.54 82.5 3.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.47 1.508 . . . . 0.0 109.268 169.788 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 43.35 55.1 4.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.873 2.069 . . . . 0.0 112.026 -169.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 116.23 -64.82 0.33 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.009 1.766 . . . . 0.0 112.556 -177.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.01 111.03 3.53 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 126.812 2.045 . . . . 0.0 112.266 -171.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.14 113.31 3.39 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.273 1.982 . . . . 0.0 110.654 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -66.93 118.71 10.78 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.005 0.922 . . . . 0.0 111.157 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -84.89 120.74 26.81 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.904 0.882 . . . . 0.0 109.024 171.24 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.6 mm -118.43 138.17 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.738 0.815 . . . . 0.0 109.997 179.484 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -137.09 134.84 36.91 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.149 1.38 . . . . 0.0 111.065 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 CA--C 1.538 0.485 0 C-N-CA 126.3 1.84 . . . . 0.0 107.88 174.634 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.355 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -134.98 101.6 4.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.852 1.261 . . . . 0.0 110.68 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -103.61 122.0 44.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.087 2.155 . . . . 0.0 109.231 -171.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.8 tp -115.47 102.94 10.27 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.309 1.844 . . . . 0.0 110.424 -176.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.5 t -78.73 130.64 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.166 1.387 . . . . 0.0 108.373 169.809 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 m -127.69 172.3 10.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.115 1.366 . . . . 0.0 111.411 175.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.7 t30 57.46 50.4 11.31 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.847 1.659 . . . . 0.0 112.763 -173.872 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.2 mt -98.78 -168.22 1.6 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.883 1.673 . . . . 0.0 109.306 169.145 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -148.61 161.94 40.69 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.967 -1.083 . . . . 0.0 111.972 174.172 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -61.14 101.52 0.16 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.208 1.403 . . . . 0.0 109.383 169.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.48 -39.0 0.62 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.211 1.386 . . . . 0.0 111.859 -169.539 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.73 110.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.122 0.969 . . . . 0.0 109.611 170.284 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -71.98 144.24 48.94 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.766 0.826 . . . . 0.0 112.737 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.71 -52.79 63.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.841 1.656 . . . . 0.0 112.385 178.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.54 82.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.618 1.167 . . . . 0.0 113.404 174.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.84 -48.69 79.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.086 0.857 . . . . 0.0 111.763 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.4 mm -54.77 -52.87 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.883 0.873 . . . . 0.0 111.065 169.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -51.75 -54.21 31.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.246 0.618 . . . . 0.0 112.067 178.414 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.58 -50.34 74.17 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.873 1.269 . . . . 0.0 113.31 176.749 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.11 -44.86 90.99 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.315 0.961 . . . . 0.0 112.041 -176.699 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -61.27 -42.69 99.07 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 173.496 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.54 -15.3 57.61 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.29 -63.45 1.18 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.949 -1.095 . . . . 0.0 111.609 173.407 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -82.17 -18.91 41.08 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -175.465 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -139.22 -176.37 14.68 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.579 1.561 . . . . 0.0 113.346 178.257 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.9 m -126.91 120.96 30.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.367 1.467 . . . . 0.0 110.373 -176.72 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 pp -126.07 146.41 49.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.004 1.322 . . . . 0.0 112.995 -169.895 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -78.52 -49.19 13.8 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.803 2.441 . . . . 0.0 110.303 170.592 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -149.19 147.89 28.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.632 1.173 . . . . 0.0 111.884 -179.359 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -137.62 135.34 36.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.454 1.502 . . . . 0.0 110.464 171.74 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.06 146.77 32.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.865 1.266 . . . . 0.0 112.192 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.479 1.024 0 C-N-CA 125.844 1.658 . . . . 0.0 110.492 -179.402 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.9 p -144.55 159.4 42.85 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.664 1.585 . . . . 0.0 112.266 -176.46 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.78 140.85 33.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.863 1.265 . . . . 0.0 111.018 169.874 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -120.33 125.88 49.14 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.067 1.747 . . . . 0.0 110.009 -174.87 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.8 t -126.68 115.75 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.156 1.382 . . . . 0.0 109.809 -176.4 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -88.23 111.4 21.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.218 2.207 . . . . 0.0 108.461 175.474 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -98.82 159.31 15.04 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.426 2.29 . . . . 0.0 113.975 -169.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.73 -50.46 70.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.276 1.03 . . . . 0.0 111.83 169.453 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -138.06 144.26 40.87 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.733 1.613 . . . . 0.0 112.214 -173.714 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -62.63 -35.88 81.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.758 1.223 . . . . 0.0 112.901 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.13 -47.01 78.94 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.441 1.096 . . . . 0.0 112.435 172.055 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -65.88 -41.96 90.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.705 1.202 . . . . 0.0 112.038 176.436 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.62 82.61 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.859 0.864 . . . . 0.0 112.264 169.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.88 -45.62 93.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.986 1.714 . . . . 0.0 112.046 177.796 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -49.63 -58.15 5.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.958 1.303 . . . . 0.0 110.31 169.695 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.43 -49.6 61.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.93 0.892 . . . . 0.0 112.65 176.587 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 41.6 ttp -54.89 -62.01 1.94 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.362 1.065 . . . . 0.0 111.723 176.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -61.05 -38.59 86.73 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -66.68 -41.87 87.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.685 1.194 . . . . 0.0 112.899 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -109.09 -13.24 14.73 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -169.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -58.63 116.74 3.9 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.172 1.351 . . . . 0.0 111.425 171.348 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.33 -25.07 27.18 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.972 1.749 . . . . 0.0 114.359 -175.367 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.82 135.3 87.8 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.771 1.229 . . . . 0.0 110.356 -177.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -74.91 139.42 24.5 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.821 2.348 . . . . 0.0 112.816 -178.223 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.4 tp -139.24 119.12 13.29 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.936 1.694 . . . . 0.0 108.677 169.864 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.75 56.99 7.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.428 1.491 . . . . 0.0 110.729 -169.094 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.78 -60.74 4.36 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.54 1.543 . . . . 0.0 113.466 -179.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.45 135.91 96.54 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.948 1.699 . . . . 0.0 112.872 -172.546 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.2 124.28 10.34 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.497 2.798 . . . . 0.0 111.211 174.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.4 mtm -62.76 117.78 6.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.506 1.122 . . . . 0.0 111.729 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -95.65 99.04 10.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.949 1.3 . . . . 0.0 108.393 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.6 mt -103.86 135.43 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.667 0.787 . . . . 0.0 111.363 -169.81 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -127.91 151.16 49.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.969 2.508 . . . . 0.0 110.302 -177.725 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 34.8 tp . . . . . 0 N--CA 1.467 0.409 0 C-N-CA 125.737 1.615 . . . . 0.0 109.568 179.856 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.076 0 N-CA-C 112.704 -0.158 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -76.59 137.95 39.84 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.971 0.908 . . . . 0.0 112.458 178.547 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -138.52 129.58 26.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 129.02 2.928 . . . . 0.0 108.112 -175.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.73 112.15 20.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.551 1.94 . . . . 0.0 110.035 -175.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.4 t -87.04 135.1 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.58 1.552 . . . . 0.0 108.637 171.434 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.7 m -139.18 165.44 27.16 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.608 1.563 . . . . 0.0 112.575 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.4 t30 57.8 47.65 15.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.147 2.179 . . . . 0.0 113.299 -175.808 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.51 161.53 15.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.256 1.822 . . . . 0.0 110.3 169.51 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.93 144.53 54.15 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.166 -0.959 . . . . 0.0 111.008 169.397 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -59.35 -21.72 60.23 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.737 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.83 19.75 32.6 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.727 1.632 . . . . 0.0 115.425 178.049 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.29 129.37 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.483 1.641 . . . . 0.0 110.365 169.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.8 m -75.69 140.64 42.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.006 0.923 . . . . 0.0 112.55 -178.556 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.54 -50.67 72.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.018 1.327 . . . . 0.0 112.298 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.77 -46.62 71.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.309 1.444 . . . . 0.0 112.619 174.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -56.98 -53.3 59.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.397 1.079 . . . . 0.0 112.381 179.374 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.0 mm -57.33 -52.81 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.134 0.973 . . . . 0.0 111.583 173.02 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -50.33 -50.62 50.4 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.546 1.139 . . . . 0.0 112.006 178.104 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.09 -53.84 47.26 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.505 1.122 . . . . 0.0 112.917 175.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.13 -43.0 99.6 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.216 0.916 . . . . 0.0 112.643 -173.111 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -64.07 -44.79 91.31 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.64 0.654 . . . . 0.0 112.131 172.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.46 -27.5 66.14 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 176.454 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.66 -59.5 4.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.187 0.995 . . . . 0.0 111.942 173.684 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -83.8 -15.25 49.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -175.145 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -148.17 156.22 26.8 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.947 1.248 . . . . 0.0 113.96 175.344 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.4 m -94.79 111.48 23.26 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.753 1.221 . . . . 0.0 109.934 -173.304 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -137.3 155.8 49.01 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -87.38 -48.17 8.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.785 2.434 . . . . 0.0 111.487 -173.619 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -151.02 145.66 25.68 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.623 1.169 . . . . 0.0 113.141 -176.309 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.27 140.85 46.71 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.239 1.816 . . . . 0.0 110.095 169.115 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -146.51 107.59 4.18 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.933 1.693 . . . . 0.0 111.533 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.3 t . . . . . 0 N--CA 1.478 0.956 0 C-N-CA 125.303 1.441 . . . . 0.0 110.625 176.063 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 N-CA-C 113.224 0.05 . . . . 0.0 113.224 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.4 p -143.47 167.68 21.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.699 1.599 . . . . 0.0 111.395 -179.443 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -144.78 126.38 15.09 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.797 0.839 . . . . 0.0 111.782 169.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -80.15 124.54 28.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.974 1.71 . . . . 0.0 109.735 169.865 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.45 140.66 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.702 1.201 . . . . 0.0 110.107 -175.733 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -122.75 105.42 10.03 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.769 1.627 . . . . 0.0 109.204 177.068 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -78.62 160.54 27.51 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.364 1.866 . . . . 0.0 111.743 176.386 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -76.43 -27.18 56.13 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 171.077 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.18 136.62 38.36 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.453 1.501 . . . . 0.0 111.914 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -56.45 -44.37 80.45 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.808 1.643 . . . . 0.0 113.316 173.047 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.38 -46.71 76.5 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.091 0.956 . . . . 0.0 112.597 176.782 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -66.52 -41.4 88.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.928 1.291 . . . . 0.0 112.178 177.399 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.9 -48.75 75.07 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.906 0.882 . . . . 0.0 111.934 169.797 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.97 -46.41 89.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.538 1.535 . . . . 0.0 112.463 176.102 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -50.71 -56.39 12.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.169 1.388 . . . . 0.0 111.133 171.8 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.16 -49.27 69.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.55 1.14 . . . . 0.0 112.393 174.514 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.7 ttp -51.99 -59.12 4.71 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.81 1.244 . . . . 0.0 111.788 176.643 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -56.01 -49.03 74.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.95 1.3 . . . . 0.0 112.361 178.12 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -60.18 -45.15 94.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.549 1.14 . . . . 0.0 113.468 -178.701 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -102.15 -16.14 16.47 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -169.634 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -61.61 106.26 0.64 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 119.922 1.237 . . . . 0.0 110.786 169.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.96 -27.77 7.3 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 126.567 2.032 . . . . 0.0 114.142 -174.673 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.61 134.32 84.22 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 125.102 1.361 . . . . 0.0 111.012 -173.402 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.55 138.71 24.58 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.984 2.456 . . . . 0.0 112.714 -177.236 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -140.13 107.63 5.58 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.736 2.014 . . . . 0.0 108.095 175.349 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 48.45 66.48 1.06 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.742 1.617 . . . . 0.0 111.82 -169.364 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.26 -57.56 4.39 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.112 1.815 . . . . 0.0 113.403 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -65.16 131.82 95.2 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 127.036 2.134 . . . . 0.0 112.625 -173.24 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.83 119.53 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.876 2.384 . . . . 0.0 110.251 169.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.5 mtm -60.63 143.99 52.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.604 0.762 . . . . 0.0 111.968 178.392 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -119.59 130.95 55.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.236 1.414 . . . . 0.0 108.68 171.021 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mm -124.94 141.49 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.52 0.728 . . . . 0.0 110.052 -173.64 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -138.92 148.73 43.96 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.672 1.989 . . . . 0.0 110.273 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.474 0.772 0 C-N-CA 124.044 0.937 . . . . 0.0 112.225 173.094 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 CA-C-O 119.472 -0.627 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -136.53 152.51 50.59 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -173.33 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 71.9 mt -122.04 131.23 53.88 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.77 2.028 . . . . 0.0 112.266 -169.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.2 tp -86.54 111.28 20.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 168.317 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -98.61 130.51 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.108 1.363 . . . . 0.0 107.75 175.221 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.5 m -136.44 165.31 26.12 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 111.854 -174.396 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.9 t30 57.56 32.48 21.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.569 1.948 . . . . 0.0 114.395 -171.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.11 148.05 42.17 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 167.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.68 144.25 57.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.515 174.331 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -54.15 -36.58 63.48 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -169.463 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.42 20.15 51.85 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.115 1.341 . . . . 0.0 115.916 178.568 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.43 130.74 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.281 1.541 . . . . 0.0 110.774 171.543 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -76.15 140.53 41.8 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.383 1.073 . . . . 0.0 112.669 -177.737 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.43 -51.82 67.86 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.138 1.375 . . . . 0.0 112.696 175.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.29 80.16 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.443 1.097 . . . . 0.0 113.283 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.92 -51.4 69.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.884 0.874 . . . . 0.0 112.076 177.5 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.0 mm -57.05 -52.55 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.591 1.156 . . . . 0.0 111.351 172.043 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -49.38 -56.07 10.84 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.739 1.216 . . . . 0.0 111.844 176.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -57.79 -51.07 71.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.704 1.201 . . . . 0.0 113.07 176.668 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -63.8 -47.89 79.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.21 0.914 . . . . 0.0 112.35 -175.256 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -63.34 -38.61 91.83 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.7 0.682 . . . . 0.0 112.68 175.729 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.98 -13.76 60.42 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 174.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.16 -58.19 3.79 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.867 -1.146 . . . . 0.0 111.408 173.435 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -86.96 -32.58 20.01 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -176.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.43 172.25 14.88 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.525 1.536 . . . . 0.0 112.523 176.044 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 90.8 m -118.15 102.23 8.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.802 1.241 . . . . 0.0 109.439 178.843 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 pp -105.94 139.38 40.58 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -169.775 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -78.4 -45.37 22.52 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.686 2.794 . . . . 0.0 110.262 169.606 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -143.79 143.52 31.39 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.078 1.751 . . . . 0.0 111.506 -174.425 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.64 119.46 12.56 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.769 1.627 . . . . 0.0 108.587 169.304 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -137.45 104.08 5.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.995 0.918 . . . . 0.0 111.635 -175.572 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 125.411 1.484 . . . . 0.0 110.216 169.974 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.086 0 CA-C-O 120.964 0.202 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 81.5 p -139.32 165.14 27.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.096 1.359 . . . . 0.0 112.49 -175.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -150.29 161.64 42.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.743 1.617 . . . . 0.0 111.926 171.087 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -128.87 115.05 17.29 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.448 1.499 . . . . 0.0 110.234 174.811 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 14.3 t -124.89 125.62 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.694 1.198 . . . . 0.0 110.719 -169.58 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -115.13 127.56 55.65 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.613 1.965 . . . . 0.0 109.888 -171.85 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -114.12 156.59 23.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 127.68 2.392 . . . . 0.0 112.184 -171.643 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -58.7 -28.44 65.8 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.762 1.394 . . . . 0.0 114.762 -176.272 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -139.68 149.96 44.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.128 2.171 . . . . 0.0 110.618 176.829 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -57.64 -41.25 81.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.196 1.398 . . . . 0.0 112.142 170.261 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.04 -48.74 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.478 1.111 . . . . 0.0 112.376 169.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.26 -43.18 99.43 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.177 0.991 . . . . 0.0 112.62 176.543 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.12 -52.15 64.17 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.084 0.954 . . . . 0.0 111.504 169.72 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 28.5 mt -56.2 -44.02 79.07 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.69 -1.257 . . . . 0.0 113.715 176.703 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -52.6 -57.52 9.73 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.969 1.259 . . . . 0.0 111.842 171.169 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.68 -51.66 59.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.571 1.148 . . . . 0.0 112.0 177.037 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 22.6 ttt -53.87 -63.25 1.21 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.466 1.507 . . . . 0.0 112.168 176.086 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -60.75 -37.88 83.32 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -173.471 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -68.19 -43.49 77.99 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 113.169 177.351 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -103.42 -13.37 16.66 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -169.631 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -59.69 114.31 2.69 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.032 1.287 . . . . 0.0 110.867 169.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.34 -22.63 34.0 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.006 1.765 . . . . 0.0 114.424 -174.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.4 t -71.31 136.1 84.24 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.772 1.229 . . . . 0.0 110.423 -177.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.27 139.38 29.1 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.943 2.429 . . . . 0.0 112.626 -178.223 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -132.81 109.8 9.9 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.889 2.076 . . . . 0.0 106.871 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 51.65 57.39 6.6 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.145 1.378 . . . . 0.0 110.602 -168.599 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.47 -52.3 4.09 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.934 1.73 . . . . 0.0 113.726 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -68.79 129.13 92.63 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.809 2.044 . . . . 0.0 112.221 -171.876 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.55 125.24 11.01 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.2 2.6 . . . . 0.0 111.722 179.13 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.2 mtm -65.96 125.85 26.71 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.522 1.129 . . . . 0.0 112.101 177.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -99.06 112.73 24.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.918 1.287 . . . . 0.0 108.788 170.029 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mt -118.67 132.64 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.48 1.112 . . . . 0.0 111.2 -172.404 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -137.16 126.99 25.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.793 1.637 . . . . 0.0 111.635 -172.3 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 46.5 tp . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 124.33 1.052 . . . . 0.0 110.617 172.13 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.037 0 N-CA-C 112.305 -0.318 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -152.46 125.44 8.53 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.04 0.936 . . . . 0.0 112.177 178.885 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.4 mt -121.1 125.86 48.31 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.988 1.715 . . . . 0.0 112.38 -172.487 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.3 tp -89.01 116.57 27.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.698 1.999 . . . . 0.0 106.096 168.382 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.5 128.09 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.987 1.315 . . . . 0.0 108.12 -176.969 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.0 m -133.96 163.23 30.0 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.778 1.631 . . . . 0.0 112.478 -169.644 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.0 t30 54.55 35.09 22.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.078 2.151 . . . . 0.0 113.369 -169.769 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.41 154.17 37.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.553 1.141 . . . . 0.0 110.314 169.518 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.35 150.82 29.75 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.911 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -57.97 -25.49 61.09 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.305 1.042 . . . . 0.0 113.437 172.728 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -78.3 -7.47 87.81 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 125.285 1.421 . . . . 0.0 115.953 175.705 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.2 149.86 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 119.437 1.618 . . . . 0.0 111.118 174.529 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.5 m -129.57 158.13 40.14 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.603 1.561 . . . . 0.0 111.792 177.419 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.3 -51.26 70.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.247 1.419 . . . . 0.0 112.556 178.998 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.06 86.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.973 0.909 . . . . 0.0 112.749 174.45 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -59.15 -51.33 70.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.169 0.988 . . . . 0.0 112.149 176.469 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 15.1 mm -54.68 -53.91 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.533 1.133 . . . . 0.0 111.138 171.074 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -49.96 -57.5 7.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.41 1.084 . . . . 0.0 111.603 178.158 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -56.85 -50.85 71.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.251 1.021 . . . . 0.0 113.085 177.004 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -47.8 81.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.106 0.866 . . . . 0.0 112.235 -175.238 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -65.98 -41.66 90.84 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 176.011 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.59 -24.69 65.66 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 176.478 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.8 -54.14 43.58 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.144 -0.972 . . . . 0.0 112.027 174.033 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -98.33 -15.72 19.64 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -173.653 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.24 -177.57 17.45 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.575 1.56 . . . . 0.0 113.262 178.851 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.3 m -119.36 94.02 4.28 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.152 0.981 . . . . 0.0 111.264 -177.536 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.33 157.8 20.45 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.031 0.932 . . . . 0.0 112.263 179.205 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -115.57 -37.11 4.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.575 2.75 . . . . 0.0 111.717 173.676 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -140.54 144.77 36.1 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.034 1.334 . . . . 0.0 111.511 178.091 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.51 143.93 46.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.67 1.588 . . . . 0.0 110.53 169.742 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.34 147.98 26.96 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.766 2.027 . . . . 0.0 109.382 173.396 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.483 1.197 0 C-N-CA 124.645 1.178 . . . . 0.0 111.023 -173.714 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 112.329 -0.309 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.5 m -141.31 145.75 35.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.339 1.455 . . . . 0.0 111.577 -169.709 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.37 162.3 34.74 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.402 1.881 . . . . 0.0 112.398 174.066 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -137.24 106.95 6.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.991 2.116 . . . . 0.0 109.654 -175.299 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 13.2 t -124.23 126.8 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.168 0.987 . . . . 0.0 109.972 -170.035 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -115.4 144.52 43.67 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.426 1.49 . . . . 0.0 110.21 -175.479 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -132.85 154.44 50.34 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.371 2.269 . . . . 0.0 112.94 -168.931 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.56 -29.43 70.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.241 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -131.24 126.24 34.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.065 1.746 . . . . 0.0 111.393 -173.656 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.6 -43.57 98.62 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.217 1.407 . . . . 0.0 112.508 174.933 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.01 -48.96 61.32 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.585 1.154 . . . . 0.0 112.772 169.872 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.83 -42.06 97.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.626 1.17 . . . . 0.0 112.758 177.09 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.52 69.03 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.711 0.805 . . . . 0.0 111.829 169.949 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.5 tp -56.66 -46.81 80.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.074 1.349 . . . . 0.0 112.202 177.408 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -49.45 -57.93 6.09 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.628 1.571 . . . . 0.0 111.318 171.47 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.77 -50.36 66.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.614 1.166 . . . . 0.0 112.846 175.554 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 23.7 ttp -51.51 -59.17 4.55 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.137 1.375 . . . . 0.0 111.476 176.348 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -55.93 -46.94 78.33 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.004 1.321 . . . . 0.0 112.412 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.01 -41.7 97.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.904 1.282 . . . . 0.0 113.538 -178.603 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -109.19 -15.82 14.22 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -170.248 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.82 113.88 2.5 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.229 1.377 . . . . 0.0 110.995 169.803 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.03 -24.15 19.53 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.337 1.922 . . . . 0.0 114.129 -175.688 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t -69.67 128.66 91.9 Favored Pre-proline 0 N--CA 1.477 0.879 0 CA-C-N 118.643 1.221 . . . . 0.0 111.706 -170.746 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.78 123.58 13.56 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 124.121 3.214 . . . . 0.0 114.355 173.883 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 tp -86.96 77.07 9.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.732 1.613 . . . . 0.0 107.482 169.009 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 47.07 36.09 3.95 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.552 1.941 . . . . 0.0 113.504 -169.84 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 143.84 -77.06 0.28 Allowed Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.715 1.626 . . . . 0.0 112.876 -178.617 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -65.4 126.88 92.33 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 125.185 1.394 . . . . 0.0 112.302 -176.192 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.3 121.72 7.03 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.725 2.283 . . . . 0.0 111.697 -177.673 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.4 mtm -65.04 142.6 58.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.98 0.912 . . . . 0.0 111.4 174.103 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -124.95 125.27 43.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.542 1.137 . . . . 0.0 110.032 176.126 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.1 mt -128.52 137.26 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.171 0.988 . . . . 0.0 110.987 -170.292 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -137.07 125.84 23.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.988 1.715 . . . . 0.0 111.043 -177.873 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.467 0.387 0 C-N-CA 123.989 0.916 . . . . 0.0 108.643 169.885 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.897 0 N-CA-C 112.66 -0.176 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -140.57 133.49 29.19 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.886 1.275 . . . . 0.0 111.191 -176.912 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.5 mt -119.65 122.51 41.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.802 1.641 . . . . 0.0 111.746 176.112 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.4 tp -81.63 129.15 34.59 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.863 1.665 . . . . 0.0 106.852 168.401 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.01 132.86 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.669 1.188 . . . . 0.0 108.87 -176.226 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.9 m -137.46 163.02 32.1 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.205 1.802 . . . . 0.0 111.657 -172.229 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.4 t30 47.61 52.39 12.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.47 1.908 . . . . 0.0 113.158 -173.585 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.4 mt -84.22 168.87 15.32 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.834 1.654 . . . . 0.0 111.254 169.838 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.8 156.05 31.91 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.903 0.859 . . . . 0.0 112.039 169.624 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -77.41 -36.13 53.59 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.758 1.223 . . . . 0.0 112.15 -178.673 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.25 53.86 4.91 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.565 1.555 . . . . 0.0 112.539 -178.865 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.5 t -125.03 145.74 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.36 2.264 . . . . 0.0 111.57 -169.913 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.0 m -144.3 169.38 18.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.139 1.776 . . . . 0.0 111.819 -175.858 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -48.71 -57.82 5.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.773 2.029 . . . . 0.0 112.562 -178.089 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.19 87.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.189 1.395 . . . . 0.0 113.489 177.536 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.0 -52.2 66.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.151 0.98 . . . . 0.0 112.265 -179.839 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 36.2 mm -56.64 -52.45 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.882 0.873 . . . . 0.0 110.899 171.248 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -49.33 -56.18 10.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.014 0.926 . . . . 0.0 112.324 178.95 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -57.02 -52.37 65.55 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.853 0.861 . . . . 0.0 112.951 176.823 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.52 -46.43 90.19 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.893 0.77 . . . . 0.0 112.496 -176.851 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -65.09 -47.65 76.48 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.611 0.642 . . . . 0.0 112.438 174.492 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.52 64.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.244 1.017 . . . . 0.0 113.352 179.554 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.41 -45.29 72.9 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.43 1.092 . . . . 0.0 113.017 174.763 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -98.13 -19.06 18.15 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -177.41 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -159.98 153.51 24.49 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-N 120.356 1.435 . . . . 0.0 115.326 172.18 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 47.4 m -75.03 129.9 38.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.206 1.403 . . . . 0.0 111.42 -174.104 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 pp -135.62 147.04 48.49 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.643 1.177 . . . . 0.0 113.531 -174.032 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -73.91 -52.12 13.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.979 2.511 . . . . 0.0 110.246 170.03 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -150.07 153.37 36.32 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.144 1.778 . . . . 0.0 111.488 -177.727 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.55 133.82 27.97 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.929 1.691 . . . . 0.0 109.362 169.994 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.63 158.85 44.42 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.541 1.136 . . . . 0.0 113.754 -170.005 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 127.608 2.363 . . . . 0.0 108.67 169.901 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.912 0 CA-C-O 119.674 -0.514 . . . . 0.0 112.767 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.2 m -140.47 121.15 14.31 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.951 1.3 . . . . 0.0 111.528 -171.613 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.09 169.4 14.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.31 1.844 . . . . 0.0 113.232 -174.734 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -138.59 123.89 19.3 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.266 1.426 . . . . 0.0 110.832 -178.462 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.1 t -128.09 116.59 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.291 1.036 . . . . 0.0 110.904 -174.377 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -92.68 101.75 14.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.35 1.86 . . . . 0.0 108.336 179.062 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -77.38 166.56 22.97 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.653 1.981 . . . . 0.0 113.129 -178.753 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -54.26 -48.25 71.39 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 171.125 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -153.9 136.56 15.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 129.013 2.925 . . . . 0.0 109.516 -171.705 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -60.8 -37.87 83.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.086 0.954 . . . . 0.0 113.552 -176.825 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.4 -48.64 62.54 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.823 1.249 . . . . 0.0 113.093 169.999 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.12 -44.31 80.22 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.158 0.983 . . . . 0.0 112.021 173.654 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -51.87 -48.52 64.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.132 1.373 . . . . 0.0 112.853 175.12 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.5 tp -52.16 -43.47 64.12 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.49 1.916 . . . . 0.0 113.075 176.69 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -57.18 -55.19 37.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.111 0.965 . . . . 0.0 111.33 174.42 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.54 78.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.8 1.24 . . . . 0.0 112.55 175.263 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 23.6 ttp -50.61 -59.06 4.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.163 1.785 . . . . 0.0 111.272 175.488 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -56.43 -47.5 78.95 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.486 1.114 . . . . 0.0 112.44 177.572 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -58.26 -47.53 83.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.391 1.076 . . . . 0.0 113.279 179.118 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -95.22 -18.87 20.5 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -171.214 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -59.93 109.55 0.97 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 119.797 1.181 . . . . 0.0 110.591 169.684 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.25 -30.45 6.26 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.371 1.939 . . . . 0.0 113.714 -174.016 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.28 133.52 93.31 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 125.15 1.38 . . . . 0.0 110.766 -175.241 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.17 143.63 20.24 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.882 2.388 . . . . 0.0 112.94 -177.978 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 tp -125.29 107.38 10.65 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.85 2.06 . . . . 0.0 107.92 169.744 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 39.71 58.1 2.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.264 1.826 . . . . 0.0 112.463 -169.89 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.79 -45.4 2.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.122 1.344 . . . . 0.0 114.192 -179.563 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -73.13 116.59 52.3 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.23 1.412 . . . . 0.0 111.377 -171.012 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.8 114.54 3.74 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.68 2.253 . . . . 0.0 110.953 174.892 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.61 138.72 58.56 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.431 1.092 . . . . 0.0 111.754 -178.392 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -118.74 126.93 52.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.442 1.497 . . . . 0.0 109.586 175.236 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.6 mt -130.54 138.57 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.012 0.925 . . . . 0.0 111.173 -169.773 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -143.06 126.62 16.87 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.917 1.687 . . . . 0.0 111.518 -173.083 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.54 0.595 0 O-C-N 121.433 -0.792 . . . . 0.0 111.523 170.139 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.21 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -127.21 107.37 9.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.868 1.267 . . . . 0.0 110.413 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -108.91 105.56 15.16 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.283 1.833 . . . . 0.0 109.229 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.6 tp -89.51 132.86 34.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.775 2.03 . . . . 0.0 110.171 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.44 123.43 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.928 1.691 . . . . 0.0 109.379 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.3 m -127.01 160.38 31.3 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.774 1.629 . . . . 0.0 111.868 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.0 t30 54.37 46.34 25.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.519 1.928 . . . . 0.0 113.792 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 mt -78.48 157.29 28.95 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.151 1.381 . . . . 0.0 109.371 169.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.3 147.13 53.17 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.054 -1.029 . . . . 0.0 112.269 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -57.08 -28.8 62.93 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -81.8 -2.4 90.53 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.229 1.395 . . . . 0.0 115.375 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 80.9 t -66.78 140.19 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.122 1.461 . . . . 0.0 111.067 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.1 m -121.11 158.05 28.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.412 1.485 . . . . 0.0 112.694 -174.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.01 -57.34 10.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.345 1.858 . . . . 0.0 112.996 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.55 89.73 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.557 1.143 . . . . 0.0 113.242 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.11 -50.43 74.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.176 0.99 . . . . 0.0 112.099 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 mm -55.24 -52.18 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.124 0.97 . . . . 0.0 111.467 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -52.27 -51.74 56.75 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.846 0.859 . . . . 0.0 112.201 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -59.05 -53.39 58.94 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.98 1.312 . . . . 0.0 113.156 174.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.99 -43.16 99.55 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.29 0.95 . . . . 0.0 112.446 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -64.92 -41.73 95.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.73 -29.95 69.68 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 175.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.34 -57.08 12.65 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.068 0.947 . . . . 0.0 112.562 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -91.71 -16.68 26.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.95 -178.93 16.12 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.474 1.512 . . . . 0.0 114.84 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.57 107.46 12.44 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.448 1.899 . . . . 0.0 110.257 -169.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 pp -132.29 148.83 52.46 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -83.76 -51.49 7.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.725 2.41 . . . . 0.0 110.511 170.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.24 148.55 30.6 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.784 1.633 . . . . 0.0 111.374 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.61 131.83 23.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.902 1.281 . . . . 0.0 110.841 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.58 157.8 44.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.372 1.469 . . . . 0.0 113.063 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -119.89 152.96 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 126.486 1.914 . . . . 0.0 110.819 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -50.44 -46.54 56.59 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.661 1.984 . . . . 0.0 115.364 -169.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -62.76 124.44 21.04 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.852 0.861 . . . . 0.0 112.195 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -150.76 -71.28 0.17 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.5 1.12 . . . . 0.0 111.45 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -128.43 63.86 1.43 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.595 1.958 . . . . 0.0 108.549 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.3 p -152.41 -71.13 0.15 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.932 1.693 . . . . 0.0 111.548 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.92 56.76 12.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.166 1.365 . . . . 0.0 112.077 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.07 134.5 48.12 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.304 1.842 . . . . 0.0 111.328 -172.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 m -67.72 106.89 2.38 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.478 1.511 . . . . 0.0 111.664 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.5 tp -141.69 -73.89 0.32 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.452 1.501 . . . . 0.0 110.842 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.7 81.76 1.52 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.151 1.357 . . . . 0.0 111.63 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.8 m -147.48 144.59 28.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.831 1.652 . . . . 0.0 109.708 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -143.44 163.03 34.24 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.498 1.519 . . . . 0.0 112.478 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -143.02 133.97 25.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.155 1.382 . . . . 0.0 110.848 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.62 118.24 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.192 1.397 . . . . 0.0 110.004 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -81.75 100.75 9.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.661 1.585 . . . . 0.0 108.266 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -80.29 154.88 27.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.171 1.788 . . . . 0.0 112.724 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.19 -30.65 58.1 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.832 1.253 . . . . 0.0 111.733 169.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -141.04 116.26 9.97 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.218 1.807 . . . . 0.0 111.249 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -28.63 68.77 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.84 -48.17 81.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.881 0.872 . . . . 0.0 111.972 171.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.79 -39.51 94.43 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.675 1.19 . . . . 0.0 112.214 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.07 83.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.376 1.071 . . . . 0.0 112.508 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.8 tp -59.36 -44.33 92.73 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.187 1.395 . . . . 0.0 111.746 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -51.33 -55.21 19.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.781 1.232 . . . . 0.0 110.955 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.97 -48.3 76.06 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.383 1.073 . . . . 0.0 112.846 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 25.8 ttt -51.18 -60.54 3.0 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.831 1.653 . . . . 0.0 111.399 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -56.84 -44.98 82.63 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.132 0.973 . . . . 0.0 112.695 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -59.77 -44.51 93.84 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.854 1.262 . . . . 0.0 113.545 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -109.9 -16.69 13.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -59.8 115.37 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.34 1.427 . . . . 0.0 111.196 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.33 -24.78 26.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.992 1.758 . . . . 0.0 114.026 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.05 132.96 90.03 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 124.594 1.158 . . . . 0.0 110.628 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.45 142.27 23.47 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.932 2.421 . . . . 0.0 112.44 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 64.6 tp -128.14 105.32 8.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.647 1.979 . . . . 0.0 107.694 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 49.27 57.74 6.15 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.402 1.481 . . . . 0.0 111.272 -169.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.21 -54.06 4.93 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.311 1.434 . . . . 0.0 113.48 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -59.87 119.25 39.48 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 126.43 1.892 . . . . 0.0 112.103 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.58 120.7 6.87 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.952 2.435 . . . . 0.0 111.29 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.0 mtm -65.07 138.53 58.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.309 1.044 . . . . 0.0 111.059 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -122.47 125.53 46.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.643 1.177 . . . . 0.0 110.062 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.3 mt -124.46 141.19 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.508 1.123 . . . . 0.0 111.671 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -139.69 146.04 39.14 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.701 2.0 . . . . 0.0 110.869 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 66.5 tp -123.97 137.32 54.63 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.244 1.418 . . . . 0.0 111.889 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.73 148.13 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.307 2.243 . . . . 0.0 109.404 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 9.4 m -142.49 138.98 31.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.053 1.341 . . . . 0.0 109.974 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.413 1.885 . . . . 0.0 114.133 -178.688 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' HA3' ' HE2' ' A' ' 155' ' ' LYS . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -78.03 96.22 5.04 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.1 0.96 . . . . 0.0 110.963 -174.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -88.59 101.17 13.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.353 1.861 . . . . 0.0 107.426 169.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.4 tp -88.21 133.73 33.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.585 1.954 . . . . 0.0 110.028 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.89 136.84 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.41 1.484 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.0 m -140.34 167.92 21.03 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.451 1.9 . . . . 0.0 111.934 -171.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.7 t30 51.44 46.81 25.93 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.346 1.858 . . . . 0.0 113.006 -173.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -87.12 167.1 14.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.845 1.658 . . . . 0.0 109.993 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -75.45 150.58 38.24 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.964 -1.085 . . . . 0.0 110.603 169.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -49.44 -41.77 40.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.504 1.121 . . . . 0.0 113.546 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.71 9.46 73.85 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.712 1.625 . . . . 0.0 115.761 -173.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.45 147.54 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.046 1.423 . . . . 0.0 109.528 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -129.94 155.61 45.78 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -45.75 -58.14 3.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.527 2.331 . . . . 0.0 112.101 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.63 80.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.38 1.472 . . . . 0.0 113.168 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.12 -52.55 65.24 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.51 1.124 . . . . 0.0 112.143 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.5 mm -57.81 -51.52 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.739 1.216 . . . . 0.0 111.229 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -48.46 -54.21 15.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.939 1.295 . . . . 0.0 111.918 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.3 -53.75 53.88 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.663 0.785 . . . . 0.0 112.75 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.15 -45.12 89.87 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.799 0.727 . . . . 0.0 112.567 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -64.71 -43.25 94.03 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.786 0.721 . . . . 0.0 112.382 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.24 -32.77 66.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.62 -41.67 81.8 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.205 1.002 . . . . 0.0 113.16 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -113.25 -10.14 13.37 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.67 162.14 28.65 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.816 1.198 . . . . 0.0 114.382 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.26 108.55 19.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.764 1.626 . . . . 0.0 110.087 -169.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.9 pp -130.91 152.93 49.69 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.2 mmmt -93.56 -49.39 5.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.998 2.919 . . . . 0.0 111.111 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -145.87 143.02 29.34 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.228 1.411 . . . . 0.0 111.28 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -126.94 135.9 51.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.677 1.591 . . . . 0.0 110.556 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.3 166.09 25.65 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.796 2.038 . . . . 0.0 111.7 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 88.3 t -134.72 159.35 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.942 1.697 . . . . 0.0 110.8 -173.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -38.75 -48.61 1.52 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.772 2.029 . . . . 0.0 115.944 -171.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -65.88 -16.12 63.55 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -80.96 -55.28 4.89 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.569 169.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -68.03 -36.98 80.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.004 1.722 . . . . 0.0 113.754 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.8 m -135.65 -174.88 3.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.226 2.61 . . . . 0.0 110.867 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.59 -66.62 2.08 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 120.978 -1.076 . . . . 0.0 111.891 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.25 139.19 19.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.178 2.191 . . . . 0.0 109.494 173.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.5 m -127.31 173.28 9.9 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.601 1.16 . . . . 0.0 111.261 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.68 -40.18 78.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.486 0.714 . . . . 0.0 112.357 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.91 96.88 0.12 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.428 1.49 . . . . 0.0 111.169 171.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 65.4 p -139.19 156.37 47.16 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.684 1.193 . . . . 0.0 112.739 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.06 159.37 42.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.325 1.85 . . . . 0.0 111.378 172.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.63 115.03 9.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.734 1.614 . . . . 0.0 109.801 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.2 t -127.7 115.54 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.238 1.015 . . . . 0.0 110.249 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -80.83 104.75 11.55 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.366 1.467 . . . . 0.0 109.457 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -82.08 155.13 25.24 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.68 1.592 . . . . 0.0 112.163 171.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -80.46 -59.54 2.66 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.401 -0.812 . . . . 0.0 112.323 169.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -88.65 126.99 35.56 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.163 1.385 . . . . 0.0 111.441 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.411 ' HE2' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -62.72 -46.13 89.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.127 1.371 . . . . 0.0 111.822 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.45 -46.22 87.0 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.761 1.224 . . . . 0.0 112.306 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -65.75 -36.61 84.04 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.061 0.945 . . . . 0.0 112.928 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.02 -48.17 83.03 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.291 -0.88 . . . . 0.0 111.936 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.96 -42.79 90.7 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.551 1.14 . . . . 0.0 112.377 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -51.74 -57.79 8.26 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.777 1.631 . . . . 0.0 110.427 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.11 60.48 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.725 1.21 . . . . 0.0 112.425 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 21.9 ttt -49.62 -62.45 1.55 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.162 1.385 . . . . 0.0 111.667 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -57.57 -49.16 77.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.622 1.169 . . . . 0.0 112.974 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -63.24 -48.01 80.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.868 0.867 . . . . 0.0 113.258 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.05 -13.74 24.91 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -60.28 108.27 0.77 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.87 1.214 . . . . 0.0 110.739 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 119.06 -30.63 5.78 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.345 1.926 . . . . 0.0 113.933 -173.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.4 134.57 90.96 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.168 1.387 . . . . 0.0 110.635 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.41 146.05 24.32 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.822 2.348 . . . . 0.0 113.334 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 37.3 tp -135.65 108.53 7.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.762 1.625 . . . . 0.0 108.425 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 50.16 63.25 2.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.694 1.597 . . . . 0.0 111.654 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.48 -63.05 4.53 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.174 1.369 . . . . 0.0 113.384 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -63.56 131.94 95.01 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.184 1.393 . . . . 0.0 112.408 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 123.61 9.38 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.749 2.966 . . . . 0.0 111.694 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.17 132.28 49.92 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.289 1.035 . . . . 0.0 111.55 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -110.14 130.38 55.55 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.2 1.4 . . . . 0.0 109.124 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.3 mt -128.59 143.37 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.846 0.859 . . . . 0.0 111.857 -169.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -140.06 146.18 38.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.243 2.217 . . . . 0.0 110.431 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -132.79 129.3 38.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.099 1.36 . . . . 0.0 110.581 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.58 142.71 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.958 1.303 . . . . 0.0 111.797 171.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 6.3 m -64.36 148.1 51.13 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.595 1.958 . . . . 0.0 113.071 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 127.075 2.15 . . . . 0.0 113.851 173.839 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.04 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -102.94 119.59 39.12 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.14 1.376 . . . . 0.0 110.64 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 87.6 mt -127.34 131.72 50.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.494 1.518 . . . . 0.0 111.618 -171.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.9 tp -77.42 137.99 39.01 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.481 1.513 . . . . 0.0 109.091 169.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.9 122.75 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.324 1.85 . . . . 0.0 108.087 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.9 m -133.75 169.24 17.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.917 1.287 . . . . 0.0 112.937 -169.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.3 t30 54.81 46.18 25.07 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.788 2.035 . . . . 0.0 113.079 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 mt -82.37 165.59 20.16 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.485 1.514 . . . . 0.0 110.057 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.48 145.87 43.22 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.006 -1.058 . . . . 0.0 111.317 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -58.03 -26.37 62.35 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.59 -1.56 90.09 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.117 1.341 . . . . 0.0 115.477 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.4 138.39 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.229 1.514 . . . . 0.0 111.232 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.2 m -113.45 155.9 24.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.172 1.389 . . . . 0.0 113.124 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.05 -57.27 11.69 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.604 1.961 . . . . 0.0 112.991 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.29 93.45 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.214 1.005 . . . . 0.0 112.919 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -56.86 -50.42 72.52 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.294 -0.879 . . . . 0.0 111.853 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.1 mm -55.15 -53.38 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.446 1.098 . . . . 0.0 111.741 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -47.84 -59.47 3.3 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.611 0.765 . . . . 0.0 111.76 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -63.54 -43.28 97.57 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -47.0 81.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.743 1.156 . . . . 0.0 111.93 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -64.71 -40.69 95.78 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.99 -17.11 61.75 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.33 -59.03 3.11 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.915 -1.116 . . . . 0.0 111.786 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -88.16 -21.85 24.38 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.13 -178.31 15.26 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.652 1.596 . . . . 0.0 113.234 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.6 m -125.21 122.31 36.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.238 1.415 . . . . 0.0 109.549 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.66 147.09 52.33 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -91.2 -34.89 14.82 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.454 1.902 . . . . 0.0 110.949 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -137.16 142.35 42.2 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.962 1.305 . . . . 0.0 112.41 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.42 128.96 12.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.478 1.511 . . . . 0.0 109.992 169.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.0 153.25 37.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.666 1.186 . . . . 0.0 112.876 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.83 149.22 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.488 1.915 . . . . 0.0 110.009 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -51.92 -40.23 60.4 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -68.94 159.17 33.19 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -144.92 -59.15 0.36 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.255 1.422 . . . . 0.0 111.709 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -130.82 -45.55 1.05 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.934 1.693 . . . . 0.0 113.205 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.8 p -55.45 -53.63 53.85 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.355 1.862 . . . . 0.0 114.052 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.57 39.73 78.56 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.011 1.291 . . . . 0.0 113.028 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -60.06 152.39 24.19 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.299 1.839 . . . . 0.0 113.243 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 39.5 m -73.13 82.09 1.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.088 1.355 . . . . 0.0 111.399 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 50.0 tp -146.39 152.05 38.45 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.998 2.119 . . . . 0.0 109.737 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.99 70.4 0.52 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.019 1.295 . . . . 0.0 111.996 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 55.6 p -133.7 146.21 50.6 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.315 1.446 . . . . 0.0 112.81 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.41 171.99 15.67 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.291 2.236 . . . . 0.0 111.35 -174.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -143.68 135.86 26.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.889 1.676 . . . . 0.0 110.46 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.51 129.23 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.585 1.154 . . . . 0.0 110.064 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -109.1 96.91 6.63 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.357 1.463 . . . . 0.0 108.889 173.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -73.03 140.41 47.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.005 2.122 . . . . 0.0 110.103 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.81 -16.97 63.37 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 28.8 mtm105 -134.82 134.12 40.49 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.224 1.81 . . . . 0.0 110.893 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -55.27 -46.63 76.13 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.208 1.403 . . . . 0.0 112.575 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.96 -51.56 61.06 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.256 1.022 . . . . 0.0 112.028 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.55 -41.39 98.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.626 1.17 . . . . 0.0 113.077 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.67 -56.56 17.88 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.692 1.197 . . . . 0.0 111.637 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.18 -42.28 90.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.254 1.422 . . . . 0.0 112.561 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -52.12 -61.69 2.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.162 1.385 . . . . 0.0 110.89 170.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.01 -47.86 67.99 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.657 1.183 . . . . 0.0 112.601 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 35.8 ttp -51.13 -60.72 2.81 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.411 1.484 . . . . 0.0 111.29 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -59.3 -45.04 92.38 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.87 1.268 . . . . 0.0 112.879 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -58.71 -48.37 81.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.483 1.113 . . . . 0.0 113.362 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -103.48 -17.33 15.26 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -60.85 111.13 1.53 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 120.273 1.397 . . . . 0.0 111.142 170.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.05 -22.46 27.44 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.146 1.831 . . . . 0.0 114.39 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 76.3 t -70.12 133.18 87.85 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 118.573 1.186 . . . . 0.0 110.83 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.14 139.14 21.13 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.898 2.398 . . . . 0.0 112.505 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.0 tp -126.65 106.16 9.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.671 1.988 . . . . 0.0 107.887 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 47.86 57.89 5.58 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.484 1.513 . . . . 0.0 111.321 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.64 -54.4 4.8 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.228 1.394 . . . . 0.0 113.468 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.44 119.07 43.33 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.962 1.705 . . . . 0.0 112.44 -172.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.09 117.83 5.36 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.884 2.389 . . . . 0.0 111.076 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.53 141.43 58.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.596 1.158 . . . . 0.0 111.906 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -122.91 130.86 53.37 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.326 1.45 . . . . 0.0 110.249 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.7 mm -117.48 133.35 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.533 1.133 . . . . 0.0 109.918 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -140.34 151.56 45.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.835 1.254 . . . . 0.0 112.684 -171.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -134.72 174.47 10.54 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.839 2.056 . . . . 0.0 112.052 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.66 103.53 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.111 1.364 . . . . 0.0 108.822 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.0 p -65.95 -54.53 25.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.554 1.142 . . . . 0.0 112.188 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.25 1.115 0 C-N-CA 127.176 2.19 . . . . 0.0 112.145 179.909 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -75.65 126.75 31.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.979 1.312 . . . . 0.0 111.74 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -137.69 111.45 8.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.514 1.926 . . . . 0.0 110.274 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.2 tp -85.52 132.78 34.14 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.769 2.028 . . . . 0.0 110.062 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.2 t -122.47 112.74 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.428 1.491 . . . . 0.0 108.447 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.7 m -117.91 164.13 15.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.311 1.044 . . . . 0.0 111.887 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 54.73 47.67 21.94 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.324 1.85 . . . . 0.0 114.217 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.28 152.41 32.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.907 1.283 . . . . 0.0 108.932 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.71 147.36 53.37 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.869 -1.144 . . . . 0.0 110.789 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -54.93 -28.68 52.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.488 1.115 . . . . 0.0 113.881 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.67 1.02 85.32 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.329 1.442 . . . . 0.0 115.779 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.6 t -66.7 114.75 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.926 1.863 . . . . 0.0 110.484 175.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.5 m -70.73 151.99 44.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.784 1.234 . . . . 0.0 112.598 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -55.18 -48.52 73.67 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.486 1.514 . . . . 0.0 112.751 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.19 76.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.221 1.408 . . . . 0.0 113.665 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -58.5 -53.86 53.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.116 0.966 . . . . 0.0 112.807 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.5 mm -54.59 -55.48 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.342 1.057 . . . . 0.0 110.999 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -49.34 -55.74 11.86 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.255 1.422 . . . . 0.0 111.875 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.43 -49.81 76.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.533 1.133 . . . . 0.0 113.311 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -43.92 95.83 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.215 0.916 . . . . 0.0 111.417 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -66.71 -44.98 80.17 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.862 1.265 . . . . 0.0 112.708 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.0 -14.42 54.0 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.78 -63.46 1.07 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.919 -1.113 . . . . 0.0 111.479 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -83.28 -21.11 33.38 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.4 -168.76 11.68 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.151 1.834 . . . . 0.0 112.921 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 m -140.91 129.23 22.37 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.42 1.088 . . . . 0.0 110.618 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -136.54 152.57 50.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -171.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -83.0 -51.81 7.23 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.74 2.416 . . . . 0.0 111.133 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -146.54 147.92 31.64 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.084 1.353 . . . . 0.0 112.387 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.36 137.55 27.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.954 1.702 . . . . 0.0 110.825 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.42 116.19 6.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.727 1.211 . . . . 0.0 112.557 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.08 142.8 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.486 1.514 . . . . 0.0 109.755 169.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -45.57 -46.35 14.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 127.257 2.223 . . . . 0.0 115.034 -169.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -56.78 -18.17 11.77 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -174.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -50.0 -36.32 28.07 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.994 1.717 . . . . 0.0 112.613 169.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -137.5 -45.75 0.55 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.305 1.842 . . . . 0.0 114.101 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.2 m -77.24 95.96 4.44 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.838 1.255 . . . . 0.0 110.932 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.1 58.96 4.32 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.004 0.811 . . . . 0.0 113.312 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -142.1 164.96 28.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.598 1.559 . . . . 0.0 113.679 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.9 m -73.21 113.24 10.05 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.481 1.112 . . . . 0.0 109.084 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 60.5 tp -147.8 -76.52 0.17 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.017 1.327 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.52 77.65 1.36 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.124 1.345 . . . . 0.0 111.41 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.2 m -150.5 153.06 35.16 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.64 1.576 . . . . 0.0 109.757 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.55 156.69 43.85 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.266 1.426 . . . . 0.0 112.513 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -123.2 131.67 53.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.816 1.646 . . . . 0.0 109.805 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.01 144.3 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.33 1.452 . . . . 0.0 109.722 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -126.29 102.78 7.33 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.99 1.716 . . . . 0.0 108.949 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -78.13 166.38 22.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.869 1.668 . . . . 0.0 112.706 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -61.31 -35.39 77.23 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.085 0.954 . . . . 0.0 112.796 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.74 147.03 34.93 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.44 1.496 . . . . 0.0 112.474 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -55.07 -46.02 75.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.437 1.495 . . . . 0.0 112.587 170.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -50.95 -48.11 60.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.395 1.078 . . . . 0.0 112.8 172.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.21 -39.17 82.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.1 0.96 . . . . 0.0 112.568 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.08 -45.85 86.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.72 0.808 . . . . 0.0 112.035 169.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.63 -44.15 96.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.372 1.469 . . . . 0.0 111.839 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -52.7 -54.54 32.16 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.185 1.394 . . . . 0.0 111.408 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.52 -51.67 58.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.772 1.229 . . . . 0.0 112.378 173.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 30.8 ttp -52.54 -62.4 1.67 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.581 1.552 . . . . 0.0 111.286 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -57.14 -45.15 83.79 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.742 1.217 . . . . 0.0 112.755 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.87 -46.69 89.6 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.351 1.06 . . . . 0.0 113.042 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -107.75 -12.28 15.25 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -169.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -59.23 119.54 7.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.294 1.406 . . . . 0.0 111.583 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.89 -18.22 57.54 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.019 1.771 . . . . 0.0 114.323 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -72.29 128.09 89.35 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 118.839 1.319 . . . . 0.0 111.077 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.12 136.16 71.0 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.943 3.096 . . . . 0.0 113.844 172.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.0 tp -133.77 103.46 5.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.495 1.518 . . . . 0.0 107.567 169.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 51.32 62.28 2.79 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.8 1.64 . . . . 0.0 111.08 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.86 -61.64 4.71 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.467 1.508 . . . . 0.0 113.343 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -65.09 125.2 88.77 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.681 1.592 . . . . 0.0 112.118 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.8 126.23 9.96 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.486 2.791 . . . . 0.0 111.631 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -68.29 120.54 14.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.312 1.045 . . . . 0.0 111.797 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -94.17 103.49 15.53 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.92 1.288 . . . . 0.0 108.921 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -113.5 134.23 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.311 1.045 . . . . 0.0 110.862 -169.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -142.59 123.0 13.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.534 1.534 . . . . 0.0 112.157 -171.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.32 122.44 24.43 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 169.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.85 80.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 122.488 1.137 . . . . 0.0 112.051 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 7.6 p -80.25 135.0 36.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.66 1.184 . . . . 0.0 111.445 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 37.1 m . . . . . 0 C--O 1.252 1.215 0 C-N-CA 126.583 1.953 . . . . 0.0 113.945 -178.163 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 CA-C-O 121.427 0.46 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -139.59 150.75 45.39 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.372 1.469 . . . . 0.0 112.08 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.5 mt -125.42 144.52 50.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.964 1.706 . . . . 0.0 111.204 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.5 tp -117.02 99.91 7.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.874 1.669 . . . . 0.0 107.579 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.21 129.18 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.594 1.557 . . . . 0.0 108.174 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.6 m -133.28 170.85 14.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.249 1.42 . . . . 0.0 111.947 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.3 t30 56.93 38.48 29.42 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.207 1.803 . . . . 0.0 113.269 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.07 165.31 20.72 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.294 1.437 . . . . 0.0 110.552 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.76 144.34 52.75 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.39 -0.819 . . . . 0.0 109.811 168.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -56.63 -33.68 66.54 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.94 27.76 16.35 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.499 1.523 . . . . 0.0 115.244 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.59 124.74 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 118.912 1.356 . . . . 0.0 109.652 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.8 m -72.0 135.21 46.31 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.548 0.739 . . . . 0.0 112.031 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.38 -47.74 80.87 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.493 1.117 . . . . 0.0 112.935 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.38 -46.91 76.5 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.689 1.196 . . . . 0.0 112.702 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.27 -48.03 81.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.179 0.992 . . . . 0.0 112.117 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 mm -55.37 -53.65 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.454 1.102 . . . . 0.0 112.087 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -50.16 -55.39 15.29 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.697 0.681 . . . . 0.0 111.474 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -56.66 -52.06 66.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.483 1.113 . . . . 0.0 113.228 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.31 -44.92 90.09 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.12 0.873 . . . . 0.0 112.367 -175.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -63.48 -43.48 97.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.579 0.627 . . . . 0.0 112.557 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.2 -19.6 64.66 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.27 -63.24 1.12 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.185 0.994 . . . . 0.0 111.724 172.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.08 -19.17 44.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -138.32 -177.33 15.18 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.336 1.446 . . . . 0.0 113.959 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.7 m -124.62 116.11 21.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.512 1.525 . . . . 0.0 110.238 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.92 144.72 50.57 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -169.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -81.6 -42.71 19.67 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.947 2.099 . . . . 0.0 109.991 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -147.31 145.47 29.37 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.687 1.595 . . . . 0.0 111.915 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.16 114.7 7.62 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.894 1.677 . . . . 0.0 108.126 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.63 113.37 10.96 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.613 1.165 . . . . 0.0 112.165 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.79 153.9 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.325 1.45 . . . . 0.0 110.469 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -42.94 -48.55 5.91 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.715 2.006 . . . . 0.0 115.829 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -73.57 148.59 42.82 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -145.65 -63.68 0.33 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.984 1.714 . . . . 0.0 109.298 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -133.75 77.15 1.7 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.965 2.506 . . . . 0.0 105.394 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 m -135.84 166.31 23.6 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.225 1.41 . . . . 0.0 113.928 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -163.51 65.01 0.24 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.151 1.357 . . . . 0.0 112.158 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -136.41 148.72 47.93 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.16 1.784 . . . . 0.0 112.107 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 55.1 m -74.37 86.12 1.99 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.96 1.304 . . . . 0.0 109.955 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.6 tp -140.73 142.63 34.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.326 2.25 . . . . 0.0 109.161 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.39 70.75 0.41 Allowed Glycine 0 N--CA 1.469 0.86 0 C-N-CA 123.855 0.74 . . . . 0.0 113.025 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.5 p -136.79 158.73 43.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.199 1.4 . . . . 0.0 112.958 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.73 138.43 23.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.496 1.518 . . . . 0.0 111.849 172.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -106.92 124.9 50.29 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.578 1.951 . . . . 0.0 110.431 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.3 t -129.34 139.31 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.008 1.323 . . . . 0.0 110.115 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -128.96 120.33 25.91 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.919 2.088 . . . . 0.0 109.199 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -103.31 163.59 12.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.581 1.952 . . . . 0.0 113.341 -169.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.35 -36.13 58.36 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 169.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 42.5 mtm-85 -133.77 129.1 36.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.082 1.753 . . . . 0.0 111.278 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -54.68 -45.87 74.0 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.597 1.559 . . . . 0.0 113.083 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.65 -46.72 70.66 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.925 1.29 . . . . 0.0 112.801 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.08 -42.84 93.76 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.466 1.106 . . . . 0.0 112.696 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.22 71.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.707 0.803 . . . . 0.0 111.734 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.65 -47.03 80.66 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.535 1.134 . . . . 0.0 112.58 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -50.81 -58.96 4.66 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.863 1.265 . . . . 0.0 111.165 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.4 -48.12 62.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.355 1.062 . . . . 0.0 112.659 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -55.29 -65.55 0.57 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.071 1.348 . . . . 0.0 111.322 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -61.61 -34.11 75.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -64.05 -42.02 97.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.524 1.13 . . . . 0.0 113.403 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -110.66 -18.43 13.16 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -59.24 115.4 3.18 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.875 1.216 . . . . 0.0 111.19 170.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 103.78 -23.46 32.47 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.857 1.694 . . . . 0.0 114.403 -175.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.8 134.87 90.06 Favored Pre-proline 0 N--CA 1.477 0.924 0 CA-C-N 118.643 1.221 . . . . 0.0 110.216 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.35 141.85 29.29 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.671 2.248 . . . . 0.0 112.93 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -125.33 99.97 6.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.46 2.304 . . . . 0.0 106.855 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 44.02 70.53 0.31 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.992 1.717 . . . . 0.0 111.902 -169.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.6 -57.63 5.05 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.781 1.657 . . . . 0.0 113.531 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -65.76 122.76 82.33 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.996 2.119 . . . . 0.0 112.369 -172.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.79 123.87 10.15 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.867 2.378 . . . . 0.0 111.088 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.1 mtm -61.61 123.6 18.34 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.064 0.945 . . . . 0.0 111.091 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -106.83 104.89 14.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.236 1.414 . . . . 0.0 109.123 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.3 mt -106.76 130.31 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.144 0.978 . . . . 0.0 110.85 -172.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -109.43 147.08 33.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.531 1.933 . . . . 0.0 109.627 173.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -132.73 150.0 52.21 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.249 1.419 . . . . 0.0 112.386 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.45 127.56 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.51 0.724 . . . . 0.0 111.343 175.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.6 p -68.21 -58.77 3.91 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.396 1.478 . . . . 0.0 111.959 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.251 1.159 0 C-N-CA 127.134 2.174 . . . . 0.0 113.76 177.01 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.9 0 CA-C-O 120.823 0.124 . . . . 0.0 113.153 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -117.58 103.73 10.35 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.08 1.752 . . . . 0.0 109.626 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -88.55 105.37 17.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.575 2.35 . . . . 0.0 108.994 -173.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.1 tp -88.88 122.65 32.48 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.756 2.022 . . . . 0.0 109.983 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.8 t -112.11 136.55 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.101 1.76 . . . . 0.0 109.115 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.2 m -137.52 163.13 31.9 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.188 1.795 . . . . 0.0 112.307 -174.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.1 t30 57.01 33.5 23.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.933 2.093 . . . . 0.0 113.918 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.9 mt -72.0 159.03 34.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.139 0.975 . . . . 0.0 110.28 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.83 139.81 57.78 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.535 -0.728 . . . . 0.0 110.571 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.75 -20.9 62.33 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.82 11.9 62.59 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.717 1.627 . . . . 0.0 115.558 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.06 123.99 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.719 1.76 . . . . 0.0 110.33 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.6 m -81.84 149.13 28.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.445 1.098 . . . . 0.0 113.105 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.34 -54.11 50.56 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.85 1.66 . . . . 0.0 112.69 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -39.33 81.81 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.57 1.148 . . . . 0.0 112.951 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.43 -51.05 71.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.835 0.854 . . . . 0.0 111.979 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.9 mm -55.0 -53.06 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.922 0.889 . . . . 0.0 111.511 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.07 -55.32 15.34 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.796 0.839 . . . . 0.0 111.973 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -59.55 -50.96 71.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.964 1.306 . . . . 0.0 113.212 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -63.36 -43.55 97.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.271 0.941 . . . . 0.0 111.886 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -63.4 -44.99 93.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.062 0.545 . . . . 0.0 112.427 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.03 -31.87 67.42 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.5 -52.53 65.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.265 1.026 . . . . 0.0 112.77 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -95.59 -23.67 16.94 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.29 162.04 23.62 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.373 1.463 . . . . 0.0 114.458 -172.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 37.5 m -102.49 103.34 13.7 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.471 1.508 . . . . 0.0 110.424 -173.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -121.48 165.05 16.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 -35.88 2.85 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.776 2.431 . . . . 0.0 111.557 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -140.58 151.09 44.41 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.61 0.764 . . . . 0.0 111.924 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.25 141.89 35.82 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.738 1.615 . . . . 0.0 110.446 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -146.92 152.33 38.49 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.983 1.713 . . . . 0.0 111.608 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.0 t -132.14 147.0 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.1 1.76 . . . . 0.0 109.875 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -55.14 -40.92 71.13 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -58.08 155.94 10.26 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -168.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -143.65 -175.6 4.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 128.685 2.794 . . . . 0.0 108.095 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -46.57 -39.35 10.87 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.722 1.609 . . . . 0.0 114.177 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.7 m -60.4 -32.19 71.09 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.315 1.846 . . . . 0.0 114.598 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 60.64 50.58 65.99 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.833 1.682 . . . . 0.0 114.398 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -66.76 144.96 56.02 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.737 1.215 . . . . 0.0 113.83 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 45.7 m -73.61 94.59 2.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.691 1.596 . . . . 0.0 111.186 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.7 tp -143.89 -66.16 0.36 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.741 1.616 . . . . 0.0 110.745 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.3 68.14 1.52 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.873 0.749 . . . . 0.0 113.344 171.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 78.1 p -137.08 155.69 49.32 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.469 1.108 . . . . 0.0 112.257 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -143.69 158.81 43.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.417 1.487 . . . . 0.0 111.649 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -139.84 120.63 14.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.533 1.533 . . . . 0.0 110.135 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 51.5 t -124.52 118.7 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.143 1.377 . . . . 0.0 109.723 -174.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -93.04 105.55 17.64 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.712 1.205 . . . . 0.0 108.502 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -82.6 152.38 25.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.643 2.777 . . . . 0.0 112.103 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -62.93 -48.36 79.24 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.153 0.581 . . . . 0.0 112.276 170.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -123.92 138.44 54.48 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.854 1.262 . . . . 0.0 112.302 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -59.24 -46.75 87.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.559 1.544 . . . . 0.0 112.966 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.72 62.64 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.764 1.226 . . . . 0.0 113.484 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.51 -43.28 85.71 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.834 0.853 . . . . 0.0 112.32 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.87 -46.51 84.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.101 0.96 . . . . 0.0 112.514 170.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.85 -47.75 79.64 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.941 2.097 . . . . 0.0 111.182 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -51.65 -52.91 44.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.425 1.09 . . . . 0.0 111.841 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.1 -47.03 78.82 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.732 0.813 . . . . 0.0 112.845 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 41.1 ttp -53.1 -60.7 2.96 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.466 1.507 . . . . 0.0 111.454 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -35.64 80.95 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -61.63 -45.93 91.95 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.381 1.072 . . . . 0.0 113.166 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -106.11 -17.38 14.34 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 -169.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -59.65 114.75 2.9 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.204 1.366 . . . . 0.0 111.335 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.71 -23.47 26.02 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.178 1.846 . . . . 0.0 114.138 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 65.7 t -67.82 131.97 92.49 Favored Pre-proline 0 N--CA 1.476 0.866 0 CA-C-N 118.596 1.198 . . . . 0.0 110.886 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.92 121.54 5.46 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.309 2.673 . . . . 0.0 111.972 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 24.2 tp -77.55 79.2 4.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.196 1.399 . . . . 0.0 109.266 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 45.96 35.88 2.66 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.675 1.99 . . . . 0.0 113.633 -170.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 144.04 -79.94 0.24 Allowed Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.916 1.722 . . . . 0.0 112.561 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -64.11 127.06 91.46 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.172 1.389 . . . . 0.0 112.762 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.73 122.5 7.37 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.19 2.593 . . . . 0.0 111.788 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.1 mtm -66.73 136.19 55.13 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.048 0.939 . . . . 0.0 110.959 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -118.02 129.29 55.49 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.723 1.209 . . . . 0.0 109.735 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.5 mt -129.87 141.12 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.944 0.897 . . . . 0.0 112.282 -169.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -137.53 154.3 49.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.835 2.454 . . . . 0.0 110.482 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 64.8 tp -134.02 133.5 41.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.045 1.338 . . . . 0.0 111.493 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.1 m -136.64 162.39 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.118 1.767 . . . . 0.0 111.135 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.5 m -69.12 -54.52 14.55 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.376 -0.827 . . . . 0.0 110.199 169.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 128.817 2.847 . . . . 0.0 111.408 172.372 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.47 167.09 31.51 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 118.8 1.3 . . . . 0.0 112.628 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 89.5 mt -142.23 162.57 35.14 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.037 2.135 . . . . 0.0 111.678 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.8 tp -123.86 106.64 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.199 1.8 . . . . 0.0 106.917 168.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.94 129.39 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.8 m -129.78 171.9 12.21 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.68 1.192 . . . . 0.0 111.701 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.7 t30 50.77 65.07 1.58 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.876 1.671 . . . . 0.0 112.727 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.48 153.95 21.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.872 2.069 . . . . 0.0 109.685 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.44 143.81 57.46 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.737 -1.227 . . . . 0.0 110.588 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -53.4 -34.3 57.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.197 0.999 . . . . 0.0 113.567 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.23 9.0 78.67 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.343 1.449 . . . . 0.0 115.786 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.93 121.26 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.679 1.739 . . . . 0.0 109.919 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.8 m -72.78 146.31 46.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.459 1.104 . . . . 0.0 113.235 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.3 -58.32 8.78 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.798 1.639 . . . . 0.0 113.165 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.79 -37.19 78.42 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.957 0.903 . . . . 0.0 113.001 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.0 -52.31 66.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.815 0.846 . . . . 0.0 112.072 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.6 mm -54.04 -53.31 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.985 0.914 . . . . 0.0 111.318 169.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -52.32 -52.57 52.36 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.146 0.979 . . . . 0.0 112.092 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.84 -50.78 70.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.899 1.28 . . . . 0.0 113.435 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.6 -45.2 91.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.524 1.056 . . . . 0.0 112.275 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -63.0 -40.15 96.91 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.528 0.604 . . . . 0.0 112.37 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.48 -13.57 52.71 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -73.59 -61.67 1.75 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.906 -1.121 . . . . 0.0 111.252 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -85.68 -12.05 52.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.4 166.48 24.47 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.138 1.827 . . . . 0.0 112.883 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.4 m -111.99 97.72 6.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.573 1.549 . . . . 0.0 109.665 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 152' ' ' PHE . 3.7 pp -118.34 144.03 46.18 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -169.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.41 -48.62 15.09 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.803 2.041 . . . . 0.0 110.702 171.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -152.43 149.05 28.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.743 1.217 . . . . 0.0 112.362 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.58 130.41 24.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.591 1.556 . . . . 0.0 109.708 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.15 109.87 8.63 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.465 1.506 . . . . 0.0 111.544 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.9 t -76.2 152.28 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.18 1.792 . . . . 0.0 111.442 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -47.0 -45.29 20.96 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.135 2.574 . . . . 0.0 116.919 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -71.78 162.96 28.67 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -173.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -143.03 -138.09 0.1 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.682 1.593 . . . . 0.0 109.469 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -61.3 -45.12 95.77 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.602 -1.311 . . . . 0.0 110.637 169.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 m -63.74 137.06 57.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 112.014 169.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.81 65.95 2.83 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.752 1.168 . . . . 0.0 112.31 173.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -57.37 144.36 36.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.847 2.059 . . . . 0.0 112.46 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.1 m -123.85 84.23 2.25 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.259 1.424 . . . . 0.0 110.024 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 68.1 tp -131.67 -68.66 0.64 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.82 1.648 . . . . 0.0 110.944 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.67 64.99 1.05 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.915 0.769 . . . . 0.0 113.743 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.6 p -140.69 167.51 22.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.229 1.812 . . . . 0.0 111.179 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.45 125.9 12.4 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.28 1.432 . . . . 0.0 111.555 169.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.16 123.97 28.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.446 1.498 . . . . 0.0 109.849 170.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.7 140.38 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 118.907 0.776 . . . . 0.0 111.122 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -126.12 127.8 46.34 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.024 1.729 . . . . 0.0 110.176 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 131' ' ' LEU . 30.8 m-85 -110.6 158.83 18.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.19 2.196 . . . . 0.0 113.964 -169.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -76.26 -29.63 57.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.626 0.77 . . . . 0.0 112.858 170.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -141.27 129.38 22.1 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.466 1.506 . . . . 0.0 112.087 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -40.05 83.08 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.935 1.694 . . . . 0.0 112.914 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.81 -51.61 68.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.117 0.967 . . . . 0.0 112.334 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.49 -46.47 86.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.274 1.03 . . . . 0.0 112.059 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.6 -50.78 67.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.524 1.13 . . . . 0.0 112.374 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.48 -48.0 80.4 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.541 1.536 . . . . 0.0 112.102 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.25 -52.72 60.46 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.324 1.45 . . . . 0.0 112.319 172.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.87 -50.85 67.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.903 1.281 . . . . 0.0 112.011 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.9 ttt -52.19 -59.73 4.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.791 1.636 . . . . 0.0 112.032 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -51.98 -45.56 64.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.538 1.135 . . . . 0.0 112.557 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.31 -52.34 64.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.516 1.127 . . . . 0.0 113.063 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -95.82 -12.56 25.09 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -169.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -58.91 118.57 5.92 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.764 -1.21 . . . . 0.0 111.139 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.6 -16.74 54.55 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.54 1.543 . . . . 0.0 114.598 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 85.0 t -69.27 126.77 92.94 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 119.11 1.455 . . . . 0.0 110.702 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -60.16 136.93 72.08 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.773 2.982 . . . . 0.0 114.195 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 50.9 tp -136.87 101.33 4.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.503 1.521 . . . . 0.0 108.079 169.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 52.08 65.37 1.52 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.228 1.811 . . . . 0.0 111.986 -169.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.42 -65.5 4.11 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.784 1.183 . . . . 0.0 112.916 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -58.91 125.89 79.2 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.243 1.417 . . . . 0.0 112.22 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.74 127.37 12.26 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.241 2.628 . . . . 0.0 111.252 170.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.5 mtm -62.26 111.87 2.16 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.203 1.001 . . . . 0.0 111.401 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -93.2 91.56 7.33 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.362 1.465 . . . . 0.0 109.104 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 15.6 mt -89.91 138.54 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.425 1.09 . . . . 0.0 110.432 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -128.39 137.46 51.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.663 1.985 . . . . 0.0 110.875 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -11.86 61.18 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -170.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 9.3 p -153.83 158.52 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.949 2.099 . . . . 0.0 109.72 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.97 135.82 56.1 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.175 -0.953 . . . . 0.0 111.76 169.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.025 1.73 . . . . 0.0 113.674 -179.394 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -85.86 116.23 23.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.897 1.279 . . . . 0.0 109.316 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.39 101.16 7.96 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.51 1.924 . . . . 0.0 109.095 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.3 tp -83.47 133.1 34.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.26 1.824 . . . . 0.0 109.985 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.3 81.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.847 2.059 . . . . 0.0 108.419 -173.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.6 m -79.72 158.14 27.0 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.72 1.208 . . . . 0.0 112.491 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.1 t30 57.89 64.65 1.48 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.381 1.872 . . . . 0.0 113.212 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.3 mt -98.38 -116.01 0.14 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.696 1.998 . . . . 0.0 108.738 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -149.34 148.27 29.31 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.313 1.845 . . . . 0.0 110.436 172.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -74.16 71.59 1.67 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.921 1.688 . . . . 0.0 111.442 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 152.19 7.69 0.11 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.388 1.47 . . . . 0.0 116.168 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.1 t -58.35 128.8 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.485 1.643 . . . . 0.0 110.513 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.2 m -70.06 147.51 49.95 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.322 1.049 . . . . 0.0 112.46 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.86 -57.86 10.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.508 0.723 . . . . 0.0 111.651 174.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.51 -39.32 67.48 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.886 1.275 . . . . 0.0 113.239 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.65 -58.16 9.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.111 0.964 . . . . 0.0 112.039 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.8 mm -56.73 -52.28 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.438 1.095 . . . . 0.0 111.407 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -48.56 -57.54 6.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.862 1.665 . . . . 0.0 111.549 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.17 -49.28 76.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.725 1.21 . . . . 0.0 113.229 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.34 -43.41 97.8 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.671 1.123 . . . . 0.0 112.167 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -63.09 -43.96 97.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.224 0.61 . . . . 0.0 112.312 172.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.44 -19.84 63.9 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.28 -61.54 1.73 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.971 -1.081 . . . . 0.0 111.887 173.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -80.41 -25.58 38.97 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.08 -175.05 13.61 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.334 1.445 . . . . 0.0 113.53 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.6 m -127.13 122.58 34.61 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.052 . . . . 0.0 110.99 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.4 142.02 51.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.648 1.179 . . . . 0.0 113.651 -170.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.52 -44.43 19.12 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.285 2.234 . . . . 0.0 110.953 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -148.47 151.7 35.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.975 0.91 . . . . 0.0 112.695 -175.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.54 150.5 42.22 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.669 1.587 . . . . 0.0 111.637 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.23 154.98 39.9 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.36 1.864 . . . . 0.0 111.766 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.63 -126.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.427 1.091 . . . . 0.0 112.284 -174.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -64.53 -36.59 84.71 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.413 1.885 . . . . 0.0 115.725 -169.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -63.36 142.38 58.41 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.944 1.298 . . . . 0.0 112.767 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -145.19 143.7 30.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.365 1.466 . . . . 0.0 112.286 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -57.13 -58.2 9.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.246 1.818 . . . . 0.0 112.813 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.1 m -72.07 -45.29 61.31 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.913 1.685 . . . . 0.0 112.469 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 128.68 23.76 1.17 Allowed Glycine 0 CA--C 1.538 1.48 0 C-N-CA 126.56 2.029 . . . . 0.0 114.227 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -65.26 124.81 23.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.435 1.894 . . . . 0.0 111.283 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 45.7 m -65.17 125.05 23.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.17 0.988 . . . . 0.0 110.225 169.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 31.4 tp -143.4 126.23 16.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.975 0.91 . . . . 0.0 112.094 -171.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -116.23 60.91 0.41 Allowed Glycine 0 N--CA 1.471 1.01 0 C-N-CA 126.026 1.774 . . . . 0.0 110.657 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.4 m -157.67 152.07 24.86 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.928 2.491 . . . . 0.0 109.057 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -126.84 166.17 17.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.213 1.405 . . . . 0.0 111.991 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.45 133.77 23.11 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.453 1.501 . . . . 0.0 110.098 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.5 t -133.34 122.6 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.357 1.463 . . . . 0.0 109.877 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -91.55 110.03 21.34 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.488 -0.758 . . . . 0.0 109.912 169.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -80.84 149.7 29.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.047 2.139 . . . . 0.0 111.783 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.35 -19.96 63.85 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -139.05 128.57 24.45 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.542 1.937 . . . . 0.0 111.389 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -57.08 -49.23 76.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.042 1.737 . . . . 0.0 111.839 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.94 -44.57 70.75 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.489 1.116 . . . . 0.0 112.757 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -64.61 -39.66 94.12 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.66 1.184 . . . . 0.0 112.46 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.84 -45.64 91.76 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.175 0.59 . . . . 0.0 111.689 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.19 -46.67 88.92 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.335 1.454 . . . . 0.0 111.572 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -48.46 -53.87 16.33 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.005 1.722 . . . . 0.0 111.651 171.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.0 -47.95 81.48 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.883 0.873 . . . . 0.0 112.707 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 17.2 ttp -52.13 -60.56 3.05 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.537 1.535 . . . . 0.0 111.833 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.99 -36.25 80.93 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.677 0.791 . . . . 0.0 113.113 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -64.43 -44.54 90.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.351 1.06 . . . . 0.0 113.43 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.18 -15.83 14.57 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -169.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -60.8 113.11 2.32 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.204 1.366 . . . . 0.0 111.952 174.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.91 -21.91 32.91 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.852 1.692 . . . . 0.0 114.343 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.8 132.03 92.51 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 118.626 1.213 . . . . 0.0 110.533 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.56 145.83 18.74 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.954 2.436 . . . . 0.0 113.374 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.7 tp -135.54 115.1 12.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.196 2.198 . . . . 0.0 108.612 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 38.66 62.34 1.05 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.385 1.874 . . . . 0.0 113.57 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.59 2.16 90.6 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.282 1.42 . . . . 0.0 116.218 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -131.08 123.33 19.77 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.798 1.639 . . . . 0.0 112.155 -170.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.45 122.02 7.94 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.978 2.452 . . . . 0.0 111.225 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.5 mtm -64.21 130.49 44.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.261 1.025 . . . . 0.0 110.811 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -116.24 114.73 24.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.161 1.385 . . . . 0.0 109.427 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.8 mm -108.07 138.66 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.552 0.741 . . . . 0.0 111.273 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -135.99 140.81 44.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.918 1.687 . . . . 0.0 110.472 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.2 tt -128.82 123.01 31.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.166 1.386 . . . . 0.0 110.542 -170.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.56 173.43 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.908 1.683 . . . . 0.0 111.786 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.8 p -67.2 158.38 31.46 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.624 1.17 . . . . 0.0 113.245 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.252 1.187 0 C-N-CA 127.143 2.177 . . . . 0.0 113.998 178.781 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -137.43 131.03 31.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.2 1.0 . . . . 0.0 112.292 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -115.91 155.28 28.25 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.248 1.819 . . . . 0.0 110.465 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.5 tp -130.82 94.14 3.56 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.115 1.766 . . . . 0.0 106.976 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -69.7 127.49 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.8 m -128.91 171.31 12.43 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.128 1.371 . . . . 0.0 111.495 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.5 t30 58.79 30.3 19.87 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.258 1.823 . . . . 0.0 113.615 -169.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.47 162.61 26.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.529 1.131 . . . . 0.0 109.385 169.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -83.04 157.86 22.72 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.264 -0.897 . . . . 0.0 113.098 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -54.25 -37.22 64.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.599 1.159 . . . . 0.0 112.155 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.29 8.87 78.75 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.173 1.368 . . . . 0.0 116.318 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.2 130.72 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.762 1.781 . . . . 0.0 110.454 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.4 m -82.61 138.91 34.05 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.504 1.122 . . . . 0.0 112.302 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -56.78 -55.25 36.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.338 1.455 . . . . 0.0 113.395 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.46 80.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.899 0.88 . . . . 0.0 113.11 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.88 -51.39 70.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.826 0.851 . . . . 0.0 112.009 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.74 -52.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.263 1.025 . . . . 0.0 111.275 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -51.22 -55.28 18.86 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.745 0.818 . . . . 0.0 112.052 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.48 -50.73 72.68 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.678 1.191 . . . . 0.0 113.12 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.48 -45.27 91.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.379 0.991 . . . . 0.0 112.413 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -63.16 -40.89 98.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.836 0.744 . . . . 0.0 112.466 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.9 -13.21 61.46 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -71.81 -62.23 1.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.989 -1.069 . . . . 0.0 111.113 172.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -78.54 -35.46 46.1 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.61 173.18 15.47 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.489 1.518 . . . . 0.0 113.372 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.7 m -119.99 112.87 19.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.066 1.346 . . . . 0.0 109.432 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -135.07 151.6 50.91 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -169.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -73.6 -53.97 9.26 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.512 1.925 . . . . 0.0 110.426 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -154.05 153.17 31.44 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.4 139.46 45.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.529 1.932 . . . . 0.0 109.403 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.13 100.04 3.56 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.588 1.555 . . . . 0.0 111.646 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.4 156.38 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.098 1.359 . . . . 0.0 110.692 170.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -44.45 -56.2 4.45 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.754 2.421 . . . . 0.0 115.241 -174.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -61.39 149.77 37.35 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.232 0.924 . . . . 0.0 112.261 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.6 t70 69.03 -50.47 0.59 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.176 2.191 . . . . 0.0 113.606 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -54.35 -45.58 72.76 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.605 1.162 . . . . 0.0 110.705 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.7 m -119.28 148.66 42.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.141 2.176 . . . . 0.0 110.341 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.0 -52.95 40.54 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.128 0.87 . . . . 0.0 112.049 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -65.85 138.16 57.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.624 1.57 . . . . 0.0 110.664 169.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.7 m -81.33 129.54 34.66 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.243 1.017 . . . . 0.0 110.636 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.2 -130.13 0.27 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.893 1.677 . . . . 0.0 109.18 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.69 52.52 0.39 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.357 1.456 . . . . 0.0 112.407 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 52.6 p -138.24 163.23 32.28 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.824 1.249 . . . . 0.0 113.261 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.4 116.05 9.16 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.086 1.754 . . . . 0.0 111.179 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -73.56 133.74 43.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.139 0.976 . . . . 0.0 108.74 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.4 t -136.07 123.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.942 0.897 . . . . 0.0 109.874 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -109.47 112.94 25.34 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.418 1.487 . . . . 0.0 109.759 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -90.28 158.61 17.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.92 2.488 . . . . 0.0 112.944 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.22 -41.44 85.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.305 0.642 . . . . 0.0 112.357 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -132.2 134.73 45.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.868 1.667 . . . . 0.0 111.196 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -66.64 -28.93 68.87 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.17 -46.75 88.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.999 0.92 . . . . 0.0 111.301 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.48 -40.98 96.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.205 1.002 . . . . 0.0 112.361 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.24 -58.22 7.82 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.343 1.057 . . . . 0.0 111.536 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -53.12 -48.38 67.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.032 1.733 . . . . 0.0 112.077 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -52.24 -55.87 18.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.745 1.218 . . . . 0.0 111.814 173.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.01 -46.03 75.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.5 1.12 . . . . 0.0 112.625 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -52.42 -62.8 1.41 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.169 1.388 . . . . 0.0 110.812 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.27 -36.51 77.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -66.67 -44.27 82.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.249 1.02 . . . . 0.0 113.467 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -105.63 -15.12 15.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -61.85 105.59 0.58 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.662 1.119 . . . . 0.0 110.519 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.21 -21.87 9.9 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.748 2.118 . . . . 0.0 114.298 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.5 t -79.26 131.85 64.6 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 118.653 1.227 . . . . 0.0 111.695 -170.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.52 138.87 66.54 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.465 3.443 . . . . 0.0 115.457 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -138.42 103.31 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.045 2.138 . . . . 0.0 106.371 169.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 52.78 60.42 3.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.512 1.525 . . . . 0.0 111.288 -168.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.76 -64.88 4.14 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.548 1.547 . . . . 0.0 113.178 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -62.03 135.77 94.91 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.818 1.647 . . . . 0.0 112.711 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.82 131.49 12.29 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.339 2.692 . . . . 0.0 112.238 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.3 mtm -62.88 132.56 52.54 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.96 0.904 . . . . 0.0 110.917 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -118.44 115.57 24.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.608 1.163 . . . . 0.0 108.459 171.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.6 mt -105.84 126.62 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.901 0.858 . . . . 0.0 112.215 -169.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -99.13 150.44 22.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.099 2.16 . . . . 0.0 109.483 169.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.99 159.36 43.07 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.52 1.128 . . . . 0.0 112.797 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.2 m -76.22 93.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 87.2 m -67.11 -41.17 86.68 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.467 -0.771 . . . . 0.0 111.986 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 C--O 1.252 1.212 0 C-N-CA 126.427 1.891 . . . . 0.0 113.69 177.536 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -81.76 93.66 6.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.994 0.918 . . . . 0.0 109.588 172.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -89.42 101.14 13.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.966 1.306 . . . . 0.0 108.795 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.7 tp -89.95 127.59 36.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.36 1.864 . . . . 0.0 109.816 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.62 127.83 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.472 1.509 . . . . 0.0 108.859 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.0 m -128.24 168.59 15.25 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.468 1.907 . . . . 0.0 111.066 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.3 t30 59.16 51.79 6.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.996 1.719 . . . . 0.0 112.555 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.4 mt -95.48 172.82 7.84 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.715 1.606 . . . . 0.0 110.287 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -139.84 158.01 44.79 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.204 -0.935 . . . . 0.0 112.779 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -57.48 104.03 0.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.688 1.195 . . . . 0.0 110.874 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.8 -45.25 0.62 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.696 2.093 . . . . 0.0 109.474 -169.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.6 t -64.39 134.79 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.238 1.015 . . . . 0.0 108.832 169.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 61.1 m -121.74 153.76 37.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.513 1.125 . . . . 0.0 112.155 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.28 -56.73 12.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.95 1.7 . . . . 0.0 112.542 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.56 -37.78 82.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.592 1.157 . . . . 0.0 113.319 174.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -63.3 -51.7 64.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.8 0.84 . . . . 0.0 111.551 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.5 mm -54.21 -52.91 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.405 1.082 . . . . 0.0 111.221 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -51.33 -53.94 31.16 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.109 0.963 . . . . 0.0 112.323 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -60.58 -51.46 69.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.689 1.195 . . . . 0.0 113.252 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -63.6 -44.28 94.45 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.164 0.893 . . . . 0.0 112.182 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -62.69 -43.71 98.12 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.61 67.96 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.57 -53.69 52.91 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.097 0.959 . . . . 0.0 112.789 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -95.93 -16.14 21.93 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -140.59 164.36 26.34 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.019 1.295 . . . . 0.0 114.414 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -104.26 111.17 23.68 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.924 1.29 . . . . 0.0 110.943 -172.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -129.3 145.66 51.33 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.49 1.116 . . . . 0.0 113.323 -171.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -87.63 -39.39 15.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.029 1.732 . . . . 0.0 111.1 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -144.26 146.85 32.89 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.469 1.108 . . . . 0.0 112.126 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -146.96 123.41 11.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.135 1.374 . . . . 0.0 110.818 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.22 155.73 42.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.701 1.2 . . . . 0.0 112.989 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.5 t -110.34 151.73 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.804 2.042 . . . . 0.0 110.207 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -55.63 -45.21 77.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.209 1.804 . . . . 0.0 114.952 -170.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -65.17 154.6 37.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.063 0.945 . . . . 0.0 113.096 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -144.26 -130.58 0.08 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.311 1.444 . . . . 0.0 108.793 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -56.07 -48.12 76.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.033 1.288 . . . . 0.0 110.07 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.6 m -71.38 120.28 16.74 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.397 1.479 . . . . 0.0 110.966 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.87 65.12 4.17 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.687 1.137 . . . . 0.0 111.559 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -59.1 128.73 38.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.163 1.785 . . . . 0.0 112.319 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.0 m -73.81 98.1 2.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.459 1.104 . . . . 0.0 110.084 169.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 60.5 tp -153.47 -68.64 0.15 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.613 1.565 . . . . 0.0 110.626 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.89 75.2 1.2 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.687 1.137 . . . . 0.0 112.098 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.7 m -146.96 148.98 32.3 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.157 1.383 . . . . 0.0 110.82 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.66 154.48 46.42 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.593 1.557 . . . . 0.0 111.647 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -128.48 124.63 36.61 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.656 1.583 . . . . 0.0 109.907 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.09 110.09 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 125.193 1.397 . . . . 0.0 108.683 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -82.47 92.62 7.09 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.998 1.319 . . . . 0.0 108.5 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -70.6 150.13 46.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.794 1.638 . . . . 0.0 111.265 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -74.82 -27.93 60.49 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 34.7 mtm105 -135.99 138.84 42.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.241 1.817 . . . . 0.0 111.16 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -67.08 -44.13 80.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.72 1.608 . . . . 0.0 112.086 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.12 -46.85 68.92 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.677 0.791 . . . . 0.0 112.319 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.56 -44.61 96.72 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.774 1.63 . . . . 0.0 112.26 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.77 87.69 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.183 0.993 . . . . 0.0 112.878 170.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.2 -38.81 84.45 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.557 1.543 . . . . 0.0 112.428 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -49.3 -61.89 1.84 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.531 1.133 . . . . 0.0 110.059 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.38 -47.54 72.56 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.806 1.242 . . . . 0.0 112.598 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -51.51 -61.2 2.39 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.415 1.486 . . . . 0.0 111.437 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -60.16 -44.75 94.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.921 0.888 . . . . 0.0 112.388 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.29 -44.25 92.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.258 1.423 . . . . 0.0 113.387 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -109.14 -14.56 14.49 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -60.27 115.68 3.69 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.48 1.491 . . . . 0.0 111.305 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.77 55.51 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.826 1.679 . . . . 0.0 114.546 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.29 130.68 79.56 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 118.9 1.35 . . . . 0.0 110.852 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.43 135.69 69.47 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.764 2.976 . . . . 0.0 114.9 174.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.1 tp -142.02 113.76 7.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.553 1.941 . . . . 0.0 108.184 169.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 49.4 61.42 3.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.405 1.482 . . . . 0.0 111.398 -169.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.58 -61.54 4.62 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.363 1.459 . . . . 0.0 113.364 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -67.26 140.24 95.31 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 125.319 1.447 . . . . 0.0 113.719 -172.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -73.15 125.92 10.71 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.99 2.46 . . . . 0.0 110.453 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 74.6 mtm -63.5 127.8 32.94 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.366 1.067 . . . . 0.0 111.849 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -105.16 119.32 38.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.566 1.146 . . . . 0.0 109.326 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.4 mt -118.94 139.85 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.939 . . . . 0.0 112.312 -169.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -134.37 147.5 50.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.405 2.282 . . . . 0.0 110.196 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 51.6 tp -136.41 126.64 26.42 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.78 1.232 . . . . 0.0 111.235 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.55 159.63 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.232 1.413 . . . . 0.0 112.189 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 15.2 m -66.94 136.02 54.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.073 1.349 . . . . 0.0 111.6 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 52.1 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.873 1.669 . . . . 0.0 113.637 174.301 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.174 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -74.36 130.28 39.37 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.072 0.936 . . . . 0.0 110.827 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.34 124.74 23.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.906 2.082 . . . . 0.0 109.317 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.4 tp -114.56 108.02 16.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.662 1.585 . . . . 0.0 110.488 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.6 t -92.07 129.52 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.328 1.451 . . . . 0.0 108.874 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.5 m -134.81 173.25 11.9 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.006 1.722 . . . . 0.0 111.87 -175.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.7 t30 55.51 35.8 25.85 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.304 1.841 . . . . 0.0 113.192 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.73 168.94 19.14 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.649 1.179 . . . . 0.0 110.428 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -65.96 155.23 37.17 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.23 -0.918 . . . . 0.0 111.679 171.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -50.99 -28.34 9.72 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.764 2.025 . . . . 0.0 114.697 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -145.69 55.57 0.54 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-N 119.151 0.887 . . . . 0.0 115.019 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.99 136.77 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 118.085 0.943 . . . . 0.0 109.766 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 52.1 m -69.83 138.31 52.5 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.582 -0.699 . . . . 0.0 112.134 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -60.31 -53.57 56.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.524 1.129 . . . . 0.0 112.648 -174.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.92 83.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.448 1.099 . . . . 0.0 112.688 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -56.51 -53.39 58.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.856 0.862 . . . . 0.0 112.248 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.2 mm -56.83 -53.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.845 0.858 . . . . 0.0 111.458 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -53.15 -53.76 45.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.015 0.526 . . . . 0.0 112.116 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.01 -50.47 73.96 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.945 1.298 . . . . 0.0 113.054 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.48 -46.35 90.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.653 1.115 . . . . 0.0 111.914 -176.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.85 -43.08 97.21 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.94 -21.09 66.77 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.98 -58.78 5.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.96 -1.087 . . . . 0.0 111.892 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -82.31 -35.58 27.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -110.12 161.77 12.84 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.585 1.564 . . . . 0.0 114.185 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.8 m -106.09 101.81 11.27 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.878 1.671 . . . . 0.0 109.68 -174.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -137.08 153.99 50.43 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -169.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -85.94 -50.96 6.68 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.642 2.377 . . . . 0.0 111.486 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.71 150.63 33.49 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.274 1.03 . . . . 0.0 113.07 -170.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.38 138.16 32.81 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 110.787 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.79 107.16 5.01 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.937 1.295 . . . . 0.0 112.23 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.6 t -77.33 146.24 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.898 1.679 . . . . 0.0 111.009 173.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.427 ' CE1' ' H ' ' A' ' 146' ' ' GLY . 45.5 p-80 -53.22 -50.94 63.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.441 2.297 . . . . 0.0 115.194 -171.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -49.21 -40.52 33.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.972 2.109 . . . . 0.0 115.627 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -73.5 -13.25 61.02 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.812 1.245 . . . . 0.0 114.07 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -122.29 -143.83 0.34 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.167 1.787 . . . . 0.0 111.77 -176.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.9 m -59.57 152.68 21.51 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.823 2.049 . . . . 0.0 114.225 -171.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.05 57.09 3.97 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.952 1.263 . . . . 0.0 113.842 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.2 ptm85 -74.18 -172.07 1.31 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.785 2.034 . . . . 0.0 112.178 169.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.8 m -63.18 120.03 10.71 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.032 0.933 . . . . 0.0 110.337 169.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.9 mp -67.83 141.89 56.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.495 1.118 . . . . 0.0 112.339 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.427 ' H ' ' CE1' ' A' ' 137' ' ' HIS . . . 98.23 53.39 1.26 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.611 1.577 . . . . 0.0 113.036 176.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.6 m -147.38 145.3 29.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.698 1.199 . . . . 0.0 111.438 -173.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -137.41 126.49 24.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.915 1.286 . . . . 0.0 111.735 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -93.45 126.85 38.81 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.052 1.341 . . . . 0.0 109.795 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.9 t -131.24 136.09 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.554 1.542 . . . . 0.0 110.164 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -118.05 98.85 6.53 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.212 1.805 . . . . 0.0 108.779 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -75.86 158.73 31.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.474 1.51 . . . . 0.0 111.938 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -70.41 -27.32 64.19 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.774 -0.579 . . . . 0.0 112.296 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -142.91 135.0 27.18 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.564 1.546 . . . . 0.0 112.674 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -53.87 -40.5 66.62 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.48 2.312 . . . . 0.0 112.518 170.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.33 -47.44 62.68 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.281 1.032 . . . . 0.0 112.656 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -71.26 -38.01 71.92 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.275 -0.89 . . . . 0.0 112.937 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.67 -47.08 74.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.77 0.828 . . . . 0.0 111.834 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.1 -48.12 79.4 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.382 1.473 . . . . 0.0 113.036 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -52.28 -53.33 45.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.264 1.026 . . . . 0.0 111.842 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.03 -50.34 69.32 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.199 0.999 . . . . 0.0 112.445 174.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -53.03 -63.15 1.24 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.137 1.775 . . . . 0.0 111.506 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -59.99 -36.85 78.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.693 0.797 . . . . 0.0 113.026 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -66.89 -52.16 46.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.747 1.219 . . . . 0.0 112.857 176.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -96.17 -16.3 21.56 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 -169.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -59.32 109.74 0.94 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 120.154 1.343 . . . . 0.0 111.178 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 113.25 -24.74 12.1 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 126.254 1.883 . . . . 0.0 114.231 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.35 133.69 89.22 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.873 1.269 . . . . 0.0 110.66 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.68 148.88 33.27 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.946 2.431 . . . . 0.0 113.12 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 42.2 tp -128.87 94.73 3.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.4 1.88 . . . . 0.0 109.194 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 46.56 50.65 12.68 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.442 1.897 . . . . 0.0 112.931 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 114.94 -78.3 0.27 Allowed Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.065 1.793 . . . . 0.0 112.779 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.35 135.7 75.99 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 126.328 1.851 . . . . 0.0 113.351 -176.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.06 126.83 10.85 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.096 2.531 . . . . 0.0 111.207 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.5 mtm -63.66 128.72 37.09 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.613 0.765 . . . . 0.0 110.135 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -116.61 119.91 37.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.341 1.056 . . . . 0.0 109.502 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -117.55 139.93 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.198 0.999 . . . . 0.0 111.749 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -131.27 144.54 51.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.93 2.092 . . . . 0.0 110.539 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.0 tp -88.6 -101.29 0.09 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.591 1.157 . . . . 0.0 110.426 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.4 m -69.61 155.36 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.732 2.013 . . . . 0.0 112.897 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 2.9 p -140.63 147.14 38.87 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.022 2.129 . . . . 0.0 111.106 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 C--O 1.251 1.174 0 C-N-CA 126.133 1.773 . . . . 0.0 113.749 -179.591 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.172 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.01 154.65 44.21 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.625 1.712 . . . . 0.0 114.29 -178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.8 mt -120.97 118.69 30.51 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.86 2.064 . . . . 0.0 110.43 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.7 tp -82.45 109.04 16.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.0 t -92.22 83.26 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.103 1.761 . . . . 0.0 107.707 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.3 m -80.25 155.3 27.39 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.727 0.811 . . . . 0.0 112.101 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.28 79.12 0.23 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.762 2.025 . . . . 0.0 113.0 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -127.91 144.97 51.09 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.281 2.232 . . . . 0.0 109.641 171.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -77.2 151.39 35.24 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.84 -0.538 . . . . 0.0 112.358 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -57.87 -24.28 56.87 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.905 0.882 . . . . 0.0 113.337 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.85 -15.48 78.17 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 125.151 1.358 . . . . 0.0 115.792 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.21 123.21 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.585 1.693 . . . . 0.0 110.925 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 54.4 m -77.95 146.48 35.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.771 1.228 . . . . 0.0 111.982 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.78 -52.46 65.62 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.869 0.867 . . . . 0.0 112.013 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.28 62.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.753 1.221 . . . . 0.0 113.363 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.08 -55.51 34.13 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.978 0.911 . . . . 0.0 112.285 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.6 mm -55.8 -53.31 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.882 1.273 . . . . 0.0 111.082 172.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -48.97 -55.77 10.89 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.134 1.774 . . . . 0.0 111.696 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.61 -49.32 75.69 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.626 1.17 . . . . 0.0 113.379 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.23 -44.62 94.74 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.81 1.186 . . . . 0.0 112.204 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -62.09 -41.91 98.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.724 0.693 . . . . 0.0 112.227 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.29 -15.72 62.81 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.21 -60.1 2.4 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.878 -1.139 . . . . 0.0 111.533 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -81.31 -31.34 33.59 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.88 -177.57 15.23 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.644 1.592 . . . . 0.0 113.104 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.5 m -124.52 122.74 38.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.763 1.225 . . . . 0.0 110.057 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -132.37 146.94 52.33 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -78.49 -49.13 13.95 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.514 2.325 . . . . 0.0 110.986 171.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -148.12 146.11 28.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.49 1.516 . . . . 0.0 112.298 -170.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -132.47 139.67 48.07 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.245 1.818 . . . . 0.0 109.37 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.25 100.06 3.41 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.482 1.513 . . . . 0.0 111.695 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.5 t -75.09 167.14 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.253 1.421 . . . . 0.0 110.709 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -46.87 -37.19 8.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.861 2.064 . . . . 0.0 115.843 -169.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -86.53 -13.2 46.61 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.71 158.6 35.99 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.313 1.045 . . . . 0.0 112.764 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -71.34 83.96 0.78 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.734 1.214 . . . . 0.0 111.375 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 t -153.39 -178.27 6.88 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.6 2.36 . . . . 0.0 110.739 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.2 6.66 28.76 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.997 1.76 . . . . 0.0 115.63 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.87 162.6 15.99 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.82 1.31 . . . . 0.0 113.448 175.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.3 m -61.97 158.89 15.29 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.79 1.236 . . . . 0.0 112.99 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.3 tp -74.5 145.8 43.24 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.775 0.83 . . . . 0.0 111.128 173.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.64 40.75 95.14 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.339 0.971 . . . . 0.0 113.053 -173.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.7 m -160.48 158.68 29.75 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.476 2.71 . . . . 0.0 108.473 -171.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.17 166.49 21.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.5 1.12 . . . . 0.0 112.651 174.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -125.52 129.49 49.86 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.541 1.936 . . . . 0.0 109.396 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.98 115.06 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.681 1.192 . . . . 0.0 109.058 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -100.57 112.65 25.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.579 1.551 . . . . 0.0 109.647 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -84.23 163.45 19.68 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.076 2.55 . . . . 0.0 113.29 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.5 -45.04 89.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.795 0.838 . . . . 0.0 111.653 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.4 mmt-85 -137.88 141.76 40.68 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.706 1.602 . . . . 0.0 111.328 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -60.09 -34.3 73.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.764 1.626 . . . . 0.0 113.284 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.88 -51.36 69.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.247 1.019 . . . . 0.0 112.243 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.63 -40.68 95.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.004 0.921 . . . . 0.0 112.083 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.17 -54.59 37.7 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.389 1.075 . . . . 0.0 112.007 170.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 67.4 tp -53.28 -49.93 65.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.173 1.389 . . . . 0.0 112.783 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -53.03 -51.43 61.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.001 1.32 . . . . 0.0 112.173 175.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.08 78.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.012 0.925 . . . . 0.0 112.755 172.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 4.7 ttp -54.01 -58.06 8.7 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.945 1.298 . . . . 0.0 112.017 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -33.67 73.37 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -68.23 -45.01 74.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.293 1.037 . . . . 0.0 113.159 176.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -103.7 -13.35 16.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -169.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -60.13 109.78 1.05 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.225 1.375 . . . . 0.0 112.04 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.32 -17.82 39.77 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.993 1.759 . . . . 0.0 114.586 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.98 132.71 86.43 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 118.854 1.327 . . . . 0.0 110.372 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.04 142.25 19.42 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.822 2.348 . . . . 0.0 112.804 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 61.2 tp -135.35 115.67 13.49 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.063 1.745 . . . . 0.0 108.448 169.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 49.24 57.64 6.26 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.364 1.465 . . . . 0.0 111.222 -169.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.68 -56.49 4.75 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.402 1.477 . . . . 0.0 113.303 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -58.15 117.51 20.36 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 127.349 2.259 . . . . 0.0 113.835 -173.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -60.02 118.21 5.06 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.356 2.704 . . . . 0.0 110.879 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.7 mtm -70.16 116.59 10.69 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.78 0.832 . . . . 0.0 110.862 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.99 94.72 9.41 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.076 0.951 . . . . 0.0 108.806 174.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.6 mm -86.34 129.18 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.323 0.649 . . . . 0.0 109.986 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -125.21 115.53 20.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.96 1.304 . . . . 0.0 111.0 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.9 tp -79.16 139.55 37.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.64 1.576 . . . . 0.0 110.755 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 5.4 m -64.32 105.2 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-O 121.699 0.761 . . . . 0.0 110.908 169.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 94.2 m -80.87 117.16 21.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.39 1.076 . . . . 0.0 110.409 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.459 1.903 . . . . 0.0 113.712 -179.487 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.235 0 CA-C-O 121.829 0.683 . . . . 0.0 114.788 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -149.59 133.0 16.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.514 1.926 . . . . 0.0 109.808 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -137.79 105.27 5.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.935 1.694 . . . . 0.0 109.577 -170.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.9 tp -90.2 137.94 31.93 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.753 2.021 . . . . 0.0 110.039 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -130.61 127.48 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.918 1.287 . . . . 0.0 109.578 174.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.9 m -128.1 174.41 9.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.222 1.809 . . . . 0.0 110.872 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.2 t30 58.57 38.31 25.32 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.394 1.478 . . . . 0.0 112.467 -172.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.3 mt -88.73 -155.1 0.32 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.56 1.544 . . . . 0.0 109.497 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -138.96 151.7 47.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.543 1.537 . . . . 0.0 110.883 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -53.46 -24.61 13.32 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.74 -23.54 65.42 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 125.382 1.468 . . . . 0.0 115.234 172.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.35 141.54 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 118.906 1.353 . . . . 0.0 110.523 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 61.6 m -133.1 161.1 35.29 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.68 1.592 . . . . 0.0 111.788 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -53.86 -57.36 11.21 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.881 0.872 . . . . 0.0 113.2 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.61 72.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.828 0.851 . . . . 0.0 113.248 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.01 -55.56 33.41 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.066 0.946 . . . . 0.0 111.855 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.6 mm -55.49 -54.82 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.027 1.331 . . . . 0.0 111.227 172.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -47.9 -56.98 6.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.672 1.989 . . . . 0.0 111.441 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.06 -49.97 73.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.462 1.105 . . . . 0.0 113.259 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -62.41 -44.54 96.18 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.475 1.034 . . . . 0.0 112.07 -175.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -63.88 -43.47 95.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.412 0.685 . . . . 0.0 112.624 173.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.7 -20.93 62.26 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.58 -60.16 2.97 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.076 -1.015 . . . . 0.0 112.019 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -89.63 -21.33 22.86 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -174.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -134.7 -176.9 14.59 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.658 1.599 . . . . 0.0 112.885 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -127.38 129.17 47.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.279 1.032 . . . . 0.0 110.497 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.7 144.77 47.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.627 1.171 . . . . 0.0 113.801 -169.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -73.54 -50.57 20.67 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.938 2.095 . . . . 0.0 110.62 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -150.46 158.62 44.35 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.592 1.157 . . . . 0.0 112.87 -173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.43 155.69 46.88 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.005 1.722 . . . . 0.0 111.089 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.83 154.77 38.95 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.239 2.216 . . . . 0.0 110.672 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.9 t -141.1 158.78 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.225 1.81 . . . . 0.0 110.401 -176.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -30.96 -48.52 0.11 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 129.373 3.069 . . . . 0.0 116.525 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -49.81 -39.99 40.3 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.872 1.669 . . . . 0.0 113.658 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -78.61 -61.77 1.9 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.5 1.52 . . . . 0.0 111.258 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -144.24 143.59 31.11 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.412 1.885 . . . . 0.0 111.334 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 m -124.55 148.84 47.54 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.717 1.607 . . . . 0.0 112.822 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -98.98 -43.31 2.64 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.701 2.096 . . . . 0.0 111.045 169.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -128.09 129.85 47.25 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.741 2.016 . . . . 0.0 109.981 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 47.5 m -70.85 69.87 0.47 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.071 1.748 . . . . 0.0 111.822 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 68.1 tp -160.83 -47.93 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.341 2.656 . . . . 0.0 110.214 -173.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.71 103.15 0.17 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.995 1.283 . . . . 0.0 111.109 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 m -123.96 145.8 48.92 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.155 1.782 . . . . 0.0 110.969 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.68 150.94 46.73 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.867 2.067 . . . . 0.0 110.339 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -143.28 121.46 12.21 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.42 1.488 . . . . 0.0 110.028 -173.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 52.7 t -122.4 118.39 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.173 1.389 . . . . 0.0 109.514 -173.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -88.53 95.47 10.25 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -69.03 160.49 30.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.543 1.937 . . . . 0.0 112.957 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.78 -51.8 68.18 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.629 -0.669 . . . . 0.0 111.705 169.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.53 148.34 45.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.436 1.494 . . . . 0.0 112.523 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.89 -32.41 71.87 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.58 -49.73 76.37 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.109 0.964 . . . . 0.0 112.459 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.76 -37.91 89.2 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.12 0.968 . . . . 0.0 111.979 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.22 -46.61 85.56 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.874 0.87 . . . . 0.0 112.037 169.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.95 -49.98 72.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.479 1.512 . . . . 0.0 111.493 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -50.08 -54.33 21.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.46 1.504 . . . . 0.0 111.677 174.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.2 75.64 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.29 1.036 . . . . 0.0 112.803 173.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -54.76 -63.26 1.21 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.675 1.19 . . . . 0.0 111.422 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -59.57 -32.77 70.67 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -64.49 -51.09 64.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.693 1.197 . . . . 0.0 113.148 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -106.89 -11.07 15.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -169.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -61.86 117.1 5.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.341 1.428 . . . . 0.0 111.857 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 92.59 -12.44 69.77 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.025 1.298 . . . . 0.0 114.83 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 64.7 t -66.94 135.24 94.08 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 119.205 1.502 . . . . 0.0 109.858 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.3 145.97 31.06 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.793 2.329 . . . . 0.0 112.724 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.5 tp -122.27 92.5 3.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.259 1.824 . . . . 0.0 108.992 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 47.65 50.05 15.62 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.287 1.835 . . . . 0.0 112.715 -169.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 116.07 -75.62 0.27 Allowed Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.114 1.816 . . . . 0.0 112.885 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.61 131.81 85.64 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 126.264 1.826 . . . . 0.0 113.549 -175.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.13 130.09 13.86 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.256 2.638 . . . . 0.0 111.683 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -68.28 114.59 6.88 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.426 1.09 . . . . 0.0 111.401 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -86.16 103.35 14.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.224 1.009 . . . . 0.0 109.349 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.3 mt -99.96 137.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.832 0.853 . . . . 0.0 111.516 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -133.26 152.17 51.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.0 2.52 . . . . 0.0 110.671 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -148.73 166.57 28.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.969 0.908 . . . . 0.0 113.274 -169.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.38 88.76 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.122 0.969 . . . . 0.0 110.603 169.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.0 p -59.69 -59.09 5.99 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.877 1.671 . . . . 0.0 111.195 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.251 1.161 0 C-N-CA 126.191 1.796 . . . . 0.0 110.995 169.747 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -134.13 133.62 41.25 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.457 1.129 . . . . 0.0 111.561 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.7 mt -117.04 120.01 37.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.995 1.718 . . . . 0.0 111.302 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.0 tp -84.22 129.29 34.9 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 t -119.4 137.84 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.888 1.275 . . . . 0.0 109.215 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.3 m -136.73 165.99 24.63 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.123 2.169 . . . . 0.0 111.416 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.7 t30 52.95 59.63 4.33 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.493 1.917 . . . . 0.0 113.119 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.9 mt -109.7 147.72 32.65 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.247 1.819 . . . . 0.0 107.92 169.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -78.6 156.43 29.12 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.286 -0.884 . . . . 0.0 112.595 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -52.35 -34.48 47.69 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.702 1.201 . . . . 0.0 112.472 169.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.86 -7.34 87.44 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.217 1.389 . . . . 0.0 116.31 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.93 119.09 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.903 1.852 . . . . 0.0 110.492 177.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.7 m -78.82 147.53 33.2 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.055 1.342 . . . . 0.0 112.844 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.21 -53.62 55.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.471 1.508 . . . . 0.0 112.807 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.17 79.11 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.407 1.083 . . . . 0.0 113.189 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.41 -52.32 66.1 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.934 0.894 . . . . 0.0 112.211 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.8 mm -55.89 -51.81 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.39 1.076 . . . . 0.0 111.342 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -50.48 -54.51 21.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.202 1.001 . . . . 0.0 111.952 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.46 -50.9 72.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.68 1.192 . . . . 0.0 113.32 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.52 -44.75 89.88 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.549 1.068 . . . . 0.0 112.743 -174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -62.62 -39.81 94.98 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.904 0.774 . . . . 0.0 112.209 173.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.25 -2.72 11.32 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 174.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.47 -62.04 1.69 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.819 -1.176 . . . . 0.0 110.779 170.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -76.82 -19.66 57.27 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -139.45 -162.42 9.11 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.442 1.496 . . . . 0.0 111.94 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.08 136.93 42.39 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 118.104 0.952 . . . . 0.0 111.709 175.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.89 147.17 46.3 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.548 1.139 . . . . 0.0 113.472 -170.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.21 -46.54 20.16 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.391 2.276 . . . . 0.0 111.291 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -149.25 145.71 27.23 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.474 1.11 . . . . 0.0 112.611 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.63 143.47 50.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.265 1.826 . . . . 0.0 110.194 169.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.38 99.9 3.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.441 1.496 . . . . 0.0 111.542 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.23 147.54 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.699 1.6 . . . . 0.0 111.59 175.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.478 ' HB3' ' H ' ' A' ' 147' ' ' THR . 25.6 p80 -25.69 -58.18 0.07 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 130.056 3.342 . . . . 0.0 117.102 -171.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -58.11 -22.43 50.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.276 1.431 . . . . 0.0 114.709 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -66.89 106.87 2.02 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.308 0.958 . . . . 0.0 108.635 168.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -45.53 116.99 1.29 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.574 1.95 . . . . 0.0 115.217 -169.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.3 m -153.35 163.59 39.65 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.47 2.708 . . . . 0.0 110.092 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.92 62.76 3.92 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.086 0.85 . . . . 0.0 113.079 174.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -136.24 160.4 38.81 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.563 1.945 . . . . 0.0 113.8 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.4 m -68.53 142.37 55.26 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.816 1.246 . . . . 0.0 111.104 169.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.63 160.36 32.7 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.421 0.688 . . . . 0.0 111.858 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.57 40.93 26.01 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.752 1.168 . . . . 0.0 113.823 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.478 ' H ' ' HB3' ' A' ' 137' ' ' HIS . 81.8 p -142.09 172.65 12.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.762 2.425 . . . . 0.0 112.003 -173.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.08 164.4 38.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.893 1.277 . . . . 0.0 111.584 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -131.2 126.2 34.95 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.999 1.72 . . . . 0.0 109.503 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.85 114.07 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.175 0.99 . . . . 0.0 110.938 -171.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -89.94 104.24 16.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.919 1.687 . . . . 0.0 109.901 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -77.42 150.63 35.0 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.683 2.793 . . . . 0.0 113.108 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -61.84 -36.91 82.59 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 47.1 mtm-85 -135.79 129.67 32.85 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.724 2.01 . . . . 0.0 110.088 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -66.23 -29.86 70.2 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.93 75.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.965 0.906 . . . . 0.0 111.796 170.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -62.73 -39.16 93.2 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.861 1.264 . . . . 0.0 112.137 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.16 37.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.561 1.145 . . . . 0.0 112.068 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 64.9 tp -52.98 -48.55 67.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.261 1.424 . . . . 0.0 112.116 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -51.89 -59.58 4.16 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.534 1.533 . . . . 0.0 111.47 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.52 -48.78 62.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.909 1.283 . . . . 0.0 112.618 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.7 ttp -53.58 -61.83 2.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.296 1.438 . . . . 0.0 111.492 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -62.04 -35.52 78.84 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.94 -56.23 14.52 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.477 1.111 . . . . 0.0 113.181 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -91.9 -13.85 30.57 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -168.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -61.2 107.3 0.73 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.104 1.32 . . . . 0.0 110.531 169.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 114.51 -24.2 11.48 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.306 1.908 . . . . 0.0 114.311 -174.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.83 133.85 86.16 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.765 1.226 . . . . 0.0 110.694 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.3 142.66 21.52 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.846 2.364 . . . . 0.0 113.245 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 42.1 tp -133.76 110.08 9.56 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.779 2.032 . . . . 0.0 108.13 169.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 47.63 60.17 3.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.491 1.517 . . . . 0.0 111.731 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.93 -55.96 5.05 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.177 1.37 . . . . 0.0 113.302 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -59.33 121.78 58.86 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.067 1.747 . . . . 0.0 112.978 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 117.56 5.1 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.492 2.128 . . . . 0.0 110.177 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -64.17 133.43 52.89 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.44 1.096 . . . . 0.0 111.128 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -109.53 124.48 51.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.154 0.981 . . . . 0.0 109.804 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.8 mt -127.13 137.84 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.974 1.31 . . . . 0.0 110.924 -170.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -138.95 123.02 17.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.802 1.641 . . . . 0.0 111.331 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 42.5 tp -70.77 142.26 51.39 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.972 1.309 . . . . 0.0 111.25 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.7 p -50.46 -48.39 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.419 1.488 . . . . 0.0 113.49 174.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.3 m -71.38 123.26 21.94 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.546 1.139 . . . . 0.0 111.025 173.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.329 1.851 . . . . 0.0 114.022 179.336 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -147.89 126.89 12.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.099 1.449 . . . . 0.0 111.774 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.7 121.14 44.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.438 1.495 . . . . 0.0 111.608 174.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.0 tp -81.73 128.79 34.35 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 168.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.07 135.81 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.987 1.315 . . . . 0.0 108.388 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.55 170.37 16.19 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.525 1.53 . . . . 0.0 111.43 -176.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.2 t30 56.0 42.5 28.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.503 1.521 . . . . 0.0 112.611 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.0 mt -81.82 150.91 27.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.842 0.857 . . . . 0.0 110.03 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.07 140.26 35.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.513 0.725 . . . . 0.0 111.689 174.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -67.86 88.92 0.27 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.29 1.043 . . . . 0.0 109.539 170.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 156.93 -25.64 0.49 Allowed Glycine 0 CA--C 1.538 1.483 0 C-N-CA 127.073 2.273 . . . . 0.0 112.56 -169.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.1 t -58.3 118.01 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.87 1.268 . . . . 0.0 109.931 170.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 64.7 m -77.44 145.41 37.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.915 0.886 . . . . 0.0 112.714 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.28 -53.34 58.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.376 1.47 . . . . 0.0 112.633 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.18 87.5 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.44 1.096 . . . . 0.0 113.027 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.16 -47.96 83.75 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.622 0.769 . . . . 0.0 112.1 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mm -54.53 -53.19 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.903 0.881 . . . . 0.0 111.063 169.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -52.03 -54.0 35.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.485 0.584 . . . . 0.0 112.265 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.14 -50.72 72.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.712 1.205 . . . . 0.0 113.307 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.59 -45.46 90.28 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.122 0.874 . . . . 0.0 111.928 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -62.8 -44.36 96.37 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.573 0.624 . . . . 0.0 112.384 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.35 -31.52 65.81 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.82 -48.37 81.54 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.305 1.042 . . . . 0.0 112.666 174.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -101.43 -17.16 16.6 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -173.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -141.16 157.43 26.03 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 119.613 1.097 . . . . 0.0 114.25 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.6 m -96.55 109.46 22.05 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.98 1.312 . . . . 0.0 109.736 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.0 143.3 50.02 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.673 1.189 . . . . 0.0 114.001 -169.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.2 -48.64 19.66 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.686 2.394 . . . . 0.0 110.29 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -148.28 147.78 29.71 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.291 1.437 . . . . 0.0 111.933 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.34 122.14 13.5 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.23 1.412 . . . . 0.0 109.795 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.08 138.5 26.71 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.868 0.867 . . . . 0.0 112.671 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.24 148.32 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.417 1.887 . . . . 0.0 111.082 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 31.8 p80 -37.44 -47.05 0.85 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 128.541 2.737 . . . . 0.0 116.92 -169.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -47.38 -46.23 25.72 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.97 1.308 . . . . 0.0 111.99 -174.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.87 -57.87 2.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.546 1.538 . . . . 0.0 111.576 170.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -50.37 -50.77 50.47 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.525 1.93 . . . . 0.0 113.434 -171.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 m -105.99 19.77 20.01 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.326 1.851 . . . . 0.0 112.204 -173.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.69 -36.65 1.41 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.902 1.715 . . . . 0.0 115.555 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 166.52 24.41 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.647 2.379 . . . . 0.0 112.591 -172.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.2 m -59.0 113.88 2.3 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.345 1.458 . . . . 0.0 111.891 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.6 tp -136.35 -26.54 1.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.93 1.292 . . . . 0.0 114.411 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.24 37.81 20.24 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.525 1.06 . . . . 0.0 113.66 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.3 p -136.39 167.74 20.77 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.568 1.947 . . . . 0.0 112.006 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.16 170.35 18.63 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.928 -1.108 . . . . 0.0 111.423 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -136.2 121.64 19.39 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.156 1.782 . . . . 0.0 108.676 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.0 t -120.46 114.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.469 1.108 . . . . 0.0 108.925 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -100.33 111.19 23.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.918 2.087 . . . . 0.0 108.719 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -92.12 167.25 12.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.49 2.716 . . . . 0.0 113.165 -174.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -61.98 -54.13 45.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.741 0.816 . . . . 0.0 111.139 169.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -141.02 147.29 38.45 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.06 1.744 . . . . 0.0 112.038 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -54.43 -30.35 52.31 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.894 1.678 . . . . 0.0 114.211 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.7 -55.1 36.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.418 1.087 . . . . 0.0 112.496 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.44 -36.15 80.63 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.638 -0.664 . . . . 0.0 112.303 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.76 -54.91 38.63 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.246 1.018 . . . . 0.0 111.891 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.7 mt -53.99 -47.68 71.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.125 1.37 . . . . 0.0 112.505 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -50.68 -58.35 6.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.95 1.3 . . . . 0.0 111.534 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.87 -49.1 69.25 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.727 1.211 . . . . 0.0 112.628 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 53.4 ttp -53.22 -59.26 4.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.511 1.524 . . . . 0.0 111.779 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -25.53 68.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -75.0 -48.77 22.45 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.983 0.913 . . . . 0.0 113.195 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -102.37 -11.59 18.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 -169.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -59.06 116.7 4.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.028 1.285 . . . . 0.0 111.403 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 100.89 -13.3 59.15 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.788 1.661 . . . . 0.0 114.732 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.7 t -71.47 128.58 89.82 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 119.258 1.529 . . . . 0.0 110.945 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.52 136.87 77.03 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.882 3.054 . . . . 0.0 114.375 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 35.5 tp -139.49 110.57 6.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.861 1.664 . . . . 0.0 108.344 169.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 49.54 60.5 3.74 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.439 1.496 . . . . 0.0 111.536 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.31 -63.64 4.39 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.136 1.351 . . . . 0.0 113.147 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.33 134.78 94.68 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.902 1.281 . . . . 0.0 112.804 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.51 127.14 12.19 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.31 2.673 . . . . 0.0 111.714 172.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -66.02 117.61 8.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.62 1.168 . . . . 0.0 112.094 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -85.49 115.67 23.35 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.2 mt -120.83 132.0 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.643 1.177 . . . . 0.0 110.668 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -144.63 124.77 13.67 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.435 1.494 . . . . 0.0 112.139 -169.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 12.2 tp -68.62 127.04 31.59 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.81 169.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.6 m -104.74 -15.04 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.055 0.942 . . . . 0.0 113.433 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 12.8 m -59.9 136.44 58.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.945 1.298 . . . . 0.0 111.168 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--O 1.251 1.15 0 C-N-CA 125.68 1.592 . . . . 0.0 113.384 176.477 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -92.48 83.98 5.04 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.123 0.961 . . . . 0.0 109.907 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -80.46 128.7 33.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.19 2.196 . . . . 0.0 109.114 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.6 tp -121.32 109.75 15.29 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.643 1.577 . . . . 0.0 110.307 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.4 138.71 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.57 1.548 . . . . 0.0 109.11 170.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.6 m -139.06 168.38 19.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.988 2.115 . . . . 0.0 111.494 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.7 t30 55.69 41.39 30.48 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.311 1.845 . . . . 0.0 113.147 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.81 154.73 31.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.286 1.034 . . . . 0.0 110.314 169.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.61 144.98 55.29 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.524 -0.735 . . . . 0.0 111.197 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -73.11 68.99 1.0 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.732 1.213 . . . . 0.0 110.795 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.36 -11.86 0.06 OUTLIER Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.745 1.64 . . . . 0.0 115.587 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.05 119.87 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.72 1.76 . . . . 0.0 110.642 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -72.0 140.62 49.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.255 1.022 . . . . 0.0 112.893 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.85 -47.18 86.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.845 1.258 . . . . 0.0 112.501 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.96 -45.6 74.95 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.461 1.104 . . . . 0.0 112.694 172.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.95 -47.91 84.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.825 0.85 . . . . 0.0 111.991 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mm -53.46 -53.79 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.523 1.129 . . . . 0.0 111.921 170.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -50.7 -57.23 8.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.543 0.737 . . . . 0.0 111.222 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -56.0 -50.46 70.79 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.299 1.04 . . . . 0.0 113.16 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.69 -48.56 71.65 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.995 0.816 . . . . 0.0 112.23 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -63.82 -41.34 97.88 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.78 0.718 . . . . 0.0 112.664 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.58 -10.48 52.29 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -75.42 -60.97 2.07 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.863 -1.148 . . . . 0.0 111.314 172.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -81.26 -30.18 34.16 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.83 -169.76 13.21 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.722 1.63 . . . . 0.0 112.568 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 m -136.94 123.88 21.42 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.587 -0.949 . . . . 0.0 111.703 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 pp -128.63 145.84 51.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.235 1.414 . . . . 0.0 113.439 -170.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -82.48 -47.31 12.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.914 2.086 . . . . 0.0 111.298 173.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -145.89 149.98 35.27 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.391 1.076 . . . . 0.0 112.324 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.58 147.64 37.99 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.054 1.342 . . . . 0.0 111.599 169.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.58 109.58 4.3 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.457 1.503 . . . . 0.0 111.776 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.86 152.5 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.742 1.217 . . . . 0.0 109.716 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -54.93 -46.86 74.98 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.968 1.707 . . . . 0.0 114.588 -175.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -61.17 151.78 30.43 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.677 0.791 . . . . 0.0 111.866 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 66.95 -46.4 0.46 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.981 2.113 . . . . 0.0 113.476 -169.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -41.91 84.85 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.489 1.916 . . . . 0.0 111.579 169.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.1 m -136.07 156.38 48.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.87 2.468 . . . . 0.0 111.579 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -102.89 66.4 0.36 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.159 1.362 . . . . 0.0 110.591 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -139.46 142.79 37.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.673 1.989 . . . . 0.0 111.315 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.4 m -77.29 75.15 3.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.277 1.031 . . . . 0.0 109.717 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 34.3 tp -107.85 -52.34 2.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.179 1.392 . . . . 0.0 112.917 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.81 59.42 5.16 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.144 0.878 . . . . 0.0 113.164 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.2 p -140.96 159.27 42.57 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.271 1.428 . . . . 0.0 111.773 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.87 119.59 11.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.714 1.205 . . . . 0.0 111.426 171.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.52 130.95 34.54 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.203 1.001 . . . . 0.0 109.965 172.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.19 117.66 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.681 1.593 . . . . 0.0 109.794 -174.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -87.96 101.23 13.55 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.931 0.892 . . . . 0.0 109.382 171.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -74.29 153.76 39.23 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.984 2.114 . . . . 0.0 112.015 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -62.66 -37.15 85.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 91.1 mmt-85 -141.26 141.21 33.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.51 1.524 . . . . 0.0 111.854 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -58.42 -42.9 88.29 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.572 1.549 . . . . 0.0 113.114 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.23 -51.8 61.0 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.191 0.997 . . . . 0.0 112.697 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.15 -42.28 99.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.195 0.998 . . . . 0.0 112.572 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.5 -47.22 79.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.318 1.047 . . . . 0.0 112.672 170.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.64 -46.99 88.2 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.567 1.547 . . . . 0.0 111.773 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -50.94 -56.44 12.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.818 1.247 . . . . 0.0 111.412 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.49 -50.98 61.66 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.22 1.008 . . . . 0.0 112.599 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 31.2 ttp -52.8 -62.43 1.65 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.754 1.622 . . . . 0.0 111.673 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -62.95 -37.33 86.62 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -65.09 -54.46 29.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.639 1.176 . . . . 0.0 112.557 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -90.59 -14.77 31.81 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -169.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.1 109.32 0.82 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 120.101 1.318 . . . . 0.0 110.923 169.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 116.74 -28.84 7.19 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 126.461 1.982 . . . . 0.0 113.923 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.12 134.2 85.38 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.121 1.368 . . . . 0.0 110.737 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.64 141.74 25.19 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.944 2.429 . . . . 0.0 112.721 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.2 tp -137.08 111.68 8.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.762 1.625 . . . . 0.0 108.734 169.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 50.69 60.16 4.06 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.756 1.622 . . . . 0.0 111.489 -169.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.01 -63.74 4.39 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.1 1.333 . . . . 0.0 113.195 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -63.91 135.03 96.13 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.737 1.215 . . . . 0.0 112.659 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.66 123.63 9.59 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.404 2.736 . . . . 0.0 111.105 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.7 mtm -62.88 129.77 41.88 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.076 0.95 . . . . 0.0 111.214 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -109.12 125.44 52.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.638 1.175 . . . . 0.0 108.291 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.29 138.64 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 118.823 0.738 . . . . 0.0 111.904 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -131.37 153.91 49.16 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.334 2.654 . . . . 0.0 109.978 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.8 tp -134.44 127.24 31.12 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.839 1.256 . . . . 0.0 111.041 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.32 -172.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.174 1.789 . . . . 0.0 111.14 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 16.6 m -144.31 139.22 28.42 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.205 1.402 . . . . 0.0 110.317 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.618 1.967 . . . . 0.0 114.059 -178.317 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -137.76 136.62 37.46 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.909 0.855 . . . . 0.0 112.671 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.76 141.05 44.43 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.129 0.972 . . . . 0.0 110.9 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.7 tp -110.67 115.51 29.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.917 2.087 . . . . 0.0 106.717 169.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.89 135.26 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.436 1.095 . . . . 0.0 110.017 -169.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 55.0 m -139.23 161.86 36.39 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.061 1.745 . . . . 0.0 112.246 -174.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.4 t30 51.11 43.26 29.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.294 2.238 . . . . 0.0 114.658 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.1 mt -78.69 164.87 24.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.264 1.426 . . . . 0.0 108.862 168.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.08 159.48 33.53 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.717 -1.239 . . . . 0.0 112.633 169.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -64.55 -41.4 96.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.585 1.554 . . . . 0.0 112.629 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.6 53.04 2.7 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.48 1.514 . . . . 0.0 112.791 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.5 t -116.11 113.74 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 126.038 1.735 . . . . 0.0 109.795 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -72.8 142.29 48.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.242 1.017 . . . . 0.0 112.26 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -56.65 -54.94 40.32 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.468 1.507 . . . . 0.0 112.316 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.31 -34.94 74.5 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.371 1.068 . . . . 0.0 113.567 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.48 -52.74 63.24 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.324 0.965 . . . . 0.0 111.465 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.1 mm -55.0 -52.7 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.343 1.057 . . . . 0.0 110.899 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -50.78 -56.29 12.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.976 0.91 . . . . 0.0 112.105 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -60.14 -48.22 82.62 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.106 1.362 . . . . 0.0 112.963 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -46.61 81.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.415 1.007 . . . . 0.0 112.121 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -60.6 -40.83 93.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.884 0.765 . . . . 0.0 112.048 173.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.5 -6.22 18.67 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -77.35 -59.83 2.62 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.755 -1.216 . . . . 0.0 111.231 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -84.46 -25.54 28.86 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -121.81 -179.58 16.02 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.657 1.599 . . . . 0.0 112.274 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.4 m -123.85 118.58 27.44 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.819 1.247 . . . . 0.0 110.223 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.76 165.08 26.76 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -169.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -93.25 -58.19 2.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.743 2.017 . . . . 0.0 111.176 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -157.93 142.67 16.42 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.408 1.083 . . . . 0.0 113.369 -172.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -105.64 155.71 18.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.658 1.183 . . . . 0.0 111.67 169.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -144.08 88.25 1.95 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.201 1.8 . . . . 0.0 110.1 173.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.0 t -82.16 134.54 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.589 1.556 . . . . 0.0 110.743 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -21.09 -71.1 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 129.436 3.094 . . . . 0.0 116.352 -169.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -48.32 -29.34 3.81 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.394 1.878 . . . . 0.0 115.48 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.28 -32.71 70.27 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.397 1.479 . . . . 0.0 113.409 175.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -134.37 -42.77 0.78 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.124 1.369 . . . . 0.0 114.564 -169.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 54.0 m -60.98 145.73 49.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.113 1.365 . . . . 0.0 112.311 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -58.66 -30.35 65.5 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.92 1.247 . . . . 0.0 114.861 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.29 158.98 43.17 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.783 2.033 . . . . 0.0 111.809 173.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 47.1 m -62.3 133.99 55.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.336 1.055 . . . . 0.0 111.046 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.38 -56.48 0.75 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.517 1.127 . . . . 0.0 113.586 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 113.78 53.66 0.44 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.98 1.276 . . . . 0.0 113.232 -174.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.3 p -141.64 164.17 30.94 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.095 1.758 . . . . 0.0 110.967 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.1 167.26 30.44 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.231 -0.918 . . . . 0.0 112.693 169.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -130.84 132.73 45.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.417 1.887 . . . . 0.0 108.717 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.8 t -135.38 109.01 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 118.93 0.786 . . . . 0.0 111.148 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -73.84 123.35 24.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.118 1.367 . . . . 0.0 110.31 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.0 161.02 17.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.9 2.48 . . . . 0.0 112.92 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -59.19 -48.28 82.21 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.844 0.858 . . . . 0.0 112.577 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -143.2 152.73 42.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.364 1.866 . . . . 0.0 110.471 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -59.92 -43.94 94.62 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.186 0.994 . . . . 0.0 112.631 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.83 -46.58 71.22 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.357 1.063 . . . . 0.0 112.905 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.58 -48.44 79.42 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.211 1.404 . . . . 0.0 111.648 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.01 -48.33 73.51 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.195 1.398 . . . . 0.0 112.637 172.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.9 tp -53.29 -42.03 66.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.734 1.614 . . . . 0.0 113.101 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -51.2 -59.94 3.65 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.502 1.121 . . . . 0.0 111.437 171.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.9 -48.88 69.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.273 1.429 . . . . 0.0 112.482 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 21.0 ttp -51.6 -61.34 2.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.011 1.724 . . . . 0.0 111.563 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -56.36 -45.86 80.26 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.461 1.504 . . . . 0.0 112.353 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -58.4 -51.18 70.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.49 1.116 . . . . 0.0 113.176 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -97.73 -16.62 19.82 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -172.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -58.33 109.26 0.74 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 120.332 1.424 . . . . 0.0 111.388 171.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.56 -26.5 8.06 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.278 1.894 . . . . 0.0 114.041 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.78 135.0 95.35 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.065 1.346 . . . . 0.0 111.044 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.33 134.19 15.41 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.923 2.416 . . . . 0.0 111.708 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 63.5 tp -125.13 102.13 7.34 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.351 1.86 . . . . 0.0 108.196 175.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 44.32 62.04 2.16 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.005 1.722 . . . . 0.0 111.763 -169.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.83 -60.88 4.42 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.105 1.336 . . . . 0.0 112.995 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -60.46 118.94 38.76 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.858 1.663 . . . . 0.0 111.993 -172.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.07 118.85 5.82 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.902 2.401 . . . . 0.0 111.354 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.9 mtp -59.74 137.95 57.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.652 1.581 . . . . 0.0 112.013 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -121.08 131.51 54.31 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.731 1.212 . . . . 0.0 110.11 170.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.3 mt -131.07 137.35 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.258 1.023 . . . . 0.0 111.065 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -130.29 171.76 12.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 129.34 3.056 . . . . 0.0 109.912 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.06 155.43 46.16 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 171.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.6 152.8 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.389 1.476 . . . . 0.0 111.264 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 4.3 m -67.39 132.62 48.02 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.412 1.085 . . . . 0.0 110.931 173.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.614 1.566 . . . . 0.0 113.699 178.077 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 CA-C-O 120.08 -0.289 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -83.53 99.33 10.07 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.057 0.928 . . . . 0.0 111.004 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 76.1 mt -75.83 108.83 8.96 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.682 1.193 . . . . 0.0 110.19 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.4 tp -80.66 125.21 29.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.784 1.233 . . . . 0.0 107.8 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.32 131.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.376 1.07 . . . . 0.0 109.135 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.7 m -135.01 168.8 18.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.763 1.625 . . . . 0.0 111.728 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.2 t30 51.65 56.5 7.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.059 1.744 . . . . 0.0 112.438 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.8 mt -101.12 151.7 21.51 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.297 1.839 . . . . 0.0 110.94 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -69.22 142.05 54.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.776 -0.577 . . . . 0.0 110.937 169.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -62.34 -16.84 56.79 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -78.43 -13.44 83.23 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.413 1.482 . . . . 0.0 115.092 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 80.4 t -66.47 136.34 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 119.26 1.53 . . . . 0.0 109.997 172.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 65.4 m -140.9 169.21 18.04 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.551 1.54 . . . . 0.0 112.355 -175.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -46.34 -58.1 4.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.703 2.001 . . . . 0.0 113.693 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.89 -49.45 71.18 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.989 0.916 . . . . 0.0 112.813 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.1 -49.53 76.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.728 1.211 . . . . 0.0 112.31 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mm -54.19 -55.55 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.839 1.255 . . . . 0.0 111.349 171.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -53.19 -53.46 50.27 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.776 0.716 . . . . 0.0 111.685 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -54.51 -51.51 64.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.859 0.864 . . . . 0.0 113.058 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -49.57 72.6 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.857 0.753 . . . . 0.0 112.555 -176.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -67.09 -38.49 85.8 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.72 -20.22 64.69 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.33 -66.45 0.54 Allowed 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.959 -1.088 . . . . 0.0 110.751 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -85.56 -17.93 34.85 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -172.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.57 -159.79 8.49 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.429 1.49 . . . . 0.0 112.862 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.1 m -144.83 133.89 22.69 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.292 1.046 . . . . 0.0 110.996 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.59 146.81 52.19 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.892 1.277 . . . . 0.0 114.365 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -74.39 -52.32 12.46 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.441 1.896 . . . . 0.0 110.194 169.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -149.03 158.84 44.5 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.23 160.67 37.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.072 1.749 . . . . 0.0 110.847 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.89 149.42 23.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.329 1.852 . . . . 0.0 110.699 170.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.95 -96.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.976 0.91 . . . . 0.0 110.803 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.48 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -136.44 -98.22 0.22 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.905 1.682 . . . . 0.0 110.926 -169.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.48 ' H ' ' CG ' ' A' ' 137' ' ' HIS . 9.3 p90 43.45 32.05 0.47 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 130.255 3.422 . . . . 0.0 115.795 169.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -162.45 171.4 17.16 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 129.385 3.074 . . . . 0.0 108.913 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -75.85 74.47 2.79 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.738 -1.226 . . . . 0.0 110.441 170.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.6 m -62.75 -39.68 94.89 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.895 1.678 . . . . 0.0 114.038 -173.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 64.47 52.39 43.78 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.336 0.97 . . . . 0.0 111.675 -170.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -146.13 154.85 42.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.112 2.165 . . . . 0.0 111.051 -169.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.4 m -59.9 108.57 0.78 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.242 1.017 . . . . 0.0 109.9 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.3 tp -76.87 166.3 23.52 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.005 0.922 . . . . 0.0 112.994 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.89 46.76 9.16 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.219 0.914 . . . . 0.0 111.208 -169.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.0 p -146.45 150.18 35.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.773 2.029 . . . . 0.0 111.258 -170.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.32 167.87 23.22 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.202 1.801 . . . . 0.0 112.511 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -132.93 131.4 40.8 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.83 2.052 . . . . 0.0 109.668 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.1 t -132.92 109.33 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.529 1.132 . . . . 0.0 109.644 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -90.63 98.98 12.1 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.253 1.421 . . . . 0.0 110.064 -176.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -73.3 155.18 39.72 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.284 1.834 . . . . 0.0 114.249 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -68.72 -45.48 71.44 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.419 1.488 . . . . 0.0 112.088 171.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 -122.38 124.04 42.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.176 1.79 . . . . 0.0 110.325 -169.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -58.6 -47.27 84.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.843 1.257 . . . . 0.0 112.176 175.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.18 -48.31 61.96 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.35 1.06 . . . . 0.0 112.783 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -67.46 -35.43 79.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.679 1.191 . . . . 0.0 112.557 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.31 -45.56 92.95 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.037 0.935 . . . . 0.0 112.353 170.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -53.8 -49.93 67.23 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.709 1.141 . . . . 0.0 111.607 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -51.59 -58.2 7.0 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.409 1.084 . . . . 0.0 111.353 174.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -50.09 -51.93 38.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.106 1.362 . . . . 0.0 112.663 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 60.9 ttp -53.63 -62.69 1.49 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.548 1.539 . . . . 0.0 111.5 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -62.49 -37.58 86.55 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -64.03 -51.04 66.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.234 1.413 . . . . 0.0 112.687 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -99.0 -14.17 19.59 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -169.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -58.83 112.61 1.71 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.154 1.343 . . . . 0.0 111.226 170.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.57 -23.25 26.81 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.054 1.788 . . . . 0.0 114.371 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.7 t -73.15 135.51 79.76 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.887 1.275 . . . . 0.0 110.393 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.53 142.92 26.86 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.952 2.435 . . . . 0.0 113.068 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.5 tp -131.82 106.27 7.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.838 1.655 . . . . 0.0 107.852 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 50.65 61.22 3.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.755 1.622 . . . . 0.0 111.377 -169.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.53 -62.95 4.21 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.135 1.35 . . . . 0.0 113.311 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -65.43 128.49 93.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.844 1.258 . . . . 0.0 112.392 -172.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.91 122.92 9.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.725 2.95 . . . . 0.0 111.897 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.4 mtm -63.18 126.06 26.15 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.065 1.346 . . . . 0.0 111.831 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -103.19 113.5 27.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.986 1.315 . . . . 0.0 109.191 172.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mt -118.37 134.69 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.552 1.141 . . . . 0.0 111.484 -169.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -136.94 153.72 50.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.335 2.254 . . . . 0.0 110.089 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.2 tp -135.2 132.74 38.29 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.842 1.257 . . . . 0.0 111.453 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.57 134.08 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.127 0.971 . . . . 0.0 112.023 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.3 m -66.02 -56.07 13.45 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.482 1.113 . . . . 0.0 112.258 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.641 1.976 . . . . 0.0 113.341 -176.769 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.87 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -132.74 152.21 51.8 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.079 0.943 . . . . 0.0 111.957 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -129.05 101.64 6.14 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.137 1.775 . . . . 0.0 108.208 -169.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.6 tp -84.45 133.36 34.49 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.14 1.376 . . . . 0.0 109.394 175.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.5 t -122.05 130.48 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.85 1.26 . . . . 0.0 108.944 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -115.19 159.73 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.968 1.707 . . . . 0.0 110.474 172.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.3 t30 60.74 71.66 0.56 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.307 1.843 . . . . 0.0 112.227 -169.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.5 mt -131.33 154.6 48.39 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.873 2.469 . . . . 0.0 108.964 169.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -88.63 151.27 22.57 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.72 -0.613 . . . . 0.0 112.364 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -58.2 -28.07 64.46 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.187 -0.945 . . . . 0.0 112.294 172.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.97 -17.08 65.0 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.052 1.31 . . . . 0.0 115.467 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.99 116.67 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.419 1.609 . . . . 0.0 110.453 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.5 m -76.31 151.24 36.78 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.698 1.199 . . . . 0.0 111.852 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.51 -50.34 74.11 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.608 -0.683 . . . . 0.0 112.243 172.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 -38.91 59.86 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.06 -56.37 23.17 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.29 1.036 . . . . 0.0 112.231 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 23.6 mm -56.1 -53.89 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.197 1.399 . . . . 0.0 111.157 173.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -47.3 -57.77 4.86 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.829 2.052 . . . . 0.0 111.47 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -59.92 -50.97 71.7 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.506 1.122 . . . . 0.0 113.122 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.6 -45.2 93.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.402 1.001 . . . . 0.0 112.149 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -63.22 -44.24 95.84 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.433 0.693 . . . . 0.0 112.415 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.13 -18.56 63.57 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -69.46 -60.14 2.52 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.818 -1.176 . . . . 0.0 111.834 173.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -85.44 -22.76 28.15 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.06 -167.31 11.2 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.681 1.61 . . . . 0.0 112.735 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.2 m -136.81 129.3 30.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.082 0.953 . . . . 0.0 111.078 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.8 pp -130.06 144.49 51.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.88 1.272 . . . . 0.0 113.376 -169.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -75.17 -50.17 17.13 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.913 2.085 . . . . 0.0 110.497 169.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.94 154.79 38.86 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.78 1.232 . . . . 0.0 112.132 -172.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -138.58 151.72 47.54 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.446 1.499 . . . . 0.0 111.541 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.12 159.21 44.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.678 1.991 . . . . 0.0 110.903 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.1 -124.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.266 1.026 . . . . 0.0 110.818 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -71.08 -35.55 71.91 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -169.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -69.53 154.35 42.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.038 1.735 . . . . 0.0 114.142 -169.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -150.06 154.92 38.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.934 2.094 . . . . 0.0 110.41 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -49.25 -33.6 13.16 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.96 1.704 . . . . 0.0 113.869 175.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.7 m -59.77 -23.97 63.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.121 1.769 . . . . 0.0 114.26 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.56 49.7 7.08 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.12 1.343 . . . . 0.0 111.855 -170.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -140.94 113.46 8.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.544 1.938 . . . . 0.0 110.58 -174.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.9 m -70.74 138.54 50.59 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.455 1.102 . . . . 0.0 111.68 173.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 35.2 tp -130.71 150.15 52.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.383 1.873 . . . . 0.0 110.229 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.43 51.11 4.45 Favored Glycine 0 N--CA 1.47 0.954 0 O-C-N 120.959 -1.088 . . . . 0.0 112.469 -171.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 37.0 p -142.01 167.71 21.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.67 1.988 . . . . 0.0 113.548 -169.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.7 157.11 43.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.725 2.01 . . . . 0.0 110.618 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -140.14 126.89 20.51 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.982 1.313 . . . . 0.0 110.212 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 52.2 t -122.34 116.03 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.813 1.245 . . . . 0.0 109.033 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -83.32 105.65 14.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.023 1.329 . . . . 0.0 108.19 173.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -82.08 153.33 26.16 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.423 2.289 . . . . 0.0 113.079 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.76 -34.01 77.19 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.987 0.915 . . . . 0.0 113.409 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -138.15 146.34 42.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.486 1.514 . . . . 0.0 113.295 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -64.18 -45.63 87.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.791 1.636 . . . . 0.0 111.782 172.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.03 -49.48 60.42 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.47 1.108 . . . . 0.0 112.265 171.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.35 -40.83 90.08 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.622 1.169 . . . . 0.0 112.792 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.37 -49.4 74.55 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.582 1.153 . . . . 0.0 112.419 170.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 54.6 tp -57.04 -49.76 74.82 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.352 1.461 . . . . 0.0 111.884 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -50.1 -52.85 31.44 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.354 1.461 . . . . 0.0 111.434 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.96 -50.86 69.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.017 0.927 . . . . 0.0 112.519 173.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -54.5 -60.23 3.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.376 1.07 . . . . 0.0 112.17 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -37.19 75.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -69.17 -43.83 73.45 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.161 0.984 . . . . 0.0 112.906 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -108.42 -8.41 15.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -169.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -58.46 116.43 3.64 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 120.054 1.297 . . . . 0.0 111.459 171.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.58 -21.54 44.72 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.869 1.7 . . . . 0.0 114.575 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.28 136.67 88.93 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 118.72 1.26 . . . . 0.0 110.451 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.8 143.57 29.95 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.725 2.284 . . . . 0.0 113.197 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -131.67 106.76 8.36 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.301 2.24 . . . . 0.0 107.015 171.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 48.0 61.67 2.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.336 1.454 . . . . 0.0 111.494 -169.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.39 -53.92 4.71 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.254 1.407 . . . . 0.0 113.483 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -59.47 119.17 37.35 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.522 1.929 . . . . 0.0 112.779 -174.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.54 120.73 7.65 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.619 2.212 . . . . 0.0 110.726 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.5 mtm -67.3 116.96 8.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.982 1.313 . . . . 0.0 112.13 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -89.59 101.43 14.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.264 1.025 . . . . 0.0 108.941 170.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.4 mt -103.89 139.81 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.275 1.03 . . . . 0.0 111.827 -170.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -134.27 126.61 30.13 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.415 1.886 . . . . 0.0 111.191 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 60.9 tp -75.79 131.7 39.95 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.769 1.228 . . . . 0.0 109.874 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.35 171.65 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.38 1.472 . . . . 0.0 112.159 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.7 p -132.77 -69.16 0.58 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.926 1.69 . . . . 0.0 110.806 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 C--O 1.251 1.135 0 C-N-CA 125.95 1.7 . . . . 0.0 112.116 171.165 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 N-CA-C 112.629 -0.188 . . . . 0.0 112.629 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -149.08 130.59 14.84 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.576 -0.955 . . . . 0.0 111.519 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 41.9 mt -119.43 121.24 39.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.018 1.727 . . . . 0.0 111.879 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.9 tp -86.05 116.01 24.0 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 168.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 49.1 t -101.83 131.05 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 108.134 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.2 m -138.78 167.84 21.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.762 1.625 . . . . 0.0 112.318 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.7 t30 52.84 46.88 25.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.005 1.722 . . . . 0.0 112.948 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.9 mt -90.76 164.34 14.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.766 1.227 . . . . 0.0 109.59 169.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.93 150.88 47.93 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.392 -0.817 . . . . 0.0 110.652 169.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -58.07 -20.82 42.48 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -128.78 39.76 1.81 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.879 1.228 . . . . 0.0 115.812 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.58 131.8 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.367 1.583 . . . . 0.0 109.276 169.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.1 m -69.92 138.92 52.81 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.487 0.715 . . . . 0.0 112.344 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.87 -52.16 66.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.068 1.347 . . . . 0.0 112.309 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.87 -40.47 80.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.98 1.312 . . . . 0.0 113.092 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.61 -52.35 65.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.9 0.88 . . . . 0.0 112.127 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.1 mm -55.11 -52.86 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.949 0.9 . . . . 0.0 111.266 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -51.89 -52.45 49.68 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.925 0.89 . . . . 0.0 112.294 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -60.43 -51.97 67.23 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.031 1.332 . . . . 0.0 113.27 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.19 -43.54 97.93 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.337 0.972 . . . . 0.0 112.22 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -62.16 -44.87 95.65 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.533 0.606 . . . . 0.0 112.022 172.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.69 -32.64 67.55 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.62 -47.3 86.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.198 0.999 . . . . 0.0 112.874 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -100.82 -15.86 17.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.92 155.1 25.75 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.641 1.115 . . . . 0.0 114.033 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.7 m -91.53 99.23 12.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.858 1.263 . . . . 0.0 110.006 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 pp -111.47 141.82 44.53 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.296 1.038 . . . . 0.0 113.742 -171.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -82.22 -46.25 13.97 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.153 2.581 . . . . 0.0 110.427 170.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -146.12 144.99 30.34 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.395 1.478 . . . . 0.0 111.481 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.62 121.96 11.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.378 1.471 . . . . 0.0 110.447 171.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.08 139.86 30.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.624 1.17 . . . . 0.0 112.704 -176.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.9 t -107.28 144.24 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.363 1.865 . . . . 0.0 111.159 -173.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -41.44 -50.11 3.88 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.468 2.307 . . . . 0.0 114.918 -169.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -58.89 -33.85 70.98 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.75 1.22 . . . . 0.0 113.147 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.57 -52.62 4.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.725 1.61 . . . . 0.0 111.749 173.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 -56.24 -58.19 9.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.616 2.366 . . . . 0.0 113.496 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.5 m -104.61 -35.91 7.67 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.976 2.111 . . . . 0.0 113.002 -169.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.03 -62.11 0.46 Allowed Glycine 0 CA--C 1.531 1.066 0 C-N-CA 126.108 1.813 . . . . 0.0 112.329 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -59.7 126.39 27.42 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.783 1.633 . . . . 0.0 112.11 -178.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.3 m -58.28 121.62 11.22 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.584 1.554 . . . . 0.0 111.875 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 43.8 tp -147.73 -48.72 0.17 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.444 1.098 . . . . 0.0 113.378 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.05 57.96 1.27 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.498 1.047 . . . . 0.0 112.159 -176.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.9 p -144.16 163.53 33.34 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.759 1.623 . . . . 0.0 111.416 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.73 168.49 20.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.635 1.174 . . . . 0.0 111.405 170.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -135.18 118.81 17.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.162 1.785 . . . . 0.0 108.828 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.61 116.65 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.239 1.016 . . . . 0.0 110.093 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -101.83 124.93 48.29 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.643 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -103.23 154.7 19.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.951 2.9 . . . . 0.0 113.042 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -68.78 -29.75 68.19 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.905 1.282 . . . . 0.0 113.63 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -138.38 136.06 35.94 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.248 1.419 . . . . 0.0 113.018 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.41 -53.55 56.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.403 2.281 . . . . 0.0 112.449 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.44 -45.37 84.78 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.191 1.397 . . . . 0.0 112.415 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.83 -38.91 92.56 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.504 -0.748 . . . . 0.0 112.567 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.96 51.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.282 0.633 . . . . 0.0 111.337 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.26 -50.22 59.65 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.5 1.92 . . . . 0.0 112.334 174.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -50.68 -59.99 3.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.805 1.642 . . . . 0.0 111.206 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.65 -46.47 70.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.381 1.073 . . . . 0.0 112.393 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.5 ttp -52.83 -59.48 4.45 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.957 1.303 . . . . 0.0 111.839 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -55.53 -50.45 69.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.217 1.007 . . . . 0.0 112.273 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -59.03 -46.34 88.46 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.851 1.661 . . . . 0.0 113.115 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -100.81 -14.81 17.85 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -60.53 106.26 0.53 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.001 1.273 . . . . 0.0 111.178 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.33 -27.33 7.37 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 126.569 2.033 . . . . 0.0 114.087 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 64.2 t -68.88 132.77 90.43 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.06 1.344 . . . . 0.0 110.876 -174.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.1 145.87 22.32 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.902 2.401 . . . . 0.0 113.39 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.8 tt -130.5 108.18 9.76 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.111 2.165 . . . . 0.0 107.32 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 44.0 57.04 4.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.936 1.694 . . . . 0.0 112.048 -169.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 87.9 -51.12 4.03 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.985 1.278 . . . . 0.0 113.706 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -62.8 119.38 50.77 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.54 1.536 . . . . 0.0 111.448 -174.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.29 118.55 5.74 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.831 2.354 . . . . 0.0 110.924 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.61 127.34 31.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.091 0.956 . . . . 0.0 110.957 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -100.78 131.11 46.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.524 1.13 . . . . 0.0 109.036 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.1 mm -124.1 135.51 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.788 0.835 . . . . 0.0 109.946 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.22 117.76 19.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.344 1.458 . . . . 0.0 110.674 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 39.7 tp -72.38 135.53 45.87 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.754 1.222 . . . . 0.0 110.147 169.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.5 m -123.18 151.26 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.16 0.984 . . . . 0.0 111.548 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.9 m -147.51 135.21 21.02 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.448 1.899 . . . . 0.0 109.86 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.7 m . . . . . 0 C--O 1.252 1.225 0 C-N-CA 125.093 1.357 . . . . 0.0 113.456 177.238 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.173 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.36 112.79 19.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.709 1.203 . . . . 0.0 111.522 179.029 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.5 117.88 23.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.842 2.457 . . . . 0.0 108.53 178.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.3 tp -105.69 125.62 51.2 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.808 2.043 . . . . 0.0 110.484 -176.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.6 t -112.78 125.44 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.148 1.779 . . . . 0.0 109.195 179.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.6 m -120.92 163.08 18.78 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.858 2.063 . . . . 0.0 110.909 177.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.7 t30 51.62 57.0 7.03 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.124 1.369 . . . . 0.0 111.281 -169.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.8 118.73 33.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.522 2.329 . . . . 0.0 107.784 -173.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.07 140.99 58.35 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -54.61 -29.02 50.67 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.777 1.631 . . . . 0.0 114.169 -178.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -75.72 -15.89 81.0 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.974 1.273 . . . . 0.0 115.353 177.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.18 122.42 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 119.155 1.478 . . . . 0.0 110.797 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.5 m -79.48 148.36 31.89 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.117 0.967 . . . . 0.0 113.22 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.75 -54.23 48.69 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.305 1.842 . . . . 0.0 112.631 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.65 87.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.035 0.934 . . . . 0.0 112.907 174.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.06 -47.55 84.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.587 0.755 . . . . 0.0 111.939 176.362 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mm -55.03 -52.53 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.035 0.934 . . . . 0.0 111.196 169.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -52.46 -52.2 55.39 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.126 0.571 . . . . 0.0 112.33 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.88 -50.51 73.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.94 1.296 . . . . 0.0 113.46 175.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.82 -44.96 91.69 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.394 0.997 . . . . 0.0 112.032 -176.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -61.75 -41.21 97.39 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 173.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.9 -13.58 46.55 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 175.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -74.59 -63.42 1.25 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.861 -1.15 . . . . 0.0 111.481 173.093 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -84.4 -12.78 53.82 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -175.406 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.36 -178.13 18.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.479 1.514 . . . . 0.0 112.942 176.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -126.65 127.49 45.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.984 1.314 . . . . 0.0 109.926 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -134.61 149.66 50.6 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.637 1.175 . . . . 0.0 114.145 -169.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -77.68 -49.87 13.62 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.643 1.977 . . . . 0.0 110.407 169.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -149.78 150.83 32.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.687 1.195 . . . . 0.0 113.111 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -127.25 154.53 44.76 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.863 1.665 . . . . 0.0 110.148 168.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.26 153.38 29.04 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.723 1.609 . . . . 0.0 112.068 179.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.9 t -125.65 158.76 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 126.82 2.048 . . . . 0.0 109.362 174.046 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -58.52 -47.75 83.14 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.409 -1.432 . . . . 0.0 114.226 -174.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -62.12 161.32 11.19 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.873 1.269 . . . . 0.0 113.335 -171.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 t70 66.56 -55.48 0.41 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 127.775 2.43 . . . . 0.0 113.578 -173.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -55.41 -47.08 76.47 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.676 1.59 . . . . 0.0 111.287 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -123.91 115.35 21.14 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.101 1.76 . . . . 0.0 109.792 170.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.85 55.4 4.9 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.446 1.022 . . . . 0.0 113.075 -178.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -146.72 138.35 24.46 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.29 2.236 . . . . 0.0 110.983 -173.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.8 m -60.93 114.32 3.01 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.516 1.126 . . . . 0.0 111.012 173.338 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.3 tp -139.3 -59.64 0.58 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.265 1.426 . . . . 0.0 111.177 -177.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.27 63.63 1.71 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.103 0.859 . . . . 0.0 113.43 172.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.8 p -143.91 154.41 43.31 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.501 1.521 . . . . 0.0 111.617 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.28 159.1 42.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.969 1.307 . . . . 0.0 111.766 173.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -144.2 133.75 23.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.876 1.67 . . . . 0.0 110.746 -172.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.86 114.79 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.446 1.098 . . . . 0.0 110.432 -177.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -79.46 104.15 9.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.328 1.451 . . . . 0.0 108.874 170.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -82.79 163.59 21.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.159 1.783 . . . . 0.0 113.389 -175.006 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -70.21 -51.48 30.62 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.827 0.851 . . . . 0.0 112.506 169.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -131.26 145.67 51.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.286 1.834 . . . . 0.0 112.354 -172.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -54.88 -56.65 17.21 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.924 2.09 . . . . 0.0 112.814 176.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.24 -47.13 72.58 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.887 1.275 . . . . 0.0 112.422 177.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -61.86 -38.86 89.83 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.459 1.103 . . . . 0.0 112.71 176.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.19 -46.46 80.68 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.458 0.703 . . . . 0.0 112.427 170.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.0 tp -59.12 -42.19 89.98 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.492 1.517 . . . . 0.0 112.147 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -48.0 -60.03 2.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.564 1.546 . . . . 0.0 110.728 169.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.73 -49.04 69.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.989 1.315 . . . . 0.0 112.592 176.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 25.0 ttp -51.81 -60.04 3.63 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.625 1.17 . . . . 0.0 111.643 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.26 -48.4 81.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.76 1.224 . . . . 0.0 112.319 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -58.1 -49.53 76.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.558 1.543 . . . . 0.0 112.993 -178.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -99.92 -12.37 19.87 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -169.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -59.47 110.57 1.14 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.336 1.425 . . . . 0.0 111.194 169.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.36 -23.8 19.61 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.494 1.997 . . . . 0.0 114.172 -175.44 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -74.28 134.41 76.97 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.825 1.25 . . . . 0.0 110.95 -174.16 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.37 139.43 20.84 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.008 2.472 . . . . 0.0 112.719 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.8 tp -136.07 113.7 10.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.508 1.523 . . . . 0.0 108.628 169.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 49.11 61.4 3.15 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.609 1.564 . . . . 0.0 111.2 -169.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.4 -62.48 4.56 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.431 1.491 . . . . 0.0 113.373 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -66.06 128.42 93.82 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.866 1.266 . . . . 0.0 112.907 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.73 116.41 4.65 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.451 2.768 . . . . 0.0 110.868 171.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.6 mtm -65.72 124.94 23.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.651 1.18 . . . . 0.0 111.666 -178.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -98.6 118.14 34.62 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mt -119.38 137.57 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.844 0.858 . . . . 0.0 112.305 -169.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -135.02 155.99 49.82 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.413 2.685 . . . . 0.0 110.032 -175.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 47.8 tp -135.86 113.49 10.92 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.448 1.099 . . . . 0.0 110.797 -177.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.01 118.29 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.942 0.897 . . . . 0.0 110.497 -175.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.4 m -144.99 137.49 26.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.987 1.715 . . . . 0.0 110.504 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.0 m . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.502 1.921 . . . . 0.0 114.025 -179.097 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.162 0 N-CA-C 113.547 0.179 . . . . 0.0 113.547 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -72.05 149.72 44.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.448 1.099 . . . . 0.0 112.112 176.389 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.4 mt -136.33 139.31 42.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 130.107 3.363 . . . . 0.0 108.758 174.163 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 65.7 tp -122.32 118.82 29.39 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.892 1.677 . . . . 0.0 108.607 174.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.82 112.25 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.123 1.369 . . . . 0.0 108.709 -169.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -127.62 173.97 9.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.789 1.235 . . . . 0.0 112.54 -169.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.0 t30 52.34 43.12 31.12 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.119 1.767 . . . . 0.0 112.891 -169.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.7 mt -77.36 153.99 33.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.149 0.98 . . . . 0.0 108.566 169.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -68.02 141.98 56.05 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.732 -1.23 . . . . 0.0 109.957 169.319 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -61.55 -19.03 61.68 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.147 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.03 0.54 82.11 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.452 1.501 . . . . 0.0 115.472 174.237 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.07 118.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.733 1.766 . . . . 0.0 110.916 175.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.5 m -71.45 148.03 47.26 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.717 1.207 . . . . 0.0 112.765 178.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -53.63 -54.38 38.55 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.831 1.652 . . . . 0.0 112.846 174.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.89 78.47 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.532 1.133 . . . . 0.0 113.299 177.161 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.85 -51.02 71.79 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.949 0.9 . . . . 0.0 112.364 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.6 mm -56.52 -52.73 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.344 1.057 . . . . 0.0 111.008 171.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -51.82 -51.85 53.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.896 0.878 . . . . 0.0 112.414 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.72 -50.06 73.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.199 1.4 . . . . 0.0 113.545 174.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.04 -43.74 98.18 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.878 1.217 . . . . 0.0 112.455 -175.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -63.51 -42.5 98.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.557 0.617 . . . . 0.0 112.371 172.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.21 71.25 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 173.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.22 -42.38 86.12 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.448 1.099 . . . . 0.0 113.085 177.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -108.36 -1.63 19.82 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -174.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.02 165.25 34.66 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 120.047 1.294 . . . . 0.0 114.628 177.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.8 m -101.47 122.94 44.7 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.096 0.958 . . . . 0.0 110.758 -177.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.05 161.9 36.83 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -93.74 -46.82 7.06 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.148 1.779 . . . . 0.0 112.131 175.659 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -141.94 143.31 33.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.295 1.038 . . . . 0.0 112.549 -173.094 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.49 118.11 6.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.808 1.643 . . . . 0.0 109.418 169.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.35 121.6 12.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.966 1.306 . . . . 0.0 112.414 -172.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.72 152.84 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.839 1.656 . . . . 0.0 110.098 170.649 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -48.94 -48.18 43.12 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.293 1.837 . . . . 0.0 115.042 -172.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -66.01 133.39 50.71 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.872 0.869 . . . . 0.0 112.736 -172.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -156.84 -84.16 0.05 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.232 1.413 . . . . 0.0 110.51 174.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -70.08 -62.13 1.5 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.173 0.989 . . . . 0.0 109.459 170.023 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.9 m -82.27 159.71 23.11 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.819 1.647 . . . . 0.0 111.222 169.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -139.85 67.82 0.5 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.359 1.457 . . . . 0.0 111.732 176.312 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.3 mtp85 -67.4 154.24 41.82 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.369 1.468 . . . . 0.0 112.364 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 57.4 m -71.77 81.53 0.88 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.114 1.366 . . . . 0.0 110.021 169.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 60.6 tp -151.28 161.33 42.91 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.525 2.33 . . . . 0.0 109.509 -170.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.13 77.19 0.28 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.809 1.195 . . . . 0.0 111.703 -178.167 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.3 m -141.39 143.0 33.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.672 1.589 . . . . 0.0 110.826 -174.409 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.83 139.29 34.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.325 1.45 . . . . 0.0 112.69 176.505 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -93.7 129.94 39.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.573 1.549 . . . . 0.0 109.429 169.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.6 t -133.16 143.59 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.596 1.559 . . . . 0.0 108.878 -177.365 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -145.47 108.24 4.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.755 -1.215 . . . . 0.0 111.006 -173.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -86.19 175.27 8.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.882 2.073 . . . . 0.0 113.628 -171.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -91.54 -65.68 0.99 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.743 1.217 . . . . 0.0 110.861 169.529 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -83.12 132.37 35.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.187 1.395 . . . . 0.0 111.89 -176.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -50.42 73.1 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.439 1.496 . . . . 0.0 112.105 179.694 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.36 -45.79 84.01 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.513 1.125 . . . . 0.0 112.246 176.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -63.7 -39.82 95.25 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.022 1.329 . . . . 0.0 112.55 177.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.51 -52.1 67.01 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.163 0.985 . . . . 0.0 111.809 170.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 62.2 tp -54.94 -47.36 74.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.142 0.977 . . . . 0.0 112.057 174.343 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -50.23 -57.18 8.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.633 1.573 . . . . 0.0 111.356 171.675 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -50.87 -46.07 60.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.651 1.18 . . . . 0.0 112.865 176.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 24.4 ttp -57.16 -67.26 0.34 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.688 0.676 . . . . 0.0 111.507 172.16 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -62.67 -36.02 81.54 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -170.272 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -64.18 -42.58 96.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.93 1.292 . . . . 0.0 112.931 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.25 -13.65 14.86 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -169.611 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.65 113.96 2.27 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.776 1.171 . . . . 0.0 111.116 169.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.58 -16.75 54.57 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.909 1.718 . . . . 0.0 114.699 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.44 129.49 85.6 Favored Pre-proline 0 N--CA 1.477 0.912 0 CA-C-N 119.085 1.442 . . . . 0.0 110.813 -176.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.98 140.19 93.05 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.809 3.006 . . . . 0.0 115.1 176.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.6 tp -138.28 104.59 5.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.366 2.266 . . . . 0.0 107.539 169.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 48.31 62.01 2.74 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.387 1.475 . . . . 0.0 111.718 -169.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.69 -59.51 4.95 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.19 1.376 . . . . 0.0 113.214 -179.35 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.5 mtt-85 -60.55 127.67 87.16 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.733 1.613 . . . . 0.0 112.682 -175.591 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.82 122.61 8.66 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.757 2.305 . . . . 0.0 110.756 170.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.5 mtm -61.69 121.61 13.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.099 0.96 . . . . 0.0 111.589 178.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -93.41 103.06 15.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.866 1.266 . . . . 0.0 108.917 174.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -115.83 131.85 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.33 1.052 . . . . 0.0 111.342 -171.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -122.54 150.18 42.92 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.647 2.379 . . . . 0.0 109.394 175.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.4 tp -80.31 -123.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.882 1.273 . . . . 0.0 110.075 174.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 20.4 m -62.38 135.91 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.12 -0.987 . . . . 0.0 110.632 171.101 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 18.7 p -72.33 -62.39 1.45 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.923 1.289 . . . . 0.0 112.969 -170.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.252 1.194 0 C-N-CA 126.77 2.028 . . . . 0.0 112.375 -175.814 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 112.609 -0.196 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -146.52 138.42 24.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.341 1.056 . . . . 0.0 111.139 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.1 mt -134.67 126.27 28.78 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.709 1.604 . . . . 0.0 112.221 -175.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.7 tp -90.8 124.7 35.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.228 1.411 . . . . 0.0 107.603 169.028 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.71 92.0 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.677 1.591 . . . . 0.0 108.597 -171.007 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.0 m -88.19 167.65 13.42 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.129 1.771 . . . . 0.0 112.581 -177.118 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.0 t30 55.35 66.77 1.14 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.175 2.19 . . . . 0.0 113.447 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.7 mt -116.16 -168.81 1.49 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.582 2.353 . . . . 0.0 110.42 174.685 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.85 150.35 47.82 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.129 -0.982 . . . . 0.0 112.322 173.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -51.01 -40.89 59.23 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.465 1.106 . . . . 0.0 112.977 175.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.27 69.51 0.43 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.479 1.514 . . . . 0.0 111.941 173.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.78 134.48 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.954 1.702 . . . . 0.0 111.855 172.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.0 m -85.52 126.25 33.7 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.819 -0.551 . . . . 0.0 110.394 170.408 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.44 -48.46 79.08 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.381 1.072 . . . . 0.0 111.961 179.245 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.17 75.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.278 1.431 . . . . 0.0 113.233 175.102 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.56 -53.16 61.45 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.176 0.991 . . . . 0.0 111.993 178.416 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 47.7 mm -57.34 -53.58 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.63 1.172 . . . . 0.0 111.169 173.087 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -49.47 -54.57 17.04 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.315 1.046 . . . . 0.0 111.553 177.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -61.37 -50.1 74.24 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.023 0.829 . . . . 0.0 112.657 178.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -47.53 85.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.939 0.79 . . . . 0.0 112.31 -176.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -64.91 -46.91 79.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.641 0.655 . . . . 0.0 112.303 175.123 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.99 -35.49 64.41 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -55.54 -45.52 77.2 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.34 1.056 . . . . 0.0 112.98 175.396 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -102.53 -19.36 14.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -175.112 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -152.63 157.68 27.43 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-N 120.096 1.316 . . . . 0.0 114.303 177.143 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.4 m -84.63 95.91 9.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.68 -0.894 . . . . 0.0 111.727 -172.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.21 143.34 29.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.635 0.774 . . . . 0.0 111.809 172.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -85.63 -48.51 8.81 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.575 2.35 . . . . 0.0 110.309 169.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -149.45 149.09 30.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.742 1.217 . . . . 0.0 112.444 -177.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -122.77 153.86 38.95 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.094 1.758 . . . . 0.0 110.96 169.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.57 -176.33 5.26 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.696 2.398 . . . . 0.0 110.938 -176.111 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 148' ' ' ALA . 0.6 OUTLIER -140.45 151.69 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 127.909 2.483 . . . . 0.0 110.099 176.458 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -42.72 99.75 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -172.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -71.15 137.29 48.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.999 1.32 . . . . 0.0 112.187 172.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -145.21 -95.88 0.1 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.357 1.063 . . . . 0.0 110.845 177.222 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -57.96 -40.61 81.0 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.373 1.469 . . . . 0.0 111.825 171.096 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.1 p -55.46 -53.16 59.77 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.406 2.283 . . . . 0.0 113.524 173.135 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.53 30.14 76.8 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.378 1.466 . . . . 0.0 113.588 -173.285 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -77.94 93.33 4.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.495 1.518 . . . . 0.0 110.945 -178.15 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.1 m -54.92 122.77 11.57 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.995 1.318 . . . . 0.0 111.296 174.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 56.6 tp -153.85 -69.12 0.14 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.743 1.217 . . . . 0.0 111.181 -173.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.39 66.86 0.13 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.461 1.505 . . . . 0.0 113.606 175.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.0 m -141.86 113.77 7.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.0 1.32 . . . . 0.0 110.077 176.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . . . -96.79 164.01 12.75 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.159 1.383 . . . . 0.0 111.373 173.445 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -143.4 126.49 16.43 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.57 1.148 . . . . 0.0 110.37 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.4 t -136.6 136.75 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.14 0.976 . . . . 0.0 110.989 -169.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -115.91 138.75 50.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.307 1.843 . . . . 0.0 109.368 178.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -127.39 158.39 37.43 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.149 2.58 . . . . 0.0 113.708 -169.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -64.47 -32.71 74.46 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.483 1.513 . . . . 0.0 114.439 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -135.93 147.56 48.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.088 1.355 . . . . 0.0 112.803 -169.441 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -58.92 -52.75 64.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.444 1.498 . . . . 0.0 111.734 169.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.98 -50.44 64.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.088 1.355 . . . . 0.0 112.195 177.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.65 -51.4 63.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.234 1.414 . . . . 0.0 112.023 175.306 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.76 -50.98 71.9 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.586 0.754 . . . . 0.0 112.429 176.116 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 80.3 mt -58.34 -47.09 84.86 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.474 1.11 . . . . 0.0 112.764 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -54.22 -55.51 27.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.943 1.297 . . . . 0.0 111.582 172.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.32 -52.74 51.46 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.691 1.196 . . . . 0.0 112.561 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 34.8 ttm -50.03 -62.03 1.81 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.665 1.586 . . . . 0.0 111.617 175.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.75 -46.8 88.02 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.121 1.368 . . . . 0.0 112.64 -177.171 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -63.03 -45.4 92.51 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.477 1.111 . . . . 0.0 113.206 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.0 -15.72 17.37 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -169.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -60.66 110.35 1.27 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.969 1.259 . . . . 0.0 110.682 169.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.96 -25.72 11.27 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.561 2.029 . . . . 0.0 114.191 -175.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.81 132.0 90.89 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.564 1.146 . . . . 0.0 111.433 -171.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.22 106.89 1.96 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.527 2.818 . . . . 0.0 112.283 -177.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 tp -75.23 89.87 2.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.177 1.391 . . . . 0.0 109.352 169.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 44.46 58.51 3.79 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.363 1.865 . . . . 0.0 111.33 -169.334 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 100.72 -47.54 1.23 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.627 1.584 . . . . 0.0 113.702 -177.23 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -68.33 107.91 2.36 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 127.002 2.121 . . . . 0.0 112.463 -169.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.17 107.9 2.22 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.984 1.789 . . . . 0.0 110.863 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.91 134.68 55.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.256 1.022 . . . . 0.0 111.138 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -119.64 112.83 19.8 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.853 0.861 . . . . 0.0 110.459 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.0 mt -108.11 132.67 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.146 0.979 . . . . 0.0 111.223 -169.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -131.03 141.48 50.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.343 2.257 . . . . 0.0 109.978 -173.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.32 144.65 53.56 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 175.054 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.4 t 51.63 -101.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 127.886 2.474 . . . . 0.0 113.22 172.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 3.0 m -154.44 147.39 24.53 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.87 2.068 . . . . 0.0 109.189 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.817 1.247 . . . . 0.0 113.333 173.909 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.208 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -150.26 101.8 3.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.7 1.2 . . . . 0.0 110.412 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 34.1 mt -95.73 107.17 19.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.339 1.055 . . . . 0.0 111.605 -177.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.5 tp -76.18 129.4 36.68 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 168.614 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.61 111.85 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.96 1.304 . . . . 0.0 108.737 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.3 m -112.53 169.95 8.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.218 1.407 . . . . 0.0 110.975 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.7 t30 57.13 78.18 0.24 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.924 1.69 . . . . 0.0 112.11 -174.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.8 mt -132.03 157.54 43.86 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.201 2.2 . . . . 0.0 110.336 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.55 145.8 50.82 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.046 -1.034 . . . . 0.0 111.656 170.023 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -57.22 -29.0 63.39 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -177.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -109.34 28.02 11.61 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.256 1.408 . . . . 0.0 115.261 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.59 119.2 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.174 1.487 . . . . 0.0 110.012 169.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.8 m -74.13 145.51 44.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.434 1.094 . . . . 0.0 112.568 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.68 -51.47 68.63 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.826 0.85 . . . . 0.0 112.094 171.361 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.45 -53.05 19.31 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.808 1.643 . . . . 0.0 112.331 175.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.88 -50.96 67.43 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.807 1.243 . . . . 0.0 112.365 177.131 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.0 mm -56.41 -56.82 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.221 1.008 . . . . 0.0 112.15 174.075 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -58.03 -43.75 86.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.709 1.141 . . . . 0.0 112.243 -178.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -59.14 -52.49 65.5 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.057 0.844 . . . . 0.0 112.775 173.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -65.03 -47.24 78.12 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.998 0.817 . . . . 0.0 112.374 -176.128 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -62.45 -40.49 96.78 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.774 0.715 . . . . 0.0 112.558 175.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.25 -13.54 60.54 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 175.457 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.85 -57.71 4.09 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.839 -1.163 . . . . 0.0 111.424 173.147 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -84.89 -33.95 22.66 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.98 -172.79 15.0 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.845 1.688 . . . . 0.0 112.801 178.021 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -131.02 120.88 24.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.579 1.152 . . . . 0.0 110.41 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -123.86 142.66 50.92 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -72.87 -52.0 16.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.733 2.413 . . . . 0.0 110.428 169.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -152.84 156.74 39.6 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.353 1.461 . . . . 0.0 112.596 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -128.88 162.77 26.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.842 1.657 . . . . 0.0 111.302 169.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.45 145.36 23.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.24 2.216 . . . . 0.0 109.806 172.077 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.2 t -140.99 147.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.517 1.527 . . . . 0.0 110.462 178.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -68.02 -48.59 65.29 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.045 1.738 . . . . 0.0 114.466 -178.247 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . 0.326 20.1 p90 31.2 69.97 0.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 130.567 3.547 . . . . 0.0 114.61 -168.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -145.84 149.26 33.97 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.392 2.277 . . . . 0.0 110.415 173.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -82.91 91.46 7.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.196 0.998 . . . . 0.0 110.334 173.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.9 m -62.93 160.95 13.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.075 1.35 . . . . 0.0 112.665 176.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -56.2 -35.87 66.57 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.124 1.345 . . . . 0.0 114.708 -178.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -134.92 175.69 9.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.376 2.27 . . . . 0.0 110.934 171.108 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 69.9 m -52.53 113.27 1.01 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.738 1.215 . . . . 0.0 112.022 177.215 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.4 tp -141.41 -107.6 0.14 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.686 1.594 . . . . 0.0 109.147 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.27 104.66 0.23 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-N 120.073 1.306 . . . . 0.0 111.072 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.6 m -126.18 133.63 51.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.138 0.975 . . . . 0.0 112.34 -173.018 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.77 160.08 37.89 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.419 1.887 . . . . 0.0 111.148 170.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -145.28 126.68 14.94 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.367 1.467 . . . . 0.0 110.222 -177.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.33 111.67 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.142 0.977 . . . . 0.0 110.863 -171.082 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -75.71 111.19 10.79 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.288 1.435 . . . . 0.0 109.43 172.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.9 150.99 21.95 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.903 2.081 . . . . 0.0 112.555 -178.333 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.82 -38.37 90.83 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 177.081 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -136.39 142.85 43.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.607 1.563 . . . . 0.0 112.335 -174.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -54.47 -52.34 62.17 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.929 1.692 . . . . 0.0 112.136 172.259 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.91 -51.9 66.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.1 1.36 . . . . 0.0 112.475 176.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -59.88 -40.66 89.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.834 0.854 . . . . 0.0 112.536 177.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.89 -51.64 68.28 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.979 0.912 . . . . 0.0 111.983 171.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 62.8 mt -55.38 -48.08 74.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.776 0.83 . . . . 0.0 112.861 173.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -54.04 -54.49 38.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.665 1.186 . . . . 0.0 112.321 175.193 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.47 -53.16 57.99 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.573 1.149 . . . . 0.0 112.299 174.128 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 19.8 ttt -52.37 -60.64 2.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.035 1.734 . . . . 0.0 112.046 177.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -59.83 -37.32 78.88 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.234 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -68.79 -46.02 69.78 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.236 1.014 . . . . 0.0 113.165 176.801 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -100.1 -14.16 18.69 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -169.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -58.52 117.03 4.07 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.88 1.218 . . . . 0.0 111.044 170.031 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.7 -16.22 58.9 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.27 1.414 . . . . 0.0 114.61 -175.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.8 t -71.84 133.07 84.46 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 118.997 1.399 . . . . 0.0 109.497 175.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.94 142.1 24.75 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.725 2.284 . . . . 0.0 112.51 -177.386 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 45.7 tp -129.95 105.02 7.7 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.35 1.46 . . . . 0.0 108.133 169.742 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 52.4 65.57 1.47 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.988 1.715 . . . . 0.0 111.135 -169.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.09 -64.04 4.3 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.24 1.4 . . . . 0.0 113.215 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.5 119.92 57.91 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 126.465 1.906 . . . . 0.0 112.774 -173.201 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -56.07 121.55 10.19 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.753 3.635 . . . . 0.0 113.58 170.273 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.47 116.64 5.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.245 1.018 . . . . 0.0 111.748 177.104 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -91.61 98.6 11.75 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.585 1.154 . . . . 0.0 109.22 171.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.3 mt -101.22 133.63 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.066 1.346 . . . . 0.0 111.149 -173.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -140.14 123.86 17.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.063 1.745 . . . . 0.0 111.42 -177.566 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.7 tp -76.69 114.5 15.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.765 0.826 . . . . 0.0 109.311 169.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.59 74.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.331 1.452 . . . . 0.0 110.249 -178.146 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 8.3 m -63.45 121.16 13.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.502 1.521 . . . . 0.0 110.576 174.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.729 1.612 . . . . 0.0 113.67 -176.799 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.872 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -143.46 152.92 42.09 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 177.121 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.7 mt -108.68 154.36 22.11 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.9 1.68 . . . . 0.0 111.535 174.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.2 tp -120.32 124.18 44.95 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.889 2.076 . . . . 0.0 107.474 170.432 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.89 85.56 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.52 1.928 . . . . 0.0 108.239 -169.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.16 166.96 19.19 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.146 1.379 . . . . 0.0 112.225 -178.058 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.7 t30 60.36 75.21 0.42 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.927 2.091 . . . . 0.0 113.134 177.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.1 mt -127.38 167.58 16.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.895 2.478 . . . . 0.0 111.489 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.2 149.57 46.17 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.96 0.886 . . . . 0.0 113.137 172.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -58.69 -31.97 68.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.556 1.943 . . . . 0.0 114.492 -178.231 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.49 31.67 7.19 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.541 1.543 . . . . 0.0 114.81 -175.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.71 147.52 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.09 1.356 . . . . 0.0 110.907 169.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.4 m -119.8 147.59 44.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.503 1.521 . . . . 0.0 112.485 -176.201 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -48.59 -57.7 5.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.682 1.993 . . . . 0.0 112.145 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.37 -46.24 76.52 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.591 1.556 . . . . 0.0 113.561 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.97 -52.78 64.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.164 0.986 . . . . 0.0 111.936 -178.608 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 43.0 mm -58.21 -52.8 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.384 1.073 . . . . 0.0 111.205 172.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -49.64 -51.69 36.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.953 1.301 . . . . 0.0 112.305 179.258 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.78 -52.3 65.67 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.368 1.067 . . . . 0.0 113.123 175.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.65 -43.89 97.67 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.214 0.915 . . . . 0.0 112.715 -177.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -62.71 -40.72 98.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.808 0.731 . . . . 0.0 112.475 173.03 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.15 -26.33 64.66 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 175.808 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -63.4 -48.88 75.99 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.144 -0.972 . . . . 0.0 112.608 174.469 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -104.8 -15.58 15.16 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 -173.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.0 162.53 21.79 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.904 1.716 . . . . 0.0 113.638 -176.459 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.9 m -112.27 100.62 8.95 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.576 1.95 . . . . 0.0 107.727 -178.049 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.25 157.2 44.99 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -168.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -77.5 -57.42 3.83 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.693 1.997 . . . . 0.0 110.042 169.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -157.24 145.65 19.48 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.234 1.414 . . . . 0.0 112.792 -174.251 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.18 133.78 55.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.378 1.471 . . . . 0.0 108.564 168.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.9 158.02 44.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.584 1.154 . . . . 0.0 113.115 -169.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.97 110.64 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.625 1.97 . . . . 0.0 109.599 178.209 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -69.92 -44.56 69.38 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.729 1.612 . . . . 0.0 112.377 177.424 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -70.2 167.43 17.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.084 1.754 . . . . 0.0 114.018 -175.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -147.57 -169.96 3.45 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.896 2.078 . . . . 0.0 109.485 169.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.83 119.05 2.59 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.822 -1.174 . . . . 0.0 110.474 169.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.8 m -135.48 152.89 51.79 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.754 1.622 . . . . 0.0 112.221 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.6 -60.46 6.98 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.519 1.057 . . . . 0.0 111.912 174.074 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.89 144.49 55.24 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.547 1.139 . . . . 0.0 111.045 169.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.1 m -63.18 119.24 9.19 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.133 0.973 . . . . 0.0 111.421 178.492 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 56.9 tp -152.3 131.49 12.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.091 1.356 . . . . 0.0 110.555 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -170.72 84.83 0.08 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.876 0.751 . . . . 0.0 112.723 178.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.0 m -146.41 126.0 13.33 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.429 1.492 . . . . 0.0 111.019 -175.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.93 162.49 12.88 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.373 1.469 . . . . 0.0 112.599 177.182 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -133.51 127.51 33.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.778 1.631 . . . . 0.0 109.986 -172.079 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.0 t -134.07 116.8 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.518 -0.739 . . . . 0.0 112.479 -169.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -90.18 116.17 27.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.963 2.105 . . . . 0.0 110.606 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -99.54 152.63 19.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.618 1.567 . . . . 0.0 113.885 -173.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -63.93 -48.55 76.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.034 0.934 . . . . 0.0 111.794 171.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -133.54 135.41 44.35 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.116 1.366 . . . . 0.0 110.912 -175.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -58.12 -43.34 87.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.263 1.425 . . . . 0.0 112.778 178.671 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.58 -50.45 60.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.488 1.115 . . . . 0.0 112.618 171.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.92 -46.61 89.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.945 0.898 . . . . 0.0 112.006 174.344 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.13 -52.87 48.96 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.513 1.125 . . . . 0.0 112.333 173.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.6 tp -55.42 -51.17 67.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.482 1.513 . . . . 0.0 112.224 174.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -52.06 51.76 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.669 1.587 . . . . 0.0 112.48 174.132 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.18 -52.93 63.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.433 1.093 . . . . 0.0 111.856 173.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -54.51 -58.89 5.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.696 1.598 . . . . 0.0 112.494 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -59.17 -36.48 75.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -177.138 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -67.81 -49.11 64.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.381 1.073 . . . . 0.0 112.996 174.549 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -94.09 -13.72 26.53 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -57.92 112.9 1.64 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.702 1.137 . . . . 0.0 110.93 169.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.5 -18.6 41.08 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.546 1.546 . . . . 0.0 114.713 -175.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 81.2 t -69.52 133.78 88.84 Favored Pre-proline 0 N--CA 1.478 0.934 0 CA-C-N 118.968 1.384 . . . . 0.0 110.189 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.38 141.78 23.16 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.872 2.381 . . . . 0.0 113.154 -175.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.3 tt -132.3 108.69 9.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.539 1.935 . . . . 0.0 107.312 169.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 48.33 64.27 1.73 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.819 1.648 . . . . 0.0 111.566 -169.208 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.92 -55.44 4.77 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.883 1.706 . . . . 0.0 113.649 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -65.81 124.02 86.41 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 127.008 2.123 . . . . 0.0 112.47 -173.3 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.32 122.97 9.48 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.291 2.661 . . . . 0.0 111.185 174.651 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.42 116.27 5.39 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.184 0.994 . . . . 0.0 111.347 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -84.78 100.66 11.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.961 0.905 . . . . 0.0 108.975 170.269 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.3 mt -107.18 130.07 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.793 0.837 . . . . 0.0 110.714 -175.442 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.21 -179.97 6.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.594 1.558 . . . . 0.0 110.591 171.749 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -119.5 154.36 33.92 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.182 1.393 . . . . 0.0 112.474 -176.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.58 136.1 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.29 1.436 . . . . 0.0 110.046 -175.123 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.6 p -140.01 146.04 38.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.973 1.709 . . . . 0.0 111.238 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.034 1.733 . . . . 0.0 113.765 -178.909 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.877 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -133.92 125.83 29.11 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.062 0.945 . . . . 0.0 110.526 -178.606 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.9 mt -106.52 131.11 54.07 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.606 1.163 . . . . 0.0 110.821 170.764 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.6 tp -99.06 100.43 11.58 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.685 1.594 . . . . 0.0 106.821 169.042 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.28 132.94 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 m -134.05 172.32 12.99 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.55 1.54 . . . . 0.0 111.381 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.3 t30 56.63 51.16 11.5 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.005 1.722 . . . . 0.0 112.662 -172.531 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.58 -158.51 0.67 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.072 1.749 . . . . 0.0 109.214 169.414 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -154.98 169.24 24.53 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.492 1.517 . . . . 0.0 110.728 178.523 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.32 -32.1 70.91 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.896 -1.128 . . . . 0.0 112.513 169.428 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.97 -28.76 69.23 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.487 1.518 . . . . 0.0 114.646 174.07 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.0 t -72.71 108.15 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.578 1.189 . . . . 0.0 109.64 174.719 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.6 m -69.81 144.0 52.76 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.02 0.928 . . . . 0.0 112.876 -177.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -54.19 -55.09 31.24 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.743 1.617 . . . . 0.0 112.886 176.354 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.87 75.77 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.483 1.113 . . . . 0.0 113.266 176.524 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.21 -52.24 63.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.704 0.802 . . . . 0.0 111.61 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.0 mm -53.26 -52.93 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.121 0.969 . . . . 0.0 111.12 169.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -52.53 -52.93 52.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.972 0.909 . . . . 0.0 112.175 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -60.2 -52.16 66.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.553 1.141 . . . . 0.0 113.16 174.543 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 pp -63.84 -43.93 94.7 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.364 0.984 . . . . 0.0 112.308 -174.182 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -62.12 -45.15 94.74 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.485 0.584 . . . . 0.0 112.068 172.143 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.7 -32.84 70.88 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 178.273 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.18 -51.21 70.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.084 0.954 . . . . 0.0 112.483 173.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -93.23 -13.03 28.81 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -174.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.55 154.36 25.89 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 120.015 1.279 . . . . 0.0 114.664 177.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.2 m -86.19 107.41 17.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.369 1.068 . . . . 0.0 110.309 -175.289 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 pp -125.96 146.31 49.92 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -173.019 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -86.72 -39.09 16.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.635 2.374 . . . . 0.0 111.547 169.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -150.22 147.38 27.62 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.591 0.632 . . . . 0.0 112.47 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.26 120.97 11.18 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.668 1.587 . . . . 0.0 109.486 171.31 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -138.4 117.24 12.35 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.38 1.472 . . . . 0.0 111.863 -172.653 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.4 t -80.65 150.1 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.065 1.746 . . . . 0.0 111.134 178.052 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -44.52 -51.94 8.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.928 2.491 . . . . 0.0 116.586 -172.07 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -61.04 127.81 33.35 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -169.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -147.75 -74.23 0.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.161 1.385 . . . . 0.0 111.214 176.857 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -129.25 37.62 4.01 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.678 2.391 . . . . 0.0 110.035 176.011 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.5 m -75.1 155.04 37.53 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.911 2.484 . . . . 0.0 113.578 -169.671 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.01 40.45 0.58 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.502 1.049 . . . . 0.0 113.984 175.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -150.51 157.32 42.87 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.362 2.265 . . . . 0.0 110.242 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.5 m -59.13 116.18 3.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.045 0.938 . . . . 0.0 110.335 169.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.5 tp -152.72 152.34 31.58 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.936 1.294 . . . . 0.0 111.247 -169.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.44 76.67 0.09 OUTLIER Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.791 0.71 . . . . 0.0 113.326 -175.911 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.9 p -141.53 168.28 20.15 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.301 1.44 . . . . 0.0 112.642 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.07 141.27 24.0 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.674 1.189 . . . . 0.0 111.398 169.714 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.91 126.02 43.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.478 1.511 . . . . 0.0 109.429 173.047 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.3 t -130.08 122.8 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.173 0.989 . . . . 0.0 110.509 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -109.1 119.01 38.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.113 2.165 . . . . 0.0 111.14 -176.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -102.75 154.47 19.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.809 2.844 . . . . 0.0 113.645 -169.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -82.38 -16.17 50.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.619 1.567 . . . . 0.0 114.554 175.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.8 mtm-85 -142.34 132.56 24.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.689 1.596 . . . . 0.0 111.042 177.531 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -56.13 -50.35 71.35 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.107 1.363 . . . . 0.0 112.545 172.771 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.43 -47.43 69.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.875 1.27 . . . . 0.0 112.162 175.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.18 -42.23 99.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.943 0.897 . . . . 0.0 112.625 175.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.72 -53.34 57.81 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.785 0.834 . . . . 0.0 111.534 171.722 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 59.3 tp -54.07 -52.1 62.0 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.826 1.25 . . . . 0.0 112.439 174.636 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -49.86 -54.77 17.4 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.253 1.821 . . . . 0.0 112.154 173.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.63 -50.84 69.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.534 1.133 . . . . 0.0 112.306 174.846 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 16.7 ttp -52.15 -60.1 3.6 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.03 1.332 . . . . 0.0 111.595 175.636 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -53.73 -49.51 67.99 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.239 1.416 . . . . 0.0 112.32 179.438 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -61.83 -47.24 85.98 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.72 1.208 . . . . 0.0 113.045 -179.203 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -99.82 -14.36 18.84 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -169.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.28 113.72 2.3 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.785 1.175 . . . . 0.0 110.984 169.825 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.43 -20.15 35.41 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.762 1.649 . . . . 0.0 114.48 -175.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.46 133.02 87.23 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-N 118.757 1.279 . . . . 0.0 110.306 -178.566 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.16 138.83 23.17 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.923 2.415 . . . . 0.0 112.457 -177.279 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.1 tp -134.93 112.37 10.58 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.1 1.76 . . . . 0.0 108.373 170.055 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 49.32 61.68 3.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.303 1.441 . . . . 0.0 111.189 -169.216 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.99 -59.94 4.47 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.798 1.666 . . . . 0.0 113.493 -179.051 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -61.95 127.82 89.75 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 127.062 2.145 . . . . 0.0 112.83 -174.079 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.98 124.67 10.79 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.178 2.585 . . . . 0.0 111.147 172.838 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.49 120.37 11.57 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.117 0.967 . . . . 0.0 111.162 177.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -98.91 102.32 14.0 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.783 1.233 . . . . 0.0 108.865 176.036 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.1 mt -108.69 135.98 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.047 0.939 . . . . 0.0 111.271 -169.768 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -128.87 123.98 34.09 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.103 1.761 . . . . 0.0 111.082 -177.141 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.8 tp -82.39 122.95 28.65 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.77 1.228 . . . . 0.0 111.076 172.361 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.9 t -83.39 96.31 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 169.138 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.0 p -66.98 -61.1 2.11 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.085 1.354 . . . . 0.0 112.738 -170.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.4 m . . . . . 0 C--O 1.252 1.189 0 C-N-CA 127.767 2.427 . . . . 0.0 114.182 -175.446 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.945 0 N-CA-C 112.338 -0.305 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -117.91 99.63 7.04 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.285 1.434 . . . . 0.0 109.961 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -100.73 101.4 12.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.607 1.563 . . . . 0.0 109.043 -176.099 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.8 tp -84.37 137.28 33.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.136 1.774 . . . . 0.0 110.505 177.139 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.0 t -129.41 129.32 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.46 1.904 . . . . 0.0 108.948 -176.517 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.0 m -139.64 166.48 24.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.25 1.42 . . . . 0.0 112.116 -176.006 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.1 t30 54.71 46.95 23.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.07 1.748 . . . . 0.0 112.914 -172.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.2 mt -83.89 164.83 19.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.3 1.44 . . . . 0.0 110.754 169.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.95 145.35 56.0 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 110.957 169.458 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -53.87 -35.0 61.08 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.561 1.544 . . . . 0.0 114.16 -176.231 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.47 16.28 58.0 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.392 1.473 . . . . 0.0 115.467 -174.65 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.26 135.25 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.217 1.509 . . . . 0.0 110.578 170.588 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.4 m -114.6 158.13 22.13 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.146 1.778 . . . . 0.0 111.583 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -52.36 -55.75 19.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.524 1.13 . . . . 0.0 113.641 -176.296 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.49 -38.99 67.1 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.197 0.999 . . . . 0.0 113.561 -177.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.83 -56.15 25.94 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.968 0.907 . . . . 0.0 111.916 176.249 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.2 mm -55.76 -53.01 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 0.0 111.02 172.919 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -48.44 -56.95 6.86 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.181 1.792 . . . . 0.0 111.673 178.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.2 -49.49 75.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.435 1.094 . . . . 0.0 113.323 176.793 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.3 -45.44 91.34 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.492 1.042 . . . . 0.0 112.201 -174.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -62.91 -40.88 98.94 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 174.098 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.51 -14.98 56.51 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 175.686 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.6 -61.91 1.71 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.825 -1.172 . . . . 0.0 111.883 173.197 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -85.18 -13.05 51.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -175.274 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -146.41 -167.79 13.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.71 1.624 . . . . 0.0 112.909 176.414 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.05 126.69 27.14 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.159 1.384 . . . . 0.0 110.177 -173.75 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.06 143.61 50.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.464 1.106 . . . . 0.0 113.737 -169.705 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -73.08 -49.61 27.62 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.966 2.106 . . . . 0.0 110.335 169.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -150.11 152.15 34.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.416 1.086 . . . . 0.0 113.237 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -119.86 151.91 38.15 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.319 1.848 . . . . 0.0 109.869 169.079 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.6 146.01 26.26 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.97 1.708 . . . . 0.0 110.402 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.1 t -133.68 142.22 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.364 1.465 . . . . 0.0 109.847 -177.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -21.04 -69.95 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 129.177 2.991 . . . . 0.0 116.667 -169.769 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -52.69 -41.17 63.63 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.106 2.162 . . . . 0.0 114.557 -179.372 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.4 -47.12 14.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.496 1.519 . . . . 0.0 111.73 176.69 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -59.96 -54.76 42.33 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.256 1.822 . . . . 0.0 113.675 -174.582 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.0 m -119.08 166.97 12.24 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.54 1.536 . . . . 0.0 112.663 -169.11 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -50.97 -60.94 6.55 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.153 1.359 . . . . 0.0 112.86 178.182 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.13 104.03 2.77 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.199 1.4 . . . . 0.0 110.237 169.512 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.4 m -129.81 170.51 13.78 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.687 1.995 . . . . 0.0 109.502 173.686 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 48.3 tp -149.27 132.76 16.66 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.236 0.925 . . . . 0.0 112.036 -177.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.75 35.13 79.41 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.394 0.997 . . . . 0.0 114.425 174.143 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -137.01 155.04 50.21 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.698 1.599 . . . . 0.0 112.127 179.313 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.5 166.86 26.93 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.998 1.719 . . . . 0.0 111.463 175.108 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -147.76 126.73 12.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.635 1.574 . . . . 0.0 109.645 -174.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.02 116.43 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.726 1.21 . . . . 0.0 109.175 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -82.6 102.87 11.72 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.781 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -77.28 155.34 32.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.177 1.791 . . . . 0.0 113.238 -175.693 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.19 -29.48 54.34 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.701 1.2 . . . . 0.0 113.298 172.663 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 138.26 38.04 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.285 1.434 . . . . 0.0 111.341 176.707 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -64.77 -36.73 85.26 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 113.914 178.466 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.37 -46.83 86.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.121 0.968 . . . . 0.0 111.672 174.688 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -58.98 -44.23 91.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.492 1.517 . . . . 0.0 112.016 173.007 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.05 -52.25 63.77 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.75 1.22 . . . . 0.0 112.612 170.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.47 -48.24 79.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.857 1.263 . . . . 0.0 112.292 176.275 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -49.55 -56.99 7.96 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.135 1.374 . . . . 0.0 111.229 171.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.68 -47.13 63.99 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.801 0.84 . . . . 0.0 112.362 175.509 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.5 ttp -56.17 -62.36 1.77 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.979 0.912 . . . . 0.0 112.467 177.034 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -61.43 -35.27 77.09 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.27 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.0 -52.81 62.47 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.365 1.466 . . . . 0.0 112.662 174.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -97.39 -14.97 20.9 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -169.703 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -59.67 110.33 1.12 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 120.16 1.346 . . . . 0.0 112.094 175.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.3 -17.36 40.58 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.149 1.833 . . . . 0.0 114.67 -177.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.61 130.27 94.09 Favored Pre-proline 0 N--CA 1.479 0.985 0 CA-C-N 118.953 1.376 . . . . 0.0 111.009 -174.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.28 112.25 2.75 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.339 2.693 . . . . 0.0 112.54 -174.515 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 59.7 tp -76.54 82.5 3.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.47 1.508 . . . . 0.0 109.268 169.788 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 43.35 55.1 4.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.873 2.069 . . . . 0.0 112.026 -169.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 116.23 -64.82 0.33 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.009 1.766 . . . . 0.0 112.556 -177.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.01 111.03 3.53 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 126.812 2.045 . . . . 0.0 112.266 -171.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.14 113.31 3.39 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.273 1.982 . . . . 0.0 110.654 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -66.93 118.71 10.78 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.005 0.922 . . . . 0.0 111.157 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -84.89 120.74 26.81 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.904 0.882 . . . . 0.0 109.024 171.24 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.6 mm -118.43 138.17 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.738 0.815 . . . . 0.0 109.997 179.484 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -137.09 134.84 36.91 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.149 1.38 . . . . 0.0 111.065 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.43 127.73 50.02 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.3 1.84 . . . . 0.0 107.88 174.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.9 m -39.38 -53.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.933 2.093 . . . . 0.0 116.131 -169.499 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.7 p -143.2 124.35 14.51 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.397 1.479 . . . . 0.0 110.919 178.512 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.879 1.671 . . . . 0.0 113.067 177.738 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.355 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -134.98 101.6 4.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.852 1.261 . . . . 0.0 110.68 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -103.61 122.0 44.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.087 2.155 . . . . 0.0 109.231 -171.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.8 tp -115.47 102.94 10.27 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.309 1.844 . . . . 0.0 110.424 -176.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.5 t -78.73 130.64 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.166 1.387 . . . . 0.0 108.373 169.809 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 m -127.69 172.3 10.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.115 1.366 . . . . 0.0 111.411 175.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.7 t30 57.46 50.4 11.31 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.847 1.659 . . . . 0.0 112.763 -173.872 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.2 mt -98.78 -168.22 1.6 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.883 1.673 . . . . 0.0 109.306 169.145 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -148.61 161.94 40.69 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.967 -1.083 . . . . 0.0 111.972 174.172 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -61.14 101.52 0.16 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.208 1.403 . . . . 0.0 109.383 169.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.48 -39.0 0.62 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.211 1.386 . . . . 0.0 111.859 -169.539 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.73 110.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.122 0.969 . . . . 0.0 109.611 170.284 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -71.98 144.24 48.94 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.766 0.826 . . . . 0.0 112.737 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.71 -52.79 63.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.841 1.656 . . . . 0.0 112.385 178.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.54 82.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.618 1.167 . . . . 0.0 113.404 174.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.84 -48.69 79.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.086 0.857 . . . . 0.0 111.763 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.4 mm -54.77 -52.87 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.883 0.873 . . . . 0.0 111.065 169.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -51.75 -54.21 31.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.246 0.618 . . . . 0.0 112.067 178.414 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.58 -50.34 74.17 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.873 1.269 . . . . 0.0 113.31 176.749 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.11 -44.86 90.99 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.315 0.961 . . . . 0.0 112.041 -176.699 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -61.27 -42.69 99.07 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 173.496 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.54 -15.3 57.61 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.29 -63.45 1.18 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.949 -1.095 . . . . 0.0 111.609 173.407 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -82.17 -18.91 41.08 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -175.465 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -139.22 -176.37 14.68 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.579 1.561 . . . . 0.0 113.346 178.257 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.9 m -126.91 120.96 30.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.367 1.467 . . . . 0.0 110.373 -176.72 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 pp -126.07 146.41 49.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.004 1.322 . . . . 0.0 112.995 -169.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -78.52 -49.19 13.8 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.803 2.441 . . . . 0.0 110.303 170.592 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -149.19 147.89 28.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.632 1.173 . . . . 0.0 111.884 -179.359 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -137.62 135.34 36.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.454 1.502 . . . . 0.0 110.464 171.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.06 146.77 32.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.865 1.266 . . . . 0.0 112.192 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.17 141.7 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.844 1.658 . . . . 0.0 110.492 -179.402 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -42.38 -50.36 5.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.062 2.145 . . . . 0.0 115.387 -169.591 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -56.56 -24.93 50.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -172.528 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.24 -48.49 78.7 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.839 1.255 . . . . 0.0 112.646 174.305 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -140.74 78.7 1.66 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.804 2.042 . . . . 0.0 109.752 173.292 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 p -75.13 -66.99 0.69 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.857 1.263 . . . . 0.0 113.22 -171.544 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.46 -54.82 4.05 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.993 1.283 . . . . 0.0 112.069 -170.235 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -131.68 135.3 46.78 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.937 2.495 . . . . 0.0 110.516 177.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.8 m -63.64 123.42 18.79 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.642 1.177 . . . . 0.0 111.505 175.7 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 55.0 tp -146.27 -73.63 0.22 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.249 1.02 . . . . 0.0 112.262 -176.762 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.27 81.39 1.28 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.193 1.377 . . . . 0.0 111.849 -175.72 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.9 p -144.55 159.4 42.85 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.664 1.585 . . . . 0.0 112.266 -176.46 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.78 140.85 33.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.863 1.265 . . . . 0.0 111.018 169.874 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -120.33 125.88 49.14 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.067 1.747 . . . . 0.0 110.009 -174.87 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.8 t -126.68 115.75 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.156 1.382 . . . . 0.0 109.809 -176.4 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -88.23 111.4 21.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.218 2.207 . . . . 0.0 108.461 175.474 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -98.82 159.31 15.04 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.426 2.29 . . . . 0.0 113.975 -169.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.73 -50.46 70.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.276 1.03 . . . . 0.0 111.83 169.453 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -138.06 144.26 40.87 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.733 1.613 . . . . 0.0 112.214 -173.714 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -62.63 -35.88 81.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.758 1.223 . . . . 0.0 112.901 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.13 -47.01 78.94 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.441 1.096 . . . . 0.0 112.435 172.055 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -65.88 -41.96 90.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.705 1.202 . . . . 0.0 112.038 176.436 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.62 82.61 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.859 0.864 . . . . 0.0 112.264 169.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.88 -45.62 93.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.986 1.714 . . . . 0.0 112.046 177.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -49.63 -58.15 5.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.958 1.303 . . . . 0.0 110.31 169.695 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.43 -49.6 61.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.93 0.892 . . . . 0.0 112.65 176.587 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 41.6 ttp -54.89 -62.01 1.94 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.362 1.065 . . . . 0.0 111.723 176.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -61.05 -38.59 86.73 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -66.68 -41.87 87.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.685 1.194 . . . . 0.0 112.899 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -109.09 -13.24 14.73 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -169.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -58.63 116.74 3.9 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.172 1.351 . . . . 0.0 111.425 171.348 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.33 -25.07 27.18 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.972 1.749 . . . . 0.0 114.359 -175.367 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.82 135.3 87.8 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.771 1.229 . . . . 0.0 110.356 -177.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -74.91 139.42 24.5 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.821 2.348 . . . . 0.0 112.816 -178.223 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.4 tp -139.24 119.12 13.29 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.936 1.694 . . . . 0.0 108.677 169.864 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.75 56.99 7.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.428 1.491 . . . . 0.0 110.729 -169.094 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.78 -60.74 4.36 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.54 1.543 . . . . 0.0 113.466 -179.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.45 135.91 96.54 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.948 1.699 . . . . 0.0 112.872 -172.546 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.2 124.28 10.34 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.497 2.798 . . . . 0.0 111.211 174.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.4 mtm -62.76 117.78 6.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.506 1.122 . . . . 0.0 111.729 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -95.65 99.04 10.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.949 1.3 . . . . 0.0 108.393 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.6 mt -103.86 135.43 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.667 0.787 . . . . 0.0 111.363 -169.81 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -127.91 151.16 49.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.969 2.508 . . . . 0.0 110.302 -177.725 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 34.8 tp -135.59 130.1 33.94 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.737 1.615 . . . . 0.0 109.568 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 57.8 t -59.58 115.75 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.786 0.834 . . . . 0.0 110.007 175.826 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 11.9 m -58.38 -56.18 25.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.771 1.628 . . . . 0.0 113.221 -169.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.562 1.945 . . . . 0.0 112.063 -174.627 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.076 0 N-CA-C 112.704 -0.158 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -76.59 137.95 39.84 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.971 0.908 . . . . 0.0 112.458 178.547 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -138.52 129.58 26.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 129.02 2.928 . . . . 0.0 108.112 -175.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.73 112.15 20.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.551 1.94 . . . . 0.0 110.035 -175.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.4 t -87.04 135.1 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.58 1.552 . . . . 0.0 108.637 171.434 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.7 m -139.18 165.44 27.16 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.608 1.563 . . . . 0.0 112.575 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.4 t30 57.8 47.65 15.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.147 2.179 . . . . 0.0 113.299 -175.808 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.51 161.53 15.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.256 1.822 . . . . 0.0 110.3 169.51 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.93 144.53 54.15 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.166 -0.959 . . . . 0.0 111.008 169.397 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -59.35 -21.72 60.23 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.83 19.75 32.6 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.727 1.632 . . . . 0.0 115.425 178.049 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.29 129.37 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.483 1.641 . . . . 0.0 110.365 169.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.8 m -75.69 140.64 42.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.006 0.923 . . . . 0.0 112.55 -178.556 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.54 -50.67 72.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.018 1.327 . . . . 0.0 112.298 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.77 -46.62 71.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.309 1.444 . . . . 0.0 112.619 174.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -56.98 -53.3 59.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.397 1.079 . . . . 0.0 112.381 179.374 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.0 mm -57.33 -52.81 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.134 0.973 . . . . 0.0 111.583 173.02 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -50.33 -50.62 50.4 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.546 1.139 . . . . 0.0 112.006 178.104 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.09 -53.84 47.26 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.505 1.122 . . . . 0.0 112.917 175.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.13 -43.0 99.6 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.216 0.916 . . . . 0.0 112.643 -173.111 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -64.07 -44.79 91.31 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.64 0.654 . . . . 0.0 112.131 172.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.46 -27.5 66.14 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 176.454 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.66 -59.5 4.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.187 0.995 . . . . 0.0 111.942 173.684 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -83.8 -15.25 49.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -175.145 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -148.17 156.22 26.8 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.947 1.248 . . . . 0.0 113.96 175.344 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.4 m -94.79 111.48 23.26 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.753 1.221 . . . . 0.0 109.934 -173.304 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -137.3 155.8 49.01 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -87.38 -48.17 8.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.785 2.434 . . . . 0.0 111.487 -173.619 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -151.02 145.66 25.68 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.623 1.169 . . . . 0.0 113.141 -176.309 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.27 140.85 46.71 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.239 1.816 . . . . 0.0 110.095 169.115 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -146.51 107.59 4.18 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.933 1.693 . . . . 0.0 111.533 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.15 147.82 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.303 1.441 . . . . 0.0 110.625 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -44.85 -53.3 7.67 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.566 1.946 . . . . 0.0 114.318 -171.425 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -57.06 -35.61 69.55 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.023 1.329 . . . . 0.0 113.751 -171.238 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.24 -49.3 74.66 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.312 1.445 . . . . 0.0 111.912 173.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -65.98 -51.76 55.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.834 1.654 . . . . 0.0 112.448 178.856 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.8 m -142.66 130.64 21.8 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.955 2.102 . . . . 0.0 111.271 -174.523 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -62.35 -28.1 70.44 Favored Glycine 0 CA--C 1.539 1.543 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 -173.256 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -59.92 138.36 57.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.546 1.538 . . . . 0.0 112.593 -178.613 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.6 m -60.31 115.35 3.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.939 1.296 . . . . 0.0 111.069 172.32 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.6 tp -137.43 -53.68 0.67 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.683 1.193 . . . . 0.0 112.571 -172.225 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.49 58.27 2.59 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.17 0.89 . . . . 0.0 113.224 174.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.4 p -143.47 167.68 21.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.699 1.599 . . . . 0.0 111.395 -179.443 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -144.78 126.38 15.09 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.797 0.839 . . . . 0.0 111.782 169.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -80.15 124.54 28.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.974 1.71 . . . . 0.0 109.735 169.865 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.45 140.66 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.702 1.201 . . . . 0.0 110.107 -175.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -122.75 105.42 10.03 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.769 1.627 . . . . 0.0 109.204 177.068 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -78.62 160.54 27.51 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.364 1.866 . . . . 0.0 111.743 176.386 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -76.43 -27.18 56.13 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 171.077 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.18 136.62 38.36 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.453 1.501 . . . . 0.0 111.914 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -56.45 -44.37 80.45 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.808 1.643 . . . . 0.0 113.316 173.047 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.38 -46.71 76.5 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.091 0.956 . . . . 0.0 112.597 176.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -66.52 -41.4 88.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.928 1.291 . . . . 0.0 112.178 177.399 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.9 -48.75 75.07 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.906 0.882 . . . . 0.0 111.934 169.797 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.97 -46.41 89.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.538 1.535 . . . . 0.0 112.463 176.102 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -50.71 -56.39 12.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.169 1.388 . . . . 0.0 111.133 171.8 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.16 -49.27 69.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.55 1.14 . . . . 0.0 112.393 174.514 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.7 ttp -51.99 -59.12 4.71 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.81 1.244 . . . . 0.0 111.788 176.643 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -56.01 -49.03 74.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.95 1.3 . . . . 0.0 112.361 178.12 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -60.18 -45.15 94.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.549 1.14 . . . . 0.0 113.468 -178.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -102.15 -16.14 16.47 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -169.634 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -61.61 106.26 0.64 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 119.922 1.237 . . . . 0.0 110.786 169.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.96 -27.77 7.3 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 126.567 2.032 . . . . 0.0 114.142 -174.673 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.61 134.32 84.22 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 125.102 1.361 . . . . 0.0 111.012 -173.402 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.55 138.71 24.58 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.984 2.456 . . . . 0.0 112.714 -177.236 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -140.13 107.63 5.58 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.736 2.014 . . . . 0.0 108.095 175.349 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 48.45 66.48 1.06 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.742 1.617 . . . . 0.0 111.82 -169.364 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.26 -57.56 4.39 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.112 1.815 . . . . 0.0 113.403 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -65.16 131.82 95.2 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 127.036 2.134 . . . . 0.0 112.625 -173.24 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.83 119.53 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.876 2.384 . . . . 0.0 110.251 169.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.5 mtm -60.63 143.99 52.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.604 0.762 . . . . 0.0 111.968 178.392 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -119.59 130.95 55.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.236 1.414 . . . . 0.0 108.68 171.021 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mm -124.94 141.49 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.52 0.728 . . . . 0.0 110.052 -173.64 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -138.92 148.73 43.96 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.672 1.989 . . . . 0.0 110.273 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.19 -176.18 4.11 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.044 0.937 . . . . 0.0 112.225 173.094 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.0 m -64.07 -158.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.453 1.901 . . . . 0.0 112.573 169.61 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.6 p -57.6 160.84 4.0 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.122 -1.611 . . . . 0.0 113.313 173.41 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 C--O 1.251 1.147 0 C-N-CA 125.406 1.482 . . . . 0.0 113.146 172.133 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 CA-C-O 119.472 -0.627 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -136.53 152.51 50.59 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -173.33 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 71.9 mt -122.04 131.23 53.88 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.77 2.028 . . . . 0.0 112.266 -169.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.2 tp -86.54 111.28 20.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 168.317 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -98.61 130.51 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.108 1.363 . . . . 0.0 107.75 175.221 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.5 m -136.44 165.31 26.12 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 111.854 -174.396 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.9 t30 57.56 32.48 21.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.569 1.948 . . . . 0.0 114.395 -171.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.11 148.05 42.17 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 167.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.68 144.25 57.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.515 174.331 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -54.15 -36.58 63.48 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -169.463 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.42 20.15 51.85 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.115 1.341 . . . . 0.0 115.916 178.568 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.43 130.74 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.281 1.541 . . . . 0.0 110.774 171.543 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -76.15 140.53 41.8 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.383 1.073 . . . . 0.0 112.669 -177.737 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.43 -51.82 67.86 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.138 1.375 . . . . 0.0 112.696 175.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.29 80.16 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.443 1.097 . . . . 0.0 113.283 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.92 -51.4 69.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.884 0.874 . . . . 0.0 112.076 177.5 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.0 mm -57.05 -52.55 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.591 1.156 . . . . 0.0 111.351 172.043 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -49.38 -56.07 10.84 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.739 1.216 . . . . 0.0 111.844 176.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -57.79 -51.07 71.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.704 1.201 . . . . 0.0 113.07 176.668 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -63.8 -47.89 79.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.21 0.914 . . . . 0.0 112.35 -175.256 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -63.34 -38.61 91.83 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.7 0.682 . . . . 0.0 112.68 175.729 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.98 -13.76 60.42 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 174.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.16 -58.19 3.79 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.867 -1.146 . . . . 0.0 111.408 173.435 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -86.96 -32.58 20.01 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -176.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.43 172.25 14.88 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.525 1.536 . . . . 0.0 112.523 176.044 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 90.8 m -118.15 102.23 8.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.802 1.241 . . . . 0.0 109.439 178.843 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 pp -105.94 139.38 40.58 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -169.775 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -78.4 -45.37 22.52 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.686 2.794 . . . . 0.0 110.262 169.606 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -143.79 143.52 31.39 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.078 1.751 . . . . 0.0 111.506 -174.425 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.64 119.46 12.56 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.769 1.627 . . . . 0.0 108.587 169.304 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -137.45 104.08 5.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.995 0.918 . . . . 0.0 111.635 -175.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.5 151.68 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.411 1.484 . . . . 0.0 110.216 169.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -46.07 -47.5 17.12 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.903 2.081 . . . . 0.0 116.038 -170.24 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -69.65 142.52 53.42 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.162 0.982 . . . . 0.0 113.603 -171.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -150.89 -108.66 0.06 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.925 2.09 . . . . 0.0 107.52 171.716 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -52.63 20.29 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.846 1.203 . . . . 0.0 108.174 168.15 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.5 m -70.04 151.32 45.66 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.298 1.439 . . . . 0.0 111.423 169.354 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -164.28 52.55 0.29 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.781 0.705 . . . . 0.0 113.884 176.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -72.17 171.37 12.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.266 1.026 . . . . 0.0 111.167 169.641 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 39.7 m -73.11 69.79 1.05 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.52 1.528 . . . . 0.0 112.601 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.41 -64.1 1.2 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.868 1.667 . . . . 0.0 110.459 176.336 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.74 52.86 6.18 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.044 0.831 . . . . 0.0 112.893 178.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 81.5 p -139.32 165.14 27.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.096 1.359 . . . . 0.0 112.49 -175.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -150.29 161.64 42.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.743 1.617 . . . . 0.0 111.926 171.087 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -128.87 115.05 17.29 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.448 1.499 . . . . 0.0 110.234 174.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 14.3 t -124.89 125.62 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.694 1.198 . . . . 0.0 110.719 -169.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -115.13 127.56 55.65 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.613 1.965 . . . . 0.0 109.888 -171.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -114.12 156.59 23.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 127.68 2.392 . . . . 0.0 112.184 -171.643 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -58.7 -28.44 65.8 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.762 1.394 . . . . 0.0 114.762 -176.272 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -139.68 149.96 44.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.128 2.171 . . . . 0.0 110.618 176.829 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -57.64 -41.25 81.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.196 1.398 . . . . 0.0 112.142 170.261 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.04 -48.74 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.478 1.111 . . . . 0.0 112.376 169.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.26 -43.18 99.43 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.177 0.991 . . . . 0.0 112.62 176.543 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.12 -52.15 64.17 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.084 0.954 . . . . 0.0 111.504 169.72 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 28.5 mt -56.2 -44.02 79.07 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.69 -1.257 . . . . 0.0 113.715 176.703 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -52.6 -57.52 9.73 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.969 1.259 . . . . 0.0 111.842 171.169 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.68 -51.66 59.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.571 1.148 . . . . 0.0 112.0 177.037 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 22.6 ttt -53.87 -63.25 1.21 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.466 1.507 . . . . 0.0 112.168 176.086 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -60.75 -37.88 83.32 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -173.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -68.19 -43.49 77.99 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 113.169 177.351 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -103.42 -13.37 16.66 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -169.631 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -59.69 114.31 2.69 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.032 1.287 . . . . 0.0 110.867 169.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.34 -22.63 34.0 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.006 1.765 . . . . 0.0 114.424 -174.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.4 t -71.31 136.1 84.24 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.772 1.229 . . . . 0.0 110.423 -177.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.27 139.38 29.1 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.943 2.429 . . . . 0.0 112.626 -178.223 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -132.81 109.8 9.9 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.889 2.076 . . . . 0.0 106.871 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 51.65 57.39 6.6 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.145 1.378 . . . . 0.0 110.602 -168.599 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.47 -52.3 4.09 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.934 1.73 . . . . 0.0 113.726 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -68.79 129.13 92.63 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.809 2.044 . . . . 0.0 112.221 -171.876 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.55 125.24 11.01 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.2 2.6 . . . . 0.0 111.722 179.13 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.2 mtm -65.96 125.85 26.71 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.522 1.129 . . . . 0.0 112.101 177.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -99.06 112.73 24.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.918 1.287 . . . . 0.0 108.788 170.029 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mt -118.67 132.64 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.48 1.112 . . . . 0.0 111.2 -172.404 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -137.16 126.99 25.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.793 1.637 . . . . 0.0 111.635 -172.3 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 46.5 tp -67.49 119.01 11.59 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.33 1.052 . . . . 0.0 110.617 172.13 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.96 -51.24 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.888 1.275 . . . . 0.0 110.028 176.425 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 18.4 p -80.94 82.17 6.99 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.096 1.758 . . . . 0.0 111.471 179.02 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.25 1.127 0 C-N-CA 126.498 1.919 . . . . 0.0 114.374 -179.619 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.037 0 N-CA-C 112.305 -0.318 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -152.46 125.44 8.53 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.04 0.936 . . . . 0.0 112.177 178.885 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.4 mt -121.1 125.86 48.31 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.988 1.715 . . . . 0.0 112.38 -172.487 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.3 tp -89.01 116.57 27.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.698 1.999 . . . . 0.0 106.096 168.382 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.5 128.09 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.987 1.315 . . . . 0.0 108.12 -176.969 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.0 m -133.96 163.23 30.0 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.778 1.631 . . . . 0.0 112.478 -169.644 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.0 t30 54.55 35.09 22.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.078 2.151 . . . . 0.0 113.369 -169.769 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.41 154.17 37.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.553 1.141 . . . . 0.0 110.314 169.518 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.35 150.82 29.75 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.911 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -57.97 -25.49 61.09 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.305 1.042 . . . . 0.0 113.437 172.728 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -78.3 -7.47 87.81 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 125.285 1.421 . . . . 0.0 115.953 175.705 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.2 149.86 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 119.437 1.618 . . . . 0.0 111.118 174.529 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.5 m -129.57 158.13 40.14 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.603 1.561 . . . . 0.0 111.792 177.419 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.3 -51.26 70.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.247 1.419 . . . . 0.0 112.556 178.998 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.06 86.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.973 0.909 . . . . 0.0 112.749 174.45 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -59.15 -51.33 70.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.169 0.988 . . . . 0.0 112.149 176.469 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 15.1 mm -54.68 -53.91 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.533 1.133 . . . . 0.0 111.138 171.074 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -49.96 -57.5 7.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.41 1.084 . . . . 0.0 111.603 178.158 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -56.85 -50.85 71.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.251 1.021 . . . . 0.0 113.085 177.004 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -47.8 81.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.106 0.866 . . . . 0.0 112.235 -175.238 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -65.98 -41.66 90.84 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 176.011 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.59 -24.69 65.66 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 176.478 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.8 -54.14 43.58 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.144 -0.972 . . . . 0.0 112.027 174.033 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -98.33 -15.72 19.64 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -173.653 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.24 -177.57 17.45 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.575 1.56 . . . . 0.0 113.262 178.851 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.3 m -119.36 94.02 4.28 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.152 0.981 . . . . 0.0 111.264 -177.536 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.33 157.8 20.45 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.031 0.932 . . . . 0.0 112.263 179.205 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -115.57 -37.11 4.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.575 2.75 . . . . 0.0 111.717 173.676 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -140.54 144.77 36.1 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.034 1.334 . . . . 0.0 111.511 178.091 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.51 143.93 46.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.67 1.588 . . . . 0.0 110.53 169.742 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.34 147.98 26.96 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.766 2.027 . . . . 0.0 109.382 173.396 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 137' ' ' HIS . 1.5 t -125.38 -153.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.645 1.178 . . . . 0.0 111.023 -173.714 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.556 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -66.27 -61.59 1.93 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.763 2.425 . . . . 0.0 112.161 -177.852 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.27 162.03 23.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.231 2.212 . . . . 0.0 113.603 172.893 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -144.3 -55.85 0.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.354 1.461 . . . . 0.0 110.219 175.377 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -124.36 -65.96 1.01 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.679 1.992 . . . . 0.0 107.512 168.823 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.6 m -69.44 151.52 45.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.006 1.323 . . . . 0.0 110.891 169.141 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.84 65.23 3.54 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.319 0.962 . . . . 0.0 112.396 173.948 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -52.41 124.73 14.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.472 1.909 . . . . 0.0 112.305 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.5 m -70.52 86.19 0.63 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.694 1.598 . . . . 0.0 111.558 177.64 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 52.0 tp -150.4 156.22 41.06 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.174 2.189 . . . . 0.0 109.507 -176.562 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -127.85 53.29 0.8 Allowed Glycine 0 N--CA 1.472 1.098 0 C-N-CA 124.878 1.228 . . . . 0.0 112.329 179.335 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.5 m -141.31 145.75 35.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.339 1.455 . . . . 0.0 111.577 -169.709 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.37 162.3 34.74 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.402 1.881 . . . . 0.0 112.398 174.066 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -137.24 106.95 6.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.991 2.116 . . . . 0.0 109.654 -175.299 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 13.2 t -124.23 126.8 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.168 0.987 . . . . 0.0 109.972 -170.035 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -115.4 144.52 43.67 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.426 1.49 . . . . 0.0 110.21 -175.479 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -132.85 154.44 50.34 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.371 2.269 . . . . 0.0 112.94 -168.931 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.56 -29.43 70.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.241 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -131.24 126.24 34.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.065 1.746 . . . . 0.0 111.393 -173.656 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.6 -43.57 98.62 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.217 1.407 . . . . 0.0 112.508 174.933 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.01 -48.96 61.32 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.585 1.154 . . . . 0.0 112.772 169.872 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.83 -42.06 97.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.626 1.17 . . . . 0.0 112.758 177.09 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.52 69.03 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.711 0.805 . . . . 0.0 111.829 169.949 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.5 tp -56.66 -46.81 80.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.074 1.349 . . . . 0.0 112.202 177.408 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -49.45 -57.93 6.09 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.628 1.571 . . . . 0.0 111.318 171.47 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.77 -50.36 66.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.614 1.166 . . . . 0.0 112.846 175.554 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 23.7 ttp -51.51 -59.17 4.55 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.137 1.375 . . . . 0.0 111.476 176.348 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -55.93 -46.94 78.33 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.004 1.321 . . . . 0.0 112.412 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.01 -41.7 97.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.904 1.282 . . . . 0.0 113.538 -178.603 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -109.19 -15.82 14.22 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -170.248 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.82 113.88 2.5 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.229 1.377 . . . . 0.0 110.995 169.803 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.03 -24.15 19.53 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.337 1.922 . . . . 0.0 114.129 -175.688 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t -69.67 128.66 91.9 Favored Pre-proline 0 N--CA 1.477 0.879 0 CA-C-N 118.643 1.221 . . . . 0.0 111.706 -170.746 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.78 123.58 13.56 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 124.121 3.214 . . . . 0.0 114.355 173.883 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 tp -86.96 77.07 9.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.732 1.613 . . . . 0.0 107.482 169.009 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 47.07 36.09 3.95 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.552 1.941 . . . . 0.0 113.504 -169.84 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 143.84 -77.06 0.28 Allowed Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.715 1.626 . . . . 0.0 112.876 -178.617 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -65.4 126.88 92.33 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 125.185 1.394 . . . . 0.0 112.302 -176.192 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.3 121.72 7.03 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.725 2.283 . . . . 0.0 111.697 -177.673 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.4 mtm -65.04 142.6 58.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.98 0.912 . . . . 0.0 111.4 174.103 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -124.95 125.27 43.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.542 1.137 . . . . 0.0 110.032 176.126 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.1 mt -128.52 137.26 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.171 0.988 . . . . 0.0 110.987 -170.292 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -137.07 125.84 23.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.988 1.715 . . . . 0.0 111.043 -177.873 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.4 tt -80.43 116.27 20.4 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.989 0.916 . . . . 0.0 108.643 169.885 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 20.6 m -96.6 136.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.002 0.921 . . . . 0.0 112.118 -170.608 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.5 p -82.1 153.23 26.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.841 1.256 . . . . 0.0 112.254 176.48 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.253 1.25 0 C-N-CA 125.77 1.628 . . . . 0.0 112.901 173.83 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.897 0 N-CA-C 112.66 -0.176 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -140.57 133.49 29.19 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.886 1.275 . . . . 0.0 111.191 -176.912 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.5 mt -119.65 122.51 41.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.802 1.641 . . . . 0.0 111.746 176.112 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.4 tp -81.63 129.15 34.59 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.863 1.665 . . . . 0.0 106.852 168.401 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.01 132.86 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.669 1.188 . . . . 0.0 108.87 -176.226 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.9 m -137.46 163.02 32.1 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.205 1.802 . . . . 0.0 111.657 -172.229 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.4 t30 47.61 52.39 12.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.47 1.908 . . . . 0.0 113.158 -173.585 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.4 mt -84.22 168.87 15.32 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.834 1.654 . . . . 0.0 111.254 169.838 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.8 156.05 31.91 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.903 0.859 . . . . 0.0 112.039 169.624 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -77.41 -36.13 53.59 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.758 1.223 . . . . 0.0 112.15 -178.673 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.25 53.86 4.91 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.565 1.555 . . . . 0.0 112.539 -178.865 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.5 t -125.03 145.74 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.36 2.264 . . . . 0.0 111.57 -169.913 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.0 m -144.3 169.38 18.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.139 1.776 . . . . 0.0 111.819 -175.858 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -48.71 -57.82 5.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.773 2.029 . . . . 0.0 112.562 -178.089 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.19 87.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.189 1.395 . . . . 0.0 113.489 177.536 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.0 -52.2 66.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.151 0.98 . . . . 0.0 112.265 -179.839 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 36.2 mm -56.64 -52.45 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.882 0.873 . . . . 0.0 110.899 171.248 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -49.33 -56.18 10.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.014 0.926 . . . . 0.0 112.324 178.95 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -57.02 -52.37 65.55 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.853 0.861 . . . . 0.0 112.951 176.823 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.52 -46.43 90.19 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.893 0.77 . . . . 0.0 112.496 -176.851 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -65.09 -47.65 76.48 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.611 0.642 . . . . 0.0 112.438 174.492 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.52 64.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.244 1.017 . . . . 0.0 113.352 179.554 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.41 -45.29 72.9 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.43 1.092 . . . . 0.0 113.017 174.763 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -98.13 -19.06 18.15 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -177.41 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -159.98 153.51 24.49 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-N 120.356 1.435 . . . . 0.0 115.326 172.18 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 47.4 m -75.03 129.9 38.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.206 1.403 . . . . 0.0 111.42 -174.104 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 pp -135.62 147.04 48.49 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.643 1.177 . . . . 0.0 113.531 -174.032 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -73.91 -52.12 13.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.979 2.511 . . . . 0.0 110.246 170.03 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -150.07 153.37 36.32 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.144 1.778 . . . . 0.0 111.488 -177.727 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.55 133.82 27.97 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.929 1.691 . . . . 0.0 109.362 169.994 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.63 158.85 44.42 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.541 1.136 . . . . 0.0 113.754 -170.005 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.68 129.62 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 127.608 2.363 . . . . 0.0 108.67 169.901 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -68.48 -44.77 74.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.841 0.856 . . . . 0.0 111.822 178.771 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -69.88 154.0 42.54 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.267 1.427 . . . . 0.0 113.054 177.434 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -141.67 -158.3 0.85 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.785 2.034 . . . . 0.0 108.511 173.736 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -76.61 51.13 0.72 Allowed 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.285 -1.51 . . . . 0.0 111.667 175.188 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.1 m -71.75 -38.71 70.36 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.076 2.151 . . . . 0.0 113.712 -171.051 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.99 -55.25 0.24 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.291 1.9 . . . . 0.0 110.861 -173.506 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.89 98.92 5.11 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.81 2.044 . . . . 0.0 108.231 169.695 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 59.5 m -63.63 128.94 38.06 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.453 0.701 . . . . 0.0 110.388 175.158 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 tp -82.4 -152.31 0.1 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.608 1.163 . . . . 0.0 111.229 -179.398 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.58 50.21 0.48 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.387 0.994 . . . . 0.0 112.767 179.06 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.2 m -140.47 121.15 14.31 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.951 1.3 . . . . 0.0 111.528 -171.613 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.09 169.4 14.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.31 1.844 . . . . 0.0 113.232 -174.734 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -138.59 123.89 19.3 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.266 1.426 . . . . 0.0 110.832 -178.462 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.1 t -128.09 116.59 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.291 1.036 . . . . 0.0 110.904 -174.377 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -92.68 101.75 14.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.35 1.86 . . . . 0.0 108.336 179.062 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -77.38 166.56 22.97 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.653 1.981 . . . . 0.0 113.129 -178.753 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -54.26 -48.25 71.39 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 171.125 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -153.9 136.56 15.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 129.013 2.925 . . . . 0.0 109.516 -171.705 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -60.8 -37.87 83.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.086 0.954 . . . . 0.0 113.552 -176.825 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.4 -48.64 62.54 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.823 1.249 . . . . 0.0 113.093 169.999 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.12 -44.31 80.22 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.158 0.983 . . . . 0.0 112.021 173.654 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -51.87 -48.52 64.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.132 1.373 . . . . 0.0 112.853 175.12 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.5 tp -52.16 -43.47 64.12 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.49 1.916 . . . . 0.0 113.075 176.69 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -57.18 -55.19 37.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.111 0.965 . . . . 0.0 111.33 174.42 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.54 78.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.8 1.24 . . . . 0.0 112.55 175.263 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 23.6 ttp -50.61 -59.06 4.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.163 1.785 . . . . 0.0 111.272 175.488 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -56.43 -47.5 78.95 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.486 1.114 . . . . 0.0 112.44 177.572 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -58.26 -47.53 83.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.391 1.076 . . . . 0.0 113.279 179.118 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -95.22 -18.87 20.5 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -171.214 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -59.93 109.55 0.97 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 119.797 1.181 . . . . 0.0 110.591 169.684 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.25 -30.45 6.26 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.371 1.939 . . . . 0.0 113.714 -174.016 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.28 133.52 93.31 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 125.15 1.38 . . . . 0.0 110.766 -175.241 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.17 143.63 20.24 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.882 2.388 . . . . 0.0 112.94 -177.978 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 tp -125.29 107.38 10.65 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.85 2.06 . . . . 0.0 107.92 169.744 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 39.71 58.1 2.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.264 1.826 . . . . 0.0 112.463 -169.89 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.79 -45.4 2.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.122 1.344 . . . . 0.0 114.192 -179.563 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -73.13 116.59 52.3 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.23 1.412 . . . . 0.0 111.377 -171.012 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.8 114.54 3.74 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.68 2.253 . . . . 0.0 110.953 174.892 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.61 138.72 58.56 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.431 1.092 . . . . 0.0 111.754 -178.392 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -118.74 126.93 52.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.442 1.497 . . . . 0.0 109.586 175.236 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.6 mt -130.54 138.57 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.012 0.925 . . . . 0.0 111.173 -169.773 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -143.06 126.62 16.87 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.917 1.687 . . . . 0.0 111.518 -173.083 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -73.73 142.14 46.32 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.433 -0.792 . . . . 0.0 111.523 170.139 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.96 172.07 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -172.495 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.1 p -60.9 138.99 58.12 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.208 1.803 . . . . 0.0 112.825 -179.209 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.25 1.108 0 C-N-CA 125.663 1.585 . . . . 0.0 112.111 177.538 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.21 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -127.21 107.37 9.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.868 1.267 . . . . 0.0 110.413 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -108.91 105.56 15.16 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.283 1.833 . . . . 0.0 109.229 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.6 tp -89.51 132.86 34.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.775 2.03 . . . . 0.0 110.171 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.44 123.43 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.928 1.691 . . . . 0.0 109.379 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.3 m -127.01 160.38 31.3 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.774 1.629 . . . . 0.0 111.868 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.0 t30 54.37 46.34 25.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.519 1.928 . . . . 0.0 113.792 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 mt -78.48 157.29 28.95 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.151 1.381 . . . . 0.0 109.371 169.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.3 147.13 53.17 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.054 -1.029 . . . . 0.0 112.269 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -57.08 -28.8 62.93 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -81.8 -2.4 90.53 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.229 1.395 . . . . 0.0 115.375 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 80.9 t -66.78 140.19 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.122 1.461 . . . . 0.0 111.067 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.1 m -121.11 158.05 28.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.412 1.485 . . . . 0.0 112.694 -174.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.01 -57.34 10.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.345 1.858 . . . . 0.0 112.996 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.55 89.73 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.557 1.143 . . . . 0.0 113.242 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.11 -50.43 74.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.176 0.99 . . . . 0.0 112.099 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 mm -55.24 -52.18 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.124 0.97 . . . . 0.0 111.467 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -52.27 -51.74 56.75 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.846 0.859 . . . . 0.0 112.201 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -59.05 -53.39 58.94 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.98 1.312 . . . . 0.0 113.156 174.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.99 -43.16 99.55 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.29 0.95 . . . . 0.0 112.446 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -64.92 -41.73 95.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.73 -29.95 69.68 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.34 -57.08 12.65 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.068 0.947 . . . . 0.0 112.562 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -91.71 -16.68 26.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.95 -178.93 16.12 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.474 1.512 . . . . 0.0 114.84 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.57 107.46 12.44 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.448 1.899 . . . . 0.0 110.257 -169.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 pp -132.29 148.83 52.46 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -83.76 -51.49 7.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.725 2.41 . . . . 0.0 110.511 170.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.24 148.55 30.6 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.784 1.633 . . . . 0.0 111.374 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.61 131.83 23.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.902 1.281 . . . . 0.0 110.841 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.58 157.8 44.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.372 1.469 . . . . 0.0 113.063 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t . . . . . 0 N--CA 1.482 1.132 0 C-N-CA 126.486 1.914 . . . . 0.0 110.819 179.905 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.8 m -147.48 144.59 28.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.831 1.652 . . . . 0.0 109.708 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -143.44 163.03 34.24 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.498 1.519 . . . . 0.0 112.478 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -143.02 133.97 25.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.155 1.382 . . . . 0.0 110.848 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.62 118.24 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.192 1.397 . . . . 0.0 110.004 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -81.75 100.75 9.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.661 1.585 . . . . 0.0 108.266 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -80.29 154.88 27.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.171 1.788 . . . . 0.0 112.724 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.19 -30.65 58.1 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.832 1.253 . . . . 0.0 111.733 169.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -141.04 116.26 9.97 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.218 1.807 . . . . 0.0 111.249 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -28.63 68.77 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.84 -48.17 81.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.881 0.872 . . . . 0.0 111.972 171.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.79 -39.51 94.43 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.675 1.19 . . . . 0.0 112.214 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.07 83.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.376 1.071 . . . . 0.0 112.508 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.8 tp -59.36 -44.33 92.73 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.187 1.395 . . . . 0.0 111.746 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -51.33 -55.21 19.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.781 1.232 . . . . 0.0 110.955 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.97 -48.3 76.06 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.383 1.073 . . . . 0.0 112.846 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 25.8 ttt -51.18 -60.54 3.0 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.831 1.653 . . . . 0.0 111.399 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -56.84 -44.98 82.63 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.132 0.973 . . . . 0.0 112.695 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -59.77 -44.51 93.84 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.854 1.262 . . . . 0.0 113.545 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -109.9 -16.69 13.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -59.8 115.37 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.34 1.427 . . . . 0.0 111.196 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.33 -24.78 26.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.992 1.758 . . . . 0.0 114.026 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.05 132.96 90.03 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 124.594 1.158 . . . . 0.0 110.628 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.45 142.27 23.47 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.932 2.421 . . . . 0.0 112.44 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 64.6 tp -128.14 105.32 8.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.647 1.979 . . . . 0.0 107.694 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 49.27 57.74 6.15 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.402 1.481 . . . . 0.0 111.272 -169.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.21 -54.06 4.93 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.311 1.434 . . . . 0.0 113.48 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -59.87 119.25 39.48 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 126.43 1.892 . . . . 0.0 112.103 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.58 120.7 6.87 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.952 2.435 . . . . 0.0 111.29 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.0 mtm -65.07 138.53 58.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.309 1.044 . . . . 0.0 111.059 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -122.47 125.53 46.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.643 1.177 . . . . 0.0 110.062 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.3 mt -124.46 141.19 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.508 1.123 . . . . 0.0 111.671 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -139.69 146.04 39.14 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.701 2.0 . . . . 0.0 110.869 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 66.5 tp . . . . . 0 N--CA 1.469 0.503 0 C-N-CA 125.244 1.418 . . . . 0.0 111.889 -176.415 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.411 ' HA3' ' HE2' ' A' ' 155' ' ' LYS . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -78.03 96.22 5.04 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.1 0.96 . . . . 0.0 110.963 -174.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -88.59 101.17 13.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.353 1.861 . . . . 0.0 107.426 169.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.4 tp -88.21 133.73 33.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.585 1.954 . . . . 0.0 110.028 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.89 136.84 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.41 1.484 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.0 m -140.34 167.92 21.03 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.451 1.9 . . . . 0.0 111.934 -171.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.7 t30 51.44 46.81 25.93 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.346 1.858 . . . . 0.0 113.006 -173.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -87.12 167.1 14.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.845 1.658 . . . . 0.0 109.993 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -75.45 150.58 38.24 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.964 -1.085 . . . . 0.0 110.603 169.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -49.44 -41.77 40.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.504 1.121 . . . . 0.0 113.546 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.71 9.46 73.85 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.712 1.625 . . . . 0.0 115.761 -173.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.45 147.54 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.046 1.423 . . . . 0.0 109.528 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -129.94 155.61 45.78 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -45.75 -58.14 3.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.527 2.331 . . . . 0.0 112.101 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.63 80.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.38 1.472 . . . . 0.0 113.168 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.12 -52.55 65.24 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.51 1.124 . . . . 0.0 112.143 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.5 mm -57.81 -51.52 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.739 1.216 . . . . 0.0 111.229 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -48.46 -54.21 15.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.939 1.295 . . . . 0.0 111.918 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.3 -53.75 53.88 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.663 0.785 . . . . 0.0 112.75 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.15 -45.12 89.87 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.799 0.727 . . . . 0.0 112.567 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -64.71 -43.25 94.03 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.786 0.721 . . . . 0.0 112.382 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.24 -32.77 66.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.62 -41.67 81.8 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.205 1.002 . . . . 0.0 113.16 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -113.25 -10.14 13.37 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.67 162.14 28.65 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.816 1.198 . . . . 0.0 114.382 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.26 108.55 19.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.764 1.626 . . . . 0.0 110.087 -169.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.9 pp -130.91 152.93 49.69 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.2 mmmt -93.56 -49.39 5.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.998 2.919 . . . . 0.0 111.111 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -145.87 143.02 29.34 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.228 1.411 . . . . 0.0 111.28 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -126.94 135.9 51.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.677 1.591 . . . . 0.0 110.556 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.3 166.09 25.65 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.796 2.038 . . . . 0.0 111.7 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 N--CA 1.481 1.111 0 C-N-CA 125.942 1.697 . . . . 0.0 110.8 -173.866 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.769 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 65.4 p -139.19 156.37 47.16 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.684 1.193 . . . . 0.0 112.739 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.06 159.37 42.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.325 1.85 . . . . 0.0 111.378 172.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.63 115.03 9.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.734 1.614 . . . . 0.0 109.801 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.2 t -127.7 115.54 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.238 1.015 . . . . 0.0 110.249 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -80.83 104.75 11.55 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.366 1.467 . . . . 0.0 109.457 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -82.08 155.13 25.24 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.68 1.592 . . . . 0.0 112.163 171.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -80.46 -59.54 2.66 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.401 -0.812 . . . . 0.0 112.323 169.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -88.65 126.99 35.56 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.163 1.385 . . . . 0.0 111.441 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.411 ' HE2' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -62.72 -46.13 89.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.127 1.371 . . . . 0.0 111.822 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.45 -46.22 87.0 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.761 1.224 . . . . 0.0 112.306 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -65.75 -36.61 84.04 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.061 0.945 . . . . 0.0 112.928 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.02 -48.17 83.03 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.291 -0.88 . . . . 0.0 111.936 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.96 -42.79 90.7 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.551 1.14 . . . . 0.0 112.377 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -51.74 -57.79 8.26 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.777 1.631 . . . . 0.0 110.427 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.11 60.48 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.725 1.21 . . . . 0.0 112.425 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 21.9 ttt -49.62 -62.45 1.55 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.162 1.385 . . . . 0.0 111.667 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -57.57 -49.16 77.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.622 1.169 . . . . 0.0 112.974 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -63.24 -48.01 80.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.868 0.867 . . . . 0.0 113.258 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.05 -13.74 24.91 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -60.28 108.27 0.77 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.87 1.214 . . . . 0.0 110.739 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 119.06 -30.63 5.78 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.345 1.926 . . . . 0.0 113.933 -173.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.4 134.57 90.96 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.168 1.387 . . . . 0.0 110.635 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.41 146.05 24.32 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.822 2.348 . . . . 0.0 113.334 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 37.3 tp -135.65 108.53 7.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.762 1.625 . . . . 0.0 108.425 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 50.16 63.25 2.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.694 1.597 . . . . 0.0 111.654 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.48 -63.05 4.53 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.174 1.369 . . . . 0.0 113.384 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -63.56 131.94 95.01 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.184 1.393 . . . . 0.0 112.408 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 123.61 9.38 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.749 2.966 . . . . 0.0 111.694 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.17 132.28 49.92 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.289 1.035 . . . . 0.0 111.55 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -110.14 130.38 55.55 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.2 1.4 . . . . 0.0 109.124 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.3 mt -128.59 143.37 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.846 0.859 . . . . 0.0 111.857 -169.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -140.06 146.18 38.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.243 2.217 . . . . 0.0 110.431 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.47 0.527 0 C-N-CA 125.099 1.36 . . . . 0.0 110.581 -179.073 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.04 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -102.94 119.59 39.12 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.14 1.376 . . . . 0.0 110.64 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 87.6 mt -127.34 131.72 50.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.494 1.518 . . . . 0.0 111.618 -171.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.9 tp -77.42 137.99 39.01 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.481 1.513 . . . . 0.0 109.091 169.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.9 122.75 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.324 1.85 . . . . 0.0 108.087 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.9 m -133.75 169.24 17.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.917 1.287 . . . . 0.0 112.937 -169.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.3 t30 54.81 46.18 25.07 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.788 2.035 . . . . 0.0 113.079 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 mt -82.37 165.59 20.16 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.485 1.514 . . . . 0.0 110.057 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.48 145.87 43.22 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.006 -1.058 . . . . 0.0 111.317 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -58.03 -26.37 62.35 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.59 -1.56 90.09 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.117 1.341 . . . . 0.0 115.477 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.4 138.39 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.229 1.514 . . . . 0.0 111.232 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.2 m -113.45 155.9 24.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.172 1.389 . . . . 0.0 113.124 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.05 -57.27 11.69 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.604 1.961 . . . . 0.0 112.991 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.29 93.45 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.214 1.005 . . . . 0.0 112.919 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -56.86 -50.42 72.52 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.294 -0.879 . . . . 0.0 111.853 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.1 mm -55.15 -53.38 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.446 1.098 . . . . 0.0 111.741 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -47.84 -59.47 3.3 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.611 0.765 . . . . 0.0 111.76 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -63.54 -43.28 97.57 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -47.0 81.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.743 1.156 . . . . 0.0 111.93 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -64.71 -40.69 95.78 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.99 -17.11 61.75 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.33 -59.03 3.11 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.915 -1.116 . . . . 0.0 111.786 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -88.16 -21.85 24.38 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.13 -178.31 15.26 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.652 1.596 . . . . 0.0 113.234 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.6 m -125.21 122.31 36.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.238 1.415 . . . . 0.0 109.549 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.66 147.09 52.33 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -91.2 -34.89 14.82 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.454 1.902 . . . . 0.0 110.949 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -137.16 142.35 42.2 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.962 1.305 . . . . 0.0 112.41 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.42 128.96 12.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.478 1.511 . . . . 0.0 109.992 169.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.0 153.25 37.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.666 1.186 . . . . 0.0 112.876 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.6 t . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 126.488 1.915 . . . . 0.0 110.009 173.383 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 N-CA-C 111.996 -0.441 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 55.6 p -133.7 146.21 50.6 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.315 1.446 . . . . 0.0 112.81 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.41 171.99 15.67 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.291 2.236 . . . . 0.0 111.35 -174.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -143.68 135.86 26.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.889 1.676 . . . . 0.0 110.46 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.51 129.23 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.585 1.154 . . . . 0.0 110.064 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -109.1 96.91 6.63 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.357 1.463 . . . . 0.0 108.889 173.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -73.03 140.41 47.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.005 2.122 . . . . 0.0 110.103 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.81 -16.97 63.37 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 28.8 mtm105 -134.82 134.12 40.49 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.224 1.81 . . . . 0.0 110.893 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -55.27 -46.63 76.13 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.208 1.403 . . . . 0.0 112.575 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.96 -51.56 61.06 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.256 1.022 . . . . 0.0 112.028 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.55 -41.39 98.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.626 1.17 . . . . 0.0 113.077 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.67 -56.56 17.88 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.692 1.197 . . . . 0.0 111.637 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.18 -42.28 90.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.254 1.422 . . . . 0.0 112.561 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -52.12 -61.69 2.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.162 1.385 . . . . 0.0 110.89 170.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.01 -47.86 67.99 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.657 1.183 . . . . 0.0 112.601 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 35.8 ttp -51.13 -60.72 2.81 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.411 1.484 . . . . 0.0 111.29 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -59.3 -45.04 92.38 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.87 1.268 . . . . 0.0 112.879 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -58.71 -48.37 81.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.483 1.113 . . . . 0.0 113.362 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -103.48 -17.33 15.26 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -60.85 111.13 1.53 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 120.273 1.397 . . . . 0.0 111.142 170.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.05 -22.46 27.44 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.146 1.831 . . . . 0.0 114.39 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 76.3 t -70.12 133.18 87.85 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 118.573 1.186 . . . . 0.0 110.83 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.14 139.14 21.13 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.898 2.398 . . . . 0.0 112.505 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.0 tp -126.65 106.16 9.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.671 1.988 . . . . 0.0 107.887 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 47.86 57.89 5.58 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.484 1.513 . . . . 0.0 111.321 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.64 -54.4 4.8 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.228 1.394 . . . . 0.0 113.468 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.44 119.07 43.33 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.962 1.705 . . . . 0.0 112.44 -172.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.09 117.83 5.36 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.884 2.389 . . . . 0.0 111.076 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.53 141.43 58.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.596 1.158 . . . . 0.0 111.906 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -122.91 130.86 53.37 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.326 1.45 . . . . 0.0 110.249 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.7 mm -117.48 133.35 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.533 1.133 . . . . 0.0 109.918 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -140.34 151.56 45.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.835 1.254 . . . . 0.0 112.684 -171.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.542 0.651 0 C-N-CA 126.839 2.056 . . . . 0.0 112.052 177.372 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -75.65 126.75 31.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.979 1.312 . . . . 0.0 111.74 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -137.69 111.45 8.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.514 1.926 . . . . 0.0 110.274 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.2 tp -85.52 132.78 34.14 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.769 2.028 . . . . 0.0 110.062 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.2 t -122.47 112.74 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.428 1.491 . . . . 0.0 108.447 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.7 m -117.91 164.13 15.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.311 1.044 . . . . 0.0 111.887 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 54.73 47.67 21.94 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.324 1.85 . . . . 0.0 114.217 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.28 152.41 32.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.907 1.283 . . . . 0.0 108.932 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.71 147.36 53.37 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.869 -1.144 . . . . 0.0 110.789 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -54.93 -28.68 52.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.488 1.115 . . . . 0.0 113.881 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.67 1.02 85.32 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.329 1.442 . . . . 0.0 115.779 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.6 t -66.7 114.75 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.926 1.863 . . . . 0.0 110.484 175.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.5 m -70.73 151.99 44.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.784 1.234 . . . . 0.0 112.598 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -55.18 -48.52 73.67 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.486 1.514 . . . . 0.0 112.751 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.19 76.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.221 1.408 . . . . 0.0 113.665 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -58.5 -53.86 53.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.116 0.966 . . . . 0.0 112.807 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.5 mm -54.59 -55.48 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.342 1.057 . . . . 0.0 110.999 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -49.34 -55.74 11.86 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.255 1.422 . . . . 0.0 111.875 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.43 -49.81 76.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.533 1.133 . . . . 0.0 113.311 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -43.92 95.83 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.215 0.916 . . . . 0.0 111.417 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -66.71 -44.98 80.17 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.862 1.265 . . . . 0.0 112.708 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.0 -14.42 54.0 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.78 -63.46 1.07 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.919 -1.113 . . . . 0.0 111.479 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -83.28 -21.11 33.38 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.4 -168.76 11.68 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.151 1.834 . . . . 0.0 112.921 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 m -140.91 129.23 22.37 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.42 1.088 . . . . 0.0 110.618 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -136.54 152.57 50.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -171.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -83.0 -51.81 7.23 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.74 2.416 . . . . 0.0 111.133 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -146.54 147.92 31.64 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.084 1.353 . . . . 0.0 112.387 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.36 137.55 27.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.954 1.702 . . . . 0.0 110.825 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.42 116.19 6.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.727 1.211 . . . . 0.0 112.557 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.48 1.054 0 C-N-CA 125.486 1.514 . . . . 0.0 109.755 169.791 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.833 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.2 m -150.5 153.06 35.16 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.64 1.576 . . . . 0.0 109.757 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.55 156.69 43.85 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.266 1.426 . . . . 0.0 112.513 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -123.2 131.67 53.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.816 1.646 . . . . 0.0 109.805 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.01 144.3 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.33 1.452 . . . . 0.0 109.722 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -126.29 102.78 7.33 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.99 1.716 . . . . 0.0 108.949 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -78.13 166.38 22.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.869 1.668 . . . . 0.0 112.706 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -61.31 -35.39 77.23 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.085 0.954 . . . . 0.0 112.796 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.74 147.03 34.93 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.44 1.496 . . . . 0.0 112.474 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -55.07 -46.02 75.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.437 1.495 . . . . 0.0 112.587 170.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -50.95 -48.11 60.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.395 1.078 . . . . 0.0 112.8 172.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.21 -39.17 82.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.1 0.96 . . . . 0.0 112.568 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.08 -45.85 86.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.72 0.808 . . . . 0.0 112.035 169.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.63 -44.15 96.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.372 1.469 . . . . 0.0 111.839 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -52.7 -54.54 32.16 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.185 1.394 . . . . 0.0 111.408 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.52 -51.67 58.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.772 1.229 . . . . 0.0 112.378 173.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 30.8 ttp -52.54 -62.4 1.67 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.581 1.552 . . . . 0.0 111.286 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -57.14 -45.15 83.79 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.742 1.217 . . . . 0.0 112.755 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.87 -46.69 89.6 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.351 1.06 . . . . 0.0 113.042 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -107.75 -12.28 15.25 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -169.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -59.23 119.54 7.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.294 1.406 . . . . 0.0 111.583 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.89 -18.22 57.54 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.019 1.771 . . . . 0.0 114.323 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -72.29 128.09 89.35 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 118.839 1.319 . . . . 0.0 111.077 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.12 136.16 71.0 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.943 3.096 . . . . 0.0 113.844 172.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.0 tp -133.77 103.46 5.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.495 1.518 . . . . 0.0 107.567 169.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 51.32 62.28 2.79 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.8 1.64 . . . . 0.0 111.08 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.86 -61.64 4.71 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.467 1.508 . . . . 0.0 113.343 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -65.09 125.2 88.77 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.681 1.592 . . . . 0.0 112.118 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.8 126.23 9.96 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.486 2.791 . . . . 0.0 111.631 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -68.29 120.54 14.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.312 1.045 . . . . 0.0 111.797 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -94.17 103.49 15.53 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.92 1.288 . . . . 0.0 108.921 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -113.5 134.23 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.311 1.045 . . . . 0.0 110.862 -169.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -142.59 123.0 13.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.534 1.534 . . . . 0.0 112.157 -171.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.0 tt . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 169.637 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 CA-C-O 121.427 0.46 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -139.59 150.75 45.39 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.372 1.469 . . . . 0.0 112.08 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.5 mt -125.42 144.52 50.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.964 1.706 . . . . 0.0 111.204 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.5 tp -117.02 99.91 7.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.874 1.669 . . . . 0.0 107.579 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.21 129.18 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.594 1.557 . . . . 0.0 108.174 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.6 m -133.28 170.85 14.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.249 1.42 . . . . 0.0 111.947 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.3 t30 56.93 38.48 29.42 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.207 1.803 . . . . 0.0 113.269 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.07 165.31 20.72 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.294 1.437 . . . . 0.0 110.552 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.76 144.34 52.75 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.39 -0.819 . . . . 0.0 109.811 168.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -56.63 -33.68 66.54 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.94 27.76 16.35 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.499 1.523 . . . . 0.0 115.244 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.59 124.74 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 118.912 1.356 . . . . 0.0 109.652 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.8 m -72.0 135.21 46.31 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.548 0.739 . . . . 0.0 112.031 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.38 -47.74 80.87 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.493 1.117 . . . . 0.0 112.935 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.38 -46.91 76.5 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.689 1.196 . . . . 0.0 112.702 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.27 -48.03 81.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.179 0.992 . . . . 0.0 112.117 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 mm -55.37 -53.65 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.454 1.102 . . . . 0.0 112.087 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -50.16 -55.39 15.29 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.697 0.681 . . . . 0.0 111.474 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -56.66 -52.06 66.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.483 1.113 . . . . 0.0 113.228 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.31 -44.92 90.09 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.12 0.873 . . . . 0.0 112.367 -175.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -63.48 -43.48 97.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.579 0.627 . . . . 0.0 112.557 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.2 -19.6 64.66 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.27 -63.24 1.12 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.185 0.994 . . . . 0.0 111.724 172.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.08 -19.17 44.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -138.32 -177.33 15.18 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.336 1.446 . . . . 0.0 113.959 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.7 m -124.62 116.11 21.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.512 1.525 . . . . 0.0 110.238 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.92 144.72 50.57 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -169.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -81.6 -42.71 19.67 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.947 2.099 . . . . 0.0 109.991 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -147.31 145.47 29.37 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.687 1.595 . . . . 0.0 111.915 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.16 114.7 7.62 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.894 1.677 . . . . 0.0 108.126 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.63 113.37 10.96 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.613 1.165 . . . . 0.0 112.165 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 125.325 1.45 . . . . 0.0 110.469 171.386 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.86 0 CA-C-O 120.437 -0.091 . . . . 0.0 113.025 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.5 p -136.79 158.73 43.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.199 1.4 . . . . 0.0 112.958 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.73 138.43 23.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.496 1.518 . . . . 0.0 111.849 172.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -106.92 124.9 50.29 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.578 1.951 . . . . 0.0 110.431 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.3 t -129.34 139.31 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.008 1.323 . . . . 0.0 110.115 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -128.96 120.33 25.91 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.919 2.088 . . . . 0.0 109.199 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -103.31 163.59 12.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.581 1.952 . . . . 0.0 113.341 -169.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.35 -36.13 58.36 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 169.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 42.5 mtm-85 -133.77 129.1 36.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.082 1.753 . . . . 0.0 111.278 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -54.68 -45.87 74.0 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.597 1.559 . . . . 0.0 113.083 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.65 -46.72 70.66 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.925 1.29 . . . . 0.0 112.801 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.08 -42.84 93.76 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.466 1.106 . . . . 0.0 112.696 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.22 71.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.707 0.803 . . . . 0.0 111.734 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.65 -47.03 80.66 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.535 1.134 . . . . 0.0 112.58 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -50.81 -58.96 4.66 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.863 1.265 . . . . 0.0 111.165 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.4 -48.12 62.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.355 1.062 . . . . 0.0 112.659 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -55.29 -65.55 0.57 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.071 1.348 . . . . 0.0 111.322 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -61.61 -34.11 75.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -64.05 -42.02 97.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.524 1.13 . . . . 0.0 113.403 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -110.66 -18.43 13.16 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -59.24 115.4 3.18 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.875 1.216 . . . . 0.0 111.19 170.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 103.78 -23.46 32.47 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.857 1.694 . . . . 0.0 114.403 -175.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.8 134.87 90.06 Favored Pre-proline 0 N--CA 1.477 0.924 0 CA-C-N 118.643 1.221 . . . . 0.0 110.216 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.35 141.85 29.29 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.671 2.248 . . . . 0.0 112.93 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -125.33 99.97 6.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.46 2.304 . . . . 0.0 106.855 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 44.02 70.53 0.31 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.992 1.717 . . . . 0.0 111.902 -169.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.6 -57.63 5.05 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.781 1.657 . . . . 0.0 113.531 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -65.76 122.76 82.33 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.996 2.119 . . . . 0.0 112.369 -172.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.79 123.87 10.15 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.867 2.378 . . . . 0.0 111.088 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.1 mtm -61.61 123.6 18.34 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.064 0.945 . . . . 0.0 111.091 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -106.83 104.89 14.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.236 1.414 . . . . 0.0 109.123 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.3 mt -106.76 130.31 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.144 0.978 . . . . 0.0 110.85 -172.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -109.43 147.08 33.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.531 1.933 . . . . 0.0 109.627 173.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 N--CA 1.47 0.533 0 C-N-CA 125.249 1.419 . . . . 0.0 112.386 -179.885 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.9 0 CA-C-O 120.823 0.124 . . . . 0.0 113.153 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -117.58 103.73 10.35 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.08 1.752 . . . . 0.0 109.626 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -88.55 105.37 17.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.575 2.35 . . . . 0.0 108.994 -173.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.1 tp -88.88 122.65 32.48 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.756 2.022 . . . . 0.0 109.983 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.8 t -112.11 136.55 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.101 1.76 . . . . 0.0 109.115 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.2 m -137.52 163.13 31.9 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.188 1.795 . . . . 0.0 112.307 -174.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.1 t30 57.01 33.5 23.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.933 2.093 . . . . 0.0 113.918 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.9 mt -72.0 159.03 34.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.139 0.975 . . . . 0.0 110.28 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.83 139.81 57.78 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.535 -0.728 . . . . 0.0 110.571 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.75 -20.9 62.33 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.82 11.9 62.59 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.717 1.627 . . . . 0.0 115.558 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.06 123.99 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.719 1.76 . . . . 0.0 110.33 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.6 m -81.84 149.13 28.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.445 1.098 . . . . 0.0 113.105 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.34 -54.11 50.56 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.85 1.66 . . . . 0.0 112.69 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -39.33 81.81 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.57 1.148 . . . . 0.0 112.951 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.43 -51.05 71.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.835 0.854 . . . . 0.0 111.979 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.9 mm -55.0 -53.06 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.922 0.889 . . . . 0.0 111.511 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.07 -55.32 15.34 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.796 0.839 . . . . 0.0 111.973 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -59.55 -50.96 71.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.964 1.306 . . . . 0.0 113.212 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -63.36 -43.55 97.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.271 0.941 . . . . 0.0 111.886 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -63.4 -44.99 93.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.062 0.545 . . . . 0.0 112.427 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.03 -31.87 67.42 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.5 -52.53 65.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.265 1.026 . . . . 0.0 112.77 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -95.59 -23.67 16.94 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.29 162.04 23.62 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.373 1.463 . . . . 0.0 114.458 -172.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 37.5 m -102.49 103.34 13.7 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.471 1.508 . . . . 0.0 110.424 -173.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -121.48 165.05 16.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 -35.88 2.85 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.776 2.431 . . . . 0.0 111.557 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -140.58 151.09 44.41 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.61 0.764 . . . . 0.0 111.924 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.25 141.89 35.82 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.738 1.615 . . . . 0.0 110.446 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -146.92 152.33 38.49 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.983 1.713 . . . . 0.0 111.608 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 N--CA 1.48 1.061 0 C-N-CA 126.1 1.76 . . . . 0.0 109.875 177.059 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 N-CA-C 113.344 0.098 . . . . 0.0 113.344 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 78.1 p -137.08 155.69 49.32 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.469 1.108 . . . . 0.0 112.257 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -143.69 158.81 43.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.417 1.487 . . . . 0.0 111.649 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -139.84 120.63 14.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.533 1.533 . . . . 0.0 110.135 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 51.5 t -124.52 118.7 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.143 1.377 . . . . 0.0 109.723 -174.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -93.04 105.55 17.64 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.712 1.205 . . . . 0.0 108.502 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -82.6 152.38 25.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.643 2.777 . . . . 0.0 112.103 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -62.93 -48.36 79.24 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.153 0.581 . . . . 0.0 112.276 170.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -123.92 138.44 54.48 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.854 1.262 . . . . 0.0 112.302 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -59.24 -46.75 87.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.559 1.544 . . . . 0.0 112.966 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.72 62.64 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.764 1.226 . . . . 0.0 113.484 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.51 -43.28 85.71 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.834 0.853 . . . . 0.0 112.32 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.87 -46.51 84.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.101 0.96 . . . . 0.0 112.514 170.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.85 -47.75 79.64 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.941 2.097 . . . . 0.0 111.182 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -51.65 -52.91 44.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.425 1.09 . . . . 0.0 111.841 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.1 -47.03 78.82 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.732 0.813 . . . . 0.0 112.845 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 41.1 ttp -53.1 -60.7 2.96 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.466 1.507 . . . . 0.0 111.454 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -35.64 80.95 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -61.63 -45.93 91.95 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.381 1.072 . . . . 0.0 113.166 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -106.11 -17.38 14.34 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 -169.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -59.65 114.75 2.9 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.204 1.366 . . . . 0.0 111.335 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.71 -23.47 26.02 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.178 1.846 . . . . 0.0 114.138 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 65.7 t -67.82 131.97 92.49 Favored Pre-proline 0 N--CA 1.476 0.866 0 CA-C-N 118.596 1.198 . . . . 0.0 110.886 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.92 121.54 5.46 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.309 2.673 . . . . 0.0 111.972 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 24.2 tp -77.55 79.2 4.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.196 1.399 . . . . 0.0 109.266 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 45.96 35.88 2.66 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.675 1.99 . . . . 0.0 113.633 -170.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 144.04 -79.94 0.24 Allowed Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.916 1.722 . . . . 0.0 112.561 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -64.11 127.06 91.46 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.172 1.389 . . . . 0.0 112.762 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.73 122.5 7.37 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.19 2.593 . . . . 0.0 111.788 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.1 mtm -66.73 136.19 55.13 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.048 0.939 . . . . 0.0 110.959 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -118.02 129.29 55.49 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.723 1.209 . . . . 0.0 109.735 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.5 mt -129.87 141.12 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.944 0.897 . . . . 0.0 112.282 -169.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -137.53 154.3 49.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.835 2.454 . . . . 0.0 110.482 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 64.8 tp . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 125.045 1.338 . . . . 0.0 111.493 -177.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.47 167.09 31.51 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 118.8 1.3 . . . . 0.0 112.628 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 89.5 mt -142.23 162.57 35.14 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.037 2.135 . . . . 0.0 111.678 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.8 tp -123.86 106.64 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.199 1.8 . . . . 0.0 106.917 168.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.94 129.39 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.8 m -129.78 171.9 12.21 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.68 1.192 . . . . 0.0 111.701 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.7 t30 50.77 65.07 1.58 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.876 1.671 . . . . 0.0 112.727 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.48 153.95 21.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.872 2.069 . . . . 0.0 109.685 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.44 143.81 57.46 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.737 -1.227 . . . . 0.0 110.588 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -53.4 -34.3 57.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.197 0.999 . . . . 0.0 113.567 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.23 9.0 78.67 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.343 1.449 . . . . 0.0 115.786 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.93 121.26 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.679 1.739 . . . . 0.0 109.919 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.8 m -72.78 146.31 46.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.459 1.104 . . . . 0.0 113.235 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.3 -58.32 8.78 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.798 1.639 . . . . 0.0 113.165 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.79 -37.19 78.42 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.957 0.903 . . . . 0.0 113.001 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.0 -52.31 66.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.815 0.846 . . . . 0.0 112.072 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.6 mm -54.04 -53.31 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.985 0.914 . . . . 0.0 111.318 169.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -52.32 -52.57 52.36 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.146 0.979 . . . . 0.0 112.092 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.84 -50.78 70.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.899 1.28 . . . . 0.0 113.435 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.6 -45.2 91.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.524 1.056 . . . . 0.0 112.275 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -63.0 -40.15 96.91 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.528 0.604 . . . . 0.0 112.37 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.48 -13.57 52.71 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -73.59 -61.67 1.75 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.906 -1.121 . . . . 0.0 111.252 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -85.68 -12.05 52.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.4 166.48 24.47 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.138 1.827 . . . . 0.0 112.883 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.4 m -111.99 97.72 6.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.573 1.549 . . . . 0.0 109.665 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 152' ' ' PHE . 3.7 pp -118.34 144.03 46.18 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -169.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.41 -48.62 15.09 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.803 2.041 . . . . 0.0 110.702 171.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -152.43 149.05 28.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.743 1.217 . . . . 0.0 112.362 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.58 130.41 24.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.591 1.556 . . . . 0.0 109.708 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.15 109.87 8.63 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.465 1.506 . . . . 0.0 111.544 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 N--CA 1.476 0.864 0 C-N-CA 126.18 1.792 . . . . 0.0 111.442 179.233 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 N-CA-C 113.743 0.257 . . . . 0.0 113.743 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.6 p -140.69 167.51 22.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.229 1.812 . . . . 0.0 111.179 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.45 125.9 12.4 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.28 1.432 . . . . 0.0 111.555 169.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.16 123.97 28.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.446 1.498 . . . . 0.0 109.849 170.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.7 140.38 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 118.907 0.776 . . . . 0.0 111.122 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -126.12 127.8 46.34 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.024 1.729 . . . . 0.0 110.176 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 131' ' ' LEU . 30.8 m-85 -110.6 158.83 18.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.19 2.196 . . . . 0.0 113.964 -169.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -76.26 -29.63 57.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.626 0.77 . . . . 0.0 112.858 170.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -141.27 129.38 22.1 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.466 1.506 . . . . 0.0 112.087 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -40.05 83.08 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.935 1.694 . . . . 0.0 112.914 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.81 -51.61 68.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.117 0.967 . . . . 0.0 112.334 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.49 -46.47 86.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.274 1.03 . . . . 0.0 112.059 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.6 -50.78 67.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.524 1.13 . . . . 0.0 112.374 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.48 -48.0 80.4 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.541 1.536 . . . . 0.0 112.102 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.25 -52.72 60.46 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.324 1.45 . . . . 0.0 112.319 172.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.87 -50.85 67.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.903 1.281 . . . . 0.0 112.011 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.9 ttt -52.19 -59.73 4.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.791 1.636 . . . . 0.0 112.032 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -51.98 -45.56 64.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.538 1.135 . . . . 0.0 112.557 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.31 -52.34 64.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.516 1.127 . . . . 0.0 113.063 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -95.82 -12.56 25.09 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -169.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -58.91 118.57 5.92 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.764 -1.21 . . . . 0.0 111.139 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.6 -16.74 54.55 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.54 1.543 . . . . 0.0 114.598 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 85.0 t -69.27 126.77 92.94 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 119.11 1.455 . . . . 0.0 110.702 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -60.16 136.93 72.08 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.773 2.982 . . . . 0.0 114.195 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 50.9 tp -136.87 101.33 4.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.503 1.521 . . . . 0.0 108.079 169.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 52.08 65.37 1.52 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.228 1.811 . . . . 0.0 111.986 -169.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.42 -65.5 4.11 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.784 1.183 . . . . 0.0 112.916 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -58.91 125.89 79.2 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.243 1.417 . . . . 0.0 112.22 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.74 127.37 12.26 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.241 2.628 . . . . 0.0 111.252 170.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.5 mtm -62.26 111.87 2.16 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.203 1.001 . . . . 0.0 111.401 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -93.2 91.56 7.33 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.362 1.465 . . . . 0.0 109.104 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 15.6 mt -89.91 138.54 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.425 1.09 . . . . 0.0 110.432 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -128.39 137.46 51.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.663 1.985 . . . . 0.0 110.875 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -170.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -85.86 116.23 23.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.897 1.279 . . . . 0.0 109.316 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.39 101.16 7.96 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.51 1.924 . . . . 0.0 109.095 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.3 tp -83.47 133.1 34.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.26 1.824 . . . . 0.0 109.985 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.3 81.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.847 2.059 . . . . 0.0 108.419 -173.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.6 m -79.72 158.14 27.0 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.72 1.208 . . . . 0.0 112.491 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.1 t30 57.89 64.65 1.48 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.381 1.872 . . . . 0.0 113.212 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.3 mt -98.38 -116.01 0.14 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.696 1.998 . . . . 0.0 108.738 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -149.34 148.27 29.31 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.313 1.845 . . . . 0.0 110.436 172.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -74.16 71.59 1.67 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.921 1.688 . . . . 0.0 111.442 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 152.19 7.69 0.11 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.388 1.47 . . . . 0.0 116.168 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.1 t -58.35 128.8 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.485 1.643 . . . . 0.0 110.513 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.2 m -70.06 147.51 49.95 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.322 1.049 . . . . 0.0 112.46 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.86 -57.86 10.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.508 0.723 . . . . 0.0 111.651 174.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.51 -39.32 67.48 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.886 1.275 . . . . 0.0 113.239 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.65 -58.16 9.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.111 0.964 . . . . 0.0 112.039 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.8 mm -56.73 -52.28 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.438 1.095 . . . . 0.0 111.407 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -48.56 -57.54 6.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.862 1.665 . . . . 0.0 111.549 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.17 -49.28 76.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.725 1.21 . . . . 0.0 113.229 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.34 -43.41 97.8 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.671 1.123 . . . . 0.0 112.167 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -63.09 -43.96 97.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.224 0.61 . . . . 0.0 112.312 172.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.44 -19.84 63.9 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.28 -61.54 1.73 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.971 -1.081 . . . . 0.0 111.887 173.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -80.41 -25.58 38.97 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.08 -175.05 13.61 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.334 1.445 . . . . 0.0 113.53 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.6 m -127.13 122.58 34.61 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.052 . . . . 0.0 110.99 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.4 142.02 51.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.648 1.179 . . . . 0.0 113.651 -170.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.52 -44.43 19.12 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.285 2.234 . . . . 0.0 110.953 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -148.47 151.7 35.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.975 0.91 . . . . 0.0 112.695 -175.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.54 150.5 42.22 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.669 1.587 . . . . 0.0 111.637 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.23 154.98 39.9 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.36 1.864 . . . . 0.0 111.766 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 124.427 1.091 . . . . 0.0 112.284 -174.772 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.01 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.4 m -157.67 152.07 24.86 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.928 2.491 . . . . 0.0 109.057 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -126.84 166.17 17.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.213 1.405 . . . . 0.0 111.991 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.45 133.77 23.11 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.453 1.501 . . . . 0.0 110.098 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.5 t -133.34 122.6 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.357 1.463 . . . . 0.0 109.877 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -91.55 110.03 21.34 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.488 -0.758 . . . . 0.0 109.912 169.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -80.84 149.7 29.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.047 2.139 . . . . 0.0 111.783 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.35 -19.96 63.85 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -139.05 128.57 24.45 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.542 1.937 . . . . 0.0 111.389 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -57.08 -49.23 76.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.042 1.737 . . . . 0.0 111.839 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.94 -44.57 70.75 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.489 1.116 . . . . 0.0 112.757 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -64.61 -39.66 94.12 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.66 1.184 . . . . 0.0 112.46 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.84 -45.64 91.76 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.175 0.59 . . . . 0.0 111.689 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.19 -46.67 88.92 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.335 1.454 . . . . 0.0 111.572 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -48.46 -53.87 16.33 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.005 1.722 . . . . 0.0 111.651 171.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.0 -47.95 81.48 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.883 0.873 . . . . 0.0 112.707 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 17.2 ttp -52.13 -60.56 3.05 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.537 1.535 . . . . 0.0 111.833 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.99 -36.25 80.93 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.677 0.791 . . . . 0.0 113.113 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -64.43 -44.54 90.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.351 1.06 . . . . 0.0 113.43 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.18 -15.83 14.57 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -169.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -60.8 113.11 2.32 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.204 1.366 . . . . 0.0 111.952 174.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.91 -21.91 32.91 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.852 1.692 . . . . 0.0 114.343 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.8 132.03 92.51 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 118.626 1.213 . . . . 0.0 110.533 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.56 145.83 18.74 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.954 2.436 . . . . 0.0 113.374 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.7 tp -135.54 115.1 12.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.196 2.198 . . . . 0.0 108.612 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 38.66 62.34 1.05 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.385 1.874 . . . . 0.0 113.57 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.59 2.16 90.6 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.282 1.42 . . . . 0.0 116.218 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -131.08 123.33 19.77 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.798 1.639 . . . . 0.0 112.155 -170.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.45 122.02 7.94 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.978 2.452 . . . . 0.0 111.225 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.5 mtm -64.21 130.49 44.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.261 1.025 . . . . 0.0 110.811 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -116.24 114.73 24.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.161 1.385 . . . . 0.0 109.427 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.8 mm -108.07 138.66 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.552 0.741 . . . . 0.0 111.273 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -135.99 140.81 44.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.918 1.687 . . . . 0.0 110.472 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.2 tt . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 125.166 1.386 . . . . 0.0 110.542 -170.632 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -137.43 131.03 31.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.2 1.0 . . . . 0.0 112.292 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -115.91 155.28 28.25 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.248 1.819 . . . . 0.0 110.465 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.5 tp -130.82 94.14 3.56 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.115 1.766 . . . . 0.0 106.976 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -69.7 127.49 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.8 m -128.91 171.31 12.43 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.128 1.371 . . . . 0.0 111.495 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.5 t30 58.79 30.3 19.87 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.258 1.823 . . . . 0.0 113.615 -169.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.47 162.61 26.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.529 1.131 . . . . 0.0 109.385 169.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -83.04 157.86 22.72 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.264 -0.897 . . . . 0.0 113.098 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -54.25 -37.22 64.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.599 1.159 . . . . 0.0 112.155 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.29 8.87 78.75 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.173 1.368 . . . . 0.0 116.318 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.2 130.72 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.762 1.781 . . . . 0.0 110.454 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.4 m -82.61 138.91 34.05 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.504 1.122 . . . . 0.0 112.302 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -56.78 -55.25 36.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.338 1.455 . . . . 0.0 113.395 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.46 80.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.899 0.88 . . . . 0.0 113.11 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.88 -51.39 70.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.826 0.851 . . . . 0.0 112.009 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.74 -52.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.263 1.025 . . . . 0.0 111.275 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -51.22 -55.28 18.86 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.745 0.818 . . . . 0.0 112.052 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.48 -50.73 72.68 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.678 1.191 . . . . 0.0 113.12 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.48 -45.27 91.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.379 0.991 . . . . 0.0 112.413 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -63.16 -40.89 98.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.836 0.744 . . . . 0.0 112.466 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.9 -13.21 61.46 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -71.81 -62.23 1.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.989 -1.069 . . . . 0.0 111.113 172.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -78.54 -35.46 46.1 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.61 173.18 15.47 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.489 1.518 . . . . 0.0 113.372 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.7 m -119.99 112.87 19.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.066 1.346 . . . . 0.0 109.432 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -135.07 151.6 50.91 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -169.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -73.6 -53.97 9.26 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.512 1.925 . . . . 0.0 110.426 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -154.05 153.17 31.44 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.4 139.46 45.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.529 1.932 . . . . 0.0 109.403 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.13 100.04 3.56 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.588 1.555 . . . . 0.0 111.646 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t . . . . . 0 N--CA 1.477 0.888 0 C-N-CA 125.098 1.359 . . . . 0.0 110.692 170.136 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.863 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 52.6 p -138.24 163.23 32.28 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.824 1.249 . . . . 0.0 113.261 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.4 116.05 9.16 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.086 1.754 . . . . 0.0 111.179 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -73.56 133.74 43.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.139 0.976 . . . . 0.0 108.74 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.4 t -136.07 123.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.942 0.897 . . . . 0.0 109.874 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -109.47 112.94 25.34 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.418 1.487 . . . . 0.0 109.759 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -90.28 158.61 17.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.92 2.488 . . . . 0.0 112.944 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.22 -41.44 85.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.305 0.642 . . . . 0.0 112.357 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -132.2 134.73 45.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.868 1.667 . . . . 0.0 111.196 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -66.64 -28.93 68.87 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.17 -46.75 88.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.999 0.92 . . . . 0.0 111.301 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.48 -40.98 96.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.205 1.002 . . . . 0.0 112.361 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.24 -58.22 7.82 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.343 1.057 . . . . 0.0 111.536 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -53.12 -48.38 67.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.032 1.733 . . . . 0.0 112.077 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -52.24 -55.87 18.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.745 1.218 . . . . 0.0 111.814 173.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.01 -46.03 75.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.5 1.12 . . . . 0.0 112.625 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -52.42 -62.8 1.41 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.169 1.388 . . . . 0.0 110.812 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.27 -36.51 77.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -66.67 -44.27 82.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.249 1.02 . . . . 0.0 113.467 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -105.63 -15.12 15.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -61.85 105.59 0.58 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.662 1.119 . . . . 0.0 110.519 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.21 -21.87 9.9 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.748 2.118 . . . . 0.0 114.298 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.5 t -79.26 131.85 64.6 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 118.653 1.227 . . . . 0.0 111.695 -170.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.52 138.87 66.54 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.465 3.443 . . . . 0.0 115.457 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -138.42 103.31 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.045 2.138 . . . . 0.0 106.371 169.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 52.78 60.42 3.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.512 1.525 . . . . 0.0 111.288 -168.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.76 -64.88 4.14 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.548 1.547 . . . . 0.0 113.178 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -62.03 135.77 94.91 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.818 1.647 . . . . 0.0 112.711 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.82 131.49 12.29 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.339 2.692 . . . . 0.0 112.238 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.3 mtm -62.88 132.56 52.54 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.96 0.904 . . . . 0.0 110.917 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -118.44 115.57 24.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.608 1.163 . . . . 0.0 108.459 171.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.6 mt -105.84 126.62 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.901 0.858 . . . . 0.0 112.215 -169.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -99.13 150.44 22.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.099 2.16 . . . . 0.0 109.483 169.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 124.52 1.128 . . . . 0.0 112.797 -179.361 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -81.76 93.66 6.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.994 0.918 . . . . 0.0 109.588 172.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -89.42 101.14 13.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.966 1.306 . . . . 0.0 108.795 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.7 tp -89.95 127.59 36.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.36 1.864 . . . . 0.0 109.816 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.62 127.83 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.472 1.509 . . . . 0.0 108.859 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.0 m -128.24 168.59 15.25 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.468 1.907 . . . . 0.0 111.066 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.3 t30 59.16 51.79 6.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.996 1.719 . . . . 0.0 112.555 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.4 mt -95.48 172.82 7.84 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.715 1.606 . . . . 0.0 110.287 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -139.84 158.01 44.79 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.204 -0.935 . . . . 0.0 112.779 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -57.48 104.03 0.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.688 1.195 . . . . 0.0 110.874 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.8 -45.25 0.62 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.696 2.093 . . . . 0.0 109.474 -169.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.6 t -64.39 134.79 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.238 1.015 . . . . 0.0 108.832 169.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 61.1 m -121.74 153.76 37.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.513 1.125 . . . . 0.0 112.155 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.28 -56.73 12.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.95 1.7 . . . . 0.0 112.542 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.56 -37.78 82.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.592 1.157 . . . . 0.0 113.319 174.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -63.3 -51.7 64.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.8 0.84 . . . . 0.0 111.551 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.5 mm -54.21 -52.91 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.405 1.082 . . . . 0.0 111.221 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -51.33 -53.94 31.16 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.109 0.963 . . . . 0.0 112.323 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -60.58 -51.46 69.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.689 1.195 . . . . 0.0 113.252 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -63.6 -44.28 94.45 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.164 0.893 . . . . 0.0 112.182 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -62.69 -43.71 98.12 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.61 67.96 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.57 -53.69 52.91 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.097 0.959 . . . . 0.0 112.789 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -95.93 -16.14 21.93 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -140.59 164.36 26.34 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.019 1.295 . . . . 0.0 114.414 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -104.26 111.17 23.68 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.924 1.29 . . . . 0.0 110.943 -172.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -129.3 145.66 51.33 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.49 1.116 . . . . 0.0 113.323 -171.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -87.63 -39.39 15.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.029 1.732 . . . . 0.0 111.1 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -144.26 146.85 32.89 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.469 1.108 . . . . 0.0 112.126 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -146.96 123.41 11.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.135 1.374 . . . . 0.0 110.818 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.22 155.73 42.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.701 1.2 . . . . 0.0 112.989 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 126.804 2.042 . . . . 0.0 110.207 178.074 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.952 0 N-CA-C 112.098 -0.401 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.7 m -146.96 148.98 32.3 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.157 1.383 . . . . 0.0 110.82 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.66 154.48 46.42 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.593 1.557 . . . . 0.0 111.647 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -128.48 124.63 36.61 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.656 1.583 . . . . 0.0 109.907 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.09 110.09 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 125.193 1.397 . . . . 0.0 108.683 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -82.47 92.62 7.09 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.998 1.319 . . . . 0.0 108.5 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -70.6 150.13 46.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.794 1.638 . . . . 0.0 111.265 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -74.82 -27.93 60.49 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 34.7 mtm105 -135.99 138.84 42.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.241 1.817 . . . . 0.0 111.16 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -67.08 -44.13 80.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.72 1.608 . . . . 0.0 112.086 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.12 -46.85 68.92 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.677 0.791 . . . . 0.0 112.319 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.56 -44.61 96.72 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.774 1.63 . . . . 0.0 112.26 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.77 87.69 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.183 0.993 . . . . 0.0 112.878 170.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.2 -38.81 84.45 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.557 1.543 . . . . 0.0 112.428 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -49.3 -61.89 1.84 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.531 1.133 . . . . 0.0 110.059 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.38 -47.54 72.56 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.806 1.242 . . . . 0.0 112.598 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -51.51 -61.2 2.39 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.415 1.486 . . . . 0.0 111.437 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -60.16 -44.75 94.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.921 0.888 . . . . 0.0 112.388 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.29 -44.25 92.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.258 1.423 . . . . 0.0 113.387 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -109.14 -14.56 14.49 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -60.27 115.68 3.69 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.48 1.491 . . . . 0.0 111.305 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.77 55.51 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.826 1.679 . . . . 0.0 114.546 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.29 130.68 79.56 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 118.9 1.35 . . . . 0.0 110.852 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.43 135.69 69.47 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.764 2.976 . . . . 0.0 114.9 174.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.1 tp -142.02 113.76 7.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.553 1.941 . . . . 0.0 108.184 169.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 49.4 61.42 3.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.405 1.482 . . . . 0.0 111.398 -169.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.58 -61.54 4.62 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.363 1.459 . . . . 0.0 113.364 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -67.26 140.24 95.31 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 125.319 1.447 . . . . 0.0 113.719 -172.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -73.15 125.92 10.71 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.99 2.46 . . . . 0.0 110.453 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 74.6 mtm -63.5 127.8 32.94 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.366 1.067 . . . . 0.0 111.849 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -105.16 119.32 38.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.566 1.146 . . . . 0.0 109.326 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.4 mt -118.94 139.85 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.939 . . . . 0.0 112.312 -169.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -134.37 147.5 50.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.405 2.282 . . . . 0.0 110.196 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 51.6 tp . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 124.78 1.232 . . . . 0.0 111.235 -176.979 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.174 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -74.36 130.28 39.37 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.072 0.936 . . . . 0.0 110.827 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.34 124.74 23.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.906 2.082 . . . . 0.0 109.317 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.4 tp -114.56 108.02 16.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.662 1.585 . . . . 0.0 110.488 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.6 t -92.07 129.52 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.328 1.451 . . . . 0.0 108.874 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.5 m -134.81 173.25 11.9 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.006 1.722 . . . . 0.0 111.87 -175.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.7 t30 55.51 35.8 25.85 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.304 1.841 . . . . 0.0 113.192 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.73 168.94 19.14 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.649 1.179 . . . . 0.0 110.428 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -65.96 155.23 37.17 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.23 -0.918 . . . . 0.0 111.679 171.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -50.99 -28.34 9.72 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.764 2.025 . . . . 0.0 114.697 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -145.69 55.57 0.54 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-N 119.151 0.887 . . . . 0.0 115.019 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.99 136.77 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 118.085 0.943 . . . . 0.0 109.766 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 52.1 m -69.83 138.31 52.5 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.582 -0.699 . . . . 0.0 112.134 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -60.31 -53.57 56.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.524 1.129 . . . . 0.0 112.648 -174.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.92 83.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.448 1.099 . . . . 0.0 112.688 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -56.51 -53.39 58.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.856 0.862 . . . . 0.0 112.248 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.2 mm -56.83 -53.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.845 0.858 . . . . 0.0 111.458 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -53.15 -53.76 45.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.015 0.526 . . . . 0.0 112.116 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.01 -50.47 73.96 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.945 1.298 . . . . 0.0 113.054 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.48 -46.35 90.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.653 1.115 . . . . 0.0 111.914 -176.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.85 -43.08 97.21 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.94 -21.09 66.77 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.98 -58.78 5.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.96 -1.087 . . . . 0.0 111.892 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -82.31 -35.58 27.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -110.12 161.77 12.84 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.585 1.564 . . . . 0.0 114.185 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.8 m -106.09 101.81 11.27 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.878 1.671 . . . . 0.0 109.68 -174.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -137.08 153.99 50.43 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -169.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -85.94 -50.96 6.68 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.642 2.377 . . . . 0.0 111.486 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.71 150.63 33.49 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.274 1.03 . . . . 0.0 113.07 -170.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.38 138.16 32.81 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 110.787 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.79 107.16 5.01 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.937 1.295 . . . . 0.0 112.23 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 125.898 1.679 . . . . 0.0 111.009 173.38 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.081 0 CA-C-O 120.016 -0.324 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.6 m -147.38 145.3 29.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.698 1.199 . . . . 0.0 111.438 -173.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -137.41 126.49 24.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.915 1.286 . . . . 0.0 111.735 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -93.45 126.85 38.81 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.052 1.341 . . . . 0.0 109.795 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.9 t -131.24 136.09 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.554 1.542 . . . . 0.0 110.164 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -118.05 98.85 6.53 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.212 1.805 . . . . 0.0 108.779 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -75.86 158.73 31.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.474 1.51 . . . . 0.0 111.938 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -70.41 -27.32 64.19 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.774 -0.579 . . . . 0.0 112.296 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -142.91 135.0 27.18 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.564 1.546 . . . . 0.0 112.674 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -53.87 -40.5 66.62 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.48 2.312 . . . . 0.0 112.518 170.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.33 -47.44 62.68 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.281 1.032 . . . . 0.0 112.656 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -71.26 -38.01 71.92 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.275 -0.89 . . . . 0.0 112.937 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.67 -47.08 74.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.77 0.828 . . . . 0.0 111.834 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.1 -48.12 79.4 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.382 1.473 . . . . 0.0 113.036 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -52.28 -53.33 45.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.264 1.026 . . . . 0.0 111.842 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.03 -50.34 69.32 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.199 0.999 . . . . 0.0 112.445 174.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -53.03 -63.15 1.24 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.137 1.775 . . . . 0.0 111.506 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -59.99 -36.85 78.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.693 0.797 . . . . 0.0 113.026 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -66.89 -52.16 46.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.747 1.219 . . . . 0.0 112.857 176.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -96.17 -16.3 21.56 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 -169.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -59.32 109.74 0.94 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 120.154 1.343 . . . . 0.0 111.178 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 113.25 -24.74 12.1 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 126.254 1.883 . . . . 0.0 114.231 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.35 133.69 89.22 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.873 1.269 . . . . 0.0 110.66 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.68 148.88 33.27 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.946 2.431 . . . . 0.0 113.12 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 42.2 tp -128.87 94.73 3.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.4 1.88 . . . . 0.0 109.194 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 46.56 50.65 12.68 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.442 1.897 . . . . 0.0 112.931 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 114.94 -78.3 0.27 Allowed Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.065 1.793 . . . . 0.0 112.779 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.35 135.7 75.99 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 126.328 1.851 . . . . 0.0 113.351 -176.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.06 126.83 10.85 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.096 2.531 . . . . 0.0 111.207 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.5 mtm -63.66 128.72 37.09 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.613 0.765 . . . . 0.0 110.135 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -116.61 119.91 37.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.341 1.056 . . . . 0.0 109.502 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -117.55 139.93 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.198 0.999 . . . . 0.0 111.749 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -131.27 144.54 51.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.93 2.092 . . . . 0.0 110.539 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.0 tp . . . . . 0 CA--C 1.545 0.754 0 C-N-CA 124.591 1.157 . . . . 0.0 110.426 175.812 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.172 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.01 154.65 44.21 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.625 1.712 . . . . 0.0 114.29 -178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.8 mt -120.97 118.69 30.51 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.86 2.064 . . . . 0.0 110.43 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.7 tp -82.45 109.04 16.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.0 t -92.22 83.26 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.103 1.761 . . . . 0.0 107.707 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.3 m -80.25 155.3 27.39 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.727 0.811 . . . . 0.0 112.101 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.28 79.12 0.23 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.762 2.025 . . . . 0.0 113.0 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -127.91 144.97 51.09 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.281 2.232 . . . . 0.0 109.641 171.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -77.2 151.39 35.24 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.84 -0.538 . . . . 0.0 112.358 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -57.87 -24.28 56.87 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.905 0.882 . . . . 0.0 113.337 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.85 -15.48 78.17 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 125.151 1.358 . . . . 0.0 115.792 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.21 123.21 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.585 1.693 . . . . 0.0 110.925 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 54.4 m -77.95 146.48 35.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.771 1.228 . . . . 0.0 111.982 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.78 -52.46 65.62 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.869 0.867 . . . . 0.0 112.013 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.28 62.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.753 1.221 . . . . 0.0 113.363 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.08 -55.51 34.13 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.978 0.911 . . . . 0.0 112.285 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.6 mm -55.8 -53.31 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.882 1.273 . . . . 0.0 111.082 172.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -48.97 -55.77 10.89 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.134 1.774 . . . . 0.0 111.696 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.61 -49.32 75.69 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.626 1.17 . . . . 0.0 113.379 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.23 -44.62 94.74 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.81 1.186 . . . . 0.0 112.204 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -62.09 -41.91 98.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.724 0.693 . . . . 0.0 112.227 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.29 -15.72 62.81 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.21 -60.1 2.4 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.878 -1.139 . . . . 0.0 111.533 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -81.31 -31.34 33.59 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.88 -177.57 15.23 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.644 1.592 . . . . 0.0 113.104 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.5 m -124.52 122.74 38.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.763 1.225 . . . . 0.0 110.057 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -132.37 146.94 52.33 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -78.49 -49.13 13.95 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.514 2.325 . . . . 0.0 110.986 171.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -148.12 146.11 28.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.49 1.516 . . . . 0.0 112.298 -170.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -132.47 139.67 48.07 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.245 1.818 . . . . 0.0 109.37 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.25 100.06 3.41 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.482 1.513 . . . . 0.0 111.695 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 N--CA 1.48 1.03 0 C-N-CA 125.253 1.421 . . . . 0.0 110.709 171.224 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.49 0 CA-C-O 121.494 0.496 . . . . 0.0 113.053 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.7 m -160.48 158.68 29.75 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.476 2.71 . . . . 0.0 108.473 -171.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.17 166.49 21.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.5 1.12 . . . . 0.0 112.651 174.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -125.52 129.49 49.86 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.541 1.936 . . . . 0.0 109.396 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.98 115.06 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.681 1.192 . . . . 0.0 109.058 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -100.57 112.65 25.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.579 1.551 . . . . 0.0 109.647 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -84.23 163.45 19.68 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.076 2.55 . . . . 0.0 113.29 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.5 -45.04 89.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.795 0.838 . . . . 0.0 111.653 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.4 mmt-85 -137.88 141.76 40.68 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.706 1.602 . . . . 0.0 111.328 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -60.09 -34.3 73.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.764 1.626 . . . . 0.0 113.284 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.88 -51.36 69.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.247 1.019 . . . . 0.0 112.243 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.63 -40.68 95.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.004 0.921 . . . . 0.0 112.083 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.17 -54.59 37.7 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.389 1.075 . . . . 0.0 112.007 170.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 67.4 tp -53.28 -49.93 65.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.173 1.389 . . . . 0.0 112.783 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -53.03 -51.43 61.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.001 1.32 . . . . 0.0 112.173 175.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.08 78.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.012 0.925 . . . . 0.0 112.755 172.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 4.7 ttp -54.01 -58.06 8.7 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.945 1.298 . . . . 0.0 112.017 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -33.67 73.37 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -68.23 -45.01 74.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.293 1.037 . . . . 0.0 113.159 176.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -103.7 -13.35 16.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -169.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -60.13 109.78 1.05 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.225 1.375 . . . . 0.0 112.04 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.32 -17.82 39.77 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.993 1.759 . . . . 0.0 114.586 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.98 132.71 86.43 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 118.854 1.327 . . . . 0.0 110.372 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.04 142.25 19.42 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.822 2.348 . . . . 0.0 112.804 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 61.2 tp -135.35 115.67 13.49 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.063 1.745 . . . . 0.0 108.448 169.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 49.24 57.64 6.26 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.364 1.465 . . . . 0.0 111.222 -169.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.68 -56.49 4.75 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.402 1.477 . . . . 0.0 113.303 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -58.15 117.51 20.36 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 127.349 2.259 . . . . 0.0 113.835 -173.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -60.02 118.21 5.06 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.356 2.704 . . . . 0.0 110.879 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.7 mtm -70.16 116.59 10.69 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.78 0.832 . . . . 0.0 110.862 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.99 94.72 9.41 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.076 0.951 . . . . 0.0 108.806 174.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.6 mm -86.34 129.18 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.323 0.649 . . . . 0.0 109.986 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -125.21 115.53 20.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.96 1.304 . . . . 0.0 111.0 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 CA--C 1.538 0.486 0 C-N-CA 125.64 1.576 . . . . 0.0 110.755 171.224 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.235 0 CA-C-O 121.829 0.683 . . . . 0.0 114.788 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -149.59 133.0 16.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.514 1.926 . . . . 0.0 109.808 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -137.79 105.27 5.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.935 1.694 . . . . 0.0 109.577 -170.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.9 tp -90.2 137.94 31.93 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.753 2.021 . . . . 0.0 110.039 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -130.61 127.48 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.918 1.287 . . . . 0.0 109.578 174.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.9 m -128.1 174.41 9.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.222 1.809 . . . . 0.0 110.872 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.2 t30 58.57 38.31 25.32 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.394 1.478 . . . . 0.0 112.467 -172.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.3 mt -88.73 -155.1 0.32 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.56 1.544 . . . . 0.0 109.497 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -138.96 151.7 47.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.543 1.537 . . . . 0.0 110.883 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -53.46 -24.61 13.32 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.74 -23.54 65.42 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 125.382 1.468 . . . . 0.0 115.234 172.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.35 141.54 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 118.906 1.353 . . . . 0.0 110.523 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 61.6 m -133.1 161.1 35.29 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.68 1.592 . . . . 0.0 111.788 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -53.86 -57.36 11.21 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.881 0.872 . . . . 0.0 113.2 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.61 72.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.828 0.851 . . . . 0.0 113.248 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.01 -55.56 33.41 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.066 0.946 . . . . 0.0 111.855 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.6 mm -55.49 -54.82 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.027 1.331 . . . . 0.0 111.227 172.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -47.9 -56.98 6.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.672 1.989 . . . . 0.0 111.441 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.06 -49.97 73.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.462 1.105 . . . . 0.0 113.259 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -62.41 -44.54 96.18 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.475 1.034 . . . . 0.0 112.07 -175.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -63.88 -43.47 95.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.412 0.685 . . . . 0.0 112.624 173.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.7 -20.93 62.26 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.58 -60.16 2.97 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.076 -1.015 . . . . 0.0 112.019 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -89.63 -21.33 22.86 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -174.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -134.7 -176.9 14.59 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.658 1.599 . . . . 0.0 112.885 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -127.38 129.17 47.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.279 1.032 . . . . 0.0 110.497 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.7 144.77 47.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.627 1.171 . . . . 0.0 113.801 -169.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -73.54 -50.57 20.67 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.938 2.095 . . . . 0.0 110.62 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -150.46 158.62 44.35 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.592 1.157 . . . . 0.0 112.87 -173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.43 155.69 46.88 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.005 1.722 . . . . 0.0 111.089 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.83 154.77 38.95 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.239 2.216 . . . . 0.0 110.672 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.9 t . . . . . 0 N--CA 1.48 1.047 0 C-N-CA 126.225 1.81 . . . . 0.0 110.401 -176.179 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.816 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 m -123.96 145.8 48.92 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.155 1.782 . . . . 0.0 110.969 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.68 150.94 46.73 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.867 2.067 . . . . 0.0 110.339 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -143.28 121.46 12.21 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.42 1.488 . . . . 0.0 110.028 -173.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 52.7 t -122.4 118.39 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.173 1.389 . . . . 0.0 109.514 -173.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -88.53 95.47 10.25 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -69.03 160.49 30.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.543 1.937 . . . . 0.0 112.957 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.78 -51.8 68.18 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.629 -0.669 . . . . 0.0 111.705 169.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.53 148.34 45.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.436 1.494 . . . . 0.0 112.523 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.89 -32.41 71.87 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.58 -49.73 76.37 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.109 0.964 . . . . 0.0 112.459 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.76 -37.91 89.2 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.12 0.968 . . . . 0.0 111.979 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.22 -46.61 85.56 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.874 0.87 . . . . 0.0 112.037 169.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.95 -49.98 72.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.479 1.512 . . . . 0.0 111.493 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -50.08 -54.33 21.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.46 1.504 . . . . 0.0 111.677 174.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.2 75.64 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.29 1.036 . . . . 0.0 112.803 173.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -54.76 -63.26 1.21 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.675 1.19 . . . . 0.0 111.422 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -59.57 -32.77 70.67 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -64.49 -51.09 64.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.693 1.197 . . . . 0.0 113.148 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -106.89 -11.07 15.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -169.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -61.86 117.1 5.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.341 1.428 . . . . 0.0 111.857 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 92.59 -12.44 69.77 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.025 1.298 . . . . 0.0 114.83 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 64.7 t -66.94 135.24 94.08 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 119.205 1.502 . . . . 0.0 109.858 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.3 145.97 31.06 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.793 2.329 . . . . 0.0 112.724 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.5 tp -122.27 92.5 3.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.259 1.824 . . . . 0.0 108.992 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 47.65 50.05 15.62 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.287 1.835 . . . . 0.0 112.715 -169.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 116.07 -75.62 0.27 Allowed Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.114 1.816 . . . . 0.0 112.885 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.61 131.81 85.64 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 126.264 1.826 . . . . 0.0 113.549 -175.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.13 130.09 13.86 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.256 2.638 . . . . 0.0 111.683 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -68.28 114.59 6.88 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.426 1.09 . . . . 0.0 111.401 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -86.16 103.35 14.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.224 1.009 . . . . 0.0 109.349 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.3 mt -99.96 137.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.832 0.853 . . . . 0.0 111.516 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -133.26 152.17 51.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.0 2.52 . . . . 0.0 110.671 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 123.969 0.908 . . . . 0.0 113.274 -169.737 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -134.13 133.62 41.25 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.457 1.129 . . . . 0.0 111.561 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.7 mt -117.04 120.01 37.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.995 1.718 . . . . 0.0 111.302 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.0 tp -84.22 129.29 34.9 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 t -119.4 137.84 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.888 1.275 . . . . 0.0 109.215 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.3 m -136.73 165.99 24.63 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.123 2.169 . . . . 0.0 111.416 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.7 t30 52.95 59.63 4.33 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.493 1.917 . . . . 0.0 113.119 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.9 mt -109.7 147.72 32.65 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.247 1.819 . . . . 0.0 107.92 169.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -78.6 156.43 29.12 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.286 -0.884 . . . . 0.0 112.595 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -52.35 -34.48 47.69 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.702 1.201 . . . . 0.0 112.472 169.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.86 -7.34 87.44 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.217 1.389 . . . . 0.0 116.31 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.93 119.09 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.903 1.852 . . . . 0.0 110.492 177.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.7 m -78.82 147.53 33.2 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.055 1.342 . . . . 0.0 112.844 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.21 -53.62 55.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.471 1.508 . . . . 0.0 112.807 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.17 79.11 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.407 1.083 . . . . 0.0 113.189 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.41 -52.32 66.1 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.934 0.894 . . . . 0.0 112.211 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.8 mm -55.89 -51.81 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.39 1.076 . . . . 0.0 111.342 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -50.48 -54.51 21.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.202 1.001 . . . . 0.0 111.952 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.46 -50.9 72.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.68 1.192 . . . . 0.0 113.32 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.52 -44.75 89.88 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.549 1.068 . . . . 0.0 112.743 -174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -62.62 -39.81 94.98 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.904 0.774 . . . . 0.0 112.209 173.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.25 -2.72 11.32 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 174.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.47 -62.04 1.69 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.819 -1.176 . . . . 0.0 110.779 170.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -76.82 -19.66 57.27 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -139.45 -162.42 9.11 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.442 1.496 . . . . 0.0 111.94 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.08 136.93 42.39 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 118.104 0.952 . . . . 0.0 111.709 175.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.89 147.17 46.3 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.548 1.139 . . . . 0.0 113.472 -170.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.21 -46.54 20.16 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.391 2.276 . . . . 0.0 111.291 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -149.25 145.71 27.23 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.474 1.11 . . . . 0.0 112.611 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.63 143.47 50.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.265 1.826 . . . . 0.0 110.194 169.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.38 99.9 3.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.441 1.496 . . . . 0.0 111.542 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.7 t . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 125.699 1.6 . . . . 0.0 111.59 175.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.392 0 CA-C-O 121.231 0.35 . . . . 0.0 113.823 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 81.8 p -142.09 172.65 12.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.762 2.425 . . . . 0.0 112.003 -173.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.08 164.4 38.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.893 1.277 . . . . 0.0 111.584 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -131.2 126.2 34.95 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.999 1.72 . . . . 0.0 109.503 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.85 114.07 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.175 0.99 . . . . 0.0 110.938 -171.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -89.94 104.24 16.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.919 1.687 . . . . 0.0 109.901 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -77.42 150.63 35.0 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.683 2.793 . . . . 0.0 113.108 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -61.84 -36.91 82.59 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 47.1 mtm-85 -135.79 129.67 32.85 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.724 2.01 . . . . 0.0 110.088 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -66.23 -29.86 70.2 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.93 75.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.965 0.906 . . . . 0.0 111.796 170.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -62.73 -39.16 93.2 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.861 1.264 . . . . 0.0 112.137 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.16 37.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.561 1.145 . . . . 0.0 112.068 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 64.9 tp -52.98 -48.55 67.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.261 1.424 . . . . 0.0 112.116 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -51.89 -59.58 4.16 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.534 1.533 . . . . 0.0 111.47 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.52 -48.78 62.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.909 1.283 . . . . 0.0 112.618 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.7 ttp -53.58 -61.83 2.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.296 1.438 . . . . 0.0 111.492 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -62.04 -35.52 78.84 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.94 -56.23 14.52 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.477 1.111 . . . . 0.0 113.181 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -91.9 -13.85 30.57 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -168.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -61.2 107.3 0.73 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.104 1.32 . . . . 0.0 110.531 169.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 114.51 -24.2 11.48 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.306 1.908 . . . . 0.0 114.311 -174.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.83 133.85 86.16 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.765 1.226 . . . . 0.0 110.694 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.3 142.66 21.52 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.846 2.364 . . . . 0.0 113.245 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 42.1 tp -133.76 110.08 9.56 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.779 2.032 . . . . 0.0 108.13 169.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 47.63 60.17 3.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.491 1.517 . . . . 0.0 111.731 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.93 -55.96 5.05 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.177 1.37 . . . . 0.0 113.302 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -59.33 121.78 58.86 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.067 1.747 . . . . 0.0 112.978 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 117.56 5.1 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.492 2.128 . . . . 0.0 110.177 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -64.17 133.43 52.89 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.44 1.096 . . . . 0.0 111.128 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -109.53 124.48 51.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.154 0.981 . . . . 0.0 109.804 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.8 mt -127.13 137.84 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.974 1.31 . . . . 0.0 110.924 -170.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -138.95 123.02 17.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.802 1.641 . . . . 0.0 111.331 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 42.5 tp . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.972 1.309 . . . . 0.0 111.25 171.671 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -147.89 126.89 12.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.099 1.449 . . . . 0.0 111.774 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.7 121.14 44.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.438 1.495 . . . . 0.0 111.608 174.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.0 tp -81.73 128.79 34.35 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 168.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.07 135.81 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.987 1.315 . . . . 0.0 108.388 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.55 170.37 16.19 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.525 1.53 . . . . 0.0 111.43 -176.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.2 t30 56.0 42.5 28.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.503 1.521 . . . . 0.0 112.611 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.0 mt -81.82 150.91 27.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.842 0.857 . . . . 0.0 110.03 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.07 140.26 35.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.513 0.725 . . . . 0.0 111.689 174.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -67.86 88.92 0.27 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.29 1.043 . . . . 0.0 109.539 170.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 156.93 -25.64 0.49 Allowed Glycine 0 CA--C 1.538 1.483 0 C-N-CA 127.073 2.273 . . . . 0.0 112.56 -169.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.1 t -58.3 118.01 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.87 1.268 . . . . 0.0 109.931 170.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 64.7 m -77.44 145.41 37.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.915 0.886 . . . . 0.0 112.714 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.28 -53.34 58.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.376 1.47 . . . . 0.0 112.633 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.18 87.5 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.44 1.096 . . . . 0.0 113.027 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.16 -47.96 83.75 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.622 0.769 . . . . 0.0 112.1 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mm -54.53 -53.19 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.903 0.881 . . . . 0.0 111.063 169.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -52.03 -54.0 35.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.485 0.584 . . . . 0.0 112.265 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.14 -50.72 72.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.712 1.205 . . . . 0.0 113.307 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.59 -45.46 90.28 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.122 0.874 . . . . 0.0 111.928 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -62.8 -44.36 96.37 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.573 0.624 . . . . 0.0 112.384 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.35 -31.52 65.81 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.82 -48.37 81.54 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.305 1.042 . . . . 0.0 112.666 174.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -101.43 -17.16 16.6 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -173.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -141.16 157.43 26.03 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 119.613 1.097 . . . . 0.0 114.25 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.6 m -96.55 109.46 22.05 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.98 1.312 . . . . 0.0 109.736 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.0 143.3 50.02 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.673 1.189 . . . . 0.0 114.001 -169.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.2 -48.64 19.66 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.686 2.394 . . . . 0.0 110.29 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -148.28 147.78 29.71 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.291 1.437 . . . . 0.0 111.933 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.34 122.14 13.5 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.23 1.412 . . . . 0.0 109.795 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.08 138.5 26.71 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.868 0.867 . . . . 0.0 112.671 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 N--CA 1.477 0.905 0 C-N-CA 126.417 1.887 . . . . 0.0 111.082 -174.757 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.336 0 N-CA-C 113.66 0.224 . . . . 0.0 113.66 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.3 p -136.39 167.74 20.77 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.568 1.947 . . . . 0.0 112.006 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.16 170.35 18.63 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.928 -1.108 . . . . 0.0 111.423 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -136.2 121.64 19.39 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.156 1.782 . . . . 0.0 108.676 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.0 t -120.46 114.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.469 1.108 . . . . 0.0 108.925 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -100.33 111.19 23.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.918 2.087 . . . . 0.0 108.719 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -92.12 167.25 12.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.49 2.716 . . . . 0.0 113.165 -174.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -61.98 -54.13 45.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.741 0.816 . . . . 0.0 111.139 169.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -141.02 147.29 38.45 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.06 1.744 . . . . 0.0 112.038 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -54.43 -30.35 52.31 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.894 1.678 . . . . 0.0 114.211 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.7 -55.1 36.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.418 1.087 . . . . 0.0 112.496 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.44 -36.15 80.63 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.638 -0.664 . . . . 0.0 112.303 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.76 -54.91 38.63 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.246 1.018 . . . . 0.0 111.891 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.7 mt -53.99 -47.68 71.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.125 1.37 . . . . 0.0 112.505 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -50.68 -58.35 6.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.95 1.3 . . . . 0.0 111.534 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.87 -49.1 69.25 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.727 1.211 . . . . 0.0 112.628 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 53.4 ttp -53.22 -59.26 4.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.511 1.524 . . . . 0.0 111.779 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -25.53 68.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -75.0 -48.77 22.45 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.983 0.913 . . . . 0.0 113.195 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -102.37 -11.59 18.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 -169.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -59.06 116.7 4.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.028 1.285 . . . . 0.0 111.403 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 100.89 -13.3 59.15 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.788 1.661 . . . . 0.0 114.732 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.7 t -71.47 128.58 89.82 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 119.258 1.529 . . . . 0.0 110.945 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.52 136.87 77.03 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.882 3.054 . . . . 0.0 114.375 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 35.5 tp -139.49 110.57 6.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.861 1.664 . . . . 0.0 108.344 169.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 49.54 60.5 3.74 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.439 1.496 . . . . 0.0 111.536 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.31 -63.64 4.39 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.136 1.351 . . . . 0.0 113.147 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.33 134.78 94.68 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.902 1.281 . . . . 0.0 112.804 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.51 127.14 12.19 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.31 2.673 . . . . 0.0 111.714 172.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -66.02 117.61 8.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.62 1.168 . . . . 0.0 112.094 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -85.49 115.67 23.35 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.2 mt -120.83 132.0 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.643 1.177 . . . . 0.0 110.668 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -144.63 124.77 13.67 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.435 1.494 . . . . 0.0 112.139 -169.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 12.2 tp . . . . . 0 CA--C 1.541 0.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.81 169.716 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -92.48 83.98 5.04 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.123 0.961 . . . . 0.0 109.907 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -80.46 128.7 33.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.19 2.196 . . . . 0.0 109.114 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.6 tp -121.32 109.75 15.29 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.643 1.577 . . . . 0.0 110.307 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.4 138.71 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.57 1.548 . . . . 0.0 109.11 170.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.6 m -139.06 168.38 19.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.988 2.115 . . . . 0.0 111.494 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.7 t30 55.69 41.39 30.48 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.311 1.845 . . . . 0.0 113.147 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.81 154.73 31.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.286 1.034 . . . . 0.0 110.314 169.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.61 144.98 55.29 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.524 -0.735 . . . . 0.0 111.197 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -73.11 68.99 1.0 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.732 1.213 . . . . 0.0 110.795 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.36 -11.86 0.06 OUTLIER Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.745 1.64 . . . . 0.0 115.587 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.05 119.87 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.72 1.76 . . . . 0.0 110.642 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -72.0 140.62 49.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.255 1.022 . . . . 0.0 112.893 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.85 -47.18 86.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.845 1.258 . . . . 0.0 112.501 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.96 -45.6 74.95 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.461 1.104 . . . . 0.0 112.694 172.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.95 -47.91 84.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.825 0.85 . . . . 0.0 111.991 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mm -53.46 -53.79 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.523 1.129 . . . . 0.0 111.921 170.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -50.7 -57.23 8.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.543 0.737 . . . . 0.0 111.222 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -56.0 -50.46 70.79 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.299 1.04 . . . . 0.0 113.16 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.69 -48.56 71.65 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.995 0.816 . . . . 0.0 112.23 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -63.82 -41.34 97.88 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.78 0.718 . . . . 0.0 112.664 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.58 -10.48 52.29 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -75.42 -60.97 2.07 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.863 -1.148 . . . . 0.0 111.314 172.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -81.26 -30.18 34.16 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.83 -169.76 13.21 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.722 1.63 . . . . 0.0 112.568 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 m -136.94 123.88 21.42 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.587 -0.949 . . . . 0.0 111.703 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 pp -128.63 145.84 51.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.235 1.414 . . . . 0.0 113.439 -170.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -82.48 -47.31 12.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.914 2.086 . . . . 0.0 111.298 173.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -145.89 149.98 35.27 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.391 1.076 . . . . 0.0 112.324 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.58 147.64 37.99 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.054 1.342 . . . . 0.0 111.599 169.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.58 109.58 4.3 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.457 1.503 . . . . 0.0 111.776 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.478 0.935 0 C-N-CA 124.742 1.217 . . . . 0.0 109.716 169.58 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 CA-C-O 120.527 -0.041 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.2 p -140.96 159.27 42.57 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.271 1.428 . . . . 0.0 111.773 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.87 119.59 11.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.714 1.205 . . . . 0.0 111.426 171.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.52 130.95 34.54 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.203 1.001 . . . . 0.0 109.965 172.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.19 117.66 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.681 1.593 . . . . 0.0 109.794 -174.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -87.96 101.23 13.55 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.931 0.892 . . . . 0.0 109.382 171.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -74.29 153.76 39.23 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.984 2.114 . . . . 0.0 112.015 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -62.66 -37.15 85.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 91.1 mmt-85 -141.26 141.21 33.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.51 1.524 . . . . 0.0 111.854 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -58.42 -42.9 88.29 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.572 1.549 . . . . 0.0 113.114 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.23 -51.8 61.0 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.191 0.997 . . . . 0.0 112.697 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.15 -42.28 99.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.195 0.998 . . . . 0.0 112.572 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.5 -47.22 79.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.318 1.047 . . . . 0.0 112.672 170.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.64 -46.99 88.2 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.567 1.547 . . . . 0.0 111.773 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -50.94 -56.44 12.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.818 1.247 . . . . 0.0 111.412 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.49 -50.98 61.66 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.22 1.008 . . . . 0.0 112.599 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 31.2 ttp -52.8 -62.43 1.65 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.754 1.622 . . . . 0.0 111.673 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -62.95 -37.33 86.62 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -65.09 -54.46 29.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.639 1.176 . . . . 0.0 112.557 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -90.59 -14.77 31.81 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -169.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.1 109.32 0.82 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 120.101 1.318 . . . . 0.0 110.923 169.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 116.74 -28.84 7.19 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 126.461 1.982 . . . . 0.0 113.923 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.12 134.2 85.38 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.121 1.368 . . . . 0.0 110.737 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.64 141.74 25.19 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.944 2.429 . . . . 0.0 112.721 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.2 tp -137.08 111.68 8.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.762 1.625 . . . . 0.0 108.734 169.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 50.69 60.16 4.06 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.756 1.622 . . . . 0.0 111.489 -169.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.01 -63.74 4.39 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.1 1.333 . . . . 0.0 113.195 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -63.91 135.03 96.13 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.737 1.215 . . . . 0.0 112.659 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.66 123.63 9.59 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.404 2.736 . . . . 0.0 111.105 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.7 mtm -62.88 129.77 41.88 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.076 0.95 . . . . 0.0 111.214 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -109.12 125.44 52.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.638 1.175 . . . . 0.0 108.291 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.29 138.64 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 118.823 0.738 . . . . 0.0 111.904 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -131.37 153.91 49.16 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.334 2.654 . . . . 0.0 109.978 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.8 tp . . . . . 0 N--CA 1.469 0.5 0 C-N-CA 124.839 1.256 . . . . 0.0 111.041 179.147 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -137.76 136.62 37.46 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.909 0.855 . . . . 0.0 112.671 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.76 141.05 44.43 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.129 0.972 . . . . 0.0 110.9 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.7 tp -110.67 115.51 29.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.917 2.087 . . . . 0.0 106.717 169.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.89 135.26 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.436 1.095 . . . . 0.0 110.017 -169.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 55.0 m -139.23 161.86 36.39 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.061 1.745 . . . . 0.0 112.246 -174.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.4 t30 51.11 43.26 29.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.294 2.238 . . . . 0.0 114.658 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.1 mt -78.69 164.87 24.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.264 1.426 . . . . 0.0 108.862 168.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.08 159.48 33.53 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.717 -1.239 . . . . 0.0 112.633 169.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -64.55 -41.4 96.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.585 1.554 . . . . 0.0 112.629 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.6 53.04 2.7 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.48 1.514 . . . . 0.0 112.791 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.5 t -116.11 113.74 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 126.038 1.735 . . . . 0.0 109.795 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -72.8 142.29 48.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.242 1.017 . . . . 0.0 112.26 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -56.65 -54.94 40.32 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.468 1.507 . . . . 0.0 112.316 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.31 -34.94 74.5 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.371 1.068 . . . . 0.0 113.567 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.48 -52.74 63.24 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.324 0.965 . . . . 0.0 111.465 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.1 mm -55.0 -52.7 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.343 1.057 . . . . 0.0 110.899 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -50.78 -56.29 12.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.976 0.91 . . . . 0.0 112.105 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -60.14 -48.22 82.62 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.106 1.362 . . . . 0.0 112.963 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -46.61 81.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.415 1.007 . . . . 0.0 112.121 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -60.6 -40.83 93.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.884 0.765 . . . . 0.0 112.048 173.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.5 -6.22 18.67 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -77.35 -59.83 2.62 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.755 -1.216 . . . . 0.0 111.231 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -84.46 -25.54 28.86 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -121.81 -179.58 16.02 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.657 1.599 . . . . 0.0 112.274 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.4 m -123.85 118.58 27.44 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.819 1.247 . . . . 0.0 110.223 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.76 165.08 26.76 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -169.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -93.25 -58.19 2.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.743 2.017 . . . . 0.0 111.176 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -157.93 142.67 16.42 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.408 1.083 . . . . 0.0 113.369 -172.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -105.64 155.71 18.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.658 1.183 . . . . 0.0 111.67 169.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -144.08 88.25 1.95 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.201 1.8 . . . . 0.0 110.1 173.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.476 0.857 0 C-N-CA 125.589 1.556 . . . . 0.0 110.743 178.091 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 CA-C-O 120.365 -0.131 . . . . 0.0 113.232 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.3 p -141.64 164.17 30.94 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.095 1.758 . . . . 0.0 110.967 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.1 167.26 30.44 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.231 -0.918 . . . . 0.0 112.693 169.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -130.84 132.73 45.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.417 1.887 . . . . 0.0 108.717 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.8 t -135.38 109.01 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 118.93 0.786 . . . . 0.0 111.148 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -73.84 123.35 24.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.118 1.367 . . . . 0.0 110.31 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.0 161.02 17.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.9 2.48 . . . . 0.0 112.92 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -59.19 -48.28 82.21 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.844 0.858 . . . . 0.0 112.577 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -143.2 152.73 42.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.364 1.866 . . . . 0.0 110.471 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -59.92 -43.94 94.62 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.186 0.994 . . . . 0.0 112.631 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.83 -46.58 71.22 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.357 1.063 . . . . 0.0 112.905 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.58 -48.44 79.42 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.211 1.404 . . . . 0.0 111.648 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.01 -48.33 73.51 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.195 1.398 . . . . 0.0 112.637 172.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.9 tp -53.29 -42.03 66.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.734 1.614 . . . . 0.0 113.101 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -51.2 -59.94 3.65 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.502 1.121 . . . . 0.0 111.437 171.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.9 -48.88 69.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.273 1.429 . . . . 0.0 112.482 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 21.0 ttp -51.6 -61.34 2.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.011 1.724 . . . . 0.0 111.563 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -56.36 -45.86 80.26 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.461 1.504 . . . . 0.0 112.353 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -58.4 -51.18 70.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.49 1.116 . . . . 0.0 113.176 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -97.73 -16.62 19.82 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -172.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -58.33 109.26 0.74 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 120.332 1.424 . . . . 0.0 111.388 171.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.56 -26.5 8.06 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.278 1.894 . . . . 0.0 114.041 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.78 135.0 95.35 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.065 1.346 . . . . 0.0 111.044 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.33 134.19 15.41 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.923 2.416 . . . . 0.0 111.708 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 63.5 tp -125.13 102.13 7.34 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.351 1.86 . . . . 0.0 108.196 175.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 44.32 62.04 2.16 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.005 1.722 . . . . 0.0 111.763 -169.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.83 -60.88 4.42 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.105 1.336 . . . . 0.0 112.995 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -60.46 118.94 38.76 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.858 1.663 . . . . 0.0 111.993 -172.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.07 118.85 5.82 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.902 2.401 . . . . 0.0 111.354 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.9 mtp -59.74 137.95 57.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.652 1.581 . . . . 0.0 112.013 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -121.08 131.51 54.31 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.731 1.212 . . . . 0.0 110.11 170.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.3 mt -131.07 137.35 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.258 1.023 . . . . 0.0 111.065 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -130.29 171.76 12.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 129.34 3.056 . . . . 0.0 109.912 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 171.527 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 CA-C-O 120.08 -0.289 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -83.53 99.33 10.07 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.057 0.928 . . . . 0.0 111.004 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 76.1 mt -75.83 108.83 8.96 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.682 1.193 . . . . 0.0 110.19 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.4 tp -80.66 125.21 29.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.784 1.233 . . . . 0.0 107.8 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.32 131.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.376 1.07 . . . . 0.0 109.135 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.7 m -135.01 168.8 18.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.763 1.625 . . . . 0.0 111.728 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.2 t30 51.65 56.5 7.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.059 1.744 . . . . 0.0 112.438 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.8 mt -101.12 151.7 21.51 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.297 1.839 . . . . 0.0 110.94 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -69.22 142.05 54.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.776 -0.577 . . . . 0.0 110.937 169.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -62.34 -16.84 56.79 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -78.43 -13.44 83.23 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.413 1.482 . . . . 0.0 115.092 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 80.4 t -66.47 136.34 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 119.26 1.53 . . . . 0.0 109.997 172.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 65.4 m -140.9 169.21 18.04 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.551 1.54 . . . . 0.0 112.355 -175.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -46.34 -58.1 4.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.703 2.001 . . . . 0.0 113.693 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.89 -49.45 71.18 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.989 0.916 . . . . 0.0 112.813 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.1 -49.53 76.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.728 1.211 . . . . 0.0 112.31 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mm -54.19 -55.55 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.839 1.255 . . . . 0.0 111.349 171.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -53.19 -53.46 50.27 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.776 0.716 . . . . 0.0 111.685 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -54.51 -51.51 64.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.859 0.864 . . . . 0.0 113.058 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -49.57 72.6 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.857 0.753 . . . . 0.0 112.555 -176.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -67.09 -38.49 85.8 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.72 -20.22 64.69 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.33 -66.45 0.54 Allowed 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.959 -1.088 . . . . 0.0 110.751 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -85.56 -17.93 34.85 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -172.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.57 -159.79 8.49 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.429 1.49 . . . . 0.0 112.862 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.1 m -144.83 133.89 22.69 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.292 1.046 . . . . 0.0 110.996 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.59 146.81 52.19 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.892 1.277 . . . . 0.0 114.365 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -74.39 -52.32 12.46 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.441 1.896 . . . . 0.0 110.194 169.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -149.03 158.84 44.5 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.23 160.67 37.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.072 1.749 . . . . 0.0 110.847 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.89 149.42 23.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.329 1.852 . . . . 0.0 110.699 170.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.48 1.057 0 C-N-CA 123.976 0.91 . . . . 0.0 110.803 176.006 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.131 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.0 p -146.45 150.18 35.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.773 2.029 . . . . 0.0 111.258 -170.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.32 167.87 23.22 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.202 1.801 . . . . 0.0 112.511 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -132.93 131.4 40.8 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.83 2.052 . . . . 0.0 109.668 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.1 t -132.92 109.33 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.529 1.132 . . . . 0.0 109.644 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -90.63 98.98 12.1 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.253 1.421 . . . . 0.0 110.064 -176.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -73.3 155.18 39.72 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.284 1.834 . . . . 0.0 114.249 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -68.72 -45.48 71.44 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.419 1.488 . . . . 0.0 112.088 171.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 -122.38 124.04 42.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.176 1.79 . . . . 0.0 110.325 -169.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -58.6 -47.27 84.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.843 1.257 . . . . 0.0 112.176 175.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.18 -48.31 61.96 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.35 1.06 . . . . 0.0 112.783 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -67.46 -35.43 79.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.679 1.191 . . . . 0.0 112.557 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.31 -45.56 92.95 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.037 0.935 . . . . 0.0 112.353 170.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -53.8 -49.93 67.23 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.709 1.141 . . . . 0.0 111.607 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -51.59 -58.2 7.0 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.409 1.084 . . . . 0.0 111.353 174.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -50.09 -51.93 38.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.106 1.362 . . . . 0.0 112.663 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 60.9 ttp -53.63 -62.69 1.49 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.548 1.539 . . . . 0.0 111.5 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -62.49 -37.58 86.55 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -64.03 -51.04 66.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.234 1.413 . . . . 0.0 112.687 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -99.0 -14.17 19.59 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -169.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -58.83 112.61 1.71 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.154 1.343 . . . . 0.0 111.226 170.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.57 -23.25 26.81 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.054 1.788 . . . . 0.0 114.371 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.7 t -73.15 135.51 79.76 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.887 1.275 . . . . 0.0 110.393 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.53 142.92 26.86 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.952 2.435 . . . . 0.0 113.068 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.5 tp -131.82 106.27 7.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.838 1.655 . . . . 0.0 107.852 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 50.65 61.22 3.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.755 1.622 . . . . 0.0 111.377 -169.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.53 -62.95 4.21 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.135 1.35 . . . . 0.0 113.311 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -65.43 128.49 93.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.844 1.258 . . . . 0.0 112.392 -172.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.91 122.92 9.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.725 2.95 . . . . 0.0 111.897 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.4 mtm -63.18 126.06 26.15 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.065 1.346 . . . . 0.0 111.831 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -103.19 113.5 27.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.986 1.315 . . . . 0.0 109.191 172.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mt -118.37 134.69 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.552 1.141 . . . . 0.0 111.484 -169.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -136.94 153.72 50.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.335 2.254 . . . . 0.0 110.089 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.2 tp . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 124.842 1.257 . . . . 0.0 111.453 -176.381 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.87 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -132.74 152.21 51.8 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.079 0.943 . . . . 0.0 111.957 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -129.05 101.64 6.14 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.137 1.775 . . . . 0.0 108.208 -169.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.6 tp -84.45 133.36 34.49 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.14 1.376 . . . . 0.0 109.394 175.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.5 t -122.05 130.48 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.85 1.26 . . . . 0.0 108.944 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -115.19 159.73 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.968 1.707 . . . . 0.0 110.474 172.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.3 t30 60.74 71.66 0.56 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.307 1.843 . . . . 0.0 112.227 -169.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.5 mt -131.33 154.6 48.39 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.873 2.469 . . . . 0.0 108.964 169.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -88.63 151.27 22.57 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.72 -0.613 . . . . 0.0 112.364 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -58.2 -28.07 64.46 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.187 -0.945 . . . . 0.0 112.294 172.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.97 -17.08 65.0 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.052 1.31 . . . . 0.0 115.467 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.99 116.67 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.419 1.609 . . . . 0.0 110.453 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.5 m -76.31 151.24 36.78 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.698 1.199 . . . . 0.0 111.852 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.51 -50.34 74.11 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.608 -0.683 . . . . 0.0 112.243 172.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 -38.91 59.86 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.06 -56.37 23.17 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.29 1.036 . . . . 0.0 112.231 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 23.6 mm -56.1 -53.89 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.197 1.399 . . . . 0.0 111.157 173.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -47.3 -57.77 4.86 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.829 2.052 . . . . 0.0 111.47 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -59.92 -50.97 71.7 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.506 1.122 . . . . 0.0 113.122 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.6 -45.2 93.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.402 1.001 . . . . 0.0 112.149 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -63.22 -44.24 95.84 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.433 0.693 . . . . 0.0 112.415 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.13 -18.56 63.57 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -69.46 -60.14 2.52 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.818 -1.176 . . . . 0.0 111.834 173.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -85.44 -22.76 28.15 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.06 -167.31 11.2 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.681 1.61 . . . . 0.0 112.735 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.2 m -136.81 129.3 30.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.082 0.953 . . . . 0.0 111.078 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.8 pp -130.06 144.49 51.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.88 1.272 . . . . 0.0 113.376 -169.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -75.17 -50.17 17.13 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.913 2.085 . . . . 0.0 110.497 169.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.94 154.79 38.86 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.78 1.232 . . . . 0.0 112.132 -172.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -138.58 151.72 47.54 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.446 1.499 . . . . 0.0 111.541 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.12 159.21 44.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.678 1.991 . . . . 0.0 110.903 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 124.266 1.026 . . . . 0.0 110.818 -177.494 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 CA-C-O 121.11 0.283 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 37.0 p -142.01 167.71 21.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.67 1.988 . . . . 0.0 113.548 -169.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.7 157.11 43.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.725 2.01 . . . . 0.0 110.618 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -140.14 126.89 20.51 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.982 1.313 . . . . 0.0 110.212 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 52.2 t -122.34 116.03 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.813 1.245 . . . . 0.0 109.033 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -83.32 105.65 14.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.023 1.329 . . . . 0.0 108.19 173.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -82.08 153.33 26.16 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.423 2.289 . . . . 0.0 113.079 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.76 -34.01 77.19 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.987 0.915 . . . . 0.0 113.409 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -138.15 146.34 42.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.486 1.514 . . . . 0.0 113.295 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -64.18 -45.63 87.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.791 1.636 . . . . 0.0 111.782 172.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.03 -49.48 60.42 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.47 1.108 . . . . 0.0 112.265 171.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.35 -40.83 90.08 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.622 1.169 . . . . 0.0 112.792 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.37 -49.4 74.55 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.582 1.153 . . . . 0.0 112.419 170.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 54.6 tp -57.04 -49.76 74.82 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.352 1.461 . . . . 0.0 111.884 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -50.1 -52.85 31.44 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.354 1.461 . . . . 0.0 111.434 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.96 -50.86 69.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.017 0.927 . . . . 0.0 112.519 173.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -54.5 -60.23 3.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.376 1.07 . . . . 0.0 112.17 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -37.19 75.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -69.17 -43.83 73.45 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.161 0.984 . . . . 0.0 112.906 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -108.42 -8.41 15.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -169.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -58.46 116.43 3.64 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 120.054 1.297 . . . . 0.0 111.459 171.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.58 -21.54 44.72 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.869 1.7 . . . . 0.0 114.575 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.28 136.67 88.93 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 118.72 1.26 . . . . 0.0 110.451 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.8 143.57 29.95 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.725 2.284 . . . . 0.0 113.197 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -131.67 106.76 8.36 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.301 2.24 . . . . 0.0 107.015 171.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 48.0 61.67 2.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.336 1.454 . . . . 0.0 111.494 -169.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.39 -53.92 4.71 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.254 1.407 . . . . 0.0 113.483 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -59.47 119.17 37.35 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.522 1.929 . . . . 0.0 112.779 -174.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.54 120.73 7.65 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.619 2.212 . . . . 0.0 110.726 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.5 mtm -67.3 116.96 8.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.982 1.313 . . . . 0.0 112.13 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -89.59 101.43 14.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.264 1.025 . . . . 0.0 108.941 170.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.4 mt -103.89 139.81 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.275 1.03 . . . . 0.0 111.827 -170.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -134.27 126.61 30.13 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.415 1.886 . . . . 0.0 111.191 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 124.769 1.228 . . . . 0.0 109.874 169.647 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 N-CA-C 112.629 -0.188 . . . . 0.0 112.629 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -149.08 130.59 14.84 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.576 -0.955 . . . . 0.0 111.519 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 41.9 mt -119.43 121.24 39.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.018 1.727 . . . . 0.0 111.879 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.9 tp -86.05 116.01 24.0 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 168.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 49.1 t -101.83 131.05 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 108.134 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.2 m -138.78 167.84 21.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.762 1.625 . . . . 0.0 112.318 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.7 t30 52.84 46.88 25.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.005 1.722 . . . . 0.0 112.948 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.9 mt -90.76 164.34 14.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.766 1.227 . . . . 0.0 109.59 169.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.93 150.88 47.93 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.392 -0.817 . . . . 0.0 110.652 169.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -58.07 -20.82 42.48 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -128.78 39.76 1.81 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.879 1.228 . . . . 0.0 115.812 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.58 131.8 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.367 1.583 . . . . 0.0 109.276 169.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.1 m -69.92 138.92 52.81 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.487 0.715 . . . . 0.0 112.344 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.87 -52.16 66.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.068 1.347 . . . . 0.0 112.309 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.87 -40.47 80.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.98 1.312 . . . . 0.0 113.092 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.61 -52.35 65.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.9 0.88 . . . . 0.0 112.127 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.1 mm -55.11 -52.86 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.949 0.9 . . . . 0.0 111.266 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -51.89 -52.45 49.68 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.925 0.89 . . . . 0.0 112.294 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -60.43 -51.97 67.23 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.031 1.332 . . . . 0.0 113.27 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.19 -43.54 97.93 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.337 0.972 . . . . 0.0 112.22 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -62.16 -44.87 95.65 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.533 0.606 . . . . 0.0 112.022 172.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.69 -32.64 67.55 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.62 -47.3 86.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.198 0.999 . . . . 0.0 112.874 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -100.82 -15.86 17.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.92 155.1 25.75 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.641 1.115 . . . . 0.0 114.033 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.7 m -91.53 99.23 12.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.858 1.263 . . . . 0.0 110.006 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 pp -111.47 141.82 44.53 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.296 1.038 . . . . 0.0 113.742 -171.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -82.22 -46.25 13.97 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.153 2.581 . . . . 0.0 110.427 170.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -146.12 144.99 30.34 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.395 1.478 . . . . 0.0 111.481 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.62 121.96 11.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.378 1.471 . . . . 0.0 110.447 171.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.08 139.86 30.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.624 1.17 . . . . 0.0 112.704 -176.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.481 1.091 0 C-N-CA 126.363 1.865 . . . . 0.0 111.159 -173.461 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 N-CA-C 112.159 -0.377 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.9 p -144.16 163.53 33.34 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.759 1.623 . . . . 0.0 111.416 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.73 168.49 20.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.635 1.174 . . . . 0.0 111.405 170.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -135.18 118.81 17.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.162 1.785 . . . . 0.0 108.828 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.61 116.65 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.239 1.016 . . . . 0.0 110.093 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -101.83 124.93 48.29 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.643 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -103.23 154.7 19.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.951 2.9 . . . . 0.0 113.042 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -68.78 -29.75 68.19 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.905 1.282 . . . . 0.0 113.63 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -138.38 136.06 35.94 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.248 1.419 . . . . 0.0 113.018 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.41 -53.55 56.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.403 2.281 . . . . 0.0 112.449 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.44 -45.37 84.78 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.191 1.397 . . . . 0.0 112.415 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.83 -38.91 92.56 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.504 -0.748 . . . . 0.0 112.567 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.96 51.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.282 0.633 . . . . 0.0 111.337 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.26 -50.22 59.65 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.5 1.92 . . . . 0.0 112.334 174.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -50.68 -59.99 3.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.805 1.642 . . . . 0.0 111.206 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.65 -46.47 70.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.381 1.073 . . . . 0.0 112.393 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.5 ttp -52.83 -59.48 4.45 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.957 1.303 . . . . 0.0 111.839 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -55.53 -50.45 69.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.217 1.007 . . . . 0.0 112.273 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -59.03 -46.34 88.46 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.851 1.661 . . . . 0.0 113.115 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -100.81 -14.81 17.85 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -60.53 106.26 0.53 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.001 1.273 . . . . 0.0 111.178 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.33 -27.33 7.37 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 126.569 2.033 . . . . 0.0 114.087 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 64.2 t -68.88 132.77 90.43 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.06 1.344 . . . . 0.0 110.876 -174.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.1 145.87 22.32 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.902 2.401 . . . . 0.0 113.39 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.8 tt -130.5 108.18 9.76 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.111 2.165 . . . . 0.0 107.32 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 44.0 57.04 4.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.936 1.694 . . . . 0.0 112.048 -169.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 87.9 -51.12 4.03 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.985 1.278 . . . . 0.0 113.706 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -62.8 119.38 50.77 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.54 1.536 . . . . 0.0 111.448 -174.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.29 118.55 5.74 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.831 2.354 . . . . 0.0 110.924 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.61 127.34 31.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.091 0.956 . . . . 0.0 110.957 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -100.78 131.11 46.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.524 1.13 . . . . 0.0 109.036 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.1 mm -124.1 135.51 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.788 0.835 . . . . 0.0 109.946 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.22 117.76 19.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.344 1.458 . . . . 0.0 110.674 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 39.7 tp . . . . . 0 CA--C 1.536 0.425 0 C-N-CA 124.754 1.222 . . . . 0.0 110.147 169.967 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.173 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.36 112.79 19.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.709 1.203 . . . . 0.0 111.522 179.029 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.5 117.88 23.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.842 2.457 . . . . 0.0 108.53 178.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.3 tp -105.69 125.62 51.2 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.808 2.043 . . . . 0.0 110.484 -176.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.6 t -112.78 125.44 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.148 1.779 . . . . 0.0 109.195 179.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.6 m -120.92 163.08 18.78 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.858 2.063 . . . . 0.0 110.909 177.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.7 t30 51.62 57.0 7.03 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.124 1.369 . . . . 0.0 111.281 -169.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.8 118.73 33.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.522 2.329 . . . . 0.0 107.784 -173.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.07 140.99 58.35 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -54.61 -29.02 50.67 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.777 1.631 . . . . 0.0 114.169 -178.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -75.72 -15.89 81.0 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.974 1.273 . . . . 0.0 115.353 177.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.18 122.42 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 119.155 1.478 . . . . 0.0 110.797 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.5 m -79.48 148.36 31.89 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.117 0.967 . . . . 0.0 113.22 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.75 -54.23 48.69 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.305 1.842 . . . . 0.0 112.631 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.65 87.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.035 0.934 . . . . 0.0 112.907 174.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.06 -47.55 84.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.587 0.755 . . . . 0.0 111.939 176.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mm -55.03 -52.53 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.035 0.934 . . . . 0.0 111.196 169.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -52.46 -52.2 55.39 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.126 0.571 . . . . 0.0 112.33 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.88 -50.51 73.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.94 1.296 . . . . 0.0 113.46 175.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.82 -44.96 91.69 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.394 0.997 . . . . 0.0 112.032 -176.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -61.75 -41.21 97.39 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 173.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.9 -13.58 46.55 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 175.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -74.59 -63.42 1.25 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.861 -1.15 . . . . 0.0 111.481 173.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -84.4 -12.78 53.82 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -175.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.36 -178.13 18.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.479 1.514 . . . . 0.0 112.942 176.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -126.65 127.49 45.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.984 1.314 . . . . 0.0 109.926 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -134.61 149.66 50.6 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.637 1.175 . . . . 0.0 114.145 -169.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -77.68 -49.87 13.62 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.643 1.977 . . . . 0.0 110.407 169.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -149.78 150.83 32.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.687 1.195 . . . . 0.0 113.111 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -127.25 154.53 44.76 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.863 1.665 . . . . 0.0 110.148 168.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.26 153.38 29.04 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.723 1.609 . . . . 0.0 112.068 179.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.481 1.124 0 C-N-CA 126.82 2.048 . . . . 0.0 109.362 174.046 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.898 0 N-CA-C 113.43 0.132 . . . . 0.0 113.43 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.8 p -143.91 154.41 43.31 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.501 1.521 . . . . 0.0 111.617 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.28 159.1 42.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.969 1.307 . . . . 0.0 111.766 173.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -144.2 133.75 23.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.876 1.67 . . . . 0.0 110.746 -172.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.86 114.79 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.446 1.098 . . . . 0.0 110.432 -177.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -79.46 104.15 9.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.328 1.451 . . . . 0.0 108.874 170.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -82.79 163.59 21.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.159 1.783 . . . . 0.0 113.389 -175.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -70.21 -51.48 30.62 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.827 0.851 . . . . 0.0 112.506 169.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -131.26 145.67 51.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.286 1.834 . . . . 0.0 112.354 -172.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -54.88 -56.65 17.21 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.924 2.09 . . . . 0.0 112.814 176.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.24 -47.13 72.58 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.887 1.275 . . . . 0.0 112.422 177.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -61.86 -38.86 89.83 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.459 1.103 . . . . 0.0 112.71 176.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.19 -46.46 80.68 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.458 0.703 . . . . 0.0 112.427 170.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.0 tp -59.12 -42.19 89.98 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.492 1.517 . . . . 0.0 112.147 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -48.0 -60.03 2.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.564 1.546 . . . . 0.0 110.728 169.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.73 -49.04 69.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.989 1.315 . . . . 0.0 112.592 176.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 25.0 ttp -51.81 -60.04 3.63 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.625 1.17 . . . . 0.0 111.643 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.26 -48.4 81.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.76 1.224 . . . . 0.0 112.319 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -58.1 -49.53 76.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.558 1.543 . . . . 0.0 112.993 -178.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -99.92 -12.37 19.87 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -169.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -59.47 110.57 1.14 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.336 1.425 . . . . 0.0 111.194 169.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.36 -23.8 19.61 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.494 1.997 . . . . 0.0 114.172 -175.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -74.28 134.41 76.97 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.825 1.25 . . . . 0.0 110.95 -174.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.37 139.43 20.84 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.008 2.472 . . . . 0.0 112.719 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.8 tp -136.07 113.7 10.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.508 1.523 . . . . 0.0 108.628 169.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 49.11 61.4 3.15 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.609 1.564 . . . . 0.0 111.2 -169.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.4 -62.48 4.56 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.431 1.491 . . . . 0.0 113.373 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -66.06 128.42 93.82 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.866 1.266 . . . . 0.0 112.907 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.73 116.41 4.65 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.451 2.768 . . . . 0.0 110.868 171.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.6 mtm -65.72 124.94 23.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.651 1.18 . . . . 0.0 111.666 -178.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -98.6 118.14 34.62 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mt -119.38 137.57 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.844 0.858 . . . . 0.0 112.305 -169.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -135.02 155.99 49.82 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.413 2.685 . . . . 0.0 110.032 -175.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 N--CA 1.468 0.447 0 C-N-CA 124.448 1.099 . . . . 0.0 110.797 -177.348 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.162 0 N-CA-C 113.547 0.179 . . . . 0.0 113.547 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -72.05 149.72 44.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.448 1.099 . . . . 0.0 112.112 176.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.4 mt -136.33 139.31 42.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 130.107 3.363 . . . . 0.0 108.758 174.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 65.7 tp -122.32 118.82 29.39 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.892 1.677 . . . . 0.0 108.607 174.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.82 112.25 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.123 1.369 . . . . 0.0 108.709 -169.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -127.62 173.97 9.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.789 1.235 . . . . 0.0 112.54 -169.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.0 t30 52.34 43.12 31.12 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.119 1.767 . . . . 0.0 112.891 -169.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.7 mt -77.36 153.99 33.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.149 0.98 . . . . 0.0 108.566 169.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -68.02 141.98 56.05 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.732 -1.23 . . . . 0.0 109.957 169.319 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -61.55 -19.03 61.68 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.03 0.54 82.11 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.452 1.501 . . . . 0.0 115.472 174.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.07 118.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.733 1.766 . . . . 0.0 110.916 175.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.5 m -71.45 148.03 47.26 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.717 1.207 . . . . 0.0 112.765 178.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -53.63 -54.38 38.55 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.831 1.652 . . . . 0.0 112.846 174.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.89 78.47 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.532 1.133 . . . . 0.0 113.299 177.161 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.85 -51.02 71.79 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.949 0.9 . . . . 0.0 112.364 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.6 mm -56.52 -52.73 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.344 1.057 . . . . 0.0 111.008 171.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -51.82 -51.85 53.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.896 0.878 . . . . 0.0 112.414 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.72 -50.06 73.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.199 1.4 . . . . 0.0 113.545 174.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.04 -43.74 98.18 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.878 1.217 . . . . 0.0 112.455 -175.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -63.51 -42.5 98.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.557 0.617 . . . . 0.0 112.371 172.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.21 71.25 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 173.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.22 -42.38 86.12 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.448 1.099 . . . . 0.0 113.085 177.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -108.36 -1.63 19.82 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -174.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.02 165.25 34.66 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 120.047 1.294 . . . . 0.0 114.628 177.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.8 m -101.47 122.94 44.7 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.096 0.958 . . . . 0.0 110.758 -177.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.05 161.9 36.83 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -93.74 -46.82 7.06 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.148 1.779 . . . . 0.0 112.131 175.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -141.94 143.31 33.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.295 1.038 . . . . 0.0 112.549 -173.094 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.49 118.11 6.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.808 1.643 . . . . 0.0 109.418 169.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.35 121.6 12.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.966 1.306 . . . . 0.0 112.414 -172.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 125.839 1.656 . . . . 0.0 110.098 170.649 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.725 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.3 m -141.39 143.0 33.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.672 1.589 . . . . 0.0 110.826 -174.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.83 139.29 34.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.325 1.45 . . . . 0.0 112.69 176.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -93.7 129.94 39.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.573 1.549 . . . . 0.0 109.429 169.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.6 t -133.16 143.59 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.596 1.559 . . . . 0.0 108.878 -177.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -145.47 108.24 4.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.755 -1.215 . . . . 0.0 111.006 -173.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -86.19 175.27 8.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.882 2.073 . . . . 0.0 113.628 -171.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -91.54 -65.68 0.99 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.743 1.217 . . . . 0.0 110.861 169.529 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -83.12 132.37 35.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.187 1.395 . . . . 0.0 111.89 -176.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -50.42 73.1 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.439 1.496 . . . . 0.0 112.105 179.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.36 -45.79 84.01 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.513 1.125 . . . . 0.0 112.246 176.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -63.7 -39.82 95.25 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.022 1.329 . . . . 0.0 112.55 177.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.51 -52.1 67.01 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.163 0.985 . . . . 0.0 111.809 170.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 62.2 tp -54.94 -47.36 74.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.142 0.977 . . . . 0.0 112.057 174.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -50.23 -57.18 8.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.633 1.573 . . . . 0.0 111.356 171.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -50.87 -46.07 60.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.651 1.18 . . . . 0.0 112.865 176.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 24.4 ttp -57.16 -67.26 0.34 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.688 0.676 . . . . 0.0 111.507 172.16 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -62.67 -36.02 81.54 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -170.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -64.18 -42.58 96.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.93 1.292 . . . . 0.0 112.931 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.25 -13.65 14.86 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -169.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.65 113.96 2.27 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.776 1.171 . . . . 0.0 111.116 169.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.58 -16.75 54.57 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.909 1.718 . . . . 0.0 114.699 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.44 129.49 85.6 Favored Pre-proline 0 N--CA 1.477 0.912 0 CA-C-N 119.085 1.442 . . . . 0.0 110.813 -176.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.98 140.19 93.05 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.809 3.006 . . . . 0.0 115.1 176.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.6 tp -138.28 104.59 5.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.366 2.266 . . . . 0.0 107.539 169.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 48.31 62.01 2.74 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.387 1.475 . . . . 0.0 111.718 -169.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.69 -59.51 4.95 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.19 1.376 . . . . 0.0 113.214 -179.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.5 mtt-85 -60.55 127.67 87.16 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.733 1.613 . . . . 0.0 112.682 -175.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.82 122.61 8.66 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.757 2.305 . . . . 0.0 110.756 170.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.5 mtm -61.69 121.61 13.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.099 0.96 . . . . 0.0 111.589 178.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -93.41 103.06 15.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.866 1.266 . . . . 0.0 108.917 174.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -115.83 131.85 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.33 1.052 . . . . 0.0 111.342 -171.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -122.54 150.18 42.92 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.647 2.379 . . . . 0.0 109.394 175.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.4 tp . . . . . 0 CA--C 1.548 0.89 0 C-N-CA 124.882 1.273 . . . . 0.0 110.075 174.732 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 112.609 -0.196 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -146.52 138.42 24.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.341 1.056 . . . . 0.0 111.139 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.1 mt -134.67 126.27 28.78 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.709 1.604 . . . . 0.0 112.221 -175.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.7 tp -90.8 124.7 35.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.228 1.411 . . . . 0.0 107.603 169.028 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.71 92.0 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.677 1.591 . . . . 0.0 108.597 -171.007 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.0 m -88.19 167.65 13.42 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.129 1.771 . . . . 0.0 112.581 -177.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.0 t30 55.35 66.77 1.14 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.175 2.19 . . . . 0.0 113.447 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.7 mt -116.16 -168.81 1.49 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.582 2.353 . . . . 0.0 110.42 174.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.85 150.35 47.82 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.129 -0.982 . . . . 0.0 112.322 173.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -51.01 -40.89 59.23 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.465 1.106 . . . . 0.0 112.977 175.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.27 69.51 0.43 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.479 1.514 . . . . 0.0 111.941 173.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.78 134.48 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.954 1.702 . . . . 0.0 111.855 172.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.0 m -85.52 126.25 33.7 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.819 -0.551 . . . . 0.0 110.394 170.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.44 -48.46 79.08 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.381 1.072 . . . . 0.0 111.961 179.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.17 75.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.278 1.431 . . . . 0.0 113.233 175.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.56 -53.16 61.45 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.176 0.991 . . . . 0.0 111.993 178.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 47.7 mm -57.34 -53.58 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.63 1.172 . . . . 0.0 111.169 173.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -49.47 -54.57 17.04 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.315 1.046 . . . . 0.0 111.553 177.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -61.37 -50.1 74.24 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.023 0.829 . . . . 0.0 112.657 178.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -47.53 85.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.939 0.79 . . . . 0.0 112.31 -176.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -64.91 -46.91 79.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.641 0.655 . . . . 0.0 112.303 175.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.99 -35.49 64.41 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -55.54 -45.52 77.2 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.34 1.056 . . . . 0.0 112.98 175.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -102.53 -19.36 14.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -175.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -152.63 157.68 27.43 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-N 120.096 1.316 . . . . 0.0 114.303 177.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.4 m -84.63 95.91 9.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.68 -0.894 . . . . 0.0 111.727 -172.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.21 143.34 29.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.635 0.774 . . . . 0.0 111.809 172.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -85.63 -48.51 8.81 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.575 2.35 . . . . 0.0 110.309 169.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -149.45 149.09 30.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.742 1.217 . . . . 0.0 112.444 -177.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -122.77 153.86 38.95 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.094 1.758 . . . . 0.0 110.96 169.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.57 -176.33 5.26 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.696 2.398 . . . . 0.0 110.938 -176.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 148' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.477 0.875 0 C-N-CA 127.909 2.483 . . . . 0.0 110.099 176.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.71 0 CA-C-O 119.894 -0.392 . . . . 0.0 113.606 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.0 m -141.86 113.77 7.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.0 1.32 . . . . 0.0 110.077 176.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . . . -96.79 164.01 12.75 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.159 1.383 . . . . 0.0 111.373 173.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -143.4 126.49 16.43 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.57 1.148 . . . . 0.0 110.37 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.4 t -136.6 136.75 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.14 0.976 . . . . 0.0 110.989 -169.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -115.91 138.75 50.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.307 1.843 . . . . 0.0 109.368 178.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -127.39 158.39 37.43 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.149 2.58 . . . . 0.0 113.708 -169.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -64.47 -32.71 74.46 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.483 1.513 . . . . 0.0 114.439 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -135.93 147.56 48.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.088 1.355 . . . . 0.0 112.803 -169.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -58.92 -52.75 64.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.444 1.498 . . . . 0.0 111.734 169.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.98 -50.44 64.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.088 1.355 . . . . 0.0 112.195 177.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.65 -51.4 63.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.234 1.414 . . . . 0.0 112.023 175.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.76 -50.98 71.9 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.586 0.754 . . . . 0.0 112.429 176.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 80.3 mt -58.34 -47.09 84.86 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.474 1.11 . . . . 0.0 112.764 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -54.22 -55.51 27.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.943 1.297 . . . . 0.0 111.582 172.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.32 -52.74 51.46 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.691 1.196 . . . . 0.0 112.561 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 34.8 ttm -50.03 -62.03 1.81 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.665 1.586 . . . . 0.0 111.617 175.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.75 -46.8 88.02 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.121 1.368 . . . . 0.0 112.64 -177.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -63.03 -45.4 92.51 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.477 1.111 . . . . 0.0 113.206 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.0 -15.72 17.37 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -169.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -60.66 110.35 1.27 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.969 1.259 . . . . 0.0 110.682 169.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.96 -25.72 11.27 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.561 2.029 . . . . 0.0 114.191 -175.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.81 132.0 90.89 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.564 1.146 . . . . 0.0 111.433 -171.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.22 106.89 1.96 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.527 2.818 . . . . 0.0 112.283 -177.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 tp -75.23 89.87 2.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.177 1.391 . . . . 0.0 109.352 169.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 44.46 58.51 3.79 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.363 1.865 . . . . 0.0 111.33 -169.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 100.72 -47.54 1.23 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.627 1.584 . . . . 0.0 113.702 -177.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -68.33 107.91 2.36 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 127.002 2.121 . . . . 0.0 112.463 -169.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.17 107.9 2.22 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.984 1.789 . . . . 0.0 110.863 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.91 134.68 55.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.256 1.022 . . . . 0.0 111.138 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -119.64 112.83 19.8 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.853 0.861 . . . . 0.0 110.459 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.0 mt -108.11 132.67 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.146 0.979 . . . . 0.0 111.223 -169.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -131.03 141.48 50.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.343 2.257 . . . . 0.0 109.978 -173.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 CA--C 1.544 0.734 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 175.054 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.208 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -150.26 101.8 3.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.7 1.2 . . . . 0.0 110.412 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 34.1 mt -95.73 107.17 19.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.339 1.055 . . . . 0.0 111.605 -177.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.5 tp -76.18 129.4 36.68 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 168.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.61 111.85 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.96 1.304 . . . . 0.0 108.737 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.3 m -112.53 169.95 8.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.218 1.407 . . . . 0.0 110.975 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.7 t30 57.13 78.18 0.24 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.924 1.69 . . . . 0.0 112.11 -174.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.8 mt -132.03 157.54 43.86 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.201 2.2 . . . . 0.0 110.336 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.55 145.8 50.82 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.046 -1.034 . . . . 0.0 111.656 170.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -57.22 -29.0 63.39 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -177.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -109.34 28.02 11.61 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.256 1.408 . . . . 0.0 115.261 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.59 119.2 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.174 1.487 . . . . 0.0 110.012 169.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.8 m -74.13 145.51 44.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.434 1.094 . . . . 0.0 112.568 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.68 -51.47 68.63 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.826 0.85 . . . . 0.0 112.094 171.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.45 -53.05 19.31 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.808 1.643 . . . . 0.0 112.331 175.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.88 -50.96 67.43 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.807 1.243 . . . . 0.0 112.365 177.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.0 mm -56.41 -56.82 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.221 1.008 . . . . 0.0 112.15 174.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -58.03 -43.75 86.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.709 1.141 . . . . 0.0 112.243 -178.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -59.14 -52.49 65.5 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.057 0.844 . . . . 0.0 112.775 173.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -65.03 -47.24 78.12 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.998 0.817 . . . . 0.0 112.374 -176.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -62.45 -40.49 96.78 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.774 0.715 . . . . 0.0 112.558 175.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.25 -13.54 60.54 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 175.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.85 -57.71 4.09 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.839 -1.163 . . . . 0.0 111.424 173.147 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -84.89 -33.95 22.66 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.98 -172.79 15.0 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.845 1.688 . . . . 0.0 112.801 178.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -131.02 120.88 24.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.579 1.152 . . . . 0.0 110.41 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -123.86 142.66 50.92 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -72.87 -52.0 16.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.733 2.413 . . . . 0.0 110.428 169.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -152.84 156.74 39.6 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.353 1.461 . . . . 0.0 112.596 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -128.88 162.77 26.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.842 1.657 . . . . 0.0 111.302 169.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.45 145.36 23.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.24 2.216 . . . . 0.0 109.806 172.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 125.517 1.527 . . . . 0.0 110.462 178.779 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.775 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.6 m -126.18 133.63 51.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.138 0.975 . . . . 0.0 112.34 -173.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.77 160.08 37.89 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.419 1.887 . . . . 0.0 111.148 170.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -145.28 126.68 14.94 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.367 1.467 . . . . 0.0 110.222 -177.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.33 111.67 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.142 0.977 . . . . 0.0 110.863 -171.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -75.71 111.19 10.79 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.288 1.435 . . . . 0.0 109.43 172.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.9 150.99 21.95 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.903 2.081 . . . . 0.0 112.555 -178.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.82 -38.37 90.83 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 177.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -136.39 142.85 43.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.607 1.563 . . . . 0.0 112.335 -174.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -54.47 -52.34 62.17 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.929 1.692 . . . . 0.0 112.136 172.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.91 -51.9 66.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.1 1.36 . . . . 0.0 112.475 176.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -59.88 -40.66 89.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.834 0.854 . . . . 0.0 112.536 177.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.89 -51.64 68.28 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.979 0.912 . . . . 0.0 111.983 171.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 62.8 mt -55.38 -48.08 74.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.776 0.83 . . . . 0.0 112.861 173.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -54.04 -54.49 38.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.665 1.186 . . . . 0.0 112.321 175.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.47 -53.16 57.99 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.573 1.149 . . . . 0.0 112.299 174.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 19.8 ttt -52.37 -60.64 2.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.035 1.734 . . . . 0.0 112.046 177.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -59.83 -37.32 78.88 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -68.79 -46.02 69.78 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.236 1.014 . . . . 0.0 113.165 176.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -100.1 -14.16 18.69 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -169.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -58.52 117.03 4.07 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.88 1.218 . . . . 0.0 111.044 170.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.7 -16.22 58.9 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.27 1.414 . . . . 0.0 114.61 -175.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.8 t -71.84 133.07 84.46 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 118.997 1.399 . . . . 0.0 109.497 175.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.94 142.1 24.75 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.725 2.284 . . . . 0.0 112.51 -177.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 45.7 tp -129.95 105.02 7.7 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.35 1.46 . . . . 0.0 108.133 169.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 52.4 65.57 1.47 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.988 1.715 . . . . 0.0 111.135 -169.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.09 -64.04 4.3 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.24 1.4 . . . . 0.0 113.215 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.5 119.92 57.91 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 126.465 1.906 . . . . 0.0 112.774 -173.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -56.07 121.55 10.19 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.753 3.635 . . . . 0.0 113.58 170.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.47 116.64 5.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.245 1.018 . . . . 0.0 111.748 177.104 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -91.61 98.6 11.75 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.585 1.154 . . . . 0.0 109.22 171.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.3 mt -101.22 133.63 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.066 1.346 . . . . 0.0 111.149 -173.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -140.14 123.86 17.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.063 1.745 . . . . 0.0 111.42 -177.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.7 tp . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 123.765 0.826 . . . . 0.0 109.311 169.694 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.872 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -143.46 152.92 42.09 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 177.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.7 mt -108.68 154.36 22.11 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.9 1.68 . . . . 0.0 111.535 174.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.2 tp -120.32 124.18 44.95 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.889 2.076 . . . . 0.0 107.474 170.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.89 85.56 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.52 1.928 . . . . 0.0 108.239 -169.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.16 166.96 19.19 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.146 1.379 . . . . 0.0 112.225 -178.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.7 t30 60.36 75.21 0.42 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.927 2.091 . . . . 0.0 113.134 177.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.1 mt -127.38 167.58 16.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.895 2.478 . . . . 0.0 111.489 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.2 149.57 46.17 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.96 0.886 . . . . 0.0 113.137 172.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -58.69 -31.97 68.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.556 1.943 . . . . 0.0 114.492 -178.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.49 31.67 7.19 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.541 1.543 . . . . 0.0 114.81 -175.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.71 147.52 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.09 1.356 . . . . 0.0 110.907 169.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.4 m -119.8 147.59 44.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.503 1.521 . . . . 0.0 112.485 -176.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -48.59 -57.7 5.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.682 1.993 . . . . 0.0 112.145 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.37 -46.24 76.52 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.591 1.556 . . . . 0.0 113.561 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.97 -52.78 64.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.164 0.986 . . . . 0.0 111.936 -178.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 43.0 mm -58.21 -52.8 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.384 1.073 . . . . 0.0 111.205 172.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -49.64 -51.69 36.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.953 1.301 . . . . 0.0 112.305 179.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.78 -52.3 65.67 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.368 1.067 . . . . 0.0 113.123 175.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.65 -43.89 97.67 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.214 0.915 . . . . 0.0 112.715 -177.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -62.71 -40.72 98.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.808 0.731 . . . . 0.0 112.475 173.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.15 -26.33 64.66 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 175.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -63.4 -48.88 75.99 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.144 -0.972 . . . . 0.0 112.608 174.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -104.8 -15.58 15.16 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 -173.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.0 162.53 21.79 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.904 1.716 . . . . 0.0 113.638 -176.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.9 m -112.27 100.62 8.95 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.576 1.95 . . . . 0.0 107.727 -178.049 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.25 157.2 44.99 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -168.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -77.5 -57.42 3.83 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.693 1.997 . . . . 0.0 110.042 169.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -157.24 145.65 19.48 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.234 1.414 . . . . 0.0 112.792 -174.251 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.18 133.78 55.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.378 1.471 . . . . 0.0 108.564 168.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.9 158.02 44.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.584 1.154 . . . . 0.0 113.115 -169.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.686 0 C-N-CA 126.625 1.97 . . . . 0.0 109.599 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.841 0 CA-C-O 119.699 -0.5 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.0 m -146.41 126.0 13.33 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.429 1.492 . . . . 0.0 111.019 -175.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.93 162.49 12.88 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.373 1.469 . . . . 0.0 112.599 177.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -133.51 127.51 33.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.778 1.631 . . . . 0.0 109.986 -172.079 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.0 t -134.07 116.8 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.518 -0.739 . . . . 0.0 112.479 -169.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -90.18 116.17 27.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.963 2.105 . . . . 0.0 110.606 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -99.54 152.63 19.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.618 1.567 . . . . 0.0 113.885 -173.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -63.93 -48.55 76.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.034 0.934 . . . . 0.0 111.794 171.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -133.54 135.41 44.35 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.116 1.366 . . . . 0.0 110.912 -175.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -58.12 -43.34 87.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.263 1.425 . . . . 0.0 112.778 178.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.58 -50.45 60.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.488 1.115 . . . . 0.0 112.618 171.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.92 -46.61 89.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.945 0.898 . . . . 0.0 112.006 174.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.13 -52.87 48.96 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.513 1.125 . . . . 0.0 112.333 173.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.6 tp -55.42 -51.17 67.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.482 1.513 . . . . 0.0 112.224 174.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -52.06 51.76 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.669 1.587 . . . . 0.0 112.48 174.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.18 -52.93 63.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.433 1.093 . . . . 0.0 111.856 173.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -54.51 -58.89 5.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.696 1.598 . . . . 0.0 112.494 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -59.17 -36.48 75.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -177.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -67.81 -49.11 64.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.381 1.073 . . . . 0.0 112.996 174.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -94.09 -13.72 26.53 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -57.92 112.9 1.64 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.702 1.137 . . . . 0.0 110.93 169.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.5 -18.6 41.08 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.546 1.546 . . . . 0.0 114.713 -175.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 81.2 t -69.52 133.78 88.84 Favored Pre-proline 0 N--CA 1.478 0.934 0 CA-C-N 118.968 1.384 . . . . 0.0 110.189 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.38 141.78 23.16 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.872 2.381 . . . . 0.0 113.154 -175.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.3 tt -132.3 108.69 9.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.539 1.935 . . . . 0.0 107.312 169.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 48.33 64.27 1.73 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.819 1.648 . . . . 0.0 111.566 -169.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.92 -55.44 4.77 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.883 1.706 . . . . 0.0 113.649 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -65.81 124.02 86.41 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 127.008 2.123 . . . . 0.0 112.47 -173.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.32 122.97 9.48 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.291 2.661 . . . . 0.0 111.185 174.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.42 116.27 5.39 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.184 0.994 . . . . 0.0 111.347 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -84.78 100.66 11.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.961 0.905 . . . . 0.0 108.975 170.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.3 mt -107.18 130.07 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.793 0.837 . . . . 0.0 110.714 -175.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.21 -179.97 6.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.594 1.558 . . . . 0.0 110.591 171.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 N--CA 1.47 0.563 0 C-N-CA 125.182 1.393 . . . . 0.0 112.474 -176.666 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.877 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -133.92 125.83 29.11 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.062 0.945 . . . . 0.0 110.526 -178.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.9 mt -106.52 131.11 54.07 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.606 1.163 . . . . 0.0 110.821 170.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.6 tp -99.06 100.43 11.58 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.685 1.594 . . . . 0.0 106.821 169.042 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.28 132.94 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 m -134.05 172.32 12.99 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.55 1.54 . . . . 0.0 111.381 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.3 t30 56.63 51.16 11.5 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.005 1.722 . . . . 0.0 112.662 -172.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.58 -158.51 0.67 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.072 1.749 . . . . 0.0 109.214 169.414 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -154.98 169.24 24.53 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.492 1.517 . . . . 0.0 110.728 178.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.32 -32.1 70.91 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.896 -1.128 . . . . 0.0 112.513 169.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.97 -28.76 69.23 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.487 1.518 . . . . 0.0 114.646 174.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.0 t -72.71 108.15 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.578 1.189 . . . . 0.0 109.64 174.719 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.6 m -69.81 144.0 52.76 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.02 0.928 . . . . 0.0 112.876 -177.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -54.19 -55.09 31.24 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.743 1.617 . . . . 0.0 112.886 176.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.87 75.77 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.483 1.113 . . . . 0.0 113.266 176.524 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.21 -52.24 63.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.704 0.802 . . . . 0.0 111.61 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.0 mm -53.26 -52.93 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.121 0.969 . . . . 0.0 111.12 169.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -52.53 -52.93 52.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.972 0.909 . . . . 0.0 112.175 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -60.2 -52.16 66.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.553 1.141 . . . . 0.0 113.16 174.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 pp -63.84 -43.93 94.7 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.364 0.984 . . . . 0.0 112.308 -174.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -62.12 -45.15 94.74 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.485 0.584 . . . . 0.0 112.068 172.143 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.7 -32.84 70.88 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 178.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.18 -51.21 70.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.084 0.954 . . . . 0.0 112.483 173.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -93.23 -13.03 28.81 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -174.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.55 154.36 25.89 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 120.015 1.279 . . . . 0.0 114.664 177.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.2 m -86.19 107.41 17.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.369 1.068 . . . . 0.0 110.309 -175.289 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 pp -125.96 146.31 49.92 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -173.019 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -86.72 -39.09 16.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.635 2.374 . . . . 0.0 111.547 169.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -150.22 147.38 27.62 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.591 0.632 . . . . 0.0 112.47 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.26 120.97 11.18 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.668 1.587 . . . . 0.0 109.486 171.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -138.4 117.24 12.35 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.38 1.472 . . . . 0.0 111.863 -172.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.4 t . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 126.065 1.746 . . . . 0.0 111.134 178.052 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.934 0 CA-C-O 120.048 -0.307 . . . . 0.0 113.326 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.9 p -141.53 168.28 20.15 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.301 1.44 . . . . 0.0 112.642 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.07 141.27 24.0 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.674 1.189 . . . . 0.0 111.398 169.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.91 126.02 43.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.478 1.511 . . . . 0.0 109.429 173.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.3 t -130.08 122.8 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.173 0.989 . . . . 0.0 110.509 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -109.1 119.01 38.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.113 2.165 . . . . 0.0 111.14 -176.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -102.75 154.47 19.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.809 2.844 . . . . 0.0 113.645 -169.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -82.38 -16.17 50.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.619 1.567 . . . . 0.0 114.554 175.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.8 mtm-85 -142.34 132.56 24.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.689 1.596 . . . . 0.0 111.042 177.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -56.13 -50.35 71.35 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.107 1.363 . . . . 0.0 112.545 172.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.43 -47.43 69.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.875 1.27 . . . . 0.0 112.162 175.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.18 -42.23 99.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.943 0.897 . . . . 0.0 112.625 175.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.72 -53.34 57.81 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.785 0.834 . . . . 0.0 111.534 171.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 59.3 tp -54.07 -52.1 62.0 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.826 1.25 . . . . 0.0 112.439 174.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -49.86 -54.77 17.4 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.253 1.821 . . . . 0.0 112.154 173.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.63 -50.84 69.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.534 1.133 . . . . 0.0 112.306 174.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 16.7 ttp -52.15 -60.1 3.6 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.03 1.332 . . . . 0.0 111.595 175.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -53.73 -49.51 67.99 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.239 1.416 . . . . 0.0 112.32 179.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -61.83 -47.24 85.98 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.72 1.208 . . . . 0.0 113.045 -179.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -99.82 -14.36 18.84 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -169.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.28 113.72 2.3 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.785 1.175 . . . . 0.0 110.984 169.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.43 -20.15 35.41 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.762 1.649 . . . . 0.0 114.48 -175.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.46 133.02 87.23 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-N 118.757 1.279 . . . . 0.0 110.306 -178.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.16 138.83 23.17 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.923 2.415 . . . . 0.0 112.457 -177.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.1 tp -134.93 112.37 10.58 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.1 1.76 . . . . 0.0 108.373 170.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 49.32 61.68 3.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.303 1.441 . . . . 0.0 111.189 -169.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.99 -59.94 4.47 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.798 1.666 . . . . 0.0 113.493 -179.051 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -61.95 127.82 89.75 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 127.062 2.145 . . . . 0.0 112.83 -174.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.98 124.67 10.79 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.178 2.585 . . . . 0.0 111.147 172.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.49 120.37 11.57 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.117 0.967 . . . . 0.0 111.162 177.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -98.91 102.32 14.0 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.783 1.233 . . . . 0.0 108.865 176.036 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.1 mt -108.69 135.98 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.047 0.939 . . . . 0.0 111.271 -169.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -128.87 123.98 34.09 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.103 1.761 . . . . 0.0 111.082 -177.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 CA--C 1.534 0.346 0 C-N-CA 124.77 1.228 . . . . 0.0 111.076 172.361 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.945 0 N-CA-C 112.338 -0.305 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -117.91 99.63 7.04 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.285 1.434 . . . . 0.0 109.961 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -100.73 101.4 12.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.607 1.563 . . . . 0.0 109.043 -176.099 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.8 tp -84.37 137.28 33.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.136 1.774 . . . . 0.0 110.505 177.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.0 t -129.41 129.32 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.46 1.904 . . . . 0.0 108.948 -176.517 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.0 m -139.64 166.48 24.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.25 1.42 . . . . 0.0 112.116 -176.006 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.1 t30 54.71 46.95 23.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.07 1.748 . . . . 0.0 112.914 -172.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.2 mt -83.89 164.83 19.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.3 1.44 . . . . 0.0 110.754 169.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.95 145.35 56.0 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 110.957 169.458 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -53.87 -35.0 61.08 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.561 1.544 . . . . 0.0 114.16 -176.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.47 16.28 58.0 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.392 1.473 . . . . 0.0 115.467 -174.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.26 135.25 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.217 1.509 . . . . 0.0 110.578 170.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.4 m -114.6 158.13 22.13 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.146 1.778 . . . . 0.0 111.583 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -52.36 -55.75 19.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.524 1.13 . . . . 0.0 113.641 -176.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.49 -38.99 67.1 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.197 0.999 . . . . 0.0 113.561 -177.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.83 -56.15 25.94 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.968 0.907 . . . . 0.0 111.916 176.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.2 mm -55.76 -53.01 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 0.0 111.02 172.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -48.44 -56.95 6.86 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.181 1.792 . . . . 0.0 111.673 178.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.2 -49.49 75.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.435 1.094 . . . . 0.0 113.323 176.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.3 -45.44 91.34 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.492 1.042 . . . . 0.0 112.201 -174.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -62.91 -40.88 98.94 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 174.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.51 -14.98 56.51 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 175.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.6 -61.91 1.71 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.825 -1.172 . . . . 0.0 111.883 173.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -85.18 -13.05 51.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -175.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -146.41 -167.79 13.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.71 1.624 . . . . 0.0 112.909 176.414 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.05 126.69 27.14 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.159 1.384 . . . . 0.0 110.177 -173.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.06 143.61 50.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.464 1.106 . . . . 0.0 113.737 -169.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -73.08 -49.61 27.62 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.966 2.106 . . . . 0.0 110.335 169.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -150.11 152.15 34.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.416 1.086 . . . . 0.0 113.237 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -119.86 151.91 38.15 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.319 1.848 . . . . 0.0 109.869 169.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.6 146.01 26.26 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.97 1.708 . . . . 0.0 110.402 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.1 t . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 125.364 1.465 . . . . 0.0 109.847 -177.877 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.247 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -137.01 155.04 50.21 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.698 1.599 . . . . 0.0 112.127 179.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.5 166.86 26.93 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.998 1.719 . . . . 0.0 111.463 175.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -147.76 126.73 12.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.635 1.574 . . . . 0.0 109.645 -174.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.02 116.43 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.726 1.21 . . . . 0.0 109.175 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -82.6 102.87 11.72 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -77.28 155.34 32.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.177 1.791 . . . . 0.0 113.238 -175.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.19 -29.48 54.34 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.701 1.2 . . . . 0.0 113.298 172.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 138.26 38.04 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.285 1.434 . . . . 0.0 111.341 176.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -64.77 -36.73 85.26 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 113.914 178.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.37 -46.83 86.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.121 0.968 . . . . 0.0 111.672 174.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -58.98 -44.23 91.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.492 1.517 . . . . 0.0 112.016 173.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.05 -52.25 63.77 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.75 1.22 . . . . 0.0 112.612 170.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.47 -48.24 79.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.857 1.263 . . . . 0.0 112.292 176.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -49.55 -56.99 7.96 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.135 1.374 . . . . 0.0 111.229 171.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.68 -47.13 63.99 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.801 0.84 . . . . 0.0 112.362 175.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.5 ttp -56.17 -62.36 1.77 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.979 0.912 . . . . 0.0 112.467 177.034 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -61.43 -35.27 77.09 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.27 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.0 -52.81 62.47 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.365 1.466 . . . . 0.0 112.662 174.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -97.39 -14.97 20.9 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -169.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -59.67 110.33 1.12 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 120.16 1.346 . . . . 0.0 112.094 175.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.3 -17.36 40.58 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.149 1.833 . . . . 0.0 114.67 -177.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.61 130.27 94.09 Favored Pre-proline 0 N--CA 1.479 0.985 0 CA-C-N 118.953 1.376 . . . . 0.0 111.009 -174.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.28 112.25 2.75 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.339 2.693 . . . . 0.0 112.54 -174.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 59.7 tp -76.54 82.5 3.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.47 1.508 . . . . 0.0 109.268 169.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 43.35 55.1 4.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.873 2.069 . . . . 0.0 112.026 -169.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 116.23 -64.82 0.33 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.009 1.766 . . . . 0.0 112.556 -177.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.01 111.03 3.53 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 126.812 2.045 . . . . 0.0 112.266 -171.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.14 113.31 3.39 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.273 1.982 . . . . 0.0 110.654 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -66.93 118.71 10.78 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.005 0.922 . . . . 0.0 111.157 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -84.89 120.74 26.81 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.904 0.882 . . . . 0.0 109.024 171.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.6 mm -118.43 138.17 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.738 0.815 . . . . 0.0 109.997 179.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -137.09 134.84 36.91 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.149 1.38 . . . . 0.0 111.065 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 CA--C 1.538 0.485 0 C-N-CA 126.3 1.84 . . . . 0.0 107.88 174.634 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.355 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -134.98 101.6 4.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.852 1.261 . . . . 0.0 110.68 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -103.61 122.0 44.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.087 2.155 . . . . 0.0 109.231 -171.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.8 tp -115.47 102.94 10.27 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.309 1.844 . . . . 0.0 110.424 -176.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.5 t -78.73 130.64 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.166 1.387 . . . . 0.0 108.373 169.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 m -127.69 172.3 10.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.115 1.366 . . . . 0.0 111.411 175.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.7 t30 57.46 50.4 11.31 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.847 1.659 . . . . 0.0 112.763 -173.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.2 mt -98.78 -168.22 1.6 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.883 1.673 . . . . 0.0 109.306 169.145 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -148.61 161.94 40.69 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.967 -1.083 . . . . 0.0 111.972 174.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -61.14 101.52 0.16 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.208 1.403 . . . . 0.0 109.383 169.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.48 -39.0 0.62 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.211 1.386 . . . . 0.0 111.859 -169.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.73 110.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.122 0.969 . . . . 0.0 109.611 170.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -71.98 144.24 48.94 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.766 0.826 . . . . 0.0 112.737 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.71 -52.79 63.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.841 1.656 . . . . 0.0 112.385 178.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.54 82.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.618 1.167 . . . . 0.0 113.404 174.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.84 -48.69 79.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.086 0.857 . . . . 0.0 111.763 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.4 mm -54.77 -52.87 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.883 0.873 . . . . 0.0 111.065 169.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -51.75 -54.21 31.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.246 0.618 . . . . 0.0 112.067 178.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.58 -50.34 74.17 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.873 1.269 . . . . 0.0 113.31 176.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.11 -44.86 90.99 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.315 0.961 . . . . 0.0 112.041 -176.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -61.27 -42.69 99.07 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 173.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.54 -15.3 57.61 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.29 -63.45 1.18 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.949 -1.095 . . . . 0.0 111.609 173.407 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -82.17 -18.91 41.08 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -175.465 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -139.22 -176.37 14.68 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.579 1.561 . . . . 0.0 113.346 178.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.9 m -126.91 120.96 30.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.367 1.467 . . . . 0.0 110.373 -176.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 pp -126.07 146.41 49.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.004 1.322 . . . . 0.0 112.995 -169.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -78.52 -49.19 13.8 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.803 2.441 . . . . 0.0 110.303 170.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -149.19 147.89 28.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.632 1.173 . . . . 0.0 111.884 -179.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -137.62 135.34 36.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.454 1.502 . . . . 0.0 110.464 171.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.06 146.77 32.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.865 1.266 . . . . 0.0 112.192 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.479 1.024 0 C-N-CA 125.844 1.658 . . . . 0.0 110.492 -179.402 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.9 p -144.55 159.4 42.85 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.664 1.585 . . . . 0.0 112.266 -176.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.78 140.85 33.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.863 1.265 . . . . 0.0 111.018 169.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -120.33 125.88 49.14 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.067 1.747 . . . . 0.0 110.009 -174.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.8 t -126.68 115.75 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.156 1.382 . . . . 0.0 109.809 -176.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -88.23 111.4 21.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.218 2.207 . . . . 0.0 108.461 175.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -98.82 159.31 15.04 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.426 2.29 . . . . 0.0 113.975 -169.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.73 -50.46 70.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.276 1.03 . . . . 0.0 111.83 169.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -138.06 144.26 40.87 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.733 1.613 . . . . 0.0 112.214 -173.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -62.63 -35.88 81.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.758 1.223 . . . . 0.0 112.901 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.13 -47.01 78.94 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.441 1.096 . . . . 0.0 112.435 172.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -65.88 -41.96 90.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.705 1.202 . . . . 0.0 112.038 176.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.62 82.61 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.859 0.864 . . . . 0.0 112.264 169.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.88 -45.62 93.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.986 1.714 . . . . 0.0 112.046 177.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -49.63 -58.15 5.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.958 1.303 . . . . 0.0 110.31 169.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.43 -49.6 61.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.93 0.892 . . . . 0.0 112.65 176.587 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 41.6 ttp -54.89 -62.01 1.94 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.362 1.065 . . . . 0.0 111.723 176.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -61.05 -38.59 86.73 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -66.68 -41.87 87.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.685 1.194 . . . . 0.0 112.899 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -109.09 -13.24 14.73 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -169.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -58.63 116.74 3.9 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.172 1.351 . . . . 0.0 111.425 171.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.33 -25.07 27.18 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.972 1.749 . . . . 0.0 114.359 -175.367 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.82 135.3 87.8 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.771 1.229 . . . . 0.0 110.356 -177.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -74.91 139.42 24.5 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.821 2.348 . . . . 0.0 112.816 -178.223 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.4 tp -139.24 119.12 13.29 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.936 1.694 . . . . 0.0 108.677 169.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.75 56.99 7.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.428 1.491 . . . . 0.0 110.729 -169.094 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.78 -60.74 4.36 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.54 1.543 . . . . 0.0 113.466 -179.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.45 135.91 96.54 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.948 1.699 . . . . 0.0 112.872 -172.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.2 124.28 10.34 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.497 2.798 . . . . 0.0 111.211 174.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.4 mtm -62.76 117.78 6.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.506 1.122 . . . . 0.0 111.729 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -95.65 99.04 10.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.949 1.3 . . . . 0.0 108.393 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.6 mt -103.86 135.43 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.667 0.787 . . . . 0.0 111.363 -169.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -127.91 151.16 49.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.969 2.508 . . . . 0.0 110.302 -177.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 34.8 tp . . . . . 0 N--CA 1.467 0.409 0 C-N-CA 125.737 1.615 . . . . 0.0 109.568 179.856 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.076 0 N-CA-C 112.704 -0.158 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -76.59 137.95 39.84 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.971 0.908 . . . . 0.0 112.458 178.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -138.52 129.58 26.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 129.02 2.928 . . . . 0.0 108.112 -175.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.73 112.15 20.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.551 1.94 . . . . 0.0 110.035 -175.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.4 t -87.04 135.1 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.58 1.552 . . . . 0.0 108.637 171.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.7 m -139.18 165.44 27.16 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.608 1.563 . . . . 0.0 112.575 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.4 t30 57.8 47.65 15.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.147 2.179 . . . . 0.0 113.299 -175.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.51 161.53 15.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.256 1.822 . . . . 0.0 110.3 169.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.93 144.53 54.15 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.166 -0.959 . . . . 0.0 111.008 169.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -59.35 -21.72 60.23 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.83 19.75 32.6 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.727 1.632 . . . . 0.0 115.425 178.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.29 129.37 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.483 1.641 . . . . 0.0 110.365 169.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.8 m -75.69 140.64 42.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.006 0.923 . . . . 0.0 112.55 -178.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.54 -50.67 72.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.018 1.327 . . . . 0.0 112.298 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.77 -46.62 71.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.309 1.444 . . . . 0.0 112.619 174.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -56.98 -53.3 59.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.397 1.079 . . . . 0.0 112.381 179.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.0 mm -57.33 -52.81 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.134 0.973 . . . . 0.0 111.583 173.02 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.472 HE22 HD11 ' A' ' 131' ' ' LEU . 15.9 tp60 -50.33 -50.62 50.4 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.546 1.139 . . . . 0.0 112.006 178.104 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.09 -53.84 47.26 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.505 1.122 . . . . 0.0 112.917 175.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.13 -43.0 99.6 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.216 0.916 . . . . 0.0 112.643 -173.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -64.07 -44.79 91.31 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.64 0.654 . . . . 0.0 112.131 172.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.46 -27.5 66.14 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 176.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.66 -59.5 4.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.187 0.995 . . . . 0.0 111.942 173.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -83.8 -15.25 49.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -175.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -148.17 156.22 26.8 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.947 1.248 . . . . 0.0 113.96 175.344 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.4 m -94.79 111.48 23.26 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.753 1.221 . . . . 0.0 109.934 -173.304 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.472 HD11 HE22 ' A' ' 122' ' ' GLN . 2.9 pp -137.3 155.8 49.01 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -87.38 -48.17 8.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.785 2.434 . . . . 0.0 111.487 -173.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -151.02 145.66 25.68 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.623 1.169 . . . . 0.0 113.141 -176.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.27 140.85 46.71 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.239 1.816 . . . . 0.0 110.095 169.115 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -146.51 107.59 4.18 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.933 1.693 . . . . 0.0 111.533 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.3 t . . . . . 0 N--CA 1.478 0.956 0 C-N-CA 125.303 1.441 . . . . 0.0 110.625 176.063 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 N-CA-C 113.224 0.05 . . . . 0.0 113.224 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.4 p -143.47 167.68 21.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.699 1.599 . . . . 0.0 111.395 -179.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -144.78 126.38 15.09 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.797 0.839 . . . . 0.0 111.782 169.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -80.15 124.54 28.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.974 1.71 . . . . 0.0 109.735 169.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.45 140.66 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.702 1.201 . . . . 0.0 110.107 -175.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -122.75 105.42 10.03 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.769 1.627 . . . . 0.0 109.204 177.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -78.62 160.54 27.51 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.364 1.866 . . . . 0.0 111.743 176.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -76.43 -27.18 56.13 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 171.077 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.18 136.62 38.36 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.453 1.501 . . . . 0.0 111.914 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -56.45 -44.37 80.45 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.808 1.643 . . . . 0.0 113.316 173.047 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.38 -46.71 76.5 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.091 0.956 . . . . 0.0 112.597 176.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -66.52 -41.4 88.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.928 1.291 . . . . 0.0 112.178 177.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.9 -48.75 75.07 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.906 0.882 . . . . 0.0 111.934 169.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.97 -46.41 89.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.538 1.535 . . . . 0.0 112.463 176.102 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -50.71 -56.39 12.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.169 1.388 . . . . 0.0 111.133 171.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.16 -49.27 69.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.55 1.14 . . . . 0.0 112.393 174.514 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.7 ttp -51.99 -59.12 4.71 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.81 1.244 . . . . 0.0 111.788 176.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -56.01 -49.03 74.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.95 1.3 . . . . 0.0 112.361 178.12 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -60.18 -45.15 94.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.549 1.14 . . . . 0.0 113.468 -178.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -102.15 -16.14 16.47 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -169.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -61.61 106.26 0.64 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 119.922 1.237 . . . . 0.0 110.786 169.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.96 -27.77 7.3 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 126.567 2.032 . . . . 0.0 114.142 -174.673 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.61 134.32 84.22 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 125.102 1.361 . . . . 0.0 111.012 -173.402 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.55 138.71 24.58 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.984 2.456 . . . . 0.0 112.714 -177.236 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -140.13 107.63 5.58 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.736 2.014 . . . . 0.0 108.095 175.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 48.45 66.48 1.06 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.742 1.617 . . . . 0.0 111.82 -169.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.26 -57.56 4.39 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.112 1.815 . . . . 0.0 113.403 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -65.16 131.82 95.2 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 127.036 2.134 . . . . 0.0 112.625 -173.24 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.83 119.53 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.876 2.384 . . . . 0.0 110.251 169.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.5 mtm -60.63 143.99 52.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.604 0.762 . . . . 0.0 111.968 178.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -119.59 130.95 55.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.236 1.414 . . . . 0.0 108.68 171.021 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mm -124.94 141.49 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.52 0.728 . . . . 0.0 110.052 -173.64 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -138.92 148.73 43.96 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.672 1.989 . . . . 0.0 110.273 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.474 0.772 0 C-N-CA 124.044 0.937 . . . . 0.0 112.225 173.094 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 CA-C-O 119.472 -0.627 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -136.53 152.51 50.59 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -173.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 71.9 mt -122.04 131.23 53.88 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.77 2.028 . . . . 0.0 112.266 -169.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.2 tp -86.54 111.28 20.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 168.317 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -98.61 130.51 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.108 1.363 . . . . 0.0 107.75 175.221 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.5 m -136.44 165.31 26.12 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 111.854 -174.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.9 t30 57.56 32.48 21.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.569 1.948 . . . . 0.0 114.395 -171.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.11 148.05 42.17 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 167.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.68 144.25 57.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.515 174.331 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -54.15 -36.58 63.48 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -169.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.42 20.15 51.85 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.115 1.341 . . . . 0.0 115.916 178.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.43 130.74 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.281 1.541 . . . . 0.0 110.774 171.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -76.15 140.53 41.8 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.383 1.073 . . . . 0.0 112.669 -177.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.43 -51.82 67.86 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.138 1.375 . . . . 0.0 112.696 175.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.29 80.16 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.443 1.097 . . . . 0.0 113.283 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.92 -51.4 69.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.884 0.874 . . . . 0.0 112.076 177.5 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.0 mm -57.05 -52.55 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.591 1.156 . . . . 0.0 111.351 172.043 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -49.38 -56.07 10.84 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.739 1.216 . . . . 0.0 111.844 176.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -57.79 -51.07 71.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.704 1.201 . . . . 0.0 113.07 176.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -63.8 -47.89 79.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.21 0.914 . . . . 0.0 112.35 -175.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -63.34 -38.61 91.83 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.7 0.682 . . . . 0.0 112.68 175.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.98 -13.76 60.42 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 174.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.16 -58.19 3.79 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.867 -1.146 . . . . 0.0 111.408 173.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -86.96 -32.58 20.01 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -176.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.43 172.25 14.88 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.525 1.536 . . . . 0.0 112.523 176.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 90.8 m -118.15 102.23 8.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.802 1.241 . . . . 0.0 109.439 178.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 pp -105.94 139.38 40.58 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -169.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -78.4 -45.37 22.52 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.686 2.794 . . . . 0.0 110.262 169.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -143.79 143.52 31.39 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.078 1.751 . . . . 0.0 111.506 -174.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.64 119.46 12.56 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.769 1.627 . . . . 0.0 108.587 169.304 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -137.45 104.08 5.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.995 0.918 . . . . 0.0 111.635 -175.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 125.411 1.484 . . . . 0.0 110.216 169.974 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.086 0 CA-C-O 120.964 0.202 . . . . 0.0 112.893 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 81.5 p -139.32 165.14 27.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.096 1.359 . . . . 0.0 112.49 -175.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -150.29 161.64 42.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.743 1.617 . . . . 0.0 111.926 171.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -128.87 115.05 17.29 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.448 1.499 . . . . 0.0 110.234 174.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 14.3 t -124.89 125.62 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.694 1.198 . . . . 0.0 110.719 -169.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -115.13 127.56 55.65 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.613 1.965 . . . . 0.0 109.888 -171.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -114.12 156.59 23.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 127.68 2.392 . . . . 0.0 112.184 -171.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -58.7 -28.44 65.8 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.762 1.394 . . . . 0.0 114.762 -176.272 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -139.68 149.96 44.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.128 2.171 . . . . 0.0 110.618 176.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -57.64 -41.25 81.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.196 1.398 . . . . 0.0 112.142 170.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.04 -48.74 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.478 1.111 . . . . 0.0 112.376 169.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.26 -43.18 99.43 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.177 0.991 . . . . 0.0 112.62 176.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.12 -52.15 64.17 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.084 0.954 . . . . 0.0 111.504 169.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 28.5 mt -56.2 -44.02 79.07 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.69 -1.257 . . . . 0.0 113.715 176.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -52.6 -57.52 9.73 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.969 1.259 . . . . 0.0 111.842 171.169 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.68 -51.66 59.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.571 1.148 . . . . 0.0 112.0 177.037 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 22.6 ttt -53.87 -63.25 1.21 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.466 1.507 . . . . 0.0 112.168 176.086 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -60.75 -37.88 83.32 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -173.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -68.19 -43.49 77.99 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 113.169 177.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -103.42 -13.37 16.66 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -169.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -59.69 114.31 2.69 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.032 1.287 . . . . 0.0 110.867 169.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.34 -22.63 34.0 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.006 1.765 . . . . 0.0 114.424 -174.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.4 t -71.31 136.1 84.24 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.772 1.229 . . . . 0.0 110.423 -177.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.27 139.38 29.1 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.943 2.429 . . . . 0.0 112.626 -178.223 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -132.81 109.8 9.9 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.889 2.076 . . . . 0.0 106.871 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 51.65 57.39 6.6 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.145 1.378 . . . . 0.0 110.602 -168.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.47 -52.3 4.09 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.934 1.73 . . . . 0.0 113.726 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -68.79 129.13 92.63 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.809 2.044 . . . . 0.0 112.221 -171.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.55 125.24 11.01 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.2 2.6 . . . . 0.0 111.722 179.13 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.2 mtm -65.96 125.85 26.71 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.522 1.129 . . . . 0.0 112.101 177.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -99.06 112.73 24.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.918 1.287 . . . . 0.0 108.788 170.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mt -118.67 132.64 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.48 1.112 . . . . 0.0 111.2 -172.404 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -137.16 126.99 25.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.793 1.637 . . . . 0.0 111.635 -172.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 46.5 tp . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 124.33 1.052 . . . . 0.0 110.617 172.13 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.037 0 N-CA-C 112.305 -0.318 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -152.46 125.44 8.53 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.04 0.936 . . . . 0.0 112.177 178.885 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.4 mt -121.1 125.86 48.31 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.988 1.715 . . . . 0.0 112.38 -172.487 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.3 tp -89.01 116.57 27.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.698 1.999 . . . . 0.0 106.096 168.382 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.5 128.09 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.987 1.315 . . . . 0.0 108.12 -176.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.0 m -133.96 163.23 30.0 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.778 1.631 . . . . 0.0 112.478 -169.644 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.0 t30 54.55 35.09 22.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.078 2.151 . . . . 0.0 113.369 -169.769 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.41 154.17 37.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.553 1.141 . . . . 0.0 110.314 169.518 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.35 150.82 29.75 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -57.97 -25.49 61.09 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.305 1.042 . . . . 0.0 113.437 172.728 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -78.3 -7.47 87.81 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 125.285 1.421 . . . . 0.0 115.953 175.705 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.2 149.86 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 119.437 1.618 . . . . 0.0 111.118 174.529 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.5 m -129.57 158.13 40.14 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.603 1.561 . . . . 0.0 111.792 177.419 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.3 -51.26 70.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.247 1.419 . . . . 0.0 112.556 178.998 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.06 86.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.973 0.909 . . . . 0.0 112.749 174.45 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -59.15 -51.33 70.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.169 0.988 . . . . 0.0 112.149 176.469 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 15.1 mm -54.68 -53.91 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.533 1.133 . . . . 0.0 111.138 171.074 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -49.96 -57.5 7.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.41 1.084 . . . . 0.0 111.603 178.158 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -56.85 -50.85 71.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.251 1.021 . . . . 0.0 113.085 177.004 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -47.8 81.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.106 0.866 . . . . 0.0 112.235 -175.238 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -65.98 -41.66 90.84 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 176.011 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.59 -24.69 65.66 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 176.478 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.8 -54.14 43.58 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.144 -0.972 . . . . 0.0 112.027 174.033 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -98.33 -15.72 19.64 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -173.653 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.24 -177.57 17.45 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.575 1.56 . . . . 0.0 113.262 178.851 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.3 m -119.36 94.02 4.28 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.152 0.981 . . . . 0.0 111.264 -177.536 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.33 157.8 20.45 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.031 0.932 . . . . 0.0 112.263 179.205 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -115.57 -37.11 4.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.575 2.75 . . . . 0.0 111.717 173.676 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -140.54 144.77 36.1 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.034 1.334 . . . . 0.0 111.511 178.091 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.51 143.93 46.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.67 1.588 . . . . 0.0 110.53 169.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.34 147.98 26.96 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.766 2.027 . . . . 0.0 109.382 173.396 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.483 1.197 0 C-N-CA 124.645 1.178 . . . . 0.0 111.023 -173.714 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 112.329 -0.309 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.5 m -141.31 145.75 35.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.339 1.455 . . . . 0.0 111.577 -169.709 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.37 162.3 34.74 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.402 1.881 . . . . 0.0 112.398 174.066 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -137.24 106.95 6.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.991 2.116 . . . . 0.0 109.654 -175.299 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 13.2 t -124.23 126.8 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.168 0.987 . . . . 0.0 109.972 -170.035 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -115.4 144.52 43.67 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.426 1.49 . . . . 0.0 110.21 -175.479 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -132.85 154.44 50.34 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.371 2.269 . . . . 0.0 112.94 -168.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.56 -29.43 70.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.241 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -131.24 126.24 34.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.065 1.746 . . . . 0.0 111.393 -173.656 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.6 -43.57 98.62 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.217 1.407 . . . . 0.0 112.508 174.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.01 -48.96 61.32 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.585 1.154 . . . . 0.0 112.772 169.872 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.83 -42.06 97.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.626 1.17 . . . . 0.0 112.758 177.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.52 69.03 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.711 0.805 . . . . 0.0 111.829 169.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.5 tp -56.66 -46.81 80.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.074 1.349 . . . . 0.0 112.202 177.408 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -49.45 -57.93 6.09 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.628 1.571 . . . . 0.0 111.318 171.47 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.77 -50.36 66.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.614 1.166 . . . . 0.0 112.846 175.554 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 23.7 ttp -51.51 -59.17 4.55 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.137 1.375 . . . . 0.0 111.476 176.348 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -55.93 -46.94 78.33 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.004 1.321 . . . . 0.0 112.412 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.01 -41.7 97.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.904 1.282 . . . . 0.0 113.538 -178.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -109.19 -15.82 14.22 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -170.248 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.82 113.88 2.5 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.229 1.377 . . . . 0.0 110.995 169.803 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.03 -24.15 19.53 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.337 1.922 . . . . 0.0 114.129 -175.688 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t -69.67 128.66 91.9 Favored Pre-proline 0 N--CA 1.477 0.879 0 CA-C-N 118.643 1.221 . . . . 0.0 111.706 -170.746 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.78 123.58 13.56 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 124.121 3.214 . . . . 0.0 114.355 173.883 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 tp -86.96 77.07 9.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.732 1.613 . . . . 0.0 107.482 169.009 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 47.07 36.09 3.95 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.552 1.941 . . . . 0.0 113.504 -169.84 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 143.84 -77.06 0.28 Allowed Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.715 1.626 . . . . 0.0 112.876 -178.617 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -65.4 126.88 92.33 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 125.185 1.394 . . . . 0.0 112.302 -176.192 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.3 121.72 7.03 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.725 2.283 . . . . 0.0 111.697 -177.673 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.4 mtm -65.04 142.6 58.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.98 0.912 . . . . 0.0 111.4 174.103 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -124.95 125.27 43.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.542 1.137 . . . . 0.0 110.032 176.126 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.1 mt -128.52 137.26 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.171 0.988 . . . . 0.0 110.987 -170.292 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -137.07 125.84 23.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.988 1.715 . . . . 0.0 111.043 -177.873 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 N--CA 1.467 0.387 0 C-N-CA 123.989 0.916 . . . . 0.0 108.643 169.885 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.897 0 N-CA-C 112.66 -0.176 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -140.57 133.49 29.19 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.886 1.275 . . . . 0.0 111.191 -176.912 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.5 mt -119.65 122.51 41.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.802 1.641 . . . . 0.0 111.746 176.112 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.4 tp -81.63 129.15 34.59 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.863 1.665 . . . . 0.0 106.852 168.401 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.01 132.86 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.669 1.188 . . . . 0.0 108.87 -176.226 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.9 m -137.46 163.02 32.1 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.205 1.802 . . . . 0.0 111.657 -172.229 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.4 t30 47.61 52.39 12.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.47 1.908 . . . . 0.0 113.158 -173.585 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.4 mt -84.22 168.87 15.32 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.834 1.654 . . . . 0.0 111.254 169.838 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.8 156.05 31.91 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.903 0.859 . . . . 0.0 112.039 169.624 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -77.41 -36.13 53.59 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.758 1.223 . . . . 0.0 112.15 -178.673 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.25 53.86 4.91 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.565 1.555 . . . . 0.0 112.539 -178.865 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.5 t -125.03 145.74 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.36 2.264 . . . . 0.0 111.57 -169.913 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.0 m -144.3 169.38 18.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.139 1.776 . . . . 0.0 111.819 -175.858 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -48.71 -57.82 5.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.773 2.029 . . . . 0.0 112.562 -178.089 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.19 87.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.189 1.395 . . . . 0.0 113.489 177.536 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.0 -52.2 66.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.151 0.98 . . . . 0.0 112.265 -179.839 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 36.2 mm -56.64 -52.45 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.882 0.873 . . . . 0.0 110.899 171.248 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -49.33 -56.18 10.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.014 0.926 . . . . 0.0 112.324 178.95 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -57.02 -52.37 65.55 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.853 0.861 . . . . 0.0 112.951 176.823 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.52 -46.43 90.19 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.893 0.77 . . . . 0.0 112.496 -176.851 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -65.09 -47.65 76.48 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.611 0.642 . . . . 0.0 112.438 174.492 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.52 64.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.244 1.017 . . . . 0.0 113.352 179.554 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.41 -45.29 72.9 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.43 1.092 . . . . 0.0 113.017 174.763 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -98.13 -19.06 18.15 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -177.41 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -159.98 153.51 24.49 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-N 120.356 1.435 . . . . 0.0 115.326 172.18 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 47.4 m -75.03 129.9 38.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.206 1.403 . . . . 0.0 111.42 -174.104 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 pp -135.62 147.04 48.49 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.643 1.177 . . . . 0.0 113.531 -174.032 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -73.91 -52.12 13.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.979 2.511 . . . . 0.0 110.246 170.03 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -150.07 153.37 36.32 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.144 1.778 . . . . 0.0 111.488 -177.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.55 133.82 27.97 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.929 1.691 . . . . 0.0 109.362 169.994 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.63 158.85 44.42 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.541 1.136 . . . . 0.0 113.754 -170.005 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 127.608 2.363 . . . . 0.0 108.67 169.901 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.912 0 CA-C-O 119.674 -0.514 . . . . 0.0 112.767 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.2 m -140.47 121.15 14.31 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.951 1.3 . . . . 0.0 111.528 -171.613 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.09 169.4 14.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.31 1.844 . . . . 0.0 113.232 -174.734 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -138.59 123.89 19.3 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.266 1.426 . . . . 0.0 110.832 -178.462 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.1 t -128.09 116.59 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.291 1.036 . . . . 0.0 110.904 -174.377 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -92.68 101.75 14.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.35 1.86 . . . . 0.0 108.336 179.062 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -77.38 166.56 22.97 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.653 1.981 . . . . 0.0 113.129 -178.753 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -54.26 -48.25 71.39 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 171.125 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -153.9 136.56 15.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 129.013 2.925 . . . . 0.0 109.516 -171.705 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -60.8 -37.87 83.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.086 0.954 . . . . 0.0 113.552 -176.825 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.4 -48.64 62.54 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.823 1.249 . . . . 0.0 113.093 169.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.12 -44.31 80.22 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.158 0.983 . . . . 0.0 112.021 173.654 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -51.87 -48.52 64.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.132 1.373 . . . . 0.0 112.853 175.12 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.5 tp -52.16 -43.47 64.12 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.49 1.916 . . . . 0.0 113.075 176.69 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -57.18 -55.19 37.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.111 0.965 . . . . 0.0 111.33 174.42 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.54 78.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.8 1.24 . . . . 0.0 112.55 175.263 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 23.6 ttp -50.61 -59.06 4.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.163 1.785 . . . . 0.0 111.272 175.488 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -56.43 -47.5 78.95 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.486 1.114 . . . . 0.0 112.44 177.572 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -58.26 -47.53 83.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.391 1.076 . . . . 0.0 113.279 179.118 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -95.22 -18.87 20.5 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -171.214 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -59.93 109.55 0.97 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 119.797 1.181 . . . . 0.0 110.591 169.684 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.25 -30.45 6.26 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.371 1.939 . . . . 0.0 113.714 -174.016 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.28 133.52 93.31 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 125.15 1.38 . . . . 0.0 110.766 -175.241 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.17 143.63 20.24 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.882 2.388 . . . . 0.0 112.94 -177.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 tp -125.29 107.38 10.65 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.85 2.06 . . . . 0.0 107.92 169.744 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 39.71 58.1 2.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.264 1.826 . . . . 0.0 112.463 -169.89 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.79 -45.4 2.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.122 1.344 . . . . 0.0 114.192 -179.563 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -73.13 116.59 52.3 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.23 1.412 . . . . 0.0 111.377 -171.012 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.8 114.54 3.74 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.68 2.253 . . . . 0.0 110.953 174.892 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.61 138.72 58.56 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.431 1.092 . . . . 0.0 111.754 -178.392 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -118.74 126.93 52.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.442 1.497 . . . . 0.0 109.586 175.236 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.6 mt -130.54 138.57 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.012 0.925 . . . . 0.0 111.173 -169.773 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -143.06 126.62 16.87 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.917 1.687 . . . . 0.0 111.518 -173.083 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.54 0.595 0 O-C-N 121.433 -0.792 . . . . 0.0 111.523 170.139 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.21 0 N-CA-C 111.489 -0.645 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -127.21 107.37 9.95 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.868 1.267 . . . . 0.0 110.413 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -108.91 105.56 15.16 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.283 1.833 . . . . 0.0 109.229 -169.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.6 tp -89.51 132.86 34.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.775 2.03 . . . . 0.0 110.171 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.2 t -127.44 123.43 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.928 1.691 . . . . 0.0 109.379 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.3 m -127.01 160.38 31.3 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.774 1.629 . . . . 0.0 111.868 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.0 t30 54.37 46.34 25.29 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.519 1.928 . . . . 0.0 113.792 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.4 mt -78.48 157.29 28.95 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.151 1.381 . . . . 0.0 109.371 169.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -64.3 147.13 53.17 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.054 -1.029 . . . . 0.0 112.269 173.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -57.08 -28.8 62.93 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -81.8 -2.4 90.53 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.229 1.395 . . . . 0.0 115.375 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 80.9 t -66.78 140.19 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.122 1.461 . . . . 0.0 111.067 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.1 m -121.11 158.05 28.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.412 1.485 . . . . 0.0 112.694 -174.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.01 -57.34 10.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.345 1.858 . . . . 0.0 112.996 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.55 89.73 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.557 1.143 . . . . 0.0 113.242 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -59.11 -50.43 74.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.176 0.99 . . . . 0.0 112.099 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 mm -55.24 -52.18 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.124 0.97 . . . . 0.0 111.467 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -52.27 -51.74 56.75 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.846 0.859 . . . . 0.0 112.201 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -59.05 -53.39 58.94 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.98 1.312 . . . . 0.0 113.156 174.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.99 -43.16 99.55 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.29 0.95 . . . . 0.0 112.446 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -64.92 -41.73 95.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.73 -29.95 69.68 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 175.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.34 -57.08 12.65 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.068 0.947 . . . . 0.0 112.562 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -91.71 -16.68 26.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.95 -178.93 16.12 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.474 1.512 . . . . 0.0 114.84 -172.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.57 107.46 12.44 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.448 1.899 . . . . 0.0 110.257 -169.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 pp -132.29 148.83 52.46 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -83.76 -51.49 7.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.725 2.41 . . . . 0.0 110.511 170.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.24 148.55 30.6 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.784 1.633 . . . . 0.0 111.374 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.61 131.83 23.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.902 1.281 . . . . 0.0 110.841 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.58 157.8 44.33 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.372 1.469 . . . . 0.0 113.063 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -119.89 152.96 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 126.486 1.914 . . . . 0.0 110.819 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -50.44 -46.54 56.59 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.661 1.984 . . . . 0.0 115.364 -169.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -62.76 124.44 21.04 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.852 0.861 . . . . 0.0 112.195 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -150.76 -71.28 0.17 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.5 1.12 . . . . 0.0 111.45 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -128.43 63.86 1.43 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.595 1.958 . . . . 0.0 108.549 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.3 p -152.41 -71.13 0.15 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.932 1.693 . . . . 0.0 111.548 -169.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.92 56.76 12.89 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.166 1.365 . . . . 0.0 112.077 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.07 134.5 48.12 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.304 1.842 . . . . 0.0 111.328 -172.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 m -67.72 106.89 2.38 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.478 1.511 . . . . 0.0 111.664 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.5 tp -141.69 -73.89 0.32 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.452 1.501 . . . . 0.0 110.842 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.7 81.76 1.52 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.151 1.357 . . . . 0.0 111.63 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.8 m -147.48 144.59 28.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.831 1.652 . . . . 0.0 109.708 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -143.44 163.03 34.24 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.498 1.519 . . . . 0.0 112.478 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -143.02 133.97 25.54 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.155 1.382 . . . . 0.0 110.848 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.62 118.24 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.192 1.397 . . . . 0.0 110.004 -176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -81.75 100.75 9.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.661 1.585 . . . . 0.0 108.266 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -80.29 154.88 27.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.171 1.788 . . . . 0.0 112.724 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -76.19 -30.65 58.1 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.832 1.253 . . . . 0.0 111.733 169.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -141.04 116.26 9.97 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.218 1.807 . . . . 0.0 111.249 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -28.63 68.77 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.84 -48.17 81.77 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.881 0.872 . . . . 0.0 111.972 171.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.79 -39.51 94.43 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.675 1.19 . . . . 0.0 112.214 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.07 83.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.376 1.071 . . . . 0.0 112.508 169.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.8 tp -59.36 -44.33 92.73 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.187 1.395 . . . . 0.0 111.746 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.6 tttm -51.33 -55.21 19.62 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.781 1.232 . . . . 0.0 110.955 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.97 -48.3 76.06 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.383 1.073 . . . . 0.0 112.846 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 25.8 ttt -51.18 -60.54 3.0 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.831 1.653 . . . . 0.0 111.399 174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -56.84 -44.98 82.63 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.132 0.973 . . . . 0.0 112.695 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -59.77 -44.51 93.84 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.854 1.262 . . . . 0.0 113.545 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -109.9 -16.69 13.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -59.8 115.37 3.33 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.34 1.427 . . . . 0.0 111.196 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.33 -24.78 26.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.992 1.758 . . . . 0.0 114.026 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.4 t -69.05 132.96 90.03 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 124.594 1.158 . . . . 0.0 110.628 -176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.45 142.27 23.47 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.932 2.421 . . . . 0.0 112.44 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 64.6 tp -128.14 105.32 8.29 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.647 1.979 . . . . 0.0 107.694 170.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 49.27 57.74 6.15 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.402 1.481 . . . . 0.0 111.272 -169.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.21 -54.06 4.93 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.311 1.434 . . . . 0.0 113.48 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -59.87 119.25 39.48 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 126.43 1.892 . . . . 0.0 112.103 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.58 120.7 6.87 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.952 2.435 . . . . 0.0 111.29 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.0 mtm -65.07 138.53 58.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.309 1.044 . . . . 0.0 111.059 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -122.47 125.53 46.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.643 1.177 . . . . 0.0 110.062 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.3 mt -124.46 141.19 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.508 1.123 . . . . 0.0 111.671 -169.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -139.69 146.04 39.14 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.701 2.0 . . . . 0.0 110.869 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 66.5 tp -123.97 137.32 54.63 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.244 1.418 . . . . 0.0 111.889 -176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.73 148.13 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 127.307 2.243 . . . . 0.0 109.404 176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 9.4 m -142.49 138.98 31.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.053 1.341 . . . . 0.0 109.974 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.7 m . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.413 1.885 . . . . 0.0 114.133 -178.688 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' HA3' ' HE2' ' A' ' 155' ' ' LYS . . . . . . . . 0 N--CA 1.469 0.85 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -78.03 96.22 5.04 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.1 0.96 . . . . 0.0 110.963 -174.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -88.59 101.17 13.69 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.353 1.861 . . . . 0.0 107.426 169.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.4 tp -88.21 133.73 33.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.585 1.954 . . . . 0.0 110.028 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -123.89 136.84 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.41 1.484 . . . . 0.0 109.571 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.0 m -140.34 167.92 21.03 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.451 1.9 . . . . 0.0 111.934 -171.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.7 t30 51.44 46.81 25.93 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.346 1.858 . . . . 0.0 113.006 -173.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.8 mt -87.12 167.1 14.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.845 1.658 . . . . 0.0 109.993 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -75.45 150.58 38.24 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 120.964 -1.085 . . . . 0.0 110.603 169.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -49.44 -41.77 40.99 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.504 1.121 . . . . 0.0 113.546 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.71 9.46 73.85 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.712 1.625 . . . . 0.0 115.761 -173.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.45 147.54 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.046 1.423 . . . . 0.0 109.528 169.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -129.94 155.61 45.78 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -45.75 -58.14 3.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.527 2.331 . . . . 0.0 112.101 175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.91 -47.63 80.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.38 1.472 . . . . 0.0 113.168 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -59.12 -52.55 65.24 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.51 1.124 . . . . 0.0 112.143 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.5 mm -57.81 -51.52 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.739 1.216 . . . . 0.0 111.229 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -48.46 -54.21 15.03 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.939 1.295 . . . . 0.0 111.918 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.3 -53.75 53.88 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.663 0.785 . . . . 0.0 112.75 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.15 -45.12 89.87 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.799 0.727 . . . . 0.0 112.567 -173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -64.71 -43.25 94.03 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.786 0.721 . . . . 0.0 112.382 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.24 -32.77 66.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -57.62 -41.67 81.8 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.205 1.002 . . . . 0.0 113.16 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -113.25 -10.14 13.37 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -174.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.67 162.14 28.65 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.816 1.198 . . . . 0.0 114.382 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.26 108.55 19.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.764 1.626 . . . . 0.0 110.087 -169.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.9 pp -130.91 152.93 49.69 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.2 mmmt -93.56 -49.39 5.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 128.998 2.919 . . . . 0.0 111.111 -178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 37.3 tptt -145.87 143.02 29.34 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.228 1.411 . . . . 0.0 111.28 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -126.94 135.9 51.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.677 1.591 . . . . 0.0 110.556 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.3 166.09 25.65 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.796 2.038 . . . . 0.0 111.7 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 88.3 t -134.72 159.35 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.942 1.697 . . . . 0.0 110.8 -173.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -38.75 -48.61 1.52 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.772 2.029 . . . . 0.0 115.944 -171.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -65.88 -16.12 63.55 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -80.96 -55.28 4.89 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.569 169.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -68.03 -36.98 80.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.004 1.722 . . . . 0.0 113.754 -175.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.8 m -135.65 -174.88 3.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.226 2.61 . . . . 0.0 110.867 -176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.59 -66.62 2.08 Favored Glycine 0 CA--C 1.536 1.373 0 O-C-N 120.978 -1.076 . . . . 0.0 111.891 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.25 139.19 19.96 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.178 2.191 . . . . 0.0 109.494 173.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.5 m -127.31 173.28 9.9 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.601 1.16 . . . . 0.0 111.261 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.68 -40.18 78.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.486 0.714 . . . . 0.0 112.357 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.91 96.88 0.12 Allowed Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.428 1.49 . . . . 0.0 111.169 171.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 65.4 p -139.19 156.37 47.16 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.684 1.193 . . . . 0.0 112.739 -175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.06 159.37 42.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.325 1.85 . . . . 0.0 111.378 172.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.63 115.03 9.86 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.734 1.614 . . . . 0.0 109.801 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.2 t -127.7 115.54 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.238 1.015 . . . . 0.0 110.249 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -80.83 104.75 11.55 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.366 1.467 . . . . 0.0 109.457 169.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -82.08 155.13 25.24 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.68 1.592 . . . . 0.0 112.163 171.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -80.46 -59.54 2.66 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.401 -0.812 . . . . 0.0 112.323 169.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -88.65 126.99 35.56 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.163 1.385 . . . . 0.0 111.441 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.411 ' HE2' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -62.72 -46.13 89.52 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.127 1.371 . . . . 0.0 111.822 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.45 -46.22 87.0 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.761 1.224 . . . . 0.0 112.306 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -65.75 -36.61 84.04 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.061 0.945 . . . . 0.0 112.928 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.02 -48.17 83.03 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.291 -0.88 . . . . 0.0 111.936 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.96 -42.79 90.7 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.551 1.14 . . . . 0.0 112.377 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -51.74 -57.79 8.26 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.777 1.631 . . . . 0.0 110.427 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.31 -51.11 60.48 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.725 1.21 . . . . 0.0 112.425 177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 21.9 ttt -49.62 -62.45 1.55 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.162 1.385 . . . . 0.0 111.667 173.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -57.57 -49.16 77.28 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.622 1.169 . . . . 0.0 112.974 -176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -63.24 -48.01 80.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.868 0.867 . . . . 0.0 113.258 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -95.05 -13.74 24.91 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -60.28 108.27 0.77 Allowed 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.87 1.214 . . . . 0.0 110.739 169.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 119.06 -30.63 5.78 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.345 1.926 . . . . 0.0 113.933 -173.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.4 134.57 90.96 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 125.168 1.387 . . . . 0.0 110.635 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.41 146.05 24.32 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.822 2.348 . . . . 0.0 113.334 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 37.3 tp -135.65 108.53 7.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.762 1.625 . . . . 0.0 108.425 169.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 50.16 63.25 2.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.694 1.597 . . . . 0.0 111.654 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.48 -63.05 4.53 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.174 1.369 . . . . 0.0 113.384 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -63.56 131.94 95.01 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.184 1.393 . . . . 0.0 112.408 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 123.61 9.38 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.749 2.966 . . . . 0.0 111.694 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.17 132.28 49.92 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.289 1.035 . . . . 0.0 111.55 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -110.14 130.38 55.55 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.2 1.4 . . . . 0.0 109.124 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.3 mt -128.59 143.37 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.846 0.859 . . . . 0.0 111.857 -169.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -140.06 146.18 38.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.243 2.217 . . . . 0.0 110.431 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -132.79 129.3 38.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.099 1.36 . . . . 0.0 110.581 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.58 142.71 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.958 1.303 . . . . 0.0 111.797 171.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 6.3 m -64.36 148.1 51.13 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.595 1.958 . . . . 0.0 113.071 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 C--O 1.252 1.219 0 C-N-CA 127.075 2.15 . . . . 0.0 113.851 173.839 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.04 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -102.94 119.59 39.12 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.14 1.376 . . . . 0.0 110.64 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 87.6 mt -127.34 131.72 50.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.494 1.518 . . . . 0.0 111.618 -171.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.9 tp -77.42 137.99 39.01 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.481 1.513 . . . . 0.0 109.091 169.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.9 122.75 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 126.324 1.85 . . . . 0.0 108.087 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.9 m -133.75 169.24 17.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.917 1.287 . . . . 0.0 112.937 -169.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.3 t30 54.81 46.18 25.07 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.788 2.035 . . . . 0.0 113.079 -173.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 mt -82.37 165.59 20.16 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.485 1.514 . . . . 0.0 110.057 169.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -74.48 145.87 43.22 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.006 -1.058 . . . . 0.0 111.317 169.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -58.03 -26.37 62.35 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.59 -1.56 90.09 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.117 1.341 . . . . 0.0 115.477 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.4 138.39 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.229 1.514 . . . . 0.0 111.232 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.2 m -113.45 155.9 24.48 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.172 1.389 . . . . 0.0 113.124 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.05 -57.27 11.69 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.604 1.961 . . . . 0.0 112.991 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.66 -39.29 93.45 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.214 1.005 . . . . 0.0 112.919 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -56.86 -50.42 72.52 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.294 -0.879 . . . . 0.0 111.853 177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.1 mm -55.15 -53.38 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.446 1.098 . . . . 0.0 111.741 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -47.84 -59.47 3.3 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.611 0.765 . . . . 0.0 111.76 177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -63.54 -43.28 97.57 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -47.0 81.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.743 1.156 . . . . 0.0 111.93 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -64.71 -40.69 95.78 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.99 -17.11 61.75 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 175.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.33 -59.03 3.11 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.915 -1.116 . . . . 0.0 111.786 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -88.16 -21.85 24.38 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.13 -178.31 15.26 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.652 1.596 . . . . 0.0 113.234 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.6 m -125.21 122.31 36.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.238 1.415 . . . . 0.0 109.549 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 pp -132.66 147.09 52.33 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -91.2 -34.89 14.82 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.454 1.902 . . . . 0.0 110.949 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.2 ttmm -137.16 142.35 42.2 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.962 1.305 . . . . 0.0 112.41 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.42 128.96 12.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.478 1.511 . . . . 0.0 109.992 169.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.0 153.25 37.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.666 1.186 . . . . 0.0 112.876 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.6 t -117.83 149.22 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 126.488 1.915 . . . . 0.0 110.009 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -51.92 -40.23 60.4 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -68.94 159.17 33.19 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -170.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -144.92 -59.15 0.36 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.255 1.422 . . . . 0.0 111.709 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -130.82 -45.55 1.05 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.934 1.693 . . . . 0.0 113.205 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 60.8 p -55.45 -53.63 53.85 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.355 1.862 . . . . 0.0 114.052 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.57 39.73 78.56 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.011 1.291 . . . . 0.0 113.028 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -60.06 152.39 24.19 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.299 1.839 . . . . 0.0 113.243 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 39.5 m -73.13 82.09 1.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.088 1.355 . . . . 0.0 111.399 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 50.0 tp -146.39 152.05 38.45 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.998 2.119 . . . . 0.0 109.737 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.99 70.4 0.52 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.019 1.295 . . . . 0.0 111.996 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 55.6 p -133.7 146.21 50.6 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.315 1.446 . . . . 0.0 112.81 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.41 171.99 15.67 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.291 2.236 . . . . 0.0 111.35 -174.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -143.68 135.86 26.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.889 1.676 . . . . 0.0 110.46 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.51 129.23 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.585 1.154 . . . . 0.0 110.064 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -109.1 96.91 6.63 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.357 1.463 . . . . 0.0 108.889 173.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -73.03 140.41 47.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 127.005 2.122 . . . . 0.0 110.103 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.81 -16.97 63.37 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 28.8 mtm105 -134.82 134.12 40.49 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.224 1.81 . . . . 0.0 110.893 -175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -55.27 -46.63 76.13 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.208 1.403 . . . . 0.0 112.575 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.96 -51.56 61.06 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.256 1.022 . . . . 0.0 112.028 173.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.55 -41.39 98.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.626 1.17 . . . . 0.0 113.077 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.67 -56.56 17.88 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.692 1.197 . . . . 0.0 111.637 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 84.0 mt -59.18 -42.28 90.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.254 1.422 . . . . 0.0 112.561 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -52.12 -61.69 2.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.162 1.385 . . . . 0.0 110.89 170.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.01 -47.86 67.99 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.657 1.183 . . . . 0.0 112.601 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 35.8 ttp -51.13 -60.72 2.81 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.411 1.484 . . . . 0.0 111.29 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -59.3 -45.04 92.38 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.87 1.268 . . . . 0.0 112.879 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -58.71 -48.37 81.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.483 1.113 . . . . 0.0 113.362 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -103.48 -17.33 15.26 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -60.85 111.13 1.53 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 120.273 1.397 . . . . 0.0 111.142 170.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.05 -22.46 27.44 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.146 1.831 . . . . 0.0 114.39 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 76.3 t -70.12 133.18 87.85 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 118.573 1.186 . . . . 0.0 110.83 -175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.14 139.14 21.13 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.898 2.398 . . . . 0.0 112.505 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.0 tp -126.65 106.16 9.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.671 1.988 . . . . 0.0 107.887 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 47.86 57.89 5.58 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.484 1.513 . . . . 0.0 111.321 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 85.64 -54.4 4.8 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.228 1.394 . . . . 0.0 113.468 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.44 119.07 43.33 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.962 1.705 . . . . 0.0 112.44 -172.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.09 117.83 5.36 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.884 2.389 . . . . 0.0 111.076 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.53 141.43 58.77 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.596 1.158 . . . . 0.0 111.906 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -122.91 130.86 53.37 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.326 1.45 . . . . 0.0 110.249 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.7 mm -117.48 133.35 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.533 1.133 . . . . 0.0 109.918 -175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -140.34 151.56 45.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.835 1.254 . . . . 0.0 112.684 -171.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -134.72 174.47 10.54 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.839 2.056 . . . . 0.0 112.052 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.66 103.53 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.111 1.364 . . . . 0.0 108.822 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.0 p -65.95 -54.53 25.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.554 1.142 . . . . 0.0 112.188 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.25 1.115 0 C-N-CA 127.176 2.19 . . . . 0.0 112.145 179.909 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 N-CA-C 111.818 -0.513 . . . . 0.0 111.818 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -75.65 126.75 31.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.979 1.312 . . . . 0.0 111.74 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -137.69 111.45 8.22 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.514 1.926 . . . . 0.0 110.274 -169.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.2 tp -85.52 132.78 34.14 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.769 2.028 . . . . 0.0 110.062 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.2 t -122.47 112.74 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.428 1.491 . . . . 0.0 108.447 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.7 m -117.91 164.13 15.51 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.311 1.044 . . . . 0.0 111.887 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 t30 54.73 47.67 21.94 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.324 1.85 . . . . 0.0 114.217 -176.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.28 152.41 32.51 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.907 1.283 . . . . 0.0 108.932 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -66.71 147.36 53.37 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.869 -1.144 . . . . 0.0 110.789 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -54.93 -28.68 52.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.488 1.115 . . . . 0.0 113.881 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.67 1.02 85.32 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.329 1.442 . . . . 0.0 115.779 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.6 t -66.7 114.75 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 119.926 1.863 . . . . 0.0 110.484 175.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.5 m -70.73 151.99 44.29 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.784 1.234 . . . . 0.0 112.598 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -55.18 -48.52 73.67 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.486 1.514 . . . . 0.0 112.751 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.19 76.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.221 1.408 . . . . 0.0 113.665 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -58.5 -53.86 53.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.116 0.966 . . . . 0.0 112.807 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.5 mm -54.59 -55.48 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.342 1.057 . . . . 0.0 110.999 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -49.34 -55.74 11.86 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.255 1.422 . . . . 0.0 111.875 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.43 -49.81 76.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.533 1.133 . . . . 0.0 113.311 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.28 -43.92 95.83 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.215 0.916 . . . . 0.0 111.417 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -66.71 -44.98 80.17 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.862 1.265 . . . . 0.0 112.708 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.0 -14.42 54.0 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -69.78 -63.46 1.07 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.919 -1.113 . . . . 0.0 111.479 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -83.28 -21.11 33.38 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.4 -168.76 11.68 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.151 1.834 . . . . 0.0 112.921 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 m -140.91 129.23 22.37 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.42 1.088 . . . . 0.0 110.618 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -136.54 152.57 50.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -171.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -83.0 -51.81 7.23 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.74 2.416 . . . . 0.0 111.133 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -146.54 147.92 31.64 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.084 1.353 . . . . 0.0 112.387 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.36 137.55 27.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.954 1.702 . . . . 0.0 110.825 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.42 116.19 6.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.727 1.211 . . . . 0.0 112.557 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.6 t -83.08 142.8 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.486 1.514 . . . . 0.0 109.755 169.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -45.57 -46.35 14.13 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 127.257 2.223 . . . . 0.0 115.034 -169.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -56.78 -18.17 11.77 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -174.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -50.0 -36.32 28.07 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.994 1.717 . . . . 0.0 112.613 169.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -137.5 -45.75 0.55 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.305 1.842 . . . . 0.0 114.101 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.2 m -77.24 95.96 4.44 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.838 1.255 . . . . 0.0 110.932 173.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.1 58.96 4.32 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.004 0.811 . . . . 0.0 113.312 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -142.1 164.96 28.74 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.598 1.559 . . . . 0.0 113.679 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.9 m -73.21 113.24 10.05 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.481 1.112 . . . . 0.0 109.084 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 60.5 tp -147.8 -76.52 0.17 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.017 1.327 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.52 77.65 1.36 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 125.124 1.345 . . . . 0.0 111.41 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.2 m -150.5 153.06 35.16 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.64 1.576 . . . . 0.0 109.757 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.55 156.69 43.85 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.266 1.426 . . . . 0.0 112.513 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -123.2 131.67 53.77 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.816 1.646 . . . . 0.0 109.805 173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.01 144.3 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.33 1.452 . . . . 0.0 109.722 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -126.29 102.78 7.33 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.99 1.716 . . . . 0.0 108.949 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -78.13 166.38 22.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.869 1.668 . . . . 0.0 112.706 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -61.31 -35.39 77.23 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.085 0.954 . . . . 0.0 112.796 170.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.74 147.03 34.93 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.44 1.496 . . . . 0.0 112.474 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -55.07 -46.02 75.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.437 1.495 . . . . 0.0 112.587 170.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -50.95 -48.11 60.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.395 1.078 . . . . 0.0 112.8 172.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.21 -39.17 82.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.1 0.96 . . . . 0.0 112.568 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.08 -45.85 86.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.72 0.808 . . . . 0.0 112.035 169.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 28.4 tp -60.63 -44.15 96.71 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.372 1.469 . . . . 0.0 111.839 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -52.7 -54.54 32.16 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.185 1.394 . . . . 0.0 111.408 171.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.52 -51.67 58.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.772 1.229 . . . . 0.0 112.378 173.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 30.8 ttp -52.54 -62.4 1.67 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.581 1.552 . . . . 0.0 111.286 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -57.14 -45.15 83.79 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.742 1.217 . . . . 0.0 112.755 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -60.87 -46.69 89.6 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.351 1.06 . . . . 0.0 113.042 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -107.75 -12.28 15.25 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -169.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -59.23 119.54 7.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.294 1.406 . . . . 0.0 111.583 172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 97.89 -18.22 57.54 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.019 1.771 . . . . 0.0 114.323 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.8 t -72.29 128.09 89.35 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 118.839 1.319 . . . . 0.0 111.077 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.12 136.16 71.0 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.943 3.096 . . . . 0.0 113.844 172.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.0 tp -133.77 103.46 5.87 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.495 1.518 . . . . 0.0 107.567 169.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 51.32 62.28 2.79 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.8 1.64 . . . . 0.0 111.08 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.86 -61.64 4.71 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.467 1.508 . . . . 0.0 113.343 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -65.09 125.2 88.77 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.681 1.592 . . . . 0.0 112.118 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.8 126.23 9.96 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.486 2.791 . . . . 0.0 111.631 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -68.29 120.54 14.59 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.312 1.045 . . . . 0.0 111.797 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -94.17 103.49 15.53 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.92 1.288 . . . . 0.0 108.921 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -113.5 134.23 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.311 1.045 . . . . 0.0 110.862 -169.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -142.59 123.0 13.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.534 1.534 . . . . 0.0 112.157 -171.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.32 122.44 24.43 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 169.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.85 80.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 122.488 1.137 . . . . 0.0 112.051 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 7.6 p -80.25 135.0 36.16 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.66 1.184 . . . . 0.0 111.445 169.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 37.1 m . . . . . 0 C--O 1.252 1.215 0 C-N-CA 126.583 1.953 . . . . 0.0 113.945 -178.163 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 CA-C-O 121.427 0.46 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -139.59 150.75 45.39 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.372 1.469 . . . . 0.0 112.08 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.5 mt -125.42 144.52 50.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.964 1.706 . . . . 0.0 111.204 171.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.5 tp -117.02 99.91 7.39 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.874 1.669 . . . . 0.0 107.579 169.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.21 129.18 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.594 1.557 . . . . 0.0 108.174 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.6 m -133.28 170.85 14.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.249 1.42 . . . . 0.0 111.947 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.3 t30 56.93 38.48 29.42 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.207 1.803 . . . . 0.0 113.269 -175.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.07 165.31 20.72 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.294 1.437 . . . . 0.0 110.552 169.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -69.76 144.34 52.75 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.39 -0.819 . . . . 0.0 109.811 168.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -56.63 -33.68 66.54 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.94 27.76 16.35 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.499 1.523 . . . . 0.0 115.244 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.59 124.74 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 118.912 1.356 . . . . 0.0 109.652 169.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.8 m -72.0 135.21 46.31 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.548 0.739 . . . . 0.0 112.031 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.38 -47.74 80.87 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.493 1.117 . . . . 0.0 112.935 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.38 -46.91 76.5 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.689 1.196 . . . . 0.0 112.702 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -58.27 -48.03 81.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.179 0.992 . . . . 0.0 112.117 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 mm -55.37 -53.65 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.454 1.102 . . . . 0.0 112.087 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -50.16 -55.39 15.29 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 118.697 0.681 . . . . 0.0 111.474 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -56.66 -52.06 66.34 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.483 1.113 . . . . 0.0 113.228 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.31 -44.92 90.09 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.12 0.873 . . . . 0.0 112.367 -175.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -63.48 -43.48 97.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.579 0.627 . . . . 0.0 112.557 174.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.2 -19.6 64.66 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.27 -63.24 1.12 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.185 0.994 . . . . 0.0 111.724 172.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.08 -19.17 44.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -175.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -138.32 -177.33 15.18 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.336 1.446 . . . . 0.0 113.959 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.7 m -124.62 116.11 21.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.512 1.525 . . . . 0.0 110.238 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.92 144.72 50.57 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -169.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -81.6 -42.71 19.67 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.947 2.099 . . . . 0.0 109.991 169.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -147.31 145.47 29.37 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.687 1.595 . . . . 0.0 111.915 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.16 114.7 7.62 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.894 1.677 . . . . 0.0 108.126 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.63 113.37 10.96 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.613 1.165 . . . . 0.0 112.165 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.79 153.9 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.325 1.45 . . . . 0.0 110.469 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -42.94 -48.55 5.91 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.715 2.006 . . . . 0.0 115.829 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -73.57 148.59 42.82 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -170.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -145.65 -63.68 0.33 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.984 1.714 . . . . 0.0 109.298 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -133.75 77.15 1.7 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 127.965 2.506 . . . . 0.0 105.394 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.6 m -135.84 166.31 23.6 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.225 1.41 . . . . 0.0 113.928 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -163.51 65.01 0.24 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.151 1.357 . . . . 0.0 112.158 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -136.41 148.72 47.93 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.16 1.784 . . . . 0.0 112.107 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 55.1 m -74.37 86.12 1.99 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.96 1.304 . . . . 0.0 109.955 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.6 tp -140.73 142.63 34.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.326 2.25 . . . . 0.0 109.161 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.39 70.75 0.41 Allowed Glycine 0 N--CA 1.469 0.86 0 C-N-CA 123.855 0.74 . . . . 0.0 113.025 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 71.5 p -136.79 158.73 43.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.199 1.4 . . . . 0.0 112.958 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.73 138.43 23.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.496 1.518 . . . . 0.0 111.849 172.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -106.92 124.9 50.29 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.578 1.951 . . . . 0.0 110.431 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.3 t -129.34 139.31 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.008 1.323 . . . . 0.0 110.115 -171.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -128.96 120.33 25.91 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 126.919 2.088 . . . . 0.0 109.199 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -103.31 163.59 12.17 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.581 1.952 . . . . 0.0 113.341 -169.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -76.35 -36.13 58.36 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 169.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 42.5 mtm-85 -133.77 129.1 36.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.082 1.753 . . . . 0.0 111.278 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -54.68 -45.87 74.0 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.597 1.559 . . . . 0.0 113.083 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.65 -46.72 70.66 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.925 1.29 . . . . 0.0 112.801 172.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.08 -42.84 93.76 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.466 1.106 . . . . 0.0 112.696 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.85 -50.22 71.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.707 0.803 . . . . 0.0 111.734 169.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.9 tp -56.65 -47.03 80.66 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.535 1.134 . . . . 0.0 112.58 175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -50.81 -58.96 4.66 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.863 1.265 . . . . 0.0 111.165 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.4 -48.12 62.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.355 1.062 . . . . 0.0 112.659 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -55.29 -65.55 0.57 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.071 1.348 . . . . 0.0 111.322 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -61.61 -34.11 75.08 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -173.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -64.05 -42.02 97.18 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.524 1.13 . . . . 0.0 113.403 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -110.66 -18.43 13.16 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -169.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -59.24 115.4 3.18 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.875 1.216 . . . . 0.0 111.19 170.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 103.78 -23.46 32.47 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.857 1.694 . . . . 0.0 114.403 -175.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.3 t -68.8 134.87 90.06 Favored Pre-proline 0 N--CA 1.477 0.924 0 CA-C-N 118.643 1.221 . . . . 0.0 110.216 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.35 141.85 29.29 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.671 2.248 . . . . 0.0 112.93 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -125.33 99.97 6.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.46 2.304 . . . . 0.0 106.855 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 44.02 70.53 0.31 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.992 1.717 . . . . 0.0 111.902 -169.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.6 -57.63 5.05 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.781 1.657 . . . . 0.0 113.531 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -65.76 122.76 82.33 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.996 2.119 . . . . 0.0 112.369 -172.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.79 123.87 10.15 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.867 2.378 . . . . 0.0 111.088 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.1 mtm -61.61 123.6 18.34 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.064 0.945 . . . . 0.0 111.091 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -106.83 104.89 14.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.236 1.414 . . . . 0.0 109.123 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.3 mt -106.76 130.31 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.144 0.978 . . . . 0.0 110.85 -172.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -109.43 147.08 33.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.531 1.933 . . . . 0.0 109.627 173.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -132.73 150.0 52.21 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.249 1.419 . . . . 0.0 112.386 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.45 127.56 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.51 0.724 . . . . 0.0 111.343 175.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.6 p -68.21 -58.77 3.91 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.396 1.478 . . . . 0.0 111.959 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.251 1.159 0 C-N-CA 127.134 2.174 . . . . 0.0 113.76 177.01 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.9 0 CA-C-O 120.823 0.124 . . . . 0.0 113.153 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -117.58 103.73 10.35 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.08 1.752 . . . . 0.0 109.626 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -88.55 105.37 17.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.575 2.35 . . . . 0.0 108.994 -173.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.1 tp -88.88 122.65 32.48 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.756 2.022 . . . . 0.0 109.983 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.8 t -112.11 136.55 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.101 1.76 . . . . 0.0 109.115 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.2 m -137.52 163.13 31.9 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.188 1.795 . . . . 0.0 112.307 -174.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.1 t30 57.01 33.5 23.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.933 2.093 . . . . 0.0 113.918 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.9 mt -72.0 159.03 34.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.139 0.975 . . . . 0.0 110.28 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -66.83 139.81 57.78 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.535 -0.728 . . . . 0.0 110.571 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.75 -20.9 62.33 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -98.82 11.9 62.59 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.717 1.627 . . . . 0.0 115.558 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.5 t -61.06 123.99 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 119.719 1.76 . . . . 0.0 110.33 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.6 m -81.84 149.13 28.47 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.445 1.098 . . . . 0.0 113.105 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.34 -54.11 50.56 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.85 1.66 . . . . 0.0 112.69 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.08 -39.33 81.81 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.57 1.148 . . . . 0.0 112.951 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.43 -51.05 71.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.835 0.854 . . . . 0.0 111.979 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.9 mm -55.0 -53.06 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.922 0.889 . . . . 0.0 111.511 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -50.07 -55.32 15.34 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.796 0.839 . . . . 0.0 111.973 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -59.55 -50.96 71.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.964 1.306 . . . . 0.0 113.212 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -63.36 -43.55 97.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.271 0.941 . . . . 0.0 111.886 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -63.4 -44.99 93.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.062 0.545 . . . . 0.0 112.427 172.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.03 -31.87 67.42 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.5 -52.53 65.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.265 1.026 . . . . 0.0 112.77 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -95.59 -23.67 16.94 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.29 162.04 23.62 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.373 1.463 . . . . 0.0 114.458 -172.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 37.5 m -102.49 103.34 13.7 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.471 1.508 . . . . 0.0 110.424 -173.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -121.48 165.05 16.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 -35.88 2.85 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.776 2.431 . . . . 0.0 111.557 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -140.58 151.09 44.41 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.61 0.764 . . . . 0.0 111.924 173.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.25 141.89 35.82 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.738 1.615 . . . . 0.0 110.446 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -146.92 152.33 38.49 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.983 1.713 . . . . 0.0 111.608 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.0 t -132.14 147.0 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.1 1.76 . . . . 0.0 109.875 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -55.14 -40.92 71.13 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -58.08 155.94 10.26 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -168.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -143.65 -175.6 4.63 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 128.685 2.794 . . . . 0.0 108.095 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -46.57 -39.35 10.87 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.722 1.609 . . . . 0.0 114.177 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.7 m -60.4 -32.19 71.09 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.315 1.846 . . . . 0.0 114.598 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 60.64 50.58 65.99 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.833 1.682 . . . . 0.0 114.398 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -66.76 144.96 56.02 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.737 1.215 . . . . 0.0 113.83 -174.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 45.7 m -73.61 94.59 2.19 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.691 1.596 . . . . 0.0 111.186 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.7 tp -143.89 -66.16 0.36 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.741 1.616 . . . . 0.0 110.745 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.3 68.14 1.52 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.873 0.749 . . . . 0.0 113.344 171.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 78.1 p -137.08 155.69 49.32 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.469 1.108 . . . . 0.0 112.257 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -143.69 158.81 43.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.417 1.487 . . . . 0.0 111.649 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -139.84 120.63 14.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.533 1.533 . . . . 0.0 110.135 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 51.5 t -124.52 118.7 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.143 1.377 . . . . 0.0 109.723 -174.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -93.04 105.55 17.64 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.712 1.205 . . . . 0.0 108.502 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -82.6 152.38 25.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.643 2.777 . . . . 0.0 112.103 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -62.93 -48.36 79.24 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.153 0.581 . . . . 0.0 112.276 170.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -123.92 138.44 54.48 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.854 1.262 . . . . 0.0 112.302 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -59.24 -46.75 87.64 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.559 1.544 . . . . 0.0 112.966 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.72 62.64 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.764 1.226 . . . . 0.0 113.484 174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.51 -43.28 85.71 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.834 0.853 . . . . 0.0 112.32 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.87 -46.51 84.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.101 0.96 . . . . 0.0 112.514 170.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -56.85 -47.75 79.64 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.941 2.097 . . . . 0.0 111.182 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -51.65 -52.91 44.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.425 1.09 . . . . 0.0 111.841 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.1 -47.03 78.82 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.732 0.813 . . . . 0.0 112.845 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 41.1 ttp -53.1 -60.7 2.96 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.466 1.507 . . . . 0.0 111.454 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -35.64 80.95 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -61.63 -45.93 91.95 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.381 1.072 . . . . 0.0 113.166 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -106.11 -17.38 14.34 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 -169.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -59.65 114.75 2.9 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 120.204 1.366 . . . . 0.0 111.335 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.71 -23.47 26.02 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.178 1.846 . . . . 0.0 114.138 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 65.7 t -67.82 131.97 92.49 Favored Pre-proline 0 N--CA 1.476 0.866 0 CA-C-N 118.596 1.198 . . . . 0.0 110.886 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.92 121.54 5.46 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.309 2.673 . . . . 0.0 111.972 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 24.2 tp -77.55 79.2 4.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.196 1.399 . . . . 0.0 109.266 169.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 45.96 35.88 2.66 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.675 1.99 . . . . 0.0 113.633 -170.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 144.04 -79.94 0.24 Allowed Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.916 1.722 . . . . 0.0 112.561 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -64.11 127.06 91.46 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.172 1.389 . . . . 0.0 112.762 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.73 122.5 7.37 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.19 2.593 . . . . 0.0 111.788 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.1 mtm -66.73 136.19 55.13 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.048 0.939 . . . . 0.0 110.959 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -118.02 129.29 55.49 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.723 1.209 . . . . 0.0 109.735 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.5 mt -129.87 141.12 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.944 0.897 . . . . 0.0 112.282 -169.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -137.53 154.3 49.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.835 2.454 . . . . 0.0 110.482 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 64.8 tp -134.02 133.5 41.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.045 1.338 . . . . 0.0 111.493 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.1 m -136.64 162.39 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.118 1.767 . . . . 0.0 111.135 173.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.5 m -69.12 -54.52 14.55 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.376 -0.827 . . . . 0.0 110.199 169.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 128.817 2.847 . . . . 0.0 111.408 172.372 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.47 167.09 31.51 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 118.8 1.3 . . . . 0.0 112.628 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 89.5 mt -142.23 162.57 35.14 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.037 2.135 . . . . 0.0 111.678 171.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.8 tp -123.86 106.64 10.62 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.199 1.8 . . . . 0.0 106.917 168.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.94 129.39 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.8 m -129.78 171.9 12.21 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.68 1.192 . . . . 0.0 111.701 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.7 t30 50.77 65.07 1.58 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.876 1.671 . . . . 0.0 112.727 -174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.7 mt -106.48 153.95 21.55 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.872 2.069 . . . . 0.0 109.685 169.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.44 143.81 57.46 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 120.737 -1.227 . . . . 0.0 110.588 169.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -53.4 -34.3 57.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.197 0.999 . . . . 0.0 113.567 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.23 9.0 78.67 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.343 1.449 . . . . 0.0 115.786 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.6 t -62.93 121.26 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 119.679 1.739 . . . . 0.0 109.919 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 22.8 m -72.78 146.31 46.45 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.459 1.104 . . . . 0.0 113.235 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -57.3 -58.32 8.78 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.798 1.639 . . . . 0.0 113.165 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.79 -37.19 78.42 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.957 0.903 . . . . 0.0 113.001 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.0 -52.31 66.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.815 0.846 . . . . 0.0 112.072 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.6 mm -54.04 -53.31 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.985 0.914 . . . . 0.0 111.318 169.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -52.32 -52.57 52.36 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.146 0.979 . . . . 0.0 112.092 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.84 -50.78 70.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.899 1.28 . . . . 0.0 113.435 174.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.6 -45.2 91.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.524 1.056 . . . . 0.0 112.275 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -63.0 -40.15 96.91 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.528 0.604 . . . . 0.0 112.37 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.48 -13.57 52.71 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -73.59 -61.67 1.75 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.906 -1.121 . . . . 0.0 111.252 171.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -85.68 -12.05 52.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.4 166.48 24.47 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.138 1.827 . . . . 0.0 112.883 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 31.4 m -111.99 97.72 6.86 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.573 1.549 . . . . 0.0 109.665 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 152' ' ' PHE . 3.7 pp -118.34 144.03 46.18 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -169.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -78.41 -48.62 15.09 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.803 2.041 . . . . 0.0 110.702 171.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -152.43 149.05 28.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.743 1.217 . . . . 0.0 112.362 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.58 130.41 24.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.591 1.556 . . . . 0.0 109.708 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -135.15 109.87 8.63 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.465 1.506 . . . . 0.0 111.544 -175.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.9 t -76.2 152.28 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.18 1.792 . . . . 0.0 111.442 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -47.0 -45.29 20.96 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.135 2.574 . . . . 0.0 116.919 -171.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -71.78 162.96 28.67 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -173.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -143.03 -138.09 0.1 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.682 1.593 . . . . 0.0 109.469 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -61.3 -45.12 95.77 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.602 -1.311 . . . . 0.0 110.637 169.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 29.7 m -63.74 137.06 57.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 112.014 169.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.81 65.95 2.83 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.752 1.168 . . . . 0.0 112.31 173.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -57.37 144.36 36.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.847 2.059 . . . . 0.0 112.46 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.1 m -123.85 84.23 2.25 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.259 1.424 . . . . 0.0 110.024 174.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 68.1 tp -131.67 -68.66 0.64 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.82 1.648 . . . . 0.0 110.944 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.67 64.99 1.05 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.915 0.769 . . . . 0.0 113.743 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.6 p -140.69 167.51 22.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.229 1.812 . . . . 0.0 111.179 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.45 125.9 12.4 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.28 1.432 . . . . 0.0 111.555 169.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -80.16 123.97 28.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.446 1.498 . . . . 0.0 109.849 170.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.7 140.38 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 118.907 0.776 . . . . 0.0 111.122 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -126.12 127.8 46.34 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.024 1.729 . . . . 0.0 110.176 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 131' ' ' LEU . 30.8 m-85 -110.6 158.83 18.13 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.19 2.196 . . . . 0.0 113.964 -169.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -76.26 -29.63 57.55 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.626 0.77 . . . . 0.0 112.858 170.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -141.27 129.38 22.1 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.466 1.506 . . . . 0.0 112.087 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -40.05 83.08 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.935 1.694 . . . . 0.0 112.914 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.81 -51.61 68.27 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.117 0.967 . . . . 0.0 112.334 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -58.49 -46.47 86.61 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.274 1.03 . . . . 0.0 112.059 173.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.6 -50.78 67.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.524 1.13 . . . . 0.0 112.374 174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 55.6 tp -57.48 -48.0 80.4 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.541 1.536 . . . . 0.0 112.102 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.25 -52.72 60.46 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.324 1.45 . . . . 0.0 112.319 172.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.87 -50.85 67.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.903 1.281 . . . . 0.0 112.011 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.9 ttt -52.19 -59.73 4.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.791 1.636 . . . . 0.0 112.032 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -51.98 -45.56 64.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.538 1.135 . . . . 0.0 112.557 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.31 -52.34 64.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.516 1.127 . . . . 0.0 113.063 177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -95.82 -12.56 25.09 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -169.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -58.91 118.57 5.92 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.764 -1.21 . . . . 0.0 111.139 172.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.6 -16.74 54.55 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.54 1.543 . . . . 0.0 114.598 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 85.0 t -69.27 126.77 92.94 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 119.11 1.455 . . . . 0.0 110.702 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -60.16 136.93 72.08 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.773 2.982 . . . . 0.0 114.195 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 50.9 tp -136.87 101.33 4.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.503 1.521 . . . . 0.0 108.079 169.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 52.08 65.37 1.52 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.228 1.811 . . . . 0.0 111.986 -169.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.42 -65.5 4.11 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.784 1.183 . . . . 0.0 112.916 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -58.91 125.89 79.2 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 125.243 1.417 . . . . 0.0 112.22 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.74 127.37 12.26 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.241 2.628 . . . . 0.0 111.252 170.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.5 mtm -62.26 111.87 2.16 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.203 1.001 . . . . 0.0 111.401 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -93.2 91.56 7.33 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.362 1.465 . . . . 0.0 109.104 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 15.6 mt -89.91 138.54 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.425 1.09 . . . . 0.0 110.432 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -128.39 137.46 51.88 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.663 1.985 . . . . 0.0 110.875 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -11.86 61.18 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 -170.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 9.3 p -153.83 158.52 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.949 2.099 . . . . 0.0 109.72 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.97 135.82 56.1 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.175 -0.953 . . . . 0.0 111.76 169.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.025 1.73 . . . . 0.0 113.674 -179.394 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -85.86 116.23 23.98 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.897 1.279 . . . . 0.0 109.316 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.39 101.16 7.96 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.51 1.924 . . . . 0.0 109.095 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.3 tp -83.47 133.1 34.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.26 1.824 . . . . 0.0 109.985 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.3 t -123.3 81.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 126.847 2.059 . . . . 0.0 108.419 -173.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.6 m -79.72 158.14 27.0 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.72 1.208 . . . . 0.0 112.491 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.1 t30 57.89 64.65 1.48 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.381 1.872 . . . . 0.0 113.212 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.3 mt -98.38 -116.01 0.14 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.696 1.998 . . . . 0.0 108.738 169.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -149.34 148.27 29.31 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.313 1.845 . . . . 0.0 110.436 172.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -74.16 71.59 1.67 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.921 1.688 . . . . 0.0 111.442 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 152.19 7.69 0.11 Allowed Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.388 1.47 . . . . 0.0 116.168 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.1 t -58.35 128.8 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.485 1.643 . . . . 0.0 110.513 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 25.2 m -70.06 147.51 49.95 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.322 1.049 . . . . 0.0 112.46 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.86 -57.86 10.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.508 0.723 . . . . 0.0 111.651 174.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.51 -39.32 67.48 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.886 1.275 . . . . 0.0 113.239 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.65 -58.16 9.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.111 0.964 . . . . 0.0 112.039 175.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.8 mm -56.73 -52.28 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.438 1.095 . . . . 0.0 111.407 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -48.56 -57.54 6.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.862 1.665 . . . . 0.0 111.549 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.17 -49.28 76.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.725 1.21 . . . . 0.0 113.229 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.34 -43.41 97.8 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.671 1.123 . . . . 0.0 112.167 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -63.09 -43.96 97.05 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.224 0.61 . . . . 0.0 112.312 172.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.44 -19.84 63.9 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 175.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.28 -61.54 1.73 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 120.971 -1.081 . . . . 0.0 111.887 173.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -80.41 -25.58 38.97 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.08 -175.05 13.61 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.334 1.445 . . . . 0.0 113.53 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.6 m -127.13 122.58 34.61 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.331 1.052 . . . . 0.0 110.99 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.4 142.02 51.53 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.648 1.179 . . . . 0.0 113.651 -170.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -80.52 -44.43 19.12 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.285 2.234 . . . . 0.0 110.953 170.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -148.47 151.7 35.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.975 0.91 . . . . 0.0 112.695 -175.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.54 150.5 42.22 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.669 1.587 . . . . 0.0 111.637 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.23 154.98 39.9 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.36 1.864 . . . . 0.0 111.766 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 t -133.63 -126.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.427 1.091 . . . . 0.0 112.284 -174.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -64.53 -36.59 84.71 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.413 1.885 . . . . 0.0 115.725 -169.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -63.36 142.38 58.41 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.944 1.298 . . . . 0.0 112.767 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -145.19 143.7 30.45 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.365 1.466 . . . . 0.0 112.286 -169.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -57.13 -58.2 9.26 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.246 1.818 . . . . 0.0 112.813 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.1 m -72.07 -45.29 61.31 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.913 1.685 . . . . 0.0 112.469 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 128.68 23.76 1.17 Allowed Glycine 0 CA--C 1.538 1.48 0 C-N-CA 126.56 2.029 . . . . 0.0 114.227 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -65.26 124.81 23.18 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.435 1.894 . . . . 0.0 111.283 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 45.7 m -65.17 125.05 23.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.17 0.988 . . . . 0.0 110.225 169.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 31.4 tp -143.4 126.23 16.15 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.975 0.91 . . . . 0.0 112.094 -171.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -116.23 60.91 0.41 Allowed Glycine 0 N--CA 1.471 1.01 0 C-N-CA 126.026 1.774 . . . . 0.0 110.657 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.4 m -157.67 152.07 24.86 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 127.928 2.491 . . . . 0.0 109.057 -170.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -126.84 166.17 17.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.213 1.405 . . . . 0.0 111.991 175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -144.45 133.77 23.11 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.453 1.501 . . . . 0.0 110.098 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 48.5 t -133.34 122.6 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.357 1.463 . . . . 0.0 109.877 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -91.55 110.03 21.34 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.488 -0.758 . . . . 0.0 109.912 169.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -80.84 149.7 29.43 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.047 2.139 . . . . 0.0 111.783 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.35 -19.96 63.85 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 171.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -139.05 128.57 24.45 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.542 1.937 . . . . 0.0 111.389 -175.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -57.08 -49.23 76.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.042 1.737 . . . . 0.0 111.839 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.94 -44.57 70.75 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.489 1.116 . . . . 0.0 112.757 174.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -64.61 -39.66 94.12 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.66 1.184 . . . . 0.0 112.46 176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.84 -45.64 91.76 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.175 0.59 . . . . 0.0 111.689 169.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.19 -46.67 88.92 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.335 1.454 . . . . 0.0 111.572 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -48.46 -53.87 16.33 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.005 1.722 . . . . 0.0 111.651 171.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.0 -47.95 81.48 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.883 0.873 . . . . 0.0 112.707 172.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 17.2 ttp -52.13 -60.56 3.05 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.537 1.535 . . . . 0.0 111.833 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.99 -36.25 80.93 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.677 0.791 . . . . 0.0 113.113 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -64.43 -44.54 90.84 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.351 1.06 . . . . 0.0 113.43 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -107.18 -15.83 14.57 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -169.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -60.8 113.11 2.32 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.204 1.366 . . . . 0.0 111.952 174.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.91 -21.91 32.91 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.852 1.692 . . . . 0.0 114.343 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.8 132.03 92.51 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-N 118.626 1.213 . . . . 0.0 110.533 -176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.56 145.83 18.74 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.954 2.436 . . . . 0.0 113.374 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.7 tp -135.54 115.1 12.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.196 2.198 . . . . 0.0 108.612 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 38.66 62.34 1.05 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.385 1.874 . . . . 0.0 113.57 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.59 2.16 90.6 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.282 1.42 . . . . 0.0 116.218 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -131.08 123.33 19.77 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.798 1.639 . . . . 0.0 112.155 -170.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.45 122.02 7.94 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.978 2.452 . . . . 0.0 111.225 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.5 mtm -64.21 130.49 44.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.261 1.025 . . . . 0.0 110.811 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -116.24 114.73 24.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.161 1.385 . . . . 0.0 109.427 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.8 mm -108.07 138.66 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.552 0.741 . . . . 0.0 111.273 -169.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -135.99 140.81 44.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.918 1.687 . . . . 0.0 110.472 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.2 tt -128.82 123.01 31.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.166 1.386 . . . . 0.0 110.542 -170.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.56 173.43 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.908 1.683 . . . . 0.0 111.786 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.8 p -67.2 158.38 31.46 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.624 1.17 . . . . 0.0 113.245 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 C--O 1.252 1.187 0 C-N-CA 127.143 2.177 . . . . 0.0 113.998 178.781 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.151 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -137.43 131.03 31.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.2 1.0 . . . . 0.0 112.292 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -115.91 155.28 28.25 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.248 1.819 . . . . 0.0 110.465 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 57.5 tp -130.82 94.14 3.56 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.115 1.766 . . . . 0.0 106.976 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.4 t -69.7 127.49 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.8 m -128.91 171.31 12.43 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.128 1.371 . . . . 0.0 111.495 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 63.5 t30 58.79 30.3 19.87 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.258 1.823 . . . . 0.0 113.615 -169.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.47 162.61 26.25 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.529 1.131 . . . . 0.0 109.385 169.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -83.04 157.86 22.72 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.264 -0.897 . . . . 0.0 113.098 178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -54.25 -37.22 64.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.599 1.159 . . . . 0.0 112.155 169.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.29 8.87 78.75 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.173 1.368 . . . . 0.0 116.318 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.0 t -68.2 130.72 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.762 1.781 . . . . 0.0 110.454 172.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.4 m -82.61 138.91 34.05 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.504 1.122 . . . . 0.0 112.302 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -56.78 -55.25 36.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.338 1.455 . . . . 0.0 113.395 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.46 80.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.899 0.88 . . . . 0.0 113.11 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.88 -51.39 70.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.826 0.851 . . . . 0.0 112.009 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.74 -52.09 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.263 1.025 . . . . 0.0 111.275 171.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -51.22 -55.28 18.86 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.745 0.818 . . . . 0.0 112.052 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -58.48 -50.73 72.68 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.678 1.191 . . . . 0.0 113.12 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.48 -45.27 91.51 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.379 0.991 . . . . 0.0 112.413 -176.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -63.16 -40.89 98.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.836 0.744 . . . . 0.0 112.466 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.9 -13.21 61.46 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -71.81 -62.23 1.5 Allowed 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.989 -1.069 . . . . 0.0 111.113 172.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -78.54 -35.46 46.1 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.61 173.18 15.47 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.489 1.518 . . . . 0.0 113.372 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.7 m -119.99 112.87 19.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.066 1.346 . . . . 0.0 109.432 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -135.07 151.6 50.91 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -169.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -73.6 -53.97 9.26 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.512 1.925 . . . . 0.0 110.426 169.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -154.05 153.17 31.44 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.4 139.46 45.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.529 1.932 . . . . 0.0 109.403 169.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.13 100.04 3.56 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.588 1.555 . . . . 0.0 111.646 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.2 t -62.4 156.38 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.098 1.359 . . . . 0.0 110.692 170.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -44.45 -56.2 4.45 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.754 2.421 . . . . 0.0 115.241 -174.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -61.39 149.77 37.35 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.232 0.924 . . . . 0.0 112.261 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.6 t70 69.03 -50.47 0.59 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.176 2.191 . . . . 0.0 113.606 -169.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -54.35 -45.58 72.76 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.605 1.162 . . . . 0.0 110.705 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.7 m -119.28 148.66 42.9 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.141 2.176 . . . . 0.0 110.341 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.0 -52.95 40.54 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.128 0.87 . . . . 0.0 112.049 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -65.85 138.16 57.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.624 1.57 . . . . 0.0 110.664 169.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.7 m -81.33 129.54 34.66 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.243 1.017 . . . . 0.0 110.636 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.2 -130.13 0.27 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.893 1.677 . . . . 0.0 109.18 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.69 52.52 0.39 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.357 1.456 . . . . 0.0 112.407 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 52.6 p -138.24 163.23 32.28 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.824 1.249 . . . . 0.0 113.261 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.4 116.05 9.16 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.086 1.754 . . . . 0.0 111.179 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -73.56 133.74 43.62 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.139 0.976 . . . . 0.0 108.74 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 18.4 t -136.07 123.96 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.942 0.897 . . . . 0.0 109.874 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -109.47 112.94 25.34 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.418 1.487 . . . . 0.0 109.759 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -90.28 158.61 17.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.92 2.488 . . . . 0.0 112.944 -172.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.22 -41.44 85.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.305 0.642 . . . . 0.0 112.357 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -132.2 134.73 45.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.868 1.667 . . . . 0.0 111.196 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -66.64 -28.93 68.87 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.17 -46.75 88.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.999 0.92 . . . . 0.0 111.301 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.48 -40.98 96.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.205 1.002 . . . . 0.0 112.361 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.24 -58.22 7.82 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.343 1.057 . . . . 0.0 111.536 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -53.12 -48.38 67.89 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.032 1.733 . . . . 0.0 112.077 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -52.24 -55.87 18.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.745 1.218 . . . . 0.0 111.814 173.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.01 -46.03 75.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.5 1.12 . . . . 0.0 112.625 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -52.42 -62.8 1.41 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.169 1.388 . . . . 0.0 110.812 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -60.27 -36.51 77.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.431 0.901 . . . . 0.0 113.431 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -66.67 -44.27 82.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.249 1.02 . . . . 0.0 113.467 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -105.63 -15.12 15.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -61.85 105.59 0.58 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 119.662 1.119 . . . . 0.0 110.519 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.21 -21.87 9.9 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.748 2.118 . . . . 0.0 114.298 -173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 66.5 t -79.26 131.85 64.6 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 118.653 1.227 . . . . 0.0 111.695 -170.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -53.52 138.87 66.54 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.465 3.443 . . . . 0.0 115.457 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -138.42 103.31 4.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.045 2.138 . . . . 0.0 106.371 169.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 52.78 60.42 3.81 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.512 1.525 . . . . 0.0 111.288 -168.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.76 -64.88 4.14 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.548 1.547 . . . . 0.0 113.178 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -62.03 135.77 94.91 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.818 1.647 . . . . 0.0 112.711 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.82 131.49 12.29 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.339 2.692 . . . . 0.0 112.238 -177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.3 mtm -62.88 132.56 52.54 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.96 0.904 . . . . 0.0 110.917 169.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -118.44 115.57 24.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.608 1.163 . . . . 0.0 108.459 171.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.6 mt -105.84 126.62 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.901 0.858 . . . . 0.0 112.215 -169.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -99.13 150.44 22.03 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.099 2.16 . . . . 0.0 109.483 169.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.99 159.36 43.07 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.52 1.128 . . . . 0.0 112.797 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.2 m -76.22 93.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 168.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 87.2 m -67.11 -41.17 86.68 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.467 -0.771 . . . . 0.0 111.986 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.5 m . . . . . 0 C--O 1.252 1.212 0 C-N-CA 126.427 1.891 . . . . 0.0 113.69 177.536 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 112.278 -0.329 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -81.76 93.66 6.86 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.994 0.918 . . . . 0.0 109.588 172.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -89.42 101.14 13.82 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.966 1.306 . . . . 0.0 108.795 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.7 tp -89.95 127.59 36.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.36 1.864 . . . . 0.0 109.816 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.62 127.83 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.472 1.509 . . . . 0.0 108.859 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.0 m -128.24 168.59 15.25 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.468 1.907 . . . . 0.0 111.066 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.3 t30 59.16 51.79 6.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.996 1.719 . . . . 0.0 112.555 -175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.4 mt -95.48 172.82 7.84 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.715 1.606 . . . . 0.0 110.287 169.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -139.84 158.01 44.79 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.204 -0.935 . . . . 0.0 112.779 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -57.48 104.03 0.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.688 1.195 . . . . 0.0 110.874 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 151.8 -45.25 0.62 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.696 2.093 . . . . 0.0 109.474 -169.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 30.6 t -64.39 134.79 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.238 1.015 . . . . 0.0 108.832 169.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 61.1 m -121.74 153.76 37.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.513 1.125 . . . . 0.0 112.155 -175.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.28 -56.73 12.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.95 1.7 . . . . 0.0 112.542 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.56 -37.78 82.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.592 1.157 . . . . 0.0 113.319 174.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -63.3 -51.7 64.99 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.8 0.84 . . . . 0.0 111.551 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.5 mm -54.21 -52.91 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.405 1.082 . . . . 0.0 111.221 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -51.33 -53.94 31.16 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.109 0.963 . . . . 0.0 112.323 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -60.58 -51.46 69.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.689 1.195 . . . . 0.0 113.252 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -63.6 -44.28 94.45 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.164 0.893 . . . . 0.0 112.182 -173.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -62.69 -43.71 98.12 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.61 67.96 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.57 -53.69 52.91 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.097 0.959 . . . . 0.0 112.789 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -95.93 -16.14 21.93 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -140.59 164.36 26.34 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.019 1.295 . . . . 0.0 114.414 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -104.26 111.17 23.68 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.924 1.29 . . . . 0.0 110.943 -172.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -129.3 145.66 51.33 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.49 1.116 . . . . 0.0 113.323 -171.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -87.63 -39.39 15.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.029 1.732 . . . . 0.0 111.1 169.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -144.26 146.85 32.89 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.469 1.108 . . . . 0.0 112.126 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -146.96 123.41 11.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.135 1.374 . . . . 0.0 110.818 171.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.22 155.73 42.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.701 1.2 . . . . 0.0 112.989 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.5 t -110.34 151.73 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.804 2.042 . . . . 0.0 110.207 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -55.63 -45.21 77.62 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.209 1.804 . . . . 0.0 114.952 -170.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -65.17 154.6 37.52 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.063 0.945 . . . . 0.0 113.096 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -144.26 -130.58 0.08 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.311 1.444 . . . . 0.0 108.793 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 61.8 ttt85 -56.07 -48.12 76.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.033 1.288 . . . . 0.0 110.07 169.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.6 m -71.38 120.28 16.74 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 125.397 1.479 . . . . 0.0 110.966 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.87 65.12 4.17 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.687 1.137 . . . . 0.0 111.559 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -59.1 128.73 38.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.163 1.785 . . . . 0.0 112.319 -176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.0 m -73.81 98.1 2.89 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.459 1.104 . . . . 0.0 110.084 169.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 60.5 tp -153.47 -68.64 0.15 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.613 1.565 . . . . 0.0 110.626 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.89 75.2 1.2 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.687 1.137 . . . . 0.0 112.098 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.7 m -146.96 148.98 32.3 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.157 1.383 . . . . 0.0 110.82 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.66 154.48 46.42 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.593 1.557 . . . . 0.0 111.647 176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -128.48 124.63 36.61 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.656 1.583 . . . . 0.0 109.907 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 42.7 t -120.09 110.09 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 125.193 1.397 . . . . 0.0 108.683 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -82.47 92.62 7.09 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.998 1.319 . . . . 0.0 108.5 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -70.6 150.13 46.36 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.794 1.638 . . . . 0.0 111.265 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -74.82 -27.93 60.49 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 34.7 mtm105 -135.99 138.84 42.68 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.241 1.817 . . . . 0.0 111.16 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -67.08 -44.13 80.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.72 1.608 . . . . 0.0 112.086 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.12 -46.85 68.92 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.677 0.791 . . . . 0.0 112.319 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.56 -44.61 96.72 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.774 1.63 . . . . 0.0 112.26 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.77 87.69 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.183 0.993 . . . . 0.0 112.878 170.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.2 -38.81 84.45 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.557 1.543 . . . . 0.0 112.428 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -49.3 -61.89 1.84 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.531 1.133 . . . . 0.0 110.059 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.38 -47.54 72.56 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.806 1.242 . . . . 0.0 112.598 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -51.51 -61.2 2.39 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.415 1.486 . . . . 0.0 111.437 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -60.16 -44.75 94.77 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.921 0.888 . . . . 0.0 112.388 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -59.29 -44.25 92.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.258 1.423 . . . . 0.0 113.387 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -109.14 -14.56 14.49 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -60.27 115.68 3.69 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 120.48 1.491 . . . . 0.0 111.305 172.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 101.1 -17.77 55.51 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.826 1.679 . . . . 0.0 114.546 -174.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.4 t -75.29 130.68 79.56 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-N 118.9 1.35 . . . . 0.0 110.852 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.43 135.69 69.47 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.764 2.976 . . . . 0.0 114.9 174.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.1 tp -142.02 113.76 7.91 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.553 1.941 . . . . 0.0 108.184 169.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 49.4 61.42 3.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.405 1.482 . . . . 0.0 111.398 -169.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.58 -61.54 4.62 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.363 1.459 . . . . 0.0 113.364 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -67.26 140.24 95.31 Favored Pre-proline 0 N--CA 1.473 0.709 0 C-N-CA 125.319 1.447 . . . . 0.0 113.719 -172.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -73.15 125.92 10.71 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.99 2.46 . . . . 0.0 110.453 169.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 74.6 mtm -63.5 127.8 32.94 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.366 1.067 . . . . 0.0 111.849 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -105.16 119.32 38.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.566 1.146 . . . . 0.0 109.326 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.4 mt -118.94 139.85 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.939 . . . . 0.0 112.312 -169.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -134.37 147.5 50.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.405 2.282 . . . . 0.0 110.196 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 51.6 tp -136.41 126.64 26.42 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.78 1.232 . . . . 0.0 111.235 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.55 159.63 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.232 1.413 . . . . 0.0 112.189 175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 15.2 m -66.94 136.02 54.71 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.073 1.349 . . . . 0.0 111.6 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 52.1 m . . . . . 0 C--O 1.253 1.26 0 C-N-CA 125.873 1.669 . . . . 0.0 113.637 174.301 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.174 0 CA-C-O 120.056 -0.302 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -74.36 130.28 39.37 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.072 0.936 . . . . 0.0 110.827 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -136.34 124.74 23.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.906 2.082 . . . . 0.0 109.317 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.4 tp -114.56 108.02 16.28 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.662 1.585 . . . . 0.0 110.488 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.6 t -92.07 129.52 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.328 1.451 . . . . 0.0 108.874 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.5 m -134.81 173.25 11.9 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.006 1.722 . . . . 0.0 111.87 -175.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.7 t30 55.51 35.8 25.85 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.304 1.841 . . . . 0.0 113.192 -171.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.5 mt -77.73 168.94 19.14 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.649 1.179 . . . . 0.0 110.428 169.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -65.96 155.23 37.17 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.23 -0.918 . . . . 0.0 111.679 171.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -50.99 -28.34 9.72 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.764 2.025 . . . . 0.0 114.697 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -145.69 55.57 0.54 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-N 119.151 0.887 . . . . 0.0 115.019 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.99 136.77 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 CA-C-N 118.085 0.943 . . . . 0.0 109.766 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 52.1 m -69.83 138.31 52.5 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.582 -0.699 . . . . 0.0 112.134 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -60.31 -53.57 56.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.524 1.129 . . . . 0.0 112.648 -174.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.92 83.88 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.448 1.099 . . . . 0.0 112.688 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -56.51 -53.39 58.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.856 0.862 . . . . 0.0 112.248 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.2 mm -56.83 -53.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.845 0.858 . . . . 0.0 111.458 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -53.15 -53.76 45.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.015 0.526 . . . . 0.0 112.116 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.01 -50.47 73.96 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.945 1.298 . . . . 0.0 113.054 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.48 -46.35 90.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.653 1.115 . . . . 0.0 111.914 -176.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -63.85 -43.08 97.21 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 173.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.94 -21.09 66.77 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -64.98 -58.78 5.22 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.96 -1.087 . . . . 0.0 111.892 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -82.31 -35.58 27.79 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -110.12 161.77 12.84 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.585 1.564 . . . . 0.0 114.185 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 45.8 m -106.09 101.81 11.27 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.878 1.671 . . . . 0.0 109.68 -174.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.6 pp -137.08 153.99 50.43 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -169.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -85.94 -50.96 6.68 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 127.642 2.377 . . . . 0.0 111.486 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -148.71 150.63 33.49 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.274 1.03 . . . . 0.0 113.07 -170.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.38 138.16 32.81 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 110.787 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -141.79 107.16 5.01 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.937 1.295 . . . . 0.0 112.23 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.6 t -77.33 146.24 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.898 1.679 . . . . 0.0 111.009 173.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.427 ' CE1' ' H ' ' A' ' 146' ' ' GLY . 45.5 p-80 -53.22 -50.94 63.69 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.441 2.297 . . . . 0.0 115.194 -171.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -49.21 -40.52 33.9 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.972 2.109 . . . . 0.0 115.627 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -73.5 -13.25 61.02 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.812 1.245 . . . . 0.0 114.07 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -122.29 -143.83 0.34 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.167 1.787 . . . . 0.0 111.77 -176.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.9 m -59.57 152.68 21.51 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.823 2.049 . . . . 0.0 114.225 -171.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.05 57.09 3.97 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.952 1.263 . . . . 0.0 113.842 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.2 ptm85 -74.18 -172.07 1.31 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.785 2.034 . . . . 0.0 112.178 169.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.8 m -63.18 120.03 10.71 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.032 0.933 . . . . 0.0 110.337 169.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.9 mp -67.83 141.89 56.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.495 1.118 . . . . 0.0 112.339 -175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.427 ' H ' ' CE1' ' A' ' 137' ' ' HIS . . . 98.23 53.39 1.26 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.611 1.577 . . . . 0.0 113.036 176.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.6 m -147.38 145.3 29.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.698 1.199 . . . . 0.0 111.438 -173.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -137.41 126.49 24.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.915 1.286 . . . . 0.0 111.735 171.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -93.45 126.85 38.81 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.052 1.341 . . . . 0.0 109.795 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.9 t -131.24 136.09 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.554 1.542 . . . . 0.0 110.164 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -118.05 98.85 6.53 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.212 1.805 . . . . 0.0 108.779 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -75.86 158.73 31.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.474 1.51 . . . . 0.0 111.938 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -70.41 -27.32 64.19 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.774 -0.579 . . . . 0.0 112.296 169.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -142.91 135.0 27.18 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.564 1.546 . . . . 0.0 112.674 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -53.87 -40.5 66.62 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.48 2.312 . . . . 0.0 112.518 170.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.33 -47.44 62.68 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.281 1.032 . . . . 0.0 112.656 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -71.26 -38.01 71.92 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.275 -0.89 . . . . 0.0 112.937 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.67 -47.08 74.04 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.77 0.828 . . . . 0.0 111.834 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.1 -48.12 79.4 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.382 1.473 . . . . 0.0 113.036 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -52.28 -53.33 45.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.264 1.026 . . . . 0.0 111.842 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.03 -50.34 69.32 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.199 0.999 . . . . 0.0 112.445 174.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -53.03 -63.15 1.24 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.137 1.775 . . . . 0.0 111.506 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -59.99 -36.85 78.07 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.693 0.797 . . . . 0.0 113.026 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -66.89 -52.16 46.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.747 1.219 . . . . 0.0 112.857 176.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -96.17 -16.3 21.56 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 -169.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -59.32 109.74 0.94 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 120.154 1.343 . . . . 0.0 111.178 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 113.25 -24.74 12.1 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 126.254 1.883 . . . . 0.0 114.231 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.35 133.69 89.22 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.873 1.269 . . . . 0.0 110.66 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.68 148.88 33.27 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.946 2.431 . . . . 0.0 113.12 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 42.2 tp -128.87 94.73 3.91 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.4 1.88 . . . . 0.0 109.194 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 46.56 50.65 12.68 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.442 1.897 . . . . 0.0 112.931 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 114.94 -78.3 0.27 Allowed Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.065 1.793 . . . . 0.0 112.779 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.35 135.7 75.99 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 126.328 1.851 . . . . 0.0 113.351 -176.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.06 126.83 10.85 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.096 2.531 . . . . 0.0 111.207 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.5 mtm -63.66 128.72 37.09 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.613 0.765 . . . . 0.0 110.135 169.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -116.61 119.91 37.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.341 1.056 . . . . 0.0 109.502 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -117.55 139.93 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.198 0.999 . . . . 0.0 111.749 -169.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -131.27 144.54 51.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.93 2.092 . . . . 0.0 110.539 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 11.0 tp -88.6 -101.29 0.09 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.591 1.157 . . . . 0.0 110.426 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.4 m -69.61 155.36 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.732 2.013 . . . . 0.0 112.897 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 2.9 p -140.63 147.14 38.87 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.022 2.129 . . . . 0.0 111.106 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 C--O 1.251 1.174 0 C-N-CA 126.133 1.773 . . . . 0.0 113.749 -179.591 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.172 0 N-CA-C 108.904 -1.678 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.01 154.65 44.21 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.625 1.712 . . . . 0.0 114.29 -178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.8 mt -120.97 118.69 30.51 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.86 2.064 . . . . 0.0 110.43 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.7 tp -82.45 109.04 16.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 169.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.0 t -92.22 83.26 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.103 1.761 . . . . 0.0 107.707 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.3 m -80.25 155.3 27.39 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.727 0.811 . . . . 0.0 112.101 -176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.28 79.12 0.23 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.762 2.025 . . . . 0.0 113.0 -174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -127.91 144.97 51.09 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.281 2.232 . . . . 0.0 109.641 171.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -77.2 151.39 35.24 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.84 -0.538 . . . . 0.0 112.358 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -57.87 -24.28 56.87 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.905 0.882 . . . . 0.0 113.337 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -72.85 -15.48 78.17 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 125.151 1.358 . . . . 0.0 115.792 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.4 t -68.21 123.21 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.585 1.693 . . . . 0.0 110.925 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 54.4 m -77.95 146.48 35.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.771 1.228 . . . . 0.0 111.982 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.78 -52.46 65.62 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.869 0.867 . . . . 0.0 112.013 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.55 -40.28 62.38 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.753 1.221 . . . . 0.0 113.363 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -59.08 -55.51 34.13 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.978 0.911 . . . . 0.0 112.285 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.6 mm -55.8 -53.31 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.882 1.273 . . . . 0.0 111.082 172.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -48.97 -55.77 10.89 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.134 1.774 . . . . 0.0 111.696 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -62.61 -49.32 75.69 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.626 1.17 . . . . 0.0 113.379 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.23 -44.62 94.74 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.81 1.186 . . . . 0.0 112.204 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -62.09 -41.91 98.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.724 0.693 . . . . 0.0 112.227 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.29 -15.72 62.81 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.21 -60.1 2.4 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.878 -1.139 . . . . 0.0 111.533 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -81.31 -31.34 33.59 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.88 -177.57 15.23 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.644 1.592 . . . . 0.0 113.104 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.5 m -124.52 122.74 38.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.763 1.225 . . . . 0.0 110.057 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -132.37 146.94 52.33 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -169.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -78.49 -49.13 13.95 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.514 2.325 . . . . 0.0 110.986 171.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -148.12 146.11 28.64 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.49 1.516 . . . . 0.0 112.298 -170.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -132.47 139.67 48.07 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.245 1.818 . . . . 0.0 109.37 169.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.25 100.06 3.41 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.482 1.513 . . . . 0.0 111.695 -177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.5 t -75.09 167.14 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.253 1.421 . . . . 0.0 110.709 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -46.87 -37.19 8.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.861 2.064 . . . . 0.0 115.843 -169.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -86.53 -13.2 46.61 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -70.71 158.6 35.99 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.313 1.045 . . . . 0.0 112.764 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -71.34 83.96 0.78 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.734 1.214 . . . . 0.0 111.375 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 t -153.39 -178.27 6.88 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.6 2.36 . . . . 0.0 110.739 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -111.2 6.66 28.76 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.997 1.76 . . . . 0.0 115.63 -175.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.87 162.6 15.99 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.82 1.31 . . . . 0.0 113.448 175.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.3 m -61.97 158.89 15.29 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.79 1.236 . . . . 0.0 112.99 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.3 tp -74.5 145.8 43.24 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.775 0.83 . . . . 0.0 111.128 173.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 58.64 40.75 95.14 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.339 0.971 . . . . 0.0 113.053 -173.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.7 m -160.48 158.68 29.75 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.476 2.71 . . . . 0.0 108.473 -171.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.17 166.49 21.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.5 1.12 . . . . 0.0 112.651 174.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -125.52 129.49 49.86 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.541 1.936 . . . . 0.0 109.396 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.7 t -126.98 115.06 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.681 1.192 . . . . 0.0 109.058 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -100.57 112.65 25.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.579 1.551 . . . . 0.0 109.647 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -84.23 163.45 19.68 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.076 2.55 . . . . 0.0 113.29 -172.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.5 -45.04 89.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.795 0.838 . . . . 0.0 111.653 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 76.4 mmt-85 -137.88 141.76 40.68 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.706 1.602 . . . . 0.0 111.328 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -60.09 -34.3 73.27 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.764 1.626 . . . . 0.0 113.284 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.88 -51.36 69.91 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.247 1.019 . . . . 0.0 112.243 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.63 -40.68 95.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.004 0.921 . . . . 0.0 112.083 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.17 -54.59 37.7 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.389 1.075 . . . . 0.0 112.007 170.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 67.4 tp -53.28 -49.93 65.92 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.173 1.389 . . . . 0.0 112.783 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -53.03 -51.43 61.73 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.001 1.32 . . . . 0.0 112.173 175.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.08 78.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.012 0.925 . . . . 0.0 112.755 172.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 4.7 ttp -54.01 -58.06 8.7 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.945 1.298 . . . . 0.0 112.017 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -33.67 73.37 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -68.23 -45.01 74.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.293 1.037 . . . . 0.0 113.159 176.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -103.7 -13.35 16.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 116.452 2.019 . . . . 0.0 116.452 -169.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -60.13 109.78 1.05 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 120.225 1.375 . . . . 0.0 112.04 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.32 -17.82 39.77 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.993 1.759 . . . . 0.0 114.586 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.98 132.71 86.43 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 118.854 1.327 . . . . 0.0 110.372 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.04 142.25 19.42 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.822 2.348 . . . . 0.0 112.804 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 61.2 tp -135.35 115.67 13.49 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.063 1.745 . . . . 0.0 108.448 169.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 49.24 57.64 6.26 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.364 1.465 . . . . 0.0 111.222 -169.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.68 -56.49 4.75 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.402 1.477 . . . . 0.0 113.303 -176.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -58.15 117.51 20.36 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 127.349 2.259 . . . . 0.0 113.835 -173.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -60.02 118.21 5.06 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.356 2.704 . . . . 0.0 110.879 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.7 mtm -70.16 116.59 10.69 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.78 0.832 . . . . 0.0 110.862 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.99 94.72 9.41 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.076 0.951 . . . . 0.0 108.806 174.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.6 mm -86.34 129.18 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.323 0.649 . . . . 0.0 109.986 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -125.21 115.53 20.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.96 1.304 . . . . 0.0 111.0 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.9 tp -79.16 139.55 37.97 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.64 1.576 . . . . 0.0 110.755 171.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 5.4 m -64.32 105.2 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-O 121.699 0.761 . . . . 0.0 110.908 169.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 94.2 m -80.87 117.16 21.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.39 1.076 . . . . 0.0 110.409 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 23.0 m . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.459 1.903 . . . . 0.0 113.712 -179.487 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.235 0 CA-C-O 121.829 0.683 . . . . 0.0 114.788 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 66.2 tttp -149.59 133.0 16.58 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.514 1.926 . . . . 0.0 109.808 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -137.79 105.27 5.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.935 1.694 . . . . 0.0 109.577 -170.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 49.9 tp -90.2 137.94 31.93 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.753 2.021 . . . . 0.0 110.039 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -130.61 127.48 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.918 1.287 . . . . 0.0 109.578 174.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.9 m -128.1 174.41 9.26 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.222 1.809 . . . . 0.0 110.872 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 38.2 t30 58.57 38.31 25.32 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.394 1.478 . . . . 0.0 112.467 -172.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.3 mt -88.73 -155.1 0.32 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.56 1.544 . . . . 0.0 109.497 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -138.96 151.7 47.09 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.543 1.537 . . . . 0.0 110.883 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -53.46 -24.61 13.32 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.74 -23.54 65.42 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 125.382 1.468 . . . . 0.0 115.234 172.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.35 141.54 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 118.906 1.353 . . . . 0.0 110.523 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 61.6 m -133.1 161.1 35.29 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.68 1.592 . . . . 0.0 111.788 -177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -53.86 -57.36 11.21 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.881 0.872 . . . . 0.0 113.2 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.61 72.44 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.828 0.851 . . . . 0.0 113.248 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -58.01 -55.56 33.41 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.066 0.946 . . . . 0.0 111.855 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.6 mm -55.49 -54.82 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.027 1.331 . . . . 0.0 111.227 172.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -47.9 -56.98 6.31 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.672 1.989 . . . . 0.0 111.441 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.06 -49.97 73.83 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.462 1.105 . . . . 0.0 113.259 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -62.41 -44.54 96.18 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.475 1.034 . . . . 0.0 112.07 -175.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -63.88 -43.47 95.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.412 0.685 . . . . 0.0 112.624 173.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.7 -20.93 62.26 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.58 -60.16 2.97 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.076 -1.015 . . . . 0.0 112.019 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -89.63 -21.33 22.86 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -174.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -134.7 -176.9 14.59 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.658 1.599 . . . . 0.0 112.885 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -127.38 129.17 47.1 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.279 1.032 . . . . 0.0 110.497 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.7 144.77 47.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.627 1.171 . . . . 0.0 113.801 -169.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -73.54 -50.57 20.67 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.938 2.095 . . . . 0.0 110.62 169.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -150.46 158.62 44.35 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.592 1.157 . . . . 0.0 112.87 -173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.43 155.69 46.88 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.005 1.722 . . . . 0.0 111.089 169.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.83 154.77 38.95 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.239 2.216 . . . . 0.0 110.672 174.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.9 t -141.1 158.78 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.225 1.81 . . . . 0.0 110.401 -176.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -30.96 -48.52 0.11 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 129.373 3.069 . . . . 0.0 116.525 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -49.81 -39.99 40.3 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.872 1.669 . . . . 0.0 113.658 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -78.61 -61.77 1.9 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.5 1.52 . . . . 0.0 111.258 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -144.24 143.59 31.11 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.412 1.885 . . . . 0.0 111.334 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 m -124.55 148.84 47.54 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.717 1.607 . . . . 0.0 112.822 -178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -98.98 -43.31 2.64 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.701 2.096 . . . . 0.0 111.045 169.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -128.09 129.85 47.25 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.741 2.016 . . . . 0.0 109.981 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 47.5 m -70.85 69.87 0.47 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.071 1.748 . . . . 0.0 111.822 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 68.1 tp -160.83 -47.93 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.341 2.656 . . . . 0.0 110.214 -173.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.71 103.15 0.17 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.995 1.283 . . . . 0.0 111.109 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 m -123.96 145.8 48.92 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.155 1.782 . . . . 0.0 110.969 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.68 150.94 46.73 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.867 2.067 . . . . 0.0 110.339 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -143.28 121.46 12.21 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.42 1.488 . . . . 0.0 110.028 -173.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 52.7 t -122.4 118.39 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.173 1.389 . . . . 0.0 109.514 -173.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -88.53 95.47 10.25 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -69.03 160.49 30.87 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.543 1.937 . . . . 0.0 112.957 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.78 -51.8 68.18 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.629 -0.669 . . . . 0.0 111.705 169.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -137.53 148.34 45.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.436 1.494 . . . . 0.0 112.523 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.89 -32.41 71.87 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.58 -49.73 76.37 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.109 0.964 . . . . 0.0 112.459 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.76 -37.91 89.2 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.12 0.968 . . . . 0.0 111.979 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.22 -46.61 85.56 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.874 0.87 . . . . 0.0 112.037 169.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.95 -49.98 72.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.479 1.512 . . . . 0.0 111.493 174.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -50.08 -54.33 21.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.46 1.504 . . . . 0.0 111.677 174.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.21 -47.2 75.64 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.29 1.036 . . . . 0.0 112.803 173.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -54.76 -63.26 1.21 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.675 1.19 . . . . 0.0 111.422 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -59.57 -32.77 70.67 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -64.49 -51.09 64.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.693 1.197 . . . . 0.0 113.148 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -106.89 -11.07 15.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -169.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -61.86 117.1 5.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 120.341 1.428 . . . . 0.0 111.857 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 92.59 -12.44 69.77 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.025 1.298 . . . . 0.0 114.83 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 64.7 t -66.94 135.24 94.08 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 119.205 1.502 . . . . 0.0 109.858 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.3 145.97 31.06 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.793 2.329 . . . . 0.0 112.724 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.5 tp -122.27 92.5 3.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.259 1.824 . . . . 0.0 108.992 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 47.65 50.05 15.62 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.287 1.835 . . . . 0.0 112.715 -169.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 116.07 -75.62 0.27 Allowed Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.114 1.816 . . . . 0.0 112.885 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.61 131.81 85.64 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 126.264 1.826 . . . . 0.0 113.549 -175.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.13 130.09 13.86 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.256 2.638 . . . . 0.0 111.683 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -68.28 114.59 6.88 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.426 1.09 . . . . 0.0 111.401 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -86.16 103.35 14.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.224 1.009 . . . . 0.0 109.349 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.3 mt -99.96 137.43 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.832 0.853 . . . . 0.0 111.516 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -133.26 152.17 51.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 128.0 2.52 . . . . 0.0 110.671 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -148.73 166.57 28.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.969 0.908 . . . . 0.0 113.274 -169.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.38 88.76 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.122 0.969 . . . . 0.0 110.603 169.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.0 p -59.69 -59.09 5.99 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.877 1.671 . . . . 0.0 111.195 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 C--O 1.251 1.161 0 C-N-CA 126.191 1.796 . . . . 0.0 110.995 169.747 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -134.13 133.62 41.25 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.457 1.129 . . . . 0.0 111.561 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.7 mt -117.04 120.01 37.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.995 1.718 . . . . 0.0 111.302 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.0 tp -84.22 129.29 34.9 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 168.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 t -119.4 137.84 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.888 1.275 . . . . 0.0 109.215 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.3 m -136.73 165.99 24.63 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.123 2.169 . . . . 0.0 111.416 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 64.7 t30 52.95 59.63 4.33 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.493 1.917 . . . . 0.0 113.119 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.9 mt -109.7 147.72 32.65 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.247 1.819 . . . . 0.0 107.92 169.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -78.6 156.43 29.12 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.286 -0.884 . . . . 0.0 112.595 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -52.35 -34.48 47.69 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.702 1.201 . . . . 0.0 112.472 169.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -77.86 -7.34 87.44 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.217 1.389 . . . . 0.0 116.31 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -69.93 119.09 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.903 1.852 . . . . 0.0 110.492 177.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.7 m -78.82 147.53 33.2 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.055 1.342 . . . . 0.0 112.844 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -57.21 -53.62 55.99 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.471 1.508 . . . . 0.0 112.807 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.76 -40.17 79.11 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.407 1.083 . . . . 0.0 113.189 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.41 -52.32 66.1 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.934 0.894 . . . . 0.0 112.211 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.8 mm -55.89 -51.81 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.39 1.076 . . . . 0.0 111.342 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -50.48 -54.51 21.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.202 1.001 . . . . 0.0 111.952 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.46 -50.9 72.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.68 1.192 . . . . 0.0 113.32 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -64.52 -44.75 89.88 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.549 1.068 . . . . 0.0 112.743 -174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -62.62 -39.81 94.98 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.904 0.774 . . . . 0.0 112.209 173.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.25 -2.72 11.32 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 174.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -83.47 -62.04 1.69 Allowed 'General case' 0 CA--C 1.541 0.624 0 O-C-N 120.819 -1.176 . . . . 0.0 110.779 170.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -76.82 -19.66 57.27 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -139.45 -162.42 9.11 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.442 1.496 . . . . 0.0 111.94 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.08 136.93 42.39 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 118.104 0.952 . . . . 0.0 111.709 175.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 pp -136.89 147.17 46.3 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.548 1.139 . . . . 0.0 113.472 -170.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -78.21 -46.54 20.16 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.391 2.276 . . . . 0.0 111.291 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -149.25 145.71 27.23 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.474 1.11 . . . . 0.0 112.611 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.63 143.47 50.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.265 1.826 . . . . 0.0 110.194 169.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.38 99.9 3.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.441 1.496 . . . . 0.0 111.542 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.7 t -78.23 147.54 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.699 1.6 . . . . 0.0 111.59 175.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.478 ' HB3' ' H ' ' A' ' 147' ' ' THR . 25.6 p80 -25.69 -58.18 0.07 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 130.056 3.342 . . . . 0.0 117.102 -171.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -58.11 -22.43 50.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.276 1.431 . . . . 0.0 114.709 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -66.89 106.87 2.02 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.308 0.958 . . . . 0.0 108.635 168.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -45.53 116.99 1.29 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.574 1.95 . . . . 0.0 115.217 -169.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.3 m -153.35 163.59 39.65 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.47 2.708 . . . . 0.0 110.092 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.92 62.76 3.92 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.086 0.85 . . . . 0.0 113.079 174.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -136.24 160.4 38.81 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.563 1.945 . . . . 0.0 113.8 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.4 m -68.53 142.37 55.26 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.816 1.246 . . . . 0.0 111.104 169.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.63 160.36 32.7 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.421 0.688 . . . . 0.0 111.858 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.57 40.93 26.01 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 124.752 1.168 . . . . 0.0 113.823 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.478 ' H ' ' HB3' ' A' ' 137' ' ' HIS . 81.8 p -142.09 172.65 12.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.762 2.425 . . . . 0.0 112.003 -173.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.08 164.4 38.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.893 1.277 . . . . 0.0 111.584 169.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -131.2 126.2 34.95 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.999 1.72 . . . . 0.0 109.503 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.85 114.07 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.175 0.99 . . . . 0.0 110.938 -171.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -89.94 104.24 16.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.919 1.687 . . . . 0.0 109.901 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -77.42 150.63 35.0 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 128.683 2.793 . . . . 0.0 113.108 176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -61.84 -36.91 82.59 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 47.1 mtm-85 -135.79 129.67 32.85 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.724 2.01 . . . . 0.0 110.088 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -66.23 -29.86 70.2 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.93 75.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.965 0.906 . . . . 0.0 111.796 170.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -62.73 -39.16 93.2 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.861 1.264 . . . . 0.0 112.137 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.72 -55.16 37.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.561 1.145 . . . . 0.0 112.068 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 64.9 tp -52.98 -48.55 67.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.261 1.424 . . . . 0.0 112.116 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -51.89 -59.58 4.16 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.534 1.533 . . . . 0.0 111.47 172.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.52 -48.78 62.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.909 1.283 . . . . 0.0 112.618 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.7 ttp -53.58 -61.83 2.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.296 1.438 . . . . 0.0 111.492 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -62.04 -35.52 78.84 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.94 -56.23 14.52 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.477 1.111 . . . . 0.0 113.181 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -91.9 -13.85 30.57 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -168.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -61.2 107.3 0.73 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.104 1.32 . . . . 0.0 110.531 169.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 114.51 -24.2 11.48 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.306 1.908 . . . . 0.0 114.311 -174.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.83 133.85 86.16 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.765 1.226 . . . . 0.0 110.694 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.3 142.66 21.52 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.846 2.364 . . . . 0.0 113.245 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 42.1 tp -133.76 110.08 9.56 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.779 2.032 . . . . 0.0 108.13 169.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 47.63 60.17 3.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.491 1.517 . . . . 0.0 111.731 -169.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.93 -55.96 5.05 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.177 1.37 . . . . 0.0 113.302 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -59.33 121.78 58.86 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.067 1.747 . . . . 0.0 112.978 -174.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.87 117.56 5.1 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.492 2.128 . . . . 0.0 110.177 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -64.17 133.43 52.89 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.44 1.096 . . . . 0.0 111.128 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -109.53 124.48 51.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.154 0.981 . . . . 0.0 109.804 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.8 mt -127.13 137.84 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.974 1.31 . . . . 0.0 110.924 -170.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -138.95 123.02 17.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.802 1.641 . . . . 0.0 111.331 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 42.5 tp -70.77 142.26 51.39 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.972 1.309 . . . . 0.0 111.25 171.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.7 p -50.46 -48.39 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.419 1.488 . . . . 0.0 113.49 174.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.3 m -71.38 123.26 21.94 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.546 1.139 . . . . 0.0 111.025 173.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.329 1.851 . . . . 0.0 114.022 179.336 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -147.89 126.89 12.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.099 1.449 . . . . 0.0 111.774 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.7 121.14 44.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.438 1.495 . . . . 0.0 111.608 174.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.0 tp -81.73 128.79 34.35 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 168.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.5 t -116.07 135.81 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.987 1.315 . . . . 0.0 108.388 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.55 170.37 16.19 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.525 1.53 . . . . 0.0 111.43 -176.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.2 t30 56.0 42.5 28.5 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.503 1.521 . . . . 0.0 112.611 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.0 mt -81.82 150.91 27.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.842 0.857 . . . . 0.0 110.03 169.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.07 140.26 35.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.513 0.725 . . . . 0.0 111.689 174.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -67.86 88.92 0.27 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.29 1.043 . . . . 0.0 109.539 170.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 156.93 -25.64 0.49 Allowed Glycine 0 CA--C 1.538 1.483 0 C-N-CA 127.073 2.273 . . . . 0.0 112.56 -169.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.1 t -58.3 118.01 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.87 1.268 . . . . 0.0 109.931 170.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 64.7 m -77.44 145.41 37.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.915 0.886 . . . . 0.0 112.714 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -56.28 -53.34 58.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.376 1.47 . . . . 0.0 112.633 176.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.18 87.5 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.44 1.096 . . . . 0.0 113.027 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.16 -47.96 83.75 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.622 0.769 . . . . 0.0 112.1 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mm -54.53 -53.19 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.903 0.881 . . . . 0.0 111.063 169.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -52.03 -54.0 35.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.485 0.584 . . . . 0.0 112.265 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -58.14 -50.72 72.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.712 1.205 . . . . 0.0 113.307 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.59 -45.46 90.28 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.122 0.874 . . . . 0.0 111.928 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -62.8 -44.36 96.37 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.573 0.624 . . . . 0.0 112.384 173.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.35 -31.52 65.81 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 178.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.82 -48.37 81.54 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.305 1.042 . . . . 0.0 112.666 174.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -101.43 -17.16 16.6 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -173.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -141.16 157.43 26.03 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 119.613 1.097 . . . . 0.0 114.25 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.6 m -96.55 109.46 22.05 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.98 1.312 . . . . 0.0 109.736 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -123.0 143.3 50.02 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.673 1.189 . . . . 0.0 114.001 -169.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.2 -48.64 19.66 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 127.686 2.394 . . . . 0.0 110.29 169.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -148.28 147.78 29.71 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.291 1.437 . . . . 0.0 111.933 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -142.34 122.14 13.5 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.23 1.412 . . . . 0.0 109.795 170.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.08 138.5 26.71 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.868 0.867 . . . . 0.0 112.671 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.9 t -104.24 148.32 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.417 1.887 . . . . 0.0 111.082 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 31.8 p80 -37.44 -47.05 0.85 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 128.541 2.737 . . . . 0.0 116.92 -169.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -47.38 -46.23 25.72 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.97 1.308 . . . . 0.0 111.99 -174.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.87 -57.87 2.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.546 1.538 . . . . 0.0 111.576 170.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -50.37 -50.77 50.47 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.525 1.93 . . . . 0.0 113.434 -171.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 m -105.99 19.77 20.01 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.326 1.851 . . . . 0.0 112.204 -173.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.69 -36.65 1.41 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.902 1.715 . . . . 0.0 115.555 172.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.73 166.52 24.41 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.647 2.379 . . . . 0.0 112.591 -172.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.2 m -59.0 113.88 2.3 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.345 1.458 . . . . 0.0 111.891 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 21.6 tp -136.35 -26.54 1.12 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.93 1.292 . . . . 0.0 114.411 -174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.24 37.81 20.24 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.525 1.06 . . . . 0.0 113.66 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.3 p -136.39 167.74 20.77 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.568 1.947 . . . . 0.0 112.006 -175.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.16 170.35 18.63 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.928 -1.108 . . . . 0.0 111.423 169.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -136.2 121.64 19.39 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 126.156 1.782 . . . . 0.0 108.676 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.0 t -120.46 114.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.469 1.108 . . . . 0.0 108.925 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -100.33 111.19 23.45 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.918 2.087 . . . . 0.0 108.719 -175.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -92.12 167.25 12.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.49 2.716 . . . . 0.0 113.165 -174.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -61.98 -54.13 45.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.741 0.816 . . . . 0.0 111.139 169.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 71.5 mtp180 -141.02 147.29 38.45 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.06 1.744 . . . . 0.0 112.038 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -54.43 -30.35 52.31 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.894 1.678 . . . . 0.0 114.211 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.7 -55.1 36.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.418 1.087 . . . . 0.0 112.496 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.44 -36.15 80.63 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.638 -0.664 . . . . 0.0 112.303 178.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.76 -54.91 38.63 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.246 1.018 . . . . 0.0 111.891 169.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.7 mt -53.99 -47.68 71.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.125 1.37 . . . . 0.0 112.505 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -50.68 -58.35 6.09 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.95 1.3 . . . . 0.0 111.534 172.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.87 -49.1 69.25 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.727 1.211 . . . . 0.0 112.628 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 53.4 ttp -53.22 -59.26 4.78 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.511 1.524 . . . . 0.0 111.779 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -25.53 68.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -75.0 -48.77 22.45 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.983 0.913 . . . . 0.0 113.195 172.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -102.37 -11.59 18.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.871 2.174 . . . . 0.0 116.871 -169.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -59.06 116.7 4.01 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.028 1.285 . . . . 0.0 111.403 171.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 100.89 -13.3 59.15 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.788 1.661 . . . . 0.0 114.732 -177.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.7 t -71.47 128.58 89.82 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 119.258 1.529 . . . . 0.0 110.945 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.52 136.87 77.03 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.882 3.054 . . . . 0.0 114.375 174.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 35.5 tp -139.49 110.57 6.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.861 1.664 . . . . 0.0 108.344 169.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 49.54 60.5 3.74 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.439 1.496 . . . . 0.0 111.536 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.31 -63.64 4.39 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.136 1.351 . . . . 0.0 113.147 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.33 134.78 94.68 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.902 1.281 . . . . 0.0 112.804 -173.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.51 127.14 12.19 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.31 2.673 . . . . 0.0 111.714 172.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -66.02 117.61 8.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.62 1.168 . . . . 0.0 112.094 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -85.49 115.67 23.35 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.2 mt -120.83 132.0 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.643 1.177 . . . . 0.0 110.668 -175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -144.63 124.77 13.67 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.435 1.494 . . . . 0.0 112.139 -169.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 12.2 tp -68.62 127.04 31.59 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.81 169.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.6 m -104.74 -15.04 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.055 0.942 . . . . 0.0 113.433 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 12.8 m -59.9 136.44 58.01 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.945 1.298 . . . . 0.0 111.168 169.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--O 1.251 1.15 0 C-N-CA 125.68 1.592 . . . . 0.0 113.384 176.477 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -92.48 83.98 5.04 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.123 0.961 . . . . 0.0 109.907 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -80.46 128.7 33.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.19 2.196 . . . . 0.0 109.114 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.6 tp -121.32 109.75 15.29 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.643 1.577 . . . . 0.0 110.307 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.4 138.71 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.57 1.548 . . . . 0.0 109.11 170.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.6 m -139.06 168.38 19.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.988 2.115 . . . . 0.0 111.494 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 47.7 t30 55.69 41.39 30.48 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.311 1.845 . . . . 0.0 113.147 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.0 mt -77.81 154.73 31.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.286 1.034 . . . . 0.0 110.314 169.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.61 144.98 55.29 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.524 -0.735 . . . . 0.0 111.197 169.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -73.11 68.99 1.0 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.732 1.213 . . . . 0.0 110.795 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.36 -11.86 0.06 OUTLIER Glycine 0 CA--C 1.539 1.566 0 C-N-CA 125.745 1.64 . . . . 0.0 115.587 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.05 119.87 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.72 1.76 . . . . 0.0 110.642 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -72.0 140.62 49.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.255 1.022 . . . . 0.0 112.893 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.85 -47.18 86.2 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.845 1.258 . . . . 0.0 112.501 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.96 -45.6 74.95 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.461 1.104 . . . . 0.0 112.694 172.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.95 -47.91 84.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.825 0.85 . . . . 0.0 111.991 177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.1 mm -53.46 -53.79 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.523 1.129 . . . . 0.0 111.921 170.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -50.7 -57.23 8.8 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.543 0.737 . . . . 0.0 111.222 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -56.0 -50.46 70.79 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.299 1.04 . . . . 0.0 113.16 178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.69 -48.56 71.65 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.995 0.816 . . . . 0.0 112.23 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -63.82 -41.34 97.88 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.78 0.718 . . . . 0.0 112.664 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.58 -10.48 52.29 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 175.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -75.42 -60.97 2.07 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.863 -1.148 . . . . 0.0 111.314 172.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -81.26 -30.18 34.16 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.83 -169.76 13.21 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.722 1.63 . . . . 0.0 112.568 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 m -136.94 123.88 21.42 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.587 -0.949 . . . . 0.0 111.703 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.1 pp -128.63 145.84 51.03 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.235 1.414 . . . . 0.0 113.439 -170.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -82.48 -47.31 12.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.914 2.086 . . . . 0.0 111.298 173.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -145.89 149.98 35.27 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.391 1.076 . . . . 0.0 112.324 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.58 147.64 37.99 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.054 1.342 . . . . 0.0 111.599 169.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.58 109.58 4.3 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.457 1.503 . . . . 0.0 111.776 175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.86 152.5 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.742 1.217 . . . . 0.0 109.716 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -54.93 -46.86 74.98 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.968 1.707 . . . . 0.0 114.588 -175.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -61.17 151.78 30.43 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.677 0.791 . . . . 0.0 111.866 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 66.95 -46.4 0.46 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.981 2.113 . . . . 0.0 113.476 -169.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.17 -41.91 84.85 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.489 1.916 . . . . 0.0 111.579 169.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 63.1 m -136.07 156.38 48.81 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.87 2.468 . . . . 0.0 111.579 170.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -102.89 66.4 0.36 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.159 1.362 . . . . 0.0 110.591 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -139.46 142.79 37.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.673 1.989 . . . . 0.0 111.315 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.4 m -77.29 75.15 3.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.277 1.031 . . . . 0.0 109.717 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 34.3 tp -107.85 -52.34 2.78 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.179 1.392 . . . . 0.0 112.917 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.81 59.42 5.16 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.144 0.878 . . . . 0.0 113.164 174.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.2 p -140.96 159.27 42.57 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.271 1.428 . . . . 0.0 111.773 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.87 119.59 11.16 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.714 1.205 . . . . 0.0 111.426 171.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -87.52 130.95 34.54 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.203 1.001 . . . . 0.0 109.965 172.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.19 117.66 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.681 1.593 . . . . 0.0 109.794 -174.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -87.96 101.23 13.55 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.931 0.892 . . . . 0.0 109.382 171.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -74.29 153.76 39.23 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.984 2.114 . . . . 0.0 112.015 174.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -62.66 -37.15 85.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 91.1 mmt-85 -141.26 141.21 33.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.51 1.524 . . . . 0.0 111.854 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -58.42 -42.9 88.29 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.572 1.549 . . . . 0.0 113.114 175.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.23 -51.8 61.0 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.191 0.997 . . . . 0.0 112.697 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.15 -42.28 99.43 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.195 0.998 . . . . 0.0 112.572 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.5 -47.22 79.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.318 1.047 . . . . 0.0 112.672 170.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.64 -46.99 88.2 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.567 1.547 . . . . 0.0 111.773 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -50.94 -56.44 12.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.818 1.247 . . . . 0.0 111.412 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.49 -50.98 61.66 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.22 1.008 . . . . 0.0 112.599 174.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 31.2 ttp -52.8 -62.43 1.65 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.754 1.622 . . . . 0.0 111.673 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -62.95 -37.33 86.62 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -65.09 -54.46 29.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.639 1.176 . . . . 0.0 112.557 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -90.59 -14.77 31.81 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -169.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.1 109.32 0.82 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 120.101 1.318 . . . . 0.0 110.923 169.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 116.74 -28.84 7.19 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 126.461 1.982 . . . . 0.0 113.923 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 56.5 t -71.12 134.2 85.38 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.121 1.368 . . . . 0.0 110.737 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.64 141.74 25.19 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.944 2.429 . . . . 0.0 112.721 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 49.2 tp -137.08 111.68 8.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.762 1.625 . . . . 0.0 108.734 169.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 50.69 60.16 4.06 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.756 1.622 . . . . 0.0 111.489 -169.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.01 -63.74 4.39 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.1 1.333 . . . . 0.0 113.195 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -63.91 135.03 96.13 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.737 1.215 . . . . 0.0 112.659 -173.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.66 123.63 9.59 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.404 2.736 . . . . 0.0 111.105 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.7 mtm -62.88 129.77 41.88 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.076 0.95 . . . . 0.0 111.214 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -109.12 125.44 52.16 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.638 1.175 . . . . 0.0 108.291 169.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.29 138.64 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 118.823 0.738 . . . . 0.0 111.904 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -131.37 153.91 49.16 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 128.334 2.654 . . . . 0.0 109.978 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.8 tp -134.44 127.24 31.12 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.839 1.256 . . . . 0.0 111.041 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.32 -172.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.174 1.789 . . . . 0.0 111.14 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 16.6 m -144.31 139.22 28.42 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.205 1.402 . . . . 0.0 110.317 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.618 1.967 . . . . 0.0 114.059 -178.317 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -137.76 136.62 37.46 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 117.909 0.855 . . . . 0.0 112.671 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.76 141.05 44.43 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.129 0.972 . . . . 0.0 110.9 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.7 tp -110.67 115.51 29.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.917 2.087 . . . . 0.0 106.717 169.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.89 135.26 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.436 1.095 . . . . 0.0 110.017 -169.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 55.0 m -139.23 161.86 36.39 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.061 1.745 . . . . 0.0 112.246 -174.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.4 t30 51.11 43.26 29.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.294 2.238 . . . . 0.0 114.658 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 90.1 mt -78.69 164.87 24.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.264 1.426 . . . . 0.0 108.862 168.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -73.08 159.48 33.53 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 120.717 -1.239 . . . . 0.0 112.633 169.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -64.55 -41.4 96.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.585 1.554 . . . . 0.0 112.629 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -92.6 53.04 2.7 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.48 1.514 . . . . 0.0 112.791 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 84.5 t -116.11 113.74 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 126.038 1.735 . . . . 0.0 109.795 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.6 m -72.8 142.29 48.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.242 1.017 . . . . 0.0 112.26 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -56.65 -54.94 40.32 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.468 1.507 . . . . 0.0 112.316 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.31 -34.94 74.5 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.371 1.068 . . . . 0.0 113.567 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.48 -52.74 63.24 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.324 0.965 . . . . 0.0 111.465 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.1 mm -55.0 -52.7 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.343 1.057 . . . . 0.0 110.899 170.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -50.78 -56.29 12.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.976 0.91 . . . . 0.0 112.105 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -60.14 -48.22 82.62 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.106 1.362 . . . . 0.0 112.963 177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 -46.61 81.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.415 1.007 . . . . 0.0 112.121 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -60.6 -40.83 93.26 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.884 0.765 . . . . 0.0 112.048 173.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.5 -6.22 18.67 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -77.35 -59.83 2.62 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.755 -1.216 . . . . 0.0 111.231 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -84.46 -25.54 28.86 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -121.81 -179.58 16.02 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.657 1.599 . . . . 0.0 112.274 171.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.4 m -123.85 118.58 27.44 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.819 1.247 . . . . 0.0 110.223 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.76 165.08 26.76 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -169.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -93.25 -58.19 2.38 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.743 2.017 . . . . 0.0 111.176 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -157.93 142.67 16.42 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.408 1.083 . . . . 0.0 113.369 -172.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -105.64 155.71 18.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.658 1.183 . . . . 0.0 111.67 169.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -144.08 88.25 1.95 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.201 1.8 . . . . 0.0 110.1 173.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.0 t -82.16 134.54 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.589 1.556 . . . . 0.0 110.743 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -21.09 -71.1 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 129.436 3.094 . . . . 0.0 116.352 -169.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -48.32 -29.34 3.81 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.394 1.878 . . . . 0.0 115.48 -175.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.28 -32.71 70.27 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.397 1.479 . . . . 0.0 113.409 175.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -134.37 -42.77 0.78 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.124 1.369 . . . . 0.0 114.564 -169.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 54.0 m -60.98 145.73 49.54 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.113 1.365 . . . . 0.0 112.311 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -58.66 -30.35 65.5 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.92 1.247 . . . . 0.0 114.861 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.29 158.98 43.17 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.783 2.033 . . . . 0.0 111.809 173.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 47.1 m -62.3 133.99 55.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.336 1.055 . . . . 0.0 111.046 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.6 tp -136.38 -56.48 0.75 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.517 1.127 . . . . 0.0 113.586 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 113.78 53.66 0.44 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.98 1.276 . . . . 0.0 113.232 -174.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.3 p -141.64 164.17 30.94 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.095 1.758 . . . . 0.0 110.967 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.1 167.26 30.44 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.231 -0.918 . . . . 0.0 112.693 169.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -130.84 132.73 45.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.417 1.887 . . . . 0.0 108.717 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.8 t -135.38 109.01 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 118.93 0.786 . . . . 0.0 111.148 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -73.84 123.35 24.04 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.118 1.367 . . . . 0.0 110.31 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.0 161.02 17.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.9 2.48 . . . . 0.0 112.92 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -59.19 -48.28 82.21 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.844 0.858 . . . . 0.0 112.577 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -143.2 152.73 42.08 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.364 1.866 . . . . 0.0 110.471 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -59.92 -43.94 94.62 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.186 0.994 . . . . 0.0 112.631 171.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.83 -46.58 71.22 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.357 1.063 . . . . 0.0 112.905 171.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -62.58 -48.44 79.42 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.211 1.404 . . . . 0.0 111.648 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.01 -48.33 73.51 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.195 1.398 . . . . 0.0 112.637 172.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.9 tp -53.29 -42.03 66.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.734 1.614 . . . . 0.0 113.101 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -51.2 -59.94 3.65 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.502 1.121 . . . . 0.0 111.437 171.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.9 -48.88 69.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.273 1.429 . . . . 0.0 112.482 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 21.0 ttp -51.6 -61.34 2.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.011 1.724 . . . . 0.0 111.563 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -56.36 -45.86 80.26 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.461 1.504 . . . . 0.0 112.353 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -58.4 -51.18 70.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.49 1.116 . . . . 0.0 113.176 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -97.73 -16.62 19.82 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.918 1.821 . . . . 0.0 115.918 -172.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -58.33 109.26 0.74 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 120.332 1.424 . . . . 0.0 111.388 171.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.56 -26.5 8.06 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.278 1.894 . . . . 0.0 114.041 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.78 135.0 95.35 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.065 1.346 . . . . 0.0 111.044 -175.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.33 134.19 15.41 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.923 2.416 . . . . 0.0 111.708 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 63.5 tp -125.13 102.13 7.34 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.351 1.86 . . . . 0.0 108.196 175.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 44.32 62.04 2.16 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.005 1.722 . . . . 0.0 111.763 -169.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.83 -60.88 4.42 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.105 1.336 . . . . 0.0 112.995 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -60.46 118.94 38.76 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 125.858 1.663 . . . . 0.0 111.993 -172.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.07 118.85 5.82 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.902 2.401 . . . . 0.0 111.354 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.9 mtp -59.74 137.95 57.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.652 1.581 . . . . 0.0 112.013 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -121.08 131.51 54.31 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.731 1.212 . . . . 0.0 110.11 170.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.3 mt -131.07 137.35 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.258 1.023 . . . . 0.0 111.065 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -130.29 171.76 12.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 129.34 3.056 . . . . 0.0 109.912 175.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.06 155.43 46.16 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 171.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.6 152.8 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.389 1.476 . . . . 0.0 111.264 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 4.3 m -67.39 132.62 48.02 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.412 1.085 . . . . 0.0 110.931 173.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.614 1.566 . . . . 0.0 113.699 178.077 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 CA-C-O 120.08 -0.289 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -83.53 99.33 10.07 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.057 0.928 . . . . 0.0 111.004 175.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 76.1 mt -75.83 108.83 8.96 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.682 1.193 . . . . 0.0 110.19 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.4 tp -80.66 125.21 29.74 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.784 1.233 . . . . 0.0 107.8 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.32 131.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.376 1.07 . . . . 0.0 109.135 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.7 m -135.01 168.8 18.45 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.763 1.625 . . . . 0.0 111.728 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.2 t30 51.65 56.5 7.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.059 1.744 . . . . 0.0 112.438 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.8 mt -101.12 151.7 21.51 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.297 1.839 . . . . 0.0 110.94 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -69.22 142.05 54.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.776 -0.577 . . . . 0.0 110.937 169.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -62.34 -16.84 56.79 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -78.43 -13.44 83.23 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 125.413 1.482 . . . . 0.0 115.092 172.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 80.4 t -66.47 136.34 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 119.26 1.53 . . . . 0.0 109.997 172.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 65.4 m -140.9 169.21 18.04 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.551 1.54 . . . . 0.0 112.355 -175.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -46.34 -58.1 4.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.703 2.001 . . . . 0.0 113.693 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.89 -49.45 71.18 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.989 0.916 . . . . 0.0 112.813 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.1 -49.53 76.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.728 1.211 . . . . 0.0 112.31 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mm -54.19 -55.55 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.839 1.255 . . . . 0.0 111.349 171.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -53.19 -53.46 50.27 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.776 0.716 . . . . 0.0 111.685 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -54.51 -51.51 64.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.859 0.864 . . . . 0.0 113.058 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.7 -49.57 72.6 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.857 0.753 . . . . 0.0 112.555 -176.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -67.09 -38.49 85.8 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -62.72 -20.22 64.69 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.33 -66.45 0.54 Allowed 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.959 -1.088 . . . . 0.0 110.751 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -85.56 -17.93 34.85 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -172.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.57 -159.79 8.49 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.429 1.49 . . . . 0.0 112.862 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.1 m -144.83 133.89 22.69 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.292 1.046 . . . . 0.0 110.996 174.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.59 146.81 52.19 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.892 1.277 . . . . 0.0 114.365 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -74.39 -52.32 12.46 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.441 1.896 . . . . 0.0 110.194 169.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -149.03 158.84 44.5 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.23 160.67 37.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.072 1.749 . . . . 0.0 110.847 169.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.89 149.42 23.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.329 1.852 . . . . 0.0 110.699 170.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.95 -96.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.976 0.91 . . . . 0.0 110.803 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.48 ' CG ' ' H ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -136.44 -98.22 0.22 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.905 1.682 . . . . 0.0 110.926 -169.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.48 ' H ' ' CG ' ' A' ' 137' ' ' HIS . 9.3 p90 43.45 32.05 0.47 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 130.255 3.422 . . . . 0.0 115.795 169.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -162.45 171.4 17.16 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 129.385 3.074 . . . . 0.0 108.913 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -75.85 74.47 2.79 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.738 -1.226 . . . . 0.0 110.441 170.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.6 m -62.75 -39.68 94.89 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.895 1.678 . . . . 0.0 114.038 -173.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 64.47 52.39 43.78 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.336 0.97 . . . . 0.0 111.675 -170.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -146.13 154.85 42.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.112 2.165 . . . . 0.0 111.051 -169.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.4 m -59.9 108.57 0.78 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.242 1.017 . . . . 0.0 109.9 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.3 tp -76.87 166.3 23.52 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.005 0.922 . . . . 0.0 112.994 -169.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 77.89 46.76 9.16 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.219 0.914 . . . . 0.0 111.208 -169.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.0 p -146.45 150.18 35.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.773 2.029 . . . . 0.0 111.258 -170.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.32 167.87 23.22 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.202 1.801 . . . . 0.0 112.511 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -132.93 131.4 40.8 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.83 2.052 . . . . 0.0 109.668 176.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.1 t -132.92 109.33 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.529 1.132 . . . . 0.0 109.644 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -90.63 98.98 12.1 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.253 1.421 . . . . 0.0 110.064 -176.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -73.3 155.18 39.72 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.284 1.834 . . . . 0.0 114.249 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -68.72 -45.48 71.44 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.419 1.488 . . . . 0.0 112.088 171.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 -122.38 124.04 42.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.176 1.79 . . . . 0.0 110.325 -169.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -58.6 -47.27 84.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.843 1.257 . . . . 0.0 112.176 175.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.18 -48.31 61.96 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.35 1.06 . . . . 0.0 112.783 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -67.46 -35.43 79.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.679 1.191 . . . . 0.0 112.557 175.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.31 -45.56 92.95 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.037 0.935 . . . . 0.0 112.353 170.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -53.8 -49.93 67.23 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.709 1.141 . . . . 0.0 111.607 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 18.3 ttpt -51.59 -58.2 7.0 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.409 1.084 . . . . 0.0 111.353 174.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -50.09 -51.93 38.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.106 1.362 . . . . 0.0 112.663 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 60.9 ttp -53.63 -62.69 1.49 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.548 1.539 . . . . 0.0 111.5 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -62.49 -37.58 86.55 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -64.03 -51.04 66.03 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.234 1.413 . . . . 0.0 112.687 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -99.0 -14.17 19.59 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -169.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -58.83 112.61 1.71 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.154 1.343 . . . . 0.0 111.226 170.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 107.57 -23.25 26.81 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.054 1.788 . . . . 0.0 114.371 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.7 t -73.15 135.51 79.76 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.887 1.275 . . . . 0.0 110.393 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.53 142.92 26.86 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.952 2.435 . . . . 0.0 113.068 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 58.5 tp -131.82 106.27 7.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.838 1.655 . . . . 0.0 107.852 169.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 50.65 61.22 3.34 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.755 1.622 . . . . 0.0 111.377 -169.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.53 -62.95 4.21 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.135 1.35 . . . . 0.0 113.311 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -65.43 128.49 93.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.844 1.258 . . . . 0.0 112.392 -172.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.91 122.92 9.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.725 2.95 . . . . 0.0 111.897 175.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 75.4 mtm -63.18 126.06 26.15 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.065 1.346 . . . . 0.0 111.831 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -103.19 113.5 27.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.986 1.315 . . . . 0.0 109.191 172.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mt -118.37 134.69 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.552 1.141 . . . . 0.0 111.484 -169.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -136.94 153.72 50.63 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.335 2.254 . . . . 0.0 110.089 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 59.2 tp -135.2 132.74 38.29 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.842 1.257 . . . . 0.0 111.453 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.57 134.08 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.127 0.971 . . . . 0.0 112.023 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.3 m -66.02 -56.07 13.45 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.482 1.113 . . . . 0.0 112.258 -176.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.253 1.245 0 C-N-CA 126.641 1.976 . . . . 0.0 113.341 -176.769 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.87 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -132.74 152.21 51.8 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 122.079 0.943 . . . . 0.0 111.957 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -129.05 101.64 6.14 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.137 1.775 . . . . 0.0 108.208 -169.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.6 tp -84.45 133.36 34.49 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.14 1.376 . . . . 0.0 109.394 175.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.5 t -122.05 130.48 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.85 1.26 . . . . 0.0 108.944 171.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -115.19 159.73 20.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.968 1.707 . . . . 0.0 110.474 172.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.3 t30 60.74 71.66 0.56 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.307 1.843 . . . . 0.0 112.227 -169.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.5 mt -131.33 154.6 48.39 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.873 2.469 . . . . 0.0 108.964 169.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -88.63 151.27 22.57 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.72 -0.613 . . . . 0.0 112.364 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -58.2 -28.07 64.46 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.187 -0.945 . . . . 0.0 112.294 172.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -65.97 -17.08 65.0 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.052 1.31 . . . . 0.0 115.467 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.99 116.67 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.419 1.609 . . . . 0.0 110.453 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 59.5 m -76.31 151.24 36.78 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.698 1.199 . . . . 0.0 111.852 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -58.51 -50.34 74.11 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.608 -0.683 . . . . 0.0 112.243 172.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 -38.91 59.86 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.06 -56.37 23.17 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.29 1.036 . . . . 0.0 112.231 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 23.6 mm -56.1 -53.89 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.197 1.399 . . . . 0.0 111.157 173.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -47.3 -57.77 4.86 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.829 2.052 . . . . 0.0 111.47 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -59.92 -50.97 71.7 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.506 1.122 . . . . 0.0 113.122 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.6 -45.2 93.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.402 1.001 . . . . 0.0 112.149 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -63.22 -44.24 95.84 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.433 0.693 . . . . 0.0 112.415 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.13 -18.56 63.57 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -69.46 -60.14 2.52 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.818 -1.176 . . . . 0.0 111.834 173.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -85.44 -22.76 28.15 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -175.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -136.06 -167.31 11.2 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.681 1.61 . . . . 0.0 112.735 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.2 m -136.81 129.3 30.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.082 0.953 . . . . 0.0 111.078 -178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.8 pp -130.06 144.49 51.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.88 1.272 . . . . 0.0 113.376 -169.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -75.17 -50.17 17.13 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.913 2.085 . . . . 0.0 110.497 169.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.94 154.79 38.86 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.78 1.232 . . . . 0.0 112.132 -172.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -138.58 151.72 47.54 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.446 1.499 . . . . 0.0 111.541 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -149.12 159.21 44.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.678 1.991 . . . . 0.0 110.903 170.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.1 -124.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.266 1.026 . . . . 0.0 110.818 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -71.08 -35.55 71.91 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -169.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -69.53 154.35 42.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.038 1.735 . . . . 0.0 114.142 -169.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -150.06 154.92 38.95 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.934 2.094 . . . . 0.0 110.41 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -49.25 -33.6 13.16 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.96 1.704 . . . . 0.0 113.869 175.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.7 m -59.77 -23.97 63.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.121 1.769 . . . . 0.0 114.26 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.56 49.7 7.08 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.12 1.343 . . . . 0.0 111.855 -170.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -140.94 113.46 8.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.544 1.938 . . . . 0.0 110.58 -174.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.9 m -70.74 138.54 50.59 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.455 1.102 . . . . 0.0 111.68 173.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 35.2 tp -130.71 150.15 52.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.383 1.873 . . . . 0.0 110.229 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.43 51.11 4.45 Favored Glycine 0 N--CA 1.47 0.954 0 O-C-N 120.959 -1.088 . . . . 0.0 112.469 -171.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 37.0 p -142.01 167.71 21.49 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.67 1.988 . . . . 0.0 113.548 -169.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.7 157.11 43.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.725 2.01 . . . . 0.0 110.618 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -140.14 126.89 20.51 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.982 1.313 . . . . 0.0 110.212 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 52.2 t -122.34 116.03 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.813 1.245 . . . . 0.0 109.033 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -83.32 105.65 14.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.023 1.329 . . . . 0.0 108.19 173.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -82.08 153.33 26.16 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.423 2.289 . . . . 0.0 113.079 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.76 -34.01 77.19 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.987 0.915 . . . . 0.0 113.409 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -138.15 146.34 42.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.486 1.514 . . . . 0.0 113.295 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -64.18 -45.63 87.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.791 1.636 . . . . 0.0 111.782 172.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.03 -49.48 60.42 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.47 1.108 . . . . 0.0 112.265 171.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -66.35 -40.83 90.08 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.622 1.169 . . . . 0.0 112.792 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.37 -49.4 74.55 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.582 1.153 . . . . 0.0 112.419 170.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 54.6 tp -57.04 -49.76 74.82 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.352 1.461 . . . . 0.0 111.884 173.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -50.1 -52.85 31.44 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.354 1.461 . . . . 0.0 111.434 174.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.96 -50.86 69.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.017 0.927 . . . . 0.0 112.519 173.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -54.5 -60.23 3.63 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.376 1.07 . . . . 0.0 112.17 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -37.19 75.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -69.17 -43.83 73.45 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.161 0.984 . . . . 0.0 112.906 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -108.42 -8.41 15.61 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 -169.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -58.46 116.43 3.64 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 120.054 1.297 . . . . 0.0 111.459 171.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.58 -21.54 44.72 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.869 1.7 . . . . 0.0 114.575 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.28 136.67 88.93 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 118.72 1.26 . . . . 0.0 110.451 -177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.8 143.57 29.95 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.725 2.284 . . . . 0.0 113.197 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -131.67 106.76 8.36 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.301 2.24 . . . . 0.0 107.015 171.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 48.0 61.67 2.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.336 1.454 . . . . 0.0 111.494 -169.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.39 -53.92 4.71 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.254 1.407 . . . . 0.0 113.483 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -59.47 119.17 37.35 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.522 1.929 . . . . 0.0 112.779 -174.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.54 120.73 7.65 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.619 2.212 . . . . 0.0 110.726 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.5 mtm -67.3 116.96 8.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.982 1.313 . . . . 0.0 112.13 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -89.59 101.43 14.11 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.264 1.025 . . . . 0.0 108.941 170.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.4 mt -103.89 139.81 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.275 1.03 . . . . 0.0 111.827 -170.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -134.27 126.61 30.13 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.415 1.886 . . . . 0.0 111.191 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 60.9 tp -75.79 131.7 39.95 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.769 1.228 . . . . 0.0 109.874 169.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.35 171.65 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.38 1.472 . . . . 0.0 112.159 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.7 p -132.77 -69.16 0.58 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.926 1.69 . . . . 0.0 110.806 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 C--O 1.251 1.135 0 C-N-CA 125.95 1.7 . . . . 0.0 112.116 171.165 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 N-CA-C 112.629 -0.188 . . . . 0.0 112.629 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -149.08 130.59 14.84 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.576 -0.955 . . . . 0.0 111.519 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 41.9 mt -119.43 121.24 39.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.018 1.727 . . . . 0.0 111.879 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.9 tp -86.05 116.01 24.0 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 168.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 49.1 t -101.83 131.05 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 108.134 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.2 m -138.78 167.84 21.11 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.762 1.625 . . . . 0.0 112.318 -169.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.7 t30 52.84 46.88 25.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.005 1.722 . . . . 0.0 112.948 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 77.9 mt -90.76 164.34 14.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.766 1.227 . . . . 0.0 109.59 169.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.93 150.88 47.93 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 121.392 -0.817 . . . . 0.0 110.652 169.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -58.07 -20.82 42.48 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -128.78 39.76 1.81 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.879 1.228 . . . . 0.0 115.812 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -68.58 131.8 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.367 1.583 . . . . 0.0 109.276 169.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.1 m -69.92 138.92 52.81 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.487 0.715 . . . . 0.0 112.344 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -58.87 -52.16 66.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.068 1.347 . . . . 0.0 112.309 -177.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.87 -40.47 80.27 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.98 1.312 . . . . 0.0 113.092 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.61 -52.35 65.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.9 0.88 . . . . 0.0 112.127 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.1 mm -55.11 -52.86 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.949 0.9 . . . . 0.0 111.266 170.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -51.89 -52.45 49.68 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.925 0.89 . . . . 0.0 112.294 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -60.43 -51.97 67.23 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.031 1.332 . . . . 0.0 113.27 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.19 -43.54 97.93 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.337 0.972 . . . . 0.0 112.22 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -62.16 -44.87 95.65 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.533 0.606 . . . . 0.0 112.022 172.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -57.69 -32.64 67.55 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.62 -47.3 86.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.198 0.999 . . . . 0.0 112.874 174.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -100.82 -15.86 17.48 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -173.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.92 155.1 25.75 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.641 1.115 . . . . 0.0 114.033 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 24.7 m -91.53 99.23 12.2 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.858 1.263 . . . . 0.0 110.006 -174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 pp -111.47 141.82 44.53 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.296 1.038 . . . . 0.0 113.742 -171.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -82.22 -46.25 13.97 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.153 2.581 . . . . 0.0 110.427 170.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -146.12 144.99 30.34 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.395 1.478 . . . . 0.0 111.481 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.62 121.96 11.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.378 1.471 . . . . 0.0 110.447 171.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.08 139.86 30.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.624 1.17 . . . . 0.0 112.704 -176.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.9 t -107.28 144.24 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.363 1.865 . . . . 0.0 111.159 -173.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -41.44 -50.11 3.88 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.468 2.307 . . . . 0.0 114.918 -169.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -58.89 -33.85 70.98 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.75 1.22 . . . . 0.0 113.147 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -91.57 -52.62 4.68 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.725 1.61 . . . . 0.0 111.749 173.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 -56.24 -58.19 9.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.616 2.366 . . . . 0.0 113.496 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.5 m -104.61 -35.91 7.67 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.976 2.111 . . . . 0.0 113.002 -169.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 103.03 -62.11 0.46 Allowed Glycine 0 CA--C 1.531 1.066 0 C-N-CA 126.108 1.813 . . . . 0.0 112.329 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -59.7 126.39 27.42 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.783 1.633 . . . . 0.0 112.11 -178.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.3 m -58.28 121.62 11.22 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.584 1.554 . . . . 0.0 111.875 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 43.8 tp -147.73 -48.72 0.17 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.444 1.098 . . . . 0.0 113.378 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.05 57.96 1.27 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.498 1.047 . . . . 0.0 112.159 -176.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.9 p -144.16 163.53 33.34 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.759 1.623 . . . . 0.0 111.416 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.73 168.49 20.6 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.635 1.174 . . . . 0.0 111.405 170.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -135.18 118.81 17.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.162 1.785 . . . . 0.0 108.828 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.61 116.65 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.239 1.016 . . . . 0.0 110.093 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -101.83 124.93 48.29 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.24 1.416 . . . . 0.0 109.643 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -103.23 154.7 19.07 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 128.951 2.9 . . . . 0.0 113.042 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -68.78 -29.75 68.19 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.905 1.282 . . . . 0.0 113.63 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -138.38 136.06 35.94 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.248 1.419 . . . . 0.0 113.018 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.41 -53.55 56.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.403 2.281 . . . . 0.0 112.449 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.44 -45.37 84.78 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.191 1.397 . . . . 0.0 112.415 176.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.83 -38.91 92.56 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.504 -0.748 . . . . 0.0 112.567 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.96 51.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.282 0.633 . . . . 0.0 111.337 171.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -51.26 -50.22 59.65 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.5 1.92 . . . . 0.0 112.334 174.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -50.68 -59.99 3.5 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.805 1.642 . . . . 0.0 111.206 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.65 -46.47 70.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.381 1.073 . . . . 0.0 112.393 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.5 ttp -52.83 -59.48 4.45 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.957 1.303 . . . . 0.0 111.839 175.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -55.53 -50.45 69.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.217 1.007 . . . . 0.0 112.273 177.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -59.03 -46.34 88.46 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.851 1.661 . . . . 0.0 113.115 -177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -100.81 -14.81 17.85 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -60.53 106.26 0.53 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 120.001 1.273 . . . . 0.0 111.178 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 118.33 -27.33 7.37 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 126.569 2.033 . . . . 0.0 114.087 -175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 64.2 t -68.88 132.77 90.43 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 125.06 1.344 . . . . 0.0 110.876 -174.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.1 145.87 22.32 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.902 2.401 . . . . 0.0 113.39 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.8 tt -130.5 108.18 9.76 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.111 2.165 . . . . 0.0 107.32 169.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 44.0 57.04 4.37 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.936 1.694 . . . . 0.0 112.048 -169.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 87.9 -51.12 4.03 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.985 1.278 . . . . 0.0 113.706 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -62.8 119.38 50.77 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.54 1.536 . . . . 0.0 111.448 -174.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -71.29 118.55 5.74 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.831 2.354 . . . . 0.0 110.924 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.61 127.34 31.1 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.091 0.956 . . . . 0.0 110.957 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -100.78 131.11 46.83 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.524 1.13 . . . . 0.0 109.036 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.1 mm -124.1 135.51 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.788 0.835 . . . . 0.0 109.946 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.22 117.76 19.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.344 1.458 . . . . 0.0 110.674 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 39.7 tp -72.38 135.53 45.87 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.754 1.222 . . . . 0.0 110.147 169.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.5 m -123.18 151.26 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.16 0.984 . . . . 0.0 111.548 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.9 m -147.51 135.21 21.02 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.448 1.899 . . . . 0.0 109.86 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 54.7 m . . . . . 0 C--O 1.252 1.225 0 C-N-CA 125.093 1.357 . . . . 0.0 113.456 177.238 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.173 0 N-CA-C 112.303 -0.319 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.36 112.79 19.87 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.709 1.203 . . . . 0.0 111.522 179.029 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.5 117.88 23.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.842 2.457 . . . . 0.0 108.53 178.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.3 tp -105.69 125.62 51.2 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.808 2.043 . . . . 0.0 110.484 -176.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.6 t -112.78 125.44 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.148 1.779 . . . . 0.0 109.195 179.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.6 m -120.92 163.08 18.78 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.858 2.063 . . . . 0.0 110.909 177.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.7 t30 51.62 57.0 7.03 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.124 1.369 . . . . 0.0 111.281 -169.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.8 118.73 33.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.522 2.329 . . . . 0.0 107.784 -173.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.07 140.99 58.35 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -54.61 -29.02 50.67 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.777 1.631 . . . . 0.0 114.169 -178.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -75.72 -15.89 81.0 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 124.974 1.273 . . . . 0.0 115.353 177.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.18 122.42 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 119.155 1.478 . . . . 0.0 110.797 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.5 m -79.48 148.36 31.89 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.117 0.967 . . . . 0.0 113.22 -178.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.75 -54.23 48.69 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.305 1.842 . . . . 0.0 112.631 -179.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.65 87.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.035 0.934 . . . . 0.0 112.907 174.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.06 -47.55 84.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.587 0.755 . . . . 0.0 111.939 176.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mm -55.03 -52.53 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.035 0.934 . . . . 0.0 111.196 169.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -52.46 -52.2 55.39 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.126 0.571 . . . . 0.0 112.33 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.88 -50.51 73.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.94 1.296 . . . . 0.0 113.46 175.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.82 -44.96 91.69 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.394 0.997 . . . . 0.0 112.032 -176.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -61.75 -41.21 97.39 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 173.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.9 -13.58 46.55 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 175.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -74.59 -63.42 1.25 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.861 -1.15 . . . . 0.0 111.481 173.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -84.4 -12.78 53.82 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -175.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.36 -178.13 18.08 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.479 1.514 . . . . 0.0 112.942 176.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -126.65 127.49 45.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.984 1.314 . . . . 0.0 109.926 -179.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -134.61 149.66 50.6 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.637 1.175 . . . . 0.0 114.145 -169.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -77.68 -49.87 13.62 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.643 1.977 . . . . 0.0 110.407 169.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -149.78 150.83 32.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.687 1.195 . . . . 0.0 113.111 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -127.25 154.53 44.76 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.863 1.665 . . . . 0.0 110.148 168.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -156.26 153.38 29.04 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.723 1.609 . . . . 0.0 112.068 179.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.9 t -125.65 158.76 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 126.82 2.048 . . . . 0.0 109.362 174.046 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -58.52 -47.75 83.14 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 120.409 -1.432 . . . . 0.0 114.226 -174.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -62.12 161.32 11.19 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.873 1.269 . . . . 0.0 113.335 -171.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 t70 66.56 -55.48 0.41 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 127.775 2.43 . . . . 0.0 113.578 -173.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -55.41 -47.08 76.47 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.676 1.59 . . . . 0.0 111.287 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.5 m -123.91 115.35 21.14 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.101 1.76 . . . . 0.0 109.792 170.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.85 55.4 4.9 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.446 1.022 . . . . 0.0 113.075 -178.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -146.72 138.35 24.46 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.29 2.236 . . . . 0.0 110.983 -173.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.8 m -60.93 114.32 3.01 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.516 1.126 . . . . 0.0 111.012 173.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.3 tp -139.3 -59.64 0.58 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.265 1.426 . . . . 0.0 111.177 -177.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.27 63.63 1.71 Allowed Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.103 0.859 . . . . 0.0 113.43 172.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.8 p -143.91 154.41 43.31 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.501 1.521 . . . . 0.0 111.617 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.28 159.1 42.94 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.969 1.307 . . . . 0.0 111.766 173.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -144.2 133.75 23.46 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.876 1.67 . . . . 0.0 110.746 -172.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.86 114.79 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.446 1.098 . . . . 0.0 110.432 -177.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -79.46 104.15 9.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.328 1.451 . . . . 0.0 108.874 170.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -82.79 163.59 21.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.159 1.783 . . . . 0.0 113.389 -175.006 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -70.21 -51.48 30.62 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.827 0.851 . . . . 0.0 112.506 169.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -131.26 145.67 51.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.286 1.834 . . . . 0.0 112.354 -172.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -54.88 -56.65 17.21 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.924 2.09 . . . . 0.0 112.814 176.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.24 -47.13 72.58 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.887 1.275 . . . . 0.0 112.422 177.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -61.86 -38.86 89.83 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.459 1.103 . . . . 0.0 112.71 176.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.19 -46.46 80.68 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.458 0.703 . . . . 0.0 112.427 170.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 47.0 tp -59.12 -42.19 89.98 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.492 1.517 . . . . 0.0 112.147 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -48.0 -60.03 2.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.564 1.546 . . . . 0.0 110.728 169.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.73 -49.04 69.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.989 1.315 . . . . 0.0 112.592 176.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 25.0 ttp -51.81 -60.04 3.63 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.625 1.17 . . . . 0.0 111.643 177.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.26 -48.4 81.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.76 1.224 . . . . 0.0 112.319 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -58.1 -49.53 76.63 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.558 1.543 . . . . 0.0 112.993 -178.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -99.92 -12.37 19.87 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 -169.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -59.47 110.57 1.14 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 120.336 1.425 . . . . 0.0 111.194 169.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.36 -23.8 19.61 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.494 1.997 . . . . 0.0 114.172 -175.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -74.28 134.41 76.97 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 124.825 1.25 . . . . 0.0 110.95 -174.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.37 139.43 20.84 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.008 2.472 . . . . 0.0 112.719 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 54.8 tp -136.07 113.7 10.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.508 1.523 . . . . 0.0 108.628 169.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 49.11 61.4 3.15 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.609 1.564 . . . . 0.0 111.2 -169.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.4 -62.48 4.56 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.431 1.491 . . . . 0.0 113.373 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 59.1 mtt180 -66.06 128.42 93.82 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 124.866 1.266 . . . . 0.0 112.907 -169.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.73 116.41 4.65 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.451 2.768 . . . . 0.0 110.868 171.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.6 mtm -65.72 124.94 23.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.651 1.18 . . . . 0.0 111.666 -178.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -98.6 118.14 34.62 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 169.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mt -119.38 137.57 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.844 0.858 . . . . 0.0 112.305 -169.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -135.02 155.99 49.82 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 128.413 2.685 . . . . 0.0 110.032 -175.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 47.8 tp -135.86 113.49 10.92 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.448 1.099 . . . . 0.0 110.797 -177.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.6 t -66.01 118.29 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.942 0.897 . . . . 0.0 110.497 -175.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.4 m -144.99 137.49 26.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.987 1.715 . . . . 0.0 110.504 -174.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.0 m . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.502 1.921 . . . . 0.0 114.025 -179.097 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.162 0 N-CA-C 113.547 0.179 . . . . 0.0 113.547 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -72.05 149.72 44.61 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.448 1.099 . . . . 0.0 112.112 176.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.4 mt -136.33 139.31 42.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 130.107 3.363 . . . . 0.0 108.758 174.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 65.7 tp -122.32 118.82 29.39 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.892 1.677 . . . . 0.0 108.607 174.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.82 112.25 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.123 1.369 . . . . 0.0 108.709 -169.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -127.62 173.97 9.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.789 1.235 . . . . 0.0 112.54 -169.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.0 t30 52.34 43.12 31.12 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.119 1.767 . . . . 0.0 112.891 -169.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.7 mt -77.36 153.99 33.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.149 0.98 . . . . 0.0 108.566 169.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -68.02 141.98 56.05 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.732 -1.23 . . . . 0.0 109.957 169.319 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -61.55 -19.03 61.68 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -89.03 0.54 82.11 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 125.452 1.501 . . . . 0.0 115.472 174.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.07 118.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.733 1.766 . . . . 0.0 110.916 175.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.5 m -71.45 148.03 47.26 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.717 1.207 . . . . 0.0 112.765 178.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -53.63 -54.38 38.55 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.831 1.652 . . . . 0.0 112.846 174.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.89 78.47 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.532 1.133 . . . . 0.0 113.299 177.161 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.85 -51.02 71.79 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.949 0.9 . . . . 0.0 112.364 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.6 mm -56.52 -52.73 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.344 1.057 . . . . 0.0 111.008 171.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -51.82 -51.85 53.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.896 0.878 . . . . 0.0 112.414 179.392 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.72 -50.06 73.95 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.199 1.4 . . . . 0.0 113.545 174.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.04 -43.74 98.18 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.878 1.217 . . . . 0.0 112.455 -175.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -63.51 -42.5 98.47 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.557 0.617 . . . . 0.0 112.371 172.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.21 71.25 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 173.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.22 -42.38 86.12 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.448 1.099 . . . . 0.0 113.085 177.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -108.36 -1.63 19.82 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -174.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.02 165.25 34.66 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 120.047 1.294 . . . . 0.0 114.628 177.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.8 m -101.47 122.94 44.7 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.096 0.958 . . . . 0.0 110.758 -177.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.05 161.9 36.83 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -93.74 -46.82 7.06 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.148 1.779 . . . . 0.0 112.131 175.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -141.94 143.31 33.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.295 1.038 . . . . 0.0 112.549 -173.094 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -150.49 118.11 6.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.808 1.643 . . . . 0.0 109.418 169.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -143.35 121.6 12.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.966 1.306 . . . . 0.0 112.414 -172.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.8 t -73.72 152.84 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.839 1.656 . . . . 0.0 110.098 170.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 19.7 p-80 -48.94 -48.18 43.12 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.293 1.837 . . . . 0.0 115.042 -172.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -66.01 133.39 50.71 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.872 0.869 . . . . 0.0 112.736 -172.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -156.84 -84.16 0.05 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.232 1.413 . . . . 0.0 110.51 174.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -70.08 -62.13 1.5 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.173 0.989 . . . . 0.0 109.459 170.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 56.9 m -82.27 159.71 23.11 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.819 1.647 . . . . 0.0 111.222 169.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -139.85 67.82 0.5 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.359 1.457 . . . . 0.0 111.732 176.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.3 mtp85 -67.4 154.24 41.82 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.369 1.468 . . . . 0.0 112.364 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 57.4 m -71.77 81.53 0.88 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.114 1.366 . . . . 0.0 110.021 169.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 60.6 tp -151.28 161.33 42.91 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.525 2.33 . . . . 0.0 109.509 -170.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.13 77.19 0.28 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.809 1.195 . . . . 0.0 111.703 -178.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 46.3 m -141.39 143.0 33.71 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.672 1.589 . . . . 0.0 110.826 -174.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.83 139.29 34.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.325 1.45 . . . . 0.0 112.69 176.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -93.7 129.94 39.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.573 1.549 . . . . 0.0 109.429 169.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 92.6 t -133.16 143.59 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.596 1.559 . . . . 0.0 108.878 -177.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -145.47 108.24 4.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.755 -1.215 . . . . 0.0 111.006 -173.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -86.19 175.27 8.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.882 2.073 . . . . 0.0 113.628 -171.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -91.54 -65.68 0.99 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.743 1.217 . . . . 0.0 110.861 169.529 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 89.2 mtm-85 -83.12 132.37 35.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.187 1.395 . . . . 0.0 111.89 -176.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -50.42 73.1 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.439 1.496 . . . . 0.0 112.105 179.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.36 -45.79 84.01 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.513 1.125 . . . . 0.0 112.246 176.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -63.7 -39.82 95.25 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.022 1.329 . . . . 0.0 112.55 177.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -59.51 -52.1 67.01 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.163 0.985 . . . . 0.0 111.809 170.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 62.2 tp -54.94 -47.36 74.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.142 0.977 . . . . 0.0 112.057 174.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -50.23 -57.18 8.38 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.633 1.573 . . . . 0.0 111.356 171.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -50.87 -46.07 60.25 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.651 1.18 . . . . 0.0 112.865 176.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 24.4 ttp -57.16 -67.26 0.34 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.688 0.676 . . . . 0.0 111.507 172.16 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -62.67 -36.02 81.54 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -170.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -64.18 -42.58 96.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.93 1.292 . . . . 0.0 112.931 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -108.25 -13.65 14.86 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -169.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.65 113.96 2.27 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.776 1.171 . . . . 0.0 111.116 169.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 102.58 -16.75 54.57 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.909 1.718 . . . . 0.0 114.699 -175.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.44 129.49 85.6 Favored Pre-proline 0 N--CA 1.477 0.912 0 CA-C-N 119.085 1.442 . . . . 0.0 110.813 -176.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.98 140.19 93.05 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.809 3.006 . . . . 0.0 115.1 176.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 28.6 tp -138.28 104.59 5.23 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.366 2.266 . . . . 0.0 107.539 169.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 48.31 62.01 2.74 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.387 1.475 . . . . 0.0 111.718 -169.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 83.69 -59.51 4.95 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.19 1.376 . . . . 0.0 113.214 -179.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 80.5 mtt-85 -60.55 127.67 87.16 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.733 1.613 . . . . 0.0 112.682 -175.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.82 122.61 8.66 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.757 2.305 . . . . 0.0 110.756 170.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.5 mtm -61.69 121.61 13.26 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.099 0.96 . . . . 0.0 111.589 178.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -93.41 103.06 15.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.866 1.266 . . . . 0.0 108.917 174.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.6 mt -115.83 131.85 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.33 1.052 . . . . 0.0 111.342 -171.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -122.54 150.18 42.92 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.647 2.379 . . . . 0.0 109.394 175.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 17.4 tp -80.31 -123.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.882 1.273 . . . . 0.0 110.075 174.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 20.4 m -62.38 135.91 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.12 -0.987 . . . . 0.0 110.632 171.101 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 18.7 p -72.33 -62.39 1.45 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.923 1.289 . . . . 0.0 112.969 -170.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.252 1.194 0 C-N-CA 126.77 2.028 . . . . 0.0 112.375 -175.814 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.061 0 N-CA-C 112.609 -0.196 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -146.52 138.42 24.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.341 1.056 . . . . 0.0 111.139 -174.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.1 mt -134.67 126.27 28.78 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.709 1.604 . . . . 0.0 112.221 -175.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.7 tp -90.8 124.7 35.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.228 1.411 . . . . 0.0 107.603 169.028 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.71 92.0 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.677 1.591 . . . . 0.0 108.597 -171.007 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.0 m -88.19 167.65 13.42 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.129 1.771 . . . . 0.0 112.581 -177.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 40.0 t30 55.35 66.77 1.14 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.175 2.19 . . . . 0.0 113.447 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.7 mt -116.16 -168.81 1.49 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.582 2.353 . . . . 0.0 110.42 174.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.85 150.35 47.82 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.129 -0.982 . . . . 0.0 112.322 173.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -51.01 -40.89 59.23 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.465 1.106 . . . . 0.0 112.977 175.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.27 69.51 0.43 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.479 1.514 . . . . 0.0 111.941 173.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 t -48.78 134.48 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.954 1.702 . . . . 0.0 111.855 172.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.0 m -85.52 126.25 33.7 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.819 -0.551 . . . . 0.0 110.394 170.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -57.44 -48.46 79.08 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.381 1.072 . . . . 0.0 111.961 179.245 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.17 75.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.278 1.431 . . . . 0.0 113.233 175.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.56 -53.16 61.45 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.176 0.991 . . . . 0.0 111.993 178.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 47.7 mm -57.34 -53.58 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.63 1.172 . . . . 0.0 111.169 173.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -49.47 -54.57 17.04 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.315 1.046 . . . . 0.0 111.553 177.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -61.37 -50.1 74.24 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.023 0.829 . . . . 0.0 112.657 178.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -47.53 85.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.939 0.79 . . . . 0.0 112.31 -176.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -64.91 -46.91 79.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.641 0.655 . . . . 0.0 112.303 175.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.99 -35.49 64.41 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 178.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -55.54 -45.52 77.2 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.34 1.056 . . . . 0.0 112.98 175.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -102.53 -19.36 14.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -175.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -152.63 157.68 27.43 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-N 120.096 1.316 . . . . 0.0 114.303 177.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.4 m -84.63 95.91 9.03 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.68 -0.894 . . . . 0.0 111.727 -172.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.21 143.34 29.66 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.635 0.774 . . . . 0.0 111.809 172.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -85.63 -48.51 8.81 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.575 2.35 . . . . 0.0 110.309 169.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -149.45 149.09 30.25 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.742 1.217 . . . . 0.0 112.444 -177.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -122.77 153.86 38.95 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.094 1.758 . . . . 0.0 110.96 169.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -161.57 -176.33 5.26 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.696 2.398 . . . . 0.0 110.938 -176.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 148' ' ' ALA . 0.6 OUTLIER -140.45 151.69 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 127.909 2.483 . . . . 0.0 110.099 176.458 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -42.72 99.75 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -172.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -71.15 137.29 48.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.999 1.32 . . . . 0.0 112.187 172.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -145.21 -95.88 0.1 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.357 1.063 . . . . 0.0 110.845 177.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -57.96 -40.61 81.0 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.373 1.469 . . . . 0.0 111.825 171.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.1 p -55.46 -53.16 59.77 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.406 2.283 . . . . 0.0 113.524 173.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 65.53 30.14 76.8 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.378 1.466 . . . . 0.0 113.588 -173.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -77.94 93.33 4.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.495 1.518 . . . . 0.0 110.945 -178.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.1 m -54.92 122.77 11.57 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.995 1.318 . . . . 0.0 111.296 174.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 56.6 tp -153.85 -69.12 0.14 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.743 1.217 . . . . 0.0 111.181 -173.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.39 66.86 0.13 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 125.461 1.505 . . . . 0.0 113.606 175.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.0 m -141.86 113.77 7.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.0 1.32 . . . . 0.0 110.077 176.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 136' ' ' VAL . . . -96.79 164.01 12.75 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.159 1.383 . . . . 0.0 111.373 173.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -143.4 126.49 16.43 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.57 1.148 . . . . 0.0 110.37 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 11.4 t -136.6 136.75 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.14 0.976 . . . . 0.0 110.989 -169.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -115.91 138.75 50.89 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.307 1.843 . . . . 0.0 109.368 178.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -127.39 158.39 37.43 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.149 2.58 . . . . 0.0 113.708 -169.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -64.47 -32.71 74.46 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.483 1.513 . . . . 0.0 114.439 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -135.93 147.56 48.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.088 1.355 . . . . 0.0 112.803 -169.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -58.92 -52.75 64.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.444 1.498 . . . . 0.0 111.734 169.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.98 -50.44 64.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.088 1.355 . . . . 0.0 112.195 177.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.65 -51.4 63.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.234 1.414 . . . . 0.0 112.023 175.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -58.76 -50.98 71.9 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.586 0.754 . . . . 0.0 112.429 176.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 80.3 mt -58.34 -47.09 84.86 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.474 1.11 . . . . 0.0 112.764 177.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -54.22 -55.51 27.3 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.943 1.297 . . . . 0.0 111.582 172.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.32 -52.74 51.46 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.691 1.196 . . . . 0.0 112.561 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 34.8 ttm -50.03 -62.03 1.81 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.665 1.586 . . . . 0.0 111.617 175.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -59.75 -46.8 88.02 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.121 1.368 . . . . 0.0 112.64 -177.171 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -63.03 -45.4 92.51 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.477 1.111 . . . . 0.0 113.206 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.0 -15.72 17.37 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -169.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -60.66 110.35 1.27 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 119.969 1.259 . . . . 0.0 110.682 169.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 112.96 -25.72 11.27 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.561 2.029 . . . . 0.0 114.191 -175.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.4 t -68.81 132.0 90.89 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.564 1.146 . . . . 0.0 111.433 -171.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.22 106.89 1.96 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.527 2.818 . . . . 0.0 112.283 -177.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 tp -75.23 89.87 2.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.177 1.391 . . . . 0.0 109.352 169.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 44.46 58.51 3.79 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.363 1.865 . . . . 0.0 111.33 -169.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 100.72 -47.54 1.23 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.627 1.584 . . . . 0.0 113.702 -177.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -68.33 107.91 2.36 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 127.002 2.121 . . . . 0.0 112.463 -169.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.17 107.9 2.22 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.984 1.789 . . . . 0.0 110.863 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.91 134.68 55.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.256 1.022 . . . . 0.0 111.138 -179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -119.64 112.83 19.8 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.853 0.861 . . . . 0.0 110.459 178.045 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.0 mt -108.11 132.67 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.146 0.979 . . . . 0.0 111.223 -169.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -131.03 141.48 50.22 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.343 2.257 . . . . 0.0 109.978 -173.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.32 144.65 53.56 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 175.054 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.4 t 51.63 -101.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 127.886 2.474 . . . . 0.0 113.22 172.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 3.0 m -154.44 147.39 24.53 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.87 2.068 . . . . 0.0 109.189 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.817 1.247 . . . . 0.0 113.333 173.909 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.208 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -150.26 101.8 3.02 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.7 1.2 . . . . 0.0 110.412 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 34.1 mt -95.73 107.17 19.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.339 1.055 . . . . 0.0 111.605 -177.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.5 tp -76.18 129.4 36.68 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 168.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.61 111.85 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.96 1.304 . . . . 0.0 108.737 -178.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.3 m -112.53 169.95 8.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.218 1.407 . . . . 0.0 110.975 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.7 t30 57.13 78.18 0.24 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.924 1.69 . . . . 0.0 112.11 -174.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.8 mt -132.03 157.54 43.86 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.201 2.2 . . . . 0.0 110.336 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.55 145.8 50.82 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.046 -1.034 . . . . 0.0 111.656 170.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -57.22 -29.0 63.39 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -177.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -109.34 28.02 11.61 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.256 1.408 . . . . 0.0 115.261 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.59 119.2 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-N 119.174 1.487 . . . . 0.0 110.012 169.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.8 m -74.13 145.51 44.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.434 1.094 . . . . 0.0 112.568 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.68 -51.47 68.63 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.826 0.85 . . . . 0.0 112.094 171.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.45 -53.05 19.31 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.808 1.643 . . . . 0.0 112.331 175.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -54.88 -50.96 67.43 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.807 1.243 . . . . 0.0 112.365 177.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.0 mm -56.41 -56.82 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.221 1.008 . . . . 0.0 112.15 174.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -58.03 -43.75 86.96 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.709 1.141 . . . . 0.0 112.243 -178.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -59.14 -52.49 65.5 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.057 0.844 . . . . 0.0 112.775 173.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -65.03 -47.24 78.12 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.998 0.817 . . . . 0.0 112.374 -176.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -62.45 -40.49 96.78 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.774 0.715 . . . . 0.0 112.558 175.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -66.25 -13.54 60.54 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 175.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.85 -57.71 4.09 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.839 -1.163 . . . . 0.0 111.424 173.147 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -84.89 -33.95 22.66 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -177.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.98 -172.79 15.0 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.845 1.688 . . . . 0.0 112.801 178.021 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -131.02 120.88 24.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.579 1.152 . . . . 0.0 110.41 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.2 pp -123.86 142.66 50.92 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -169.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -72.87 -52.0 16.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 127.733 2.413 . . . . 0.0 110.428 169.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -152.84 156.74 39.6 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.353 1.461 . . . . 0.0 112.596 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -128.88 162.77 26.74 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.842 1.657 . . . . 0.0 111.302 169.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.45 145.36 23.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.24 2.216 . . . . 0.0 109.806 172.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.2 t -140.99 147.66 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.517 1.527 . . . . 0.0 110.462 178.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -68.02 -48.59 65.29 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.045 1.738 . . . . 0.0 114.466 -178.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . 0.326 20.1 p90 31.2 69.97 0.09 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 130.567 3.547 . . . . 0.0 114.61 -168.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -145.84 149.26 33.97 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.392 2.277 . . . . 0.0 110.415 173.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -82.91 91.46 7.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.196 0.998 . . . . 0.0 110.334 173.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.9 m -62.93 160.95 13.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.075 1.35 . . . . 0.0 112.665 176.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -56.2 -35.87 66.57 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.124 1.345 . . . . 0.0 114.708 -178.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -134.92 175.69 9.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 127.376 2.27 . . . . 0.0 110.934 171.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 69.9 m -52.53 113.27 1.01 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.738 1.215 . . . . 0.0 112.022 177.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 30.4 tp -141.41 -107.6 0.14 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.686 1.594 . . . . 0.0 109.147 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.27 104.66 0.23 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-N 120.073 1.306 . . . . 0.0 111.072 -177.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.6 m -126.18 133.63 51.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.138 0.975 . . . . 0.0 112.34 -173.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.77 160.08 37.89 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.419 1.887 . . . . 0.0 111.148 170.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -145.28 126.68 14.94 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.367 1.467 . . . . 0.0 110.222 -177.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.33 111.67 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.142 0.977 . . . . 0.0 110.863 -171.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -75.71 111.19 10.79 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.288 1.435 . . . . 0.0 109.43 172.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.9 150.99 21.95 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.903 2.081 . . . . 0.0 112.555 -178.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -63.82 -38.37 90.83 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 177.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -136.39 142.85 43.75 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.607 1.563 . . . . 0.0 112.335 -174.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.4 mmmt -54.47 -52.34 62.17 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.929 1.692 . . . . 0.0 112.136 172.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.91 -51.9 66.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.1 1.36 . . . . 0.0 112.475 176.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -59.88 -40.66 89.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.834 0.854 . . . . 0.0 112.536 177.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.89 -51.64 68.28 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.979 0.912 . . . . 0.0 111.983 171.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 62.8 mt -55.38 -48.08 74.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.776 0.83 . . . . 0.0 112.861 173.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -54.04 -54.49 38.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.665 1.186 . . . . 0.0 112.321 175.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.47 -53.16 57.99 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.573 1.149 . . . . 0.0 112.299 174.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 19.8 ttt -52.37 -60.64 2.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.035 1.734 . . . . 0.0 112.046 177.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -59.83 -37.32 78.88 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -176.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -68.79 -46.02 69.78 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.236 1.014 . . . . 0.0 113.165 176.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -100.1 -14.16 18.69 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -169.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -58.52 117.03 4.07 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.88 1.218 . . . . 0.0 111.044 170.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 99.7 -16.22 58.9 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.27 1.414 . . . . 0.0 114.61 -175.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.8 t -71.84 133.07 84.46 Favored Pre-proline 0 N--CA 1.477 0.886 0 CA-C-N 118.997 1.399 . . . . 0.0 109.497 175.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.94 142.1 24.75 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.725 2.284 . . . . 0.0 112.51 -177.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 45.7 tp -129.95 105.02 7.7 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.35 1.46 . . . . 0.0 108.133 169.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 52.4 65.57 1.47 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.988 1.715 . . . . 0.0 111.135 -169.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.09 -64.04 4.3 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.24 1.4 . . . . 0.0 113.215 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.5 119.92 57.91 Favored Pre-proline 0 CA--C 1.55 0.942 0 C-N-CA 126.465 1.906 . . . . 0.0 112.774 -173.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -56.07 121.55 10.19 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.753 3.635 . . . . 0.0 113.58 170.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.47 116.64 5.77 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.245 1.018 . . . . 0.0 111.748 177.104 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -91.61 98.6 11.75 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.585 1.154 . . . . 0.0 109.22 171.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.3 mt -101.22 133.63 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.066 1.346 . . . . 0.0 111.149 -173.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -140.14 123.86 17.3 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.063 1.745 . . . . 0.0 111.42 -177.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 45.7 tp -76.69 114.5 15.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.765 0.826 . . . . 0.0 109.311 169.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.59 74.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.331 1.452 . . . . 0.0 110.249 -178.146 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 8.3 m -63.45 121.16 13.14 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.502 1.521 . . . . 0.0 110.576 174.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.253 1.246 0 C-N-CA 125.729 1.612 . . . . 0.0 113.67 -176.799 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.872 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -143.46 152.92 42.09 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 177.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.7 mt -108.68 154.36 22.11 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.9 1.68 . . . . 0.0 111.535 174.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 24.2 tp -120.32 124.18 44.95 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.889 2.076 . . . . 0.0 107.474 170.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.2 t -118.89 85.56 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.52 1.928 . . . . 0.0 108.239 -169.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.16 166.96 19.19 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.146 1.379 . . . . 0.0 112.225 -178.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.7 t30 60.36 75.21 0.42 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.927 2.091 . . . . 0.0 113.134 177.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.1 mt -127.38 167.58 16.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.895 2.478 . . . . 0.0 111.489 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.2 149.57 46.17 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.96 0.886 . . . . 0.0 113.137 172.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -58.69 -31.97 68.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.556 1.943 . . . . 0.0 114.492 -178.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -110.49 31.67 7.19 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.541 1.543 . . . . 0.0 114.81 -175.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 50.9 t -67.71 147.52 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.09 1.356 . . . . 0.0 110.907 169.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.4 m -119.8 147.59 44.47 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.503 1.521 . . . . 0.0 112.485 -176.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -48.59 -57.7 5.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.682 1.993 . . . . 0.0 112.145 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.37 -46.24 76.52 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.591 1.556 . . . . 0.0 113.561 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.97 -52.78 64.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.164 0.986 . . . . 0.0 111.936 -178.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 43.0 mm -58.21 -52.8 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.384 1.073 . . . . 0.0 111.205 172.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -49.64 -51.69 36.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.953 1.301 . . . . 0.0 112.305 179.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.78 -52.3 65.67 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.368 1.067 . . . . 0.0 113.123 175.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.65 -43.89 97.67 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.214 0.915 . . . . 0.0 112.715 -177.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -62.71 -40.72 98.03 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.808 0.731 . . . . 0.0 112.475 173.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.15 -26.33 64.66 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 175.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -63.4 -48.88 75.99 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.144 -0.972 . . . . 0.0 112.608 174.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -104.8 -15.58 15.16 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 -173.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.0 162.53 21.79 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.904 1.716 . . . . 0.0 113.638 -176.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.9 m -112.27 100.62 8.95 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.576 1.95 . . . . 0.0 107.727 -178.049 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -132.25 157.2 44.99 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -168.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -77.5 -57.42 3.83 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.693 1.997 . . . . 0.0 110.042 169.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -157.24 145.65 19.48 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.234 1.414 . . . . 0.0 112.792 -174.251 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.18 133.78 55.19 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.378 1.471 . . . . 0.0 108.564 168.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.9 158.02 44.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.584 1.154 . . . . 0.0 113.115 -169.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.97 110.64 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.625 1.97 . . . . 0.0 109.599 178.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -69.92 -44.56 69.38 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.729 1.612 . . . . 0.0 112.377 177.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -70.2 167.43 17.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.084 1.754 . . . . 0.0 114.018 -175.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -147.57 -169.96 3.45 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.896 2.078 . . . . 0.0 109.485 169.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.83 119.05 2.59 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.822 -1.174 . . . . 0.0 110.474 169.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.8 m -135.48 152.89 51.79 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.754 1.622 . . . . 0.0 112.221 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.6 -60.46 6.98 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.519 1.057 . . . . 0.0 111.912 174.074 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.89 144.49 55.24 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.547 1.139 . . . . 0.0 111.045 169.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.1 m -63.18 119.24 9.19 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.133 0.973 . . . . 0.0 111.421 178.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 56.9 tp -152.3 131.49 12.74 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.091 1.356 . . . . 0.0 110.555 179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -170.72 84.83 0.08 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.876 0.751 . . . . 0.0 112.723 178.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 98.0 m -146.41 126.0 13.33 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.429 1.492 . . . . 0.0 111.019 -175.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -102.93 162.49 12.88 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.373 1.469 . . . . 0.0 112.599 177.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -133.51 127.51 33.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.778 1.631 . . . . 0.0 109.986 -172.079 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 9.0 t -134.07 116.8 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.518 -0.739 . . . . 0.0 112.479 -169.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -90.18 116.17 27.97 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.963 2.105 . . . . 0.0 110.606 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -99.54 152.63 19.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.618 1.567 . . . . 0.0 113.885 -173.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -63.93 -48.55 76.09 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.034 0.934 . . . . 0.0 111.794 171.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -133.54 135.41 44.35 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.116 1.366 . . . . 0.0 110.912 -175.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -58.12 -43.34 87.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.263 1.425 . . . . 0.0 112.778 178.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.58 -50.45 60.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.488 1.115 . . . . 0.0 112.618 171.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.92 -46.61 89.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.945 0.898 . . . . 0.0 112.006 174.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.13 -52.87 48.96 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.513 1.125 . . . . 0.0 112.333 173.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.6 tp -55.42 -51.17 67.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.482 1.513 . . . . 0.0 112.224 174.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.79 -52.06 51.76 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.669 1.587 . . . . 0.0 112.48 174.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.18 -52.93 63.33 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.433 1.093 . . . . 0.0 111.856 173.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -54.51 -58.89 5.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.696 1.598 . . . . 0.0 112.494 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -59.17 -36.48 75.37 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -177.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -67.81 -49.11 64.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.381 1.073 . . . . 0.0 112.996 174.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -94.09 -13.72 26.53 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -57.92 112.9 1.64 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.702 1.137 . . . . 0.0 110.93 169.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 105.5 -18.6 41.08 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.546 1.546 . . . . 0.0 114.713 -175.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 81.2 t -69.52 133.78 88.84 Favored Pre-proline 0 N--CA 1.478 0.934 0 CA-C-N 118.968 1.384 . . . . 0.0 110.189 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.38 141.78 23.16 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.872 2.381 . . . . 0.0 113.154 -175.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 8.3 tt -132.3 108.69 9.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.539 1.935 . . . . 0.0 107.312 169.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 48.33 64.27 1.73 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.819 1.648 . . . . 0.0 111.566 -169.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 80.92 -55.44 4.77 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.883 1.706 . . . . 0.0 113.649 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -65.81 124.02 86.41 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 127.008 2.123 . . . . 0.0 112.47 -173.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.32 122.97 9.48 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.291 2.661 . . . . 0.0 111.185 174.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.42 116.27 5.39 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.184 0.994 . . . . 0.0 111.347 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -84.78 100.66 11.68 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.961 0.905 . . . . 0.0 108.975 170.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.3 mt -107.18 130.07 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.793 0.837 . . . . 0.0 110.714 -175.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.21 -179.97 6.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.594 1.558 . . . . 0.0 110.591 171.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -119.5 154.36 33.92 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.182 1.393 . . . . 0.0 112.474 -176.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.58 136.1 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.29 1.436 . . . . 0.0 110.046 -175.123 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.6 p -140.01 146.04 38.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.973 1.709 . . . . 0.0 111.238 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.034 1.733 . . . . 0.0 113.765 -178.909 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.877 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -133.92 125.83 29.11 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.062 0.945 . . . . 0.0 110.526 -178.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 35.9 mt -106.52 131.11 54.07 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.606 1.163 . . . . 0.0 110.821 170.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.6 tp -99.06 100.43 11.58 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.685 1.594 . . . . 0.0 106.821 169.042 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.28 132.94 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 m -134.05 172.32 12.99 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.55 1.54 . . . . 0.0 111.381 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.3 t30 56.63 51.16 11.5 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.005 1.722 . . . . 0.0 112.662 -172.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.58 -158.51 0.67 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.072 1.749 . . . . 0.0 109.214 169.414 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -154.98 169.24 24.53 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.492 1.517 . . . . 0.0 110.728 178.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.32 -32.1 70.91 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.896 -1.128 . . . . 0.0 112.513 169.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -60.97 -28.76 69.23 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.487 1.518 . . . . 0.0 114.646 174.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.0 t -72.71 108.15 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.578 1.189 . . . . 0.0 109.64 174.719 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.6 m -69.81 144.0 52.76 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.02 0.928 . . . . 0.0 112.876 -177.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -54.19 -55.09 31.24 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.743 1.617 . . . . 0.0 112.886 176.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.87 75.77 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.483 1.113 . . . . 0.0 113.266 176.524 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.21 -52.24 63.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.704 0.802 . . . . 0.0 111.61 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.0 mm -53.26 -52.93 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.121 0.969 . . . . 0.0 111.12 169.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -52.53 -52.93 52.31 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.972 0.909 . . . . 0.0 112.175 -179.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -60.2 -52.16 66.49 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.553 1.141 . . . . 0.0 113.16 174.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 pp -63.84 -43.93 94.7 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.364 0.984 . . . . 0.0 112.308 -174.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -62.12 -45.15 94.74 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.485 0.584 . . . . 0.0 112.068 172.143 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.7 -32.84 70.88 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 178.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -60.18 -51.21 70.57 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.084 0.954 . . . . 0.0 112.483 173.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -93.23 -13.03 28.81 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -174.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.55 154.36 25.89 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 120.015 1.279 . . . . 0.0 114.664 177.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.2 m -86.19 107.41 17.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.369 1.068 . . . . 0.0 110.309 -175.289 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 pp -125.96 146.31 49.92 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -173.019 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -86.72 -39.09 16.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.635 2.374 . . . . 0.0 111.547 169.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -150.22 147.38 27.62 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 118.591 0.632 . . . . 0.0 112.47 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -144.26 120.97 11.18 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.668 1.587 . . . . 0.0 109.486 171.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -138.4 117.24 12.35 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.38 1.472 . . . . 0.0 111.863 -172.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.4 t -80.65 150.1 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.065 1.746 . . . . 0.0 111.134 178.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -44.52 -51.94 8.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.928 2.491 . . . . 0.0 116.586 -172.07 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -61.04 127.81 33.35 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -169.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -147.75 -74.23 0.19 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.161 1.385 . . . . 0.0 111.214 176.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -129.25 37.62 4.01 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.678 2.391 . . . . 0.0 110.035 176.011 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.5 m -75.1 155.04 37.53 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.911 2.484 . . . . 0.0 113.578 -169.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -156.01 40.45 0.58 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.502 1.049 . . . . 0.0 113.984 175.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -150.51 157.32 42.87 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.362 2.265 . . . . 0.0 110.242 179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.5 m -59.13 116.18 3.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.045 0.938 . . . . 0.0 110.335 169.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.5 tp -152.72 152.34 31.58 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.936 1.294 . . . . 0.0 111.247 -169.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.44 76.67 0.09 OUTLIER Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.791 0.71 . . . . 0.0 113.326 -175.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.9 p -141.53 168.28 20.15 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.301 1.44 . . . . 0.0 112.642 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.07 141.27 24.0 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.674 1.189 . . . . 0.0 111.398 169.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.91 126.02 43.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.478 1.511 . . . . 0.0 109.429 173.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 20.3 t -130.08 122.8 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.173 0.989 . . . . 0.0 110.509 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -109.1 119.01 38.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.113 2.165 . . . . 0.0 111.14 -176.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -102.75 154.47 19.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.809 2.844 . . . . 0.0 113.645 -169.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -82.38 -16.17 50.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.619 1.567 . . . . 0.0 114.554 175.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 82.8 mtm-85 -142.34 132.56 24.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.689 1.596 . . . . 0.0 111.042 177.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 tppt? -56.13 -50.35 71.35 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.107 1.363 . . . . 0.0 112.545 172.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.43 -47.43 69.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.875 1.27 . . . . 0.0 112.162 175.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.18 -42.23 99.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.943 0.897 . . . . 0.0 112.625 175.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.72 -53.34 57.81 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.785 0.834 . . . . 0.0 111.534 171.722 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 59.3 tp -54.07 -52.1 62.0 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.826 1.25 . . . . 0.0 112.439 174.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -49.86 -54.77 17.4 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.253 1.821 . . . . 0.0 112.154 173.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -55.63 -50.84 69.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.534 1.133 . . . . 0.0 112.306 174.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 16.7 ttp -52.15 -60.1 3.6 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.03 1.332 . . . . 0.0 111.595 175.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -53.73 -49.51 67.99 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.239 1.416 . . . . 0.0 112.32 179.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -61.83 -47.24 85.98 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.72 1.208 . . . . 0.0 113.045 -179.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -99.82 -14.36 18.84 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -169.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -59.28 113.72 2.3 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.785 1.175 . . . . 0.0 110.984 169.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.43 -20.15 35.41 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.762 1.649 . . . . 0.0 114.48 -175.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.46 133.02 87.23 Favored Pre-proline 0 N--CA 1.478 0.925 0 CA-C-N 118.757 1.279 . . . . 0.0 110.306 -178.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.16 138.83 23.17 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.923 2.415 . . . . 0.0 112.457 -177.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.1 tp -134.93 112.37 10.58 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.1 1.76 . . . . 0.0 108.373 170.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 49.32 61.68 3.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.303 1.441 . . . . 0.0 111.189 -169.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.99 -59.94 4.47 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.798 1.666 . . . . 0.0 113.493 -179.051 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -61.95 127.82 89.75 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 127.062 2.145 . . . . 0.0 112.83 -174.079 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -70.98 124.67 10.79 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.178 2.585 . . . . 0.0 111.147 172.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.8 mtm -63.49 120.37 11.57 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.117 0.967 . . . . 0.0 111.162 177.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -98.91 102.32 14.0 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.783 1.233 . . . . 0.0 108.865 176.036 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.1 mt -108.69 135.98 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.047 0.939 . . . . 0.0 111.271 -169.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -128.87 123.98 34.09 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.103 1.761 . . . . 0.0 111.082 -177.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 52.8 tp -82.39 122.95 28.65 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.77 1.228 . . . . 0.0 111.076 172.361 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 40.9 t -83.39 96.31 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 169.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.0 p -66.98 -61.1 2.11 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.085 1.354 . . . . 0.0 112.738 -170.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 21.4 m . . . . . 0 C--O 1.252 1.189 0 C-N-CA 127.767 2.427 . . . . 0.0 114.182 -175.446 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.945 0 N-CA-C 112.338 -0.305 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -117.91 99.63 7.04 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.285 1.434 . . . . 0.0 109.961 179.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -100.73 101.4 12.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.607 1.563 . . . . 0.0 109.043 -176.099 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.8 tp -84.37 137.28 33.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.136 1.774 . . . . 0.0 110.505 177.139 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.0 t -129.41 129.32 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.46 1.904 . . . . 0.0 108.948 -176.517 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.0 m -139.64 166.48 24.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.25 1.42 . . . . 0.0 112.116 -176.006 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.1 t30 54.71 46.95 23.58 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.07 1.748 . . . . 0.0 112.914 -172.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.2 mt -83.89 164.83 19.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.3 1.44 . . . . 0.0 110.754 169.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -63.95 145.35 56.0 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 110.957 169.458 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -53.87 -35.0 61.08 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.561 1.544 . . . . 0.0 114.16 -176.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.47 16.28 58.0 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.392 1.473 . . . . 0.0 115.467 -174.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.26 135.25 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.217 1.509 . . . . 0.0 110.578 170.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.4 m -114.6 158.13 22.13 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.146 1.778 . . . . 0.0 111.583 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -52.36 -55.75 19.53 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.524 1.13 . . . . 0.0 113.641 -176.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.49 -38.99 67.1 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.197 0.999 . . . . 0.0 113.561 -177.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -58.83 -56.15 25.94 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.968 0.907 . . . . 0.0 111.916 176.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.2 mm -55.76 -53.01 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 0.0 111.02 172.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -48.44 -56.95 6.86 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.181 1.792 . . . . 0.0 111.673 178.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -62.2 -49.49 75.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.435 1.094 . . . . 0.0 113.323 176.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 pp -63.3 -45.44 91.34 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.492 1.042 . . . . 0.0 112.201 -174.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -62.91 -40.88 98.94 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 174.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.51 -14.98 56.51 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 175.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.6 -61.91 1.71 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.825 -1.172 . . . . 0.0 111.883 173.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -85.18 -13.05 51.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -175.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -146.41 -167.79 13.05 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.71 1.624 . . . . 0.0 112.909 176.414 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.05 126.69 27.14 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.159 1.384 . . . . 0.0 110.177 -173.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 pp -131.06 143.61 50.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.464 1.106 . . . . 0.0 113.737 -169.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -73.08 -49.61 27.62 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.966 2.106 . . . . 0.0 110.335 169.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -150.11 152.15 34.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.416 1.086 . . . . 0.0 113.237 -179.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -119.86 151.91 38.15 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.319 1.848 . . . . 0.0 109.869 169.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.6 146.01 26.26 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.97 1.708 . . . . 0.0 110.402 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.1 t -133.68 142.22 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.364 1.465 . . . . 0.0 109.847 -177.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -21.04 -69.95 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 129.177 2.991 . . . . 0.0 116.667 -169.769 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -52.69 -41.17 63.63 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.106 2.162 . . . . 0.0 114.557 -179.372 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.4 -47.12 14.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.496 1.519 . . . . 0.0 111.73 176.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -59.96 -54.76 42.33 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.256 1.822 . . . . 0.0 113.675 -174.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 51.0 m -119.08 166.97 12.24 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.54 1.536 . . . . 0.0 112.663 -169.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -50.97 -60.94 6.55 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.153 1.359 . . . . 0.0 112.86 178.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.13 104.03 2.77 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.199 1.4 . . . . 0.0 110.237 169.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.4 m -129.81 170.51 13.78 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.687 1.995 . . . . 0.0 109.502 173.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 48.3 tp -149.27 132.76 16.66 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.236 0.925 . . . . 0.0 112.036 -177.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.75 35.13 79.41 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.394 0.997 . . . . 0.0 114.425 174.143 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.1 p -137.01 155.04 50.21 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.698 1.599 . . . . 0.0 112.127 179.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.5 166.86 26.93 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.998 1.719 . . . . 0.0 111.463 175.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -147.76 126.73 12.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.635 1.574 . . . . 0.0 109.645 -174.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 46.5 t -122.02 116.43 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.726 1.21 . . . . 0.0 109.175 -178.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -82.6 102.87 11.72 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -77.28 155.34 32.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.177 1.791 . . . . 0.0 113.238 -175.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.19 -29.48 54.34 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.701 1.2 . . . . 0.0 113.298 172.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.41 138.26 38.04 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.285 1.434 . . . . 0.0 111.341 176.707 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.9 ttpp -64.77 -36.73 85.26 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 113.914 178.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.37 -46.83 86.89 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.121 0.968 . . . . 0.0 111.672 174.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -58.98 -44.23 91.53 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.492 1.517 . . . . 0.0 112.016 173.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.05 -52.25 63.77 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.75 1.22 . . . . 0.0 112.612 170.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.47 -48.24 79.73 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.857 1.263 . . . . 0.0 112.292 176.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -49.55 -56.99 7.96 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.135 1.374 . . . . 0.0 111.229 171.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.68 -47.13 63.99 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.801 0.84 . . . . 0.0 112.362 175.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.5 ttp -56.17 -62.36 1.77 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.979 0.912 . . . . 0.0 112.467 177.034 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -61.43 -35.27 77.09 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.27 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.0 -52.81 62.47 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.365 1.466 . . . . 0.0 112.662 174.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -97.39 -14.97 20.9 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -169.703 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -59.67 110.33 1.12 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 120.16 1.346 . . . . 0.0 112.094 175.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 106.3 -17.36 40.58 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.149 1.833 . . . . 0.0 114.67 -177.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.61 130.27 94.09 Favored Pre-proline 0 N--CA 1.479 0.985 0 CA-C-N 118.953 1.376 . . . . 0.0 111.009 -174.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.28 112.25 2.75 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.339 2.693 . . . . 0.0 112.54 -174.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 59.7 tp -76.54 82.5 3.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.47 1.508 . . . . 0.0 109.268 169.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 43.35 55.1 4.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.873 2.069 . . . . 0.0 112.026 -169.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 116.23 -64.82 0.33 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.009 1.766 . . . . 0.0 112.556 -177.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.01 111.03 3.53 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 126.812 2.045 . . . . 0.0 112.266 -171.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.14 113.31 3.39 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 122.273 1.982 . . . . 0.0 110.654 178.23 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.0 mtm -66.93 118.71 10.78 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.005 0.922 . . . . 0.0 111.157 -178.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -84.89 120.74 26.81 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.904 0.882 . . . . 0.0 109.024 171.24 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 5.6 mm -118.43 138.17 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.738 0.815 . . . . 0.0 109.997 179.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -137.09 134.84 36.91 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.149 1.38 . . . . 0.0 111.065 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.43 127.73 50.02 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.3 1.84 . . . . 0.0 107.88 174.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.9 m -39.38 -53.78 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 126.933 2.093 . . . . 0.0 116.131 -169.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.7 p -143.2 124.35 14.51 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.397 1.479 . . . . 0.0 110.919 178.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.879 1.671 . . . . 0.0 113.067 177.738 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.355 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -134.98 101.6 4.94 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.852 1.261 . . . . 0.0 110.68 179.341 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -103.61 122.0 44.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.087 2.155 . . . . 0.0 109.231 -171.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.8 tp -115.47 102.94 10.27 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.309 1.844 . . . . 0.0 110.424 -176.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.5 t -78.73 130.64 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.166 1.387 . . . . 0.0 108.373 169.809 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.2 m -127.69 172.3 10.91 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.115 1.366 . . . . 0.0 111.411 175.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.7 t30 57.46 50.4 11.31 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.847 1.659 . . . . 0.0 112.763 -173.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.2 mt -98.78 -168.22 1.6 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.883 1.673 . . . . 0.0 109.306 169.145 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -148.61 161.94 40.69 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 120.967 -1.083 . . . . 0.0 111.972 174.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -61.14 101.52 0.16 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.208 1.403 . . . . 0.0 109.383 169.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 155.48 -39.0 0.62 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.211 1.386 . . . . 0.0 111.859 -169.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -64.73 110.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.122 0.969 . . . . 0.0 109.611 170.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.4 m -71.98 144.24 48.94 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.766 0.826 . . . . 0.0 112.737 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.71 -52.79 63.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.841 1.656 . . . . 0.0 112.385 178.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.78 -37.54 82.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.618 1.167 . . . . 0.0 113.404 174.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -61.84 -48.69 79.43 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.086 0.857 . . . . 0.0 111.763 179.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.4 mm -54.77 -52.87 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.883 0.873 . . . . 0.0 111.065 169.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -51.75 -54.21 31.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.246 0.618 . . . . 0.0 112.067 178.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -58.58 -50.34 74.17 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.873 1.269 . . . . 0.0 113.31 176.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.11 -44.86 90.99 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.315 0.961 . . . . 0.0 112.041 -176.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -61.27 -42.69 99.07 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 173.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.54 -15.3 57.61 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -73.29 -63.45 1.18 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.949 -1.095 . . . . 0.0 111.609 173.407 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -82.17 -18.91 41.08 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -175.465 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -139.22 -176.37 14.68 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.579 1.561 . . . . 0.0 113.346 178.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 12.9 m -126.91 120.96 30.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.367 1.467 . . . . 0.0 110.373 -176.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 pp -126.07 146.41 49.93 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.004 1.322 . . . . 0.0 112.995 -169.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -78.52 -49.19 13.8 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 127.803 2.441 . . . . 0.0 110.303 170.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -149.19 147.89 28.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.632 1.173 . . . . 0.0 111.884 -179.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -137.62 135.34 36.5 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.454 1.502 . . . . 0.0 110.464 171.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.06 146.77 32.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.865 1.266 . . . . 0.0 112.192 -179.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.17 141.7 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.844 1.658 . . . . 0.0 110.492 -179.402 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -42.38 -50.36 5.1 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.062 2.145 . . . . 0.0 115.387 -169.591 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -56.56 -24.93 50.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -172.528 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.24 -48.49 78.7 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.839 1.255 . . . . 0.0 112.646 174.305 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -140.74 78.7 1.66 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.804 2.042 . . . . 0.0 109.752 173.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 27.6 p -75.13 -66.99 0.69 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.857 1.263 . . . . 0.0 113.22 -171.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.46 -54.82 4.05 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.993 1.283 . . . . 0.0 112.069 -170.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -131.68 135.3 46.78 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.937 2.495 . . . . 0.0 110.516 177.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.8 m -63.64 123.42 18.79 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.642 1.177 . . . . 0.0 111.505 175.7 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 55.0 tp -146.27 -73.63 0.22 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.249 1.02 . . . . 0.0 112.262 -176.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.27 81.39 1.28 Allowed Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.193 1.377 . . . . 0.0 111.849 -175.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.9 p -144.55 159.4 42.85 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.664 1.585 . . . . 0.0 112.266 -176.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -141.78 140.85 33.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.863 1.265 . . . . 0.0 111.018 169.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -120.33 125.88 49.14 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.067 1.747 . . . . 0.0 110.009 -174.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 24.8 t -126.68 115.75 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.156 1.382 . . . . 0.0 109.809 -176.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -88.23 111.4 21.61 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.218 2.207 . . . . 0.0 108.461 175.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -98.82 159.31 15.04 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.426 2.29 . . . . 0.0 113.975 -169.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.73 -50.46 70.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.276 1.03 . . . . 0.0 111.83 169.453 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -138.06 144.26 40.87 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.733 1.613 . . . . 0.0 112.214 -173.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -62.63 -35.88 81.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.758 1.223 . . . . 0.0 112.901 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.13 -47.01 78.94 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.441 1.096 . . . . 0.0 112.435 172.055 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -65.88 -41.96 90.92 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.705 1.202 . . . . 0.0 112.038 176.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.62 82.61 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.859 0.864 . . . . 0.0 112.264 169.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 56.7 tp -60.88 -45.62 93.85 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.986 1.714 . . . . 0.0 112.046 177.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -49.63 -58.15 5.82 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.958 1.303 . . . . 0.0 110.31 169.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -51.43 -49.6 61.35 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.93 0.892 . . . . 0.0 112.65 176.587 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 41.6 ttp -54.89 -62.01 1.94 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.362 1.065 . . . . 0.0 111.723 176.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -61.05 -38.59 86.73 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -175.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -66.68 -41.87 87.43 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.685 1.194 . . . . 0.0 112.899 -179.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -109.09 -13.24 14.73 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 116.043 1.868 . . . . 0.0 116.043 -169.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -58.63 116.74 3.9 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.172 1.351 . . . . 0.0 111.425 171.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.33 -25.07 27.18 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.972 1.749 . . . . 0.0 114.359 -175.367 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.2 t -69.82 135.3 87.8 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 124.771 1.229 . . . . 0.0 110.356 -177.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -74.91 139.42 24.5 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.821 2.348 . . . . 0.0 112.816 -178.223 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.4 tp -139.24 119.12 13.29 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.936 1.694 . . . . 0.0 108.677 169.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.75 56.99 7.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.428 1.491 . . . . 0.0 110.729 -169.094 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.78 -60.74 4.36 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.54 1.543 . . . . 0.0 113.466 -179.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.45 135.91 96.54 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.948 1.699 . . . . 0.0 112.872 -172.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.2 124.28 10.34 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.497 2.798 . . . . 0.0 111.211 174.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.4 mtm -62.76 117.78 6.8 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.506 1.122 . . . . 0.0 111.729 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -95.65 99.04 10.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.949 1.3 . . . . 0.0 108.393 172.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.6 mt -103.86 135.43 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.667 0.787 . . . . 0.0 111.363 -169.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -127.91 151.16 49.43 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.969 2.508 . . . . 0.0 110.302 -177.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 34.8 tp -135.59 130.1 33.94 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.737 1.615 . . . . 0.0 109.568 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 57.8 t -59.58 115.75 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.786 0.834 . . . . 0.0 110.007 175.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 11.9 m -58.38 -56.18 25.47 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.771 1.628 . . . . 0.0 113.221 -169.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.562 1.945 . . . . 0.0 112.063 -174.627 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.076 0 N-CA-C 112.704 -0.158 . . . . 0.0 112.704 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt -76.59 137.95 39.84 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.971 0.908 . . . . 0.0 112.458 178.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -138.52 129.58 26.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 129.02 2.928 . . . . 0.0 108.112 -175.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.73 112.15 20.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.551 1.94 . . . . 0.0 110.035 -175.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.4 t -87.04 135.1 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.58 1.552 . . . . 0.0 108.637 171.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.7 m -139.18 165.44 27.16 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.608 1.563 . . . . 0.0 112.575 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.4 t30 57.8 47.65 15.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.147 2.179 . . . . 0.0 113.299 -175.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.51 161.53 15.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.256 1.822 . . . . 0.0 110.3 169.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.93 144.53 54.15 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.166 -0.959 . . . . 0.0 111.008 169.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -59.35 -21.72 60.23 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -176.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -107.83 19.75 32.6 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 125.727 1.632 . . . . 0.0 115.425 178.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.29 129.37 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.483 1.641 . . . . 0.0 110.365 169.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.8 m -75.69 140.64 42.61 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.006 0.923 . . . . 0.0 112.55 -178.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.54 -50.67 72.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.018 1.327 . . . . 0.0 112.298 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.77 -46.62 71.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.309 1.444 . . . . 0.0 112.619 174.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -56.98 -53.3 59.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.397 1.079 . . . . 0.0 112.381 179.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.0 mm -57.33 -52.81 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.134 0.973 . . . . 0.0 111.583 173.02 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.472 HE22 HD11 ' A' ' 131' ' ' LEU . 15.9 tp60 -50.33 -50.62 50.4 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.546 1.139 . . . . 0.0 112.006 178.104 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.09 -53.84 47.26 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.505 1.122 . . . . 0.0 112.917 175.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.13 -43.0 99.6 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.216 0.916 . . . . 0.0 112.643 -173.111 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -64.07 -44.79 91.31 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.64 0.654 . . . . 0.0 112.131 172.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.46 -27.5 66.14 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 176.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.66 -59.5 4.83 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.187 0.995 . . . . 0.0 111.942 173.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -83.8 -15.25 49.09 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -175.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -148.17 156.22 26.8 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 119.947 1.248 . . . . 0.0 113.96 175.344 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.4 m -94.79 111.48 23.26 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.753 1.221 . . . . 0.0 109.934 -173.304 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.472 HD11 HE22 ' A' ' 122' ' ' GLN . 2.9 pp -137.3 155.8 49.01 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -87.38 -48.17 8.2 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.785 2.434 . . . . 0.0 111.487 -173.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -151.02 145.66 25.68 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.623 1.169 . . . . 0.0 113.141 -176.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.27 140.85 46.71 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.239 1.816 . . . . 0.0 110.095 169.115 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -146.51 107.59 4.18 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.933 1.693 . . . . 0.0 111.533 179.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.15 147.82 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.303 1.441 . . . . 0.0 110.625 176.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -44.85 -53.3 7.67 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.566 1.946 . . . . 0.0 114.318 -171.425 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -57.06 -35.61 69.55 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.023 1.329 . . . . 0.0 113.751 -171.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.24 -49.3 74.66 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.312 1.445 . . . . 0.0 111.912 173.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -65.98 -51.76 55.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.834 1.654 . . . . 0.0 112.448 178.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.8 m -142.66 130.64 21.8 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.955 2.102 . . . . 0.0 111.271 -174.523 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -62.35 -28.1 70.44 Favored Glycine 0 CA--C 1.539 1.543 0 N-CA-C 116.079 1.192 . . . . 0.0 116.079 -173.256 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.9 mtp85 -59.92 138.36 57.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.546 1.538 . . . . 0.0 112.593 -178.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.6 m -60.31 115.35 3.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.939 1.296 . . . . 0.0 111.069 172.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 24.6 tp -137.43 -53.68 0.67 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.683 1.193 . . . . 0.0 112.571 -172.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.49 58.27 2.59 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.17 0.89 . . . . 0.0 113.224 174.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 68.4 p -143.47 167.68 21.63 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.699 1.599 . . . . 0.0 111.395 -179.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -144.78 126.38 15.09 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.797 0.839 . . . . 0.0 111.782 169.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -80.15 124.54 28.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.974 1.71 . . . . 0.0 109.735 169.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.45 140.66 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.702 1.201 . . . . 0.0 110.107 -175.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -122.75 105.42 10.03 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.769 1.627 . . . . 0.0 109.204 177.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -78.62 160.54 27.51 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.364 1.866 . . . . 0.0 111.743 176.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -76.43 -27.18 56.13 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 171.077 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.18 136.62 38.36 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.453 1.501 . . . . 0.0 111.914 -179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -56.45 -44.37 80.45 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.808 1.643 . . . . 0.0 113.316 173.047 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.38 -46.71 76.5 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.091 0.956 . . . . 0.0 112.597 176.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -66.52 -41.4 88.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.928 1.291 . . . . 0.0 112.178 177.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.9 -48.75 75.07 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.906 0.882 . . . . 0.0 111.934 169.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.97 -46.41 89.52 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.538 1.535 . . . . 0.0 112.463 176.102 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -50.71 -56.39 12.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.169 1.388 . . . . 0.0 111.133 171.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.16 -49.27 69.67 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.55 1.14 . . . . 0.0 112.393 174.514 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.7 ttp -51.99 -59.12 4.71 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.81 1.244 . . . . 0.0 111.788 176.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -56.01 -49.03 74.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.95 1.3 . . . . 0.0 112.361 178.12 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -60.18 -45.15 94.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.549 1.14 . . . . 0.0 113.468 -178.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -102.15 -16.14 16.47 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -169.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -61.61 106.26 0.64 Allowed 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 119.922 1.237 . . . . 0.0 110.786 169.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.96 -27.77 7.3 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 126.567 2.032 . . . . 0.0 114.142 -174.673 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.61 134.32 84.22 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 125.102 1.361 . . . . 0.0 111.012 -173.402 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.55 138.71 24.58 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.984 2.456 . . . . 0.0 112.714 -177.236 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -140.13 107.63 5.58 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.736 2.014 . . . . 0.0 108.095 175.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 48.45 66.48 1.06 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.742 1.617 . . . . 0.0 111.82 -169.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.26 -57.56 4.39 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.112 1.815 . . . . 0.0 113.403 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 77.7 mtt85 -65.16 131.82 95.2 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 127.036 2.134 . . . . 0.0 112.625 -173.24 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.83 119.53 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.876 2.384 . . . . 0.0 110.251 169.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 78.5 mtm -60.63 143.99 52.83 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.604 0.762 . . . . 0.0 111.968 178.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -119.59 130.95 55.38 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.236 1.414 . . . . 0.0 108.68 171.021 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mm -124.94 141.49 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.52 0.728 . . . . 0.0 110.052 -173.64 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -138.92 148.73 43.96 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.672 1.989 . . . . 0.0 110.273 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.19 -176.18 4.11 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.044 0.937 . . . . 0.0 112.225 173.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.0 m -64.07 -158.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 126.453 1.901 . . . . 0.0 112.573 169.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.6 p -57.6 160.84 4.0 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.122 -1.611 . . . . 0.0 113.313 173.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 40.1 m . . . . . 0 C--O 1.251 1.147 0 C-N-CA 125.406 1.482 . . . . 0.0 113.146 172.133 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 CA-C-O 119.472 -0.627 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.1 pttp -136.53 152.51 50.59 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -173.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 71.9 mt -122.04 131.23 53.88 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.77 2.028 . . . . 0.0 112.266 -169.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.2 tp -86.54 111.28 20.45 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 168.317 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.4 t -98.61 130.51 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.108 1.363 . . . . 0.0 107.75 175.221 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.5 m -136.44 165.31 26.12 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 111.854 -174.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.9 t30 57.56 32.48 21.89 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.569 1.948 . . . . 0.0 114.395 -171.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.8 mt -74.11 148.05 42.17 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 167.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -63.68 144.25 57.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.515 174.331 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -54.15 -36.58 63.48 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -169.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.42 20.15 51.85 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.115 1.341 . . . . 0.0 115.916 178.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.0 t -62.43 130.74 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.281 1.541 . . . . 0.0 110.774 171.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -76.15 140.53 41.8 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.383 1.073 . . . . 0.0 112.669 -177.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.43 -51.82 67.86 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.138 1.375 . . . . 0.0 112.696 175.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.29 80.16 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.443 1.097 . . . . 0.0 113.283 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.92 -51.4 69.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.884 0.874 . . . . 0.0 112.076 177.5 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 14.0 mm -57.05 -52.55 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.591 1.156 . . . . 0.0 111.351 172.043 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -49.38 -56.07 10.84 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.739 1.216 . . . . 0.0 111.844 176.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -57.79 -51.07 71.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.704 1.201 . . . . 0.0 113.07 176.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 pp -63.8 -47.89 79.06 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.21 0.914 . . . . 0.0 112.35 -175.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -63.34 -38.61 91.83 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.7 0.682 . . . . 0.0 112.68 175.729 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.98 -13.76 60.42 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 174.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.16 -58.19 3.79 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.867 -1.146 . . . . 0.0 111.408 173.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -86.96 -32.58 20.01 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -176.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -111.43 172.25 14.88 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.525 1.536 . . . . 0.0 112.523 176.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 90.8 m -118.15 102.23 8.85 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.802 1.241 . . . . 0.0 109.439 178.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.3 pp -105.94 139.38 40.58 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -169.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -78.4 -45.37 22.52 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 128.686 2.794 . . . . 0.0 110.262 169.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -143.79 143.52 31.39 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.078 1.751 . . . . 0.0 111.506 -174.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.64 119.46 12.56 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.769 1.627 . . . . 0.0 108.587 169.304 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -137.45 104.08 5.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.995 0.918 . . . . 0.0 111.635 -175.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.5 151.68 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.411 1.484 . . . . 0.0 110.216 169.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -46.07 -47.5 17.12 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.903 2.081 . . . . 0.0 116.038 -170.24 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -69.65 142.52 53.42 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.162 0.982 . . . . 0.0 113.603 -171.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -150.89 -108.66 0.06 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.925 2.09 . . . . 0.0 107.52 171.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -52.63 20.29 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 119.846 1.203 . . . . 0.0 108.174 168.15 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.5 m -70.04 151.32 45.66 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.298 1.439 . . . . 0.0 111.423 169.354 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -164.28 52.55 0.29 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.781 0.705 . . . . 0.0 113.884 176.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -72.17 171.37 12.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.266 1.026 . . . . 0.0 111.167 169.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 39.7 m -73.11 69.79 1.05 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.52 1.528 . . . . 0.0 112.601 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.41 -64.1 1.2 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.868 1.667 . . . . 0.0 110.459 176.336 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.74 52.86 6.18 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.044 0.831 . . . . 0.0 112.893 178.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 81.5 p -139.32 165.14 27.99 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.096 1.359 . . . . 0.0 112.49 -175.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -150.29 161.64 42.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.743 1.617 . . . . 0.0 111.926 171.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -128.87 115.05 17.29 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.448 1.499 . . . . 0.0 110.234 174.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 14.3 t -124.89 125.62 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.694 1.198 . . . . 0.0 110.719 -169.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -115.13 127.56 55.65 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.613 1.965 . . . . 0.0 109.888 -171.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -114.12 156.59 23.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 127.68 2.392 . . . . 0.0 112.184 -171.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -58.7 -28.44 65.8 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.762 1.394 . . . . 0.0 114.762 -176.272 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -139.68 149.96 44.32 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.128 2.171 . . . . 0.0 110.618 176.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -57.64 -41.25 81.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.196 1.398 . . . . 0.0 112.142 170.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.04 -48.74 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.478 1.111 . . . . 0.0 112.376 169.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.26 -43.18 99.43 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.177 0.991 . . . . 0.0 112.62 176.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.12 -52.15 64.17 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.084 0.954 . . . . 0.0 111.504 169.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 28.5 mt -56.2 -44.02 79.07 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.69 -1.257 . . . . 0.0 113.715 176.703 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -52.6 -57.52 9.73 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.969 1.259 . . . . 0.0 111.842 171.169 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -52.68 -51.66 59.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.571 1.148 . . . . 0.0 112.0 177.037 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 22.6 ttt -53.87 -63.25 1.21 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.466 1.507 . . . . 0.0 112.168 176.086 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -60.75 -37.88 83.32 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -173.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -68.19 -43.49 77.99 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 113.169 177.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -103.42 -13.37 16.66 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -169.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -59.69 114.31 2.69 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.032 1.287 . . . . 0.0 110.867 169.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 104.34 -22.63 34.0 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 126.006 1.765 . . . . 0.0 114.424 -174.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.4 t -71.31 136.1 84.24 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.772 1.229 . . . . 0.0 110.423 -177.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.27 139.38 29.1 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.943 2.429 . . . . 0.0 112.626 -178.223 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -132.81 109.8 9.9 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.889 2.076 . . . . 0.0 106.871 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 51.65 57.39 6.6 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.145 1.378 . . . . 0.0 110.602 -168.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 79.47 -52.3 4.09 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.934 1.73 . . . . 0.0 113.726 -179.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 49.9 mtp180 -68.79 129.13 92.63 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 126.809 2.044 . . . . 0.0 112.221 -171.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -71.55 125.24 11.01 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.2 2.6 . . . . 0.0 111.722 179.13 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 77.2 mtm -65.96 125.85 26.71 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.522 1.129 . . . . 0.0 112.101 177.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -99.06 112.73 24.78 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.918 1.287 . . . . 0.0 108.788 170.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mt -118.67 132.64 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.48 1.112 . . . . 0.0 111.2 -172.404 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -137.16 126.99 25.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.793 1.637 . . . . 0.0 111.635 -172.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 46.5 tp -67.49 119.01 11.59 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.33 1.052 . . . . 0.0 110.617 172.13 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.96 -51.24 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.888 1.275 . . . . 0.0 110.028 176.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 18.4 p -80.94 82.17 6.99 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.096 1.758 . . . . 0.0 111.471 179.02 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--O 1.25 1.127 0 C-N-CA 126.498 1.919 . . . . 0.0 114.374 -179.619 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.037 0 N-CA-C 112.305 -0.318 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -152.46 125.44 8.53 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.04 0.936 . . . . 0.0 112.177 178.885 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.4 mt -121.1 125.86 48.31 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.988 1.715 . . . . 0.0 112.38 -172.487 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.3 tp -89.01 116.57 27.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.698 1.999 . . . . 0.0 106.096 168.382 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.0 t -112.5 128.09 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.987 1.315 . . . . 0.0 108.12 -176.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.0 m -133.96 163.23 30.0 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.778 1.631 . . . . 0.0 112.478 -169.644 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.0 t30 54.55 35.09 22.66 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.078 2.151 . . . . 0.0 113.369 -169.769 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.41 154.17 37.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.553 1.141 . . . . 0.0 110.314 169.518 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -80.35 150.82 29.75 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -57.97 -25.49 61.09 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.305 1.042 . . . . 0.0 113.437 172.728 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -78.3 -7.47 87.81 Favored Glycine 0 CA--C 1.541 1.688 0 C-N-CA 125.285 1.421 . . . . 0.0 115.953 175.705 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.1 t -63.2 149.86 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 119.437 1.618 . . . . 0.0 111.118 174.529 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 70.5 m -129.57 158.13 40.14 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.603 1.561 . . . . 0.0 111.792 177.419 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.3 -51.26 70.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.247 1.419 . . . . 0.0 112.556 178.998 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.06 86.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.973 0.909 . . . . 0.0 112.749 174.45 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -59.15 -51.33 70.48 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.169 0.988 . . . . 0.0 112.149 176.469 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 15.1 mm -54.68 -53.91 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.533 1.133 . . . . 0.0 111.138 171.074 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -49.96 -57.5 7.39 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.41 1.084 . . . . 0.0 111.603 178.158 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -56.85 -50.85 71.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.251 1.021 . . . . 0.0 113.085 177.004 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.12 -47.8 81.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.106 0.866 . . . . 0.0 112.235 -175.238 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -65.98 -41.66 90.84 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 176.011 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.59 -24.69 65.66 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 176.478 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.8 -54.14 43.58 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.144 -0.972 . . . . 0.0 112.027 174.033 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -98.33 -15.72 19.64 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -173.653 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -142.24 -177.57 17.45 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.575 1.56 . . . . 0.0 113.262 178.851 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.3 m -119.36 94.02 4.28 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.152 0.981 . . . . 0.0 111.264 -177.536 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.9 pp -85.33 157.8 20.45 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.031 0.932 . . . . 0.0 112.263 179.205 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -115.57 -37.11 4.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.575 2.75 . . . . 0.0 111.717 173.676 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -140.54 144.77 36.1 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.034 1.334 . . . . 0.0 111.511 178.091 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -135.51 143.93 46.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.67 1.588 . . . . 0.0 110.53 169.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.34 147.98 26.96 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.766 2.027 . . . . 0.0 109.382 173.396 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 137' ' ' HIS . 1.5 t -125.38 -153.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 124.645 1.178 . . . . 0.0 111.023 -173.714 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.556 ' H ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -66.27 -61.59 1.93 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.763 2.425 . . . . 0.0 112.161 -177.852 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.27 162.03 23.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 127.231 2.212 . . . . 0.0 113.603 172.893 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -144.3 -55.85 0.36 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.354 1.461 . . . . 0.0 110.219 175.377 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -124.36 -65.96 1.01 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.679 1.992 . . . . 0.0 107.512 168.823 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 44.6 m -69.44 151.52 45.99 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.006 1.323 . . . . 0.0 110.891 169.141 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.84 65.23 3.54 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.319 0.962 . . . . 0.0 112.396 173.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -52.41 124.73 14.13 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.472 1.909 . . . . 0.0 112.305 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.5 m -70.52 86.19 0.63 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.694 1.598 . . . . 0.0 111.558 177.64 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 52.0 tp -150.4 156.22 41.06 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.174 2.189 . . . . 0.0 109.507 -176.562 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -127.85 53.29 0.8 Allowed Glycine 0 N--CA 1.472 1.098 0 C-N-CA 124.878 1.228 . . . . 0.0 112.329 179.335 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.5 m -141.31 145.75 35.87 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.339 1.455 . . . . 0.0 111.577 -169.709 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.37 162.3 34.74 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.402 1.881 . . . . 0.0 112.398 174.066 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -137.24 106.95 6.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.991 2.116 . . . . 0.0 109.654 -175.299 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 13.2 t -124.23 126.8 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.168 0.987 . . . . 0.0 109.972 -170.035 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -115.4 144.52 43.67 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.426 1.49 . . . . 0.0 110.21 -175.479 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -132.85 154.44 50.34 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.371 2.269 . . . . 0.0 112.94 -168.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.56 -29.43 70.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 175.241 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -131.24 126.24 34.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.065 1.746 . . . . 0.0 111.393 -173.656 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.6 -43.57 98.62 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.217 1.407 . . . . 0.0 112.508 174.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.01 -48.96 61.32 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.585 1.154 . . . . 0.0 112.772 169.872 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.83 -42.06 97.71 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.626 1.17 . . . . 0.0 112.758 177.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -57.31 -51.52 69.03 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.711 0.805 . . . . 0.0 111.829 169.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 50.5 tp -56.66 -46.81 80.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.074 1.349 . . . . 0.0 112.202 177.408 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -49.45 -57.93 6.09 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.628 1.571 . . . . 0.0 111.318 171.47 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -53.77 -50.36 66.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.614 1.166 . . . . 0.0 112.846 175.554 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 23.7 ttp -51.51 -59.17 4.55 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.137 1.375 . . . . 0.0 111.476 176.348 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -55.93 -46.94 78.33 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.004 1.321 . . . . 0.0 112.412 178.189 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.01 -41.7 97.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.904 1.282 . . . . 0.0 113.538 -178.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -109.19 -15.82 14.22 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -170.248 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -59.82 113.88 2.5 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.229 1.377 . . . . 0.0 110.995 169.803 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.03 -24.15 19.53 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.337 1.922 . . . . 0.0 114.129 -175.688 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t -69.67 128.66 91.9 Favored Pre-proline 0 N--CA 1.477 0.879 0 CA-C-N 118.643 1.221 . . . . 0.0 111.706 -170.746 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.78 123.58 13.56 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 124.121 3.214 . . . . 0.0 114.355 173.883 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 tp -86.96 77.07 9.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.732 1.613 . . . . 0.0 107.482 169.009 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 47.07 36.09 3.95 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.552 1.941 . . . . 0.0 113.504 -169.84 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 143.84 -77.06 0.28 Allowed Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.715 1.626 . . . . 0.0 112.876 -178.617 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -65.4 126.88 92.33 Favored Pre-proline 0 N--CA 1.478 0.967 0 C-N-CA 125.185 1.394 . . . . 0.0 112.302 -176.192 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.3 121.72 7.03 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.725 2.283 . . . . 0.0 111.697 -177.673 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.4 mtm -65.04 142.6 58.36 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.98 0.912 . . . . 0.0 111.4 174.103 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -124.95 125.27 43.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.542 1.137 . . . . 0.0 110.032 176.126 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.1 mt -128.52 137.26 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.171 0.988 . . . . 0.0 110.987 -170.292 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -137.07 125.84 23.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.988 1.715 . . . . 0.0 111.043 -177.873 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.4 tt -80.43 116.27 20.4 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.989 0.916 . . . . 0.0 108.643 169.885 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 20.6 m -96.6 136.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.002 0.921 . . . . 0.0 112.118 -170.608 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.5 p -82.1 153.23 26.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.841 1.256 . . . . 0.0 112.254 176.48 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--O 1.253 1.25 0 C-N-CA 125.77 1.628 . . . . 0.0 112.901 173.83 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.897 0 N-CA-C 112.66 -0.176 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -140.57 133.49 29.19 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.886 1.275 . . . . 0.0 111.191 -176.912 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.5 mt -119.65 122.51 41.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.802 1.641 . . . . 0.0 111.746 176.112 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.4 tp -81.63 129.15 34.59 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.863 1.665 . . . . 0.0 106.852 168.401 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.01 132.86 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.669 1.188 . . . . 0.0 108.87 -176.226 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.9 m -137.46 163.02 32.1 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 126.205 1.802 . . . . 0.0 111.657 -172.229 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.4 t30 47.61 52.39 12.61 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.47 1.908 . . . . 0.0 113.158 -173.585 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 22.4 mt -84.22 168.87 15.32 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.834 1.654 . . . . 0.0 111.254 169.838 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.8 156.05 31.91 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.903 0.859 . . . . 0.0 112.039 169.624 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -77.41 -36.13 53.59 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.758 1.223 . . . . 0.0 112.15 -178.673 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -83.25 53.86 4.91 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.565 1.555 . . . . 0.0 112.539 -178.865 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.5 t -125.03 145.74 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.36 2.264 . . . . 0.0 111.57 -169.913 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 55.0 m -144.3 169.38 18.01 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.139 1.776 . . . . 0.0 111.819 -175.858 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -48.71 -57.82 5.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.773 2.029 . . . . 0.0 112.562 -178.089 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.19 87.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.189 1.395 . . . . 0.0 113.489 177.536 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.0 -52.2 66.39 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.151 0.98 . . . . 0.0 112.265 -179.839 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 36.2 mm -56.64 -52.45 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.882 0.873 . . . . 0.0 110.899 171.248 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -49.33 -56.18 10.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.014 0.926 . . . . 0.0 112.324 178.95 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -57.02 -52.37 65.55 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.853 0.861 . . . . 0.0 112.951 176.823 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.52 -46.43 90.19 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.893 0.77 . . . . 0.0 112.496 -176.851 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -65.09 -47.65 76.48 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.611 0.642 . . . . 0.0 112.438 174.492 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.52 64.7 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.244 1.017 . . . . 0.0 113.352 179.554 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.41 -45.29 72.9 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.43 1.092 . . . . 0.0 113.017 174.763 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -98.13 -19.06 18.15 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -177.41 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -159.98 153.51 24.49 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-N 120.356 1.435 . . . . 0.0 115.326 172.18 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 47.4 m -75.03 129.9 38.4 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.206 1.403 . . . . 0.0 111.42 -174.104 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.1 pp -135.62 147.04 48.49 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.643 1.177 . . . . 0.0 113.531 -174.032 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -73.91 -52.12 13.94 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.979 2.511 . . . . 0.0 110.246 170.03 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -150.07 153.37 36.32 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.144 1.778 . . . . 0.0 111.488 -177.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -141.55 133.82 27.97 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.929 1.691 . . . . 0.0 109.362 169.994 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -148.63 158.85 44.42 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.541 1.136 . . . . 0.0 113.754 -170.005 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.68 129.62 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 127.608 2.363 . . . . 0.0 108.67 169.901 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -68.48 -44.77 74.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.841 0.856 . . . . 0.0 111.822 178.771 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -69.88 154.0 42.54 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.267 1.427 . . . . 0.0 113.054 177.434 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -141.67 -158.3 0.85 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.785 2.034 . . . . 0.0 108.511 173.736 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 15.5 mmp_? -76.61 51.13 0.72 Allowed 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.285 -1.51 . . . . 0.0 111.667 175.188 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.1 m -71.75 -38.71 70.36 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.076 2.151 . . . . 0.0 113.712 -171.051 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.99 -55.25 0.24 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.291 1.9 . . . . 0.0 110.861 -173.506 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.89 98.92 5.11 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.81 2.044 . . . . 0.0 108.231 169.695 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 59.5 m -63.63 128.94 38.06 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.453 0.701 . . . . 0.0 110.388 175.158 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.3 tp -82.4 -152.31 0.1 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.608 1.163 . . . . 0.0 111.229 -179.398 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.58 50.21 0.48 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.387 0.994 . . . . 0.0 112.767 179.06 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.2 m -140.47 121.15 14.31 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.951 1.3 . . . . 0.0 111.528 -171.613 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.09 169.4 14.78 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.31 1.844 . . . . 0.0 113.232 -174.734 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -138.59 123.89 19.3 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.266 1.426 . . . . 0.0 110.832 -178.462 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.1 t -128.09 116.59 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.291 1.036 . . . . 0.0 110.904 -174.377 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -92.68 101.75 14.16 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.35 1.86 . . . . 0.0 108.336 179.062 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -77.38 166.56 22.97 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.653 1.981 . . . . 0.0 113.129 -178.753 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -54.26 -48.25 71.39 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 171.125 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -153.9 136.56 15.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 129.013 2.925 . . . . 0.0 109.516 -171.705 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -60.8 -37.87 83.4 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.086 0.954 . . . . 0.0 113.552 -176.825 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -51.4 -48.64 62.54 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.823 1.249 . . . . 0.0 113.093 169.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.12 -44.31 80.22 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.158 0.983 . . . . 0.0 112.021 173.654 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -51.87 -48.52 64.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.132 1.373 . . . . 0.0 112.853 175.12 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.5 tp -52.16 -43.47 64.12 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.49 1.916 . . . . 0.0 113.075 176.69 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -57.18 -55.19 37.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.111 0.965 . . . . 0.0 111.33 174.42 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.54 78.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.8 1.24 . . . . 0.0 112.55 175.263 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 23.6 ttp -50.61 -59.06 4.44 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.163 1.785 . . . . 0.0 111.272 175.488 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -56.43 -47.5 78.95 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.486 1.114 . . . . 0.0 112.44 177.572 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -58.26 -47.53 83.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.391 1.076 . . . . 0.0 113.279 179.118 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -95.22 -18.87 20.5 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -171.214 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -59.93 109.55 0.97 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 119.797 1.181 . . . . 0.0 110.591 169.684 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 117.25 -30.45 6.26 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.371 1.939 . . . . 0.0 113.714 -174.016 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.28 133.52 93.31 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 125.15 1.38 . . . . 0.0 110.766 -175.241 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.17 143.63 20.24 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.882 2.388 . . . . 0.0 112.94 -177.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 tp -125.29 107.38 10.65 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.85 2.06 . . . . 0.0 107.92 169.744 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 39.71 58.1 2.11 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.264 1.826 . . . . 0.0 112.463 -169.89 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 93.79 -45.4 2.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.122 1.344 . . . . 0.0 114.192 -179.563 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -73.13 116.59 52.3 Favored Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 125.23 1.412 . . . . 0.0 111.377 -171.012 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.8 114.54 3.74 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.68 2.253 . . . . 0.0 110.953 174.892 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.61 138.72 58.56 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.431 1.092 . . . . 0.0 111.754 -178.392 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -118.74 126.93 52.99 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.442 1.497 . . . . 0.0 109.586 175.236 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.6 mt -130.54 138.57 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.012 0.925 . . . . 0.0 111.173 -169.773 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -143.06 126.62 16.87 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.917 1.687 . . . . 0.0 111.518 -173.083 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -73.73 142.14 46.32 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.433 -0.792 . . . . 0.0 111.523 170.139 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.96 172.07 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -172.495 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.1 p -60.9 138.99 58.12 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.208 1.803 . . . . 0.0 112.825 -179.209 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.25 1.108 0 C-N-CA 125.663 1.585 . . . . 0.0 112.111 177.538 . . . . . . . . 0 0 . 1 stop_ save_